Classification | International Glaucoma Review #

List of abstracts related to

25462 Characteristics of respondents with glaucoma and dry eye in a national panel survey
Schmier J K; Covert D W
Clinical Ophthalmology 2009; 3: 645-650

Listed by Classification

2.1 Conjunctiva (1056 abstracts found)

94838 Relationship between OSDI score and biomicroscopic ocular surface damages in glaucomatous patients treated with preserved antiglaucomatous eye drops
Lajmi H
Journal Fran�ais d'Ophtalmologie 2021; 44: 1326-1331 (IGR: 22-2)

94658 Brimonidine related acute follicular conjunctivitis: Onset time and clinical presentations, a long-term follow-up
Yeh PH
Medicine 2021; 100: e26724 (IGR: 22-2)

94856 Risk Factors for Ocular Surface Disease in Tunisian Users of Preserved Antiglaucomatous Eye Drops
Lajmi H
Journal of current ophthalmology 2021; 33: 128-135 (IGR: 22-2)

94658 Brimonidine related acute follicular conjunctivitis: Onset time and clinical presentations, a long-term follow-up
Cheng YC
Medicine 2021; 100: e26724 (IGR: 22-2)

94856 Risk Factors for Ocular Surface Disease in Tunisian Users of Preserved Antiglaucomatous Eye Drops
Hmaied W
Journal of current ophthalmology 2021; 33: 128-135 (IGR: 22-2)

94838 Relationship between OSDI score and biomicroscopic ocular surface damages in glaucomatous patients treated with preserved antiglaucomatous eye drops
Chelly Z
Journal Fran�ais d'Ophtalmologie 2021; 44: 1326-1331 (IGR: 22-2)

94658 Brimonidine related acute follicular conjunctivitis: Onset time and clinical presentations, a long-term follow-up
Shie SS
Medicine 2021; 100: e26724 (IGR: 22-2)

94856 Risk Factors for Ocular Surface Disease in Tunisian Users of Preserved Antiglaucomatous Eye Drops
Achour BB
Journal of current ophthalmology 2021; 33: 128-135 (IGR: 22-2)

94838 Relationship between OSDI score and biomicroscopic ocular surface damages in glaucomatous patients treated with preserved antiglaucomatous eye drops
Choura R
Journal Fran�ais d'Ophtalmologie 2021; 44: 1326-1331 (IGR: 22-2)

94856 Risk Factors for Ocular Surface Disease in Tunisian Users of Preserved Antiglaucomatous Eye Drops
Zahaf A
Journal of current ophthalmology 2021; 33: 128-135 (IGR: 22-2)

94838 Relationship between OSDI score and biomicroscopic ocular surface damages in glaucomatous patients treated with preserved antiglaucomatous eye drops
Mansour KB
Journal Fran�ais d'Ophtalmologie 2021; 44: 1326-1331 (IGR: 22-2)

94658 Brimonidine related acute follicular conjunctivitis: Onset time and clinical presentations, a long-term follow-up
Lee YS; Shen SC
Medicine 2021; 100: e26724 (IGR: 22-2)

94838 Relationship between OSDI score and biomicroscopic ocular surface damages in glaucomatous patients treated with preserved antiglaucomatous eye drops
Hmaied W
Journal Fran�ais d'Ophtalmologie 2021; 44: 1326-1331 (IGR: 22-2)

94658 Brimonidine related acute follicular conjunctivitis: Onset time and clinical presentations, a long-term follow-up
Chen HS; Wu WC; Su WW
Medicine 2021; 100: e26724 (IGR: 22-2)

92109 Corneal epithelium and limbal region alterations due to glaucoma medications evaluated by anterior segment optic coherence tomography: a case-control study
Güçlü H
Cutaneous and Ocular Toxicology 2021; 40: 85-94 (IGR: 22-1)

92698 Critical role of mass spectrometry proteomics in tear biomarker discovery for multifactorial ocular diseases (Review)
Ma JYW
International Journal of Molecular Medicine 2021; 47: (IGR: 22-1)

92071 New strategies for the management of ocular surface disease in glaucoma patients
Voicu L
Current Opinions in Ophthalmology 2021; 32: 134-140 (IGR: 22-1)

92408 Effect of steroid eyedrops after trabeculectomy in glaucoma patients: a keratograph analysis
Fares NT
Arquivos Brasileiros de Oftalmologia 2021; 84: 345-351 (IGR: 22-1)

92623 TGFβ1, MMPs and cytokines profiles in ocular surface: Possible tear biomarkers for pseudoexfoliation
Sahay P
PLoS ONE 2021; 16: e0249759 (IGR: 22-1)

92384 Tear Film Cytokine Profile of Patients With the Boston Keratoprosthesis Type 1: Comparing Patients With and Without Glaucoma
Geoffrion D
Investigative Ophthalmology and Visual Science 2021; 62: 20 (IGR: 22-1)

92066 Dry eye disease among Glaucoma patients on topical hypotensive medications, in a tertiary hospital, Ethiopia
Sahlu M
BMC Ophthalmology 2021; 21: 155 (IGR: 22-1)

92698 Critical role of mass spectrometry proteomics in tear biomarker discovery for multifactorial ocular diseases (Review)
Sze YH
International Journal of Molecular Medicine 2021; 47: (IGR: 22-1)

92066 Dry eye disease among Glaucoma patients on topical hypotensive medications, in a tertiary hospital, Ethiopia
Giorgis AT
BMC Ophthalmology 2021; 21: 155 (IGR: 22-1)

92623 TGFβ1, MMPs and cytokines profiles in ocular surface: Possible tear biomarkers for pseudoexfoliation
Reddy S
PLoS ONE 2021; 16: e0249759 (IGR: 22-1)

92384 Tear Film Cytokine Profile of Patients With the Boston Keratoprosthesis Type 1: Comparing Patients With and Without Glaucoma
Robert MC
Investigative Ophthalmology and Visual Science 2021; 62: 20 (IGR: 22-1)

92109 Corneal epithelium and limbal region alterations due to glaucoma medications evaluated by anterior segment optic coherence tomography: a case-control study
Çınar AK
Cutaneous and Ocular Toxicology 2021; 40: 85-94 (IGR: 22-1)

92071 New strategies for the management of ocular surface disease in glaucoma patients
Salim S
Current Opinions in Ophthalmology 2021; 32: 134-140 (IGR: 22-1)

92408 Effect of steroid eyedrops after trabeculectomy in glaucoma patients: a keratograph analysis
Portela RC; Machado LF
Arquivos Brasileiros de Oftalmologia 2021; 84: 345-351 (IGR: 22-1)

92623 TGFβ1, MMPs and cytokines profiles in ocular surface: Possible tear biomarkers for pseudoexfoliation
Prusty BK
PLoS ONE 2021; 16: e0249759 (IGR: 22-1)

92384 Tear Film Cytokine Profile of Patients With the Boston Keratoprosthesis Type 1: Comparing Patients With and Without Glaucoma
Di Polo A
Investigative Ophthalmology and Visual Science 2021; 62: 20 (IGR: 22-1)

92698 Critical role of mass spectrometry proteomics in tear biomarker discovery for multifactorial ocular diseases (Review)
Bian JF
International Journal of Molecular Medicine 2021; 47: (IGR: 22-1)

92109 Corneal epithelium and limbal region alterations due to glaucoma medications evaluated by anterior segment optic coherence tomography: a case-control study
Çınar AC
Cutaneous and Ocular Toxicology 2021; 40: 85-94 (IGR: 22-1)

92384 Tear Film Cytokine Profile of Patients With the Boston Keratoprosthesis Type 1: Comparing Patients With and Without Glaucoma
Koenekoop RK
Investigative Ophthalmology and Visual Science 2021; 62: 20 (IGR: 22-1)

92109 Corneal epithelium and limbal region alterations due to glaucoma medications evaluated by anterior segment optic coherence tomography: a case-control study
Akaray İ
Cutaneous and Ocular Toxicology 2021; 40: 85-94 (IGR: 22-1)

92408 Effect of steroid eyedrops after trabeculectomy in glaucoma patients: a keratograph analysis
Polizelli M
Arquivos Brasileiros de Oftalmologia 2021; 84: 345-351 (IGR: 22-1)

92623 TGFβ1, MMPs and cytokines profiles in ocular surface: Possible tear biomarkers for pseudoexfoliation
Modak R
PLoS ONE 2021; 16: e0249759 (IGR: 22-1)

92698 Critical role of mass spectrometry proteomics in tear biomarker discovery for multifactorial ocular diseases (Review)
Lam TC
International Journal of Molecular Medicine 2021; 47: (IGR: 22-1)

92408 Effect of steroid eyedrops after trabeculectomy in glaucoma patients: a keratograph analysis
Freitas D
Arquivos Brasileiros de Oftalmologia 2021; 84: 345-351 (IGR: 22-1)

92623 TGFβ1, MMPs and cytokines profiles in ocular surface: Possible tear biomarkers for pseudoexfoliation
Rao A
PLoS ONE 2021; 16: e0249759 (IGR: 22-1)

92109 Corneal epithelium and limbal region alterations due to glaucoma medications evaluated by anterior segment optic coherence tomography: a case-control study
Şambel Aykutlu M
Cutaneous and Ocular Toxicology 2021; 40: 85-94 (IGR: 22-1)

92384 Tear Film Cytokine Profile of Patients With the Boston Keratoprosthesis Type 1: Comparing Patients With and Without Glaucoma
Agoumi Y
Investigative Ophthalmology and Visual Science 2021; 62: 20 (IGR: 22-1)

92109 Corneal epithelium and limbal region alterations due to glaucoma medications evaluated by anterior segment optic coherence tomography: a case-control study
Sakallıoğlu AK
Cutaneous and Ocular Toxicology 2021; 40: 85-94 (IGR: 22-1)

92408 Effect of steroid eyedrops after trabeculectomy in glaucoma patients: a keratograph analysis
Paranhos A
Arquivos Brasileiros de Oftalmologia 2021; 84: 345-351 (IGR: 22-1)

92384 Tear Film Cytokine Profile of Patients With the Boston Keratoprosthesis Type 1: Comparing Patients With and Without Glaucoma
Harissi-Dagher M
Investigative Ophthalmology and Visual Science 2021; 62: 20 (IGR: 22-1)

92408 Effect of steroid eyedrops after trabeculectomy in glaucoma patients: a keratograph analysis
Prata TS
Arquivos Brasileiros de Oftalmologia 2021; 84: 345-351 (IGR: 22-1)

92109 Corneal epithelium and limbal region alterations due to glaucoma medications evaluated by anterior segment optic coherence tomography: a case-control study
Gürlü V
Cutaneous and Ocular Toxicology 2021; 40: 85-94 (IGR: 22-1)

92408 Effect of steroid eyedrops after trabeculectomy in glaucoma patients: a keratograph analysis
Gracitelli CPB
Arquivos Brasileiros de Oftalmologia 2021; 84: 345-351 (IGR: 22-1)

91447 Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients
Ruangvaravate N
Clinical Ophthalmology 2020; 14: 3109-3119 (IGR: 21-4)

91070 Comparative analysis of ocular redness score evaluated automatically in glaucoma patients under different topical medications
Giannaccare G
European Journal of Ophthalmology 2020; 0: 1120672120969612 (IGR: 21-4)

91819 Topical preservative-free ophthalmic treatments: an unmet clinical need
Figus M
Expert Opinion on Drug Delivery 2020; 0: 1-18 (IGR: 21-4)

91833 Short-Term Effects of Different Types of Anti-Glaucoma Eyedrop on the Sclero-Conjunctival Vasculature Assessed Using Anterior Segment OCTA in Normal Human Eyes: A Pilot Study
Akagi T
Journal of clinical medicine 2020; 9: (IGR: 21-4)

91624 Signs and Symptoms of Ocular Surface Disease: The Reasons for Patient Dissatisfaction with Glaucoma Treatments
Stalmans I
Clinical Ophthalmology 2020; 14: 3675-3680 (IGR: 21-4)

91073 Comparison of Clinical Outcomes with Open Versus Closed Conjunctiva Implantation of the XEN45 Gel Stent
Do A
Ophthalmology. Glaucoma 2021; 4: 343-349 (IGR: 21-4)

91141 A Tenon's capsule/bulbar conjunctiva interface biomimetic to model fibrosis and local drug delivery
Kozdon K
PLoS ONE 2020; 15: e0241569 (IGR: 21-4)

91342 THE EFFECT OF THERAPY ON THE OCULAR SURFACE IN PATIENTS WITH UNILATERAL PEDIATRIC GLAUCOMA Purpose: The aim of the study was to evaluate ocular surface and
Janderová M
?eska a Slovenska Oftalmologie 2021; 77: 28-34 (IGR: 21-4)

91648 Assessment of ocular surface disease in glaucoma patients with benzalkonium chloride-preserved latanoprost eye drops: a short-term longitudinal study
Su CC
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 1243-1251 (IGR: 21-4)

91202 Effect of Autologous Serum Eyedrops on Ocular Surface Disease Caused by Preserved Glaucoma Eyedrops
So HR
Journal of clinical medicine 2020; 9: (IGR: 21-4)

91240 A Case of Primary Open-angle Glaucoma With Conjunctival Laceration After Micropulse Transscleral Cyclophotocoagulation
Kiyama Y
Journal of Glaucoma 2020; 29: e135-e137 (IGR: 21-4)

91260 Assessment of Ocular Surface Disease in Glaucoma Patients in Ghana
Kobia-Acquah E
Journal of Glaucoma 2021; 30: 180-186 (IGR: 21-4)

90945 Management of Ocular Surface Disease in Glaucoma: A Survey of Canadian Glaucoma Specialists
Muzychuk A
Journal of Glaucoma 2020; 29: 1162-1172 (IGR: 21-4)

91202 Effect of Autologous Serum Eyedrops on Ocular Surface Disease Caused by Preserved Glaucoma Eyedrops
Park HYL
Journal of clinical medicine 2020; 9: (IGR: 21-4)

91447 Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients
Choojun K
Clinical Ophthalmology 2020; 14: 3109-3119 (IGR: 21-4)

91624 Signs and Symptoms of Ocular Surface Disease: The Reasons for Patient Dissatisfaction with Glaucoma Treatments
Lemij H
Clinical Ophthalmology 2020; 14: 3675-3680 (IGR: 21-4)

90945 Management of Ocular Surface Disease in Glaucoma: A Survey of Canadian Glaucoma Specialists
Racine L
Journal of Glaucoma 2020; 29: 1162-1172 (IGR: 21-4)

91819 Topical preservative-free ophthalmic treatments: an unmet clinical need
Agnifili L
Expert Opinion on Drug Delivery 2020; 0: 1-18 (IGR: 21-4)

91070 Comparative analysis of ocular redness score evaluated automatically in glaucoma patients under different topical medications
Pellegrini M
European Journal of Ophthalmology 2020; 0: 1120672120969612 (IGR: 21-4)

91648 Assessment of ocular surface disease in glaucoma patients with benzalkonium chloride-preserved latanoprost eye drops: a short-term longitudinal study
Lee YC
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 1243-1251 (IGR: 21-4)

91141 A Tenon's capsule/bulbar conjunctiva interface biomimetic to model fibrosis and local drug delivery
Caridi B
PLoS ONE 2020; 15: e0241569 (IGR: 21-4)

91833 Short-Term Effects of Different Types of Anti-Glaucoma Eyedrop on the Sclero-Conjunctival Vasculature Assessed Using Anterior Segment OCTA in Normal Human Eyes: A Pilot Study
Okamoto Y
Journal of clinical medicine 2020; 9: (IGR: 21-4)

91342 THE EFFECT OF THERAPY ON THE OCULAR SURFACE IN PATIENTS WITH UNILATERAL PEDIATRIC GLAUCOMA Purpose: The aim of the study was to evaluate ocular surface and
Filouš A
?eska a Slovenska Oftalmologie 2021; 77: 28-34 (IGR: 21-4)

91073 Comparison of Clinical Outcomes with Open Versus Closed Conjunctiva Implantation of the XEN45 Gel Stent
McGlumphy E
Ophthalmology. Glaucoma 2021; 4: 343-349 (IGR: 21-4)

91240 A Case of Primary Open-angle Glaucoma With Conjunctival Laceration After Micropulse Transscleral Cyclophotocoagulation
Nakashima KI
Journal of Glaucoma 2020; 29: e135-e137 (IGR: 21-4)

91260 Assessment of Ocular Surface Disease in Glaucoma Patients in Ghana
Gyekye GA
Journal of Glaucoma 2021; 30: 180-186 (IGR: 21-4)

91648 Assessment of ocular surface disease in glaucoma patients with benzalkonium chloride-preserved latanoprost eye drops: a short-term longitudinal study
Lee PRC
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 1243-1251 (IGR: 21-4)

91240 A Case of Primary Open-angle Glaucoma With Conjunctival Laceration After Micropulse Transscleral Cyclophotocoagulation
Inoue T
Journal of Glaucoma 2020; 29: e135-e137 (IGR: 21-4)

91070 Comparative analysis of ocular redness score evaluated automatically in glaucoma patients under different topical medications
Bernabei F
European Journal of Ophthalmology 2020; 0: 1120672120969612 (IGR: 21-4)

90945 Management of Ocular Surface Disease in Glaucoma: A Survey of Canadian Glaucoma Specialists
Robert MC
Journal of Glaucoma 2020; 29: 1162-1172 (IGR: 21-4)

91819 Topical preservative-free ophthalmic treatments: an unmet clinical need
Lanzini M
Expert Opinion on Drug Delivery 2020; 0: 1-18 (IGR: 21-4)

91141 A Tenon's capsule/bulbar conjunctiva interface biomimetic to model fibrosis and local drug delivery
Duru I
PLoS ONE 2020; 15: e0241569 (IGR: 21-4)

91624 Signs and Symptoms of Ocular Surface Disease: The Reasons for Patient Dissatisfaction with Glaucoma Treatments
Clarke J
Clinical Ophthalmology 2020; 14: 3675-3680 (IGR: 21-4)

91342 THE EFFECT OF THERAPY ON THE OCULAR SURFACE IN PATIENTS WITH UNILATERAL PEDIATRIC GLAUCOMA Purpose: The aim of the study was to evaluate ocular surface and
Hložánek M
?eska a Slovenska Oftalmologie 2021; 77: 28-34 (IGR: 21-4)

91073 Comparison of Clinical Outcomes with Open Versus Closed Conjunctiva Implantation of the XEN45 Gel Stent
Shukla A
Ophthalmology. Glaucoma 2021; 4: 343-349 (IGR: 21-4)

91447 Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients
Srikulsasitorn B
Clinical Ophthalmology 2020; 14: 3109-3119 (IGR: 21-4)

91202 Effect of Autologous Serum Eyedrops on Ocular Surface Disease Caused by Preserved Glaucoma Eyedrops
Chung SH
Journal of clinical medicine 2020; 9: (IGR: 21-4)

91260 Assessment of Ocular Surface Disease in Glaucoma Patients in Ghana
Antwi-Adjei EK
Journal of Glaucoma 2021; 30: 180-186 (IGR: 21-4)

91833 Short-Term Effects of Different Types of Anti-Glaucoma Eyedrop on the Sclero-Conjunctival Vasculature Assessed Using Anterior Segment OCTA in Normal Human Eyes: A Pilot Study
Kameda T
Journal of clinical medicine 2020; 9: (IGR: 21-4)

91141 A Tenon's capsule/bulbar conjunctiva interface biomimetic to model fibrosis and local drug delivery
Ezra DG
PLoS ONE 2020; 15: e0241569 (IGR: 21-4)

91833 Short-Term Effects of Different Types of Anti-Glaucoma Eyedrop on the Sclero-Conjunctival Vasculature Assessed Using Anterior Segment OCTA in Normal Human Eyes: A Pilot Study
Suda K
Journal of clinical medicine 2020; 9: (IGR: 21-4)

91260 Assessment of Ocular Surface Disease in Glaucoma Patients in Ghana
Koomson NY
Journal of Glaucoma 2021; 30: 180-186 (IGR: 21-4)

90945 Management of Ocular Surface Disease in Glaucoma: A Survey of Canadian Glaucoma Specialists
Birt C
Journal of Glaucoma 2020; 29: 1162-1172 (IGR: 21-4)

91070 Comparative analysis of ocular redness score evaluated automatically in glaucoma patients under different topical medications
Senni C
European Journal of Ophthalmology 2020; 0: 1120672120969612 (IGR: 21-4)

91342 THE EFFECT OF THERAPY ON THE OCULAR SURFACE IN PATIENTS WITH UNILATERAL PEDIATRIC GLAUCOMA Purpose: The aim of the study was to evaluate ocular surface and
Dotřelová D
?eska a Slovenska Oftalmologie 2021; 77: 28-34 (IGR: 21-4)

91447 Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients
Chokboonpiem J
Clinical Ophthalmology 2020; 14: 3109-3119 (IGR: 21-4)

91202 Effect of Autologous Serum Eyedrops on Ocular Surface Disease Caused by Preserved Glaucoma Eyedrops
Kim HS
Journal of clinical medicine 2020; 9: (IGR: 21-4)

91073 Comparison of Clinical Outcomes with Open Versus Closed Conjunctiva Implantation of the XEN45 Gel Stent
Dangda S
Ophthalmology. Glaucoma 2021; 4: 343-349 (IGR: 21-4)

91819 Topical preservative-free ophthalmic treatments: an unmet clinical need
Brescia L
Expert Opinion on Drug Delivery 2020; 0: 1-18 (IGR: 21-4)

91624 Signs and Symptoms of Ocular Surface Disease: The Reasons for Patient Dissatisfaction with Glaucoma Treatments
Baudouin C;
Clinical Ophthalmology 2020; 14: 3675-3680 (IGR: 21-4)

91819 Topical preservative-free ophthalmic treatments: an unmet clinical need
Sartini F
Expert Opinion on Drug Delivery 2020; 0: 1-18 (IGR: 21-4)

91202 Effect of Autologous Serum Eyedrops on Ocular Surface Disease Caused by Preserved Glaucoma Eyedrops
Byun YS
Journal of clinical medicine 2020; 9: (IGR: 21-4)

91342 THE EFFECT OF THERAPY ON THE OCULAR SURFACE IN PATIENTS WITH UNILATERAL PEDIATRIC GLAUCOMA Purpose: The aim of the study was to evaluate ocular surface and
Mahelková G
?eska a Slovenska Oftalmologie 2021; 77: 28-34 (IGR: 21-4)

91070 Comparative analysis of ocular redness score evaluated automatically in glaucoma patients under different topical medications
Aloi M
European Journal of Ophthalmology 2020; 0: 1120672120969612 (IGR: 21-4)

91260 Assessment of Ocular Surface Disease in Glaucoma Patients in Ghana
Cobbina F
Journal of Glaucoma 2021; 30: 180-186 (IGR: 21-4)

91819 Topical preservative-free ophthalmic treatments: an unmet clinical need
Sartini F
Expert Opinion on Drug Delivery 2020; 0: 1-18 (IGR: 21-4)

91833 Short-Term Effects of Different Types of Anti-Glaucoma Eyedrop on the Sclero-Conjunctival Vasculature Assessed Using Anterior Segment OCTA in Normal Human Eyes: A Pilot Study
Nakanishi H
Journal of clinical medicine 2020; 9: (IGR: 21-4)

91447 Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients
Asanatong D
Clinical Ophthalmology 2020; 14: 3109-3119 (IGR: 21-4)

91073 Comparison of Clinical Outcomes with Open Versus Closed Conjunctiva Implantation of the XEN45 Gel Stent
Schuman JS
Ophthalmology. Glaucoma 2021; 4: 343-349 (IGR: 21-4)

90945 Management of Ocular Surface Disease in Glaucoma: A Survey of Canadian Glaucoma Specialists
Penner V
Journal of Glaucoma 2020; 29: 1162-1172 (IGR: 21-4)

91819 Topical preservative-free ophthalmic treatments: an unmet clinical need
Sartini F
Expert Opinion on Drug Delivery 2020; 0: 1-18 (IGR: 21-4)

91141 A Tenon's capsule/bulbar conjunctiva interface biomimetic to model fibrosis and local drug delivery
Phillips JB
PLoS ONE 2020; 15: e0241569 (IGR: 21-4)

91833 Short-Term Effects of Different Types of Anti-Glaucoma Eyedrop on the Sclero-Conjunctival Vasculature Assessed Using Anterior Segment OCTA in Normal Human Eyes: A Pilot Study
Miyake M
Journal of clinical medicine 2020; 9: (IGR: 21-4)

91260 Assessment of Ocular Surface Disease in Glaucoma Patients in Ghana
Donkor R
Journal of Glaucoma 2021; 30: 180-186 (IGR: 21-4)

91073 Comparison of Clinical Outcomes with Open Versus Closed Conjunctiva Implantation of the XEN45 Gel Stent
Boland MV
Ophthalmology. Glaucoma 2021; 4: 343-349 (IGR: 21-4)

91141 A Tenon's capsule/bulbar conjunctiva interface biomimetic to model fibrosis and local drug delivery
Bailly M
PLoS ONE 2020; 15: e0241569 (IGR: 21-4)

90945 Management of Ocular Surface Disease in Glaucoma: A Survey of Canadian Glaucoma Specialists
Harasymowycz P
Journal of Glaucoma 2020; 29: 1162-1172 (IGR: 21-4)

91447 Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients
Trakanwitthayarak S
Clinical Ophthalmology 2020; 14: 3109-3119 (IGR: 21-4)

91070 Comparative analysis of ocular redness score evaluated automatically in glaucoma patients under different topical medications
Scalzo GC
European Journal of Ophthalmology 2020; 0: 1120672120969612 (IGR: 21-4)

91819 Topical preservative-free ophthalmic treatments: an unmet clinical need
Mastropasqua L
Expert Opinion on Drug Delivery 2020; 0: 1-18 (IGR: 21-4)

91833 Short-Term Effects of Different Types of Anti-Glaucoma Eyedrop on the Sclero-Conjunctival Vasculature Assessed Using Anterior Segment OCTA in Normal Human Eyes: A Pilot Study
Ikeda HO
Journal of clinical medicine 2020; 9: (IGR: 21-4)

91260 Assessment of Ocular Surface Disease in Glaucoma Patients in Ghana
Akowuah PK
Journal of Glaucoma 2021; 30: 180-186 (IGR: 21-4)

91073 Comparison of Clinical Outcomes with Open Versus Closed Conjunctiva Implantation of the XEN45 Gel Stent
Yohannan J
Ophthalmology. Glaucoma 2021; 4: 343-349 (IGR: 21-4)

91819 Topical preservative-free ophthalmic treatments: an unmet clinical need
Posarelli C
Expert Opinion on Drug Delivery 2020; 0: 1-18 (IGR: 21-4)

90945 Management of Ocular Surface Disease in Glaucoma: A Survey of Canadian Glaucoma Specialists
Crichton A
Journal of Glaucoma 2020; 29: 1162-1172 (IGR: 21-4)

91070 Comparative analysis of ocular redness score evaluated automatically in glaucoma patients under different topical medications
Ceravolo D
European Journal of Ophthalmology 2020; 0: 1120672120969612 (IGR: 21-4)

91073 Comparison of Clinical Outcomes with Open Versus Closed Conjunctiva Implantation of the XEN45 Gel Stent
Panarelli JF
Ophthalmology. Glaucoma 2021; 4: 343-349 (IGR: 21-4)

90945 Management of Ocular Surface Disease in Glaucoma: A Survey of Canadian Glaucoma Specialists
Ford B; Ford B
Journal of Glaucoma 2020; 29: 1162-1172 (IGR: 21-4)

91833 Short-Term Effects of Different Types of Anti-Glaucoma Eyedrop on the Sclero-Conjunctival Vasculature Assessed Using Anterior Segment OCTA in Normal Human Eyes: A Pilot Study
Yamada T
Journal of clinical medicine 2020; 9: (IGR: 21-4)

91070 Comparative analysis of ocular redness score evaluated automatically in glaucoma patients under different topical medications
Iovino C; Scorcia V
European Journal of Ophthalmology 2020; 0: 1120672120969612 (IGR: 21-4)

91833 Short-Term Effects of Different Types of Anti-Glaucoma Eyedrop on the Sclero-Conjunctival Vasculature Assessed Using Anterior Segment OCTA in Normal Human Eyes: A Pilot Study
Kadomoto S
Journal of clinical medicine 2020; 9: (IGR: 21-4)

91073 Comparison of Clinical Outcomes with Open Versus Closed Conjunctiva Implantation of the XEN45 Gel Stent
Craven ER
Ophthalmology. Glaucoma 2021; 4: 343-349 (IGR: 21-4)

90945 Management of Ocular Surface Disease in Glaucoma: A Survey of Canadian Glaucoma Specialists
Gooi P; Harissi-Dagher M
Journal of Glaucoma 2020; 29: 1162-1172 (IGR: 21-4)

91833 Short-Term Effects of Different Types of Anti-Glaucoma Eyedrop on the Sclero-Conjunctival Vasculature Assessed Using Anterior Segment OCTA in Normal Human Eyes: A Pilot Study
Uji A; Tsujikawa A
Journal of clinical medicine 2020; 9: (IGR: 21-4)

90502 The Efficacy Between Conventional Lid Hygiene and Additional Thermal Pulsatile System in Meibomian Gland Dysfunction Patients Treated with Long-Term Anti-Glaucoma Medications in a Randomized Controlled Trial
Kasetsuwan N
Clinical Ophthalmology 2020; 14: 2891-2902 (IGR: 21-3)

90439 Comparison of inferior conjunctival autografting and conjunctival tissue grafting from pterygium itself in the cases of filtering blebs and glaucoma suspects-A retrospective analysis
Kodavoor SK
Indian Journal of Ophthalmology 2020; 68: 2084-2087 (IGR: 21-3)

90459 Profiling ocular surface responses to preserved and non-preserved topical glaucoma medications: A 2-year randomized evaluation study
Mohammed I
Clinical and Experimental Ophthalmology 2020; 48: 973-982 (IGR: 21-3)

90799 Conjunctival thickness as a predictive imaging biomarker for the glaucoma filtration surgery outcome: An optical coherence tomography study
Mastropasqua L
Clinical and Experimental Ophthalmology 2020; 48: 1192-1200 (IGR: 21-3)

90473 Effect of Long-Term Topical Antiglaucoma Medication Use on the Ocular Surface
Awe OO
Nigerian medical journal : journal of the Nigeria Medical Association 2020; 61: 184-188 (IGR: 21-3)

90711 The effect of successful trabeculectomy on the ocular surface and tear proteomics-a prospective cohort study with 1-year follow-up
Vaajanen A
Acta Ophthalmologica 2021; 99: 160-170 (IGR: 21-3)

90855 Prospective Interventional Cohort Study of Ocular Surface Disease Changes in Eyes After Trabecular Micro-Bypass Stent(s) Implantation (iStent or iStent inject) with Phacoemulsification
Schweitzer JA
Ophthalmology and therapy 2020; 9: 941-953 (IGR: 21-3)

90275 Late-onset Subconjunctival Abscess Secondary to Serratia marcescens Associated With Unexposed Ahmed Glaucoma Valve Implant
Sosuan GMN
Journal of Glaucoma 2020; 29: e110-e112 (IGR: 21-3)

90252 Conjunctival structure of glaucomatous eyes treated with anti-glaucoma eye drops: a cross-sectional study using anterior segment optical coherence tomography
Gozawa M
BMC Ophthalmology 2020; 20: 244 (IGR: 21-3)

90507 The protective effect of 3% diquafosol on meibomian gland morphology in glaucoma patients treated with prostaglandin analogs: a 12-month follow-up study
Guo Y; Ha JY
BMC Ophthalmology 2020; 20: 277 (IGR: 21-3)

90252 Conjunctival structure of glaucomatous eyes treated with anti-glaucoma eye drops: a cross-sectional study using anterior segment optical coherence tomography
Takamura Y
BMC Ophthalmology 2020; 20: 244 (IGR: 21-3)

90459 Profiling ocular surface responses to preserved and non-preserved topical glaucoma medications: A 2-year randomized evaluation study
Kulkarni B
Clinical and Experimental Ophthalmology 2020; 48: 973-982 (IGR: 21-3)

90502 The Efficacy Between Conventional Lid Hygiene and Additional Thermal Pulsatile System in Meibomian Gland Dysfunction Patients Treated with Long-Term Anti-Glaucoma Medications in a Randomized Controlled Trial
Suwajanakorn D
Clinical Ophthalmology 2020; 14: 2891-2902 (IGR: 21-3)

90711 The effect of successful trabeculectomy on the ocular surface and tear proteomics-a prospective cohort study with 1-year follow-up
Nättinen J
Acta Ophthalmologica 2021; 99: 160-170 (IGR: 21-3)

90799 Conjunctival thickness as a predictive imaging biomarker for the glaucoma filtration surgery outcome: An optical coherence tomography study
Brescia L
Clinical and Experimental Ophthalmology 2020; 48: 1192-1200 (IGR: 21-3)

90439 Comparison of inferior conjunctival autografting and conjunctival tissue grafting from pterygium itself in the cases of filtering blebs and glaucoma suspects-A retrospective analysis
Soundarya B
Indian Journal of Ophthalmology 2020; 68: 2084-2087 (IGR: 21-3)

90473 Effect of Long-Term Topical Antiglaucoma Medication Use on the Ocular Surface
Onakpoya OH
Nigerian medical journal : journal of the Nigeria Medical Association 2020; 61: 184-188 (IGR: 21-3)

90855 Prospective Interventional Cohort Study of Ocular Surface Disease Changes in Eyes After Trabecular Micro-Bypass Stent(s) Implantation (iStent or iStent inject) with Phacoemulsification
Hauser WH
Ophthalmology and therapy 2020; 9: 941-953 (IGR: 21-3)

90275 Late-onset Subconjunctival Abscess Secondary to Serratia marcescens Associated With Unexposed Ahmed Glaucoma Valve Implant
Leuenberger EU
Journal of Glaucoma 2020; 29: e110-e112 (IGR: 21-3)

90711 The effect of successful trabeculectomy on the ocular surface and tear proteomics-a prospective cohort study with 1-year follow-up
Aapola U
Acta Ophthalmologica 2021; 99: 160-170 (IGR: 21-3)

90855 Prospective Interventional Cohort Study of Ocular Surface Disease Changes in Eyes After Trabecular Micro-Bypass Stent(s) Implantation (iStent or iStent inject) with Phacoemulsification
Ibach M
Ophthalmology and therapy 2020; 9: 941-953 (IGR: 21-3)

90502 The Efficacy Between Conventional Lid Hygiene and Additional Thermal Pulsatile System in Meibomian Gland Dysfunction Patients Treated with Long-Term Anti-Glaucoma Medications in a Randomized Controlled Trial
Tantipat C
Clinical Ophthalmology 2020; 14: 2891-2902 (IGR: 21-3)

90439 Comparison of inferior conjunctival autografting and conjunctival tissue grafting from pterygium itself in the cases of filtering blebs and glaucoma suspects-A retrospective analysis
Dandapani R
Indian Journal of Ophthalmology 2020; 68: 2084-2087 (IGR: 21-3)

90252 Conjunctival structure of glaucomatous eyes treated with anti-glaucoma eye drops: a cross-sectional study using anterior segment optical coherence tomography
Iwasaki K
BMC Ophthalmology 2020; 20: 244 (IGR: 21-3)

90473 Effect of Long-Term Topical Antiglaucoma Medication Use on the Ocular Surface
Adeoye AO
Nigerian medical journal : journal of the Nigeria Medical Association 2020; 61: 184-188 (IGR: 21-3)

90507 The protective effect of 3% diquafosol on meibomian gland morphology in glaucoma patients treated with prostaglandin analogs: a 12-month follow-up study
Piao HL
BMC Ophthalmology 2020; 20: 277 (IGR: 21-3)

90799 Conjunctival thickness as a predictive imaging biomarker for the glaucoma filtration surgery outcome: An optical coherence tomography study
Oddone F
Clinical and Experimental Ophthalmology 2020; 48: 1192-1200 (IGR: 21-3)

90459 Profiling ocular surface responses to preserved and non-preserved topical glaucoma medications: A 2-year randomized evaluation study
Faraj LA
Clinical and Experimental Ophthalmology 2020; 48: 973-982 (IGR: 21-3)

90799 Conjunctival thickness as a predictive imaging biomarker for the glaucoma filtration surgery outcome: An optical coherence tomography study
Sacchi M
Clinical and Experimental Ophthalmology 2020; 48: 1192-1200 (IGR: 21-3)

90252 Conjunctival structure of glaucomatous eyes treated with anti-glaucoma eye drops: a cross-sectional study using anterior segment optical coherence tomography
Arimura S
BMC Ophthalmology 2020; 20: 244 (IGR: 21-3)

90507 The protective effect of 3% diquafosol on meibomian gland morphology in glaucoma patients treated with prostaglandin analogs: a 12-month follow-up study
Sung MS
BMC Ophthalmology 2020; 20: 277 (IGR: 21-3)

90711 The effect of successful trabeculectomy on the ocular surface and tear proteomics-a prospective cohort study with 1-year follow-up
Gielen F
Acta Ophthalmologica 2021; 99: 160-170 (IGR: 21-3)

90459 Profiling ocular surface responses to preserved and non-preserved topical glaucoma medications: A 2-year randomized evaluation study
Abbas A
Clinical and Experimental Ophthalmology 2020; 48: 973-982 (IGR: 21-3)

90502 The Efficacy Between Conventional Lid Hygiene and Additional Thermal Pulsatile System in Meibomian Gland Dysfunction Patients Treated with Long-Term Anti-Glaucoma Medications in a Randomized Controlled Trial
Reinprayoon U
Clinical Ophthalmology 2020; 14: 2891-2902 (IGR: 21-3)

90855 Prospective Interventional Cohort Study of Ocular Surface Disease Changes in Eyes After Trabecular Micro-Bypass Stent(s) Implantation (iStent or iStent inject) with Phacoemulsification
Baartman B
Ophthalmology and therapy 2020; 9: 941-953 (IGR: 21-3)

90799 Conjunctival thickness as a predictive imaging biomarker for the glaucoma filtration surgery outcome: An optical coherence tomography study
Aloia R
Clinical and Experimental Ophthalmology 2020; 48: 1192-1200 (IGR: 21-3)

90855 Prospective Interventional Cohort Study of Ocular Surface Disease Changes in Eyes After Trabecular Micro-Bypass Stent(s) Implantation (iStent or iStent inject) with Phacoemulsification
Gollamudi SR
Ophthalmology and therapy 2020; 9: 941-953 (IGR: 21-3)

90252 Conjunctival structure of glaucomatous eyes treated with anti-glaucoma eye drops: a cross-sectional study using anterior segment optical coherence tomography
Inatani M
BMC Ophthalmology 2020; 20: 244 (IGR: 21-3)

90459 Profiling ocular surface responses to preserved and non-preserved topical glaucoma medications: A 2-year randomized evaluation study
Dua HS
Clinical and Experimental Ophthalmology 2020; 48: 973-982 (IGR: 21-3)

90711 The effect of successful trabeculectomy on the ocular surface and tear proteomics-a prospective cohort study with 1-year follow-up
Uusitalo H
Acta Ophthalmologica 2021; 99: 160-170 (IGR: 21-3)

90507 The protective effect of 3% diquafosol on meibomian gland morphology in glaucoma patients treated with prostaglandin analogs: a 12-month follow-up study
Park SW
BMC Ophthalmology 2020; 20: 277 (IGR: 21-3)

90459 Profiling ocular surface responses to preserved and non-preserved topical glaucoma medications: A 2-year randomized evaluation study
King AJ
Clinical and Experimental Ophthalmology 2020; 48: 973-982 (IGR: 21-3)

90855 Prospective Interventional Cohort Study of Ocular Surface Disease Changes in Eyes After Trabecular Micro-Bypass Stent(s) Implantation (iStent or iStent inject) with Phacoemulsification
Crothers AW
Ophthalmology and therapy 2020; 9: 941-953 (IGR: 21-3)

90799 Conjunctival thickness as a predictive imaging biomarker for the glaucoma filtration surgery outcome: An optical coherence tomography study
Totta M; Scatena B
Clinical and Experimental Ophthalmology 2020; 48: 1192-1200 (IGR: 21-3)

90855 Prospective Interventional Cohort Study of Ocular Surface Disease Changes in Eyes After Trabecular Micro-Bypass Stent(s) Implantation (iStent or iStent inject) with Phacoemulsification
Linn JE
Ophthalmology and therapy 2020; 9: 941-953 (IGR: 21-3)

90799 Conjunctival thickness as a predictive imaging biomarker for the glaucoma filtration surgery outcome: An optical coherence tomography study
Mastropasqua R
Clinical and Experimental Ophthalmology 2020; 48: 1192-1200 (IGR: 21-3)

90855 Prospective Interventional Cohort Study of Ocular Surface Disease Changes in Eyes After Trabecular Micro-Bypass Stent(s) Implantation (iStent or iStent inject) with Phacoemulsification
Berdahl JP
Ophthalmology and therapy 2020; 9: 941-953 (IGR: 21-3)

90799 Conjunctival thickness as a predictive imaging biomarker for the glaucoma filtration surgery outcome: An optical coherence tomography study
Agnifili L
Clinical and Experimental Ophthalmology 2020; 48: 1192-1200 (IGR: 21-3)

86221 Tear Meniscus Imaging by Anterior Segment-Optical Coherence Tomography in Medically Controlled Glaucoma
Agnifili L
Journal of Glaucoma 2020; 29: 374-380 (IGR: 21-2)

86509 XEN Gel Stent Open Conjunctiva Technique: A Practical Approach Paper
Panarelli JF
Advances in Therapy 2020; 37: 2538-2549 (IGR: 21-2)

86080 Continuous anti-glaucoma drug therapy as a risk factor of dry eye
Erichev VP
Vestnik Oftalmologii 2019; 135: 117-123 (IGR: 21-2)

86078 The effect of preservative-free treatment of primary open-angle glaucoma on the state of ocular surface in combination therapy (intermediate results)
Dorofeev DA
Vestnik Oftalmologii 2019; 135: 52-59 (IGR: 21-2)

86140 Tear and aqueous humour cytokine profile in primary open-angle glaucoma
Burgos-Blasco B
Acta Ophthalmologica 2020; 98: e768-e772 (IGR: 21-2)

86078 The effect of preservative-free treatment of primary open-angle glaucoma on the state of ocular surface in combination therapy (intermediate results)
Tur EV
Vestnik Oftalmologii 2019; 135: 52-59 (IGR: 21-2)

86080 Continuous anti-glaucoma drug therapy as a risk factor of dry eye
Petrov SY
Vestnik Oftalmologii 2019; 135: 117-123 (IGR: 21-2)

86140 Tear and aqueous humour cytokine profile in primary open-angle glaucoma
Vidal-Villegas B
Acta Ophthalmologica 2020; 98: e768-e772 (IGR: 21-2)

86080 Continuous anti-glaucoma drug therapy as a risk factor of dry eye
Petrov SY; Petrov SY
Vestnik Oftalmologii 2019; 135: 117-123 (IGR: 21-2)

86221 Tear Meniscus Imaging by Anterior Segment-Optical Coherence Tomography in Medically Controlled Glaucoma
Brescia L
Journal of Glaucoma 2020; 29: 374-380 (IGR: 21-2)

86080 Continuous anti-glaucoma drug therapy as a risk factor of dry eye
Petrov SY
Vestnik Oftalmologii 2019; 135: 117-123 (IGR: 21-2)

86509 XEN Gel Stent Open Conjunctiva Technique: A Practical Approach Paper
Yan DB
Advances in Therapy 2020; 37: 2538-2549 (IGR: 21-2)

86080 Continuous anti-glaucoma drug therapy as a risk factor of dry eye
Volzhanin AV
Vestnik Oftalmologii 2019; 135: 117-123 (IGR: 21-2)

86509 XEN Gel Stent Open Conjunctiva Technique: A Practical Approach Paper
Francis B
Advances in Therapy 2020; 37: 2538-2549 (IGR: 21-2)

86080 Continuous anti-glaucoma drug therapy as a risk factor of dry eye
Volzhanin AV
Vestnik Oftalmologii 2019; 135: 117-123 (IGR: 21-2)

86221 Tear Meniscus Imaging by Anterior Segment-Optical Coherence Tomography in Medically Controlled Glaucoma
Scatena B
Journal of Glaucoma 2020; 29: 374-380 (IGR: 21-2)

86140 Tear and aqueous humour cytokine profile in primary open-angle glaucoma
Saenz-Frances F
Acta Ophthalmologica 2020; 98: e768-e772 (IGR: 21-2)

86080 Continuous anti-glaucoma drug therapy as a risk factor of dry eye
Volzhanin AV; Volzhanin AV
Vestnik Oftalmologii 2019; 135: 117-123 (IGR: 21-2)

86078 The effect of preservative-free treatment of primary open-angle glaucoma on the state of ocular surface in combination therapy (intermediate results)
Vizgalova LO
Vestnik Oftalmologii 2019; 135: 52-59 (IGR: 21-2)

86140 Tear and aqueous humour cytokine profile in primary open-angle glaucoma
Morales-Fernandez L
Acta Ophthalmologica 2020; 98: e768-e772 (IGR: 21-2)

86080 Continuous anti-glaucoma drug therapy as a risk factor of dry eye
Ghazaryan SA
Vestnik Oftalmologii 2019; 135: 117-123 (IGR: 21-2)

86078 The effect of preservative-free treatment of primary open-angle glaucoma on the state of ocular surface in combination therapy (intermediate results)
Tryapitsin ID
Vestnik Oftalmologii 2019; 135: 52-59 (IGR: 21-2)

86509 XEN Gel Stent Open Conjunctiva Technique: A Practical Approach Paper
Craven ER
Advances in Therapy 2020; 37: 2538-2549 (IGR: 21-2)

86221 Tear Meniscus Imaging by Anterior Segment-Optical Coherence Tomography in Medically Controlled Glaucoma
Oddone F
Journal of Glaucoma 2020; 29: 374-380 (IGR: 21-2)

86078 The effect of preservative-free treatment of primary open-angle glaucoma on the state of ocular surface in combination therapy (intermediate results)
Ciganov AZ
Vestnik Oftalmologii 2019; 135: 52-59 (IGR: 21-2)

86140 Tear and aqueous humour cytokine profile in primary open-angle glaucoma
Perucho-Gonzalez L
Acta Ophthalmologica 2020; 98: e768-e772 (IGR: 21-2)

86221 Tear Meniscus Imaging by Anterior Segment-Optical Coherence Tomography in Medically Controlled Glaucoma
Figus M
Journal of Glaucoma 2020; 29: 374-380 (IGR: 21-2)

86140 Tear and aqueous humour cytokine profile in primary open-angle glaucoma
Garcia-Feijoo J
Acta Ophthalmologica 2020; 98: e768-e772 (IGR: 21-2)

86221 Tear Meniscus Imaging by Anterior Segment-Optical Coherence Tomography in Medically Controlled Glaucoma
Perna F; Doronzo E
Journal of Glaucoma 2020; 29: 374-380 (IGR: 21-2)

86140 Tear and aqueous humour cytokine profile in primary open-angle glaucoma
Martinez-de-la-Casa JM
Acta Ophthalmologica 2020; 98: e768-e772 (IGR: 21-2)

86221 Tear Meniscus Imaging by Anterior Segment-Optical Coherence Tomography in Medically Controlled Glaucoma
D'Ugo E; Mastropasqua L
Journal of Glaucoma 2020; 29: 374-380 (IGR: 21-2)

84873 The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 () Knockout Mice Treated with Antiglaucoma Eye Medications
Yagi-Yaguchi Y
Diagnostics (Basel, Switzerland) 2020; 10: (IGR: 21-1)

85089 Impact of Ocular Surface Disease Treatment in Patients with Glaucoma
Mylla Boso AL
Clinical Ophthalmology 2020; 14: 103-111 (IGR: 21-1)

84702 Relationship between OSDI questionnaire and ocular surface changes in glaucomatous patients
Guarnieri A
International Ophthalmology 2020; 40: 741-751 (IGR: 21-1)

84877 Ocular surface analysis and automatic non-invasive assessment of tear film breakup location, extension and progression in patients with glaucoma
Guarnieri A
BMC Ophthalmology 2020; 20: 12 (IGR: 21-1)

84838 Ocular Surface Changes in Prostaglandin Analogue-Treated Patients
Shen W
Journal of Ophthalmology 2019; 2019: 9798272 (IGR: 21-1)

85151 Mitochondrial Dysfunctions May Be One of the Major Causative Factors Underlying Detrimental Effects of Benzalkonium Chloride
Rogov AG
Oxidative medicine and cellular longevity 2020; 2020: 8956504 (IGR: 21-1)

85195 In vivo confocal microscopy: qualitative investigation of the conjunctival and corneal surface in open angle glaucomatous patients undergoing the XEN-Gel implant, trabeculectomy or medical therapy
Baiocchi S
Eye and vision (London, England) 2020; 7: 15 (IGR: 21-1)

84702 Relationship between OSDI questionnaire and ocular surface changes in glaucomatous patients
Carnero E
International Ophthalmology 2020; 40: 741-751 (IGR: 21-1)

84877 Ocular surface analysis and automatic non-invasive assessment of tear film breakup location, extension and progression in patients with glaucoma
Carnero E
BMC Ophthalmology 2020; 20: 12 (IGR: 21-1)

84838 Ocular Surface Changes in Prostaglandin Analogue-Treated Patients
Huang B
Journal of Ophthalmology 2019; 2019: 9798272 (IGR: 21-1)

85151 Mitochondrial Dysfunctions May Be One of the Major Causative Factors Underlying Detrimental Effects of Benzalkonium Chloride
Goleva TN
Oxidative medicine and cellular longevity 2020; 2020: 8956504 (IGR: 21-1)

85089 Impact of Ocular Surface Disease Treatment in Patients with Glaucoma
Gasperi E
Clinical Ophthalmology 2020; 14: 103-111 (IGR: 21-1)

84702 Relationship between OSDI questionnaire and ocular surface changes in glaucomatous patients
Carnero E
International Ophthalmology 2020; 40: 741-751 (IGR: 21-1)

84873 The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 () Knockout Mice Treated with Antiglaucoma Eye Medications
Kojima T
Diagnostics (Basel, Switzerland) 2020; 10: (IGR: 21-1)

85195 In vivo confocal microscopy: qualitative investigation of the conjunctival and corneal surface in open angle glaucomatous patients undergoing the XEN-Gel implant, trabeculectomy or medical therapy
Mazzotta C
Eye and vision (London, England) 2020; 7: 15 (IGR: 21-1)

84873 The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 () Knockout Mice Treated with Antiglaucoma Eye Medications
Higa K
Diagnostics (Basel, Switzerland) 2020; 10: (IGR: 21-1)

85195 In vivo confocal microscopy: qualitative investigation of the conjunctival and corneal surface in open angle glaucomatous patients undergoing the XEN-Gel implant, trabeculectomy or medical therapy
Sgheri A
Eye and vision (London, England) 2020; 7: 15 (IGR: 21-1)

84702 Relationship between OSDI questionnaire and ocular surface changes in glaucomatous patients
Bleau AM
International Ophthalmology 2020; 40: 741-751 (IGR: 21-1)

85151 Mitochondrial Dysfunctions May Be One of the Major Causative Factors Underlying Detrimental Effects of Benzalkonium Chloride
Sukhanova EI
Oxidative medicine and cellular longevity 2020; 2020: 8956504 (IGR: 21-1)

84702 Relationship between OSDI questionnaire and ocular surface changes in glaucomatous patients
Bleau AM
International Ophthalmology 2020; 40: 741-751 (IGR: 21-1)

84877 Ocular surface analysis and automatic non-invasive assessment of tear film breakup location, extension and progression in patients with glaucoma
Bleau AM
BMC Ophthalmology 2020; 20: 12 (IGR: 21-1)

85089 Impact of Ocular Surface Disease Treatment in Patients with Glaucoma
Fernandes L
Clinical Ophthalmology 2020; 14: 103-111 (IGR: 21-1)

84838 Ocular Surface Changes in Prostaglandin Analogue-Treated Patients
Yang J
Journal of Ophthalmology 2019; 2019: 9798272 (IGR: 21-1)

85195 In vivo confocal microscopy: qualitative investigation of the conjunctival and corneal surface in open angle glaucomatous patients undergoing the XEN-Gel implant, trabeculectomy or medical therapy
Di Maggio A
Eye and vision (London, England) 2020; 7: 15 (IGR: 21-1)

85089 Impact of Ocular Surface Disease Treatment in Patients with Glaucoma
Costa VP
Clinical Ophthalmology 2020; 14: 103-111 (IGR: 21-1)

85151 Mitochondrial Dysfunctions May Be One of the Major Causative Factors Underlying Detrimental Effects of Benzalkonium Chloride
Epremyan KK
Oxidative medicine and cellular longevity 2020; 2020: 8956504 (IGR: 21-1)

84873 The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 () Knockout Mice Treated with Antiglaucoma Eye Medications
Dogru M
Diagnostics (Basel, Switzerland) 2020; 10: (IGR: 21-1)

84877 Ocular surface analysis and automatic non-invasive assessment of tear film breakup location, extension and progression in patients with glaucoma
López de Aguileta Castaño N
BMC Ophthalmology 2020; 20: 12 (IGR: 21-1)

84702 Relationship between OSDI questionnaire and ocular surface changes in glaucomatous patients
Alfonso-Bartolozzi B
International Ophthalmology 2020; 40: 741-751 (IGR: 21-1)

85089 Impact of Ocular Surface Disease Treatment in Patients with Glaucoma
Alves M
Clinical Ophthalmology 2020; 14: 103-111 (IGR: 21-1)

85195 In vivo confocal microscopy: qualitative investigation of the conjunctival and corneal surface in open angle glaucomatous patients undergoing the XEN-Gel implant, trabeculectomy or medical therapy
Bagaglia SA
Eye and vision (London, England) 2020; 7: 15 (IGR: 21-1)

85151 Mitochondrial Dysfunctions May Be One of the Major Causative Factors Underlying Detrimental Effects of Benzalkonium Chloride
Trendeleva TA
Oxidative medicine and cellular longevity 2020; 2020: 8956504 (IGR: 21-1)

84702 Relationship between OSDI questionnaire and ocular surface changes in glaucomatous patients
Moreno-Montañés J
International Ophthalmology 2020; 40: 741-751 (IGR: 21-1)

84877 Ocular surface analysis and automatic non-invasive assessment of tear film breakup location, extension and progression in patients with glaucoma
Llorente Ortega M
BMC Ophthalmology 2020; 20: 12 (IGR: 21-1)

84873 The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 () Knockout Mice Treated with Antiglaucoma Eye Medications
Ibrahim OM
Diagnostics (Basel, Switzerland) 2020; 10: (IGR: 21-1)

85151 Mitochondrial Dysfunctions May Be One of the Major Causative Factors Underlying Detrimental Effects of Benzalkonium Chloride
Ovchenkova AP
Oxidative medicine and cellular longevity 2020; 2020: 8956504 (IGR: 21-1)

84877 Ocular surface analysis and automatic non-invasive assessment of tear film breakup location, extension and progression in patients with glaucoma
Moreno-Montañés J
BMC Ophthalmology 2020; 20: 12 (IGR: 21-1)

84873 The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 () Knockout Mice Treated with Antiglaucoma Eye Medications
Shimizu T
Diagnostics (Basel, Switzerland) 2020; 10: (IGR: 21-1)

85195 In vivo confocal microscopy: qualitative investigation of the conjunctival and corneal surface in open angle glaucomatous patients undergoing the XEN-Gel implant, trabeculectomy or medical therapy
Posarelli M
Eye and vision (London, England) 2020; 7: 15 (IGR: 21-1)

84873 The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 () Knockout Mice Treated with Antiglaucoma Eye Medications
Tsubota K
Diagnostics (Basel, Switzerland) 2020; 10: (IGR: 21-1)

85195 In vivo confocal microscopy: qualitative investigation of the conjunctival and corneal surface in open angle glaucomatous patients undergoing the XEN-Gel implant, trabeculectomy or medical therapy
Ciompi L
Eye and vision (London, England) 2020; 7: 15 (IGR: 21-1)

85151 Mitochondrial Dysfunctions May Be One of the Major Causative Factors Underlying Detrimental Effects of Benzalkonium Chloride
Aliverdieva DA
Oxidative medicine and cellular longevity 2020; 2020: 8956504 (IGR: 21-1)

84873 The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 () Knockout Mice Treated with Antiglaucoma Eye Medications
Shimazaki J
Diagnostics (Basel, Switzerland) 2020; 10: (IGR: 21-1)

85195 In vivo confocal microscopy: qualitative investigation of the conjunctival and corneal surface in open angle glaucomatous patients undergoing the XEN-Gel implant, trabeculectomy or medical therapy
Meduri A
Eye and vision (London, England) 2020; 7: 15 (IGR: 21-1)

85151 Mitochondrial Dysfunctions May Be One of the Major Causative Factors Underlying Detrimental Effects of Benzalkonium Chloride
Zvyagilskaya RA
Oxidative medicine and cellular longevity 2020; 2020: 8956504 (IGR: 21-1)

85195 In vivo confocal microscopy: qualitative investigation of the conjunctival and corneal surface in open angle glaucomatous patients undergoing the XEN-Gel implant, trabeculectomy or medical therapy
Tosi GM
Eye and vision (London, England) 2020; 7: 15 (IGR: 21-1)

82254 Multi-Omics Approach for Studying Tears in Treatment-Naïve Glaucoma Patients
Rossi C
International journal of molecular sciences 2019; 20: (IGR: 20-4)

82159 Tear neuromediators in eyes on chronic topical antiglaucoma therapy with and without BAK preservatives
Murugesan V
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82590 Effects of Preservative on the Meibomian Gland in Glaucoma Patients Treated with Prostaglandin Analogues
Ha JY
Chonnam medical journal 2019; 55: 156-162 (IGR: 20-4)

81989 Comparison of conjunctival vascularity changes using optical coherence tomography angiography after trabeculectomy and phacotrabeculectomy
Seo JH
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 2239-2255 (IGR: 20-4)

82758 Ocular Surface Disease with BAK preserved Travoprost and Polyquaternium 1(Polyquad) preserved Travoprost
Kumar S
Romanian journal of ophthalmology 2019; 63: 249-256 (IGR: 20-4)

82072 Dry Eye Symptoms and Ocular Pain in Veterans with Glaucoma
Tirpack AR
Journal of clinical medicine 2019; 8: (IGR: 20-4)

82032 All‑trans‑retinoic acid modulates TGF‑β‑induced apoptosis, proliferation, migration and extracellular matrix synthesis of conjunctival fibroblasts by inhibiting PI3K/AKT signaling
Liang L
Molecular medicine reports 2019; 20: 2929-2935 (IGR: 20-4)

82141 Histopathologic Analysis of Conjunctival Lymphoproliferative Disease After Topical Brimonidine Use
Hwang HB
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 503-511 (IGR: 20-4)

82631 Glaucoma Patch Graft Surgery Utilizing Corneas Augmented with Collagen Cross-linking
Stone DU
Middle East African Journal of Ophthalmology 2019; 26: 148-152 (IGR: 20-4)

82052 Effect of topical glaucoma medication on tear lipid layer thickness in patients with unilateral glaucoma
Lee SM
Indian Journal of Ophthalmology 2019; 67: 1297-1302 (IGR: 20-4)

82072 Dry Eye Symptoms and Ocular Pain in Veterans with Glaucoma
Tirpack AR
Journal of clinical medicine 2019; 8: (IGR: 20-4)

82631 Glaucoma Patch Graft Surgery Utilizing Corneas Augmented with Collagen Cross-linking
Craven ER
Middle East African Journal of Ophthalmology 2019; 26: 148-152 (IGR: 20-4)

82758 Ocular Surface Disease with BAK preserved Travoprost and Polyquaternium 1(Polyquad) preserved Travoprost
Singh T
Romanian journal of ophthalmology 2019; 63: 249-256 (IGR: 20-4)

82141 Histopathologic Analysis of Conjunctival Lymphoproliferative Disease After Topical Brimonidine Use
Kim SY
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 503-511 (IGR: 20-4)

82052 Effect of topical glaucoma medication on tear lipid layer thickness in patients with unilateral glaucoma
Lee JE
Indian Journal of Ophthalmology 2019; 67: 1297-1302 (IGR: 20-4)

82072 Dry Eye Symptoms and Ocular Pain in Veterans with Glaucoma
Vanner E
Journal of clinical medicine 2019; 8: (IGR: 20-4)

82254 Multi-Omics Approach for Studying Tears in Treatment-Naïve Glaucoma Patients
Cicalini I
International journal of molecular sciences 2019; 20: (IGR: 20-4)

82590 Effects of Preservative on the Meibomian Gland in Glaucoma Patients Treated with Prostaglandin Analogues
Sung MS
Chonnam medical journal 2019; 55: 156-162 (IGR: 20-4)

82032 All‑trans‑retinoic acid modulates TGF‑β‑induced apoptosis, proliferation, migration and extracellular matrix synthesis of conjunctival fibroblasts by inhibiting PI3K/AKT signaling
Wang X
Molecular medicine reports 2019; 20: 2929-2935 (IGR: 20-4)

82159 Tear neuromediators in eyes on chronic topical antiglaucoma therapy with and without BAK preservatives
Dwivedi R
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

81989 Comparison of conjunctival vascularity changes using optical coherence tomography angiography after trabeculectomy and phacotrabeculectomy
Lee Y
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 2239-2255 (IGR: 20-4)

82032 All‑trans‑retinoic acid modulates TGF‑β‑induced apoptosis, proliferation, migration and extracellular matrix synthesis of conjunctival fibroblasts by inhibiting PI3K/AKT signaling
Zheng Y
Molecular medicine reports 2019; 20: 2929-2935 (IGR: 20-4)

82072 Dry Eye Symptoms and Ocular Pain in Veterans with Glaucoma
Parrish JM
Journal of clinical medicine 2019; 8: (IGR: 20-4)

82254 Multi-Omics Approach for Studying Tears in Treatment-Naïve Glaucoma Patients
Cufaro MC
International journal of molecular sciences 2019; 20: (IGR: 20-4)

82758 Ocular Surface Disease with BAK preserved Travoprost and Polyquaternium 1(Polyquad) preserved Travoprost
Ichhpujani P
Romanian journal of ophthalmology 2019; 63: 249-256 (IGR: 20-4)

82052 Effect of topical glaucoma medication on tear lipid layer thickness in patients with unilateral glaucoma
Kim SI
Indian Journal of Ophthalmology 2019; 67: 1297-1302 (IGR: 20-4)

82159 Tear neuromediators in eyes on chronic topical antiglaucoma therapy with and without BAK preservatives
Saini M
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82141 Histopathologic Analysis of Conjunctival Lymphoproliferative Disease After Topical Brimonidine Use
Ohn K
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 503-511 (IGR: 20-4)

82631 Glaucoma Patch Graft Surgery Utilizing Corneas Augmented with Collagen Cross-linking
Ahmad SI
Middle East African Journal of Ophthalmology 2019; 26: 148-152 (IGR: 20-4)

82590 Effects of Preservative on the Meibomian Gland in Glaucoma Patients Treated with Prostaglandin Analogues
Park SW
Chonnam medical journal 2019; 55: 156-162 (IGR: 20-4)

81989 Comparison of conjunctival vascularity changes using optical coherence tomography angiography after trabeculectomy and phacotrabeculectomy
Shin JH
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 2239-2255 (IGR: 20-4)

82072 Dry Eye Symptoms and Ocular Pain in Veterans with Glaucoma
Galor A
Journal of clinical medicine 2019; 8: (IGR: 20-4)

81989 Comparison of conjunctival vascularity changes using optical coherence tomography angiography after trabeculectomy and phacotrabeculectomy
Kim YA
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 2239-2255 (IGR: 20-4)

82159 Tear neuromediators in eyes on chronic topical antiglaucoma therapy with and without BAK preservatives
Gupta V
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82032 All‑trans‑retinoic acid modulates TGF‑β‑induced apoptosis, proliferation, migration and extracellular matrix synthesis of conjunctival fibroblasts by inhibiting PI3K/AKT signaling
Liu Y
Molecular medicine reports 2019; 20: 2929-2935 (IGR: 20-4)

82254 Multi-Omics Approach for Studying Tears in Treatment-Naïve Glaucoma Patients
Agnifili L
International journal of molecular sciences 2019; 20: (IGR: 20-4)

82631 Glaucoma Patch Graft Surgery Utilizing Corneas Augmented with Collagen Cross-linking
AlBeshri A
Middle East African Journal of Ophthalmology 2019; 26: 148-152 (IGR: 20-4)

82052 Effect of topical glaucoma medication on tear lipid layer thickness in patients with unilateral glaucoma
Jung JH
Indian Journal of Ophthalmology 2019; 67: 1297-1302 (IGR: 20-4)

82758 Ocular Surface Disease with BAK preserved Travoprost and Polyquaternium 1(Polyquad) preserved Travoprost
Vohra S
Romanian journal of ophthalmology 2019; 63: 249-256 (IGR: 20-4)

82159 Tear neuromediators in eyes on chronic topical antiglaucoma therapy with and without BAK preservatives
Dada T
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

81989 Comparison of conjunctival vascularity changes using optical coherence tomography angiography after trabeculectomy and phacotrabeculectomy
Park KH
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 2239-2255 (IGR: 20-4)

82631 Glaucoma Patch Graft Surgery Utilizing Corneas Augmented with Collagen Cross-linking
Owaidhah OA
Middle East African Journal of Ophthalmology 2019; 26: 148-152 (IGR: 20-4)

82072 Dry Eye Symptoms and Ocular Pain in Veterans with Glaucoma
Hua HU
Journal of clinical medicine 2019; 8: (IGR: 20-4)

82052 Effect of topical glaucoma medication on tear lipid layer thickness in patients with unilateral glaucoma
Shin J
Indian Journal of Ophthalmology 2019; 67: 1297-1302 (IGR: 20-4)

82254 Multi-Omics Approach for Studying Tears in Treatment-Naïve Glaucoma Patients
Mastropasqua L; Lanuti P
International journal of molecular sciences 2019; 20: (IGR: 20-4)

82072 Dry Eye Symptoms and Ocular Pain in Veterans with Glaucoma
Wellik SR
Journal of clinical medicine 2019; 8: (IGR: 20-4)

82159 Tear neuromediators in eyes on chronic topical antiglaucoma therapy with and without BAK preservatives
Vivekanandhan S
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82254 Multi-Omics Approach for Studying Tears in Treatment-Naïve Glaucoma Patients
Marchisio M; De Laurenzi V; Del Boccio P; Pieragostino D
International journal of molecular sciences 2019; 20: (IGR: 20-4)

81061 Tear Film, Conjunctival and Corneal Modifications Induced by Glaucoma Treatment
Roberti G
Current Medicinal Chemistry 2019; 0: (IGR: 20-3)

80473 Evaluation of Antiglaucomatous Drops on Conjunctival Thickness in Patients with Primary Open-Angle Glaucoma
Tekin S
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 216-222 (IGR: 20-3)

81184 What information can be obtained from the tears of a patient with primary open angle glaucoma?
Tamkovich S
Clinica Chimica Acta 2019; 495: 529-537 (IGR: 20-3)

80991 Steroid-induced glaucoma and blindness in vernal keratoconjunctivitis
Senthil S
British Journal of Ophthalmology 2020; 104: 265-269 (IGR: 20-3)

81271 Pseudopemphigoid Induced by Topical Glaucoma Medications
Geerling G
Klinische Monatsbl�tter f�r Augenheilkunde 2019; 236: 762-766 (IGR: 20-3)

81351 Meibomian gland dropout rate as a method to assess meibomian gland morphologic changes during use of preservative-containing or preservative-free topical prostaglandin analogues
Lee SY
PLoS ONE 2019; 14: e0218886 (IGR: 20-3)

80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Sakamoto E
Scientific reports 2019; 9: 3755 (IGR: 20-3)

81401 Glaucoma With Alkaptonuria as a Result of Pigment Accumulation
Okutucu M
Journal of Glaucoma 2019; 28: e112-e114 (IGR: 20-3)

80577 Tear film stability after trabeculectomy and its relationship with bleb morphology
Meng JY
Chinese Journal of Ophthalmology 2019; 55: 214-219 (IGR: 20-3)

81067 Anterior Segment Optical Coherence Tomography Angiography Imaging of Conjunctiva and Intrasclera in Treated Primary Open-Angle Glaucoma
Akagi T
American Journal of Ophthalmology 2019; 208: 313-322 (IGR: 20-3)

80765 Ocular Surface Evaluation After the Substitution of Benzalkonium Chloride Preserved Prostaglandin Eye Drops by a Preservative-free Prostaglandin Analogue
Lopes NLV
Medical hypothesis, discovery and innovation in ophthalmology 2019; 8: 52-56 (IGR: 20-3)

81017 Extracellular MMP-9-Based Assessment of Ocular Surface Inflammation in Patients with Primary Open-Angle Glaucoma
Zaleska-Żmijewska A
Journal of Ophthalmology 2019; 2019: 1240537 (IGR: 20-3)

81447 Bimatoprost loaded nanovesicular long-acting sub-conjunctival in-situ gelling implant: In vitro and in vivo evaluation
Yadav M
Materials science & engineering. C, Materials for biological applications 2019; 103: 109730 (IGR: 20-3)

81271 Pseudopemphigoid Induced by Topical Glaucoma Medications
Roth M
Klinische Monatsbl�tter f�r Augenheilkunde 2019; 236: 762-766 (IGR: 20-3)

80765 Ocular Surface Evaluation After the Substitution of Benzalkonium Chloride Preserved Prostaglandin Eye Drops by a Preservative-free Prostaglandin Analogue
Gracitelli CPB
Medical hypothesis, discovery and innovation in ophthalmology 2019; 8: 52-56 (IGR: 20-3)

81067 Anterior Segment Optical Coherence Tomography Angiography Imaging of Conjunctiva and Intrasclera in Treated Primary Open-Angle Glaucoma
Uji A
American Journal of Ophthalmology 2019; 208: 313-322 (IGR: 20-3)

80991 Steroid-induced glaucoma and blindness in vernal keratoconjunctivitis
Thakur M
British Journal of Ophthalmology 2020; 104: 265-269 (IGR: 20-3)

80473 Evaluation of Antiglaucomatous Drops on Conjunctival Thickness in Patients with Primary Open-Angle Glaucoma
Seven E
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 216-222 (IGR: 20-3)

80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Ishida W
Scientific reports 2019; 9: 3755 (IGR: 20-3)

81017 Extracellular MMP-9-Based Assessment of Ocular Surface Inflammation in Patients with Primary Open-Angle Glaucoma
Strzemecka E
Journal of Ophthalmology 2019; 2019: 1240537 (IGR: 20-3)

81447 Bimatoprost loaded nanovesicular long-acting sub-conjunctival in-situ gelling implant: In vitro and in vivo evaluation
Guzman-Aranguez A
Materials science & engineering. C, Materials for biological applications 2019; 103: 109730 (IGR: 20-3)

81061 Tear Film, Conjunctival and Corneal Modifications Induced by Glaucoma Treatment
Tanga L
Current Medicinal Chemistry 2019; 0: (IGR: 20-3)

80577 Tear film stability after trabeculectomy and its relationship with bleb morphology
Wang X
Chinese Journal of Ophthalmology 2019; 55: 214-219 (IGR: 20-3)

81401 Glaucoma With Alkaptonuria as a Result of Pigment Accumulation
Aslan MG
Journal of Glaucoma 2019; 28: e112-e114 (IGR: 20-3)

81184 What information can be obtained from the tears of a patient with primary open angle glaucoma?
Grigor'eva A
Clinica Chimica Acta 2019; 495: 529-537 (IGR: 20-3)

81017 Extracellular MMP-9-Based Assessment of Ocular Surface Inflammation in Patients with Primary Open-Angle Glaucoma
Wawrzyniak ZM
Journal of Ophthalmology 2019; 2019: 1240537 (IGR: 20-3)

81067 Anterior Segment Optical Coherence Tomography Angiography Imaging of Conjunctiva and Intrasclera in Treated Primary Open-Angle Glaucoma
Okamoto Y
American Journal of Ophthalmology 2019; 208: 313-322 (IGR: 20-3)

80577 Tear film stability after trabeculectomy and its relationship with bleb morphology
Wen L
Chinese Journal of Ophthalmology 2019; 55: 214-219 (IGR: 20-3)

81184 What information can be obtained from the tears of a patient with primary open angle glaucoma?
Eremina A
Clinica Chimica Acta 2019; 495: 529-537 (IGR: 20-3)

80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Sumi T
Scientific reports 2019; 9: 3755 (IGR: 20-3)

80765 Ocular Surface Evaluation After the Substitution of Benzalkonium Chloride Preserved Prostaglandin Eye Drops by a Preservative-free Prostaglandin Analogue
Chalita MR
Medical hypothesis, discovery and innovation in ophthalmology 2019; 8: 52-56 (IGR: 20-3)

81401 Glaucoma With Alkaptonuria as a Result of Pigment Accumulation
Findik H
Journal of Glaucoma 2019; 28: e112-e114 (IGR: 20-3)

81447 Bimatoprost loaded nanovesicular long-acting sub-conjunctival in-situ gelling implant: In vitro and in vivo evaluation
Perez De Lara MJ
Materials science & engineering. C, Materials for biological applications 2019; 103: 109730 (IGR: 20-3)

80473 Evaluation of Antiglaucomatous Drops on Conjunctival Thickness in Patients with Primary Open-Angle Glaucoma
Batur M
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 216-222 (IGR: 20-3)

81061 Tear Film, Conjunctival and Corneal Modifications Induced by Glaucoma Treatment
Manni G
Current Medicinal Chemistry 2019; 0: (IGR: 20-3)

80991 Steroid-induced glaucoma and blindness in vernal keratoconjunctivitis
Rao HL
British Journal of Ophthalmology 2020; 104: 265-269 (IGR: 20-3)

81401 Glaucoma With Alkaptonuria as a Result of Pigment Accumulation
Yavuz G
Journal of Glaucoma 2019; 28: e112-e114 (IGR: 20-3)

80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Kishimoto T
Scientific reports 2019; 9: 3755 (IGR: 20-3)

81447 Bimatoprost loaded nanovesicular long-acting sub-conjunctival in-situ gelling implant: In vitro and in vivo evaluation
Singh M
Materials science & engineering. C, Materials for biological applications 2019; 103: 109730 (IGR: 20-3)

81017 Extracellular MMP-9-Based Assessment of Ocular Surface Inflammation in Patients with Primary Open-Angle Glaucoma
Szaflik JP
Journal of Ophthalmology 2019; 2019: 1240537 (IGR: 20-3)

81061 Tear Film, Conjunctival and Corneal Modifications Induced by Glaucoma Treatment
Riva I
Current Medicinal Chemistry 2019; 0: (IGR: 20-3)

81067 Anterior Segment Optical Coherence Tomography Angiography Imaging of Conjunctiva and Intrasclera in Treated Primary Open-Angle Glaucoma
Suda K
American Journal of Ophthalmology 2019; 208: 313-322 (IGR: 20-3)

80577 Tear film stability after trabeculectomy and its relationship with bleb morphology
Shen RY
Chinese Journal of Ophthalmology 2019; 55: 214-219 (IGR: 20-3)

80765 Ocular Surface Evaluation After the Substitution of Benzalkonium Chloride Preserved Prostaglandin Eye Drops by a Preservative-free Prostaglandin Analogue
de Faria NVL
Medical hypothesis, discovery and innovation in ophthalmology 2019; 8: 52-56 (IGR: 20-3)

81184 What information can be obtained from the tears of a patient with primary open angle glaucoma?
Tupikin A
Clinica Chimica Acta 2019; 495: 529-537 (IGR: 20-3)

80991 Steroid-induced glaucoma and blindness in vernal keratoconjunctivitis
Mohamed A
British Journal of Ophthalmology 2020; 104: 265-269 (IGR: 20-3)

80991 Steroid-induced glaucoma and blindness in vernal keratoconjunctivitis
Jonnadula GB
British Journal of Ophthalmology 2020; 104: 265-269 (IGR: 20-3)

81447 Bimatoprost loaded nanovesicular long-acting sub-conjunctival in-situ gelling implant: In vitro and in vivo evaluation
Singh J
Materials science & engineering. C, Materials for biological applications 2019; 103: 109730 (IGR: 20-3)

81067 Anterior Segment Optical Coherence Tomography Angiography Imaging of Conjunctiva and Intrasclera in Treated Primary Open-Angle Glaucoma
Kameda T
American Journal of Ophthalmology 2019; 208: 313-322 (IGR: 20-3)

81184 What information can be obtained from the tears of a patient with primary open angle glaucoma?
Kabilov M
Clinica Chimica Acta 2019; 495: 529-537 (IGR: 20-3)

80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Tada K
Scientific reports 2019; 9: 3755 (IGR: 20-3)

81061 Tear Film, Conjunctival and Corneal Modifications Induced by Glaucoma Treatment
Verticchio AC
Current Medicinal Chemistry 2019; 0: (IGR: 20-3)

80577 Tear film stability after trabeculectomy and its relationship with bleb morphology
Wu HX
Chinese Journal of Ophthalmology 2019; 55: 214-219 (IGR: 20-3)

80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Fukuda K
Scientific reports 2019; 9: 3755 (IGR: 20-3)

81067 Anterior Segment Optical Coherence Tomography Angiography Imaging of Conjunctiva and Intrasclera in Treated Primary Open-Angle Glaucoma
Nakanishi H
American Journal of Ophthalmology 2019; 208: 313-322 (IGR: 20-3)

81184 What information can be obtained from the tears of a patient with primary open angle glaucoma?
Chernykh V
Clinica Chimica Acta 2019; 495: 529-537 (IGR: 20-3)

80991 Steroid-induced glaucoma and blindness in vernal keratoconjunctivitis
Sangwan V
British Journal of Ophthalmology 2020; 104: 265-269 (IGR: 20-3)

81447 Bimatoprost loaded nanovesicular long-acting sub-conjunctival in-situ gelling implant: In vitro and in vivo evaluation
Kaur IP
Materials science & engineering. C, Materials for biological applications 2019; 103: 109730 (IGR: 20-3)

81061 Tear Film, Conjunctival and Corneal Modifications Induced by Glaucoma Treatment
Berardo F
Current Medicinal Chemistry 2019; 0: (IGR: 20-3)

80577 Tear film stability after trabeculectomy and its relationship with bleb morphology
Zhang TT
Chinese Journal of Ophthalmology 2019; 55: 214-219 (IGR: 20-3)

81061 Tear Film, Conjunctival and Corneal Modifications Induced by Glaucoma Treatment
Carnevale C
Current Medicinal Chemistry 2019; 0: (IGR: 20-3)

80577 Tear film stability after trabeculectomy and its relationship with bleb morphology
Zhang C
Chinese Journal of Ophthalmology 2019; 55: 214-219 (IGR: 20-3)

81061 Tear Film, Conjunctival and Corneal Modifications Induced by Glaucoma Treatment
Carnevale C
Current Medicinal Chemistry 2019; 0: (IGR: 20-3)

81184 What information can be obtained from the tears of a patient with primary open angle glaucoma?
Vlassov V
Clinica Chimica Acta 2019; 495: 529-537 (IGR: 20-3)

80991 Steroid-induced glaucoma and blindness in vernal keratoconjunctivitis
Garudadri CS
British Journal of Ophthalmology 2020; 104: 265-269 (IGR: 20-3)

81067 Anterior Segment Optical Coherence Tomography Angiography Imaging of Conjunctiva and Intrasclera in Treated Primary Open-Angle Glaucoma
Ikeda HO
American Journal of Ophthalmology 2019; 208: 313-322 (IGR: 20-3)

80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Yoneda T
Scientific reports 2019; 9: 3755 (IGR: 20-3)

81061 Tear Film, Conjunctival and Corneal Modifications Induced by Glaucoma Treatment
Oddone F
Current Medicinal Chemistry 2019; 0: (IGR: 20-3)

81184 What information can be obtained from the tears of a patient with primary open angle glaucoma?
Ryabchikova E
Clinica Chimica Acta 2019; 495: 529-537 (IGR: 20-3)

80577 Tear film stability after trabeculectomy and its relationship with bleb morphology
Liang YB
Chinese Journal of Ophthalmology 2019; 55: 214-219 (IGR: 20-3)

81067 Anterior Segment Optical Coherence Tomography Angiography Imaging of Conjunctiva and Intrasclera in Treated Primary Open-Angle Glaucoma
Miyake M
American Journal of Ophthalmology 2019; 208: 313-322 (IGR: 20-3)

80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Kuroiwa H
Scientific reports 2019; 9: 3755 (IGR: 20-3)

81067 Anterior Segment Optical Coherence Tomography Angiography Imaging of Conjunctiva and Intrasclera in Treated Primary Open-Angle Glaucoma
Nakano E
American Journal of Ophthalmology 2019; 208: 313-322 (IGR: 20-3)

80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Terao E; Fujisawa Y
Scientific reports 2019; 9: 3755 (IGR: 20-3)

81067 Anterior Segment Optical Coherence Tomography Angiography Imaging of Conjunctiva and Intrasclera in Treated Primary Open-Angle Glaucoma
Motozawa N; Tsujikawa A
American Journal of Ophthalmology 2019; 208: 313-322 (IGR: 20-3)

80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Nakakura S; Jian K; Okumichi H; Kiuchi Y; Fukushima A
Scientific reports 2019; 9: 3755 (IGR: 20-3)

79566 Effectiveness of 0.1% topical salicylic acid on blepharoconjunctivitis affecting glaucoma patients treated with topical prostaglandin analogues: a prospective randomized trial
Librando A
International Journal of Ophthalmology 2018; 11: 1936-1940 (IGR: 20-2)

79897 Recurrent Exposure of XEN Gel Stent Implant and Conjunctival Erosion
Arnould L
Journal of Glaucoma 2019; 28: e37-e40 (IGR: 20-2)

79810 Iatrogenic limbal stem cell deficiency following drainage surgery for glaucoma
Muthusamy K
Canadian Journal of Ophthalmology 2018; 53: 574-579 (IGR: 20-2)

79329 Influence of Treating Ocular Surface Disease on Intraocular Pressure in Glaucoma Patients Intolerant to Their Topical Treatments: A Report of 10 Cases
Dubrulle P
Journal of Glaucoma 2018; 27: 1105-1111 (IGR: 20-2)

79583 Conjunctival Goblet Cells, the Overlooked Cells in Glaucoma Treatment
Tiedemann D; Mouhammad ZA
Journal of Glaucoma 2019; 28: 325-333 (IGR: 20-2)

79566 Effectiveness of 0.1% topical salicylic acid on blepharoconjunctivitis affecting glaucoma patients treated with topical prostaglandin analogues: a prospective randomized trial
Carlesimo SC
International Journal of Ophthalmology 2018; 11: 1936-1940 (IGR: 20-2)

79810 Iatrogenic limbal stem cell deficiency following drainage surgery for glaucoma
Tuft SJ
Canadian Journal of Ophthalmology 2018; 53: 574-579 (IGR: 20-2)

79897 Recurrent Exposure of XEN Gel Stent Implant and Conjunctival Erosion
Theillac V
Journal of Glaucoma 2019; 28: e37-e40 (IGR: 20-2)

79329 Influence of Treating Ocular Surface Disease on Intraocular Pressure in Glaucoma Patients Intolerant to Their Topical Treatments: A Report of 10 Cases
Labbé A
Journal of Glaucoma 2018; 27: 1105-1111 (IGR: 20-2)

79566 Effectiveness of 0.1% topical salicylic acid on blepharoconjunctivitis affecting glaucoma patients treated with topical prostaglandin analogues: a prospective randomized trial
Albanese G
International Journal of Ophthalmology 2018; 11: 1936-1940 (IGR: 20-2)

79583 Conjunctival Goblet Cells, the Overlooked Cells in Glaucoma Treatment
Utheim TP
Journal of Glaucoma 2019; 28: 325-333 (IGR: 20-2)

79329 Influence of Treating Ocular Surface Disease on Intraocular Pressure in Glaucoma Patients Intolerant to Their Topical Treatments: A Report of 10 Cases
Brasnu E
Journal of Glaucoma 2018; 27: 1105-1111 (IGR: 20-2)

79897 Recurrent Exposure of XEN Gel Stent Implant and Conjunctival Erosion
Moran S; Gatinel D
Journal of Glaucoma 2019; 28: e37-e40 (IGR: 20-2)

79329 Influence of Treating Ocular Surface Disease on Intraocular Pressure in Glaucoma Patients Intolerant to Their Topical Treatments: A Report of 10 Cases
Liang H
Journal of Glaucoma 2018; 27: 1105-1111 (IGR: 20-2)

79583 Conjunctival Goblet Cells, the Overlooked Cells in Glaucoma Treatment
Dartt DA
Journal of Glaucoma 2019; 28: 325-333 (IGR: 20-2)

79566 Effectiveness of 0.1% topical salicylic acid on blepharoconjunctivitis affecting glaucoma patients treated with topical prostaglandin analogues: a prospective randomized trial
Albanese GM
International Journal of Ophthalmology 2018; 11: 1936-1940 (IGR: 20-2)

79583 Conjunctival Goblet Cells, the Overlooked Cells in Glaucoma Treatment
Heegaard S
Journal of Glaucoma 2019; 28: 325-333 (IGR: 20-2)

79329 Influence of Treating Ocular Surface Disease on Intraocular Pressure in Glaucoma Patients Intolerant to Their Topical Treatments: A Report of 10 Cases
Hamard P
Journal of Glaucoma 2018; 27: 1105-1111 (IGR: 20-2)

79566 Effectiveness of 0.1% topical salicylic acid on blepharoconjunctivitis affecting glaucoma patients treated with topical prostaglandin analogues: a prospective randomized trial
Migliorini R
International Journal of Ophthalmology 2018; 11: 1936-1940 (IGR: 20-2)

79897 Recurrent Exposure of XEN Gel Stent Implant and Conjunctival Erosion
Grise-Dulac A
Journal of Glaucoma 2019; 28: e37-e40 (IGR: 20-2)

79329 Influence of Treating Ocular Surface Disease on Intraocular Pressure in Glaucoma Patients Intolerant to Their Topical Treatments: A Report of 10 Cases
Meziani L
Journal of Glaucoma 2018; 27: 1105-1111 (IGR: 20-2)

79583 Conjunctival Goblet Cells, the Overlooked Cells in Glaucoma Treatment
Petrovski G
Journal of Glaucoma 2019; 28: 325-333 (IGR: 20-2)

79566 Effectiveness of 0.1% topical salicylic acid on blepharoconjunctivitis affecting glaucoma patients treated with topical prostaglandin analogues: a prospective randomized trial
Pacella E
International Journal of Ophthalmology 2018; 11: 1936-1940 (IGR: 20-2)

79329 Influence of Treating Ocular Surface Disease on Intraocular Pressure in Glaucoma Patients Intolerant to Their Topical Treatments: A Report of 10 Cases
Baudouin C
Journal of Glaucoma 2018; 27: 1105-1111 (IGR: 20-2)

79583 Conjunctival Goblet Cells, the Overlooked Cells in Glaucoma Treatment
Kolko M
Journal of Glaucoma 2019; 28: 325-333 (IGR: 20-2)

78810 Development of Targeted siRNA Nanocomplexes to Prevent Fibrosis in Experimental Glaucoma Filtration Surgery
Fernando O
Molecular Therapy 2018; 26: 2812-2822 (IGR: 20-1)

79239 Structural and molecular tear film changes in glaucoma
Mastropasqua R
Current Medicinal Chemistry 2018; 0: (IGR: 20-1)

78599 Evaluation of Ocular Surface Disease in Patients With Glaucoma: Clinical Parameters, Self-report Assessment, and Keratograph Analysis
Portela RC
Journal of Glaucoma 2018; 27: 794-801 (IGR: 20-1)

79293 Brinzolamide-induced Follicular Conjunctivitis
Young JW
Journal of Glaucoma 2018; 27: e183-e184 (IGR: 20-1)

79231 Comorbidities and Prescribed Medications in Patients With or Without Dry Eye Disease: A Population-Based Study
Dana R
American Journal of Ophthalmology 2019; 198: 181-192 (IGR: 20-1)

78775 Factors Associated with Conjunctival Erosions after Ahmed Glaucoma Valve Implantation
Zhou D
Journal of ophthalmic & vision research 2018; 13: 411-418 (IGR: 20-1)

78968 Cytokine expression in tears of patients with glaucoma or dry eye disease: A prospective, observational cohort study
Benitez-del-Castillo J
European Journal of Ophthalmology 2018; 0: 1120672118795399 (IGR: 20-1)

79246 Objective ocular surface tolerance in patients with glaucoma treated with topical preserved or unpreserved prostaglandin analogues
El Ameen A
European Journal of Ophthalmology 2018; 0: 1120672118805877 (IGR: 20-1)

78498 Conjunctival and Intrascleral Vasculatures Assessed Using Anterior Segment Optical Coherence Tomography Angiography in Normal Eyes
Akagi T
American Journal of Ophthalmology 2018; 196: 1-9 (IGR: 20-1)

79289 The impact of topical intraocular pressure lowering medications on the ocular surface of glaucoma patients: A review
Asiedu K
Journal of current ophthalmology 2019; 31: 8-15 (IGR: 20-1)

78523 Tear biomarkers in latanoprost and bimatoprost treated eyes
Reddy S
PLoS ONE 2018; 13: e0201740 (IGR: 20-1)

79246 Objective ocular surface tolerance in patients with glaucoma treated with topical preserved or unpreserved prostaglandin analogues
Vandermeer G
European Journal of Ophthalmology 2018; 0: 1120672118805877 (IGR: 20-1)

79231 Comorbidities and Prescribed Medications in Patients With or Without Dry Eye Disease: A Population-Based Study
Bradley JL
American Journal of Ophthalmology 2019; 198: 181-192 (IGR: 20-1)

78775 Factors Associated with Conjunctival Erosions after Ahmed Glaucoma Valve Implantation
Zhou XY
Journal of ophthalmic & vision research 2018; 13: 411-418 (IGR: 20-1)

79239 Structural and molecular tear film changes in glaucoma
Agnifili L
Current Medicinal Chemistry 2018; 0: (IGR: 20-1)

78498 Conjunctival and Intrascleral Vasculatures Assessed Using Anterior Segment Optical Coherence Tomography Angiography in Normal Eyes
Uji A
American Journal of Ophthalmology 2018; 196: 1-9 (IGR: 20-1)

79289 The impact of topical intraocular pressure lowering medications on the ocular surface of glaucoma patients: A review
Abu SL
Journal of current ophthalmology 2019; 31: 8-15 (IGR: 20-1)

78523 Tear biomarkers in latanoprost and bimatoprost treated eyes
Sahay P
PLoS ONE 2018; 13: e0201740 (IGR: 20-1)

78968 Cytokine expression in tears of patients with glaucoma or dry eye disease: A prospective, observational cohort study
Cantu-Dibildox J
European Journal of Ophthalmology 2018; 0: 1120672118795399 (IGR: 20-1)

78599 Evaluation of Ocular Surface Disease in Patients With Glaucoma: Clinical Parameters, Self-report Assessment, and Keratograph Analysis
Fares NT
Journal of Glaucoma 2018; 27: 794-801 (IGR: 20-1)

79293 Brinzolamide-induced Follicular Conjunctivitis
Clements JL
Journal of Glaucoma 2018; 27: e183-e184 (IGR: 20-1)

78810 Development of Targeted siRNA Nanocomplexes to Prevent Fibrosis in Experimental Glaucoma Filtration Surgery
Tagalakis AD
Molecular Therapy 2018; 26: 2812-2822 (IGR: 20-1)

78775 Factors Associated with Conjunctival Erosions after Ahmed Glaucoma Valve Implantation
Mas-Ramirez AM
Journal of ophthalmic & vision research 2018; 13: 411-418 (IGR: 20-1)

78968 Cytokine expression in tears of patients with glaucoma or dry eye disease: A prospective, observational cohort study
Sanz-González SM
European Journal of Ophthalmology 2018; 0: 1120672118795399 (IGR: 20-1)

79293 Brinzolamide-induced Follicular Conjunctivitis
Morrison JC
Journal of Glaucoma 2018; 27: e183-e184 (IGR: 20-1)

78498 Conjunctival and Intrascleral Vasculatures Assessed Using Anterior Segment Optical Coherence Tomography Angiography in Normal Eyes
Huang AS
American Journal of Ophthalmology 2018; 196: 1-9 (IGR: 20-1)

79246 Objective ocular surface tolerance in patients with glaucoma treated with topical preserved or unpreserved prostaglandin analogues
Khanna RK
European Journal of Ophthalmology 2018; 0: 1120672118805877 (IGR: 20-1)

78523 Tear biomarkers in latanoprost and bimatoprost treated eyes
Padhy D
PLoS ONE 2018; 13: e0201740 (IGR: 20-1)

78810 Development of Targeted siRNA Nanocomplexes to Prevent Fibrosis in Experimental Glaucoma Filtration Surgery
Awwad S
Molecular Therapy 2018; 26: 2812-2822 (IGR: 20-1)

78599 Evaluation of Ocular Surface Disease in Patients With Glaucoma: Clinical Parameters, Self-report Assessment, and Keratograph Analysis
Machado LF
Journal of Glaucoma 2018; 27: 794-801 (IGR: 20-1)

79231 Comorbidities and Prescribed Medications in Patients With or Without Dry Eye Disease: A Population-Based Study
Guerin A
American Journal of Ophthalmology 2019; 198: 181-192 (IGR: 20-1)

79239 Structural and molecular tear film changes in glaucoma
Mastropasqua L
Current Medicinal Chemistry 2018; 0: (IGR: 20-1)

78523 Tear biomarkers in latanoprost and bimatoprost treated eyes
Sarangi S
PLoS ONE 2018; 13: e0201740 (IGR: 20-1)

78775 Factors Associated with Conjunctival Erosions after Ahmed Glaucoma Valve Implantation
Kim C
Journal of ophthalmic & vision research 2018; 13: 411-418 (IGR: 20-1)

78968 Cytokine expression in tears of patients with glaucoma or dry eye disease: A prospective, observational cohort study
Zanón-Moreno V
European Journal of Ophthalmology 2018; 0: 1120672118795399 (IGR: 20-1)

79231 Comorbidities and Prescribed Medications in Patients With or Without Dry Eye Disease: A Population-Based Study
Pivneva I
American Journal of Ophthalmology 2019; 198: 181-192 (IGR: 20-1)

78498 Conjunctival and Intrascleral Vasculatures Assessed Using Anterior Segment Optical Coherence Tomography Angiography in Normal Eyes
Weinreb RN
American Journal of Ophthalmology 2018; 196: 1-9 (IGR: 20-1)

78810 Development of Targeted siRNA Nanocomplexes to Prevent Fibrosis in Experimental Glaucoma Filtration Surgery
Brocchini S
Molecular Therapy 2018; 26: 2812-2822 (IGR: 20-1)

79293 Brinzolamide-induced Follicular Conjunctivitis
Takusagawa HL
Journal of Glaucoma 2018; 27: e183-e184 (IGR: 20-1)

79246 Objective ocular surface tolerance in patients with glaucoma treated with topical preserved or unpreserved prostaglandin analogues
Pisella PJ
European Journal of Ophthalmology 2018; 0: 1120672118805877 (IGR: 20-1)

78599 Evaluation of Ocular Surface Disease in Patients With Glaucoma: Clinical Parameters, Self-report Assessment, and Keratograph Analysis
São Leão AF; de Freitas D
Journal of Glaucoma 2018; 27: 794-801 (IGR: 20-1)

78523 Tear biomarkers in latanoprost and bimatoprost treated eyes
Suar M
PLoS ONE 2018; 13: e0201740 (IGR: 20-1)

78775 Factors Associated with Conjunctival Erosions after Ahmed Glaucoma Valve Implantation
Juzych MS
Journal of ophthalmic & vision research 2018; 13: 411-418 (IGR: 20-1)

78810 Development of Targeted siRNA Nanocomplexes to Prevent Fibrosis in Experimental Glaucoma Filtration Surgery
Khaw PT
Molecular Therapy 2018; 26: 2812-2822 (IGR: 20-1)

78968 Cytokine expression in tears of patients with glaucoma or dry eye disease: A prospective, observational cohort study
Pinazo-Duran MD
European Journal of Ophthalmology 2018; 0: 1120672118795399 (IGR: 20-1)

79231 Comorbidities and Prescribed Medications in Patients With or Without Dry Eye Disease: A Population-Based Study
Evans AM
American Journal of Ophthalmology 2019; 198: 181-192 (IGR: 20-1)

78498 Conjunctival and Intrascleral Vasculatures Assessed Using Anterior Segment Optical Coherence Tomography Angiography in Normal Eyes
Yamada T
American Journal of Ophthalmology 2018; 196: 1-9 (IGR: 20-1)

79231 Comorbidities and Prescribed Medications in Patients With or Without Dry Eye Disease: A Population-Based Study
Stillman IÖ
American Journal of Ophthalmology 2019; 198: 181-192 (IGR: 20-1)

78498 Conjunctival and Intrascleral Vasculatures Assessed Using Anterior Segment Optical Coherence Tomography Angiography in Normal Eyes
Miyata M
American Journal of Ophthalmology 2018; 196: 1-9 (IGR: 20-1)

78810 Development of Targeted siRNA Nanocomplexes to Prevent Fibrosis in Experimental Glaucoma Filtration Surgery
Hart SL
Molecular Therapy 2018; 26: 2812-2822 (IGR: 20-1)

78523 Tear biomarkers in latanoprost and bimatoprost treated eyes
Modak R
PLoS ONE 2018; 13: e0201740 (IGR: 20-1)

78775 Factors Associated with Conjunctival Erosions after Ahmed Glaucoma Valve Implantation
Nassiri N
Journal of ophthalmic & vision research 2018; 13: 411-418 (IGR: 20-1)

78599 Evaluation of Ocular Surface Disease in Patients With Glaucoma: Clinical Parameters, Self-report Assessment, and Keratograph Analysis
Paranhos A
Journal of Glaucoma 2018; 27: 794-801 (IGR: 20-1)

78498 Conjunctival and Intrascleral Vasculatures Assessed Using Anterior Segment Optical Coherence Tomography Angiography in Normal Eyes
Kameda T
American Journal of Ophthalmology 2018; 196: 1-9 (IGR: 20-1)

78523 Tear biomarkers in latanoprost and bimatoprost treated eyes
Rao A
PLoS ONE 2018; 13: e0201740 (IGR: 20-1)

78599 Evaluation of Ocular Surface Disease in Patients With Glaucoma: Clinical Parameters, Self-report Assessment, and Keratograph Analysis
Prata TS
Journal of Glaucoma 2018; 27: 794-801 (IGR: 20-1)

78775 Factors Associated with Conjunctival Erosions after Ahmed Glaucoma Valve Implantation
Hughes BA
Journal of ophthalmic & vision research 2018; 13: 411-418 (IGR: 20-1)

78810 Development of Targeted siRNA Nanocomplexes to Prevent Fibrosis in Experimental Glaucoma Filtration Surgery
Yu-Wai-Man C
Molecular Therapy 2018; 26: 2812-2822 (IGR: 20-1)

78498 Conjunctival and Intrascleral Vasculatures Assessed Using Anterior Segment Optical Coherence Tomography Angiography in Normal Eyes
Ikeda HO
American Journal of Ophthalmology 2018; 196: 1-9 (IGR: 20-1)

78599 Evaluation of Ocular Surface Disease in Patients With Glaucoma: Clinical Parameters, Self-report Assessment, and Keratograph Analysis
Gracitelli CPB
Journal of Glaucoma 2018; 27: 794-801 (IGR: 20-1)

78498 Conjunctival and Intrascleral Vasculatures Assessed Using Anterior Segment Optical Coherence Tomography Angiography in Normal Eyes
Tsujikawa A
American Journal of Ophthalmology 2018; 196: 1-9 (IGR: 20-1)

78156 Reduction in Ocular Hypotensive Eyedrops by Ab Interno Trabeculotomy Improves Not Only Ocular Surface Condition But Also Quality of Vision
Kashiwagi K
Journal of Ophthalmology 2018; 2018: 8165476 (IGR: 19-4)

77990 Altered expression level of inflammation-related genes and long-term changes in ocular surface after trabeculectomy, a prospective cohort study
Tong L
Ocular Surface 2018; 16: 441-447 (IGR: 19-4)

78189 Effect of long-term topical latanoprost medication on conjunctival thickness in patients with glaucoma
Li QS; Bao FF
International Journal of Ophthalmology 2018; 11: 1158-1162 (IGR: 19-4)

77990 Altered expression level of inflammation-related genes and long-term changes in ocular surface after trabeculectomy, a prospective cohort study
Hou AH
Ocular Surface 2018; 16: 441-447 (IGR: 19-4)

78156 Reduction in Ocular Hypotensive Eyedrops by Ab Interno Trabeculotomy Improves Not Only Ocular Surface Condition But Also Quality of Vision
Matsubara M
Journal of Ophthalmology 2018; 2018: 8165476 (IGR: 19-4)

78189 Effect of long-term topical latanoprost medication on conjunctival thickness in patients with glaucoma
Zhang ZY
International Journal of Ophthalmology 2018; 11: 1158-1162 (IGR: 19-4)

77990 Altered expression level of inflammation-related genes and long-term changes in ocular surface after trabeculectomy, a prospective cohort study
Wong TT
Ocular Surface 2018; 16: 441-447 (IGR: 19-4)

78189 Effect of long-term topical latanoprost medication on conjunctival thickness in patients with glaucoma
Ma K
International Journal of Ophthalmology 2018; 11: 1158-1162 (IGR: 19-4)

76887 Intraocular light scatter in patients on topical intraocular pressure-lowering medication
Pérez-Bartolomé F
European Journal of Ophthalmology 2018; 0: 1120672117753667 (IGR: 19-3)

76990 Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical Hypotensiv
Roberti G
Advances in Therapy 2018; 35: 686-696 (IGR: 19-3)

76239 Eyelid Changes Related to Meibomian Gland Dysfunction in Early Middle-Aged Patients Using Topical Glaucoma Medications
Kim JH
Cornea 2018; 37: 421-425 (IGR: 19-3)

76429 Meibomian Gland Features and Conjunctival Goblet Cell Density in Glaucomatous Patients Controlled With Prostaglandin/Timolol Fixed Combinations: A Case Control, Cross-sectional Study
Agnifili L
Journal of Glaucoma 2018; 27: 364-370 (IGR: 19-3)

76819 High Prevalence of Ocular Surface Disease Among Glaucoma Patients in Thailand
Ruangvaravate N
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 387-394 (IGR: 19-3)

76880 Assessment of Corneal Changes Associated with Topical Antiglaucoma Therapy Using in vivo Confocal Microscopy
Baghdasaryan E
Ophthalmic Research 2018; 0: (IGR: 19-3)

76562
Di Staso S
In vivo (Athens, Greece) 2018; 32: 211-220 (IGR: 19-3)

76521 Effect of brimonidine, an α2 adrenergic agonist, on human meibomian gland epithelial cells
Han X
Experimental Eye Research 2018; 170: 20-28 (IGR: 19-3)

77182 Ocular surface status in glaucoma and ocular hypertension patients with existing corneal disorders switched from latanoprost 0.005% to tafluprost 0.0015%: comparison of two prostaglandin analogues with different concentrations of benzalkonium chloride
Wong TT
Clinical and Experimental Ophthalmology 2018; 0: (IGR: 19-3)

76638 Exploring topical anti-glaucoma medication effects on the ocular surface in the context of the current understanding of dry eye
Wong ABC
Ocular Surface 2018; 16: 289-293 (IGR: 19-3)

76563
Di Staso S
In vivo (Athens, Greece) 2018; 32: 437-443 (IGR: 19-3)

76584 Conjunctival repair after glaucoma drainage device exposure using collagen-glycosaminoglycane matrices
Rosentreter A
BMC Ophthalmology 2018; 18: 60 (IGR: 19-3)

77008 Effect of a punctal plug on ocular surface disease in patients using topical prostaglandin analogues: a randomized controlled trial
Sherwin JC
Clinical and Experimental Ophthalmology 2018; 0: (IGR: 19-3)

76992 Influence of glaucoma surgery on the ocular surface using oculus keratograph
Zhong S
International Ophthalmology 2019; 39: 745-752 (IGR: 19-3)

76819 High Prevalence of Ocular Surface Disease Among Glaucoma Patients in Thailand
Prabhasawat P
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 387-394 (IGR: 19-3)

76239 Eyelid Changes Related to Meibomian Gland Dysfunction in Early Middle-Aged Patients Using Topical Glaucoma Medications
Shin YU
Cornea 2018; 37: 421-425 (IGR: 19-3)

76562
Agnifili L
In vivo (Athens, Greece) 2018; 32: 211-220 (IGR: 19-3)

76887 Intraocular light scatter in patients on topical intraocular pressure-lowering medication
Martínez de la Casa JM
European Journal of Ophthalmology 2018; 0: 1120672117753667 (IGR: 19-3)

76563
Agnifili L
In vivo (Athens, Greece) 2018; 32: 437-443 (IGR: 19-3)

76584 Conjunctival repair after glaucoma drainage device exposure using collagen-glycosaminoglycane matrices
Lappas A
BMC Ophthalmology 2018; 18: 60 (IGR: 19-3)

77008 Effect of a punctal plug on ocular surface disease in patients using topical prostaglandin analogues: a randomized controlled trial
Ratnarajan G
Clinical and Experimental Ophthalmology 2018; 0: (IGR: 19-3)

76429 Meibomian Gland Features and Conjunctival Goblet Cell Density in Glaucomatous Patients Controlled With Prostaglandin/Timolol Fixed Combinations: A Case Control, Cross-sectional Study
Mastropasqua R
Journal of Glaucoma 2018; 27: 364-370 (IGR: 19-3)

76990 Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical Hypotensiv
Agnifili L
Advances in Therapy 2018; 35: 686-696 (IGR: 19-3)

76992 Influence of glaucoma surgery on the ocular surface using oculus keratograph
Zhou H
International Ophthalmology 2019; 39: 745-752 (IGR: 19-3)

77182 Ocular surface status in glaucoma and ocular hypertension patients with existing corneal disorders switched from latanoprost 0.005% to tafluprost 0.0015%: comparison of two prostaglandin analogues with different concentrations of benzalkonium chloride
Aung T
Clinical and Experimental Ophthalmology 2018; 0: (IGR: 19-3)

76880 Assessment of Corneal Changes Associated with Topical Antiglaucoma Therapy Using in vivo Confocal Microscopy
Tepelus TC
Ophthalmic Research 2018; 0: (IGR: 19-3)

76521 Effect of brimonidine, an α2 adrenergic agonist, on human meibomian gland epithelial cells
Liu Y
Experimental Eye Research 2018; 170: 20-28 (IGR: 19-3)

76638 Exploring topical anti-glaucoma medication effects on the ocular surface in the context of the current understanding of dry eye
Wang MTM
Ocular Surface 2018; 16: 289-293 (IGR: 19-3)

77008 Effect of a punctal plug on ocular surface disease in patients using topical prostaglandin analogues: a randomized controlled trial
Elahi B
Clinical and Experimental Ophthalmology 2018; 0: (IGR: 19-3)

76584 Conjunctival repair after glaucoma drainage device exposure using collagen-glycosaminoglycane matrices
Widder RA
BMC Ophthalmology 2018; 18: 60 (IGR: 19-3)

76887 Intraocular light scatter in patients on topical intraocular pressure-lowering medication
Arriola-Villalobos P
European Journal of Ophthalmology 2018; 0: 1120672117753667 (IGR: 19-3)

77182 Ocular surface status in glaucoma and ocular hypertension patients with existing corneal disorders switched from latanoprost 0.005% to tafluprost 0.0015%: comparison of two prostaglandin analogues with different concentrations of benzalkonium chloride
Ho CL
Clinical and Experimental Ophthalmology 2018; 0: (IGR: 19-3)

76992 Influence of glaucoma surgery on the ocular surface using oculus keratograph
Chen X
International Ophthalmology 2019; 39: 745-752 (IGR: 19-3)

76819 High Prevalence of Ocular Surface Disease Among Glaucoma Patients in Thailand
Vachirasakchai V
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 387-394 (IGR: 19-3)

76880 Assessment of Corneal Changes Associated with Topical Antiglaucoma Therapy Using in vivo Confocal Microscopy
Vickers LA
Ophthalmic Research 2018; 0: (IGR: 19-3)

76562
Cecannecchia S
In vivo (Athens, Greece) 2018; 32: 211-220 (IGR: 19-3)

76990 Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical Hypotensiv
Berardo F
Advances in Therapy 2018; 35: 686-696 (IGR: 19-3)

76239 Eyelid Changes Related to Meibomian Gland Dysfunction in Early Middle-Aged Patients Using Topical Glaucoma Medications
Seong M
Cornea 2018; 37: 421-425 (IGR: 19-3)

76429 Meibomian Gland Features and Conjunctival Goblet Cell Density in Glaucomatous Patients Controlled With Prostaglandin/Timolol Fixed Combinations: A Case Control, Cross-sectional Study
Fasanella V
Journal of Glaucoma 2018; 27: 364-370 (IGR: 19-3)

76521 Effect of brimonidine, an α2 adrenergic agonist, on human meibomian gland epithelial cells
Kam WR
Experimental Eye Research 2018; 170: 20-28 (IGR: 19-3)

76563
Ciancaglini M
In vivo (Athens, Greece) 2018; 32: 437-443 (IGR: 19-3)

76638 Exploring topical anti-glaucoma medication effects on the ocular surface in the context of the current understanding of dry eye
Liu K; Prime ZJ
Ocular Surface 2018; 16: 289-293 (IGR: 19-3)

76521 Effect of brimonidine, an α2 adrenergic agonist, on human meibomian gland epithelial cells
Sullivan DA
Experimental Eye Research 2018; 170: 20-28 (IGR: 19-3)

76584 Conjunctival repair after glaucoma drainage device exposure using collagen-glycosaminoglycane matrices
Alnawaiseh M
BMC Ophthalmology 2018; 18: 60 (IGR: 19-3)

77008 Effect of a punctal plug on ocular surface disease in patients using topical prostaglandin analogues: a randomized controlled trial
Bilkiewicz-Pawelec A
Clinical and Experimental Ophthalmology 2018; 0: (IGR: 19-3)

76239 Eyelid Changes Related to Meibomian Gland Dysfunction in Early Middle-Aged Patients Using Topical Glaucoma Medications
Cho HY
Cornea 2018; 37: 421-425 (IGR: 19-3)

76429 Meibomian Gland Features and Conjunctival Goblet Cell Density in Glaucomatous Patients Controlled With Prostaglandin/Timolol Fixed Combinations: A Case Control, Cross-sectional Study
Brescia L
Journal of Glaucoma 2018; 27: 364-370 (IGR: 19-3)

76992 Influence of glaucoma surgery on the ocular surface using oculus keratograph
Zhang W
International Ophthalmology 2019; 39: 745-752 (IGR: 19-3)

76563
Murano G
In vivo (Athens, Greece) 2018; 32: 437-443 (IGR: 19-3)

76880 Assessment of Corneal Changes Associated with Topical Antiglaucoma Therapy Using in vivo Confocal Microscopy
Huang P
Ophthalmic Research 2018; 0: (IGR: 19-3)

76819 High Prevalence of Ocular Surface Disease Among Glaucoma Patients in Thailand
Tantimala R
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 387-394 (IGR: 19-3)

76562
DI Gregorio A
In vivo (Athens, Greece) 2018; 32: 211-220 (IGR: 19-3)

76887 Intraocular light scatter in patients on topical intraocular pressure-lowering medication
Fernández-Pérez C
European Journal of Ophthalmology 2018; 0: 1120672117753667 (IGR: 19-3)

76990 Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical Hypotensiv
Riva I
Advances in Therapy 2018; 35: 686-696 (IGR: 19-3)

76429 Meibomian Gland Features and Conjunctival Goblet Cell Density in Glaucomatous Patients Controlled With Prostaglandin/Timolol Fixed Combinations: A Case Control, Cross-sectional Study
Scatena B
Journal of Glaucoma 2018; 27: 364-370 (IGR: 19-3)

77008 Effect of a punctal plug on ocular surface disease in patients using topical prostaglandin analogues: a randomized controlled trial
Salmon JF
Clinical and Experimental Ophthalmology 2018; 0: (IGR: 19-3)

76563
Borrelli E
In vivo (Athens, Greece) 2018; 32: 437-443 (IGR: 19-3)

76584 Conjunctival repair after glaucoma drainage device exposure using collagen-glycosaminoglycane matrices
Dietlein TS
BMC Ophthalmology 2018; 18: 60 (IGR: 19-3)

76990 Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical Hypotensiv
Figus M
Advances in Therapy 2018; 35: 686-696 (IGR: 19-3)

76992 Influence of glaucoma surgery on the ocular surface using oculus keratograph
Yi L
International Ophthalmology 2019; 39: 745-752 (IGR: 19-3)

76239 Eyelid Changes Related to Meibomian Gland Dysfunction in Early Middle-Aged Patients Using Topical Glaucoma Medications
Kang MH
Cornea 2018; 37: 421-425 (IGR: 19-3)

76887 Intraocular light scatter in patients on topical intraocular pressure-lowering medication
García-Feijoó J
European Journal of Ophthalmology 2018; 0: 1120672117753667 (IGR: 19-3)

76562
Ciancaglini M
In vivo (Athens, Greece) 2018; 32: 211-220 (IGR: 19-3)

76638 Exploring topical anti-glaucoma medication effects on the ocular surface in the context of the current understanding of dry eye
Danesh-Meyer HV
Ocular Surface 2018; 16: 289-293 (IGR: 19-3)

76563
Borrelli E
In vivo (Athens, Greece) 2018; 32: 437-443 (IGR: 19-3)

76880 Assessment of Corneal Changes Associated with Topical Antiglaucoma Therapy Using in vivo Confocal Microscopy
Chopra V; Sadda SR
Ophthalmic Research 2018; 0: (IGR: 19-3)

76990 Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical Hypotensiv
Manni G
Advances in Therapy 2018; 35: 686-696 (IGR: 19-3)

76563
Mastropasqua L
In vivo (Athens, Greece) 2018; 32: 437-443 (IGR: 19-3)

76638 Exploring topical anti-glaucoma medication effects on the ocular surface in the context of the current understanding of dry eye
Craig JP
Ocular Surface 2018; 16: 289-293 (IGR: 19-3)

76429 Meibomian Gland Features and Conjunctival Goblet Cell Density in Glaucomatous Patients Controlled With Prostaglandin/Timolol Fixed Combinations: A Case Control, Cross-sectional Study
Oddone F
Journal of Glaucoma 2018; 27: 364-370 (IGR: 19-3)

76880 Assessment of Corneal Changes Associated with Topical Antiglaucoma Therapy Using in vivo Confocal Microscopy
Lee OL
Ophthalmic Research 2018; 0: (IGR: 19-3)

76429 Meibomian Gland Features and Conjunctival Goblet Cell Density in Glaucomatous Patients Controlled With Prostaglandin/Timolol Fixed Combinations: A Case Control, Cross-sectional Study
Mastropasqua L
Journal of Glaucoma 2018; 27: 364-370 (IGR: 19-3)

76990 Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical Hypotensiv
Quaranta L; Oddone F
Advances in Therapy 2018; 35: 686-696 (IGR: 19-3)

75490 Management of conjunctival perforation and late Seidel after XEN surgery
Olate-Pérez Á
Archivos de la Sociedad Espa�ola de Oftalmologia 2018; 93: 93-96 (IGR: 19-2)

75313 Ocular Redness Measured with the Keratograph 5M in Patients Using Anti-Glaucoma Eye Drops
Pérez Bartolomé F
Seminars in Ophthalmology 2017; 0: 1-8 (IGR: 19-2)

75519 Meibomian Gland Performance in Glaucomatous Patients With Long-term Instillation of IOP-lowering Medications
Cho WH; Lai IC
Journal of Glaucoma 2018; 27: 176-183 (IGR: 19-2)

75313 Ocular Redness Measured with the Keratograph 5M in Patients Using Anti-Glaucoma Eye Drops
Martínez de la Casa JM
Seminars in Ophthalmology 2017; 0: 1-8 (IGR: 19-2)

75490 Management of conjunctival perforation and late Seidel after XEN surgery
Pérez-Torregrosa VT
Archivos de la Sociedad Espa�ola de Oftalmologia 2018; 93: 93-96 (IGR: 19-2)

75313 Ocular Redness Measured with the Keratograph 5M in Patients Using Anti-Glaucoma Eye Drops
Arriola Villalobos P
Seminars in Ophthalmology 2017; 0: 1-8 (IGR: 19-2)

75490 Management of conjunctival perforation and late Seidel after XEN surgery
Gargallo-Benedicto A
Archivos de la Sociedad Espa�ola de Oftalmologia 2018; 93: 93-96 (IGR: 19-2)

75519 Meibomian Gland Performance in Glaucomatous Patients With Long-term Instillation of IOP-lowering Medications
Fang PC
Journal of Glaucoma 2018; 27: 176-183 (IGR: 19-2)

75313 Ocular Redness Measured with the Keratograph 5M in Patients Using Anti-Glaucoma Eye Drops
Fernández Pérez C
Seminars in Ophthalmology 2017; 0: 1-8 (IGR: 19-2)

75519 Meibomian Gland Performance in Glaucomatous Patients With Long-term Instillation of IOP-lowering Medications
Chien CC
Journal of Glaucoma 2018; 27: 176-183 (IGR: 19-2)

75490 Management of conjunctival perforation and late Seidel after XEN surgery
Escudero-Igualada R; Cerdà-Ibáñez M
Archivos de la Sociedad Espa�ola de Oftalmologia 2018; 93: 93-96 (IGR: 19-2)

75519 Meibomian Gland Performance in Glaucomatous Patients With Long-term Instillation of IOP-lowering Medications
Tseng SL
Journal of Glaucoma 2018; 27: 176-183 (IGR: 19-2)

75313 Ocular Redness Measured with the Keratograph 5M in Patients Using Anti-Glaucoma Eye Drops
Polo V
Seminars in Ophthalmology 2017; 0: 1-8 (IGR: 19-2)

75519 Meibomian Gland Performance in Glaucomatous Patients With Long-term Instillation of IOP-lowering Medications
Lai YH
Journal of Glaucoma 2018; 27: 176-183 (IGR: 19-2)

75490 Management of conjunctival perforation and late Seidel after XEN surgery
Barreiro-Rego A
Archivos de la Sociedad Espa�ola de Oftalmologia 2018; 93: 93-96 (IGR: 19-2)

75313 Ocular Redness Measured with the Keratograph 5M in Patients Using Anti-Glaucoma Eye Drops
Sánchez Jean R; García Feijoó J
Seminars in Ophthalmology 2017; 0: 1-8 (IGR: 19-2)

75490 Management of conjunctival perforation and late Seidel after XEN surgery
Duch-Samper A
Archivos de la Sociedad Espa�ola de Oftalmologia 2018; 93: 93-96 (IGR: 19-2)

75519 Meibomian Gland Performance in Glaucomatous Patients With Long-term Instillation of IOP-lowering Medications
Huang YT; Kuo MT
Journal of Glaucoma 2018; 27: 176-183 (IGR: 19-2)

74062 The association between ocular surface measurements with visual field reliability indices and gaze tracking results in preperimetric glaucoma
Arai T
British Journal of Ophthalmology 2018; 102: 525-530 (IGR: 19-1)

74203 Changes in Ocular Surface Characteristics after Switching from Benzalkonium Chloride-Preserved Latanoprost to Preservative-Free Tafluprost or Benzalkonium Chloride-Preserved Tafluprost
Tokuda N
Journal of Ophthalmology 2017; 2017: 3540749 (IGR: 19-1)

74743 Three-dimensional Laser Scanning Confocal Analysis of Conjunctival Microcysts in Glaucomatous Patients Before and After Trabeculectomy
Di Staso S
In vivo (Athens, Greece) 2017; 31: 1081-1088 (IGR: 19-1)

74615 Use of Topical Cannabinomimetic Palmitoylethanolamide in Ocular Surface Disease Associated with Antiglaucoma Medications
Di Zazzo A
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 670-677 (IGR: 19-1)

74785 Schockmed Valve: A Novel Surgical Option for Uncontrolled Glaucoma in Eyes with Poor Conjunctiva and Encircling Bands
Fleischman D
Journal of Current Glaucoma Practice 2017; 11: 120-124 (IGR: 19-1)

74714 Conjunctival changes in different clinical variants of early pseudoexfoliation
Rao A
International Ophthalmology 2017; 0: (IGR: 19-1)

74131 Conjunctival Bacteria Flora of Glaucoma Patients During Long-Term Administration of Prostaglandin Analog Drops
Ohtani S
Investigative Ophthalmology and Visual Science 2017; 58: 3991-3996 (IGR: 19-1)

74203 Changes in Ocular Surface Characteristics after Switching from Benzalkonium Chloride-Preserved Latanoprost to Preservative-Free Tafluprost or Benzalkonium Chloride-Preserved Tafluprost
Kitaoka Y
Journal of Ophthalmology 2017; 2017: 3540749 (IGR: 19-1)

74743 Three-dimensional Laser Scanning Confocal Analysis of Conjunctival Microcysts in Glaucomatous Patients Before and After Trabeculectomy
Agnifili L
In vivo (Athens, Greece) 2017; 31: 1081-1088 (IGR: 19-1)

74131 Conjunctival Bacteria Flora of Glaucoma Patients During Long-Term Administration of Prostaglandin Analog Drops
Shimizu K
Investigative Ophthalmology and Visual Science 2017; 58: 3991-3996 (IGR: 19-1)

74615 Use of Topical Cannabinomimetic Palmitoylethanolamide in Ocular Surface Disease Associated with Antiglaucoma Medications
Roberti G
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 670-677 (IGR: 19-1)

74714 Conjunctival changes in different clinical variants of early pseudoexfoliation
Das G
International Ophthalmology 2017; 0: (IGR: 19-1)

74785 Schockmed Valve: A Novel Surgical Option for Uncontrolled Glaucoma in Eyes with Poor Conjunctiva and Encircling Bands
Kim B
Journal of Current Glaucoma Practice 2017; 11: 120-124 (IGR: 19-1)

74062 The association between ocular surface measurements with visual field reliability indices and gaze tracking results in preperimetric glaucoma
Murata H
British Journal of Ophthalmology 2018; 102: 525-530 (IGR: 19-1)

74714 Conjunctival changes in different clinical variants of early pseudoexfoliation
Sarangi S
International Ophthalmology 2017; 0: (IGR: 19-1)

74131 Conjunctival Bacteria Flora of Glaucoma Patients During Long-Term Administration of Prostaglandin Analog Drops
Nejima R
Investigative Ophthalmology and Visual Science 2017; 58: 3991-3996 (IGR: 19-1)

74062 The association between ocular surface measurements with visual field reliability indices and gaze tracking results in preperimetric glaucoma
Matsuura M
British Journal of Ophthalmology 2018; 102: 525-530 (IGR: 19-1)

74743 Three-dimensional Laser Scanning Confocal Analysis of Conjunctival Microcysts in Glaucomatous Patients Before and After Trabeculectomy
DI Gregorio A
In vivo (Athens, Greece) 2017; 31: 1081-1088 (IGR: 19-1)

74615 Use of Topical Cannabinomimetic Palmitoylethanolamide in Ocular Surface Disease Associated with Antiglaucoma Medications
Mashaghi A
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 670-677 (IGR: 19-1)

74203 Changes in Ocular Surface Characteristics after Switching from Benzalkonium Chloride-Preserved Latanoprost to Preservative-Free Tafluprost or Benzalkonium Chloride-Preserved Tafluprost
Matsuzawa A
Journal of Ophthalmology 2017; 2017: 3540749 (IGR: 19-1)

74615 Use of Topical Cannabinomimetic Palmitoylethanolamide in Ocular Surface Disease Associated with Antiglaucoma Medications
Abud TB
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 670-677 (IGR: 19-1)

74062 The association between ocular surface measurements with visual field reliability indices and gaze tracking results in preperimetric glaucoma
Usui T
British Journal of Ophthalmology 2018; 102: 525-530 (IGR: 19-1)

74714 Conjunctival changes in different clinical variants of early pseudoexfoliation
Padhy D
International Ophthalmology 2017; 0: (IGR: 19-1)

74743 Three-dimensional Laser Scanning Confocal Analysis of Conjunctival Microcysts in Glaucomatous Patients Before and After Trabeculectomy
Climastone H
In vivo (Athens, Greece) 2017; 31: 1081-1088 (IGR: 19-1)

74131 Conjunctival Bacteria Flora of Glaucoma Patients During Long-Term Administration of Prostaglandin Analog Drops
Kagaya F
Investigative Ophthalmology and Visual Science 2017; 58: 3991-3996 (IGR: 19-1)

74203 Changes in Ocular Surface Characteristics after Switching from Benzalkonium Chloride-Preserved Latanoprost to Preservative-Free Tafluprost or Benzalkonium Chloride-Preserved Tafluprost
Tsukamoto A
Journal of Ophthalmology 2017; 2017: 3540749 (IGR: 19-1)

74743 Three-dimensional Laser Scanning Confocal Analysis of Conjunctival Microcysts in Glaucomatous Patients Before and After Trabeculectomy
Galassi E
In vivo (Athens, Greece) 2017; 31: 1081-1088 (IGR: 19-1)

74062 The association between ocular surface measurements with visual field reliability indices and gaze tracking results in preperimetric glaucoma
Asaoka R
British Journal of Ophthalmology 2018; 102: 525-530 (IGR: 19-1)

74203 Changes in Ocular Surface Characteristics after Switching from Benzalkonium Chloride-Preserved Latanoprost to Preservative-Free Tafluprost or Benzalkonium Chloride-Preserved Tafluprost
Sase K
Journal of Ophthalmology 2017; 2017: 3540749 (IGR: 19-1)

74615 Use of Topical Cannabinomimetic Palmitoylethanolamide in Ocular Surface Disease Associated with Antiglaucoma Medications
Pavese D
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 670-677 (IGR: 19-1)

74131 Conjunctival Bacteria Flora of Glaucoma Patients During Long-Term Administration of Prostaglandin Analog Drops
Aihara M; Iwasaki T
Investigative Ophthalmology and Visual Science 2017; 58: 3991-3996 (IGR: 19-1)

74203 Changes in Ocular Surface Characteristics after Switching from Benzalkonium Chloride-Preserved Latanoprost to Preservative-Free Tafluprost or Benzalkonium Chloride-Preserved Tafluprost
Sakae S
Journal of Ophthalmology 2017; 2017: 3540749 (IGR: 19-1)

74615 Use of Topical Cannabinomimetic Palmitoylethanolamide in Ocular Surface Disease Associated with Antiglaucoma Medications
Bonini S
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 670-677 (IGR: 19-1)

74743 Three-dimensional Laser Scanning Confocal Analysis of Conjunctival Microcysts in Glaucomatous Patients Before and After Trabeculectomy
Fasanella V
In vivo (Athens, Greece) 2017; 31: 1081-1088 (IGR: 19-1)

74131 Conjunctival Bacteria Flora of Glaucoma Patients During Long-Term Administration of Prostaglandin Analog Drops
Shoji N
Investigative Ophthalmology and Visual Science 2017; 58: 3991-3996 (IGR: 19-1)

74203 Changes in Ocular Surface Characteristics after Switching from Benzalkonium Chloride-Preserved Latanoprost to Preservative-Free Tafluprost or Benzalkonium Chloride-Preserved Tafluprost
Takagi H
Journal of Ophthalmology 2017; 2017: 3540749 (IGR: 19-1)

74743 Three-dimensional Laser Scanning Confocal Analysis of Conjunctival Microcysts in Glaucomatous Patients Before and After Trabeculectomy
Ciancaglini M
In vivo (Athens, Greece) 2017; 31: 1081-1088 (IGR: 19-1)

74131 Conjunctival Bacteria Flora of Glaucoma Patients During Long-Term Administration of Prostaglandin Analog Drops
Miyata K
Investigative Ophthalmology and Visual Science 2017; 58: 3991-3996 (IGR: 19-1)

73056 Ocular surface disease in patients under topical treatment for glaucoma
Pérez-Bartolomé F
European Journal of Ophthalmology 2017; 0: 0 (IGR: 18-4)

72940 The Eye Drop Preservative Benzalkonium Chloride Potently Induces Mitochondrial Dysfunction and Preferentially Affects LHON Mutant Cells
Datta S
Investigative Ophthalmology and Visual Science 2017; 58: 2406-2412 (IGR: 18-4)

72837 Evaluation of Ocular Surface Disease in Asian Patients with Primary Angle Closure
Ling TE
Open Ophthalmology Journal 2017; 11: 31-39 (IGR: 18-4)

73009 Influence of Pilocarpine and Timolol on Human Meibomian Gland Epithelial Cells
Zhang Y
Cornea 2017; 36: 719-724 (IGR: 18-4)

72930 Ocular Surface and External Filtration Surgery: Mutual Relationships
Baudouin C
Developments in Ophthalmology 2017; 59: 67-79 (IGR: 18-4)

73009 Influence of Pilocarpine and Timolol on Human Meibomian Gland Epithelial Cells
Kam WR
Cornea 2017; 36: 719-724 (IGR: 18-4)

73056 Ocular surface disease in patients under topical treatment for glaucoma
Martínez-de-la-Casa JM
European Journal of Ophthalmology 2017; 0: 0 (IGR: 18-4)

72837 Evaluation of Ocular Surface Disease in Asian Patients with Primary Angle Closure
Othman K
Open Ophthalmology Journal 2017; 11: 31-39 (IGR: 18-4)

72940 The Eye Drop Preservative Benzalkonium Chloride Potently Induces Mitochondrial Dysfunction and Preferentially Affects LHON Mutant Cells
Baudouin C
Investigative Ophthalmology and Visual Science 2017; 58: 2406-2412 (IGR: 18-4)

72837 Evaluation of Ocular Surface Disease in Asian Patients with Primary Angle Closure
Yan OP
Open Ophthalmology Journal 2017; 11: 31-39 (IGR: 18-4)

72940 The Eye Drop Preservative Benzalkonium Chloride Potently Induces Mitochondrial Dysfunction and Preferentially Affects LHON Mutant Cells
Brignole-Baudouin F
Investigative Ophthalmology and Visual Science 2017; 58: 2406-2412 (IGR: 18-4)

73056 Ocular surface disease in patients under topical treatment for glaucoma
Arriola-Villalobos P
European Journal of Ophthalmology 2017; 0: 0 (IGR: 18-4)

73009 Influence of Pilocarpine and Timolol on Human Meibomian Gland Epithelial Cells
Liu Y
Cornea 2017; 36: 719-724 (IGR: 18-4)

72837 Evaluation of Ocular Surface Disease in Asian Patients with Primary Angle Closure
Rashid RA
Open Ophthalmology Journal 2017; 11: 31-39 (IGR: 18-4)

72940 The Eye Drop Preservative Benzalkonium Chloride Potently Induces Mitochondrial Dysfunction and Preferentially Affects LHON Mutant Cells
Denoyer A
Investigative Ophthalmology and Visual Science 2017; 58: 2406-2412 (IGR: 18-4)

73009 Influence of Pilocarpine and Timolol on Human Meibomian Gland Epithelial Cells
Chen X
Cornea 2017; 36: 719-724 (IGR: 18-4)

73056 Ocular surface disease in patients under topical treatment for glaucoma
Fernández-Pérez C
European Journal of Ophthalmology 2017; 0: 0 (IGR: 18-4)

73009 Influence of Pilocarpine and Timolol on Human Meibomian Gland Epithelial Cells
Sullivan DA
Cornea 2017; 36: 719-724 (IGR: 18-4)

72940 The Eye Drop Preservative Benzalkonium Chloride Potently Induces Mitochondrial Dysfunction and Preferentially Affects LHON Mutant Cells
Cortopassi GA
Investigative Ophthalmology and Visual Science 2017; 58: 2406-2412 (IGR: 18-4)

73056 Ocular surface disease in patients under topical treatment for glaucoma
Polo V
European Journal of Ophthalmology 2017; 0: 0 (IGR: 18-4)

72837 Evaluation of Ocular Surface Disease in Asian Patients with Primary Angle Closure
Tet CM; Yaakob A
Open Ophthalmology Journal 2017; 11: 31-39 (IGR: 18-4)

73056 Ocular surface disease in patients under topical treatment for glaucoma
García-Feijoó J
European Journal of Ophthalmology 2017; 0: 0 (IGR: 18-4)

72837 Evaluation of Ocular Surface Disease in Asian Patients with Primary Angle Closure
Tajudin LA
Open Ophthalmology Journal 2017; 11: 31-39 (IGR: 18-4)

71643 Cytokine biomarkers in tear film for primary open-angle glaucoma
Gupta D
Clinical Ophthalmology 2017; 11: 411-416 (IGR: 18-3)

71450 Determination of inmune response and inflammation mediators in tears: Changes in dry eye and glaucoma as compared to healthy controls
Benitez-Del-Castillo Sánchez J
Archivos de la Sociedad Espa�ola de Oftalmologia 2017; 92: 210-217 (IGR: 18-3)

71385 Oxidized low-density lipoprotein, lipid and calcium aggregates reveal oxidative stress and inflammation in the conjunctiva of glaucoma patients
Helin-Toiviainen M
Acta Ophthalmologica 2017; 95: 378-385 (IGR: 18-3)

71453 Bilateral Blebs Secondary to Spontaneous Scleral Perforations
Fernández López E
Journal of Glaucoma 2017; 26: e177-e179 (IGR: 18-3)

71643 Cytokine biomarkers in tear film for primary open-angle glaucoma
Wen JC
Clinical Ophthalmology 2017; 11: 411-416 (IGR: 18-3)

71385 Oxidized low-density lipoprotein, lipid and calcium aggregates reveal oxidative stress and inflammation in the conjunctiva of glaucoma patients
Rönkkö S
Acta Ophthalmologica 2017; 95: 378-385 (IGR: 18-3)

71450 Determination of inmune response and inflammation mediators in tears: Changes in dry eye and glaucoma as compared to healthy controls
Morillo-Rojas MD
Archivos de la Sociedad Espa�ola de Oftalmologia 2017; 92: 210-217 (IGR: 18-3)

71453 Bilateral Blebs Secondary to Spontaneous Scleral Perforations
Poon A
Journal of Glaucoma 2017; 26: e177-e179 (IGR: 18-3)

71450 Determination of inmune response and inflammation mediators in tears: Changes in dry eye and glaucoma as compared to healthy controls
Galbis-Estrada C
Archivos de la Sociedad Espa�ola de Oftalmologia 2017; 92: 210-217 (IGR: 18-3)

71453 Bilateral Blebs Secondary to Spontaneous Scleral Perforations
Huhtanen A
Journal of Glaucoma 2017; 26: e177-e179 (IGR: 18-3)

71643 Cytokine biomarkers in tear film for primary open-angle glaucoma
Huebner JL
Clinical Ophthalmology 2017; 11: 411-416 (IGR: 18-3)

71385 Oxidized low-density lipoprotein, lipid and calcium aggregates reveal oxidative stress and inflammation in the conjunctiva of glaucoma patients
Kaarniranta K
Acta Ophthalmologica 2017; 95: 378-385 (IGR: 18-3)

71453 Bilateral Blebs Secondary to Spontaneous Scleral Perforations
Lindsay R
Journal of Glaucoma 2017; 26: e177-e179 (IGR: 18-3)

71450 Determination of inmune response and inflammation mediators in tears: Changes in dry eye and glaucoma as compared to healthy controls
Pinazo-Duran MD
Archivos de la Sociedad Espa�ola de Oftalmologia 2017; 92: 210-217 (IGR: 18-3)

71385 Oxidized low-density lipoprotein, lipid and calcium aggregates reveal oxidative stress and inflammation in the conjunctiva of glaucoma patients
Puustjärvi T
Acta Ophthalmologica 2017; 95: 378-385 (IGR: 18-3)

71643 Cytokine biomarkers in tear film for primary open-angle glaucoma
Stinnett S; Kraus VB
Clinical Ophthalmology 2017; 11: 411-416 (IGR: 18-3)

71453 Bilateral Blebs Secondary to Spontaneous Scleral Perforations
Green C
Journal of Glaucoma 2017; 26: e177-e179 (IGR: 18-3)

71385 Oxidized low-density lipoprotein, lipid and calcium aggregates reveal oxidative stress and inflammation in the conjunctiva of glaucoma patients
Rekonen P; Ollikainen M
Acta Ophthalmologica 2017; 95: 378-385 (IGR: 18-3)

71643 Cytokine biomarkers in tear film for primary open-angle glaucoma
Tseng HC
Clinical Ophthalmology 2017; 11: 411-416 (IGR: 18-3)

71385 Oxidized low-density lipoprotein, lipid and calcium aggregates reveal oxidative stress and inflammation in the conjunctiva of glaucoma patients
Uusitalo H
Acta Ophthalmologica 2017; 95: 378-385 (IGR: 18-3)

71643 Cytokine biomarkers in tear film for primary open-angle glaucoma
Walsh M
Clinical Ophthalmology 2017; 11: 411-416 (IGR: 18-3)

69977 The Association of Chronic Topical Prostaglandin Analog Use With Meibomian Gland Dysfunction
Mocan MC
Journal of Glaucoma 2016; 25: 770-774 (IGR: 18-2)

70273 Tear Lipid Layer Thickness Change and Topical Anti-Glaucoma Medication Use
Lee SY
Optometry and Vision Science 2016; 93: 1210-1217 (IGR: 18-2)

70581 Ocular Surface Evaluation in Patients Treated with Prostaglandin Analogues Considering Preservative Agent
Mlčáková E
?eska a Slovenska Oftalmologie 2016; 72: 120-127 (IGR: 18-2)

70663 Time Course of Conjunctival Hyperemia Induced by a Rho-kinase Inhibitor Anti-glaucoma Eye Drop: Ripasudil 0.4
Terao E
Current Eye Research 2016; 0: 1-5 (IGR: 18-2)

69833 Corneal Haze as Prognostic Indicator of Intraocular Pressure in Primary Congenital Glaucoma
Li X
Journal of Glaucoma 2016; 25: e855-e860 (IGR: 18-2)

69977 The Association of Chronic Topical Prostaglandin Analog Use With Meibomian Gland Dysfunction
Uzunosmanoglu E
Journal of Glaucoma 2016; 25: 770-774 (IGR: 18-2)

70663 Time Course of Conjunctival Hyperemia Induced by a Rho-kinase Inhibitor Anti-glaucoma Eye Drop: Ripasudil 0.4
Nakakura S
Current Eye Research 2016; 0: 1-5 (IGR: 18-2)

70273 Tear Lipid Layer Thickness Change and Topical Anti-Glaucoma Medication Use
Lee H
Optometry and Vision Science 2016; 93: 1210-1217 (IGR: 18-2)

69833 Corneal Haze as Prognostic Indicator of Intraocular Pressure in Primary Congenital Glaucoma
Mukkamala L
Journal of Glaucoma 2016; 25: e855-e860 (IGR: 18-2)

70581 Ocular Surface Evaluation in Patients Treated with Prostaglandin Analogues Considering Preservative Agent
Mlčák P
?eska a Slovenska Oftalmologie 2016; 72: 120-127 (IGR: 18-2)

70663 Time Course of Conjunctival Hyperemia Induced by a Rho-kinase Inhibitor Anti-glaucoma Eye Drop: Ripasudil 0.4
Fujisawa Y
Current Eye Research 2016; 0: 1-5 (IGR: 18-2)

69977 The Association of Chronic Topical Prostaglandin Analog Use With Meibomian Gland Dysfunction
Kocabeyoglu S
Journal of Glaucoma 2016; 25: 770-774 (IGR: 18-2)

70581 Ocular Surface Evaluation in Patients Treated with Prostaglandin Analogues Considering Preservative Agent
Karhanová M
?eska a Slovenska Oftalmologie 2016; 72: 120-127 (IGR: 18-2)

69833 Corneal Haze as Prognostic Indicator of Intraocular Pressure in Primary Congenital Glaucoma
Origlieri CA
Journal of Glaucoma 2016; 25: e855-e860 (IGR: 18-2)

70273 Tear Lipid Layer Thickness Change and Topical Anti-Glaucoma Medication Use
Bae HW; Kim TI
Optometry and Vision Science 2016; 93: 1210-1217 (IGR: 18-2)

69833 Corneal Haze as Prognostic Indicator of Intraocular Pressure in Primary Congenital Glaucoma
Holland BK
Journal of Glaucoma 2016; 25: e855-e860 (IGR: 18-2)

70663 Time Course of Conjunctival Hyperemia Induced by a Rho-kinase Inhibitor Anti-glaucoma Eye Drop: Ripasudil 0.4
Fujio Y
Current Eye Research 2016; 0: 1-5 (IGR: 18-2)

70581 Ocular Surface Evaluation in Patients Treated with Prostaglandin Analogues Considering Preservative Agent
Langová K
?eska a Slovenska Oftalmologie 2016; 72: 120-127 (IGR: 18-2)

69977 The Association of Chronic Topical Prostaglandin Analog Use With Meibomian Gland Dysfunction
Karakaya J
Journal of Glaucoma 2016; 25: 770-774 (IGR: 18-2)

70581 Ocular Surface Evaluation in Patients Treated with Prostaglandin Analogues Considering Preservative Agent
Marešová K
?eska a Slovenska Oftalmologie 2016; 72: 120-127 (IGR: 18-2)

69977 The Association of Chronic Topical Prostaglandin Analog Use With Meibomian Gland Dysfunction
Irkec M
Journal of Glaucoma 2016; 25: 770-774 (IGR: 18-2)

70663 Time Course of Conjunctival Hyperemia Induced by a Rho-kinase Inhibitor Anti-glaucoma Eye Drop: Ripasudil 0.4
Matsuya K
Current Eye Research 2016; 0: 1-5 (IGR: 18-2)

70273 Tear Lipid Layer Thickness Change and Topical Anti-Glaucoma Medication Use
Kim CY
Optometry and Vision Science 2016; 93: 1210-1217 (IGR: 18-2)

69833 Corneal Haze as Prognostic Indicator of Intraocular Pressure in Primary Congenital Glaucoma
Fechtner RD; Khouri AS
Journal of Glaucoma 2016; 25: e855-e860 (IGR: 18-2)

70663 Time Course of Conjunctival Hyperemia Induced by a Rho-kinase Inhibitor Anti-glaucoma Eye Drop: Ripasudil 0.4
Kobayashi Y; Tabuchi H; Yoneda T; Fukushima A; Kiuchi Y
Current Eye Research 2016; 0: 1-5 (IGR: 18-2)

69273 Acute cytotoxic effects of marketed ophthalmic formulations on human corneal epithelial cells
Hakkarainen JJ
International Journal of Pharmaceutics 2016; 511: 73-78 (IGR: 18-1)

69187 InÂ vivo oximetry of human bulbar conjunctival and episcleral microvasculature using snapshot multispectral imaging
MacKenzie LE
Experimental Eye Research 2016; 149: 48-58 (IGR: 18-1)

69107 Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma
Walimbe T
Clinical Ophthalmology 2016; 10: 821-827 (IGR: 18-1)

69304 Ocular surface toxicity from glaucoma topical medications and associated preservatives such as benzalkonium chloride (BAK)
Aguayo Bonniard A
Expert Opinion on Drug Metabolism and Toxicology 2016; 0: 1-11 (IGR: 18-1)

69066 In Vivo Goblet Cell Density as a Potential Indicator of Glaucoma Filtration Surgery Outcome
Agnifili L
Investigative Ophthalmology and Visual Science 2016; 57: 2898-2905 (IGR: 18-1)

69212 Rasch Analysis of the Standard Patient Evaluation of Eye Dryness Questionnaire
Asiedu K
Eye Contact Lens 2017; 43: 394-398 (IGR: 18-1)

69304 Ocular surface toxicity from glaucoma topical medications and associated preservatives such as benzalkonium chloride (BAK)
Yeung JY
Expert Opinion on Drug Metabolism and Toxicology 2016; 0: 1-11 (IGR: 18-1)

69107 Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma
Chelerkar V
Clinical Ophthalmology 2016; 10: 821-827 (IGR: 18-1)

69187 InÂ vivo oximetry of human bulbar conjunctival and episcleral microvasculature using snapshot multispectral imaging
Choudhary TR
Experimental Eye Research 2016; 149: 48-58 (IGR: 18-1)

69273 Acute cytotoxic effects of marketed ophthalmic formulations on human corneal epithelial cells
Reinisalo M
International Journal of Pharmaceutics 2016; 511: 73-78 (IGR: 18-1)

69066 In Vivo Goblet Cell Density as a Potential Indicator of Glaucoma Filtration Surgery Outcome
Fasanella V
Investigative Ophthalmology and Visual Science 2016; 57: 2898-2905 (IGR: 18-1)

69304 Ocular surface toxicity from glaucoma topical medications and associated preservatives such as benzalkonium chloride (BAK)
Chan CC
Expert Opinion on Drug Metabolism and Toxicology 2016; 0: 1-11 (IGR: 18-1)

69066 In Vivo Goblet Cell Density as a Potential Indicator of Glaucoma Filtration Surgery Outcome
Mastropasqua R
Investigative Ophthalmology and Visual Science 2016; 57: 2898-2905 (IGR: 18-1)

69187 InÂ vivo oximetry of human bulbar conjunctival and episcleral microvasculature using snapshot multispectral imaging
McNaught AI
Experimental Eye Research 2016; 149: 48-58 (IGR: 18-1)

69273 Acute cytotoxic effects of marketed ophthalmic formulations on human corneal epithelial cells
Ragauskas S
International Journal of Pharmaceutics 2016; 511: 73-78 (IGR: 18-1)

69107 Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma
Bhagat P
Clinical Ophthalmology 2016; 10: 821-827 (IGR: 18-1)

69187 InÂ vivo oximetry of human bulbar conjunctival and episcleral microvasculature using snapshot multispectral imaging
Harvey AR
Experimental Eye Research 2016; 149: 48-58 (IGR: 18-1)

69107 Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma
Joshi A
Clinical Ophthalmology 2016; 10: 821-827 (IGR: 18-1)

69273 Acute cytotoxic effects of marketed ophthalmic formulations on human corneal epithelial cells
SeppÃ¤nen A
International Journal of Pharmaceutics 2016; 511: 73-78 (IGR: 18-1)

69066 In Vivo Goblet Cell Density as a Potential Indicator of Glaucoma Filtration Surgery Outcome
Frezzotti P
Investigative Ophthalmology and Visual Science 2016; 57: 2898-2905 (IGR: 18-1)

69304 Ocular surface toxicity from glaucoma topical medications and associated preservatives such as benzalkonium chloride (BAK)
Birt CM
Expert Opinion on Drug Metabolism and Toxicology 2016; 0: 1-11 (IGR: 18-1)

69066 In Vivo Goblet Cell Density as a Potential Indicator of Glaucoma Filtration Surgery Outcome
Curcio C
Investigative Ophthalmology and Visual Science 2016; 57: 2898-2905 (IGR: 18-1)

69273 Acute cytotoxic effects of marketed ophthalmic formulations on human corneal epithelial cells
Kaja S
International Journal of Pharmaceutics 2016; 511: 73-78 (IGR: 18-1)

69107 Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma
Raut A
Clinical Ophthalmology 2016; 10: 821-827 (IGR: 18-1)

69273 Acute cytotoxic effects of marketed ophthalmic formulations on human corneal epithelial cells
Kalesnykas G
International Journal of Pharmaceutics 2016; 511: 73-78 (IGR: 18-1)

69066 In Vivo Goblet Cell Density as a Potential Indicator of Glaucoma Filtration Surgery Outcome
Brescia L; Marchini G
Investigative Ophthalmology and Visual Science 2016; 57: 2898-2905 (IGR: 18-1)

66833 Association between glaucoma eye drops and hyperemia
Yanagi M
Japanese Journal of Ophthalmology 2016; 60: 72-77 (IGR: 17-4)

67612 The Conjunctiva in Normal Tension Glaucoma Patients is Thinner Than in Primary Open-Angle Glaucoma Patients: A Comparative Histologic Study
Van Ginderdeuren R
Journal of Glaucoma 2016; 25: e546-e549 (IGR: 17-4)

67090 Polarizable Material from a Conjunctival Biopsy in a Patient with Sarcoidosis
Ali OB
Ocular oncology and pathology 2016; 2: 202-205 (IGR: 17-4)

67588 Meibomian Gland Dysfunction in Patients Receiving Long-Term Glaucoma Medications
Uzunosmanoglu E
Cornea 2016; 35: 1112-1116 (IGR: 17-4)

66801 Clinical evaluation of the effect of diquafosol ophthalmic solution in glaucoma patients with dry eye syndrome
Jin SW
Japanese Journal of Ophthalmology 2016; 60: 150-155 (IGR: 17-4)

66699 The Ocular Surface in Medically Controlled Glaucoma: An In Vivo Confocal Study
Villani E
Investigative Ophthalmology and Visual Science 2016; 57: 1003-1010 (IGR: 17-4)

67518 Omega-3 fatty acid supplementation improves dry eye symptoms in patients with glaucoma: results of a prospective multicenter study
Tellez-Vazquez J
Clinical Ophthalmology 2016; 10: 617-626 (IGR: 17-4)

67588 Meibomian Gland Dysfunction in Patients Receiving Long-Term Glaucoma Medications
Mocan MC
Cornea 2016; 35: 1112-1116 (IGR: 17-4)

66699 The Ocular Surface in Medically Controlled Glaucoma: An In Vivo Confocal Study
Sacchi M
Investigative Ophthalmology and Visual Science 2016; 57: 1003-1010 (IGR: 17-4)

66801 Clinical evaluation of the effect of diquafosol ophthalmic solution in glaucoma patients with dry eye syndrome
Min JS
Japanese Journal of Ophthalmology 2016; 60: 150-155 (IGR: 17-4)

67612 The Conjunctiva in Normal Tension Glaucoma Patients is Thinner Than in Primary Open-Angle Glaucoma Patients: A Comparative Histologic Study
Vandewalle E
Journal of Glaucoma 2016; 25: e546-e549 (IGR: 17-4)

66833 Association between glaucoma eye drops and hyperemia
Kiuchi Y
Japanese Journal of Ophthalmology 2016; 60: 72-77 (IGR: 17-4)

67090 Polarizable Material from a Conjunctival Biopsy in a Patient with Sarcoidosis
Deroque R; Morshedi RG
Ocular oncology and pathology 2016; 2: 202-205 (IGR: 17-4)

67588 Meibomian Gland Dysfunction in Patients Receiving Long-Term Glaucoma Medications
Kocabeyoglu S
Cornea 2016; 35: 1112-1116 (IGR: 17-4)

67612 The Conjunctiva in Normal Tension Glaucoma Patients is Thinner Than in Primary Open-Angle Glaucoma Patients: A Comparative Histologic Study
Pinto LA
Journal of Glaucoma 2016; 25: e546-e549 (IGR: 17-4)

66699 The Ocular Surface in Medically Controlled Glaucoma: An In Vivo Confocal Study
Magnani F
Investigative Ophthalmology and Visual Science 2016; 57: 1003-1010 (IGR: 17-4)

66833 Association between glaucoma eye drops and hyperemia
Yuasa Y; Yoneda T
Japanese Journal of Ophthalmology 2016; 60: 72-77 (IGR: 17-4)

66699 The Ocular Surface in Medically Controlled Glaucoma: An In Vivo Confocal Study
Nicodemo A
Investigative Ophthalmology and Visual Science 2016; 57: 1003-1010 (IGR: 17-4)

67090 Polarizable Material from a Conjunctival Biopsy in a Patient with Sarcoidosis
Brown H
Ocular oncology and pathology 2016; 2: 202-205 (IGR: 17-4)

67588 Meibomian Gland Dysfunction in Patients Receiving Long-Term Glaucoma Medications
Karakaya J
Cornea 2016; 35: 1112-1116 (IGR: 17-4)

67612 The Conjunctiva in Normal Tension Glaucoma Patients is Thinner Than in Primary Open-Angle Glaucoma Patients: A Comparative Histologic Study
Stalmans I
Journal of Glaucoma 2016; 25: e546-e549 (IGR: 17-4)

67588 Meibomian Gland Dysfunction in Patients Receiving Long-Term Glaucoma Medications
Irkec M
Cornea 2016; 35: 1112-1116 (IGR: 17-4)

66833 Association between glaucoma eye drops and hyperemia
Sumi T
Japanese Journal of Ophthalmology 2016; 60: 72-77 (IGR: 17-4)

67612 The Conjunctiva in Normal Tension Glaucoma Patients is Thinner Than in Primary Open-Angle Glaucoma Patients: A Comparative Histologic Study
Zeyen T
Journal of Glaucoma 2016; 25: e546-e549 (IGR: 17-4)

66699 The Ocular Surface in Medically Controlled Glaucoma: An In Vivo Confocal Study
Williams SE; Rossi A
Investigative Ophthalmology and Visual Science 2016; 57: 1003-1010 (IGR: 17-4)

66833 Association between glaucoma eye drops and hyperemia
Hoshikawa Y; Kobayashi M
Japanese Journal of Ophthalmology 2016; 60: 72-77 (IGR: 17-4)

66699 The Ocular Surface in Medically Controlled Glaucoma: An In Vivo Confocal Study
Ratiglia R; De Cillà S
Investigative Ophthalmology and Visual Science 2016; 57: 1003-1010 (IGR: 17-4)

66833 Association between glaucoma eye drops and hyperemia
Fukushima A
Japanese Journal of Ophthalmology 2016; 60: 72-77 (IGR: 17-4)

66699 The Ocular Surface in Medically Controlled Glaucoma: An In Vivo Confocal Study
Nucci P
Investigative Ophthalmology and Visual Science 2016; 57: 1003-1010 (IGR: 17-4)

66345 Conjunctival fibrosis following filtering glaucoma surgery
Schlunck G
Experimental Eye Research 2016; 142: 76-82 (IGR: 17-3)

65932 Effect of benzalkonium chloride-free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study
Lopes JF
BMC Ophthalmology 2015; 15: 166 (IGR: 17-3)

66345 Conjunctival fibrosis following filtering glaucoma surgery
Meyer-Ter-Vehn T
Experimental Eye Research 2016; 142: 76-82 (IGR: 17-3)

65932 Effect of benzalkonium chloride-free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study
Hubatsch DA; Amaris P
BMC Ophthalmology 2015; 15: 166 (IGR: 17-3)

66345 Conjunctival fibrosis following filtering glaucoma surgery
Klink T; Grehn F
Experimental Eye Research 2016; 142: 76-82 (IGR: 17-3)

61561 Association between Glaucoma Medication Usage and Dry Eye in Taiwan
Chen HY
Optometry and Vision Science 2015; 92: e227-e232 (IGR: 17-1)

61825 Topical cyclosporine to control ocular surface disease in patients with chronic glaucoma after long-term usage of topical ocular hypotensive medications
Saini M
Eye 2015; 29: 808-814 (IGR: 17-1)

61136 Reversible Conjunctival Pigmentation Associated With Prostaglandin Use
Choi DY
Journal of Glaucoma 2016; 25: e56-e57 (IGR: 17-1)

61753 Symptoms and signs of ocular surface disease related to topical medication in patients with glaucoma
Cvenkel B
Clinical Ophthalmology 2015; 9: 625-631 (IGR: 17-1)

61285 Effects of Long-Term Antiglaucoma Eye Drops on Conjunctival Structures: An In Vivo Confocal Microscopy Study
Zhu W
Journal of Ophthalmology 2015; 2015: 165475 (IGR: 17-1)

61021 The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients
Tokuda N
Journal of Ophthalmology 2015; 2015: 689076 (IGR: 17-1)

60982 Effect of Glaucoma Medication in Tear Film Osmolarity of Patients Without Symptoms of Ocular Discomfort
Halkiadakis I
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 330-334 (IGR: 17-1)

61596 Development of a novel injectable drug delivery system for subconjunctival glaucoma treatment
Voss K
Journal of Controlled Release 2015; 214: 1-11 (IGR: 17-1)

61115 In vivo volumetric depth-resolved vasculature imaging of human limbus and sclera with 1μm swept source phase-variance optical coherence angiography
Poddar R
Journal of optics (2010) 2015; 17: (IGR: 17-1)

61129 The Effect of Pseudoexfoliation and Pseudoexfoliation Induced Dry Eye on Central Corneal Thickness
Akdemir MO
Current Eye Research 2015; 0: 1-6 (IGR: 17-1)

61366 Effect of 0.3% Hydroxypropyl Methylcellulose/Dextran Versus 0.18% Sodium Hyaluronate in the Treatment of Ocular Surface Disease in Glaucoma Patients: A Randomized, Double-Blind, and Controlled Study
Prabhasawat P
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 323-329 (IGR: 17-1)

61012 The measurement of bulbar hyperemia: challenges and pitfalls
Baudouin C
European Journal of Ophthalmology 2015; 25: 273-279 (IGR: 17-1)

60982 Effect of Glaucoma Medication in Tear Film Osmolarity of Patients Without Symptoms of Ocular Discomfort
Kontadakis GA
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 330-334 (IGR: 17-1)

61129 The Effect of Pseudoexfoliation and Pseudoexfoliation Induced Dry Eye on Central Corneal Thickness
Kirgiz A
Current Eye Research 2015; 0: 1-6 (IGR: 17-1)

61753 Symptoms and signs of ocular surface disease related to topical medication in patients with glaucoma
Štunf Š
Clinical Ophthalmology 2015; 9: 625-631 (IGR: 17-1)

61366 Effect of 0.3% Hydroxypropyl Methylcellulose/Dextran Versus 0.18% Sodium Hyaluronate in the Treatment of Ocular Surface Disease in Glaucoma Patients: A Randomized, Double-Blind, and Controlled Study
Ruangvaravate N
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 323-329 (IGR: 17-1)

61021 The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients
Kitaoka Y
Journal of Ophthalmology 2015; 2015: 689076 (IGR: 17-1)

61561 Association between Glaucoma Medication Usage and Dry Eye in Taiwan
Lin CL
Optometry and Vision Science 2015; 92: e227-e232 (IGR: 17-1)

61115 In vivo volumetric depth-resolved vasculature imaging of human limbus and sclera with 1μm swept source phase-variance optical coherence angiography
Zawadzki RJ
Journal of optics (2010) 2015; 17: (IGR: 17-1)

61012 The measurement of bulbar hyperemia: challenges and pitfalls
Barton K
European Journal of Ophthalmology 2015; 25: 273-279 (IGR: 17-1)

61825 Topical cyclosporine to control ocular surface disease in patients with chronic glaucoma after long-term usage of topical ocular hypotensive medications
Dhiman R
Eye 2015; 29: 808-814 (IGR: 17-1)

61136 Reversible Conjunctival Pigmentation Associated With Prostaglandin Use
Chang RT
Journal of Glaucoma 2016; 25: e56-e57 (IGR: 17-1)

61285 Effects of Long-Term Antiglaucoma Eye Drops on Conjunctival Structures: An In Vivo Confocal Microscopy Study
Kong X
Journal of Ophthalmology 2015; 2015: 165475 (IGR: 17-1)

61596 Development of a novel injectable drug delivery system for subconjunctival glaucoma treatment
Falke K
Journal of Controlled Release 2015; 214: 1-11 (IGR: 17-1)

61115 In vivo volumetric depth-resolved vasculature imaging of human limbus and sclera with 1μm swept source phase-variance optical coherence angiography
Cortés DE
Journal of optics (2010) 2015; 17: (IGR: 17-1)

61012 The measurement of bulbar hyperemia: challenges and pitfalls
Cucherat M
European Journal of Ophthalmology 2015; 25: 273-279 (IGR: 17-1)

61129 The Effect of Pseudoexfoliation and Pseudoexfoliation Induced Dry Eye on Central Corneal Thickness
Ayar O
Current Eye Research 2015; 0: 1-6 (IGR: 17-1)

60982 Effect of Glaucoma Medication in Tear Film Osmolarity of Patients Without Symptoms of Ocular Discomfort
Tsiakou D
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 330-334 (IGR: 17-1)

61825 Topical cyclosporine to control ocular surface disease in patients with chronic glaucoma after long-term usage of topical ocular hypotensive medications
Dada T
Eye 2015; 29: 808-814 (IGR: 17-1)

61285 Effects of Long-Term Antiglaucoma Eye Drops on Conjunctival Structures: An In Vivo Confocal Microscopy Study
Xu J
Journal of Ophthalmology 2015; 2015: 165475 (IGR: 17-1)

61596 Development of a novel injectable drug delivery system for subconjunctival glaucoma treatment
Bernsdorf A
Journal of Controlled Release 2015; 214: 1-11 (IGR: 17-1)

61136 Reversible Conjunctival Pigmentation Associated With Prostaglandin Use
Yegnashankaran K
Journal of Glaucoma 2016; 25: e56-e57 (IGR: 17-1)

61366 Effect of 0.3% Hydroxypropyl Methylcellulose/Dextran Versus 0.18% Sodium Hyaluronate in the Treatment of Ocular Surface Disease in Glaucoma Patients: A Randomized, Double-Blind, and Controlled Study
Tesavibul N
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 323-329 (IGR: 17-1)

61561 Association between Glaucoma Medication Usage and Dry Eye in Taiwan
Tsai YY
Optometry and Vision Science 2015; 92: e227-e232 (IGR: 17-1)

61021 The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients
Matsuzawa A
Journal of Ophthalmology 2015; 2015: 689076 (IGR: 17-1)

61753 Symptoms and signs of ocular surface disease related to topical medication in patients with glaucoma
Srebotnik Kirbiš I
Clinical Ophthalmology 2015; 9: 625-631 (IGR: 17-1)

61825 Topical cyclosporine to control ocular surface disease in patients with chronic glaucoma after long-term usage of topical ocular hypotensive medications
Tandon R
Eye 2015; 29: 808-814 (IGR: 17-1)

61285 Effects of Long-Term Antiglaucoma Eye Drops on Conjunctival Structures: An In Vivo Confocal Microscopy Study
Sun X
Journal of Ophthalmology 2015; 2015: 165475 (IGR: 17-1)

60982 Effect of Glaucoma Medication in Tear Film Osmolarity of Patients Without Symptoms of Ocular Discomfort
Patsea E
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 330-334 (IGR: 17-1)

61129 The Effect of Pseudoexfoliation and Pseudoexfoliation Induced Dry Eye on Central Corneal Thickness
Kaldirim H
Current Eye Research 2015; 0: 1-6 (IGR: 17-1)

61366 Effect of 0.3% Hydroxypropyl Methylcellulose/Dextran Versus 0.18% Sodium Hyaluronate in the Treatment of Ocular Surface Disease in Glaucoma Patients: A Randomized, Double-Blind, and Controlled Study
Thewthong M
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 323-329 (IGR: 17-1)

61021 The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients
Miyamoto J
Journal of Ophthalmology 2015; 2015: 689076 (IGR: 17-1)

61596 Development of a novel injectable drug delivery system for subconjunctival glaucoma treatment
Grabow N
Journal of Controlled Release 2015; 214: 1-11 (IGR: 17-1)

61561 Association between Glaucoma Medication Usage and Dry Eye in Taiwan
Kao CH
Optometry and Vision Science 2015; 92: e227-e232 (IGR: 17-1)

61753 Symptoms and signs of ocular surface disease related to topical medication in patients with glaucoma
Strojan Fležar M
Clinical Ophthalmology 2015; 9: 625-631 (IGR: 17-1)

61012 The measurement of bulbar hyperemia: challenges and pitfalls
Traverso C
European Journal of Ophthalmology 2015; 25: 273-279 (IGR: 17-1)

61115 In vivo volumetric depth-resolved vasculature imaging of human limbus and sclera with 1μm swept source phase-variance optical coherence angiography
Mannis MJ
Journal of optics (2010) 2015; 17: (IGR: 17-1)

61136 Reversible Conjunctival Pigmentation Associated With Prostaglandin Use
Friedman NJ
Journal of Glaucoma 2016; 25: e56-e57 (IGR: 17-1)

61021 The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients
Sakae S
Journal of Ophthalmology 2015; 2015: 689076 (IGR: 17-1)

60982 Effect of Glaucoma Medication in Tear Film Osmolarity of Patients Without Symptoms of Ocular Discomfort
Mitropoulos P
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 330-334 (IGR: 17-1)

61115 In vivo volumetric depth-resolved vasculature imaging of human limbus and sclera with 1μm swept source phase-variance optical coherence angiography
Werner JS
Journal of optics (2010) 2015; 17: (IGR: 17-1)

61825 Topical cyclosporine to control ocular surface disease in patients with chronic glaucoma after long-term usage of topical ocular hypotensive medications
Vanathi M
Eye 2015; 29: 808-814 (IGR: 17-1)

61129 The Effect of Pseudoexfoliation and Pseudoexfoliation Induced Dry Eye on Central Corneal Thickness
Mert M
Current Eye Research 2015; 0: 1-6 (IGR: 17-1)

61596 Development of a novel injectable drug delivery system for subconjunctival glaucoma treatment
Kastner C
Journal of Controlled Release 2015; 214: 1-11 (IGR: 17-1)

61021 The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients
Munemasa Y
Journal of Ophthalmology 2015; 2015: 689076 (IGR: 17-1)

61129 The Effect of Pseudoexfoliation and Pseudoexfoliation Induced Dry Eye on Central Corneal Thickness
Cabuk KS
Current Eye Research 2015; 0: 1-6 (IGR: 17-1)

61596 Development of a novel injectable drug delivery system for subconjunctival glaucoma treatment
Sternberg K
Journal of Controlled Release 2015; 214: 1-11 (IGR: 17-1)

60982 Effect of Glaucoma Medication in Tear Film Osmolarity of Patients Without Symptoms of Ocular Discomfort
Kandarakis AS
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 330-334 (IGR: 17-1)

61596 Development of a novel injectable drug delivery system for subconjunctival glaucoma treatment
Minrath I
Journal of Controlled Release 2015; 214: 1-11 (IGR: 17-1)

61129 The Effect of Pseudoexfoliation and Pseudoexfoliation Induced Dry Eye on Central Corneal Thickness
Taskapili M
Current Eye Research 2015; 0: 1-6 (IGR: 17-1)

61021 The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients
Takagi H
Journal of Ophthalmology 2015; 2015: 689076 (IGR: 17-1)

61596 Development of a novel injectable drug delivery system for subconjunctival glaucoma treatment
Eickner T; Wree A; Schmitz KP; Guthoff R; Witt M; Hovakimyan M
Journal of Controlled Release 2015; 214: 1-11 (IGR: 17-1)

60524 Comparison of the Toxicity Profile of Benzalkonium Chloride-Preserved Tafluprost and SofZia-Preserved Travoprost Applied to the Ocular Surface
Kanamoto T
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 156-164 (IGR: 16-4)

60682 Influence of local application of glaucoma medications-travoprost eye drops on patients' tear film function
Zhang C
Pakistan journal of pharmaceutical sciences 2015; 28: 781-784 (IGR: 16-4)

60578 Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives
Ramli N
Optometry and Vision Science 2015; 92: e222-e226 (IGR: 16-4)

60096 Lymphatic and Blood Vessel Density in Human Conjunctiva After Glaucoma Filtration Surgery
A Bouhenni R
Journal of Glaucoma 2016; 25: e35-e38 (IGR: 16-4)

60150 Excipients of preservative-free latanoprost induced inflammatory response and cytotoxicity in immortalized human HCE-2 corneal epithelial cells
Smedowski A
Journal of biochemical and pharmacological research 2014; 2: 175-184 (IGR: 16-4)

60464 Ocular surface disease in posttrabeculectomy/mitomycin C patients
Lam J
Clinical Ophthalmology 2015; 9: 187-191 (IGR: 16-4)

60589 Dry eye specific quality of life in veterans using glaucoma drops
Camp A
Contact Lens and Anterior Eye 2015; 38: 220-225 (IGR: 16-4)

60391 Time Course of Prostaglandin Analog-related Conjunctival Hyperemia and the Effect of a Nonsteroidal Anti-inflammatory Ophthalmic Solution
Sakata R
Journal of Glaucoma 2016; 25: e204-e208 (IGR: 16-4)

60084 A National Survey of Glaucoma Specialists on the Preoperative (Trabeculectomy) Management of the Ocular Surface
Tailor R
Seminars in Ophthalmology 2014; 0: 1-7 (IGR: 16-4)

60781 Topical glaucoma therapy and ocular surface disease: a prospective, controlled cohort study
Saade CE
Canadian Journal of Ophthalmology 2015; 50: 132-136 (IGR: 16-4)

60161 Effect of Korean Red Ginseng supplementation on dry eye syndrome in glaucoma patients - A randomized, double-blind, placebo-controlled study
Bae HW
Journal of ginseng research 2015; 39: 7-13 (IGR: 16-4)

60464 Ocular surface disease in posttrabeculectomy/mitomycin C patients
Wong TT
Clinical Ophthalmology 2015; 9: 187-191 (IGR: 16-4)

60084 A National Survey of Glaucoma Specialists on the Preoperative (Trabeculectomy) Management of the Ocular Surface
Batra R
Seminars in Ophthalmology 2014; 0: 1-7 (IGR: 16-4)

60781 Topical glaucoma therapy and ocular surface disease: a prospective, controlled cohort study
Lari HB
Canadian Journal of Ophthalmology 2015; 50: 132-136 (IGR: 16-4)

60150 Excipients of preservative-free latanoprost induced inflammatory response and cytotoxicity in immortalized human HCE-2 corneal epithelial cells
Paterno JJ
Journal of biochemical and pharmacological research 2014; 2: 175-184 (IGR: 16-4)

60524 Comparison of the Toxicity Profile of Benzalkonium Chloride-Preserved Tafluprost and SofZia-Preserved Travoprost Applied to the Ocular Surface
Kiuchi Y
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 156-164 (IGR: 16-4)

60391 Time Course of Prostaglandin Analog-related Conjunctival Hyperemia and the Effect of a Nonsteroidal Anti-inflammatory Ophthalmic Solution
Sakisaka T
Journal of Glaucoma 2016; 25: e204-e208 (IGR: 16-4)

60589 Dry eye specific quality of life in veterans using glaucoma drops
Wellik SR
Contact Lens and Anterior Eye 2015; 38: 220-225 (IGR: 16-4)

60578 Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives
Supramaniam G
Optometry and Vision Science 2015; 92: e222-e226 (IGR: 16-4)

60096 Lymphatic and Blood Vessel Density in Human Conjunctiva After Glaucoma Filtration Surgery
Al Jadaan I
Journal of Glaucoma 2016; 25: e35-e38 (IGR: 16-4)

60161 Effect of Korean Red Ginseng supplementation on dry eye syndrome in glaucoma patients - A randomized, double-blind, placebo-controlled study
Kim JH
Journal of ginseng research 2015; 39: 7-13 (IGR: 16-4)

60589 Dry eye specific quality of life in veterans using glaucoma drops
Tzu JH
Contact Lens and Anterior Eye 2015; 38: 220-225 (IGR: 16-4)

60391 Time Course of Prostaglandin Analog-related Conjunctival Hyperemia and the Effect of a Nonsteroidal Anti-inflammatory Ophthalmic Solution
Matsuo H
Journal of Glaucoma 2016; 25: e204-e208 (IGR: 16-4)

60524 Comparison of the Toxicity Profile of Benzalkonium Chloride-Preserved Tafluprost and SofZia-Preserved Travoprost Applied to the Ocular Surface
Tanito M
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 156-164 (IGR: 16-4)

60084 A National Survey of Glaucoma Specialists on the Preoperative (Trabeculectomy) Management of the Ocular Surface
Mohamed S
Seminars in Ophthalmology 2014; 0: 1-7 (IGR: 16-4)

60781 Topical glaucoma therapy and ocular surface disease: a prospective, controlled cohort study
Berezina TL
Canadian Journal of Ophthalmology 2015; 50: 132-136 (IGR: 16-4)

60096 Lymphatic and Blood Vessel Density in Human Conjunctiva After Glaucoma Filtration Surgery
Rassavong H
Journal of Glaucoma 2016; 25: e35-e38 (IGR: 16-4)

60161 Effect of Korean Red Ginseng supplementation on dry eye syndrome in glaucoma patients - A randomized, double-blind, placebo-controlled study
Kim S
Journal of ginseng research 2015; 39: 7-13 (IGR: 16-4)

60578 Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives
Samsudin A
Optometry and Vision Science 2015; 92: e222-e226 (IGR: 16-4)

60464 Ocular surface disease in posttrabeculectomy/mitomycin C patients
Tong L
Clinical Ophthalmology 2015; 9: 187-191 (IGR: 16-4)

60150 Excipients of preservative-free latanoprost induced inflammatory response and cytotoxicity in immortalized human HCE-2 corneal epithelial cells
Toropainen E
Journal of biochemical and pharmacological research 2014; 2: 175-184 (IGR: 16-4)

60589 Dry eye specific quality of life in veterans using glaucoma drops
Feuer W
Contact Lens and Anterior Eye 2015; 38: 220-225 (IGR: 16-4)

60161 Effect of Korean Red Ginseng supplementation on dry eye syndrome in glaucoma patients - A randomized, double-blind, placebo-controlled study
Kim M
Journal of ginseng research 2015; 39: 7-13 (IGR: 16-4)

60096 Lymphatic and Blood Vessel Density in Human Conjunctiva After Glaucoma Filtration Surgery
Al Shahwan S
Journal of Glaucoma 2016; 25: e35-e38 (IGR: 16-4)

60578 Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives
Juana A
Optometry and Vision Science 2015; 92: e222-e226 (IGR: 16-4)

60391 Time Course of Prostaglandin Analog-related Conjunctival Hyperemia and the Effect of a Nonsteroidal Anti-inflammatory Ophthalmic Solution
Miyata K
Journal of Glaucoma 2016; 25: e204-e208 (IGR: 16-4)

60524 Comparison of the Toxicity Profile of Benzalkonium Chloride-Preserved Tafluprost and SofZia-Preserved Travoprost Applied to the Ocular Surface
Mizoue S
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 156-164 (IGR: 16-4)

60781 Topical glaucoma therapy and ocular surface disease: a prospective, controlled cohort study
Fechtner RD
Canadian Journal of Ophthalmology 2015; 50: 132-136 (IGR: 16-4)

60150 Excipients of preservative-free latanoprost induced inflammatory response and cytotoxicity in immortalized human HCE-2 corneal epithelial cells
Sinha D
Journal of biochemical and pharmacological research 2014; 2: 175-184 (IGR: 16-4)

60096 Lymphatic and Blood Vessel Density in Human Conjunctiva After Glaucoma Filtration Surgery
Al Katan H
Journal of Glaucoma 2016; 25: e35-e38 (IGR: 16-4)

60150 Excipients of preservative-free latanoprost induced inflammatory response and cytotoxicity in immortalized human HCE-2 corneal epithelial cells
Wylegala E
Journal of biochemical and pharmacological research 2014; 2: 175-184 (IGR: 16-4)

60391 Time Course of Prostaglandin Analog-related Conjunctival Hyperemia and the Effect of a Nonsteroidal Anti-inflammatory Ophthalmic Solution
Aihara M
Journal of Glaucoma 2016; 25: e204-e208 (IGR: 16-4)

60589 Dry eye specific quality of life in veterans using glaucoma drops
Arheart KL
Contact Lens and Anterior Eye 2015; 38: 220-225 (IGR: 16-4)

60781 Topical glaucoma therapy and ocular surface disease: a prospective, controlled cohort study
Khouri AS
Canadian Journal of Ophthalmology 2015; 50: 132-136 (IGR: 16-4)

60161 Effect of Korean Red Ginseng supplementation on dry eye syndrome in glaucoma patients - A randomized, double-blind, placebo-controlled study
Lee N
Journal of ginseng research 2015; 39: 7-13 (IGR: 16-4)

60524 Comparison of the Toxicity Profile of Benzalkonium Chloride-Preserved Tafluprost and SofZia-Preserved Travoprost Applied to the Ocular Surface
Naito T
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 156-164 (IGR: 16-4)

60578 Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives
Zahari M; Choo MM
Optometry and Vision Science 2015; 92: e222-e226 (IGR: 16-4)

60524 Comparison of the Toxicity Profile of Benzalkonium Chloride-Preserved Tafluprost and SofZia-Preserved Travoprost Applied to the Ocular Surface
Teranishi S
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 156-164 (IGR: 16-4)

60161 Effect of Korean Red Ginseng supplementation on dry eye syndrome in glaucoma patients - A randomized, double-blind, placebo-controlled study
Hong S
Journal of ginseng research 2015; 39: 7-13 (IGR: 16-4)

60150 Excipients of preservative-free latanoprost induced inflammatory response and cytotoxicity in immortalized human HCE-2 corneal epithelial cells
Kaarniranta K
Journal of biochemical and pharmacological research 2014; 2: 175-184 (IGR: 16-4)

60589 Dry eye specific quality of life in veterans using glaucoma drops
Sastry A
Contact Lens and Anterior Eye 2015; 38: 220-225 (IGR: 16-4)

60096 Lymphatic and Blood Vessel Density in Human Conjunctiva After Glaucoma Filtration Surgery
Dunmire J
Journal of Glaucoma 2016; 25: e35-e38 (IGR: 16-4)

60161 Effect of Korean Red Ginseng supplementation on dry eye syndrome in glaucoma patients - A randomized, double-blind, placebo-controlled study
Seong GJ
Journal of ginseng research 2015; 39: 7-13 (IGR: 16-4)

60524 Comparison of the Toxicity Profile of Benzalkonium Chloride-Preserved Tafluprost and SofZia-Preserved Travoprost Applied to the Ocular Surface
Hirooka K
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 156-164 (IGR: 16-4)

60096 Lymphatic and Blood Vessel Density in Human Conjunctiva After Glaucoma Filtration Surgery
Krasniqi M
Journal of Glaucoma 2016; 25: e35-e38 (IGR: 16-4)

60589 Dry eye specific quality of life in veterans using glaucoma drops
Galor A
Contact Lens and Anterior Eye 2015; 38: 220-225 (IGR: 16-4)

60161 Effect of Korean Red Ginseng supplementation on dry eye syndrome in glaucoma patients - A randomized, double-blind, placebo-controlled study
Kim CY
Journal of ginseng research 2015; 39: 7-13 (IGR: 16-4)

60096 Lymphatic and Blood Vessel Density in Human Conjunctiva After Glaucoma Filtration Surgery
Edward DP
Journal of Glaucoma 2016; 25: e35-e38 (IGR: 16-4)

60524 Comparison of the Toxicity Profile of Benzalkonium Chloride-Preserved Tafluprost and SofZia-Preserved Travoprost Applied to the Ocular Surface
Rimayanti U
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 156-164 (IGR: 16-4)

59349 Ocular surface alterations and topical antiglaucomatous therapy: a review
Actis AG; Rolle T
Open Ophthalmology Journal 2014; 8: 67-72 (IGR: 16-3)

59287 Symptoms reported by patients with varying stages of glaucoma: review of 401 cases
Fernandez Lopez E; Karaca EE; Ekici F; Waisbourd M; Spaeth GL
Canadian Journal of Ophthalmology 2014; 49: 420-425 (IGR: 16-3)

59608 Bilateral familial nevus of Ota
Goyal S; Uwaydat SH; Phillips PH; Schaefer GB
Journal of AAPOS 2014; 18: 609-610 (IGR: 16-3)

59548 Atopic Glaucoma: Clinical and Pathophysiological Analysis
Takakuwa K; Hamanaka T; Mori K; Chin S; Shinmei Y; Funaki T; Ebihara N; Ono K; Murakami A; Matsuda A
Journal of Glaucoma 2015; 24: 662-668 (IGR: 16-3)

59588 Glaucoma medications, preservatives and the ocular surface
Aptel F; Labbé A; Baudouin C; Bron A; Lachkar Y; Sellem E; Renard JP; Nordmann JP; Rouland JF; Denis P
Journal Fran�ais d'Ophtalmologie 2014; 37: 728-736 (IGR: 16-3)

59219 Comparison of the ocular surface changes following the use of two different prostaglandin F2α analogues containing benzalkonium chloride or polyquad in rabbit eyes
Lee HJ; Jun RM; Cho MS; Choi KR
Cutaneous and Ocular Toxicology 2014; 0: 1-8 (IGR: 16-3)

59089 The effect of preservatives and antiglaucoma treatments on the ocular surface of mice with dry eye
Barabino S; Antonelli S; Cimbolini N; Mauro V; Bouzin M
Investigative Ophthalmology and Visual Science 2014; 55: 6499-6504 (IGR: 16-3)

59068 Clinical audit examining the impact of benzalkonium chloride-free anti-glaucoma medications on patients with symptoms of ocular surface disease
Goldberg I; Graham SL; Crowston JG; d'Mellow G;
Clinical and Experimental Ophthalmology 2015; 43: 214-220 (IGR: 16-3)

57207 Increased Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) Expression in the Conjunctival Epithelium Exposed to Antiglaucoma Treatments
Labbé A; Gabison E; Brignole-Baudouin F; Riancho L; Menashi S; Baudouin C
Current Eye Research 2014; 0: 1-8 (IGR: 16-2)

57188 Evaluation of conjunctival epithelium of filtering blebs by impression cytology
Muniesa MJ; González S; Buetas P; López S; Sánchez C; Matias-Guiu X
Archivos de la Sociedad Espa�ola de Oftalmologia 2014; 89: 216-221 (IGR: 16-2)

57127 Ocular surface changes in glaucomatous patients treated with and without preservatives beta-blockers
Iester M; Telani S; Frezzotti P; Motolese I; Figus M; Fogagnolo P; Perdicchi A;
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 476-481 (IGR: 16-2)

57273 Trans-conjunctival aqueous humor outflow in glaucomatous patients treated with prostaglandin analogues: an in vivo confocal microscopy study
Mastropasqua R; Fasanella V; Pedrotti E; Lanzini M; Di Staso S; Mastropasqua L; Agnifili L
Graefe's Archive for Clinical and Experimental Ophthalmology 2014; 252: 1469-1476 (IGR: 16-2)

57348 Effects of Polyquaternium- and Benzalkonium-Chloride-Preserved Travoprost on Ocular Surfaces: An Impression Cytology Study
Sezgin Akçay BI; Güney E; Bozkurt TK; Topal CS; Akkan JC; Unlü C
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 548-553 (IGR: 16-2)

57492 The effects of topical antiglaucoma drugs as monotherapy on the ocular surface: a prospective study
Aydin Kurna S; Acikgoz S; Altun A; Ozbay N; Sengor T; Olcaysu OO
Journal of Ophthalmology 2014; 2014: 460483 (IGR: 16-2)

57429 Ab interno approach to the subconjunctival space using a collagen glaucoma stent
Lewis RA
Journal of Cataract and Refractive Surgery 2014; 40: 1301-1306 (IGR: 16-2)

56364 In Vivo Laser Scanning Confocal Microscopy of the Ocular Surface in Glaucoma
Mastropasqua L; Agnifili L; Mastropasqua R; Fasanella V; Nubile M; Toto L; Carpineto P; Ciancaglini M
Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada 2014; 0: 1-16 (IGR: 16-1)

56656 Managing adverse effects of glaucoma medications
Inoue K
Clinical Ophthalmology 2014; 8: 903-913 (IGR: 16-1)

56209 Perioperative conjunctival inflammation and trabeculectomy outcome
Furtado JM; Paula JS; Soares EG; Lira RC; Rocha AM; Saloum Dhegaide NH; Rocha EM; Donadi E; Rodrigues Mde L
Ocular Immunology and Inflammation 2014; 22: 183-188 (IGR: 16-1)

55335 In vivo confocal microscopy of the ocular surface: from bench to bedside
Villani E; Baudouin C; Efron N; Hamrah P; Kojima T; Patel SV; Pflugfelder SC; Zhivov A; Dogru M
Current Eye Research 2014; 39: 213-231 (IGR: 15-4)

55417 Resolution of conjunctival sessile hemangioma with topical timolol
Lubahn JG; Lee RK; Karp CL
Cornea 2014; 33: 99-100 (IGR: 15-4)

55270 Anterior Segment Applications of In Vivo Confocal Microscopy
Kymionis GD; Diakonis VF; Shehadeh MM; Pallikaris AI; Pallikaris IG
Seminars in Ophthalmology 2015; 30: 243-251 (IGR: 15-4)

55619 External Dacryocystorhinostomy: Characteristics and Surgical Outcomes in Patients with and without Previous Dacryocystitis
Rabina G; Golan S; Neudorfer M; Leibovitch I
Journal of Ophthalmology 2013; 2013: 287524 (IGR: 15-4)

55203 Glaucoma and dry eye. Current concepts and future perspectives
Steven P; Cursiefen C
Ophthalmologe 2013; 110: 1155-1159 (IGR: 15-4)

55342 How ocular surface disease impacts the glaucoma treatment outcome
Kaštelan S; Tomić M; Metež Soldo K; Salopek-Rabatić J
BioMed research international 2013; 2013: 696328 (IGR: 15-4)

55467 In vitro effects of preservative-free and preserved prostaglandin analogs on primary cultured human conjunctival fibroblast cells
Kim EJ; Kim YH; Kang SH; Lee KW; Park YJ
Korean Journal of Ophthalmology 2013; 27: 446-453 (IGR: 15-4)

55316 Preservative toxicity in glaucoma medication: clinical evaluation of benzalkonium chloride-free 0.5% timolol eye drops
Rosin LM; Bell NP
Clinical Ophthalmology 2013; 7: 2131-2135 (IGR: 15-4)

54431 Effect of chronic anti-glaucoma medications and trabeculectomy on tear osmolarity
Lee SY; Wong TT; Chua J; Boo C; Soh YF; Tong L
Eye 2013; 27: 1142-1150 (IGR: 15-3)

54695 In vivo confocal microscopy of conjunctiva in preservative-free timolol 0.1% gel formulation therapy for glaucoma
Frezzotti P; Fogagnolo P; Haka G; Motolese I; Iester M; Bagaglia SA; Mittica P; Menicacci C; Rossetti L; Motolese E
Acta Ophthalmologica 2014; 92: e133-e140 (IGR: 15-3)

54451 Scanning electron microscopy applied to impression cytology for conjunctival damage from glaucoma therapy
Cennamo G; Forte R; Del Prete S; Cardone D
Cornea 2013; 32: 1227-1231 (IGR: 15-3)

54632 Is visual function affected in severe ocular allergies?
Leonardi A; Bonini S
Current opinion in allergy and clinical immunology 2013; 13: 558-562 (IGR: 15-3)

54858 Ocular surface evaluation in patients treated with a fixed combination of prostaglandin analogues with 0.5% timolol maleate topical monotherapy: a randomized clinical trial
Russ HH; Nogueira-Filho PA; Barros Jde N; Faria NV; Montiani-Ferreira F; Gomes JÁ,; Mello PA
Clinics 2013; 68: 1318-1324 (IGR: 15-3)

54757 The prevalence of ocular surface complaints in Brazilian patients with glaucoma or ocular hypertension
Costa VP; Marcon IM; Galvã,o Filho RP; Malta RF
Arquivos Brasileiros de Oftalmologia 2013; 76: 221-225 (IGR: 15-3)

54861 Signs and symptoms of ocular surface disease in patients on topical intraocular pressure-lowering therapy
Gomes B; Turiel PR; Marques FP; Bernardo FP; Safady MV; Portes AL; Santhiago MR
Arquivos Brasileiros de Oftalmologia 2013; 76: 282-287 (IGR: 15-3)

54624 Influence of BAK-preserved prostaglandin analog treatment on the ocular surface health in patients with newly diagnosed primary open-angle glaucoma
Tomić M; Ka&scaron,telan S; Soldo KM; Salopek-Rabatić J
BioMed research international 2013; 2013: 603782 (IGR: 15-3)

54517 Iatrogenic dry eye disease: an eledoisin/carnitine and osmolyte drops study
Nebbioso M; Evangelista M; Librando A; Plateroti AM; Pescosolido N
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2013; 67: 659-663 (IGR: 15-3)

54625 Epiconjunctival Mitomycin-C Application for Early Failing Filtering Blebs
Rao A; Chatterjee S
Seminars in Ophthalmology 2014; 29: 48-51 (IGR: 15-3)

53946 Apoptotic effects of topical antiglaucoma medications on conjunctival epithelium in glaucoma patients
Arici MK; Ozeç AV; Dursun A; Toker MI; Erdogan H
European Journal of Ophthalmology 2013; 0: 0 (IGR: 15-2)

54040 Tear film status in glaucoma patients
Jandroković S; Suić SP; Kordić R; Kuzman T; Petricek I
Collegium Antropologicum 2013; 37: 137-140 (IGR: 15-2)

53795 Evaluation of Ocular Surface Disease in Patients with Glaucoma
Mathews PM; Ramulu PY; Friedman DS; Utine CA; Akpek EK
Ophthalmology 2013; 120: 2241-2248 (IGR: 15-2)

53985 Floppy Eyelid Syndrome as an Indicator of the Presence of Glaucoma in Patients With Obstructive Sleep Apnea
Muniesa M; Sánchez-de-la-Torre M; Huerva V; Lumbierres M; Barbé F
Journal of Glaucoma 2014; 23: e81-e85 (IGR: 15-2)

53660 Brimonidine Allergy Presenting as Vernal-like Keratoconjunctivitis
Shah AA; Modi Y; Thomas B; Wellik SR; Galor A
Journal of Glaucoma 2015; 24: 89-91 (IGR: 15-2)

53587 Conjunctival goblet cells density and preservative-free tafluprost therapy for glaucoma: an in vivo confocal microscopy and impression cytology study
Mastropasqua L; Agnifili L; Fasanella V; Curcio C; Ciabattoni C; Mastropasqua R; Toto L; Ciancaglini M
Acta Ophthalmologica 2013; 91: e397-e405 (IGR: 15-2)

54020 Patients undergoing long-term treatment with antihypertensive eye drops responded positively with respect to their ocular surface disorder to oral supplementation with antioxidants and essential fatty acids
Galbis-Estrada C; Pinazo-Durán MD; Cantú-Dibildox J; Marco-Ramírez C; Díaz-Llópis M; Benítez-Del-Castillo J
Clinical Interventions in Aging 2013; 8: 711-719 (IGR: 15-2)

53692 Repair of Eyelid Retraction due to a Trabeculectomy Bleb: Case Series and Review of the Literature
Shue A; Joseph JM; Tao JP
Ophthalmic Plastic and Reconstructive Surgery 2014; 30: e32-e35 (IGR: 15-2)

53774 Forniceal conjunctival pedicle flap for the treatment of complex glaucoma drainage device tube erosion
Grover DS; Merritt J; Godfrey DG; Fellman RL
JAMA ophthalmology 2013; 131: 662-666 (IGR: 15-2)

52476 Conjunctivochalasis as a Contributing Factor for the Development of Ocular Surface Disease in Medically Treated Glaucoma Patients
Kocabeyoglu S; Mocan MC; Irkec M; Orhan M; Karakaya J
Journal of Glaucoma 2014; 23: 333-336 (IGR: 15-1)

52625 Increased intraocular pressure after extensive conjunctival removal: a case report
Lee YR; Na JH; Kim JY; Sung KR
Korean Journal of Ophthalmology 2013; 27: 141-144 (IGR: 15-1)

53184 Tear clearance and ocular symptoms in patients treated with preservative-free prostaglandins
Giménez-Gómez R; García-Catalán MR; Gallardo-Galera JM
Archivos de la Sociedad Espa�ola de Oftalmologia 2013; 88: 88-91 (IGR: 15-1)

52484 Preservative-free treatment in glaucoma: who, when, and why
Stalmans I; Sunaric Mégevand G; Cordeiro MF; Hommer A; Rossetti L; Goñi F; Heijl A; Bron A
European Journal of Ophthalmology 2013; 23: 0 (IGR: 15-1)

52437 Preservative Exposure and Surgical Outcomes in Glaucoma Patients: The PESO Study
Boimer C; Birt CM
Journal of Glaucoma 2013; 22: 730-735 (IGR: 15-1)

52612 Glaucoma therapy and ocular surface disease: current literature and recommendations
Anwar Z; Wellik SR; Galor A
Current Opinions in Ophthalmology 2013; 24: 136-143 (IGR: 15-1)

52966 Comparative cross-sectional analysis of the effects of topical antiglaucoma drugs on the ocular surface
Lee S; Kim MK; Choi HJ; Wee WR; Kim DM
Advances in Therapy 2013; 30: 420-429 (IGR: 15-1)

52816 Ocular surface tolerability of prostaglandin analogs and prostamides in patients with glaucoma or ocular hypertension
Crichton AC; Vold S; Williams JM; Hollander DA
Advances in Therapy 2013; 30: 260-270 (IGR: 15-1)

52717 The impact of trabeculectomy on ocular surface
Li LX; Liu W; Ji J
Chinese Journal of Ophthalmology 2013; 49: 185-188 (IGR: 15-1)

51902 Ocular Surface Disease and Glaucoma: How to Evaluate Impact on Quality of Life
Rossi GC; Pasinetti GM; Scudeller L; Bianchi PE
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 390-394 (IGR: 14-4)

51786 Conjunctival modifications induced by medical and surgical therapies in patients with glaucoma
Mastropasqua L; Agnifili L; Mastropasqua R; Fasanella V
Current opinion in pharmacology 2013; 13: 56-64 (IGR: 14-4)

51994 In vivo confocal microscopy of meibomian glands in glaucoma
Agnifili L; Fasanella V; Costagliola C; Ciabattoni C; Mastropasqua R; Frezzotti P; Mastropasqua L
British Journal of Ophthalmology 2013; 97: 343-349 (IGR: 14-4)

51887 Efficacy and safety of preservative-free latanoprost eyedrops, compared with BAK-preserved latanoprost in patients with ocular hypertension or glaucoma
Rouland JF; Traverso CE; Stalmans I; Fekih LE; Delval L; Renault D; Baudouin C;
British Journal of Ophthalmology 2013; 97: 196-200 (IGR: 14-4)

52005 Short-term effect of topical brinzolamide-timolol fixed combination on ocular surface of glaucoma patients
Firat PG; Samdanci E; Doganay S; Cavdar M; Sahin N; Gunduz A
International Journal of Ophthalmology 2012; 5: 714-718 (IGR: 14-4)

51964 Effects of SofZia-preserved travoprost and benzalkonium chloride-preserved latanoprost on the ocular surface -- a multicentre randomized single-masked study
Aihara M; Oshima H; Araie M;
Acta Ophthalmologica 2013; 91: e7-e14 (IGR: 14-4)

51857 Preservatives from the perspective of glaucoma surgery
Thieme H; van der Velden KK
Ophthalmologe 2012; 109: 1073-1076 (IGR: 14-4)

51687 Conjunctival Complications Related to Ahmed Glaucoma Valve Insertion
Geffen N; Buys YM; Smith M; Anraku A; Alasbali T; Rachmiel R; Trope GE
Journal of Glaucoma 2014; 23: 109-114 (IGR: 14-4)

51132 Differences in basement membrane zone components of normal conjunctiva, conjunctiva in glaucoma and normal skin
Messmer EM; Valet VM; Kampik A
Acta Ophthalmologica 2012; 90: e476-e481 (IGR: 14-3)

51341 Conjunctival inflammation in patients under topical glaucoma treatment with indication to surgery
Furtado JM; Paula JS; Soares EG; Dhegaide NH; Rocha EM; Donadi E; Rodrigues Mde L
Acta cirúrgica brasileira / Sociedade Brasileira para Desenvolvimento Pesquisa em Cirurgia 2012; 27: 732-735 (IGR: 14-3)

51178 Steroid-induced ocular hypertension in Asian children with severe vernal keratoconjunctivitis
Ang M; Ti SE; Loh R; Farzavandi S; Zhang R; Tan D; Chan C
Clinical Ophthalmology 2012; 6: 1253-1258 (IGR: 14-3)

51016 Ocular Surface Disease Exacerbated Glaucoma: Optimizing the Ocular Surface Improves Intraocular Pressure Control
Batra R; Tailor R; Mohamed S
Journal of Glaucoma 2014; 23: 56-60 (IGR: 14-3)

51187 Topical prostaglandin analogues and conjunctival inflammation in uveitic glaucoma
Taylor SR; Gurbaxani A; Sallam A; Lightman S
Open Ophthalmology Journal 2012; 6: 75-78 (IGR: 14-3)

50556 Tear Film Osmolarity in Patients Treated for Glaucoma or Ocular Hypertension
Labbé A; Terry O; Brasnu E; Van Went C; Baudouin C
Cornea 2012; 31: 994-999 (IGR: 14-2)

50444 LOXL1 Deficiency in the Lamina Cribrosa as Candidate Susceptibility Factor for a Pseudoexfoliation-Specific Risk of Glaucoma
Schlö,tzer-Schrehardt U; Hammer CM; Krysta AW; Hofmann-Rummelt C; Pasutto F; Sasaki T; Kruse FE; Zenkel M
Ophthalmology 2012; 119: 1832-1843 (IGR: 14-2)

50583 Prevalence and risk factors for ocular surface disease among patients treated over the long term for glaucoma or ocular hypertension
Baudouin C; Renard JP; Nordmann JP; Denis P; Lachkar Y; Sellem E; Rouland JF; Jeanbat V; Boué,e S
European Journal of Ophthalmology 2012; 0: 0 (IGR: 14-2)

50527 Benzalkonium chloride breaks down conjunctival immunological tolerance in a murine model
Galletti JG; Gabelloni ML; Morande PE; Sabbione F; Vermeulen ME; Trevani AS; Giordano MN
Mucosal immunology 2013; 6: 24-34 (IGR: 14-2)

49035 Impact of Ocular Surface Symptoms on Quality of Life in a United States Veterans Affairs Population
Pouyeh B; Viteri E; Feuer W; Lee DJ; Florez H; Fabian JA; Perez VL; Galor A
American Journal of Ophthalmology 2012; 153: 1061-1066 (IGR: 14-1)

49184 Comparison of the Long-Term Effects of Various Topical Antiglaucoma Medications on Meibomian Glands
Arita R; Itoh K; Maeda S; Maeda K; Furuta A; Tomidokoro A; Aihara M; Amano S
Cornea 2012; 31: 1229-1234 (IGR: 14-1)

49353 A multicenter evaluation of ocular surface disease prevalence in patients with glaucoma
Garcia-Feijoo J; Sampaolesi JR
Clinical Ophthalmology 2012; 6: 441-446 (IGR: 14-1)

49154 Prevalence of signs and symptoms of ocular surface disease in individuals treated and not treated with glaucoma medication
O',Hare F; Ghosh S; Lamoureux E; Vajpayee RB; Crowston JG
Clinical and Experimental Ophthalmology 2012; 40: 675-681 (IGR: 14-1)

48740 Quantitative study of the topographic distribution of conjunctival lymphatic vessels in the monkey
Guo W; Zhu Y; Yu PK; Yu X; Sun X; Cringle SJ; Su EN; Yu DY
Experimental Eye Research 2012; 94: 90-97 (IGR: 14-1)

48714 Differential protein expression in tears of patients with primary open angle and pseudoexfoliative glaucoma
Pieragostino D; Bucci S; Agnifili L; Fasanella V; D',Aguanno S; Mastropasqua A; Ciancaglini M; Mastropasqua L; Di Ilio C; Sacchetta P; Urbani A; Del Boccio P
Molecular bioSystems 2012; 8: 1017-1028 (IGR: 14-1)

48452 Long-term effect of BAK-free travoprost on ocular surface and intraocular pressure in glaucoma patients after transition from latanoprost
Aihara M; Otani S; Kozaki J; Unoki K; Takeuchi M; Minami K; Miyata K
Journal of Glaucoma 2012; 21: 60-64 (IGR: 14-1)

48963 Effects of preservative-free tafluprost on tear film osmolarity, tolerability, and intraocular pressure in previously treated patients with open-angle glaucoma
Janulevi?ien? I; Derka? I; Grybauskiene L; Paulauskait? R; Gromnickaite R; Kuzmien? L
Clinical Ophthalmology 2012; 6: 103-109 (IGR: 14-1)

48672 Effect of prostaglandin analogues on tear proteomics and expression of cytokines and matrix metalloproteinases in the conjunctiva and cornea
Lopilly Park HY; Kim JH; Lee KM; Park CK
Experimental Eye Research 2012; 94: 13-21 (IGR: 14-1)

49144 Free radicals and the pH of topical glaucoma medications: a lifetime of ocular chemical injury?
Lockington D; Macdonald EC; Stewart P; Young D; Caslake M; Ramaesh K
Eye 2012; 26: 734-741 (IGR: 14-1)

49081 Effects of long-term topical anti-glaucoma medications on meibomian glands
Arita R; Itoh K; Maeda S; Maeda K; Furuta A; Tomidokoro A; Aihara M; Amano S
Graefe's Archive for Clinical and Experimental Ophthalmology 2012; 250: 1181-1185 (IGR: 14-1)

49331 Ocular surface and external filtration surgery: mutual relationships
Baudouin C
Developments in Ophthalmology 2012; 50: 64-78 (IGR: 14-1)

49248 Ocular surface changes in eyes with glaucoma filtering blebs
Neves Mendes CR; Hida RY; Kasahara N
Current Eye Research 2012; 37: 309-311 (IGR: 14-1)

49058 The application of tissue engineering in reversing mitomycin C-induced ischemic conjunctiva
Peng YJ; Pan CY; Hsieh YT; Wu S; Chu HN; Hsu WC
Journal of Biomedical Materials Research - Part A 2012; 100: 1126-1135 (IGR: 14-1)

49071 Effect of mitomycin C-aided trabeculectomy on conjunctival goblet cell density
Mukhopadhyay S; Thakur SK; Dutta J; Prakash R; Shaw C; Gangopadhyay DN; Dutta H; Bhaduri G
Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH 2012; 4: 68-72 (IGR: 14-1)

48984 In vivo analysis of conjunctiva in canaloplasty for glaucoma
Mastropasqua L; Agnifili L; Salvetat ML; Ciancaglini M; Fasanella V; Nubile M; Mastropasqua R; Zeppieri M; Brusini P
British Journal of Ophthalmology 2012; 96: 634-639 (IGR: 14-1)

47862 Challenges in the clinical measurement of ocular surface disease in glaucoma patients
Pflugfelder SC; Baudouin C
Clinical Ophthalmology 2011; 5: 1575-1583 (IGR: 13-4)

48019 Conjunctival findings in hyperbaric and low-tension glaucoma: An in vivo confocal microscopy study
Agnifili L; Carpineto P; Fasanella V; Mastropasqua R; Zappacosta A; Di Staso S; Costagliola C; Mastropasqua L
Acta Ophthalmologica 2011; (IGR: 13-4)

48336 Comparative in vitro toxicology study of travoprost polyquad-preserved, travoprost BAK-preserved, and latanoprost BAK-preserved ophthalmic solutions on human conjunctival epithelial cells
Brignole-Baudouin F; Riancho L; Liang H; Baudouin C
Current Eye Research 2011; 36: 979-988 (IGR: 13-4)

48070 Effects of antiglaucoma drugs on the ocular surface in rabbits: a fixed-combination drug versus two concomitant drugs
Cho HK; Park MH; Moon JI
Japanese Journal of Ophthalmology 2011; 55: 670-675 (IGR: 13-4)

46941 About ocular surface damage
Stefan C; Pop A; Cojocaru I
Oftalmologia 2011; 55: 38-40 (IGR: 13-3)

46934 Glaucoma and ocular surface
Stefan C; Cojocaru I; Pop A
Oftalmologia 2011; 55: 30-33 (IGR: 13-3)

47061 Allergic blepharoconjunctivitis caused by antiglaucomatics-Central Slovakia experiences
Urbancek S; Kuklova M; Hazuchova HK; Martinaskova
Dermatitis 2011; 22: 185-186 (IGR: 13-3)

46844 Symptoms and signs of tear film dysfunction in glaucomatous patients
Valente C; Iester M; Corsi E; Rolando M
Journal of Ocular Pharmacology and Therapeutics 2011; 27: 281-285 (IGR: 13-3)

45803 Long-term topical antiglaucoma medications cause enhanced Tenon's capsule fibroblast proliferation and abnormal TGF-(beta) and MMP expressions: Potential effects on glaucoma filtering surgery
Leng F; Liu P; Li H; Zhang J
Current Eye Research 2011; 36: 301-309 (IGR: 13-2)

45804 Ocular surface disease in patients with ocular hypertension and glaucoma
Stewart WC; Stewart JA; Nelson LA
Current Eye Research 2011; 36: 391-398 (IGR: 13-2)

45551 Advancing the treatment of conjunctival scarring: a novel ex vivo model
Tovell VE; Dahlmann-Noor AH; Khaw PT; Bailly M
Archives of Ophthalmology 2011; 129: 619-627 (IGR: 13-2)

45442 The influence of ocular surface diseases in the management of glaucoma
Van Went C; Brasnu E; Hamard P; Baudouin C; Labb� A
Journal Fran�ais d'Ophtalmologie 2011; 34: 230-237 (IGR: 13-2)

45879 Current dilemmas and controversies in allergic contact dermatitis to ophthalmic medications
Novitskaya ES; Dean SJ; Craig JP; Alexandroff AB
Clinics in Dermatology 2011; 29: 295-299 (IGR: 13-2)

46162 Signs and symptoms of ocular surface status in glaucoma patients switched from timolol 0.5% to brinzolamide 1%/timolol 0.5% fixed combination: A 6-month efficacy and tolerability, multicenter, open-label prospective study
Rossi GCM; Tinelli C; Pasinetti GM; Fusetti M; Pallavicini C; Stringa M; Vacchi S; Stringa F; Bianchi PE
Expert Opinion in Pharmacotherapy 2011; 12: 685-690 (IGR: 13-2)

45881 Effects of benzalkonium chloride- and polyquad-preserved combination glaucoma medications on cultured human ocular surface cells
Ammar DA; Noecker RJ; Kahook MY
Advances in Therapy 2011; 28: 501-510 (IGR: 13-2)

46095 Effects of osmoprotection on symptoms, ocular surface damage, and tear film modifications caused by glaucoma therapy
Monaco G; Cacioppo V; Consonni D; Troiano P
European Journal of Ophthalmology 2011; 21: 243-250 (IGR: 13-2)

46101 Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue
Servat JJ; Bernardino CR
Drugs and Aging 2011; 28: 267-282 (IGR: 13-2)

46122 Short-term effect of topical antiglaucoma medication on tear-film stability, tear secretion, and corneal sensitivity in healthy subjects
Terai N; Muller-Holz M; Spoerl E; Pillunat LE
Clinical Ophthalmology 2011; 5: 517-525 (IGR: 13-2)

45510 Conjunctival and corneal findings in bleb-associated endophthalmitis: an in vivo confocal microscopy study
Carpineto P; Agnifili L; Nubile M; Fasanella V; Doronzo E; Mastropasqua A; Ciancaglini M
Acta Ophthalmologica 2011; 89: 388-395 (IGR: 13-2)

46313 Canaloplasty for pigmentary glaucoma with coexisting conjunctival lymphoma
Ichhpujani P; Barahimi B; Shields CL; Eagle Jr RC; Katz LJ
Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye 2011; 42: 10-11 (IGR: 13-2)

28153 A randomized, controlled comparison of macroscopic conjunctival hyperemia in patients treated with bimatoprost 0.01% or vehicle who were previously controlled on latanoprost
Craven ER; Liu C-C; Batoosingh A; Schiffman RM; Whitcup SM
Clinical Ophthalmology 2010; 4: 1433-1440 (IGR: 13-1)

27904 Expression of the antimicrobial peptide beta-defensin-2 in the conjunctival epithelial cells in primary open-angle glaucoma and over time in the postoperative period
Erichev VP; Gankovskaia LV; Koval'chuk LV; Gankovskaia OA; Dugina AE
Vestnik Oftalmologii 2010; 126: 19-22 (IGR: 13-1)

28163 The effects of topical antiglaucoma on conjunctival impression cytology in malay glaucoma patients
Hoi TS; Nor MM; Hitam WHW; Jaafar H; Shatriah I
International Medical Journal 2010; 17: 271-274 (IGR: 13-1)

27689 Conjunctival Inflammatory Cells and Their Predictive Role For Deep Sclerectomy in Primary Open-angle Glaucoma and Exfoliation Glaucoma
Helin M; R�nkk� S; Puustj�rvi T; Ter�svirta M; Ollikainen M; Uusitalo H
Journal of Glaucoma 2011; 20: 172-178 (IGR: 13-1)

28151 Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost
Katz G; Springs CL; Craven ER; Montecchi-Palmer M
Clinical Ophthalmology 2010; 4: 1253-1261 (IGR: 13-1)

27972 The association of meibomian gland dysfunction and other common ocular diseases with dry eye: A population-based study in Spain
Viso E; Gude F; Rodriguez-Ares MT
Cornea 2011; 30: 1-6 (IGR: 13-1)

27915 Rare case of allergic blepharoconjuctivitis due to dorsolamide eyedrops
Urbancek S; Hazuchova H
Contact Dermatitis 2010; 63 SUPPL. 1 (65-66 (IGR: 13-1)

27912 Ocular intolerance to antiglaucoma medications is underestimated
Bresson-Dumont H
Bulletin de la Soci�t� Belge d'Ophtalmologie 2010; 315: 47-53 (IGR: 13-1)

26986 Tear cytokine profile in medicated glaucoma patients effect of monocyte chemoattractant protein 1 on early posttrabeculectomy outcome.
Chong RS; Jiang YZ; Boey PY; Yu SJ; Htoon HM; Aung T; Khaw PT; Wong TT
Ophthalmology 2010; 117: 2353-2358 (IGR: 12-4)

27021 Age-related changes of human conjunctiva on in vivo confocal microscopy.
Zhu W; Hong J; Zheng T; Le Q; Xu J; Sun X
British Journal of Ophthalmology 2010; 94: 1448-1453 (IGR: 12-4)

27459 The tear fluid mucin 5AC change of primary angle-closure glaucoma patients after short-term medications and phacotrabeculectomy
Liu W; Li H; Lu D; Liang J; Xing X; Liu A; Zhao S; Li X; Ji J
Molecular Vision 2010; 16: 2342-2346 (IGR: 12-4)

27223 An experimental study of rabbit conjunctival epithelial toxicity using co-treatment with Mitomycin-C and a histone deacetylase inhibitor
Kim T-H; Oh HC; Yoo YH; Rho JH; Park WC; Ahn HB; Jeung WJ; Rho SH
Archives of Pharmacal Research 2010; 33: 1261-1267 (IGR: 12-4)

27307 Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells
Ammar DA; Noecker RJ; Kahook MY
Advances in Therapy 2010; 27: 837-845 (IGR: 12-4)

27502 Cytotoxicity of prostaglandin analog eye drops preserved with benzalkonium chloride in multiple corneoconjunctival cell lines
Ayaki M; Iwasawa A
Clinical Ophthalmology 2010; 4: 919-924 (IGR: 12-4)

27118 Changing the composition of buffered eye-drops prevents undesired side effects
Schrage NF; Frentz M; Reim M
British Journal of Ophthalmology 2010; 94: 1519-1522 (IGR: 12-4)

27040 In vivo analysis of conjunctiva in gold micro shunt implantation for glaucoma.
Mastropasqua L; Agnifili L; Ciancaglini M; Nubile M; Carpineto P; Fasanella V; Figus M; Lazzeri S; Nardi M
British Journal of Ophthalmology 2010; 94: 1592-1596 (IGR: 12-4)

26492 Changes in various immunological parameters of lacrimal fluid in excessive scarring after antiglaucoma surgery in patients with primary open-angle glaucoma
Erichev VP; Gankovskaia LV; Koval'chuk LV; Gankovskaia OA; Dugina AE
Vestnik Oftalmologii 2010; 126: 25-29 (IGR: 12-3)

26659 A correlation between latanoprost-induced conjunctival hyperemia and intraocular pressure-lowering effect
Kobayashi H; Kobayashi K
Journal of Glaucoma 2010; (IGR: 12-3)

26672 Ocular surface tolerability of prostaglandin analogs in patients with glaucoma or ocular hypertension
Whitson JT; Trattler WB; Matossian C; Williams J; Hollander DA
Journal of Ocular Pharmacology and Therapeutics 2010; 26: 287-292 (IGR: 12-3)

26542 Short-term effects of subconjunctival injections of 5-fluorouracil on conjunctival epithelium
Simsek T; Firat P; Ctrk M; Ozdamar Y; Elgin U
Cornea 2010; 29: 727-731 (IGR: 12-3)

26666 Outcomes of bleb excision with free autologous conjunctival patch grafting for bleb leak and hypotony after glaucoma filtering surgery
Panday M; Shantha B; George R; Boda S; Vijaya L
Journal of Glaucoma 2010; (IGR: 12-3)

26123 Treatment of glaucoma in patients with dry eye syndrome
Labb� A; Baudouin C
Journal Fran�ais d'Ophtalmologie 2010; 33: 285-290 (IGR: 12-2)

25717 The ocular surface in glaucoma
Baudouin C
Cornea 2009; 28: S14-S19 (IGR: 12-2)

25718 Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications
Fechtner RD; Godfrey DG; Budenz D; Stewart JA; Stewart WC; Jasek MC
Cornea 2010; 29: 618-621 (IGR: 12-2)

25450 Effects of prostaglandin analog therapy on the ocular surface of glaucoma patients
Horsley M B; Kahook M Y
Clinical Ophthalmology 2009; 3: 291-295 (IGR: 12-1)

25099 Do antiglaucomatous prostaglandins induce melanogenesis in human conjunctiva?: an impression cytology pilot study
Cagigrigoriu A; Boero E; Carenini AB; Rolle T; Cappia S; Bacillo E; Papotti M; Gregori D; Brovarone FV; Grignolo FM
Journal of Glaucoma 2010; 19: 44-50 (IGR: 12-1)

25093 Effects of postoperative cyclosporine ophthalmic emulsion 0.05% (Restasis) following glaucoma surgery
Fakhraie G; Lopes JF; Spaeth GL; Almodin J; Ichhpujani P; Moster MR
Clinical and Experimental Ophthalmology 2009; 37: 842-848 (IGR: 12-1)

24595 The effects of combination glaucoma medications on ocular surface epithelial cells
Ammar DA; Kahook MY
Advances in Therapy 2009; 1-6 (IGR: 11-4)

24658 Conjunctival hyperaemia associated with the fixed combinations of latanoprost/timolol and bimatoprost/ timolol in the treatment of ocular hypertension or glaucoma
Vinuesa MJ; Vinuesa I; Diaz S; Martin I; Soto J; Fernandez-Arias I
Value in Health 2009; 12: A453 (IGR: 11-4)

24768 Iatrogenic glaucoma therapy failure: The adverse effects of topical antiglaucoma medication treatment outcome
Mirza SK; Higginbotham EJ
Expert Review of Clinical Pharmacology 2009; 2: 87-99 (IGR: 11-4)

24764 Preservatives in topical ophthalmic medications: Historical and clinical perspectives
Freeman PD; Kahook MY
Expert Review of Ophthalmology 2009; 4: 59-64 (IGR: 11-4)

25004 Conjunctival vasculature patterns influencing the filtering bleb shape following trabeculectomy with limbal-based conjunctival flaps
Aihara M; Saito Y; Higashide T; Okubo S; Sasaki T; Sugiyama K
Japanese Journal of Ophthalmology 2009; 53: 374-379 (IGR: 11-4)

24581 Comparison of trabeculectomy with mitomycin C in patients of vernal keratoconjunctivitis with steroid induced glaucoma versus patients with high risk glaucoma
Farooq S; Dukht U; Tayyab A
Rawal Medical Journal 2009; 34: 54-57 (IGR: 11-4)

24047 Dry eye syndrome-related quality of life in glaucoma patients
Rossi GC; Tinelli C; Pasinetti GM; Milano G; Bianchi PE
European Journal of Ophthalmology 2009; 19: 572-579 (IGR: 11-3)

24500 Increased mast cell numbers in the conjunctiva of glaucoma patients: a possible indicator of preoperative glaucoma surgery inflammation
Chang L; Wong T; Ohbayashi M; Bunce C; Barton K; Ono S; Khaw PT
Eye 2009; 23: 1859-1865 (IGR: 11-3)

24140 Conjunctival characteristics in primary open-angle glaucoma and modifications induced by trabeculectomy with mitomycin C: an in vivo confocal microscopy study
Ciancaglini M; Carpineto P; Agnifili L; Nubile M; Fasanella V; Mattei PA; Mastropasqua L
British Journal of Ophthalmology 2009; 93: 1204-1209 (IGR: 11-3)

24252 Effect of chronic topical glaucoma medications on aerobic conjunctival bacterial flora
Sen EM; Yilmaz MB; Dansuk Z; Aksakal FN; Altinok A; Tuna T; Koklu G
Cornea 2009; 28: 266-270 (IGR: 11-3)

24372 Toxic effects of antiglaucoma drugs on superficial tissues of the eye
Pozarowska D
International Review of Allergology and Clinical Immunology 2008; 14: 112-114 (IGR: 11-3)

24273 Development of conjunctival hyperemia with the use of a fixed combination of latanoprost/timolol: systematic review and meta-analysis of clinical trials
Vinuesa-Silva JM; Vinuesa-Silva I; Pinazo-Duran MD; Soto-Alvarez J; Delgado-Ortega L; Diaz-Cerezo S
Archivos de la Sociedad Espa�ola de Oftalmologia 2009; 84: 199-207 (IGR: 11-3)

24083 The critical role of the conjunctiva in glaucoma filtration surgery
Yu DY; Morgan WH; Sun X; Su EN; Cringle SJ; Yu PK; House P; Guo W; Yu X
Progress in Retinal and Eye Research 2009; 28: 303-328 (IGR: 11-3)

23547 Ocular surface disfunction in glaucoma
Stefan C; Dumitrica DM
Oftalmologia 2008; 52: 114-119 (IGR: 11-2)

22873 Quantitative analysis of conjunctival goblet cells after chronic application of topical drops
Kahook MY; Noecker R
Advances in Therapy 2008; 25: 743-751 (IGR: 11-1)

22717 Suppression of injury-induced conjunctiva scarring by peroxisome proliferator-activated receptor γ gene transfer in mice
Yamanaka O; Miyazaki K; Kitano A; Saika S; Nakajima Y; Ikeda K
Investigative Ophthalmology and Visual Science 2009; 50: 187-193 (IGR: 11-1)

22621 Effect of latanoprost and timolol on the histopathology of the human conjunctiva
Terai N; Schl�tzer-Schrehardt U; Lampel J; B�hm AG; Rummelt C; Schmidt E; Pillunat LE
British Journal of Ophthalmology 2009; 93: 219-224 (IGR: 11-1)

22612 Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials
Honrubia F; Garc�a-S�nchez J; Polo V; de la Casa JM; Soto J
British Journal of Ophthalmology 2009; 93: 316-321 (IGR: 11-1)

22764 Tear film and ocular surface alterations in chronic users of antiglaucoma medications
Baffa LP; Ricardo JR; Dias AC; Modulo CM; Braz AM; Paula JS; Rodrigues ML; Rocha EM
Arquivos Brasileiros de Oftalmologia 2008; 71: 18-21 (IGR: 11-1)

22907 Clinical observation of dry eye before and after trbeculectomy
He X; Zhi R; Hu C
Chinese Ophthalmic Research 2008; 26: 770-772 (IGR: 11-1)

22875 A multicentre evaluation of the effect of patient education on acceptance of hyperaemia associated with bimatoprost therapy for glaucoma or ocular hypertension
Trattler W; Noecker RJ; Earl ML
Advances in Therapy 2008; 25: 179-189 (IGR: 11-1)

21694 Conjunctival modifications in ocular hypertension and primary open angle glaucoma: an in vivo confocal microscopy study
Ciancaglini M; Carpineto P; Agnifili L; Nubile M; Fasanella V; Mastropasqua L
Investigative Ophthalmology and Visual Science 2008; 49: 3042-3048 (IGR: 10-3)

21502 Mucous membrane pemphigoid with ocular involvement: Part II: Therapy
Meyer-Ter-Vehn T; Schmidt E; Zillikens D; Geerling G
Ophthalmologe 2008; 105: 405-419 (IGR: 10-3)

21883 Prevalence of ocular surface disease in glaucoma patients
Leung EW; Medeiros FA; Weinreb RN
Journal of Glaucoma 2008; 17: 350-355 (IGR: 10-3)

21104 Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears
Kahook MY; Noecker RJ
Cornea 2008; 27: 339-343 (IGR: 10-2)

21012 Phospholipases A₂ in normal human conjunctiva and from patients with primary open-angle glaucoma and exfoliation glaucoma
Helin M; R�nkk� S; Puustj�rvi T; Ter�svirta M; Uusitalo H
Graefe's Archive for Clinical and Experimental Ophthalmology 2008; 246: 739-746 (IGR: 10-2)

21393 Increased homocysteine levels in tear fluid of patients with primary open-angle glaucoma
Roedl JB; Bleich S; Schlotzer-Schrehardt U; von Ahsen N; Kornhuber J; Naumann GO; Kruse FE; Junemann AG
Ophthalmic Research 2008; 40: 249-256 (IGR: 10-2)

21395 Comparison of ocular surface side effects of topical travoprost and bimatoprost
Alag�z G; Bayer A; Boran C; Serin D; K�kner A; El�io?lu M
Ophthalmologica 2008; 22: 161-167 (IGR: 10-2)

20902 An in vivo confocal microscopy and impression cytology analysis of preserved and unpreserved levobunolol-induced conjunctival changes
Ciancaglini M; Carpineto P; Agnifili L; Nubile M; Fasanella V; Lanzini M; Calienno R; Mastropasqua L
European Journal of Ophthalmology 2008; 18: 400-407 (IGR: 10-2)

20879 In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line
Brasnu E; Brignole-Baudouin F; Riancho L; Guenoun JM; Warnet JM; Baudouin C
Current Eye Research 2008; 33: 303-312 (IGR: 10-2)

20634 Localization of TGF-β type II receptor and ED-A fibronectin in normal conjunctiva and failed filtering blebs
Meyer-Ter-Vehn T; Grehn F; Schlunck G
Molecular Vision 2008; 14: 136-141 (IGR: 10-1)

20386 The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways
Baudouin C; Liang H; Hamard P; Riancho L; Creuzot-Garcher C; Warnet JM; Brignole-Baudouin F
Ophthalmology 2008; 115: 109-115 (IGR: 10-1)

20545 Ocular surface changes in primary open angle glaucoma with long term topical anti glaucoma medication
Kamath AP; Satyanarayana S; Rodrigues FEA
Medical Journal Armed Forces India 2007; 63: 341-345 (IGR: 10-1)

15219 Trefoil factor family 1, MUC5AC and human leucocyte antigen-DR expression by conjunctival cells in patients with glaucoma treated with chronic drugs: could these markers predict the success of glaucoma surgery?
Souchier M; Buron N; Lafontaine PO; Bron AM; Baudouin C; Creuzot-Garcher C
British Journal of Ophthalmology 2006; 90: 1366-1369 (IGR: 8-4)

15265 Effect of GLC756, a novel mixed dopamine D1 receptor antagonist and dopamine D2 receptor agonist, on TNF-α release in vitro from activated rat mast cells
Laengle UW; Markstein R; Pralet D; Seewald W; Roman D
Experimental Eye Research 2006; 83: 1335-1339 (IGR: 8-4)

14936 Antiglaucoma drugs - content of preservatives and the patient's compliance
Vyborny P; Sejckova L
?eska a Slovenska Oftalmologie 2006; 62: 270-272, 274 (IGR: 8-4)

13981 In vivo confocal microscopy of filtering blebs after trabeculectomy
Messmer EM; Zapp DM; Mackert MJ; Thiel M; Kampik A
Archives of Ophthalmology 2006; 124: 1095-1103 (IGR: 8-3)

13969 Effects of topical antiglaucoma application on conjunctival impression cytology specimens
Hong S; Lee CS; Seo KY; Seong GJ; Hong YJ
American Journal of Ophthalmology 2006; 142: 185-186 (IGR: 8-3)

13026 Tryptase increases proliferative activity of human conjunctival fibroblasts through protease-activated receptor-2
Asano-Kato N; Fukagawa K; Okada N; Dogru M; Tsubota K; Fujishima H
Investigative Ophthalmology and Visual Science 2005; 46: 4622-4626 (IGR: 7-3)

13037 α₂-Adrenergic Receptors Are Present in Normal Human Conjunctiva
Diebold Y; Enriquez de Salamanca A; Calonge M; Saez V; Callejo S; Stern ME
Current Eye Research 2005; 30: 1121-1129 (IGR: 7-3)

13139 Agonistic and antagonistic action of AP2, Msx2, Pax6, Prox1 AND Six3 in the regulation of Sox2 expression
Lengler J; Bittner T; Munster D; Gawad Ael-D; Graw J
Ophthalmic Research 2005; 37: 301-309 (IGR: 7-3)

12342 Modulation of cell proliferation and collagen synthesis of porcine Tenon's fibroblasts by extracts of lens and vitreous with treatment of dexamethasone
Xu DD; Li RM; Lian L; Liu XP
Chinese Journal of Ophthalmology 2005; 41: 443-448 (IGR: 7-2)

11845 Comparative effects of TGF-β₁ and TGF-β₂ on extracellular matrix production, proliferation, migration, and collagen contraction of human Tenon's capsule fibroblasts in pseudoexfoliation and primary open-angle glaucoma
Kottler UB; Junemann AG; Aigner T; Zenkel M; Rummelt C; Schlotzer-Schrehardt U
Experimental Eye Research 2005; 80: 121-134 (IGR: 7-1)

11253 Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study
Brandt JD; Beiser JA; Gordon MO; Kass MA; Ocular Hypertension Treatment Study Group
American Journal of Ophthalmology 2004; 138: 717-722 (IGR: 6-3)

11255 Corneal thickness in children
Hussein MA; Paysse EA; Bell NP; Coats DK; Brady McCreery KM; Koch DD; Orengo-Nania S; Baskin D; Wilhelmus KR
American Journal of Ophthalmology 2004; 138: 744-748 (IGR: 6-3)

11280 Altered transcripts expression of matrix metalloproteinases and their tissue inhibitors in tenon capsule of patients with glaucoma
Liu CJ; Huang YL; Ju JP; Lu CL; Chiu AW
Journal of Glaucoma 2004; 13: 486-491 (IGR: 6-3)

10234 Flow cytometry in conjunctival impression cytology: a new tool for exploring ocular surface pathologies
Brignole-Baudouin F; Ott AC; Warnet JM; Baudouin C
Experimental Eye Research 2004; 78: 473-481 (IGR: 6-1)

10046 Transcript expression of matrix metalloproteinases in the conjunctiva following glaucoma filtration surgery in rabbits
Liu CJ; Huang YL; Chiu AW; Ju JP
Ophthalmic Research 2004; 36: 114-119 (IGR: 6-1)

9640 Flow cytometric analysis of HLA-DR, IL-6 and IL-8 expression by conjunctival epithelial cells from patients with prolonged topical antiglaucoma treatments
Bensoussan L; Blondin C; Baudouin C; Hamard P; Sabeh Afaki G; Creuzot-Garcher C; Warnet JM; Brignole-Baudouin F
Journal Fran�ais d'Ophtalmologie 2003; 26: 782-789 (IGR: 5-3)

8197 Study of the nervous-vascular reactivity of the bulbar conjunctiva in patients with primary open-angle glaucoma with normalized intraocular pressure
Egorov VV; Sorokin EL; Smoliakova GP
Vestnik Oftalmologii 2002; 118: 3-5 (IGR: 4-3)

8198 A feasible tool to detect mRNA expression of matrix metalloproteinases and their tissue inhibitors in human tenon's capsule
Huang YL; Liu CJ; Chiu AW; Wang YC; Huan SK; Lee FL; Chen SJ; Hsu WM; Hsieh SL
Ophthalmic Research 2002; 34: 375-379 (IGR: 4-3)

3394 Ocular surface changes induced by topical antiglaucoma monotherapy
Cvenkel B; Ihan A
Ophthalmologica 2002; 216: 175-179 (IGR: 4-2)

6612 Apoptosis gene expression and death receptor signaling in mitomycin-C-treated human tenon capsule fibroblasts
Crowston JG; Chang LH; Constable PH; Daniels JT; Akbar AN; Khaw PT
Investigative Ophthalmology and Visual Science 2002; 43: 692-699 (IGR: 4-1)

6314 Human Tenon's fibroblast-produced IFNβ and the prevention of T-cell apoptosis
Chang L; Crowston JG; Sabin CA; Khaw PT
Investigative Ophthalmology and Visual Science 2001; 42: 1531-1538 (IGR: 3-2)

18939 The Taa1 restriction enzyme provides a simple means to identify the Q368STOP mutation of the myocilin gene in primary open angle glaucoma
Baird PN; Dickinson J; Craig JE; Mackey DA
American Journal of Ophthalmology 2001; 131: 510-511 (IGR: 3-1)

5972 The evaluation of morphological status of bulbar conjunctiva after long-term antiglaucoma drug therapy
Pozarowska D; Toczolowski J; Wozniak F
Klinika Oczna 1999; 455-458 (IGR: 2-2)

5578 Collagen type I and III synthesis by Tenon's capsule fibroblasts in culture: individual patient characteristics and response to mitomycin C, 5-fluorouracil, and ascorbic acid
Gross RL
Transactions of the American Ophthalmological Society 1999; 97:513-543 (IGR: 2-1)

15343 Evaluation of tear secretion and tear film stability in pseudoexfoliation syndrome
Kozobolis VP; Detorakis ET; Tsopakis GM; Pallikaris IG
Acta Ophthalmologica Scandinavica 1999; 77: 406-499 (IGR: 1-3)

5184 Metaplazja plaskonablonkowa spojowki galkoweg w przebiegu dlugotrwalego stosowania lekow przeciwjaskrowych (Squamous metaplasia of bulbar conjunctiva in the course of long-term topical antiglaucoma therapy)
Wroblewska E
Klinika Oczna 1999; 101: 41-43 (IGR: 1-2)

5185 Liczba komorek kubkowych w spojowce galkowej po dlugotrwalym stosowaniu lekow przeciwjaskrowych (Goblet cells density of bulbar conjunctiva after long-term topical antiglaucoma therapy)
Wroblewska E
Klinika Oczna 1999; 101: 45-47 (IGR: 1-2)

11.16 Vehicles, delivery systems, pharmacokinetics, formulation (2608 abstracts found)

94930 Gamma sterilization and in vivo evaluation of cationic nanostructured lipid carriers as potential ocular delivery systems for antiglaucoma drugs
Youshia J
European Journal of Pharmaceutical Sciences 2021; 163: 105887 (IGR: 22-2)

94547 European real-world data about the use of a new delivery system containing a preservative-free multi-dose glaucoma treatment
Denis P
European Journal of Ophthalmology 2021; 31: 1056-1063 (IGR: 22-2)

94855 Distribution of Gold Nanoparticles in the Anterior Chamber of the Eye after Intracameral Injection for Glaucoma Therapy
Sonntag T
Pharmaceutics 2021; 13: (IGR: 22-2)

94413 Comparison of Topical Instillation From Single-dose and Multidose Eye Drop Containers in Glaucoma: A Multicenter Randomized Cross-sectional Trial
Aptel F
Journal of Glaucoma 2021; 30: 718-724 (IGR: 22-2)

94955 Surface Engineering of FLT4-Targeted Nanocarriers Enhances Cell-Softening Glaucoma Therapy
Vincent MP
ACS applied materials & interfaces 2021; 13: 32823-32836 (IGR: 22-2)

94436 Cyclodextrin-based formulation of carbonic anhydrase inhibitors for ocular delivery - A review
Jansook P
International Journal of Pharmaceutics 2021; 606: 120955 (IGR: 22-2)

94766 A Review on Newer Ocular Drug Delivery Systems with an Emphasis on Glaucoma
Peter M
Advanced pharmaceutical bulletin 2021; 11: 399-413 (IGR: 22-2)

94980 Nano-in-Nano Dendrimer Gel Particles for Efficient Topical Delivery of Antiglaucoma Drugs into the Eye
Wang J
Chemical engineering journal (Lausanne, Switzerland : 1996) 2021; 425: (IGR: 22-2)

94856 Risk Factors for Ocular Surface Disease in Tunisian Users of Preserved Antiglaucomatous Eye Drops
Lajmi H
Journal of current ophthalmology 2021; 33: 128-135 (IGR: 22-2)

94821 Phase Transition Microemulsion of Brimonidine Tartrate for Glaucoma Therapy: Preparation, Characterization and Pharmacodynamic Study
Gautam N
Current Eye Research 2021; 0: 1-9 (IGR: 22-2)

94845 Efficacy and Safety of Preservative-free Latanoprost Eyedrops Compared with Preserved Prostaglandin Analogues in Patients with Open-angle Glaucoma
Seong HJ
Korean Journal of Ophthalmology 2021; 35: 235-241 (IGR: 22-2)

94856 Risk Factors for Ocular Surface Disease in Tunisian Users of Preserved Antiglaucomatous Eye Drops
Hmaied W
Journal of current ophthalmology 2021; 33: 128-135 (IGR: 22-2)

94821 Phase Transition Microemulsion of Brimonidine Tartrate for Glaucoma Therapy: Preparation, Characterization and Pharmacodynamic Study
Kesavan K
Current Eye Research 2021; 0: 1-9 (IGR: 22-2)

94980 Nano-in-Nano Dendrimer Gel Particles for Efficient Topical Delivery of Antiglaucoma Drugs into the Eye
Li B
Chemical engineering journal (Lausanne, Switzerland : 1996) 2021; 425: (IGR: 22-2)

94930 Gamma sterilization and in vivo evaluation of cationic nanostructured lipid carriers as potential ocular delivery systems for antiglaucoma drugs
Kamel AO
European Journal of Pharmaceutical Sciences 2021; 163: 105887 (IGR: 22-2)

94547 European real-world data about the use of a new delivery system containing a preservative-free multi-dose glaucoma treatment
Duch S
European Journal of Ophthalmology 2021; 31: 1056-1063 (IGR: 22-2)

94845 Efficacy and Safety of Preservative-free Latanoprost Eyedrops Compared with Preserved Prostaglandin Analogues in Patients with Open-angle Glaucoma
Lee K
Korean Journal of Ophthalmology 2021; 35: 235-241 (IGR: 22-2)

94855 Distribution of Gold Nanoparticles in the Anterior Chamber of the Eye after Intracameral Injection for Glaucoma Therapy
Froemel F
Pharmaceutics 2021; 13: (IGR: 22-2)

94766 A Review on Newer Ocular Drug Delivery Systems with an Emphasis on Glaucoma
Panonnummal R
Advanced pharmaceutical bulletin 2021; 11: 399-413 (IGR: 22-2)

94955 Surface Engineering of FLT4-Targeted Nanocarriers Enhances Cell-Softening Glaucoma Therapy
Stack T
ACS applied materials & interfaces 2021; 13: 32823-32836 (IGR: 22-2)

94436 Cyclodextrin-based formulation of carbonic anhydrase inhibitors for ocular delivery - A review
Hnin HM
International Journal of Pharmaceutics 2021; 606: 120955 (IGR: 22-2)

94413 Comparison of Topical Instillation From Single-dose and Multidose Eye Drop Containers in Glaucoma: A Multicenter Randomized Cross-sectional Trial
Villemont AS
Journal of Glaucoma 2021; 30: 718-724 (IGR: 22-2)

94955 Surface Engineering of FLT4-Targeted Nanocarriers Enhances Cell-Softening Glaucoma Therapy
Vahabikashi A
ACS applied materials & interfaces 2021; 13: 32823-32836 (IGR: 22-2)

94845 Efficacy and Safety of Preservative-free Latanoprost Eyedrops Compared with Preserved Prostaglandin Analogues in Patients with Open-angle Glaucoma
Lee SJ
Korean Journal of Ophthalmology 2021; 35: 235-241 (IGR: 22-2)

94855 Distribution of Gold Nanoparticles in the Anterior Chamber of the Eye after Intracameral Injection for Glaucoma Therapy
Stamer WD
Pharmaceutics 2021; 13: (IGR: 22-2)

94547 European real-world data about the use of a new delivery system containing a preservative-free multi-dose glaucoma treatment
Chen E
European Journal of Ophthalmology 2021; 31: 1056-1063 (IGR: 22-2)

94856 Risk Factors for Ocular Surface Disease in Tunisian Users of Preserved Antiglaucomatous Eye Drops
Achour BB
Journal of current ophthalmology 2021; 33: 128-135 (IGR: 22-2)

94413 Comparison of Topical Instillation From Single-dose and Multidose Eye Drop Containers in Glaucoma: A Multicenter Randomized Cross-sectional Trial
Cunnac P
Journal of Glaucoma 2021; 30: 718-724 (IGR: 22-2)

94930 Gamma sterilization and in vivo evaluation of cationic nanostructured lipid carriers as potential ocular delivery systems for antiglaucoma drugs
El Shamy A
European Journal of Pharmaceutical Sciences 2021; 163: 105887 (IGR: 22-2)

94436 Cyclodextrin-based formulation of carbonic anhydrase inhibitors for ocular delivery - A review
Loftsson T
International Journal of Pharmaceutics 2021; 606: 120955 (IGR: 22-2)

94980 Nano-in-Nano Dendrimer Gel Particles for Efficient Topical Delivery of Antiglaucoma Drugs into the Eye
Huang D
Chemical engineering journal (Lausanne, Switzerland : 1996) 2021; 425: (IGR: 22-2)

94436 Cyclodextrin-based formulation of carbonic anhydrase inhibitors for ocular delivery - A review
Stefánsson E
International Journal of Pharmaceutics 2021; 606: 120955 (IGR: 22-2)

94856 Risk Factors for Ocular Surface Disease in Tunisian Users of Preserved Antiglaucomatous Eye Drops
Zahaf A
Journal of current ophthalmology 2021; 33: 128-135 (IGR: 22-2)

94855 Distribution of Gold Nanoparticles in the Anterior Chamber of the Eye after Intracameral Injection for Glaucoma Therapy
Ohlmann A
Pharmaceutics 2021; 13: (IGR: 22-2)

94955 Surface Engineering of FLT4-Targeted Nanocarriers Enhances Cell-Softening Glaucoma Therapy
Li G
ACS applied materials & interfaces 2021; 13: 32823-32836 (IGR: 22-2)

94980 Nano-in-Nano Dendrimer Gel Particles for Efficient Topical Delivery of Antiglaucoma Drugs into the Eye
Norat P
Chemical engineering journal (Lausanne, Switzerland : 1996) 2021; 425: (IGR: 22-2)

94413 Comparison of Topical Instillation From Single-dose and Multidose Eye Drop Containers in Glaucoma: A Multicenter Randomized Cross-sectional Trial
Sallit R
Journal of Glaucoma 2021; 30: 718-724 (IGR: 22-2)

94845 Efficacy and Safety of Preservative-free Latanoprost Eyedrops Compared with Preserved Prostaglandin Analogues in Patients with Open-angle Glaucoma
Kim S
Korean Journal of Ophthalmology 2021; 35: 235-241 (IGR: 22-2)

94930 Gamma sterilization and in vivo evaluation of cationic nanostructured lipid carriers as potential ocular delivery systems for antiglaucoma drugs
Mansour S
European Journal of Pharmaceutical Sciences 2021; 163: 105887 (IGR: 22-2)

94547 European real-world data about the use of a new delivery system containing a preservative-free multi-dose glaucoma treatment
Klyve P
European Journal of Ophthalmology 2021; 31: 1056-1063 (IGR: 22-2)

94980 Nano-in-Nano Dendrimer Gel Particles for Efficient Topical Delivery of Antiglaucoma Drugs into the Eye
Grannonico M
Chemical engineering journal (Lausanne, Switzerland : 1996) 2021; 425: (IGR: 22-2)

94413 Comparison of Topical Instillation From Single-dose and Multidose Eye Drop Containers in Glaucoma: A Multicenter Randomized Cross-sectional Trial
Rabilloud M
Journal of Glaucoma 2021; 30: 718-724 (IGR: 22-2)

94547 European real-world data about the use of a new delivery system containing a preservative-free multi-dose glaucoma treatment
Skov J
European Journal of Ophthalmology 2021; 31: 1056-1063 (IGR: 22-2)

94845 Efficacy and Safety of Preservative-free Latanoprost Eyedrops Compared with Preserved Prostaglandin Analogues in Patients with Open-angle Glaucoma
Park JW
Korean Journal of Ophthalmology 2021; 35: 235-241 (IGR: 22-2)

94855 Distribution of Gold Nanoparticles in the Anterior Chamber of the Eye after Intracameral Injection for Glaucoma Therapy
Fuchshofer R
Pharmaceutics 2021; 13: (IGR: 22-2)

94955 Surface Engineering of FLT4-Targeted Nanocarriers Enhances Cell-Softening Glaucoma Therapy
Perkumas KM
ACS applied materials & interfaces 2021; 13: 32823-32836 (IGR: 22-2)

94413 Comparison of Topical Instillation From Single-dose and Multidose Eye Drop Containers in Glaucoma: A Multicenter Randomized Cross-sectional Trial
Poli M
Journal of Glaucoma 2021; 30: 718-724 (IGR: 22-2)

94955 Surface Engineering of FLT4-Targeted Nanocarriers Enhances Cell-Softening Glaucoma Therapy
Ren R
ACS applied materials & interfaces 2021; 13: 32823-32836 (IGR: 22-2)

94980 Nano-in-Nano Dendrimer Gel Particles for Efficient Topical Delivery of Antiglaucoma Drugs into the Eye
Cooper RC
Chemical engineering journal (Lausanne, Switzerland : 1996) 2021; 425: (IGR: 22-2)

94547 European real-world data about the use of a new delivery system containing a preservative-free multi-dose glaucoma treatment
Puska P
European Journal of Ophthalmology 2021; 31: 1056-1063 (IGR: 22-2)

94855 Distribution of Gold Nanoparticles in the Anterior Chamber of the Eye after Intracameral Injection for Glaucoma Therapy
Breunig M
Pharmaceutics 2021; 13: (IGR: 22-2)

94413 Comparison of Topical Instillation From Single-dose and Multidose Eye Drop Containers in Glaucoma: A Multicenter Randomized Cross-sectional Trial
Denis P
Journal of Glaucoma 2021; 30: 718-724 (IGR: 22-2)

94955 Surface Engineering of FLT4-Targeted Nanocarriers Enhances Cell-Softening Glaucoma Therapy
Gong H
ACS applied materials & interfaces 2021; 13: 32823-32836 (IGR: 22-2)

94547 European real-world data about the use of a new delivery system containing a preservative-free multi-dose glaucoma treatment
Erb C
European Journal of Ophthalmology 2021; 31: 1056-1063 (IGR: 22-2)

94980 Nano-in-Nano Dendrimer Gel Particles for Efficient Topical Delivery of Antiglaucoma Drugs into the Eye
Gui Q
Chemical engineering journal (Lausanne, Switzerland : 1996) 2021; 425: (IGR: 22-2)

94955 Surface Engineering of FLT4-Targeted Nanocarriers Enhances Cell-Softening Glaucoma Therapy
Stamer WD
ACS applied materials & interfaces 2021; 13: 32823-32836 (IGR: 22-2)

94980 Nano-in-Nano Dendrimer Gel Particles for Efficient Topical Delivery of Antiglaucoma Drugs into the Eye
Chow WN; Liu X
Chemical engineering journal (Lausanne, Switzerland : 1996) 2021; 425: (IGR: 22-2)

94955 Surface Engineering of FLT4-Targeted Nanocarriers Enhances Cell-Softening Glaucoma Therapy
Johnson M; Scott EA
ACS applied materials & interfaces 2021; 13: 32823-32836 (IGR: 22-2)

94980 Nano-in-Nano Dendrimer Gel Particles for Efficient Topical Delivery of Antiglaucoma Drugs into the Eye
Yang H
Chemical engineering journal (Lausanne, Switzerland : 1996) 2021; 425: (IGR: 22-2)

92812 Pharmacokinetics and Pharmacology of Latanoprost 0.005% without Benzalkonium Chloride Vs Latanoprost 0.005% with Benzalkonium Chloride in New Zealand White Rabbits and Beagles
Halder A
Current Eye Research 2021; 46: 1031-1037 (IGR: 22-1)

92251 Latanoprost-loaded phytantriol cubosomes for the treatment of glaucoma
Bessone CDV
European Journal of Pharmaceutical Sciences 2021; 160: 105748 (IGR: 22-1)

92121 Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study
Ansari E
Advances in Therapy 2021; 38: 2990-3002 (IGR: 22-1)

92597 Optimization and Characterization of Brimonidine Tartrate Nanoparticles-loaded In Situ Gel for the Treatment of Glaucoma
Sharma PK
Current Eye Research 2021; 0: 1-14 (IGR: 22-1)

92066 Dry eye disease among Glaucoma patients on topical hypotensive medications, in a tertiary hospital, Ethiopia
Sahlu M
BMC Ophthalmology 2021; 21: 155 (IGR: 22-1)

92175 Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis
Harasymowycz P
Advances in Therapy 2021; 38: 3019-3031 (IGR: 22-1)

92598 Real-World Study on Patient Satisfaction and Tolerability After Switching to Preservative-Free Latanoprost
Erb C
Clinical Ophthalmology 2021; 15: 931-938 (IGR: 22-1)

92528 Improved Treatment Options for Glaucoma with Brimonidine-Loaded Lipid DNA Nanoparticles
Schnichels S
ACS applied materials & interfaces 2021; 13: 9445-9456 (IGR: 22-1)

92630 Formulation and Characterization of Acetazolamide/Carvedilol Niosomal Gel for Glaucoma Treatment: In Vitro, and In Vivo Study
Abdelmonem R
Pharmaceutics 2021; 13: (IGR: 22-1)

92288 Betaxolol-loaded niosomes integrated within pH-sensitive in situ forming gel for management of glaucoma
Allam A
International Journal of Pharmaceutics 2021; 598: 120380 (IGR: 22-1)

92432 A miRNA stabilizing polydopamine nano-platform for intraocular delivery of miR-21-5p in glaucoma therapy
Tan C
Journal of materials chemistry. B 2021; 9: 3335-3345 (IGR: 22-1)

91911 Advances in medical therapy for glaucoma
Ostler E
Current Opinions in Ophthalmology 2021; 32: 129-133 (IGR: 22-1)

92071 New strategies for the management of ocular surface disease in glaucoma patients
Voicu L
Current Opinions in Ophthalmology 2021; 32: 134-140 (IGR: 22-1)

92487 Comparison of the Intraocular Pressure-Lowering Effect and Safety of Preservative-Free And Preservative-Containing Brimonidine/Timolol Fixed-Combination Ophthalmic Solutions in Patients with Open-Angle Glaucoma
Kim JM
Seminars in Ophthalmology 2021; 36: 103-109 (IGR: 22-1)

92043 Nanomedicines for the treatment of glaucoma: Current status and future perspectives
Zhai Z
Acta biomaterialia 2021; 125: 41-56 (IGR: 22-1)

92224 Targeted delivery of LM22A-4 by cubosomes protects retinal ganglion cells in an experimental glaucoma model
Ding Y
Acta biomaterialia 2021; 126: 433-444 (IGR: 22-1)

92630 Formulation and Characterization of Acetazolamide/Carvedilol Niosomal Gel for Glaucoma Treatment: In Vitro, and In Vivo Study
Elhabal SF
Pharmaceutics 2021; 13: (IGR: 22-1)

92071 New strategies for the management of ocular surface disease in glaucoma patients
Salim S
Current Opinions in Ophthalmology 2021; 32: 134-140 (IGR: 22-1)

92175 Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis
Hutnik C
Advances in Therapy 2021; 38: 3019-3031 (IGR: 22-1)

92528 Improved Treatment Options for Glaucoma with Brimonidine-Loaded Lipid DNA Nanoparticles
Hurst J
ACS applied materials & interfaces 2021; 13: 9445-9456 (IGR: 22-1)

92224 Targeted delivery of LM22A-4 by cubosomes protects retinal ganglion cells in an experimental glaucoma model
Chow SH
Acta biomaterialia 2021; 126: 433-444 (IGR: 22-1)

92432 A miRNA stabilizing polydopamine nano-platform for intraocular delivery of miR-21-5p in glaucoma therapy
Jia F
Journal of materials chemistry. B 2021; 9: 3335-3345 (IGR: 22-1)

92043 Nanomedicines for the treatment of glaucoma: Current status and future perspectives
Cheng Y
Acta biomaterialia 2021; 125: 41-56 (IGR: 22-1)

92251 Latanoprost-loaded phytantriol cubosomes for the treatment of glaucoma
Akhlaghi SP
European Journal of Pharmaceutical Sciences 2021; 160: 105748 (IGR: 22-1)

92487 Comparison of the Intraocular Pressure-Lowering Effect and Safety of Preservative-Free And Preservative-Containing Brimonidine/Timolol Fixed-Combination Ophthalmic Solutions in Patients with Open-Angle Glaucoma
Kim TW
Seminars in Ophthalmology 2021; 36: 103-109 (IGR: 22-1)

91911 Advances in medical therapy for glaucoma
Rhee D
Current Opinions in Ophthalmology 2021; 32: 129-133 (IGR: 22-1)

92066 Dry eye disease among Glaucoma patients on topical hypotensive medications, in a tertiary hospital, Ethiopia
Giorgis AT
BMC Ophthalmology 2021; 21: 155 (IGR: 22-1)

92598 Real-World Study on Patient Satisfaction and Tolerability After Switching to Preservative-Free Latanoprost
Stalmans I
Clinical Ophthalmology 2021; 15: 931-938 (IGR: 22-1)

92288 Betaxolol-loaded niosomes integrated within pH-sensitive in situ forming gel for management of glaucoma
Elsabahy M
International Journal of Pharmaceutics 2021; 598: 120380 (IGR: 22-1)

92812 Pharmacokinetics and Pharmacology of Latanoprost 0.005% without Benzalkonium Chloride Vs Latanoprost 0.005% with Benzalkonium Chloride in New Zealand White Rabbits and Beagles
Khopade AJ
Current Eye Research 2021; 46: 1031-1037 (IGR: 22-1)

92121 Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study
Pavicic-Astalos J
Advances in Therapy 2021; 38: 2990-3002 (IGR: 22-1)

92597 Optimization and Characterization of Brimonidine Tartrate Nanoparticles-loaded In Situ Gel for the Treatment of Glaucoma
Chauhan MK
Current Eye Research 2021; 0: 1-14 (IGR: 22-1)

92175 Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis
Rouland JF
Advances in Therapy 2021; 38: 3019-3031 (IGR: 22-1)

92043 Nanomedicines for the treatment of glaucoma: Current status and future perspectives
Hong J
Acta biomaterialia 2021; 125: 41-56 (IGR: 22-1)

92109 Corneal epithelium and limbal region alterations due to glaucoma medications evaluated by anterior segment optic coherence tomography: a case-control study
Çınar AC
Cutaneous and Ocular Toxicology 2021; 40: 85-94 (IGR: 22-1)

92630 Formulation and Characterization of Acetazolamide/Carvedilol Niosomal Gel for Glaucoma Treatment: In Vitro, and In Vivo Study
Abdelmalak NS
Pharmaceutics 2021; 13: (IGR: 22-1)

92288 Betaxolol-loaded niosomes integrated within pH-sensitive in situ forming gel for management of glaucoma
El Badry M
International Journal of Pharmaceutics 2021; 598: 120380 (IGR: 22-1)

92432 A miRNA stabilizing polydopamine nano-platform for intraocular delivery of miR-21-5p in glaucoma therapy
Zhang P
Journal of materials chemistry. B 2021; 9: 3335-3345 (IGR: 22-1)

92251 Latanoprost-loaded phytantriol cubosomes for the treatment of glaucoma
Tártara LI
European Journal of Pharmaceutical Sciences 2021; 160: 105748 (IGR: 22-1)

92224 Targeted delivery of LM22A-4 by cubosomes protects retinal ganglion cells in an experimental glaucoma model
Chen J
Acta biomaterialia 2021; 126: 433-444 (IGR: 22-1)

92121 Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study
Ayan F
Advances in Therapy 2021; 38: 2990-3002 (IGR: 22-1)

92598 Real-World Study on Patient Satisfaction and Tolerability After Switching to Preservative-Free Latanoprost
Iliev M
Clinical Ophthalmology 2021; 15: 931-938 (IGR: 22-1)

92487 Comparison of the Intraocular Pressure-Lowering Effect and Safety of Preservative-Free And Preservative-Containing Brimonidine/Timolol Fixed-Combination Ophthalmic Solutions in Patients with Open-Angle Glaucoma
Park SW
Seminars in Ophthalmology 2021; 36: 103-109 (IGR: 22-1)

92528 Improved Treatment Options for Glaucoma with Brimonidine-Loaded Lipid DNA Nanoparticles
de Vries JW
ACS applied materials & interfaces 2021; 13: 9445-9456 (IGR: 22-1)

91911 Advances in medical therapy for glaucoma
Burney E
Current Opinions in Ophthalmology 2021; 32: 129-133 (IGR: 22-1)

92251 Latanoprost-loaded phytantriol cubosomes for the treatment of glaucoma
Quinteros DA
European Journal of Pharmaceutical Sciences 2021; 160: 105748 (IGR: 22-1)

92288 Betaxolol-loaded niosomes integrated within pH-sensitive in situ forming gel for management of glaucoma
Eleraky NE
International Journal of Pharmaceutics 2021; 598: 120380 (IGR: 22-1)

92598 Real-World Study on Patient Satisfaction and Tolerability After Switching to Preservative-Free Latanoprost
Muñoz-Negrete FJ
Clinical Ophthalmology 2021; 15: 931-938 (IGR: 22-1)

91911 Advances in medical therapy for glaucoma
Sozeri Y
Current Opinions in Ophthalmology 2021; 32: 129-133 (IGR: 22-1)

92432 A miRNA stabilizing polydopamine nano-platform for intraocular delivery of miR-21-5p in glaucoma therapy
Sun X
Journal of materials chemistry. B 2021; 9: 3335-3345 (IGR: 22-1)

92487 Comparison of the Intraocular Pressure-Lowering Effect and Safety of Preservative-Free And Preservative-Containing Brimonidine/Timolol Fixed-Combination Ophthalmic Solutions in Patients with Open-Angle Glaucoma
Park HL
Seminars in Ophthalmology 2021; 36: 103-109 (IGR: 22-1)

92224 Targeted delivery of LM22A-4 by cubosomes protects retinal ganglion cells in an experimental glaucoma model
Brun APL
Acta biomaterialia 2021; 126: 433-444 (IGR: 22-1)

92121 Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study
King AJ
Advances in Therapy 2021; 38: 2990-3002 (IGR: 22-1)

92175 Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis
Negrete FJM
Advances in Therapy 2021; 38: 3019-3031 (IGR: 22-1)

92630 Formulation and Characterization of Acetazolamide/Carvedilol Niosomal Gel for Glaucoma Treatment: In Vitro, and In Vivo Study
El-Nabarawi MA
Pharmaceutics 2021; 13: (IGR: 22-1)

92528 Improved Treatment Options for Glaucoma with Brimonidine-Loaded Lipid DNA Nanoparticles
Ullah S
ACS applied materials & interfaces 2021; 13: 9445-9456 (IGR: 22-1)

92121 Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study
Kinsella M
Advances in Therapy 2021; 38: 2990-3002 (IGR: 22-1)

92630 Formulation and Characterization of Acetazolamide/Carvedilol Niosomal Gel for Glaucoma Treatment: In Vitro, and In Vivo Study
Teaima MH
Pharmaceutics 2021; 13: (IGR: 22-1)

92528 Improved Treatment Options for Glaucoma with Brimonidine-Loaded Lipid DNA Nanoparticles
Frößl K
ACS applied materials & interfaces 2021; 13: 9445-9456 (IGR: 22-1)

92224 Targeted delivery of LM22A-4 by cubosomes protects retinal ganglion cells in an experimental glaucoma model
Wu CM
Acta biomaterialia 2021; 126: 433-444 (IGR: 22-1)

92487 Comparison of the Intraocular Pressure-Lowering Effect and Safety of Preservative-Free And Preservative-Containing Brimonidine/Timolol Fixed-Combination Ophthalmic Solutions in Patients with Open-Angle Glaucoma
Hwang YH
Seminars in Ophthalmology 2021; 36: 103-109 (IGR: 22-1)

92432 A miRNA stabilizing polydopamine nano-platform for intraocular delivery of miR-21-5p in glaucoma therapy
Qiao Y
Journal of materials chemistry. B 2021; 9: 3335-3345 (IGR: 22-1)

92251 Latanoprost-loaded phytantriol cubosomes for the treatment of glaucoma
Loh W
European Journal of Pharmaceutical Sciences 2021; 160: 105748 (IGR: 22-1)

92175 Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis
Economou MA
Advances in Therapy 2021; 38: 3019-3031 (IGR: 22-1)

92487 Comparison of the Intraocular Pressure-Lowering Effect and Safety of Preservative-Free And Preservative-Containing Brimonidine/Timolol Fixed-Combination Ophthalmic Solutions in Patients with Open-Angle Glaucoma
Jeoung JW
Seminars in Ophthalmology 2021; 36: 103-109 (IGR: 22-1)

92432 A miRNA stabilizing polydopamine nano-platform for intraocular delivery of miR-21-5p in glaucoma therapy
Chen X
Journal of materials chemistry. B 2021; 9: 3335-3345 (IGR: 22-1)

92251 Latanoprost-loaded phytantriol cubosomes for the treatment of glaucoma
Allemandi DA
European Journal of Pharmaceutical Sciences 2021; 160: 105748 (IGR: 22-1)

92121 Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study
Ng E
Advances in Therapy 2021; 38: 2990-3002 (IGR: 22-1)

92528 Improved Treatment Options for Glaucoma with Brimonidine-Loaded Lipid DNA Nanoparticles
Gruszka A
ACS applied materials & interfaces 2021; 13: 9445-9456 (IGR: 22-1)

92175 Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis
Denis P
Advances in Therapy 2021; 38: 3019-3031 (IGR: 22-1)

92224 Targeted delivery of LM22A-4 by cubosomes protects retinal ganglion cells in an experimental glaucoma model
Duff AP
Acta biomaterialia 2021; 126: 433-444 (IGR: 22-1)

92528 Improved Treatment Options for Glaucoma with Brimonidine-Loaded Lipid DNA Nanoparticles
Löscher M
ACS applied materials & interfaces 2021; 13: 9445-9456 (IGR: 22-1)

92487 Comparison of the Intraocular Pressure-Lowering Effect and Safety of Preservative-Free And Preservative-Containing Brimonidine/Timolol Fixed-Combination Ophthalmic Solutions in Patients with Open-Angle Glaucoma
Kim CY
Seminars in Ophthalmology 2021; 36: 103-109 (IGR: 22-1)

92175 Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis
Baudouin C
Advances in Therapy 2021; 38: 3019-3031 (IGR: 22-1)

92224 Targeted delivery of LM22A-4 by cubosomes protects retinal ganglion cells in an experimental glaucoma model
Wang Y
Acta biomaterialia 2021; 126: 433-444 (IGR: 22-1)

92121 Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study
Nita A
Advances in Therapy 2021; 38: 2990-3002 (IGR: 22-1)

92432 A miRNA stabilizing polydopamine nano-platform for intraocular delivery of miR-21-5p in glaucoma therapy
Wang Y
Journal of materials chemistry. B 2021; 9: 3335-3345 (IGR: 22-1)

92224 Targeted delivery of LM22A-4 by cubosomes protects retinal ganglion cells in an experimental glaucoma model
Song J
Acta biomaterialia 2021; 126: 433-444 (IGR: 22-1)

92528 Improved Treatment Options for Glaucoma with Brimonidine-Loaded Lipid DNA Nanoparticles
Bartz-Schmidt KU
ACS applied materials & interfaces 2021; 13: 9445-9456 (IGR: 22-1)

92432 A miRNA stabilizing polydopamine nano-platform for intraocular delivery of miR-21-5p in glaucoma therapy
Chen J
Journal of materials chemistry. B 2021; 9: 3335-3345 (IGR: 22-1)

92121 Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study

Advances in Therapy 2021; 38: 2990-3002 (IGR: 22-1)

92432 A miRNA stabilizing polydopamine nano-platform for intraocular delivery of miR-21-5p in glaucoma therapy
Lei Y
Journal of materials chemistry. B 2021; 9: 3335-3345 (IGR: 22-1)

92224 Targeted delivery of LM22A-4 by cubosomes protects retinal ganglion cells in an experimental glaucoma model
Wang JH
Acta biomaterialia 2021; 126: 433-444 (IGR: 22-1)

92528 Improved Treatment Options for Glaucoma with Brimonidine-Loaded Lipid DNA Nanoparticles
Spitzer MS; Herrmann A
ACS applied materials & interfaces 2021; 13: 9445-9456 (IGR: 22-1)

92224 Targeted delivery of LM22A-4 by cubosomes protects retinal ganglion cells in an experimental glaucoma model
Wong VHY; Zhao D; Nishimura T; Lee TH; Conn CE; Hsu HY; Bui BV; Liu GS; Shen HH
Acta biomaterialia 2021; 126: 433-444 (IGR: 22-1)

91466 Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model
Rodrigo MJ
Biomaterials science 2020; 8: 6246-6260 (IGR: 21-4)

91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
Konstas AG
Expert Opinion on Drug Safety 2021; 0: 1-14 (IGR: 21-4)

90873 Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1)
Medeiros FA
Ophthalmology 2020; 127: 1627-1641 (IGR: 21-4)

91624 Signs and Symptoms of Ocular Surface Disease: The Reasons for Patient Dissatisfaction with Glaucoma Treatments
Stalmans I
Clinical Ophthalmology 2020; 14: 3675-3680 (IGR: 21-4)

91799 Novel Eye Drop Delivery Aid Improves Outcomes and Satisfaction
Sanchez FG
Ophthalmology. Glaucoma 2021; 0: (IGR: 21-4)

91141 A Tenon's capsule/bulbar conjunctiva interface biomimetic to model fibrosis and local drug delivery
Kozdon K
PLoS ONE 2020; 15: e0241569 (IGR: 21-4)

91725 Physiochemical Properties and Cytotoxicity of a Benzalkonium Chloride-Free, Micellar Emulsion Ophthalmic Formulation of Latanoprost
Halder A
Clinical Ophthalmology 2020; 14: 3057-3064 (IGR: 21-4)

91266 Assessment of Corneal Epithelium Thickness in Glaucomatous Patients Undergoing Medical Treatment
Halkiadakis I
Journal of Glaucoma 2021; 30: 44-49 (IGR: 21-4)

91413 Sustained-release drug delivery systems for the treatment of glaucoma
Kesav NP
International Journal of Ophthalmology 2021; 14: 148-159 (IGR: 21-4)

91799 Novel Eye Drop Delivery Aid Improves Outcomes and Satisfaction
Sanchez FG
Ophthalmology. Glaucoma 2021; 0: (IGR: 21-4)

91202 Effect of Autologous Serum Eyedrops on Ocular Surface Disease Caused by Preserved Glaucoma Eyedrops
So HR
Journal of clinical medicine 2020; 9: (IGR: 21-4)

91695 Effects of Benzalkonium Chloride in Ophthalmic Eyedrop Medications on Corneal Epithelium
Seino S
Yakugaku Zasshi 2021; 141: 35-39 (IGR: 21-4)

91819 Topical preservative-free ophthalmic treatments: an unmet clinical need
Figus M
Expert Opinion on Drug Delivery 2020; 0: 1-18 (IGR: 21-4)

90921 Glaucoma: Management and Future Perspectives for Nanotechnology-Based Treatment Modalities
El Hoffy NM
European Journal of Pharmaceutical Sciences 2021; 158: 105648 (IGR: 21-4)

90987 Understanding the Dual Dilemma of Dry Eye and Glaucoma: An International Review
Nijm LM
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2020; 9: 481-490 (IGR: 21-4)

91669 Topical Bimatoprost Insert for Primary Open-Angle Glaucoma and Ocular Hypertension Treatment - A Phase II Controlled Study
Rubião F
Current Drug Delivery 2020; 0: (IGR: 21-4)

91260 Assessment of Ocular Surface Disease in Glaucoma Patients in Ghana
Kobia-Acquah E
Journal of Glaucoma 2021; 30: 180-186 (IGR: 21-4)

91324 Effect of preservative-free and preserved prostaglandin analogues on the histology of cornea of adult male Guinea pigs following repeated exposure
Ali AF
Folia morphologica 2022; 81: 52-64 (IGR: 21-4)

91577 Patients' Experience of Using Eye Drop Guide Device to Aid Self-Administration of Glaucoma Medications
Sakiyalak D
Clinical Ophthalmology 2020; 14: 3781-3788 (IGR: 21-4)

91553 Novel Drug Delivery Systems Fighting Glaucoma: Formulation Obstacles and Solutions
Rahić O
Pharmaceutics 2020; 13: (IGR: 21-4)

91846 Angiotensin Receptor Blockers in cyclodextrin nanoparticle eye drops: Ocular pharmacokinetics and pharmacologic effect on intraocular pressure
Lorenzo-Soler L
Acta Ophthalmologica 2021; 99: 376-382 (IGR: 21-4)

91252 Soft Contact Lens with Embedded Microtubes for Sustained and Self-Adaptive Drug Delivery for Glaucoma Treatment
Ding X
ACS applied materials & interfaces 2020; 12: 45789-45795 (IGR: 21-4)

91819 Topical preservative-free ophthalmic treatments: an unmet clinical need
Agnifili L
Expert Opinion on Drug Delivery 2020; 0: 1-18 (IGR: 21-4)

91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
Labbé A
Expert Opinion on Drug Safety 2021; 0: 1-14 (IGR: 21-4)

91252 Soft Contact Lens with Embedded Microtubes for Sustained and Self-Adaptive Drug Delivery for Glaucoma Treatment
Ben-Shlomo G
ACS applied materials & interfaces 2020; 12: 45789-45795 (IGR: 21-4)

90873 Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1)
Walters TR
Ophthalmology 2020; 127: 1627-1641 (IGR: 21-4)

91553 Novel Drug Delivery Systems Fighting Glaucoma: Formulation Obstacles and Solutions
Tucak A
Pharmaceutics 2020; 13: (IGR: 21-4)

91624 Signs and Symptoms of Ocular Surface Disease: The Reasons for Patient Dissatisfaction with Glaucoma Treatments
Lemij H
Clinical Ophthalmology 2020; 14: 3675-3680 (IGR: 21-4)

91466 Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model
Cardiel MJ
Biomaterials science 2020; 8: 6246-6260 (IGR: 21-4)

91773 Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits
Verma A
Drug Delivery 2020; 27: 888-899 (IGR: 21-4)

91577 Patients' Experience of Using Eye Drop Guide Device to Aid Self-Administration of Glaucoma Medications
Kobwanthanakun S
Clinical Ophthalmology 2020; 14: 3781-3788 (IGR: 21-4)

91324 Effect of preservative-free and preserved prostaglandin analogues on the histology of cornea of adult male Guinea pigs following repeated exposure
Salama RM
Folia morphologica 2022; 81: 52-64 (IGR: 21-4)

91846 Angiotensin Receptor Blockers in cyclodextrin nanoparticle eye drops: Ocular pharmacokinetics and pharmacologic effect on intraocular pressure
Olafsdottir OB
Acta Ophthalmologica 2021; 99: 376-382 (IGR: 21-4)

91141 A Tenon's capsule/bulbar conjunctiva interface biomimetic to model fibrosis and local drug delivery
Caridi B
PLoS ONE 2020; 15: e0241569 (IGR: 21-4)

91695 Effects of Benzalkonium Chloride in Ophthalmic Eyedrop Medications on Corneal Epithelium
Takada Y
Yakugaku Zasshi 2021; 141: 35-39 (IGR: 21-4)

91799 Novel Eye Drop Delivery Aid Improves Outcomes and Satisfaction
Mansberger SL
Ophthalmology. Glaucoma 2021; 0: (IGR: 21-4)

90921 Glaucoma: Management and Future Perspectives for Nanotechnology-Based Treatment Modalities
Abdel Azim EA
European Journal of Pharmaceutical Sciences 2021; 158: 105648 (IGR: 21-4)

90987 Understanding the Dual Dilemma of Dry Eye and Glaucoma: An International Review
de Benito-Llopis L
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2020; 9: 481-490 (IGR: 21-4)

91669 Topical Bimatoprost Insert for Primary Open-Angle Glaucoma and Ocular Hypertension Treatment - A Phase II Controlled Study
Araújo ACF
Current Drug Delivery 2020; 0: (IGR: 21-4)

91725 Physiochemical Properties and Cytotoxicity of a Benzalkonium Chloride-Free, Micellar Emulsion Ophthalmic Formulation of Latanoprost
Khopade AJ
Clinical Ophthalmology 2020; 14: 3057-3064 (IGR: 21-4)

91260 Assessment of Ocular Surface Disease in Glaucoma Patients in Ghana
Gyekye GA
Journal of Glaucoma 2021; 30: 180-186 (IGR: 21-4)

91266 Assessment of Corneal Epithelium Thickness in Glaucomatous Patients Undergoing Medical Treatment
Vernikou A
Journal of Glaucoma 2021; 30: 44-49 (IGR: 21-4)

91413 Sustained-release drug delivery systems for the treatment of glaucoma
Young CEC
International Journal of Ophthalmology 2021; 14: 148-159 (IGR: 21-4)

91202 Effect of Autologous Serum Eyedrops on Ocular Surface Disease Caused by Preserved Glaucoma Eyedrops
Park HYL
Journal of clinical medicine 2020; 9: (IGR: 21-4)

91695 Effects of Benzalkonium Chloride in Ophthalmic Eyedrop Medications on Corneal Epithelium
Saika S
Yakugaku Zasshi 2021; 141: 35-39 (IGR: 21-4)

91266 Assessment of Corneal Epithelium Thickness in Glaucomatous Patients Undergoing Medical Treatment
Tzimis V
Journal of Glaucoma 2021; 30: 44-49 (IGR: 21-4)

91553 Novel Drug Delivery Systems Fighting Glaucoma: Formulation Obstacles and Solutions
Omerović N
Pharmaceutics 2020; 13: (IGR: 21-4)

90921 Glaucoma: Management and Future Perspectives for Nanotechnology-Based Treatment Modalities
Hathout RM
European Journal of Pharmaceutical Sciences 2021; 158: 105648 (IGR: 21-4)

90987 Understanding the Dual Dilemma of Dry Eye and Glaucoma: An International Review
Rossi GC
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2020; 9: 481-490 (IGR: 21-4)

91324 Effect of preservative-free and preserved prostaglandin analogues on the histology of cornea of adult male Guinea pigs following repeated exposure
Soliman MA
Folia morphologica 2022; 81: 52-64 (IGR: 21-4)

91669 Topical Bimatoprost Insert for Primary Open-Angle Glaucoma and Ocular Hypertension Treatment - A Phase II Controlled Study
Sancio JB
Current Drug Delivery 2020; 0: (IGR: 21-4)

91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
Katsanos A
Expert Opinion on Drug Safety 2021; 0: 1-14 (IGR: 21-4)

90873 Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1)
Kolko M
Ophthalmology 2020; 127: 1627-1641 (IGR: 21-4)

91846 Angiotensin Receptor Blockers in cyclodextrin nanoparticle eye drops: Ocular pharmacokinetics and pharmacologic effect on intraocular pressure
Garhöfer G
Acta Ophthalmologica 2021; 99: 376-382 (IGR: 21-4)

91141 A Tenon's capsule/bulbar conjunctiva interface biomimetic to model fibrosis and local drug delivery
Duru I
PLoS ONE 2020; 15: e0241569 (IGR: 21-4)

91624 Signs and Symptoms of Ocular Surface Disease: The Reasons for Patient Dissatisfaction with Glaucoma Treatments
Clarke J
Clinical Ophthalmology 2020; 14: 3675-3680 (IGR: 21-4)

91252 Soft Contact Lens with Embedded Microtubes for Sustained and Self-Adaptive Drug Delivery for Glaucoma Treatment
Que L
ACS applied materials & interfaces 2020; 12: 45789-45795 (IGR: 21-4)

91773 Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits
Jain N
Drug Delivery 2020; 27: 888-899 (IGR: 21-4)

91413 Sustained-release drug delivery systems for the treatment of glaucoma
Ertel MK
International Journal of Ophthalmology 2021; 14: 148-159 (IGR: 21-4)

91202 Effect of Autologous Serum Eyedrops on Ocular Surface Disease Caused by Preserved Glaucoma Eyedrops
Chung SH
Journal of clinical medicine 2020; 9: (IGR: 21-4)

91260 Assessment of Ocular Surface Disease in Glaucoma Patients in Ghana
Antwi-Adjei EK
Journal of Glaucoma 2021; 30: 180-186 (IGR: 21-4)

91819 Topical preservative-free ophthalmic treatments: an unmet clinical need
Lanzini M
Expert Opinion on Drug Delivery 2020; 0: 1-18 (IGR: 21-4)

91799 Novel Eye Drop Delivery Aid Improves Outcomes and Satisfaction
Kung Y
Ophthalmology. Glaucoma 2021; 0: (IGR: 21-4)

91466 Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model
Fraile JM
Biomaterials science 2020; 8: 6246-6260 (IGR: 21-4)

91260 Assessment of Ocular Surface Disease in Glaucoma Patients in Ghana
Koomson NY
Journal of Glaucoma 2021; 30: 180-186 (IGR: 21-4)

90873 Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1)
Coote M
Ophthalmology 2020; 127: 1627-1641 (IGR: 21-4)

91819 Topical preservative-free ophthalmic treatments: an unmet clinical need
Brescia L
Expert Opinion on Drug Delivery 2020; 0: 1-18 (IGR: 21-4)

91413 Sustained-release drug delivery systems for the treatment of glaucoma
Seibold LK
International Journal of Ophthalmology 2021; 14: 148-159 (IGR: 21-4)

91846 Angiotensin Receptor Blockers in cyclodextrin nanoparticle eye drops: Ocular pharmacokinetics and pharmacologic effect on intraocular pressure
Jansook P
Acta Ophthalmologica 2021; 99: 376-382 (IGR: 21-4)

90987 Understanding the Dual Dilemma of Dry Eye and Glaucoma: An International Review
Vajaranant TS
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2020; 9: 481-490 (IGR: 21-4)

91799 Novel Eye Drop Delivery Aid Improves Outcomes and Satisfaction
Gardiner SK
Ophthalmology. Glaucoma 2021; 0: (IGR: 21-4)

91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
Meier-Gibbons F
Expert Opinion on Drug Safety 2021; 0: 1-14 (IGR: 21-4)

91266 Assessment of Corneal Epithelium Thickness in Glaucomatous Patients Undergoing Medical Treatment
Markopoulos I
Journal of Glaucoma 2021; 30: 44-49 (IGR: 21-4)

91553 Novel Drug Delivery Systems Fighting Glaucoma: Formulation Obstacles and Solutions
Sirbubalo M
Pharmaceutics 2020; 13: (IGR: 21-4)

91202 Effect of Autologous Serum Eyedrops on Ocular Surface Disease Caused by Preserved Glaucoma Eyedrops
Kim HS
Journal of clinical medicine 2020; 9: (IGR: 21-4)

91466 Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model
Mendez-Martinez S
Biomaterials science 2020; 8: 6246-6260 (IGR: 21-4)

91669 Topical Bimatoprost Insert for Primary Open-Angle Glaucoma and Ocular Hypertension Treatment - A Phase II Controlled Study
Nogueira BS
Current Drug Delivery 2020; 0: (IGR: 21-4)

91624 Signs and Symptoms of Ocular Surface Disease: The Reasons for Patient Dissatisfaction with Glaucoma Treatments
Baudouin C
Clinical Ophthalmology 2020; 14: 3675-3680 (IGR: 21-4)

90921 Glaucoma: Management and Future Perspectives for Nanotechnology-Based Treatment Modalities
Fouly MA
European Journal of Pharmaceutical Sciences 2021; 158: 105648 (IGR: 21-4)

91141 A Tenon's capsule/bulbar conjunctiva interface biomimetic to model fibrosis and local drug delivery
Ezra DG
PLoS ONE 2020; 15: e0241569 (IGR: 21-4)

91799 Novel Eye Drop Delivery Aid Improves Outcomes and Satisfaction
Burgoyne CF
Ophthalmology. Glaucoma 2021; 0: (IGR: 21-4)

91819 Topical preservative-free ophthalmic treatments: an unmet clinical need
Sartini F
Expert Opinion on Drug Delivery 2020; 0: 1-18 (IGR: 21-4)

91846 Angiotensin Receptor Blockers in cyclodextrin nanoparticle eye drops: Ocular pharmacokinetics and pharmacologic effect on intraocular pressure
Kristinsdottir IM
Acta Ophthalmologica 2021; 99: 376-382 (IGR: 21-4)

91266 Assessment of Corneal Epithelium Thickness in Glaucomatous Patients Undergoing Medical Treatment
Popeskou K
Journal of Glaucoma 2021; 30: 44-49 (IGR: 21-4)

90921 Glaucoma: Management and Future Perspectives for Nanotechnology-Based Treatment Modalities
Elkheshen SA
European Journal of Pharmaceutical Sciences 2021; 158: 105648 (IGR: 21-4)

91202 Effect of Autologous Serum Eyedrops on Ocular Surface Disease Caused by Preserved Glaucoma Eyedrops
Byun YS
Journal of clinical medicine 2020; 9: (IGR: 21-4)

91553 Novel Drug Delivery Systems Fighting Glaucoma: Formulation Obstacles and Solutions
Hindija L
Pharmaceutics 2020; 13: (IGR: 21-4)

90873 Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1)
Bejanian M
Ophthalmology 2020; 127: 1627-1641 (IGR: 21-4)

91819 Topical preservative-free ophthalmic treatments: an unmet clinical need
Sartini F
Expert Opinion on Drug Delivery 2020; 0: 1-18 (IGR: 21-4)

91466 Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model
Martinez-Rincon T
Biomaterials science 2020; 8: 6246-6260 (IGR: 21-4)

91260 Assessment of Ocular Surface Disease in Glaucoma Patients in Ghana
Cobbina F
Journal of Glaucoma 2021; 30: 180-186 (IGR: 21-4)

91413 Sustained-release drug delivery systems for the treatment of glaucoma
Kahook MY
International Journal of Ophthalmology 2021; 14: 148-159 (IGR: 21-4)

90987 Understanding the Dual Dilemma of Dry Eye and Glaucoma: An International Review
Coroneo MT
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2020; 9: 481-490 (IGR: 21-4)

91819 Topical preservative-free ophthalmic treatments: an unmet clinical need
Sartini F
Expert Opinion on Drug Delivery 2020; 0: 1-18 (IGR: 21-4)

91466 Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model
Martinez-Rincon T
Biomaterials science 2020; 8: 6246-6260 (IGR: 21-4)

91141 A Tenon's capsule/bulbar conjunctiva interface biomimetic to model fibrosis and local drug delivery
Phillips JB
PLoS ONE 2020; 15: e0241569 (IGR: 21-4)

91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
Irkec M
Expert Opinion on Drug Safety 2021; 0: 1-14 (IGR: 21-4)

91624 Signs and Symptoms of Ocular Surface Disease: The Reasons for Patient Dissatisfaction with Glaucoma Treatments

Clinical Ophthalmology 2020; 14: 3675-3680 (IGR: 21-4)

91669 Topical Bimatoprost Insert for Primary Open-Angle Glaucoma and Ocular Hypertension Treatment - A Phase II Controlled Study
Franca JR
Current Drug Delivery 2020; 0: (IGR: 21-4)

91466 Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model
Subias M
Biomaterials science 2020; 8: 6246-6260 (IGR: 21-4)

91260 Assessment of Ocular Surface Disease in Glaucoma Patients in Ghana
Donkor R
Journal of Glaucoma 2021; 30: 180-186 (IGR: 21-4)

91799 Novel Eye Drop Delivery Aid Improves Outcomes and Satisfaction
Cunningham ET
Ophthalmology. Glaucoma 2021; 0: (IGR: 21-4)

91141 A Tenon's capsule/bulbar conjunctiva interface biomimetic to model fibrosis and local drug delivery
Bailly M
PLoS ONE 2020; 15: e0241569 (IGR: 21-4)

91819 Topical preservative-free ophthalmic treatments: an unmet clinical need
Mastropasqua L
Expert Opinion on Drug Delivery 2020; 0: 1-18 (IGR: 21-4)

91669 Topical Bimatoprost Insert for Primary Open-Angle Glaucoma and Ocular Hypertension Treatment - A Phase II Controlled Study
Nogueira JC
Current Drug Delivery 2020; 0: (IGR: 21-4)

91553 Novel Drug Delivery Systems Fighting Glaucoma: Formulation Obstacles and Solutions
Hadžiabdić J
Pharmaceutics 2020; 13: (IGR: 21-4)

90873 Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1)
Goodkin ML
Ophthalmology 2020; 127: 1627-1641 (IGR: 21-4)

91266 Assessment of Corneal Epithelium Thickness in Glaucomatous Patients Undergoing Medical Treatment
Konstadinidou V
Journal of Glaucoma 2021; 30: 44-49 (IGR: 21-4)

91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
Boboridis KG
Expert Opinion on Drug Safety 2021; 0: 1-14 (IGR: 21-4)

91846 Angiotensin Receptor Blockers in cyclodextrin nanoparticle eye drops: Ocular pharmacokinetics and pharmacologic effect on intraocular pressure
Tan A
Acta Ophthalmologica 2021; 99: 376-382 (IGR: 21-4)

91466 Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model
Polo V
Biomaterials science 2020; 8: 6246-6260 (IGR: 21-4)

91260 Assessment of Ocular Surface Disease in Glaucoma Patients in Ghana
Akowuah PK
Journal of Glaucoma 2021; 30: 180-186 (IGR: 21-4)

91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
Holló G
Expert Opinion on Drug Safety 2021; 0: 1-14 (IGR: 21-4)

91846 Angiotensin Receptor Blockers in cyclodextrin nanoparticle eye drops: Ocular pharmacokinetics and pharmacologic effect on intraocular pressure
Loftsson T
Acta Ophthalmologica 2021; 99: 376-382 (IGR: 21-4)

91669 Topical Bimatoprost Insert for Primary Open-Angle Glaucoma and Ocular Hypertension Treatment - A Phase II Controlled Study
Ferreira AJ
Current Drug Delivery 2020; 0: (IGR: 21-4)

91799 Novel Eye Drop Delivery Aid Improves Outcomes and Satisfaction
Rees JP
Ophthalmology. Glaucoma 2021; 0: (IGR: 21-4)

90873 Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1)
Guo Q
Ophthalmology 2020; 127: 1627-1641 (IGR: 21-4)

91819 Topical preservative-free ophthalmic treatments: an unmet clinical need
Posarelli C
Expert Opinion on Drug Delivery 2020; 0: 1-18 (IGR: 21-4)

91553 Novel Drug Delivery Systems Fighting Glaucoma: Formulation Obstacles and Solutions
Vranić E
Pharmaceutics 2020; 13: (IGR: 21-4)

91669 Topical Bimatoprost Insert for Primary Open-Angle Glaucoma and Ocular Hypertension Treatment - A Phase II Controlled Study
Faraco AAG
Current Drug Delivery 2020; 0: (IGR: 21-4)

91466 Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model
Ruberte J
Biomaterials science 2020; 8: 6246-6260 (IGR: 21-4)

90873 Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1)
Zhang J
Ophthalmology 2020; 127: 1627-1641 (IGR: 21-4)

91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
García-Feijoo J
Expert Opinion on Drug Safety 2021; 0: 1-14 (IGR: 21-4)

91846 Angiotensin Receptor Blockers in cyclodextrin nanoparticle eye drops: Ocular pharmacokinetics and pharmacologic effect on intraocular pressure
Stefansson E
Acta Ophthalmologica 2021; 99: 376-382 (IGR: 21-4)

91799 Novel Eye Drop Delivery Aid Improves Outcomes and Satisfaction
Jones EP
Ophthalmology. Glaucoma 2021; 0: (IGR: 21-4)

91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
Dutton GN
Expert Opinion on Drug Safety 2021; 0: 1-14 (IGR: 21-4)

91669 Topical Bimatoprost Insert for Primary Open-Angle Glaucoma and Ocular Hypertension Treatment - A Phase II Controlled Study
Foureaux G
Current Drug Delivery 2020; 0: (IGR: 21-4)

91466 Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model
Ramirez T
Biomaterials science 2020; 8: 6246-6260 (IGR: 21-4)

91799 Novel Eye Drop Delivery Aid Improves Outcomes and Satisfaction
Kinast RM
Ophthalmology. Glaucoma 2021; 0: (IGR: 21-4)

90873 Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1)
Robinson MR
Ophthalmology 2020; 127: 1627-1641 (IGR: 21-4)

91466 Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model
Vispe E
Biomaterials science 2020; 8: 6246-6260 (IGR: 21-4)

91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
Baudouin C
Expert Opinion on Drug Safety 2021; 0: 1-14 (IGR: 21-4)

90873 Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1)
Weinreb RN
Ophthalmology 2020; 127: 1627-1641 (IGR: 21-4)

91669 Topical Bimatoprost Insert for Primary Open-Angle Glaucoma and Ocular Hypertension Treatment - A Phase II Controlled Study
Cronemberger S
Current Drug Delivery 2020; 0: (IGR: 21-4)

90873 Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1)

Ophthalmology 2020; 127: 1627-1641 (IGR: 21-4)

91466 Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model
Luna C; Mayoral JA; Garcia-Martin E
Biomaterials science 2020; 8: 6246-6260 (IGR: 21-4)

90672 Effect of aging on heat transfer, fluid flow and drug transport in anterior human eye: A computational study
Bhandari A
Journal of Controlled Release 2020; 328: 286-303 (IGR: 21-3)

90473 Effect of Long-Term Topical Antiglaucoma Medication Use on the Ocular Surface
Awe OO
Nigerian medical journal : journal of the Nigeria Medical Association 2020; 61: 184-188 (IGR: 21-3)

90851 Fasudil Loaded PLGA Microspheres as Potential Intravitreal Depot Formulation for Glaucoma Therapy
Mietzner R
Pharmaceutics 2020; 12: (IGR: 21-3)

89986 Potential Therapeutic Usage of Nanomedicine for Glaucoma Treatment
Kwon S
International Journal of Nanomedicine 2020; 15: 5745-5765 (IGR: 21-3)

90541 Nanoemulsion as a feasible and biocompatible carrier for ocular delivery of travoprost: Improved pharmacokinetic/pharmacodynamic properties
Ismail A
International Journal of Pharmaceutics 2020; 583: 119402 (IGR: 21-3)

90627 Effects of shell thickness of hollow poly(lactic acid) nanoparticles on sustained drug delivery for pharmacological treatment of glaucoma
Nguyen DD
Acta biomaterialia 2020; 111: 302-315 (IGR: 21-3)

90655 Numerical modeling of therapeutic lens drug delivery in the anterior human eye for the treatment of primary open-angle glaucoma
Bhandari A
Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine 2020; 234: 942-954 (IGR: 21-3)

90725 Targeted Delivery of Cell Softening Micelles to Schlemm's Canal Endothelial Cells for Treatment of Glaucoma
Stack T
Small (Weinheim an der Bergstrasse, Germany) 2020; 16: e2004205 (IGR: 21-3)

90618 Self-assembled DNA nanoparticles loaded with travoprost for glaucoma-treatment
Schnichels S
Nanomedicine: Nanotechnology, Biology, and Medicine 2020; 29: 102260 (IGR: 21-3)

89876 Bimatoprost Implant: First Approval
Shirley M
Drugs and Aging 2020; 37: 457-462 (IGR: 21-3)

90570 Nanoscale Drug Delivery Systems for Glaucoma: Experimental and In Silico Advances
Sharma S
Current Topics in Medicinal Chemistry 2021; 21: 115-125 (IGR: 21-3)

90679 Ocular co-Delivery of Timolol and Brimonidine from a Self-Assembling Peptide Hydrogel for the Treatment of Glaucoma: In Vitro and Ex Vivo Evaluation
Taka E
Pharmaceuticals (Basel, Switzerland) 2020; 13: (IGR: 21-3)

90021 Extraocular, periocular, and intraocular routes for sustained drug delivery for glaucoma
Kompella UB
Progress in Retinal and Eye Research 2020; 0: 100901 (IGR: 21-3)

90507 The protective effect of 3% diquafosol on meibomian gland morphology in glaucoma patients treated with prostaglandin analogs: a 12-month follow-up study
Guo Y
BMC Ophthalmology 2020; 20: 277 (IGR: 21-3)

90736 New antiglaucomatous agent for the treatment of open angle glaucoma: Polymeric inserts for drug release and in vitro and in vivo study
Cesar ALA
Journal of Biomedical Materials Research - Part A 2021; 109: 336-345 (IGR: 21-3)

90803 Micro-interaction of mucin tear film interface with particles: The inconsistency of pharmacodynamics and precorneal retention of ion-exchange, functionalized, Mt-embedded nano- and microparticles
Han X
Colloids and surfaces. B, Biointerfaces 2021; 197: 111355 (IGR: 21-3)

90630 Mucoadhesive and responsive nanogels as carriers for sustainable delivery of timolol for glaucoma therapy
Cuggino JC
Materials science & engineering. C, Materials for biological applications 2021; 118: 111383 (IGR: 21-3)

90661 Polypeptide and glycosaminoglycan polysaccharide as stabilizing polymers in nanocrystals for a safe ocular hypotensive effect
Donia M
International Journal of Biological Macromolecules 2020; 162: 1699-1710 (IGR: 21-3)

89989 Intractable Ocular Diseases and Treatment Progress
Zhang X
AAPS PharmSciTech 2020; 21: 236 (IGR: 21-3)

90679 Ocular co-Delivery of Timolol and Brimonidine from a Self-Assembling Peptide Hydrogel for the Treatment of Glaucoma: In Vitro and Ex Vivo Evaluation
Karavasili C
Pharmaceuticals (Basel, Switzerland) 2020; 13: (IGR: 21-3)

90725 Targeted Delivery of Cell Softening Micelles to Schlemm's Canal Endothelial Cells for Treatment of Glaucoma
Vincent M
Small (Weinheim an der Bergstrasse, Germany) 2020; 16: e2004205 (IGR: 21-3)

90618 Self-assembled DNA nanoparticles loaded with travoprost for glaucoma-treatment
Hurst J
Nanomedicine: Nanotechnology, Biology, and Medicine 2020; 29: 102260 (IGR: 21-3)

89986 Potential Therapeutic Usage of Nanomedicine for Glaucoma Treatment
Kim SH
International Journal of Nanomedicine 2020; 15: 5745-5765 (IGR: 21-3)

90570 Nanoscale Drug Delivery Systems for Glaucoma: Experimental and In Silico Advances
Bhatia V
Current Topics in Medicinal Chemistry 2021; 21: 115-125 (IGR: 21-3)

90803 Micro-interaction of mucin tear film interface with particles: The inconsistency of pharmacodynamics and precorneal retention of ion-exchange, functionalized, Mt-embedded nano- and microparticles
Zhao Y
Colloids and surfaces. B, Biointerfaces 2021; 197: 111355 (IGR: 21-3)

90502 The Efficacy Between Conventional Lid Hygiene and Additional Thermal Pulsatile System in Meibomian Gland Dysfunction Patients Treated with Long-Term Anti-Glaucoma Medications in a Randomized Controlled Trial
Suwajanakorn D
Clinical Ophthalmology 2020; 14: 2891-2902 (IGR: 21-3)

90021 Extraocular, periocular, and intraocular routes for sustained drug delivery for glaucoma
Hartman RR
Progress in Retinal and Eye Research 2020; 0: 100901 (IGR: 21-3)

90661 Polypeptide and glycosaminoglycan polysaccharide as stabilizing polymers in nanocrystals for a safe ocular hypotensive effect
Osman R
International Journal of Biological Macromolecules 2020; 162: 1699-1710 (IGR: 21-3)

89989 Intractable Ocular Diseases and Treatment Progress
Li S
AAPS PharmSciTech 2020; 21: 236 (IGR: 21-3)

90630 Mucoadhesive and responsive nanogels as carriers for sustainable delivery of timolol for glaucoma therapy
Tártara LI
Materials science & engineering. C, Materials for biological applications 2021; 118: 111383 (IGR: 21-3)

90627 Effects of shell thickness of hollow poly(lactic acid) nanoparticles on sustained drug delivery for pharmacological treatment of glaucoma
Luo LJ
Acta biomaterialia 2020; 111: 302-315 (IGR: 21-3)

90672 Effect of aging on heat transfer, fluid flow and drug transport in anterior human eye: A computational study
Bansal A
Journal of Controlled Release 2020; 328: 286-303 (IGR: 21-3)

90507 The protective effect of 3% diquafosol on meibomian gland morphology in glaucoma patients treated with prostaglandin analogs: a 12-month follow-up study
Ha JY
BMC Ophthalmology 2020; 20: 277 (IGR: 21-3)

90736 New antiglaucomatous agent for the treatment of open angle glaucoma: Polymeric inserts for drug release and in vitro and in vivo study
Navarro LC
Journal of Biomedical Materials Research - Part A 2021; 109: 336-345 (IGR: 21-3)

90851 Fasudil Loaded PLGA Microspheres as Potential Intravitreal Depot Formulation for Glaucoma Therapy
Kade C
Pharmaceutics 2020; 12: (IGR: 21-3)

90541 Nanoemulsion as a feasible and biocompatible carrier for ocular delivery of travoprost: Improved pharmacokinetic/pharmacodynamic properties
Nasr M
International Journal of Pharmaceutics 2020; 583: 119402 (IGR: 21-3)

90655 Numerical modeling of therapeutic lens drug delivery in the anterior human eye for the treatment of primary open-angle glaucoma
Bansal A
Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine 2020; 234: 942-954 (IGR: 21-3)

89989 Intractable Ocular Diseases and Treatment Progress
Tang Y
AAPS PharmSciTech 2020; 21: 236 (IGR: 21-3)

90661 Polypeptide and glycosaminoglycan polysaccharide as stabilizing polymers in nanocrystals for a safe ocular hypotensive effect
Awad GAS
International Journal of Biological Macromolecules 2020; 162: 1699-1710 (IGR: 21-3)

90672 Effect of aging on heat transfer, fluid flow and drug transport in anterior human eye: A computational study
Sinha N
Journal of Controlled Release 2020; 328: 286-303 (IGR: 21-3)

90655 Numerical modeling of therapeutic lens drug delivery in the anterior human eye for the treatment of primary open-angle glaucoma
Sinha N
Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine 2020; 234: 942-954 (IGR: 21-3)

90851 Fasudil Loaded PLGA Microspheres as Potential Intravitreal Depot Formulation for Glaucoma Therapy
Froemel F
Pharmaceutics 2020; 12: (IGR: 21-3)

90672 Effect of aging on heat transfer, fluid flow and drug transport in anterior human eye: A computational study
Sinha N
Journal of Controlled Release 2020; 328: 286-303 (IGR: 21-3)

90618 Self-assembled DNA nanoparticles loaded with travoprost for glaucoma-treatment
de Vries JW
Nanomedicine: Nanotechnology, Biology, and Medicine 2020; 29: 102260 (IGR: 21-3)

89986 Potential Therapeutic Usage of Nanomedicine for Glaucoma Treatment
Khang D
International Journal of Nanomedicine 2020; 15: 5745-5765 (IGR: 21-3)

90630 Mucoadhesive and responsive nanogels as carriers for sustainable delivery of timolol for glaucoma therapy
Gugliotta LM
Materials science & engineering. C, Materials for biological applications 2021; 118: 111383 (IGR: 21-3)

90679 Ocular co-Delivery of Timolol and Brimonidine from a Self-Assembling Peptide Hydrogel for the Treatment of Glaucoma: In Vitro and Ex Vivo Evaluation
Bouropoulos N
Pharmaceuticals (Basel, Switzerland) 2020; 13: (IGR: 21-3)

90541 Nanoemulsion as a feasible and biocompatible carrier for ocular delivery of travoprost: Improved pharmacokinetic/pharmacodynamic properties
Sammour O
International Journal of Pharmaceutics 2020; 583: 119402 (IGR: 21-3)

90803 Micro-interaction of mucin tear film interface with particles: The inconsistency of pharmacodynamics and precorneal retention of ion-exchange, functionalized, Mt-embedded nano- and microparticles
Liu H
Colloids and surfaces. B, Biointerfaces 2021; 197: 111355 (IGR: 21-3)

90627 Effects of shell thickness of hollow poly(lactic acid) nanoparticles on sustained drug delivery for pharmacological treatment of glaucoma
Lai JY
Acta biomaterialia 2020; 111: 302-315 (IGR: 21-3)

90725 Targeted Delivery of Cell Softening Micelles to Schlemm's Canal Endothelial Cells for Treatment of Glaucoma
Vahabikashi A
Small (Weinheim an der Bergstrasse, Germany) 2020; 16: e2004205 (IGR: 21-3)

90502 The Efficacy Between Conventional Lid Hygiene and Additional Thermal Pulsatile System in Meibomian Gland Dysfunction Patients Treated with Long-Term Anti-Glaucoma Medications in a Randomized Controlled Trial
Tantipat C
Clinical Ophthalmology 2020; 14: 2891-2902 (IGR: 21-3)

90736 New antiglaucomatous agent for the treatment of open angle glaucoma: Polymeric inserts for drug release and in vitro and in vivo study
Castilho RO
Journal of Biomedical Materials Research - Part A 2021; 109: 336-345 (IGR: 21-3)

90021 Extraocular, periocular, and intraocular routes for sustained drug delivery for glaucoma
Patil MA
Progress in Retinal and Eye Research 2020; 0: 100901 (IGR: 21-3)

90736 New antiglaucomatous agent for the treatment of open angle glaucoma: Polymeric inserts for drug release and in vitro and in vivo study
Goulart GAC
Journal of Biomedical Materials Research - Part A 2021; 109: 336-345 (IGR: 21-3)

90618 Self-assembled DNA nanoparticles loaded with travoprost for glaucoma-treatment
Ullah S
Nanomedicine: Nanotechnology, Biology, and Medicine 2020; 29: 102260 (IGR: 21-3)

90803 Micro-interaction of mucin tear film interface with particles: The inconsistency of pharmacodynamics and precorneal retention of ion-exchange, functionalized, Mt-embedded nano- and microparticles
Li H
Colloids and surfaces. B, Biointerfaces 2021; 197: 111355 (IGR: 21-3)

90502 The Efficacy Between Conventional Lid Hygiene and Additional Thermal Pulsatile System in Meibomian Gland Dysfunction Patients Treated with Long-Term Anti-Glaucoma Medications in a Randomized Controlled Trial
Reinprayoon U
Clinical Ophthalmology 2020; 14: 2891-2902 (IGR: 21-3)

90661 Polypeptide and glycosaminoglycan polysaccharide as stabilizing polymers in nanocrystals for a safe ocular hypotensive effect
Mortada N
International Journal of Biological Macromolecules 2020; 162: 1699-1710 (IGR: 21-3)

90851 Fasudil Loaded PLGA Microspheres as Potential Intravitreal Depot Formulation for Glaucoma Therapy
Pauly D
Pharmaceutics 2020; 12: (IGR: 21-3)

89989 Intractable Ocular Diseases and Treatment Progress
Guo Y
AAPS PharmSciTech 2020; 21: 236 (IGR: 21-3)

90725 Targeted Delivery of Cell Softening Micelles to Schlemm's Canal Endothelial Cells for Treatment of Glaucoma
Li G
Small (Weinheim an der Bergstrasse, Germany) 2020; 16: e2004205 (IGR: 21-3)

90630 Mucoadhesive and responsive nanogels as carriers for sustainable delivery of timolol for glaucoma therapy
Palma SD
Materials science & engineering. C, Materials for biological applications 2021; 118: 111383 (IGR: 21-3)

90679 Ocular co-Delivery of Timolol and Brimonidine from a Self-Assembling Peptide Hydrogel for the Treatment of Glaucoma: In Vitro and Ex Vivo Evaluation
Moschakis T
Pharmaceuticals (Basel, Switzerland) 2020; 13: (IGR: 21-3)

89986 Potential Therapeutic Usage of Nanomedicine for Glaucoma Treatment
Lee JY
International Journal of Nanomedicine 2020; 15: 5745-5765 (IGR: 21-3)

90851 Fasudil Loaded PLGA Microspheres as Potential Intravitreal Depot Formulation for Glaucoma Therapy
Stamer WD
Pharmaceutics 2020; 12: (IGR: 21-3)

90725 Targeted Delivery of Cell Softening Micelles to Schlemm's Canal Endothelial Cells for Treatment of Glaucoma
Perkumas KM
Small (Weinheim an der Bergstrasse, Germany) 2020; 16: e2004205 (IGR: 21-3)

90630 Mucoadhesive and responsive nanogels as carriers for sustainable delivery of timolol for glaucoma therapy
Alvarez Igarzabal CI
Materials science & engineering. C, Materials for biological applications 2021; 118: 111383 (IGR: 21-3)

90618 Self-assembled DNA nanoparticles loaded with travoprost for glaucoma-treatment
Gruszka A
Nanomedicine: Nanotechnology, Biology, and Medicine 2020; 29: 102260 (IGR: 21-3)

90736 New antiglaucomatous agent for the treatment of open angle glaucoma: Polymeric inserts for drug release and in vitro and in vivo study
Foureaux G
Journal of Biomedical Materials Research - Part A 2021; 109: 336-345 (IGR: 21-3)

90803 Micro-interaction of mucin tear film interface with particles: The inconsistency of pharmacodynamics and precorneal retention of ion-exchange, functionalized, Mt-embedded nano- and microparticles
Liu S
Colloids and surfaces. B, Biointerfaces 2021; 197: 111355 (IGR: 21-3)

89989 Intractable Ocular Diseases and Treatment Progress
Gao S
AAPS PharmSciTech 2020; 21: 236 (IGR: 21-3)

90679 Ocular co-Delivery of Timolol and Brimonidine from a Self-Assembling Peptide Hydrogel for the Treatment of Glaucoma: In Vitro and Ex Vivo Evaluation
Andreadis DDD; Zacharis CKK
Pharmaceuticals (Basel, Switzerland) 2020; 13: (IGR: 21-3)

90851 Fasudil Loaded PLGA Microspheres as Potential Intravitreal Depot Formulation for Glaucoma Therapy
Ohlmann A
Pharmaceutics 2020; 12: (IGR: 21-3)

90725 Targeted Delivery of Cell Softening Micelles to Schlemm's Canal Endothelial Cells for Treatment of Glaucoma
Stamer WD
Small (Weinheim an der Bergstrasse, Germany) 2020; 16: e2004205 (IGR: 21-3)

90736 New antiglaucomatous agent for the treatment of open angle glaucoma: Polymeric inserts for drug release and in vitro and in vivo study
Ferreira AJ
Journal of Biomedical Materials Research - Part A 2021; 109: 336-345 (IGR: 21-3)

90618 Self-assembled DNA nanoparticles loaded with travoprost for glaucoma-treatment
Kwak M
Nanomedicine: Nanotechnology, Biology, and Medicine 2020; 29: 102260 (IGR: 21-3)

90803 Micro-interaction of mucin tear film interface with particles: The inconsistency of pharmacodynamics and precorneal retention of ion-exchange, functionalized, Mt-embedded nano- and microparticles
Rupenthal ID
Colloids and surfaces. B, Biointerfaces 2021; 197: 111355 (IGR: 21-3)

90803 Micro-interaction of mucin tear film interface with particles: The inconsistency of pharmacodynamics and precorneal retention of ion-exchange, functionalized, Mt-embedded nano- and microparticles
Yang F
Colloids and surfaces. B, Biointerfaces 2021; 197: 111355 (IGR: 21-3)

90851 Fasudil Loaded PLGA Microspheres as Potential Intravitreal Depot Formulation for Glaucoma Therapy
Wegener J
Pharmaceutics 2020; 12: (IGR: 21-3)

90679 Ocular co-Delivery of Timolol and Brimonidine from a Self-Assembling Peptide Hydrogel for the Treatment of Glaucoma: In Vitro and Ex Vivo Evaluation
Fatouros DGG
Pharmaceuticals (Basel, Switzerland) 2020; 13: (IGR: 21-3)

90618 Self-assembled DNA nanoparticles loaded with travoprost for glaucoma-treatment
Löscher M
Nanomedicine: Nanotechnology, Biology, and Medicine 2020; 29: 102260 (IGR: 21-3)

90736 New antiglaucomatous agent for the treatment of open angle glaucoma: Polymeric inserts for drug release and in vitro and in vivo study
Cronemberger S
Journal of Biomedical Materials Research - Part A 2021; 109: 336-345 (IGR: 21-3)

90725 Targeted Delivery of Cell Softening Micelles to Schlemm's Canal Endothelial Cells for Treatment of Glaucoma
Johnson M
Small (Weinheim an der Bergstrasse, Germany) 2020; 16: e2004205 (IGR: 21-3)

90736 New antiglaucomatous agent for the treatment of open angle glaucoma: Polymeric inserts for drug release and in vitro and in vivo study
Gomes Faraco AA
Journal of Biomedical Materials Research - Part A 2021; 109: 336-345 (IGR: 21-3)

90851 Fasudil Loaded PLGA Microspheres as Potential Intravitreal Depot Formulation for Glaucoma Therapy
Fuchshofer R
Pharmaceutics 2020; 12: (IGR: 21-3)

90725 Targeted Delivery of Cell Softening Micelles to Schlemm's Canal Endothelial Cells for Treatment of Glaucoma
Scott E
Small (Weinheim an der Bergstrasse, Germany) 2020; 16: e2004205 (IGR: 21-3)

90618 Self-assembled DNA nanoparticles loaded with travoprost for glaucoma-treatment
Dammeier S
Nanomedicine: Nanotechnology, Biology, and Medicine 2020; 29: 102260 (IGR: 21-3)

90803 Micro-interaction of mucin tear film interface with particles: The inconsistency of pharmacodynamics and precorneal retention of ion-exchange, functionalized, Mt-embedded nano- and microparticles
Lv Z; Chen Y
Colloids and surfaces. B, Biointerfaces 2021; 197: 111355 (IGR: 21-3)

90851 Fasudil Loaded PLGA Microspheres as Potential Intravitreal Depot Formulation for Glaucoma Therapy
Breunig M
Pharmaceutics 2020; 12: (IGR: 21-3)

90618 Self-assembled DNA nanoparticles loaded with travoprost for glaucoma-treatment
Bartz-Schmidt KU
Nanomedicine: Nanotechnology, Biology, and Medicine 2020; 29: 102260 (IGR: 21-3)

90803 Micro-interaction of mucin tear film interface with particles: The inconsistency of pharmacodynamics and precorneal retention of ion-exchange, functionalized, Mt-embedded nano- and microparticles
Zang L
Colloids and surfaces. B, Biointerfaces 2021; 197: 111355 (IGR: 21-3)

90618 Self-assembled DNA nanoparticles loaded with travoprost for glaucoma-treatment
Spitzer MS; Herrmann A
Nanomedicine: Nanotechnology, Biology, and Medicine 2020; 29: 102260 (IGR: 21-3)

90803 Micro-interaction of mucin tear film interface with particles: The inconsistency of pharmacodynamics and precorneal retention of ion-exchange, functionalized, Mt-embedded nano- and microparticles
Li W; Ping Q; Tao Q; Hou D
Colloids and surfaces. B, Biointerfaces 2021; 197: 111355 (IGR: 21-3)

86724 Progress on ocular siRNA gene-silencing therapy and drug delivery systems
Jiang J
Fundamental and Clinical Pharmacology 2021; 35: 4-24 (IGR: 21-2)

86753 Micelles: Promising Ocular Drug Carriers for Anterior and Posterior Segment Diseases
Durgun ME
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 323-341 (IGR: 21-2)

86432 Reduction of intraocular pressure using timolol orally dissolving strips in the treatment of induced primary open-angle glaucoma in rabbits
El-Feky YA
Journal of Pharmacy and Pharmacology 2020; 72: 682-698 (IGR: 21-2)

86722 Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits
Roy Chowdhury U
PLoS ONE 2020; 15: e0231841 (IGR: 21-2)

86651 Sustained subconjunctival delivery of cyclosporine A using thermogelling polymers for glaucoma filtration surgery
Sun J
Journal of materials chemistry. B 2017; 5: 6400-6411 (IGR: 21-2)

86685 Latanoprost niosomes as a sustained release ocular delivery system for the management of glaucoma
Fathalla D
Drug Development and Industrial Pharmacy 2020; 46: 806-813 (IGR: 21-2)

86650 Gelatin-functionalized mesoporous silica nanoparticles with sustained release properties for intracameral pharmacotherapy of glaucoma
Liao YT
Journal of materials chemistry. B 2017; 5: 7008-7013 (IGR: 21-2)

86433 Dually functional hollow ceria nanoparticle platform for intraocular drug delivery: A push beyond the limits of static and dynamic ocular barriers toward glaucoma therapy
Luo LJ
Biomaterials 2020; 243: 119961 (IGR: 21-2)

86844 Incorporation of ion exchange functionalized-montmorillonite into solid lipid nanoparticles with low irritation enhances drug bioavailability for glaucoma treatment
Liu S
Drug Delivery 2020; 27: 652-661 (IGR: 21-2)

86715 Corneal damage and its recovery after instillation of preservative-free versus preserved latanoprost eye drops
Inoue D
Cutaneous and Ocular Toxicology 2020; 39: 158-164 (IGR: 21-2)

86080 Continuous anti-glaucoma drug therapy as a risk factor of dry eye
Erichev VP
Vestnik Oftalmologii 2019; 135: 117-123 (IGR: 21-2)

86156 Efficacy and safety evaluation of benzalkonium chloride preserved eye-drops compared with alternatively preserved and preservative-free eye-drops in the treatment of glaucoma: a systematic review and meta-analysis
Hedengran A
British Journal of Ophthalmology 2020; 104: 1512-1518 (IGR: 21-2)

86339 Co-delivery of brinzolamide and miRNA-124 by biodegradable nanoparticles as a strategy for glaucoma therapy
Li T
Drug Delivery 2020; 27: 410-421 (IGR: 21-2)

86592 Gelatin Nanoparticles-HPMC Hybrid System for Effective Ocular Topical Administration of Antihypertensive Agents
Esteban-Pérez S
Pharmaceutics 2020; 12: (IGR: 21-2)

86597 Preservative-free versus preserved glaucoma eye drops and occurrence of glaucoma surgery. A retrospective study based on the French national health insurance information system, 2008-2016
Chamard C
Acta Ophthalmologica 2020; 98: e876-e881 (IGR: 21-2)

86199 Lipid Nanoparticles as Carriers for the Treatment of Neurodegeneration Associated with Alzheimer's Disease and Glaucoma: Present and Future Challenges
López ES
Current Pharmaceutical Design 2020; 26: 1235-1250 (IGR: 21-2)

86682 Factors Predetermining Increased Aqueous Humour Flare in Long-Term Glaucoma Treatment
Pakuliene G
Journal of Ophthalmology 2020; 2020: 7345687 (IGR: 21-2)

86221 Tear Meniscus Imaging by Anterior Segment-Optical Coherence Tomography in Medically Controlled Glaucoma
Agnifili L
Journal of Glaucoma 2020; 29: 374-380 (IGR: 21-2)

86156 Efficacy and safety evaluation of benzalkonium chloride preserved eye-drops compared with alternatively preserved and preservative-free eye-drops in the treatment of glaucoma: a systematic review and meta-analysis
Steensberg AT
British Journal of Ophthalmology 2020; 104: 1512-1518 (IGR: 21-2)

86685 Latanoprost niosomes as a sustained release ocular delivery system for the management of glaucoma
Fouad EA
Drug Development and Industrial Pharmacy 2020; 46: 806-813 (IGR: 21-2)

86080 Continuous anti-glaucoma drug therapy as a risk factor of dry eye
Petrov SY
Vestnik Oftalmologii 2019; 135: 117-123 (IGR: 21-2)

86592 Gelatin Nanoparticles-HPMC Hybrid System for Effective Ocular Topical Administration of Antihypertensive Agents
Andrés-Guerrero V
Pharmaceutics 2020; 12: (IGR: 21-2)

86433 Dually functional hollow ceria nanoparticle platform for intraocular drug delivery: A push beyond the limits of static and dynamic ocular barriers toward glaucoma therapy
Nguyen DD
Biomaterials 2020; 243: 119961 (IGR: 21-2)

86650 Gelatin-functionalized mesoporous silica nanoparticles with sustained release properties for intracameral pharmacotherapy of glaucoma
Lee CH
Journal of materials chemistry. B 2017; 5: 7008-7013 (IGR: 21-2)

86432 Reduction of intraocular pressure using timolol orally dissolving strips in the treatment of induced primary open-angle glaucoma in rabbits
Mostafa DA
Journal of Pharmacy and Pharmacology 2020; 72: 682-698 (IGR: 21-2)

86221 Tear Meniscus Imaging by Anterior Segment-Optical Coherence Tomography in Medically Controlled Glaucoma
Brescia L
Journal of Glaucoma 2020; 29: 374-380 (IGR: 21-2)

86080 Continuous anti-glaucoma drug therapy as a risk factor of dry eye
Petrov SY
Vestnik Oftalmologii 2019; 135: 117-123 (IGR: 21-2)

86339 Co-delivery of brinzolamide and miRNA-124 by biodegradable nanoparticles as a strategy for glaucoma therapy
Wang Y
Drug Delivery 2020; 27: 410-421 (IGR: 21-2)

86080 Continuous anti-glaucoma drug therapy as a risk factor of dry eye
Petrov SY
Vestnik Oftalmologii 2019; 135: 117-123 (IGR: 21-2)

86724 Progress on ocular siRNA gene-silencing therapy and drug delivery systems
Zhang X
Fundamental and Clinical Pharmacology 2021; 35: 4-24 (IGR: 21-2)

86597 Preservative-free versus preserved glaucoma eye drops and occurrence of glaucoma surgery. A retrospective study based on the French national health insurance information system, 2008-2016
Larrieu S
Acta Ophthalmologica 2020; 98: e876-e881 (IGR: 21-2)

86199 Lipid Nanoparticles as Carriers for the Treatment of Neurodegeneration Associated with Alzheimer's Disease and Glaucoma: Present and Future Challenges
Machado ALL
Current Pharmaceutical Design 2020; 26: 1235-1250 (IGR: 21-2)

86682 Factors Predetermining Increased Aqueous Humour Flare in Long-Term Glaucoma Treatment
Kuzmiene L
Journal of Ophthalmology 2020; 2020: 7345687 (IGR: 21-2)

86651 Sustained subconjunctival delivery of cyclosporine A using thermogelling polymers for glaucoma filtration surgery
Liu X
Journal of materials chemistry. B 2017; 5: 6400-6411 (IGR: 21-2)

86722 Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits
Kudgus RA
PLoS ONE 2020; 15: e0231841 (IGR: 21-2)

86080 Continuous anti-glaucoma drug therapy as a risk factor of dry eye
Petrov SY
Vestnik Oftalmologii 2019; 135: 117-123 (IGR: 21-2)

86753 Micelles: Promising Ocular Drug Carriers for Anterior and Posterior Segment Diseases
Güngör S
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 323-341 (IGR: 21-2)

86844 Incorporation of ion exchange functionalized-montmorillonite into solid lipid nanoparticles with low irritation enhances drug bioavailability for glaucoma treatment
Han X
Drug Delivery 2020; 27: 652-661 (IGR: 21-2)

86715 Corneal damage and its recovery after instillation of preservative-free versus preserved latanoprost eye drops
Mohamed YH
Cutaneous and Ocular Toxicology 2020; 39: 158-164 (IGR: 21-2)

86433 Dually functional hollow ceria nanoparticle platform for intraocular drug delivery: A push beyond the limits of static and dynamic ocular barriers toward glaucoma therapy
Nguyen DD
Biomaterials 2020; 243: 119961 (IGR: 21-2)

86199 Lipid Nanoparticles as Carriers for the Treatment of Neurodegeneration Associated with Alzheimer's Disease and Glaucoma: Present and Future Challenges
Vidal LB
Current Pharmaceutical Design 2020; 26: 1235-1250 (IGR: 21-2)

86651 Sustained subconjunctival delivery of cyclosporine A using thermogelling polymers for glaucoma filtration surgery
Lei Y
Journal of materials chemistry. B 2017; 5: 6400-6411 (IGR: 21-2)

86221 Tear Meniscus Imaging by Anterior Segment-Optical Coherence Tomography in Medically Controlled Glaucoma
Scatena B
Journal of Glaucoma 2020; 29: 374-380 (IGR: 21-2)

86722 Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits
Rinkoski TA
PLoS ONE 2020; 15: e0231841 (IGR: 21-2)

86682 Factors Predetermining Increased Aqueous Humour Flare in Long-Term Glaucoma Treatment
Januleviciene I
Journal of Ophthalmology 2020; 2020: 7345687 (IGR: 21-2)

86715 Corneal damage and its recovery after instillation of preservative-free versus preserved latanoprost eye drops
Uematsu M
Cutaneous and Ocular Toxicology 2020; 39: 158-164 (IGR: 21-2)

86080 Continuous anti-glaucoma drug therapy as a risk factor of dry eye
Volzhanin AV
Vestnik Oftalmologii 2019; 135: 117-123 (IGR: 21-2)

86339 Co-delivery of brinzolamide and miRNA-124 by biodegradable nanoparticles as a strategy for glaucoma therapy
Chen J
Drug Delivery 2020; 27: 410-421 (IGR: 21-2)

86080 Continuous anti-glaucoma drug therapy as a risk factor of dry eye
Volzhanin AV
Vestnik Oftalmologii 2019; 135: 117-123 (IGR: 21-2)

86753 Micelles: Promising Ocular Drug Carriers for Anterior and Posterior Segment Diseases
Özsoy Y
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 323-341 (IGR: 21-2)

86432 Reduction of intraocular pressure using timolol orally dissolving strips in the treatment of induced primary open-angle glaucoma in rabbits
Al-Sawahli MM
Journal of Pharmacy and Pharmacology 2020; 72: 682-698 (IGR: 21-2)

86592 Gelatin Nanoparticles-HPMC Hybrid System for Effective Ocular Topical Administration of Antihypertensive Agents
López-Cano JJ
Pharmaceutics 2020; 12: (IGR: 21-2)

86156 Efficacy and safety evaluation of benzalkonium chloride preserved eye-drops compared with alternatively preserved and preservative-free eye-drops in the treatment of glaucoma: a systematic review and meta-analysis
Virgili G
British Journal of Ophthalmology 2020; 104: 1512-1518 (IGR: 21-2)

86080 Continuous anti-glaucoma drug therapy as a risk factor of dry eye
Volzhanin AV
Vestnik Oftalmologii 2019; 135: 117-123 (IGR: 21-2)

86724 Progress on ocular siRNA gene-silencing therapy and drug delivery systems
Tang Y
Fundamental and Clinical Pharmacology 2021; 35: 4-24 (IGR: 21-2)

86597 Preservative-free versus preserved glaucoma eye drops and occurrence of glaucoma surgery. A retrospective study based on the French national health insurance information system, 2008-2016
Baudouin C
Acta Ophthalmologica 2020; 98: e876-e881 (IGR: 21-2)

86650 Gelatin-functionalized mesoporous silica nanoparticles with sustained release properties for intracameral pharmacotherapy of glaucoma
Chen ST
Journal of materials chemistry. B 2017; 5: 7008-7013 (IGR: 21-2)

86685 Latanoprost niosomes as a sustained release ocular delivery system for the management of glaucoma
Soliman GM
Drug Development and Industrial Pharmacy 2020; 46: 806-813 (IGR: 21-2)

86433 Dually functional hollow ceria nanoparticle platform for intraocular drug delivery: A push beyond the limits of static and dynamic ocular barriers toward glaucoma therapy
Lai JY
Biomaterials 2020; 243: 119961 (IGR: 21-2)

86080 Continuous anti-glaucoma drug therapy as a risk factor of dry eye
Volzhanin AV
Vestnik Oftalmologii 2019; 135: 117-123 (IGR: 21-2)

86597 Preservative-free versus preserved glaucoma eye drops and occurrence of glaucoma surgery. A retrospective study based on the French national health insurance information system, 2008-2016
Bron A
Acta Ophthalmologica 2020; 98: e876-e881 (IGR: 21-2)

86650 Gelatin-functionalized mesoporous silica nanoparticles with sustained release properties for intracameral pharmacotherapy of glaucoma
Lai JY
Journal of materials chemistry. B 2017; 5: 7008-7013 (IGR: 21-2)

86080 Continuous anti-glaucoma drug therapy as a risk factor of dry eye
Ghazaryan SA
Vestnik Oftalmologii 2019; 135: 117-123 (IGR: 21-2)

86199 Lipid Nanoparticles as Carriers for the Treatment of Neurodegeneration Associated with Alzheimer's Disease and Glaucoma: Present and Future Challenges
González-Pizarro R
Current Pharmaceutical Design 2020; 26: 1235-1250 (IGR: 21-2)

86724 Progress on ocular siRNA gene-silencing therapy and drug delivery systems
Li S
Fundamental and Clinical Pharmacology 2021; 35: 4-24 (IGR: 21-2)

86592 Gelatin Nanoparticles-HPMC Hybrid System for Effective Ocular Topical Administration of Antihypertensive Agents
Molina-Martínez I
Pharmaceutics 2020; 12: (IGR: 21-2)

86844 Incorporation of ion exchange functionalized-montmorillonite into solid lipid nanoparticles with low irritation enhances drug bioavailability for glaucoma treatment
Zhao Y
Drug Delivery 2020; 27: 652-661 (IGR: 21-2)

86221 Tear Meniscus Imaging by Anterior Segment-Optical Coherence Tomography in Medically Controlled Glaucoma
Oddone F
Journal of Glaucoma 2020; 29: 374-380 (IGR: 21-2)

86715 Corneal damage and its recovery after instillation of preservative-free versus preserved latanoprost eye drops
Kitaoka T
Cutaneous and Ocular Toxicology 2020; 39: 158-164 (IGR: 21-2)

86722 Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits
Holman BH
PLoS ONE 2020; 15: e0231841 (IGR: 21-2)

86651 Sustained subconjunctival delivery of cyclosporine A using thermogelling polymers for glaucoma filtration surgery
Tang M
Journal of materials chemistry. B 2017; 5: 6400-6411 (IGR: 21-2)

86432 Reduction of intraocular pressure using timolol orally dissolving strips in the treatment of induced primary open-angle glaucoma in rabbits
El-Telbany RFA
Journal of Pharmacy and Pharmacology 2020; 72: 682-698 (IGR: 21-2)

86156 Efficacy and safety evaluation of benzalkonium chloride preserved eye-drops compared with alternatively preserved and preservative-free eye-drops in the treatment of glaucoma: a systematic review and meta-analysis
Azuara-Blanco A
British Journal of Ophthalmology 2020; 104: 1512-1518 (IGR: 21-2)

86339 Co-delivery of brinzolamide and miRNA-124 by biodegradable nanoparticles as a strategy for glaucoma therapy
Gao X
Drug Delivery 2020; 27: 410-421 (IGR: 21-2)

86432 Reduction of intraocular pressure using timolol orally dissolving strips in the treatment of induced primary open-angle glaucoma in rabbits
Zakaria S
Journal of Pharmacy and Pharmacology 2020; 72: 682-698 (IGR: 21-2)

86650 Gelatin-functionalized mesoporous silica nanoparticles with sustained release properties for intracameral pharmacotherapy of glaucoma
Wu KC
Journal of materials chemistry. B 2017; 5: 7008-7013 (IGR: 21-2)

86156 Efficacy and safety evaluation of benzalkonium chloride preserved eye-drops compared with alternatively preserved and preservative-free eye-drops in the treatment of glaucoma: a systematic review and meta-analysis
Kolko M
British Journal of Ophthalmology 2020; 104: 1512-1518 (IGR: 21-2)

86199 Lipid Nanoparticles as Carriers for the Treatment of Neurodegeneration Associated with Alzheimer's Disease and Glaucoma: Present and Future Challenges
Silva AD
Current Pharmaceutical Design 2020; 26: 1235-1250 (IGR: 21-2)

86597 Preservative-free versus preserved glaucoma eye drops and occurrence of glaucoma surgery. A retrospective study based on the French national health insurance information system, 2008-2016
Villain M
Acta Ophthalmologica 2020; 98: e876-e881 (IGR: 21-2)

86651 Sustained subconjunctival delivery of cyclosporine A using thermogelling polymers for glaucoma filtration surgery
Dai Z
Journal of materials chemistry. B 2017; 5: 6400-6411 (IGR: 21-2)

86339 Co-delivery of brinzolamide and miRNA-124 by biodegradable nanoparticles as a strategy for glaucoma therapy
Pan S
Drug Delivery 2020; 27: 410-421 (IGR: 21-2)

86221 Tear Meniscus Imaging by Anterior Segment-Optical Coherence Tomography in Medically Controlled Glaucoma
Figus M
Journal of Glaucoma 2020; 29: 374-380 (IGR: 21-2)

86592 Gelatin Nanoparticles-HPMC Hybrid System for Effective Ocular Topical Administration of Antihypertensive Agents
Herrero-Vanrell R
Pharmaceutics 2020; 12: (IGR: 21-2)

86722 Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits
Bahler CK
PLoS ONE 2020; 15: e0231841 (IGR: 21-2)

86724 Progress on ocular siRNA gene-silencing therapy and drug delivery systems
Chen J
Fundamental and Clinical Pharmacology 2021; 35: 4-24 (IGR: 21-2)

86597 Preservative-free versus preserved glaucoma eye drops and occurrence of glaucoma surgery. A retrospective study based on the French national health insurance information system, 2008-2016
Daien V
Acta Ophthalmologica 2020; 98: e876-e881 (IGR: 21-2)

86339 Co-delivery of brinzolamide and miRNA-124 by biodegradable nanoparticles as a strategy for glaucoma therapy
Su Y
Drug Delivery 2020; 27: 410-421 (IGR: 21-2)

86651 Sustained subconjunctival delivery of cyclosporine A using thermogelling polymers for glaucoma filtration surgery
Yang X
Journal of materials chemistry. B 2017; 5: 6400-6411 (IGR: 21-2)

86722 Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits
Hann CR
PLoS ONE 2020; 15: e0231841 (IGR: 21-2)

86432 Reduction of intraocular pressure using timolol orally dissolving strips in the treatment of induced primary open-angle glaucoma in rabbits
Fayez AM
Journal of Pharmacy and Pharmacology 2020; 72: 682-698 (IGR: 21-2)

86592 Gelatin Nanoparticles-HPMC Hybrid System for Effective Ocular Topical Administration of Antihypertensive Agents
Bravo-Osuna I
Pharmaceutics 2020; 12: (IGR: 21-2)

86199 Lipid Nanoparticles as Carriers for the Treatment of Neurodegeneration Associated with Alzheimer's Disease and Glaucoma: Present and Future Challenges
Souto EB
Current Pharmaceutical Design 2020; 26: 1235-1250 (IGR: 21-2)

86221 Tear Meniscus Imaging by Anterior Segment-Optical Coherence Tomography in Medically Controlled Glaucoma
Perna F
Journal of Glaucoma 2020; 29: 374-380 (IGR: 21-2)

86844 Incorporation of ion exchange functionalized-montmorillonite into solid lipid nanoparticles with low irritation enhances drug bioavailability for glaucoma treatment
D Rupenthal I
Drug Delivery 2020; 27: 652-661 (IGR: 21-2)

86339 Co-delivery of brinzolamide and miRNA-124 by biodegradable nanoparticles as a strategy for glaucoma therapy
Zhou X
Drug Delivery 2020; 27: 410-421 (IGR: 21-2)

86432 Reduction of intraocular pressure using timolol orally dissolving strips in the treatment of induced primary open-angle glaucoma in rabbits
Ahmed KA
Journal of Pharmacy and Pharmacology 2020; 72: 682-698 (IGR: 21-2)

86221 Tear Meniscus Imaging by Anterior Segment-Optical Coherence Tomography in Medically Controlled Glaucoma
Doronzo E
Journal of Glaucoma 2020; 29: 374-380 (IGR: 21-2)

86722 Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits
Reid JM
PLoS ONE 2020; 15: e0231841 (IGR: 21-2)

86844 Incorporation of ion exchange functionalized-montmorillonite into solid lipid nanoparticles with low irritation enhances drug bioavailability for glaucoma treatment
Lv Z
Drug Delivery 2020; 27: 652-661 (IGR: 21-2)

86651 Sustained subconjunctival delivery of cyclosporine A using thermogelling polymers for glaucoma filtration surgery
Yu X; Yu L
Journal of materials chemistry. B 2017; 5: 6400-6411 (IGR: 21-2)

86844 Incorporation of ion exchange functionalized-montmorillonite into solid lipid nanoparticles with low irritation enhances drug bioavailability for glaucoma treatment
Chen Y
Drug Delivery 2020; 27: 652-661 (IGR: 21-2)

86432 Reduction of intraocular pressure using timolol orally dissolving strips in the treatment of induced primary open-angle glaucoma in rabbits
Alolayan EM
Journal of Pharmacy and Pharmacology 2020; 72: 682-698 (IGR: 21-2)

86221 Tear Meniscus Imaging by Anterior Segment-Optical Coherence Tomography in Medically Controlled Glaucoma
D'Ugo E
Journal of Glaucoma 2020; 29: 374-380 (IGR: 21-2)

86722 Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits
Dosa PI; Fautsch MP
PLoS ONE 2020; 15: e0231841 (IGR: 21-2)

86844 Incorporation of ion exchange functionalized-montmorillonite into solid lipid nanoparticles with low irritation enhances drug bioavailability for glaucoma treatment
Yang F
Drug Delivery 2020; 27: 652-661 (IGR: 21-2)

86221 Tear Meniscus Imaging by Anterior Segment-Optical Coherence Tomography in Medically Controlled Glaucoma
Mastropasqua L
Journal of Glaucoma 2020; 29: 374-380 (IGR: 21-2)

86651 Sustained subconjunctival delivery of cyclosporine A using thermogelling polymers for glaucoma filtration surgery
Sun X
Journal of materials chemistry. B 2017; 5: 6400-6411 (IGR: 21-2)

86432 Reduction of intraocular pressure using timolol orally dissolving strips in the treatment of induced primary open-angle glaucoma in rabbits
El-Telbany DFA
Journal of Pharmacy and Pharmacology 2020; 72: 682-698 (IGR: 21-2)

86844 Incorporation of ion exchange functionalized-montmorillonite into solid lipid nanoparticles with low irritation enhances drug bioavailability for glaucoma treatment
Ping Q
Drug Delivery 2020; 27: 652-661 (IGR: 21-2)

86651 Sustained subconjunctival delivery of cyclosporine A using thermogelling polymers for glaucoma filtration surgery
Ding J
Journal of materials chemistry. B 2017; 5: 6400-6411 (IGR: 21-2)

86844 Incorporation of ion exchange functionalized-montmorillonite into solid lipid nanoparticles with low irritation enhances drug bioavailability for glaucoma treatment
Pan Y; Hou D
Drug Delivery 2020; 27: 652-661 (IGR: 21-2)

84572 Dendritic Effects of Injectable Biodegradable Thermogels on Pharmacotherapy of Inflammatory Glaucoma-Associated Degradation of Extracellular Matrix
Nguyen DD
Advanced healthcare materials 2019; 8: e1900702 (IGR: 21-1)

84508 Effects of topical autologous serum on the ocular surface in patients with toxic corneal epitheliopathy induced by anti-glaucoma drugs
Yoon CH
International Ophthalmology 2020; 40: 547-552 (IGR: 21-1)

84579 Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for management of glaucoma: Formulation, characterization and pharmacodynamic study
Dubey V
International Journal of Biological Macromolecules 2020; 152: 1224-1232 (IGR: 21-1)

84829 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
Craven ER
Drugs 2020; 80: 167-179 (IGR: 21-1)

85089 Impact of Ocular Surface Disease Treatment in Patients with Glaucoma
Mylla Boso AL
Clinical Ophthalmology 2020; 14: 103-111 (IGR: 21-1)

85206 Promising therapeutic drug delivery systems for glaucoma: a comprehensive review
Singh RB
Therapeutic advances in ophthalmology 2020; 12: 2515841420905740 (IGR: 21-1)

84655 Benzoic acid derivative-modified chitosan-g-poly(N-isopropylacrylamide): Methoxylation effects and pharmacological treatments of Glaucoma-related neurodegeneration
Luo LJ
Journal of Controlled Release 2020; 317: 246-258 (IGR: 21-1)

85049 The Sustained Release of Tafluprost with a Drug Delivery System Prevents the Axonal Injury-induced Loss of Retinal Ganglion Cells in Rats
Sato K
Current Eye Research 2020; 0: 1-10 (IGR: 21-1)

84144 Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study
Emad Eldeeb A
Drug Delivery 2019; 26: 509-521 (IGR: 21-1)

85206 Promising therapeutic drug delivery systems for glaucoma: a comprehensive review
Singh RB
Therapeutic advances in ophthalmology 2020; 12: 2515841420905740 (IGR: 21-1)

85091 Clinical Evaluation of a Novel Electromechanical Topical Ocular Drug Delivery System: Two Phase 1 Proof of Concept Studies
Quiroz-Mercado H
Clinical Ophthalmology 2020; 14: 139-147 (IGR: 21-1)

84927 Bimatoprost Imprinted Silicone Contact Lens to Treat Glaucoma
Yan F
AAPS PharmSciTech 2020; 21: 63 (IGR: 21-1)

84893 Sustained Nitric Oxide-Providing Small Molecule and Precise Release Behavior Study for Glaucoma Treatment
Jeong H
Molecular pharmaceutics 2020; 17: 656-665 (IGR: 21-1)

85115 Albumin Levels in Tear Film Modulate the Bioavailability of Medically-Relevant Topical Drugs
Sebbag L
Frontiers in pharmacology 2019; 10: 1560 (IGR: 21-1)

84241 Effects of rosiglitazone/PHBV drug delivery system on postoperative fibrosis in rabbit glaucoma filtration surgery model
Zhang F
Drug Delivery 2019; 26: 812-819 (IGR: 21-1)

84963 Brinzolamide Dimethyl Sulfoxide In Situ Gelling Ophthalmic Solution: Formulation Optimisation and In Vitro and In Vivo Evaluation
Bhalerao H
AAPS PharmSciTech 2020; 21: 69 (IGR: 21-1)

84241 Effects of rosiglitazone/PHBV drug delivery system on postoperative fibrosis in rabbit glaucoma filtration surgery model
Liu K
Drug Delivery 2019; 26: 812-819 (IGR: 21-1)

84655 Benzoic acid derivative-modified chitosan-g-poly(N-isopropylacrylamide): Methoxylation effects and pharmacological treatments of Glaucoma-related neurodegeneration
Nguyen DD
Journal of Controlled Release 2020; 317: 246-258 (IGR: 21-1)

84829 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
Walters T
Drugs 2020; 80: 167-179 (IGR: 21-1)

85115 Albumin Levels in Tear Film Modulate the Bioavailability of Medically-Relevant Topical Drugs
Moody LM
Frontiers in pharmacology 2019; 10: 1560 (IGR: 21-1)

85049 The Sustained Release of Tafluprost with a Drug Delivery System Prevents the Axonal Injury-induced Loss of Retinal Ganglion Cells in Rats
Nakagawa Y
Current Eye Research 2020; 0: 1-10 (IGR: 21-1)

85091 Clinical Evaluation of a Novel Electromechanical Topical Ocular Drug Delivery System: Two Phase 1 Proof of Concept Studies
Ivri E
Clinical Ophthalmology 2020; 14: 139-147 (IGR: 21-1)

84144 Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study
Salah S
Drug Delivery 2019; 26: 509-521 (IGR: 21-1)

85206 Promising therapeutic drug delivery systems for glaucoma: a comprehensive review
Ichhpujani P
Therapeutic advances in ophthalmology 2020; 12: 2515841420905740 (IGR: 21-1)

84508 Effects of topical autologous serum on the ocular surface in patients with toxic corneal epitheliopathy induced by anti-glaucoma drugs
Lee HJ
International Ophthalmology 2020; 40: 547-552 (IGR: 21-1)

85089 Impact of Ocular Surface Disease Treatment in Patients with Glaucoma
Gasperi E
Clinical Ophthalmology 2020; 14: 103-111 (IGR: 21-1)

84873 The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 () Knockout Mice Treated with Antiglaucoma Eye Medications
Kojima T
Diagnostics (Basel, Switzerland) 2020; 10: (IGR: 21-1)

84927 Bimatoprost Imprinted Silicone Contact Lens to Treat Glaucoma
Liu Y
AAPS PharmSciTech 2020; 21: 63 (IGR: 21-1)

84572 Dendritic Effects of Injectable Biodegradable Thermogels on Pharmacotherapy of Inflammatory Glaucoma-Associated Degradation of Extracellular Matrix
Luo LJ
Advanced healthcare materials 2019; 8: e1900702 (IGR: 21-1)

84963 Brinzolamide Dimethyl Sulfoxide In Situ Gelling Ophthalmic Solution: Formulation Optimisation and In Vitro and In Vivo Evaluation
Koteshwara KB
AAPS PharmSciTech 2020; 21: 69 (IGR: 21-1)

84893 Sustained Nitric Oxide-Providing Small Molecule and Precise Release Behavior Study for Glaucoma Treatment
Park S
Molecular pharmaceutics 2020; 17: 656-665 (IGR: 21-1)

84655 Benzoic acid derivative-modified chitosan-g-poly(N-isopropylacrylamide): Methoxylation effects and pharmacological treatments of Glaucoma-related neurodegeneration
Nguyen DD
Journal of Controlled Release 2020; 317: 246-258 (IGR: 21-1)

84579 Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for management of glaucoma: Formulation, characterization and pharmacodynamic study
Mohan P
International Journal of Biological Macromolecules 2020; 152: 1224-1232 (IGR: 21-1)

84829 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
Christie WC
Drugs 2020; 80: 167-179 (IGR: 21-1)

84893 Sustained Nitric Oxide-Providing Small Molecule and Precise Release Behavior Study for Glaucoma Treatment
Park K
Molecular pharmaceutics 2020; 17: 656-665 (IGR: 21-1)

84873 The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 () Knockout Mice Treated with Antiglaucoma Eye Medications
Higa K
Diagnostics (Basel, Switzerland) 2020; 10: (IGR: 21-1)

84963 Brinzolamide Dimethyl Sulfoxide In Situ Gelling Ophthalmic Solution: Formulation Optimisation and In Vitro and In Vivo Evaluation
Chandran S
AAPS PharmSciTech 2020; 21: 69 (IGR: 21-1)

84927 Bimatoprost Imprinted Silicone Contact Lens to Treat Glaucoma
Han S
AAPS PharmSciTech 2020; 21: 63 (IGR: 21-1)

85115 Albumin Levels in Tear Film Modulate the Bioavailability of Medically-Relevant Topical Drugs
Mochel JP
Frontiers in pharmacology 2019; 10: 1560 (IGR: 21-1)

84579 Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for management of glaucoma: Formulation, characterization and pharmacodynamic study
Dangi JS
International Journal of Biological Macromolecules 2020; 152: 1224-1232 (IGR: 21-1)

84508 Effects of topical autologous serum on the ocular surface in patients with toxic corneal epitheliopathy induced by anti-glaucoma drugs
Park HY
International Ophthalmology 2020; 40: 547-552 (IGR: 21-1)

84241 Effects of rosiglitazone/PHBV drug delivery system on postoperative fibrosis in rabbit glaucoma filtration surgery model
Pan Z
Drug Delivery 2019; 26: 812-819 (IGR: 21-1)

84655 Benzoic acid derivative-modified chitosan-g-poly(N-isopropylacrylamide): Methoxylation effects and pharmacological treatments of Glaucoma-related neurodegeneration
Lai JY
Journal of Controlled Release 2020; 317: 246-258 (IGR: 21-1)

85049 The Sustained Release of Tafluprost with a Drug Delivery System Prevents the Axonal Injury-induced Loss of Retinal Ganglion Cells in Rats
Omodaka K
Current Eye Research 2020; 0: 1-10 (IGR: 21-1)

85089 Impact of Ocular Surface Disease Treatment in Patients with Glaucoma
Fernandes L
Clinical Ophthalmology 2020; 14: 103-111 (IGR: 21-1)

85091 Clinical Evaluation of a Novel Electromechanical Topical Ocular Drug Delivery System: Two Phase 1 Proof of Concept Studies
Gonzalez-Salinas R
Clinical Ophthalmology 2020; 14: 139-147 (IGR: 21-1)

84144 Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study
Ghorab M
Drug Delivery 2019; 26: 509-521 (IGR: 21-1)

85206 Promising therapeutic drug delivery systems for glaucoma: a comprehensive review
Thakur S
Therapeutic advances in ophthalmology 2020; 12: 2515841420905740 (IGR: 21-1)

84572 Dendritic Effects of Injectable Biodegradable Thermogels on Pharmacotherapy of Inflammatory Glaucoma-Associated Degradation of Extracellular Matrix
Lai JY
Advanced healthcare materials 2019; 8: e1900702 (IGR: 21-1)

84508 Effects of topical autologous serum on the ocular surface in patients with toxic corneal epitheliopathy induced by anti-glaucoma drugs
Kim H
International Ophthalmology 2020; 40: 547-552 (IGR: 21-1)

85091 Clinical Evaluation of a Novel Electromechanical Topical Ocular Drug Delivery System: Two Phase 1 Proof of Concept Studies
Kourtis IC
Clinical Ophthalmology 2020; 14: 139-147 (IGR: 21-1)

84241 Effects of rosiglitazone/PHBV drug delivery system on postoperative fibrosis in rabbit glaucoma filtration surgery model
Cao M
Drug Delivery 2019; 26: 812-819 (IGR: 21-1)

85049 The Sustained Release of Tafluprost with a Drug Delivery System Prevents the Axonal Injury-induced Loss of Retinal Ganglion Cells in Rats
Asada H
Current Eye Research 2020; 0: 1-10 (IGR: 21-1)

85206 Promising therapeutic drug delivery systems for glaucoma: a comprehensive review
Jindal S
Therapeutic advances in ophthalmology 2020; 12: 2515841420905740 (IGR: 21-1)

85089 Impact of Ocular Surface Disease Treatment in Patients with Glaucoma
Costa VP
Clinical Ophthalmology 2020; 14: 103-111 (IGR: 21-1)

84873 The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 () Knockout Mice Treated with Antiglaucoma Eye Medications
Dogru M
Diagnostics (Basel, Switzerland) 2020; 10: (IGR: 21-1)

84893 Sustained Nitric Oxide-Providing Small Molecule and Precise Release Behavior Study for Glaucoma Treatment
Kim M
Molecular pharmaceutics 2020; 17: 656-665 (IGR: 21-1)

84927 Bimatoprost Imprinted Silicone Contact Lens to Treat Glaucoma
Zhao Q
AAPS PharmSciTech 2020; 21: 63 (IGR: 21-1)

84829 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
Day DG
Drugs 2020; 80: 167-179 (IGR: 21-1)

84579 Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for management of glaucoma: Formulation, characterization and pharmacodynamic study
Kesavan K
International Journal of Biological Macromolecules 2020; 152: 1224-1232 (IGR: 21-1)

84927 Bimatoprost Imprinted Silicone Contact Lens to Treat Glaucoma
Liu N
AAPS PharmSciTech 2020; 21: 63 (IGR: 21-1)

85089 Impact of Ocular Surface Disease Treatment in Patients with Glaucoma
Alves M
Clinical Ophthalmology 2020; 14: 103-111 (IGR: 21-1)

84893 Sustained Nitric Oxide-Providing Small Molecule and Precise Release Behavior Study for Glaucoma Treatment
Hong J
Molecular pharmaceutics 2020; 17: 656-665 (IGR: 21-1)

84241 Effects of rosiglitazone/PHBV drug delivery system on postoperative fibrosis in rabbit glaucoma filtration surgery model
Zhou D
Drug Delivery 2019; 26: 812-819 (IGR: 21-1)

85091 Clinical Evaluation of a Novel Electromechanical Topical Ocular Drug Delivery System: Two Phase 1 Proof of Concept Studies
Gilbert J
Clinical Ophthalmology 2020; 14: 139-147 (IGR: 21-1)

84873 The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 () Knockout Mice Treated with Antiglaucoma Eye Medications
Ibrahim OM
Diagnostics (Basel, Switzerland) 2020; 10: (IGR: 21-1)

84508 Effects of topical autologous serum on the ocular surface in patients with toxic corneal epitheliopathy induced by anti-glaucoma drugs
Kim MK
International Ophthalmology 2020; 40: 547-552 (IGR: 21-1)

85049 The Sustained Release of Tafluprost with a Drug Delivery System Prevents the Axonal Injury-induced Loss of Retinal Ganglion Cells in Rats
Fujii S
Current Eye Research 2020; 0: 1-10 (IGR: 21-1)

84829 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
Lewis RA
Drugs 2020; 80: 167-179 (IGR: 21-1)

84241 Effects of rosiglitazone/PHBV drug delivery system on postoperative fibrosis in rabbit glaucoma filtration surgery model
Liu H
Drug Delivery 2019; 26: 812-819 (IGR: 21-1)

84873 The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 () Knockout Mice Treated with Antiglaucoma Eye Medications
Shimizu T
Diagnostics (Basel, Switzerland) 2020; 10: (IGR: 21-1)

85049 The Sustained Release of Tafluprost with a Drug Delivery System Prevents the Axonal Injury-induced Loss of Retinal Ganglion Cells in Rats
Masaki K
Current Eye Research 2020; 0: 1-10 (IGR: 21-1)

85091 Clinical Evaluation of a Novel Electromechanical Topical Ocular Drug Delivery System: Two Phase 1 Proof of Concept Studies
Pérez-Vázquez JF
Clinical Ophthalmology 2020; 14: 139-147 (IGR: 21-1)

84508 Effects of topical autologous serum on the ocular surface in patients with toxic corneal epitheliopathy induced by anti-glaucoma drugs
Jeoung JW
International Ophthalmology 2020; 40: 547-552 (IGR: 21-1)

84829 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
Goodkin ML
Drugs 2020; 80: 167-179 (IGR: 21-1)

84873 The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 () Knockout Mice Treated with Antiglaucoma Eye Medications
Tsubota K
Diagnostics (Basel, Switzerland) 2020; 10: (IGR: 21-1)

84508 Effects of topical autologous serum on the ocular surface in patients with toxic corneal epitheliopathy induced by anti-glaucoma drugs
Oh JY
International Ophthalmology 2020; 40: 547-552 (IGR: 21-1)

85049 The Sustained Release of Tafluprost with a Drug Delivery System Prevents the Axonal Injury-induced Loss of Retinal Ganglion Cells in Rats
Nakazawa T
Current Eye Research 2020; 0: 1-10 (IGR: 21-1)

84829 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
Chen M
Drugs 2020; 80: 167-179 (IGR: 21-1)

84241 Effects of rosiglitazone/PHBV drug delivery system on postoperative fibrosis in rabbit glaucoma filtration surgery model
Huang Y
Drug Delivery 2019; 26: 812-819 (IGR: 21-1)

85091 Clinical Evaluation of a Novel Electromechanical Topical Ocular Drug Delivery System: Two Phase 1 Proof of Concept Studies
Blumenkranz M
Clinical Ophthalmology 2020; 14: 139-147 (IGR: 21-1)

85091 Clinical Evaluation of a Novel Electromechanical Topical Ocular Drug Delivery System: Two Phase 1 Proof of Concept Studies
Jiménez-Román J
Clinical Ophthalmology 2020; 14: 139-147 (IGR: 21-1)

84829 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
Wangsadipura V
Drugs 2020; 80: 167-179 (IGR: 21-1)

84241 Effects of rosiglitazone/PHBV drug delivery system on postoperative fibrosis in rabbit glaucoma filtration surgery model
Duan X
Drug Delivery 2019; 26: 812-819 (IGR: 21-1)

84873 The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 () Knockout Mice Treated with Antiglaucoma Eye Medications
Shimazaki J
Diagnostics (Basel, Switzerland) 2020; 10: (IGR: 21-1)

85091 Clinical Evaluation of a Novel Electromechanical Topical Ocular Drug Delivery System: Two Phase 1 Proof of Concept Studies
Marcellino G
Clinical Ophthalmology 2020; 14: 139-147 (IGR: 21-1)

84829 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
Robinson MR; Bejanian M;
Drugs 2020; 80: 167-179 (IGR: 21-1)

82758 Ocular Surface Disease with BAK preserved Travoprost and Polyquaternium 1(Polyquad) preserved Travoprost
Kumar S
Romanian journal of ophthalmology 2019; 63: 249-256 (IGR: 20-4)

82587 Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013-2019
Supuran CT
Expert Opinion on Therapeutic Patents 2019; 29: 781-792 (IGR: 20-4)

82052 Effect of topical glaucoma medication on tear lipid layer thickness in patients with unilateral glaucoma
Lee SM
Indian Journal of Ophthalmology 2019; 67: 1297-1302 (IGR: 20-4)

82430 Latanoprost uptake and release from commercial contact lenses
Horne RR
Journal of Biomaterials Science, Polymer Edition 2020; 31: 1-19 (IGR: 20-4)

82159 Tear neuromediators in eyes on chronic topical antiglaucoma therapy with and without BAK preservatives
Murugesan V
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82708 Promising Approach in the Treatment of Glaucoma Using Nanotechnology and Nanomedicine-Based Systems
Juliana FR
Molecules 2019; 24: (IGR: 20-4)

82710 Targeted Drug Delivery Systems for the Treatment of Glaucoma: Most Advanced Systems Review
Cegielska O
Polymers 2019; 11: (IGR: 20-4)

82367 Chitosan/hydroxyethyl cellulose inserts for sustained-release of dorzolamide for glaucoma treatment: In vitro and in vivo evaluation
Franca JR
International Journal of Pharmaceutics 2019; 570: 118662 (IGR: 20-4)

82571 Δ-Tetrahydrocannabinol Derivative-Loaded Nanoformulation Lowers Intraocular Pressure in Normotensive Rabbits
Taskar PS
Translational vision science & technology 2019; 8: 15 (IGR: 20-4)

82599 Applications of microneedles in delivering drugs for various ocular diseases
Gupta P
Life Sciences 2019; 237: 116907 (IGR: 20-4)

82613 Preservative-free preserved brimonidine %0.15 preparations in the treatment of glaucoma and ocular hypertension: short term evaluation of efficacy, safety, and potential advantages
Duru Z
Cutaneous and Ocular Toxicology 2020; 39: 21-24 (IGR: 20-4)

82174 The Impact of R-801 Nanoparticles as a Long Acting Topical Glaucoma Therapy
Ibrahim MM
Journal of biomedical nanotechnology 2019; 15: 1968-1981 (IGR: 20-4)

82350 Safety data on in situ gelling bimatoprost loaded nanovesicular formulations
Yadav M
Data in brief 2019; 25: 104361 (IGR: 20-4)

82590 Effects of Preservative on the Meibomian Gland in Glaucoma Patients Treated with Prostaglandin Analogues
Ha JY
Chonnam medical journal 2019; 55: 156-162 (IGR: 20-4)

82239 Leucaena leucocephala (Lam.) galactomannan nanoparticles: Optimization and characterization for ocular delivery in glaucoma treatment
Mittal N
International Journal of Biological Macromolecules 2019; 139: 1252-1262 (IGR: 20-4)

82599 Applications of microneedles in delivering drugs for various ocular diseases
Yadav KS
Life Sciences 2019; 237: 116907 (IGR: 20-4)

82708 Promising Approach in the Treatment of Glaucoma Using Nanotechnology and Nanomedicine-Based Systems
Kesse S
Molecules 2019; 24: (IGR: 20-4)

82590 Effects of Preservative on the Meibomian Gland in Glaucoma Patients Treated with Prostaglandin Analogues
Sung MS
Chonnam medical journal 2019; 55: 156-162 (IGR: 20-4)

82239 Leucaena leucocephala (Lam.) galactomannan nanoparticles: Optimization and characterization for ocular delivery in glaucoma treatment
Kaur G
International Journal of Biological Macromolecules 2019; 139: 1252-1262 (IGR: 20-4)

82710 Targeted Drug Delivery Systems for the Treatment of Glaucoma: Most Advanced Systems Review
Sajkiewicz P
Polymers 2019; 11: (IGR: 20-4)

82599 Applications of microneedles in delivering drugs for various ocular diseases
Yadav KS
Life Sciences 2019; 237: 116907 (IGR: 20-4)

82758 Ocular Surface Disease with BAK preserved Travoprost and Polyquaternium 1(Polyquad) preserved Travoprost
Singh T
Romanian journal of ophthalmology 2019; 63: 249-256 (IGR: 20-4)

82613 Preservative-free preserved brimonidine %0.15 preparations in the treatment of glaucoma and ocular hypertension: short term evaluation of efficacy, safety, and potential advantages
Ozsaygili C
Cutaneous and Ocular Toxicology 2020; 39: 21-24 (IGR: 20-4)

82174 The Impact of R-801 Nanoparticles as a Long Acting Topical Glaucoma Therapy
Jablonski MM
Journal of biomedical nanotechnology 2019; 15: 1968-1981 (IGR: 20-4)

82350 Safety data on in situ gelling bimatoprost loaded nanovesicular formulations
Guzman-Aranguez A
Data in brief 2019; 25: 104361 (IGR: 20-4)

82052 Effect of topical glaucoma medication on tear lipid layer thickness in patients with unilateral glaucoma
Lee JE
Indian Journal of Ophthalmology 2019; 67: 1297-1302 (IGR: 20-4)

82571 Δ-Tetrahydrocannabinol Derivative-Loaded Nanoformulation Lowers Intraocular Pressure in Normotensive Rabbits
Patil A
Translational vision science & technology 2019; 8: 15 (IGR: 20-4)

82587 Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013-2019
Altamimi ASA
Expert Opinion on Therapeutic Patents 2019; 29: 781-792 (IGR: 20-4)

82430 Latanoprost uptake and release from commercial contact lenses
Rich JT
Journal of Biomaterials Science, Polymer Edition 2020; 31: 1-19 (IGR: 20-4)

82367 Chitosan/hydroxyethyl cellulose inserts for sustained-release of dorzolamide for glaucoma treatment: In vitro and in vivo evaluation
Foureaux G
International Journal of Pharmaceutics 2019; 570: 118662 (IGR: 20-4)

82159 Tear neuromediators in eyes on chronic topical antiglaucoma therapy with and without BAK preservatives
Dwivedi R
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82587 Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013-2019
Carta F
Expert Opinion on Therapeutic Patents 2019; 29: 781-792 (IGR: 20-4)

82571 Δ-Tetrahydrocannabinol Derivative-Loaded Nanoformulation Lowers Intraocular Pressure in Normotensive Rabbits
Lakhani P
Translational vision science & technology 2019; 8: 15 (IGR: 20-4)

82350 Safety data on in situ gelling bimatoprost loaded nanovesicular formulations
Perez De Lara MJ
Data in brief 2019; 25: 104361 (IGR: 20-4)

82590 Effects of Preservative on the Meibomian Gland in Glaucoma Patients Treated with Prostaglandin Analogues
Park SW
Chonnam medical journal 2019; 55: 156-162 (IGR: 20-4)

82430 Latanoprost uptake and release from commercial contact lenses
Bradley MW
Journal of Biomaterials Science, Polymer Edition 2020; 31: 1-19 (IGR: 20-4)

82159 Tear neuromediators in eyes on chronic topical antiglaucoma therapy with and without BAK preservatives
Saini M
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82708 Promising Approach in the Treatment of Glaucoma Using Nanotechnology and Nanomedicine-Based Systems
Boakye-Yiadom KO
Molecules 2019; 24: (IGR: 20-4)

82758 Ocular Surface Disease with BAK preserved Travoprost and Polyquaternium 1(Polyquad) preserved Travoprost
Ichhpujani P
Romanian journal of ophthalmology 2019; 63: 249-256 (IGR: 20-4)

82367 Chitosan/hydroxyethyl cellulose inserts for sustained-release of dorzolamide for glaucoma treatment: In vitro and in vivo evaluation
Fuscaldi LL
International Journal of Pharmaceutics 2019; 570: 118662 (IGR: 20-4)

82052 Effect of topical glaucoma medication on tear lipid layer thickness in patients with unilateral glaucoma
Kim SI
Indian Journal of Ophthalmology 2019; 67: 1297-1302 (IGR: 20-4)

82430 Latanoprost uptake and release from commercial contact lenses
Pitt WG
Journal of Biomaterials Science, Polymer Edition 2020; 31: 1-19 (IGR: 20-4)

82350 Safety data on in situ gelling bimatoprost loaded nanovesicular formulations
Singh M
Data in brief 2019; 25: 104361 (IGR: 20-4)

82758 Ocular Surface Disease with BAK preserved Travoprost and Polyquaternium 1(Polyquad) preserved Travoprost
Vohra S
Romanian journal of ophthalmology 2019; 63: 249-256 (IGR: 20-4)

82571 Δ-Tetrahydrocannabinol Derivative-Loaded Nanoformulation Lowers Intraocular Pressure in Normotensive Rabbits
Ashour E
Translational vision science & technology 2019; 8: 15 (IGR: 20-4)

82367 Chitosan/hydroxyethyl cellulose inserts for sustained-release of dorzolamide for glaucoma treatment: In vitro and in vivo evaluation
Ribeiro TG
International Journal of Pharmaceutics 2019; 570: 118662 (IGR: 20-4)

82159 Tear neuromediators in eyes on chronic topical antiglaucoma therapy with and without BAK preservatives
Gupta V
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82708 Promising Approach in the Treatment of Glaucoma Using Nanotechnology and Nanomedicine-Based Systems
Veroniaina H
Molecules 2019; 24: (IGR: 20-4)

82052 Effect of topical glaucoma medication on tear lipid layer thickness in patients with unilateral glaucoma
Jung JH
Indian Journal of Ophthalmology 2019; 67: 1297-1302 (IGR: 20-4)

82367 Chitosan/hydroxyethyl cellulose inserts for sustained-release of dorzolamide for glaucoma treatment: In vitro and in vivo evaluation
Castilho RO
International Journal of Pharmaceutics 2019; 570: 118662 (IGR: 20-4)

82052 Effect of topical glaucoma medication on tear lipid layer thickness in patients with unilateral glaucoma
Shin J
Indian Journal of Ophthalmology 2019; 67: 1297-1302 (IGR: 20-4)

82159 Tear neuromediators in eyes on chronic topical antiglaucoma therapy with and without BAK preservatives
Dada T
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82708 Promising Approach in the Treatment of Glaucoma Using Nanotechnology and Nanomedicine-Based Systems
Wang H
Molecules 2019; 24: (IGR: 20-4)

82571 Δ-Tetrahydrocannabinol Derivative-Loaded Nanoformulation Lowers Intraocular Pressure in Normotensive Rabbits
Gul W
Translational vision science & technology 2019; 8: 15 (IGR: 20-4)

82350 Safety data on in situ gelling bimatoprost loaded nanovesicular formulations
Singh J
Data in brief 2019; 25: 104361 (IGR: 20-4)

82159 Tear neuromediators in eyes on chronic topical antiglaucoma therapy with and without BAK preservatives
Vivekanandhan S
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82571 Δ-Tetrahydrocannabinol Derivative-Loaded Nanoformulation Lowers Intraocular Pressure in Normotensive Rabbits
Elsohly MA
Translational vision science & technology 2019; 8: 15 (IGR: 20-4)

82350 Safety data on in situ gelling bimatoprost loaded nanovesicular formulations
Kaur IP
Data in brief 2019; 25: 104361 (IGR: 20-4)

82367 Chitosan/hydroxyethyl cellulose inserts for sustained-release of dorzolamide for glaucoma treatment: In vitro and in vivo evaluation
Yoshida MI
International Journal of Pharmaceutics 2019; 570: 118662 (IGR: 20-4)

82708 Promising Approach in the Treatment of Glaucoma Using Nanotechnology and Nanomedicine-Based Systems
Sun M
Molecules 2019; 24: (IGR: 20-4)

82367 Chitosan/hydroxyethyl cellulose inserts for sustained-release of dorzolamide for glaucoma treatment: In vitro and in vivo evaluation
Cardoso VN
International Journal of Pharmaceutics 2019; 570: 118662 (IGR: 20-4)

82571 Δ-Tetrahydrocannabinol Derivative-Loaded Nanoformulation Lowers Intraocular Pressure in Normotensive Rabbits
Murphy B; Majumdar S
Translational vision science & technology 2019; 8: 15 (IGR: 20-4)

82367 Chitosan/hydroxyethyl cellulose inserts for sustained-release of dorzolamide for glaucoma treatment: In vitro and in vivo evaluation
Fernandes SOA; Cronemberger S; Nogueira JC; Ferreira AJ; Faraco AAG
International Journal of Pharmaceutics 2019; 570: 118662 (IGR: 20-4)

81061 Tear Film, Conjunctival and Corneal Modifications Induced by Glaucoma Treatment
Roberti G
Current Medicinal Chemistry 2019; 0: (IGR: 20-3)

81134 Development and evaluation of performance characteristics of timolol-loaded composite ocular films as potential delivery platforms for treatment of glaucoma
Tighsazzadeh M
International Journal of Pharmaceutics 2019; 566: 111-125 (IGR: 20-3)

81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Aptel F
Journal of Glaucoma 2019; 28: 498-506 (IGR: 20-3)

80622 An in vivo confocal, prospective, masked, 36 months study on glaucoma patients medically treated with preservative-free or preserved monotherapy
Rossi GCM
Scientific reports 2019; 9: 4282 (IGR: 20-3)

80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Aptel F
Journal of Glaucoma 2019; 0: (IGR: 20-3)

80528 Effect of 2 Novel Sustained-release Drug Release Systems on Bleb Fibrosis: An In Vivo Trabeculectomy Study in a Rabbit Model
Swann FB
Journal of Glaucoma 2019; 28: 512-518 (IGR: 20-3)

80678 Topical application of polymeric nanomicelles in ophthalmology: a review on research efforts for the noninvasive delivery of ocular therapeutics
Grimaudo MA
Expert Opinion on Drug Delivery 2019; 16: 397-413 (IGR: 20-3)

81199 Designing of a pH-Triggered Carbopol®/HPMC In Situ Gel for Ocular Delivery of Dorzolamide HCl: In Vitro, In Vivo, and Ex Vivo Evaluation
Kouchak M
AAPS PharmSciTech 2019; 20: 210 (IGR: 20-3)

80517 Glaucoma: Current treatment and impact of advanced drug delivery systems
Yadav KS
Life Sciences 2019; 221: 362-376 (IGR: 20-3)

81070 Co-delivery of latanoprost and timolol from micelles-laden contact lenses for the treatment of glaucoma
Xu J
Journal of Controlled Release 2019; 305: 18-28 (IGR: 20-3)

80694 Patient-Reported Nonadherence with Glaucoma Therapy
Wolfram C
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 223-228 (IGR: 20-3)

80907 Effect of Ultra-Small Chitosan Nanoparticles Doped with Brimonidine on the Ultra-Structure of the Trabecular Meshwork of Glaucoma Patients
Barwal I
Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada 2019; 0: 1-15 (IGR: 20-3)

80720 Causative glaucoma treatment: promising targets and delivery systems
Mietzner R
Drug Discovery Today 2019; 24: 1606-1613 (IGR: 20-3)

80517 Glaucoma: Current treatment and impact of advanced drug delivery systems
Yadav KS
Life Sciences 2019; 221: 362-376 (IGR: 20-3)

81169 Osmoprotectants in Hybrid Liposome/HPMC Systems as Potential Glaucoma Treatment
Gómez-Ballesteros M
Polymers 2019; 11: (IGR: 20-3)

80907 Effect of Ultra-Small Chitosan Nanoparticles Doped with Brimonidine on the Ultra-Structure of the Trabecular Meshwork of Glaucoma Patients
Kumar R
Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada 2019; 0: 1-15 (IGR: 20-3)

80720 Causative glaucoma treatment: promising targets and delivery systems
Breunig M
Drug Discovery Today 2019; 24: 1606-1613 (IGR: 20-3)

80517 Glaucoma: Current treatment and impact of advanced drug delivery systems
Rajpurohit R
Life Sciences 2019; 221: 362-376 (IGR: 20-3)

80622 An in vivo confocal, prospective, masked, 36 months study on glaucoma patients medically treated with preservative-free or preserved monotherapy
Scudeller L
Scientific reports 2019; 9: 4282 (IGR: 20-3)

81070 Co-delivery of latanoprost and timolol from micelles-laden contact lenses for the treatment of glaucoma
Ge Y
Journal of Controlled Release 2019; 305: 18-28 (IGR: 20-3)

81134 Development and evaluation of performance characteristics of timolol-loaded composite ocular films as potential delivery platforms for treatment of glaucoma
Mitchell JC
International Journal of Pharmaceutics 2019; 566: 111-125 (IGR: 20-3)

80694 Patient-Reported Nonadherence with Glaucoma Therapy
Stahlberg E
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 223-228 (IGR: 20-3)

81017 Extracellular MMP-9-Based Assessment of Ocular Surface Inflammation in Patients with Primary Open-Angle Glaucoma
Strzemecka E
Journal of Ophthalmology 2019; 2019: 1240537 (IGR: 20-3)

80528 Effect of 2 Novel Sustained-release Drug Release Systems on Bleb Fibrosis: An In Vivo Trabeculectomy Study in a Rabbit Model
Singh S
Journal of Glaucoma 2019; 28: 512-518 (IGR: 20-3)

80678 Topical application of polymeric nanomicelles in ophthalmology: a review on research efforts for the noninvasive delivery of ocular therapeutics
Pescina S
Expert Opinion on Drug Delivery 2019; 16: 397-413 (IGR: 20-3)

81061 Tear Film, Conjunctival and Corneal Modifications Induced by Glaucoma Treatment
Tanga L
Current Medicinal Chemistry 2019; 0: (IGR: 20-3)

81169 Osmoprotectants in Hybrid Liposome/HPMC Systems as Potential Glaucoma Treatment
López-Cano JJ
Polymers 2019; 11: (IGR: 20-3)

81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Pfeiffer N
Journal of Glaucoma 2019; 28: 498-506 (IGR: 20-3)

80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Pfeiffer N
Journal of Glaucoma 2019; 0: (IGR: 20-3)

81199 Designing of a pH-Triggered Carbopol®/HPMC In Situ Gel for Ocular Delivery of Dorzolamide HCl: In Vitro, In Vivo, and Ex Vivo Evaluation
Mahmoodzadeh M
AAPS PharmSciTech 2019; 20: 210 (IGR: 20-3)

80694 Patient-Reported Nonadherence with Glaucoma Therapy
Pfeiffer N
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 223-228 (IGR: 20-3)

81017 Extracellular MMP-9-Based Assessment of Ocular Surface Inflammation in Patients with Primary Open-Angle Glaucoma
Wawrzyniak ZM
Journal of Ophthalmology 2019; 2019: 1240537 (IGR: 20-3)

81199 Designing of a pH-Triggered Carbopol®/HPMC In Situ Gel for Ocular Delivery of Dorzolamide HCl: In Vitro, In Vivo, and Ex Vivo Evaluation
Farrahi F
AAPS PharmSciTech 2019; 20: 210 (IGR: 20-3)

80907 Effect of Ultra-Small Chitosan Nanoparticles Doped with Brimonidine on the Ultra-Structure of the Trabecular Meshwork of Glaucoma Patients
Dada T
Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada 2019; 0: 1-15 (IGR: 20-3)

80517 Glaucoma: Current treatment and impact of advanced drug delivery systems
Sharma S
Life Sciences 2019; 221: 362-376 (IGR: 20-3)

81169 Osmoprotectants in Hybrid Liposome/HPMC Systems as Potential Glaucoma Treatment
Bravo-Osuna I
Polymers 2019; 11: (IGR: 20-3)

81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Schmickler S
Journal of Glaucoma 2019; 28: 498-506 (IGR: 20-3)

81134 Development and evaluation of performance characteristics of timolol-loaded composite ocular films as potential delivery platforms for treatment of glaucoma
Boateng JS
International Journal of Pharmaceutics 2019; 566: 111-125 (IGR: 20-3)

80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Schmickler S
Journal of Glaucoma 2019; 0: (IGR: 20-3)

80528 Effect of 2 Novel Sustained-release Drug Release Systems on Bleb Fibrosis: An In Vivo Trabeculectomy Study in a Rabbit Model
Blake D
Journal of Glaucoma 2019; 28: 512-518 (IGR: 20-3)

80622 An in vivo confocal, prospective, masked, 36 months study on glaucoma patients medically treated with preservative-free or preserved monotherapy
Lumini C
Scientific reports 2019; 9: 4282 (IGR: 20-3)

80678 Topical application of polymeric nanomicelles in ophthalmology: a review on research efforts for the noninvasive delivery of ocular therapeutics
Padula C
Expert Opinion on Drug Delivery 2019; 16: 397-413 (IGR: 20-3)

81070 Co-delivery of latanoprost and timolol from micelles-laden contact lenses for the treatment of glaucoma
Bu R
Journal of Controlled Release 2019; 305: 18-28 (IGR: 20-3)

81061 Tear Film, Conjunctival and Corneal Modifications Induced by Glaucoma Treatment
Manni G
Current Medicinal Chemistry 2019; 0: (IGR: 20-3)

81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Clarke J
Journal of Glaucoma 2019; 28: 498-506 (IGR: 20-3)

81070 Co-delivery of latanoprost and timolol from micelles-laden contact lenses for the treatment of glaucoma
Zhang A
Journal of Controlled Release 2019; 305: 18-28 (IGR: 20-3)

80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Clarke J
Journal of Glaucoma 2019; 0: (IGR: 20-3)

80678 Topical application of polymeric nanomicelles in ophthalmology: a review on research efforts for the noninvasive delivery of ocular therapeutics
Santi P
Expert Opinion on Drug Delivery 2019; 16: 397-413 (IGR: 20-3)

81017 Extracellular MMP-9-Based Assessment of Ocular Surface Inflammation in Patients with Primary Open-Angle Glaucoma
Szaflik JP
Journal of Ophthalmology 2019; 2019: 1240537 (IGR: 20-3)

81061 Tear Film, Conjunctival and Corneal Modifications Induced by Glaucoma Treatment
Riva I
Current Medicinal Chemistry 2019; 0: (IGR: 20-3)

80622 An in vivo confocal, prospective, masked, 36 months study on glaucoma patients medically treated with preservative-free or preserved monotherapy
Mirabile AV
Scientific reports 2019; 9: 4282 (IGR: 20-3)

80907 Effect of Ultra-Small Chitosan Nanoparticles Doped with Brimonidine on the Ultra-Structure of the Trabecular Meshwork of Glaucoma Patients
Yadav SC
Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada 2019; 0: 1-15 (IGR: 20-3)

81169 Osmoprotectants in Hybrid Liposome/HPMC Systems as Potential Glaucoma Treatment
Herrero-Vanrell R
Polymers 2019; 11: (IGR: 20-3)

80528 Effect of 2 Novel Sustained-release Drug Release Systems on Bleb Fibrosis: An In Vivo Trabeculectomy Study in a Rabbit Model
John V
Journal of Glaucoma 2019; 28: 512-518 (IGR: 20-3)

81061 Tear Film, Conjunctival and Corneal Modifications Induced by Glaucoma Treatment
Verticchio AC
Current Medicinal Chemistry 2019; 0: (IGR: 20-3)

81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Lavín-Dapena C
Journal of Glaucoma 2019; 28: 498-506 (IGR: 20-3)

80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Lavín-Dapena C
Journal of Glaucoma 2019; 0: (IGR: 20-3)

80622 An in vivo confocal, prospective, masked, 36 months study on glaucoma patients medically treated with preservative-free or preserved monotherapy
Picasso E
Scientific reports 2019; 9: 4282 (IGR: 20-3)

81169 Osmoprotectants in Hybrid Liposome/HPMC Systems as Potential Glaucoma Treatment
Molina-Martínez IT
Polymers 2019; 11: (IGR: 20-3)

81070 Co-delivery of latanoprost and timolol from micelles-laden contact lenses for the treatment of glaucoma
Feng S
Journal of Controlled Release 2019; 305: 18-28 (IGR: 20-3)

80678 Topical application of polymeric nanomicelles in ophthalmology: a review on research efforts for the noninvasive delivery of ocular therapeutics
Concheiro A
Expert Opinion on Drug Delivery 2019; 16: 397-413 (IGR: 20-3)

81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Lavín-Dapena C
Journal of Glaucoma 2019; 28: 498-506 (IGR: 20-3)

80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Lavín-Dapena C
Journal of Glaucoma 2019; 0: (IGR: 20-3)

80528 Effect of 2 Novel Sustained-release Drug Release Systems on Bleb Fibrosis: An In Vivo Trabeculectomy Study in a Rabbit Model
Le C
Journal of Glaucoma 2019; 28: 512-518 (IGR: 20-3)

81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Moreno-Montañés J
Journal of Glaucoma 2019; 28: 498-506 (IGR: 20-3)

80622 An in vivo confocal, prospective, masked, 36 months study on glaucoma patients medically treated with preservative-free or preserved monotherapy
Bettio F
Scientific reports 2019; 9: 4282 (IGR: 20-3)

80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Moreno-Montañés J
Journal of Glaucoma 2019; 0: (IGR: 20-3)

80528 Effect of 2 Novel Sustained-release Drug Release Systems on Bleb Fibrosis: An In Vivo Trabeculectomy Study in a Rabbit Model
Fullerton M
Journal of Glaucoma 2019; 28: 512-518 (IGR: 20-3)

81070 Co-delivery of latanoprost and timolol from micelles-laden contact lenses for the treatment of glaucoma
Wang J
Journal of Controlled Release 2019; 305: 18-28 (IGR: 20-3)

81061 Tear Film, Conjunctival and Corneal Modifications Induced by Glaucoma Treatment
Berardo F
Current Medicinal Chemistry 2019; 0: (IGR: 20-3)

80678 Topical application of polymeric nanomicelles in ophthalmology: a review on research efforts for the noninvasive delivery of ocular therapeutics
Alvarez-Lorenzo C; Nicoli S
Expert Opinion on Drug Delivery 2019; 16: 397-413 (IGR: 20-3)

81070 Co-delivery of latanoprost and timolol from micelles-laden contact lenses for the treatment of glaucoma
Gou J
Journal of Controlled Release 2019; 305: 18-28 (IGR: 20-3)

80528 Effect of 2 Novel Sustained-release Drug Release Systems on Bleb Fibrosis: An In Vivo Trabeculectomy Study in a Rabbit Model
Margo C
Journal of Glaucoma 2019; 28: 512-518 (IGR: 20-3)

81061 Tear Film, Conjunctival and Corneal Modifications Induced by Glaucoma Treatment
Carnevale C; Carnevale C
Current Medicinal Chemistry 2019; 0: (IGR: 20-3)

80622 An in vivo confocal, prospective, masked, 36 months study on glaucoma patients medically treated with preservative-free or preserved monotherapy
Pasinetti GM
Scientific reports 2019; 9: 4282 (IGR: 20-3)

81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Żarnowski T
Journal of Glaucoma 2019; 28: 498-506 (IGR: 20-3)

80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Żarnowski T
Journal of Glaucoma 2019; 0: (IGR: 20-3)

80528 Effect of 2 Novel Sustained-release Drug Release Systems on Bleb Fibrosis: An In Vivo Trabeculectomy Study in a Rabbit Model
Zhang Z
Journal of Glaucoma 2019; 28: 512-518 (IGR: 20-3)

81061 Tear Film, Conjunctival and Corneal Modifications Induced by Glaucoma Treatment
Oddone F
Current Medicinal Chemistry 2019; 0: (IGR: 20-3)

81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Csutak A
Journal of Glaucoma 2019; 28: 498-506 (IGR: 20-3)

80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Csutak A
Journal of Glaucoma 2019; 0: (IGR: 20-3)

80622 An in vivo confocal, prospective, masked, 36 months study on glaucoma patients medically treated with preservative-free or preserved monotherapy
Bianchi PE
Scientific reports 2019; 9: 4282 (IGR: 20-3)

81070 Co-delivery of latanoprost and timolol from micelles-laden contact lenses for the treatment of glaucoma
Yin T
Journal of Controlled Release 2019; 305: 18-28 (IGR: 20-3)

80528 Effect of 2 Novel Sustained-release Drug Release Systems on Bleb Fibrosis: An In Vivo Trabeculectomy Study in a Rabbit Model
Muddasani N
Journal of Glaucoma 2019; 28: 512-518 (IGR: 20-3)

81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Jugaste T
Journal of Glaucoma 2019; 28: 498-506 (IGR: 20-3)

80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Jugaste T
Journal of Glaucoma 2019; 0: (IGR: 20-3)

81070 Co-delivery of latanoprost and timolol from micelles-laden contact lenses for the treatment of glaucoma
He H
Journal of Controlled Release 2019; 305: 18-28 (IGR: 20-3)

81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Jugaste T
Journal of Glaucoma 2019; 28: 498-506 (IGR: 20-3)

80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Jugaste T
Journal of Glaucoma 2019; 0: (IGR: 20-3)

81070 Co-delivery of latanoprost and timolol from micelles-laden contact lenses for the treatment of glaucoma
Zhang Y
Journal of Controlled Release 2019; 305: 18-28 (IGR: 20-3)

80528 Effect of 2 Novel Sustained-release Drug Release Systems on Bleb Fibrosis: An In Vivo Trabeculectomy Study in a Rabbit Model
Wall J
Journal of Glaucoma 2019; 28: 512-518 (IGR: 20-3)

81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Volksone L
Journal of Glaucoma 2019; 28: 498-506 (IGR: 20-3)

80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Volksone L
Journal of Glaucoma 2019; 0: (IGR: 20-3)

81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Astakhov YS
Journal of Glaucoma 2019; 28: 498-506 (IGR: 20-3)

80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Astakhov YS
Journal of Glaucoma 2019; 0: (IGR: 20-3)

80528 Effect of 2 Novel Sustained-release Drug Release Systems on Bleb Fibrosis: An In Vivo Trabeculectomy Study in a Rabbit Model
Satija C
Journal of Glaucoma 2019; 28: 512-518 (IGR: 20-3)

81070 Co-delivery of latanoprost and timolol from micelles-laden contact lenses for the treatment of glaucoma
Tang X
Journal of Controlled Release 2019; 305: 18-28 (IGR: 20-3)

80528 Effect of 2 Novel Sustained-release Drug Release Systems on Bleb Fibrosis: An In Vivo Trabeculectomy Study in a Rabbit Model
Greenberg E
Journal of Glaucoma 2019; 28: 512-518 (IGR: 20-3)

81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Coupier L
Journal of Glaucoma 2019; 28: 498-506 (IGR: 20-3)

80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Coupier L
Journal of Glaucoma 2019; 0: (IGR: 20-3)

81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Coupier L
Journal of Glaucoma 2019; 28: 498-506 (IGR: 20-3)

80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Coupier L
Journal of Glaucoma 2019; 0: (IGR: 20-3)

81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Nordmann JP
Journal of Glaucoma 2019; 28: 498-506 (IGR: 20-3)

80528 Effect of 2 Novel Sustained-release Drug Release Systems on Bleb Fibrosis: An In Vivo Trabeculectomy Study in a Rabbit Model
Mancera N
Journal of Glaucoma 2019; 28: 512-518 (IGR: 20-3)

80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Nordmann JP
Journal of Glaucoma 2019; 0: (IGR: 20-3)

81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension
Stalmans I
Journal of Glaucoma 2019; 28: 498-506 (IGR: 20-3)

80754 Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension
Stalmans I
Journal of Glaucoma 2019; 0: (IGR: 20-3)

80528 Effect of 2 Novel Sustained-release Drug Release Systems on Bleb Fibrosis: An In Vivo Trabeculectomy Study in a Rabbit Model
Zurakowski D
Journal of Glaucoma 2019; 28: 512-518 (IGR: 20-3)

81207 Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension

Journal of Glaucoma 2019; 28: 498-506 (IGR: 20-3)

80528 Effect of 2 Novel Sustained-release Drug Release Systems on Bleb Fibrosis: An In Vivo Trabeculectomy Study in a Rabbit Model
Ayyala RS
Journal of Glaucoma 2019; 28: 512-518 (IGR: 20-3)

79766 Efficacy of the travoprost/timolol fixed combination versus the concomitant use of travoprost 0.004% and timolol 0.1% gel formulation
Kozobolis V
Clinical Ophthalmology 2018; 12: 2393-2398 (IGR: 20-2)

80027 Effect of gold nanoparticles on timolol uptake and its release kinetics from contact lenses: In vitro and in vivo evaluation
Maulvi FA
Acta biomaterialia 2019; 86: 350-362 (IGR: 20-2)

79933 Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma
Arranz-Romera A
Journal of Controlled Release 2019; 297: 26-38 (IGR: 20-2)

80054 Co-Delivery of Timolol and Brimonidine with a Polymer Thin-Film Intraocular Device
Samy KE
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 124-131 (IGR: 20-2)

79378 Brinzolamide-loaded nanoemulsions: ex vivo transcorneal permeation, cell viability and ocular irritation tests
Mahboobian MM
Pharmaceutical Development and Technology 2019; 24: 600-606 (IGR: 20-2)

79363 Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications
Lazreg S
Journal Fran�ais d'Ophtalmologie 2018; 41: 945-954 (IGR: 20-2)

79769 Thermo-sensitive nanogel-laden bicontinuous microemulsion drug-eluting contact lenses
Lee SH
Journal of Biomedical Materials Research - Part B Applied Biomaterials 2019; 107: 1159-1169 (IGR: 20-2)

79383 Thermosensitive chitosan-gelatin-based hydrogel containing curcumin-loaded nanoparticles and latanoprost as a dual-drug delivery system for glaucoma treatment
Cheng YH
Experimental Eye Research 2019; 179: 179-187 (IGR: 20-2)

79765 Better tolerance of preservative-free latanoprost compared to preserved glaucoma eye drops: the 12-month real-life FREE study
Economou MA
Clinical Ophthalmology 2018; 12: 2399-2407 (IGR: 20-2)

80061 Effect of vitamin-E integration on delivery of prostaglandin analogs from therapeutic lenses
Sekar P
Journal of Colloid and Interface Science 2019; 539: 457-467 (IGR: 20-2)

79825 Engineering and Development of Chitosan-Based Nanocoatings for Ocular Contact Lenses
Mehta P
Journal of Pharmaceutical Sciences 2019; 108: 1540-1551 (IGR: 20-2)

79521 Local Delivery and Sustained-Release of Nitric Oxide Donor Loaded in Mesoporous Silica Particles for Efficient Treatment of Primary Open-Angle Glaucoma
Hu C
Advanced healthcare materials 2018; 7: e1801047 (IGR: 20-2)

79689 Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose
Pasquale LR
Clinical Ophthalmology 2018; 12: 2451-2457 (IGR: 20-2)

80090 Rho kinase inhibitors for treatment of glaucoma
Mandell KJ
Expert Review of Ophthalmology 2011; 6: 611-622 (IGR: 20-2)

79583 Conjunctival Goblet Cells, the Overlooked Cells in Glaucoma Treatment
Tiedemann D
Journal of Glaucoma 2019; 28: 325-333 (IGR: 20-2)

79726 Gelatinized core liposomes: A new Trojan horse for the development of a novel timolol maleate glaucoma medication
Hathout RM
International Journal of Pharmaceutics 2019; 556: 192-199 (IGR: 20-2)

79378 Brinzolamide-loaded nanoemulsions: ex vivo transcorneal permeation, cell viability and ocular irritation tests
Seyfoddin A
Pharmaceutical Development and Technology 2019; 24: 600-606 (IGR: 20-2)

80054 Co-Delivery of Timolol and Brimonidine with a Polymer Thin-Film Intraocular Device
Cao Y
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 124-131 (IGR: 20-2)

79363 Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications
Merad Z
Journal Fran�ais d'Ophtalmologie 2018; 41: 945-954 (IGR: 20-2)

80090 Rho kinase inhibitors for treatment of glaucoma
Kudelka MR
Expert Review of Ophthalmology 2011; 6: 611-622 (IGR: 20-2)

79583 Conjunctival Goblet Cells, the Overlooked Cells in Glaucoma Treatment
Mouhammad ZA
Journal of Glaucoma 2019; 28: 325-333 (IGR: 20-2)

79933 Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma
Davis BM
Journal of Controlled Release 2019; 297: 26-38 (IGR: 20-2)

79765 Better tolerance of preservative-free latanoprost compared to preserved glaucoma eye drops: the 12-month real-life FREE study
Laukeland HK
Clinical Ophthalmology 2018; 12: 2399-2407 (IGR: 20-2)

79521 Local Delivery and Sustained-Release of Nitric Oxide Donor Loaded in Mesoporous Silica Particles for Efficient Treatment of Primary Open-Angle Glaucoma
Sun J
Advanced healthcare materials 2018; 7: e1801047 (IGR: 20-2)

79689 Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose
Lin S
Clinical Ophthalmology 2018; 12: 2451-2457 (IGR: 20-2)

79766 Efficacy of the travoprost/timolol fixed combination versus the concomitant use of travoprost 0.004% and timolol 0.1% gel formulation
Konstantinidis A
Clinical Ophthalmology 2018; 12: 2393-2398 (IGR: 20-2)

79825 Engineering and Development of Chitosan-Based Nanocoatings for Ocular Contact Lenses
Al-Kinani AA
Journal of Pharmaceutical Sciences 2019; 108: 1540-1551 (IGR: 20-2)

79383 Thermosensitive chitosan-gelatin-based hydrogel containing curcumin-loaded nanoparticles and latanoprost as a dual-drug delivery system for glaucoma treatment
Ko YC
Experimental Eye Research 2019; 179: 179-187 (IGR: 20-2)

80027 Effect of gold nanoparticles on timolol uptake and its release kinetics from contact lenses: In vitro and in vivo evaluation
Patil RJ
Acta biomaterialia 2019; 86: 350-362 (IGR: 20-2)

79726 Gelatinized core liposomes: A new Trojan horse for the development of a novel timolol maleate glaucoma medication
Gad HA
International Journal of Pharmaceutics 2019; 556: 192-199 (IGR: 20-2)

79769 Thermo-sensitive nanogel-laden bicontinuous microemulsion drug-eluting contact lenses
Kim HJ
Journal of Biomedical Materials Research - Part B Applied Biomaterials 2019; 107: 1159-1169 (IGR: 20-2)

80061 Effect of vitamin-E integration on delivery of prostaglandin analogs from therapeutic lenses
Chauhan A
Journal of Colloid and Interface Science 2019; 539: 457-467 (IGR: 20-2)

79769 Thermo-sensitive nanogel-laden bicontinuous microemulsion drug-eluting contact lenses
Kim DH
Journal of Biomedical Materials Research - Part B Applied Biomaterials 2019; 107: 1159-1169 (IGR: 20-2)

79383 Thermosensitive chitosan-gelatin-based hydrogel containing curcumin-loaded nanoparticles and latanoprost as a dual-drug delivery system for glaucoma treatment
Chang YF
Experimental Eye Research 2019; 179: 179-187 (IGR: 20-2)

79766 Efficacy of the travoprost/timolol fixed combination versus the concomitant use of travoprost 0.004% and timolol 0.1% gel formulation
Sideroudi H
Clinical Ophthalmology 2018; 12: 2393-2398 (IGR: 20-2)

79521 Local Delivery and Sustained-Release of Nitric Oxide Donor Loaded in Mesoporous Silica Particles for Efficient Treatment of Primary Open-Angle Glaucoma
Zhang Y
Advanced healthcare materials 2018; 7: e1801047 (IGR: 20-2)

79825 Engineering and Development of Chitosan-Based Nanocoatings for Ocular Contact Lenses
Arshad MS
Journal of Pharmaceutical Sciences 2019; 108: 1540-1551 (IGR: 20-2)

79583 Conjunctival Goblet Cells, the Overlooked Cells in Glaucoma Treatment
Utheim TP
Journal of Glaucoma 2019; 28: 325-333 (IGR: 20-2)

79689 Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose
Weinreb RN
Clinical Ophthalmology 2018; 12: 2451-2457 (IGR: 20-2)

80027 Effect of gold nanoparticles on timolol uptake and its release kinetics from contact lenses: In vitro and in vivo evaluation
Desai AR
Acta biomaterialia 2019; 86: 350-362 (IGR: 20-2)

79363 Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications
Nouri MT
Journal Fran�ais d'Ophtalmologie 2018; 41: 945-954 (IGR: 20-2)

80090 Rho kinase inhibitors for treatment of glaucoma
Wirostko B
Expert Review of Ophthalmology 2011; 6: 611-622 (IGR: 20-2)

79933 Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma
Bravo-Osuna I
Journal of Controlled Release 2019; 297: 26-38 (IGR: 20-2)

79726 Gelatinized core liposomes: A new Trojan horse for the development of a novel timolol maleate glaucoma medication
Abdel-Hafez SM
International Journal of Pharmaceutics 2019; 556: 192-199 (IGR: 20-2)

79378 Brinzolamide-loaded nanoemulsions: ex vivo transcorneal permeation, cell viability and ocular irritation tests
Aboofazeli R
Pharmaceutical Development and Technology 2019; 24: 600-606 (IGR: 20-2)

80054 Co-Delivery of Timolol and Brimonidine with a Polymer Thin-Film Intraocular Device
Kim J
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 124-131 (IGR: 20-2)

79765 Better tolerance of preservative-free latanoprost compared to preserved glaucoma eye drops: the 12-month real-life FREE study
Grabska-Liberek I
Clinical Ophthalmology 2018; 12: 2399-2407 (IGR: 20-2)

79689 Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose
Tsai JC
Clinical Ophthalmology 2018; 12: 2451-2457 (IGR: 20-2)

79765 Better tolerance of preservative-free latanoprost compared to preserved glaucoma eye drops: the 12-month real-life FREE study
Rouland JF
Clinical Ophthalmology 2018; 12: 2399-2407 (IGR: 20-2)

79363 Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications
Garout R
Journal Fran�ais d'Ophtalmologie 2018; 41: 945-954 (IGR: 20-2)

79769 Thermo-sensitive nanogel-laden bicontinuous microemulsion drug-eluting contact lenses
Chang WS
Journal of Biomedical Materials Research - Part B Applied Biomaterials 2019; 107: 1159-1169 (IGR: 20-2)

80027 Effect of gold nanoparticles on timolol uptake and its release kinetics from contact lenses: In vitro and in vivo evaluation
Shukla MR
Acta biomaterialia 2019; 86: 350-362 (IGR: 20-2)

79825 Engineering and Development of Chitosan-Based Nanocoatings for Ocular Contact Lenses
Singh N
Journal of Pharmaceutical Sciences 2019; 108: 1540-1551 (IGR: 20-2)

79583 Conjunctival Goblet Cells, the Overlooked Cells in Glaucoma Treatment
Dartt DA
Journal of Glaucoma 2019; 28: 325-333 (IGR: 20-2)

79378 Brinzolamide-loaded nanoemulsions: ex vivo transcorneal permeation, cell viability and ocular irritation tests
Foroutan SM
Pharmaceutical Development and Technology 2019; 24: 600-606 (IGR: 20-2)

79521 Local Delivery and Sustained-Release of Nitric Oxide Donor Loaded in Mesoporous Silica Particles for Efficient Treatment of Primary Open-Angle Glaucoma
Chen J
Advanced healthcare materials 2018; 7: e1801047 (IGR: 20-2)

79726 Gelatinized core liposomes: A new Trojan horse for the development of a novel timolol maleate glaucoma medication
Nasser N
International Journal of Pharmaceutics 2019; 556: 192-199 (IGR: 20-2)

80054 Co-Delivery of Timolol and Brimonidine with a Polymer Thin-Film Intraocular Device
Konichi da Silva NR
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 124-131 (IGR: 20-2)

79766 Efficacy of the travoprost/timolol fixed combination versus the concomitant use of travoprost 0.004% and timolol 0.1% gel formulation
Teus M
Clinical Ophthalmology 2018; 12: 2393-2398 (IGR: 20-2)

79383 Thermosensitive chitosan-gelatin-based hydrogel containing curcumin-loaded nanoparticles and latanoprost as a dual-drug delivery system for glaucoma treatment
Huang SH
Experimental Eye Research 2019; 179: 179-187 (IGR: 20-2)

79933 Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma
Esteban-Pérez S; Molina-Martínez IT
Journal of Controlled Release 2019; 297: 26-38 (IGR: 20-2)

79521 Local Delivery and Sustained-Release of Nitric Oxide Donor Loaded in Mesoporous Silica Particles for Efficient Treatment of Primary Open-Angle Glaucoma
Lei Y
Advanced healthcare materials 2018; 7: e1801047 (IGR: 20-2)

79689 Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose
Kramm RL
Clinical Ophthalmology 2018; 12: 2451-2457 (IGR: 20-2)

80027 Effect of gold nanoparticles on timolol uptake and its release kinetics from contact lenses: In vitro and in vivo evaluation
Vaidya RJ
Acta biomaterialia 2019; 86: 350-362 (IGR: 20-2)

79378 Brinzolamide-loaded nanoemulsions: ex vivo transcorneal permeation, cell viability and ocular irritation tests
Rupenthal ID
Pharmaceutical Development and Technology 2019; 24: 600-606 (IGR: 20-2)

80054 Co-Delivery of Timolol and Brimonidine with a Polymer Thin-Film Intraocular Device
Phone A
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 124-131 (IGR: 20-2)

79726 Gelatinized core liposomes: A new Trojan horse for the development of a novel timolol maleate glaucoma medication
Khalil N
International Journal of Pharmaceutics 2019; 556: 192-199 (IGR: 20-2)

79363 Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications
Derdour A
Journal Fran�ais d'Ophtalmologie 2018; 41: 945-954 (IGR: 20-2)

79583 Conjunctival Goblet Cells, the Overlooked Cells in Glaucoma Treatment
Heegaard S
Journal of Glaucoma 2019; 28: 325-333 (IGR: 20-2)

79825 Engineering and Development of Chitosan-Based Nanocoatings for Ocular Contact Lenses
van der Merwe SM
Journal of Pharmaceutical Sciences 2019; 108: 1540-1551 (IGR: 20-2)

79383 Thermosensitive chitosan-gelatin-based hydrogel containing curcumin-loaded nanoparticles and latanoprost as a dual-drug delivery system for glaucoma treatment
Liu CJ
Experimental Eye Research 2019; 179: 179-187 (IGR: 20-2)

79769 Thermo-sensitive nanogel-laden bicontinuous microemulsion drug-eluting contact lenses
Vales TP
Journal of Biomedical Materials Research - Part B Applied Biomaterials 2019; 107: 1159-1169 (IGR: 20-2)

79726 Gelatinized core liposomes: A new Trojan horse for the development of a novel timolol maleate glaucoma medication
Ateyya T
International Journal of Pharmaceutics 2019; 556: 192-199 (IGR: 20-2)

79933 Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma
Shamsher E
Journal of Controlled Release 2019; 297: 26-38 (IGR: 20-2)

79689 Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose
Ianchulev T
Clinical Ophthalmology 2018; 12: 2451-2457 (IGR: 20-2)

80054 Co-Delivery of Timolol and Brimonidine with a Polymer Thin-Film Intraocular Device
Bloomer MM
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 124-131 (IGR: 20-2)

79583 Conjunctival Goblet Cells, the Overlooked Cells in Glaucoma Treatment
Petrovski G
Journal of Glaucoma 2019; 28: 325-333 (IGR: 20-2)

80027 Effect of gold nanoparticles on timolol uptake and its release kinetics from contact lenses: In vitro and in vivo evaluation
Ranch KM
Acta biomaterialia 2019; 86: 350-362 (IGR: 20-2)

79769 Thermo-sensitive nanogel-laden bicontinuous microemulsion drug-eluting contact lenses
Kim JW
Journal of Biomedical Materials Research - Part B Applied Biomaterials 2019; 107: 1159-1169 (IGR: 20-2)

79363 Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications
Ghroud N
Journal Fran�ais d'Ophtalmologie 2018; 41: 945-954 (IGR: 20-2)

79521 Local Delivery and Sustained-Release of Nitric Oxide Donor Loaded in Mesoporous Silica Particles for Efficient Treatment of Primary Open-Angle Glaucoma
Sun X
Advanced healthcare materials 2018; 7: e1801047 (IGR: 20-2)

79825 Engineering and Development of Chitosan-Based Nanocoatings for Ocular Contact Lenses
Chang MW
Journal of Pharmaceutical Sciences 2019; 108: 1540-1551 (IGR: 20-2)

80054 Co-Delivery of Timolol and Brimonidine with a Polymer Thin-Film Intraocular Device
Bhisitkul RB
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 124-131 (IGR: 20-2)

79726 Gelatinized core liposomes: A new Trojan horse for the development of a novel timolol maleate glaucoma medication
Amr A
International Journal of Pharmaceutics 2019; 556: 192-199 (IGR: 20-2)

79363 Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications
Kherroubi R
Journal Fran�ais d'Ophtalmologie 2018; 41: 945-954 (IGR: 20-2)

79769 Thermo-sensitive nanogel-laden bicontinuous microemulsion drug-eluting contact lenses
Kim KH
Journal of Biomedical Materials Research - Part B Applied Biomaterials 2019; 107: 1159-1169 (IGR: 20-2)

79933 Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma
Ravindran N
Journal of Controlled Release 2019; 297: 26-38 (IGR: 20-2)

79825 Engineering and Development of Chitosan-Based Nanocoatings for Ocular Contact Lenses
Alany RG
Journal of Pharmaceutical Sciences 2019; 108: 1540-1551 (IGR: 20-2)

79521 Local Delivery and Sustained-Release of Nitric Oxide Donor Loaded in Mesoporous Silica Particles for Efficient Treatment of Primary Open-Angle Glaucoma
Deng Y
Advanced healthcare materials 2018; 7: e1801047 (IGR: 20-2)

80027 Effect of gold nanoparticles on timolol uptake and its release kinetics from contact lenses: In vitro and in vivo evaluation
Vyas BA
Acta biomaterialia 2019; 86: 350-362 (IGR: 20-2)

79583 Conjunctival Goblet Cells, the Overlooked Cells in Glaucoma Treatment
Kolko M
Journal of Glaucoma 2019; 28: 325-333 (IGR: 20-2)

80054 Co-Delivery of Timolol and Brimonidine with a Polymer Thin-Film Intraocular Device
Desai TA
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 124-131 (IGR: 20-2)

79825 Engineering and Development of Chitosan-Based Nanocoatings for Ocular Contact Lenses
Ahmad Z
Journal of Pharmaceutical Sciences 2019; 108: 1540-1551 (IGR: 20-2)

79726 Gelatinized core liposomes: A new Trojan horse for the development of a novel timolol maleate glaucoma medication
Yasser N
International Journal of Pharmaceutics 2019; 556: 192-199 (IGR: 20-2)

79933 Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma
Guo L
Journal of Controlled Release 2019; 297: 26-38 (IGR: 20-2)

79769 Thermo-sensitive nanogel-laden bicontinuous microemulsion drug-eluting contact lenses
Kim JK
Journal of Biomedical Materials Research - Part B Applied Biomaterials 2019; 107: 1159-1169 (IGR: 20-2)

80027 Effect of gold nanoparticles on timolol uptake and its release kinetics from contact lenses: In vitro and in vivo evaluation
Shah SA
Acta biomaterialia 2019; 86: 350-362 (IGR: 20-2)

79363 Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications
Meziane M
Journal Fran�ais d'Ophtalmologie 2018; 41: 945-954 (IGR: 20-2)

79933 Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma
Cordeiro MF
Journal of Controlled Release 2019; 297: 26-38 (IGR: 20-2)

80027 Effect of gold nanoparticles on timolol uptake and its release kinetics from contact lenses: In vitro and in vivo evaluation
Shah DO
Acta biomaterialia 2019; 86: 350-362 (IGR: 20-2)

79363 Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications
Belkacem S
Journal Fran�ais d'Ophtalmologie 2018; 41: 945-954 (IGR: 20-2)

79726 Gelatinized core liposomes: A new Trojan horse for the development of a novel timolol maleate glaucoma medication
Nasr S
International Journal of Pharmaceutics 2019; 556: 192-199 (IGR: 20-2)

79363 Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications
Ouhadj O
Journal Fran�ais d'Ophtalmologie 2018; 41: 945-954 (IGR: 20-2)

79726 Gelatinized core liposomes: A new Trojan horse for the development of a novel timolol maleate glaucoma medication
Metwally AA
International Journal of Pharmaceutics 2019; 556: 192-199 (IGR: 20-2)

79933 Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma
Herrero-Vanrell R
Journal of Controlled Release 2019; 297: 26-38 (IGR: 20-2)

79363 Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications
Baudouin C; Tiar M
Journal Fran�ais d'Ophtalmologie 2018; 41: 945-954 (IGR: 20-2)

79289 The impact of topical intraocular pressure lowering medications on the ocular surface of glaucoma patients: A review
Asiedu K
Journal of current ophthalmology 2019; 31: 8-15 (IGR: 20-1)

79181 Formulation and Characterization of Carvedilol Leciplex for Glaucoma Treatment: In-Vitro, Ex-Vivo and In-Vivo Study
Hassan DH
Pharmaceutics 2018; 10: (IGR: 20-1)

78445 Metal-organic frameworks, NH-MIL-88(Fe), as carriers for ophthalmic delivery of brimonidine
Kim SN
Acta biomaterialia 2018; 79: 344-353 (IGR: 20-1)

78766 Patient attitudes toward novel glaucoma drug delivery approaches
Wang BB
Digital journal of ophthalmology : DJO / sponsored by Massachusetts Eye and Ear Infirmary 2018; 24: 16-23 (IGR: 20-1)

78845 A review on recent drug delivery systems for posterior segment of eye
Nayak K
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2018; 107: 1564-1582 (IGR: 20-1)

79202 Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target Tissues
Seal JR
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 50-57 (IGR: 20-1)

79236 Nanotechnology-Ocular Devices for Glaucoma Treatment: A Literature Review
Cardigos J
Current Eye Research 2019; 44: 111-117 (IGR: 20-1)

78830 Thermo-sensitive gel in glaucoma therapy for enhanced bioavailability: In vitro characterization, in vivo pharmacokinetics and pharmacodynamics study
Zeng Y
Life Sciences 2018; 212: 80-86 (IGR: 20-1)

79223 TPGS modified nanoliposomes as an effective ocular delivery system to treat glaucoma
Jin Q
International Journal of Pharmaceutics 2018; 553: 21-28 (IGR: 20-1)

78391 Chitosan-Gelatin Hydrogel Crosslinked With Oxidized Sucrose for the Ocular Delivery of Timolol Maleate
El-Feky GS
Journal of Pharmaceutical Sciences 2018; 107: 3098-3104 (IGR: 20-1)

79172 Intracameral Delivery of Layer-by-Layer Coated siRNA Nanoparticles for Glaucoma Therapy
Dillinger AE
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: e1803239 (IGR: 20-1)

78540 Development of a biodegradable antifibrotic local drug delivery system for glaucoma microstents
Stahnke T
Bioscience reports 2018; 38: (IGR: 20-1)

78830 Thermo-sensitive gel in glaucoma therapy for enhanced bioavailability: In vitro characterization, in vivo pharmacokinetics and pharmacodynamics study
Chen J
Life Sciences 2018; 212: 80-86 (IGR: 20-1)

78391 Chitosan-Gelatin Hydrogel Crosslinked With Oxidized Sucrose for the Ocular Delivery of Timolol Maleate
Zayed GM
Journal of Pharmaceutical Sciences 2018; 107: 3098-3104 (IGR: 20-1)

78540 Development of a biodegradable antifibrotic local drug delivery system for glaucoma microstents
Siewert S
Bioscience reports 2018; 38: (IGR: 20-1)

79172 Intracameral Delivery of Layer-by-Layer Coated siRNA Nanoparticles for Glaucoma Therapy
Guter M
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: e1803239 (IGR: 20-1)

79223 TPGS modified nanoliposomes as an effective ocular delivery system to treat glaucoma
Li H
International Journal of Pharmaceutics 2018; 553: 21-28 (IGR: 20-1)

79181 Formulation and Characterization of Carvedilol Leciplex for Glaucoma Treatment: In-Vitro, Ex-Vivo and In-Vivo Study
Abdelmonem R
Pharmaceutics 2018; 10: (IGR: 20-1)

78445 Metal-organic frameworks, NH-MIL-88(Fe), as carriers for ophthalmic delivery of brimonidine
Park CG
Acta biomaterialia 2018; 79: 344-353 (IGR: 20-1)

78766 Patient attitudes toward novel glaucoma drug delivery approaches
Lin MM
Digital journal of ophthalmology : DJO / sponsored by Massachusetts Eye and Ear Infirmary 2018; 24: 16-23 (IGR: 20-1)

79236 Nanotechnology-Ocular Devices for Glaucoma Treatment: A Literature Review
Ferreira Q
Current Eye Research 2019; 44: 111-117 (IGR: 20-1)

78845 A review on recent drug delivery systems for posterior segment of eye
Misra M
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2018; 107: 1564-1582 (IGR: 20-1)

79289 The impact of topical intraocular pressure lowering medications on the ocular surface of glaucoma patients: A review
Abu SL
Journal of current ophthalmology 2019; 31: 8-15 (IGR: 20-1)

79202 Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target Tissues
Robinson MR
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 50-57 (IGR: 20-1)

78766 Patient attitudes toward novel glaucoma drug delivery approaches
Nguyen T
Digital journal of ophthalmology : DJO / sponsored by Massachusetts Eye and Ear Infirmary 2018; 24: 16-23 (IGR: 20-1)

79236 Nanotechnology-Ocular Devices for Glaucoma Treatment: A Literature Review
Crisóstomo S
Current Eye Research 2019; 44: 111-117 (IGR: 20-1)

78540 Development of a biodegradable antifibrotic local drug delivery system for glaucoma microstents
Reske T
Bioscience reports 2018; 38: (IGR: 20-1)

78391 Chitosan-Gelatin Hydrogel Crosslinked With Oxidized Sucrose for the Ocular Delivery of Timolol Maleate
Elshaier YAMM
Journal of Pharmaceutical Sciences 2018; 107: 3098-3104 (IGR: 20-1)

79172 Intracameral Delivery of Layer-by-Layer Coated siRNA Nanoparticles for Glaucoma Therapy
Froemel F
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: e1803239 (IGR: 20-1)

79202 Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target Tissues
Burke J
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 50-57 (IGR: 20-1)

78830 Thermo-sensitive gel in glaucoma therapy for enhanced bioavailability: In vitro characterization, in vivo pharmacokinetics and pharmacodynamics study
Li Y
Life Sciences 2018; 212: 80-86 (IGR: 20-1)

79181 Formulation and Characterization of Carvedilol Leciplex for Glaucoma Treatment: In-Vitro, Ex-Vivo and In-Vivo Study
Abdellatif MM
Pharmaceutics 2018; 10: (IGR: 20-1)

78445 Metal-organic frameworks, NH-MIL-88(Fe), as carriers for ophthalmic delivery of brimonidine
Huh BK
Acta biomaterialia 2018; 79: 344-353 (IGR: 20-1)

79223 TPGS modified nanoliposomes as an effective ocular delivery system to treat glaucoma
Jin Z
International Journal of Pharmaceutics 2018; 553: 21-28 (IGR: 20-1)

79172 Intracameral Delivery of Layer-by-Layer Coated siRNA Nanoparticles for Glaucoma Therapy
Weber GR
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: e1803239 (IGR: 20-1)

78391 Chitosan-Gelatin Hydrogel Crosslinked With Oxidized Sucrose for the Ocular Delivery of Timolol Maleate
Alsharif FM
Journal of Pharmaceutical Sciences 2018; 107: 3098-3104 (IGR: 20-1)

79202 Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target Tissues
Bejanian M
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 50-57 (IGR: 20-1)

78540 Development of a biodegradable antifibrotic local drug delivery system for glaucoma microstents
Schmidt W
Bioscience reports 2018; 38: (IGR: 20-1)

79236 Nanotechnology-Ocular Devices for Glaucoma Treatment: A Literature Review
Moura-Coelho N
Current Eye Research 2019; 44: 111-117 (IGR: 20-1)

79223 TPGS modified nanoliposomes as an effective ocular delivery system to treat glaucoma
Huang L
International Journal of Pharmaceutics 2018; 553: 21-28 (IGR: 20-1)

78445 Metal-organic frameworks, NH-MIL-88(Fe), as carriers for ophthalmic delivery of brimonidine
Lee SH
Acta biomaterialia 2018; 79: 344-353 (IGR: 20-1)

78766 Patient attitudes toward novel glaucoma drug delivery approaches
Turalba AV
Digital journal of ophthalmology : DJO / sponsored by Massachusetts Eye and Ear Infirmary 2018; 24: 16-23 (IGR: 20-1)

78830 Thermo-sensitive gel in glaucoma therapy for enhanced bioavailability: In vitro characterization, in vivo pharmacokinetics and pharmacodynamics study
Huang J
Life Sciences 2018; 212: 80-86 (IGR: 20-1)

79223 TPGS modified nanoliposomes as an effective ocular delivery system to treat glaucoma
Wang F
International Journal of Pharmaceutics 2018; 553: 21-28 (IGR: 20-1)

79236 Nanotechnology-Ocular Devices for Glaucoma Treatment: A Literature Review
Cunha JP
Current Eye Research 2019; 44: 111-117 (IGR: 20-1)

78830 Thermo-sensitive gel in glaucoma therapy for enhanced bioavailability: In vitro characterization, in vivo pharmacokinetics and pharmacodynamics study
Huang Z
Life Sciences 2018; 212: 80-86 (IGR: 20-1)

79172 Intracameral Delivery of Layer-by-Layer Coated siRNA Nanoparticles for Glaucoma Therapy
Perkumas K
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: e1803239 (IGR: 20-1)

79202 Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target Tissues
Coote M
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 50-57 (IGR: 20-1)

78540 Development of a biodegradable antifibrotic local drug delivery system for glaucoma microstents
Schmitz KP
Bioscience reports 2018; 38: (IGR: 20-1)

78445 Metal-organic frameworks, NH-MIL-88(Fe), as carriers for ophthalmic delivery of brimonidine
Min CH
Acta biomaterialia 2018; 79: 344-353 (IGR: 20-1)

79223 TPGS modified nanoliposomes as an effective ocular delivery system to treat glaucoma
Zhou Y
International Journal of Pharmaceutics 2018; 553: 21-28 (IGR: 20-1)

78830 Thermo-sensitive gel in glaucoma therapy for enhanced bioavailability: In vitro characterization, in vivo pharmacokinetics and pharmacodynamics study
Huang Y
Life Sciences 2018; 212: 80-86 (IGR: 20-1)

79172 Intracameral Delivery of Layer-by-Layer Coated siRNA Nanoparticles for Glaucoma Therapy
Stamer WD
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: e1803239 (IGR: 20-1)

79202 Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target Tissues
Attar M
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 50-57 (IGR: 20-1)

78540 Development of a biodegradable antifibrotic local drug delivery system for glaucoma microstents
Grabow N
Bioscience reports 2018; 38: (IGR: 20-1)

79236 Nanotechnology-Ocular Devices for Glaucoma Treatment: A Literature Review
Pinto LA
Current Eye Research 2019; 44: 111-117 (IGR: 20-1)

78445 Metal-organic frameworks, NH-MIL-88(Fe), as carriers for ophthalmic delivery of brimonidine
Lee YY
Acta biomaterialia 2018; 79: 344-353 (IGR: 20-1)

79236 Nanotechnology-Ocular Devices for Glaucoma Treatment: A Literature Review
Ferreira JT
Current Eye Research 2019; 44: 111-117 (IGR: 20-1)

78445 Metal-organic frameworks, NH-MIL-88(Fe), as carriers for ophthalmic delivery of brimonidine
Kim YK
Acta biomaterialia 2018; 79: 344-353 (IGR: 20-1)

78830 Thermo-sensitive gel in glaucoma therapy for enhanced bioavailability: In vitro characterization, in vivo pharmacokinetics and pharmacodynamics study
Pan X
Life Sciences 2018; 212: 80-86 (IGR: 20-1)

78540 Development of a biodegradable antifibrotic local drug delivery system for glaucoma microstents
Guthoff RF
Bioscience reports 2018; 38: (IGR: 20-1)

79172 Intracameral Delivery of Layer-by-Layer Coated siRNA Nanoparticles for Glaucoma Therapy
Ohlmann A
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: e1803239 (IGR: 20-1)

79223 TPGS modified nanoliposomes as an effective ocular delivery system to treat glaucoma
Liu Y
International Journal of Pharmaceutics 2018; 553: 21-28 (IGR: 20-1)

78830 Thermo-sensitive gel in glaucoma therapy for enhanced bioavailability: In vitro characterization, in vivo pharmacokinetics and pharmacodynamics study
Wu C
Life Sciences 2018; 212: 80-86 (IGR: 20-1)

79172 Intracameral Delivery of Layer-by-Layer Coated siRNA Nanoparticles for Glaucoma Therapy
Fuchshofer R
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: e1803239 (IGR: 20-1)

79223 TPGS modified nanoliposomes as an effective ocular delivery system to treat glaucoma
Jiang C
International Journal of Pharmaceutics 2018; 553: 21-28 (IGR: 20-1)

78540 Development of a biodegradable antifibrotic local drug delivery system for glaucoma microstents
Wree A
Bioscience reports 2018; 38: (IGR: 20-1)

78445 Metal-organic frameworks, NH-MIL-88(Fe), as carriers for ophthalmic delivery of brimonidine
Park KH
Acta biomaterialia 2018; 79: 344-353 (IGR: 20-1)

79172 Intracameral Delivery of Layer-by-Layer Coated siRNA Nanoparticles for Glaucoma Therapy
Breunig M
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: e1803239 (IGR: 20-1)

78445 Metal-organic frameworks, NH-MIL-88(Fe), as carriers for ophthalmic delivery of brimonidine
Choy YB
Acta biomaterialia 2018; 79: 344-353 (IGR: 20-1)

79223 TPGS modified nanoliposomes as an effective ocular delivery system to treat glaucoma
Oswald J; Wu J; Song X
International Journal of Pharmaceutics 2018; 553: 21-28 (IGR: 20-1)

78129 Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine
Kim SN
Molecular pharmaceutics 2018; 15: 3143-3152 (IGR: 19-4)

77935 Controlled-release nanotherapeutics: State of translation
Tan YF
Journal of Controlled Release 2018; 284: 39-48 (IGR: 19-4)

78135 Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma
Li J
International Journal of Nanomedicine 2018; 13: 3975-3987 (IGR: 19-4)

78256 Old and New Drug Classes Expanding To Include Glaucoma Treatments
Kish T
P and T 2018; 43: 489-502 (IGR: 19-4)

78172 Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease
Davis BM
Scientific reports 2018; 8: 11066 (IGR: 19-4)

78063 Preservatives in glaucoma medication
Steven DW
British Journal of Ophthalmology 2018; 102: 1497-1503 (IGR: 19-4)

77935 Controlled-release nanotherapeutics: State of translation
Tan YF
Journal of Controlled Release 2018; 284: 39-48 (IGR: 19-4)

78105 Treatment merits of Latanoprost/Thymoquinone - Encapsulated liposome for glaucomatus rabbits
Fahmy HM
International Journal of Pharmaceutics 2018; 548: 597-608 (IGR: 19-4)

78109 The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension
Misiuk-Hojlo M
European Journal of Ophthalmology 2018; 0: 1120672118785280 (IGR: 19-4)

78063 Preservatives in glaucoma medication
Alaghband P
British Journal of Ophthalmology 2018; 102: 1497-1503 (IGR: 19-4)

78172 Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease
Pahlitzsch M
Scientific reports 2018; 8: 11066 (IGR: 19-4)

78105 Treatment merits of Latanoprost/Thymoquinone - Encapsulated liposome for glaucomatus rabbits
Saad EAES
International Journal of Pharmaceutics 2018; 548: 597-608 (IGR: 19-4)

78135 Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma
Tian S
International Journal of Nanomedicine 2018; 13: 3975-3987 (IGR: 19-4)

77935 Controlled-release nanotherapeutics: State of translation
Lao LL
Journal of Controlled Release 2018; 284: 39-48 (IGR: 19-4)

78109 The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension
Pomorska M
European Journal of Ophthalmology 2018; 0: 1120672118785280 (IGR: 19-4)

78129 Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine
Ko SA
Molecular pharmaceutics 2018; 15: 3143-3152 (IGR: 19-4)

78109 The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension
Mulak M
European Journal of Ophthalmology 2018; 0: 1120672118785280 (IGR: 19-4)

78172 Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease
Guo L
Scientific reports 2018; 8: 11066 (IGR: 19-4)

78063 Preservatives in glaucoma medication
Lim KS
British Journal of Ophthalmology 2018; 102: 1497-1503 (IGR: 19-4)

78129 Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine
Park CG
Molecular pharmaceutics 2018; 15: 3143-3152 (IGR: 19-4)

78105 Treatment merits of Latanoprost/Thymoquinone - Encapsulated liposome for glaucomatus rabbits
Sabra NM
International Journal of Pharmaceutics 2018; 548: 597-608 (IGR: 19-4)

78135 Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma
Tao Q
International Journal of Nanomedicine 2018; 13: 3975-3987 (IGR: 19-4)

77935 Controlled-release nanotherapeutics: State of translation
Xiong GM
Journal of Controlled Release 2018; 284: 39-48 (IGR: 19-4)

78129 Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine
Lee SH
Molecular pharmaceutics 2018; 15: 3143-3152 (IGR: 19-4)

78105 Treatment merits of Latanoprost/Thymoquinone - Encapsulated liposome for glaucomatus rabbits
El-Gohary AA
International Journal of Pharmaceutics 2018; 548: 597-608 (IGR: 19-4)

78172 Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease
Balendra S
Scientific reports 2018; 8: 11066 (IGR: 19-4)

78109 The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension
Rekas M
European Journal of Ophthalmology 2018; 0: 1120672118785280 (IGR: 19-4)

77935 Controlled-release nanotherapeutics: State of translation
Venkatraman S
Journal of Controlled Release 2018; 284: 39-48 (IGR: 19-4)

78135 Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma
Zhao Y; Gui R
International Journal of Nanomedicine 2018; 13: 3975-3987 (IGR: 19-4)

78109 The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension
Wierzbowska J
European Journal of Ophthalmology 2018; 0: 1120672118785280 (IGR: 19-4)

78105 Treatment merits of Latanoprost/Thymoquinone - Encapsulated liposome for glaucomatus rabbits
Mohamed FF
International Journal of Pharmaceutics 2018; 548: 597-608 (IGR: 19-4)

78172 Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease
Shah P
Scientific reports 2018; 8: 11066 (IGR: 19-4)

78129 Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine
Huh BK
Molecular pharmaceutics 2018; 15: 3143-3152 (IGR: 19-4)

78109 The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension
Prost M
European Journal of Ophthalmology 2018; 0: 1120672118785280 (IGR: 19-4)

78135 Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma
Yang F
International Journal of Nanomedicine 2018; 13: 3975-3987 (IGR: 19-4)

78172 Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease
Ravindran N
Scientific reports 2018; 8: 11066 (IGR: 19-4)

78105 Treatment merits of Latanoprost/Thymoquinone - Encapsulated liposome for glaucomatus rabbits
Gaber MH
International Journal of Pharmaceutics 2018; 548: 597-608 (IGR: 19-4)

78129 Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine
Park YH
Molecular pharmaceutics 2018; 15: 3143-3152 (IGR: 19-4)

78135 Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma
Zang L
International Journal of Nanomedicine 2018; 13: 3975-3987 (IGR: 19-4)

78129 Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine
Kim YK
Molecular pharmaceutics 2018; 15: 3143-3152 (IGR: 19-4)

78172 Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease
Malaguarnera G
Scientific reports 2018; 8: 11066 (IGR: 19-4)

78109 The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension
Wasyluk J; Lubinski W
European Journal of Ophthalmology 2018; 0: 1120672118785280 (IGR: 19-4)

78172 Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease
Sisa C
Scientific reports 2018; 8: 11066 (IGR: 19-4)

78135 Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma
Chen Y
International Journal of Nanomedicine 2018; 13: 3975-3987 (IGR: 19-4)

78129 Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine
Ha A
Molecular pharmaceutics 2018; 15: 3143-3152 (IGR: 19-4)

78172 Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease
Shamsher E
Scientific reports 2018; 8: 11066 (IGR: 19-4)

78129 Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine
Park KH
Molecular pharmaceutics 2018; 15: 3143-3152 (IGR: 19-4)

78135 Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma
Ping Q
International Journal of Nanomedicine 2018; 13: 3975-3987 (IGR: 19-4)

78109 The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension
Podboraczynska-Jodko K; Romaniuk W
European Journal of Ophthalmology 2018; 0: 1120672118785280 (IGR: 19-4)

78129 Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine
Choy YB
Molecular pharmaceutics 2018; 15: 3143-3152 (IGR: 19-4)

78135 Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma
Hou D
International Journal of Nanomedicine 2018; 13: 3975-3987 (IGR: 19-4)

78172 Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease
Hamze H; Noor A
Scientific reports 2018; 8: 11066 (IGR: 19-4)

78109 The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension
Kinasz R; Ortyl-Markiewicz R
European Journal of Ophthalmology 2018; 0: 1120672118785280 (IGR: 19-4)

78172 Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease
Sornsute A
Scientific reports 2018; 8: 11066 (IGR: 19-4)

78109 The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension
Mocko L
European Journal of Ophthalmology 2018; 0: 1120672118785280 (IGR: 19-4)

78172 Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease
Somavarapu S
Scientific reports 2018; 8: 11066 (IGR: 19-4)

78109 The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension
Zaleska-Zmijewska A
European Journal of Ophthalmology 2018; 0: 1120672118785280 (IGR: 19-4)

78172 Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease
Cordeiro MF
Scientific reports 2018; 8: 11066 (IGR: 19-4)

78109 The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension
Rokicki D; Baudouin C
European Journal of Ophthalmology 2018; 0: 1120672118785280 (IGR: 19-4)

76188 Drop instillation and glaucoma
Davis SA
Current Opinions in Ophthalmology 2018; 29: 171-177 (IGR: 19-3)

76819 High Prevalence of Ocular Surface Disease Among Glaucoma Patients in Thailand
Ruangvaravate N
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 387-394 (IGR: 19-3)

76812 Effect of changing from preserved prostaglandins to preservative-free tafluprost in patients with glaucoma on tear film thickness
Hommer A
European Journal of Ophthalmology 2018; 28: 385-392 (IGR: 19-3)

76957 Delivery of therapeutics for deep-seated ocular conditions - status quo
Nguyen H
Journal of Pharmacy and Pharmacology 2018; 70: 994-1001 (IGR: 19-3)

76552 Modulation of Schlemm's canal endothelial cell stiffness via latrunculin loaded block copolymer micelles
Stack T
Journal of Biomedical Materials Research - Part A 2018; 106: 1771-1779 (IGR: 19-3)

77208 Evaluating Eye Drop Instillation Technique and Its Determinants in Glaucoma Patients
Gao X
Journal of Ophthalmology 2018; 2018: 1376020 (IGR: 19-3)

77022 Exploring gelatin nanoparticles as novel nanocarriers for Timolol Maleate: Augmented in-vivo efficacy and safe histological profile
Shokry M
International Journal of Pharmaceutics 2018; 545: 229-239 (IGR: 19-3)

76857 Sustained Dorzolamide Release Prevents Axonal and Retinal Ganglion Cell Loss in a Rat Model of IOP-Glaucoma
Pitha I
Translational vision science & technology 2018; 7: 13 (IGR: 19-3)

76887 Intraocular light scatter in patients on topical intraocular pressure-lowering medication
Pérez-Bartolomé F
European Journal of Ophthalmology 2018; 0: 1120672117753667 (IGR: 19-3)

76239 Eyelid Changes Related to Meibomian Gland Dysfunction in Early Middle-Aged Patients Using Topical Glaucoma Medications
Kim JH
Cornea 2018; 37: 421-425 (IGR: 19-3)

77020 Co-delivery of timolol and hyaluronic acid from semi-circular ring-implanted contact lenses for the treatment of glaucoma: in vitro and in vivo evaluation
Desai AR
Biomaterials science 2018; 6: 1580-1591 (IGR: 19-3)

76638 Exploring topical anti-glaucoma medication effects on the ocular surface in the context of the current understanding of dry eye
Wong ABC
Ocular Surface 2018; 16: 289-293 (IGR: 19-3)

77293 Efficacy of three different formulations of brimonidine for control of intraocular pressure in primary open-angle glaucoma: A 6-week randomized trial
Bhatti A
Oman journal of ophthalmology 2018; 11: 140-143 (IGR: 19-3)

76887 Intraocular light scatter in patients on topical intraocular pressure-lowering medication
Martínez de la Casa JM
European Journal of Ophthalmology 2018; 0: 1120672117753667 (IGR: 19-3)

76812 Effect of changing from preserved prostaglandins to preservative-free tafluprost in patients with glaucoma on tear film thickness
Schmidl D
European Journal of Ophthalmology 2018; 28: 385-392 (IGR: 19-3)

76552 Modulation of Schlemm's canal endothelial cell stiffness via latrunculin loaded block copolymer micelles
Vahabikashi A
Journal of Biomedical Materials Research - Part A 2018; 106: 1771-1779 (IGR: 19-3)

76638 Exploring topical anti-glaucoma medication effects on the ocular surface in the context of the current understanding of dry eye
Wang MTM
Ocular Surface 2018; 16: 289-293 (IGR: 19-3)

76188 Drop instillation and glaucoma
Sleath B
Current Opinions in Ophthalmology 2018; 29: 171-177 (IGR: 19-3)

76990 Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical Hypotensiv
Agnifili L
Advances in Therapy 2018; 35: 686-696 (IGR: 19-3)

77022 Exploring gelatin nanoparticles as novel nanocarriers for Timolol Maleate: Augmented in-vivo efficacy and safe histological profile
Hathout RM
International Journal of Pharmaceutics 2018; 545: 229-239 (IGR: 19-3)

77293 Efficacy of three different formulations of brimonidine for control of intraocular pressure in primary open-angle glaucoma: A 6-week randomized trial
Singh G
Oman journal of ophthalmology 2018; 11: 140-143 (IGR: 19-3)

77182 Ocular surface status in glaucoma and ocular hypertension patients with existing corneal disorders switched from latanoprost 0.005% to tafluprost 0.0015%: comparison of two prostaglandin analogues with different concentrations of benzalkonium chloride
Aung T
Clinical and Experimental Ophthalmology 2018; 0: (IGR: 19-3)

77208 Evaluating Eye Drop Instillation Technique and Its Determinants in Glaucoma Patients
Yang Q
Journal of Ophthalmology 2018; 2018: 1376020 (IGR: 19-3)

77020 Co-delivery of timolol and hyaluronic acid from semi-circular ring-implanted contact lenses for the treatment of glaucoma: in vitro and in vivo evaluation
Maulvi FA
Biomaterials science 2018; 6: 1580-1591 (IGR: 19-3)

76239 Eyelid Changes Related to Meibomian Gland Dysfunction in Early Middle-Aged Patients Using Topical Glaucoma Medications
Shin YU
Cornea 2018; 37: 421-425 (IGR: 19-3)

76819 High Prevalence of Ocular Surface Disease Among Glaucoma Patients in Thailand
Prabhasawat P
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 387-394 (IGR: 19-3)

76957 Delivery of therapeutics for deep-seated ocular conditions - status quo
Eng S
Journal of Pharmacy and Pharmacology 2018; 70: 994-1001 (IGR: 19-3)

76857 Sustained Dorzolamide Release Prevents Axonal and Retinal Ganglion Cell Loss in a Rat Model of IOP-Glaucoma
Kimball EC
Translational vision science & technology 2018; 7: 13 (IGR: 19-3)

76638 Exploring topical anti-glaucoma medication effects on the ocular surface in the context of the current understanding of dry eye
Liu K
Ocular Surface 2018; 16: 289-293 (IGR: 19-3)

76819 High Prevalence of Ocular Surface Disease Among Glaucoma Patients in Thailand
Vachirasakchai V
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 387-394 (IGR: 19-3)

76188 Drop instillation and glaucoma
Carpenter DM
Current Opinions in Ophthalmology 2018; 29: 171-177 (IGR: 19-3)

76552 Modulation of Schlemm's canal endothelial cell stiffness via latrunculin loaded block copolymer micelles
Johnson M
Journal of Biomedical Materials Research - Part A 2018; 106: 1771-1779 (IGR: 19-3)

76990 Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical Hypotensiv
Berardo F
Advances in Therapy 2018; 35: 686-696 (IGR: 19-3)

76812 Effect of changing from preserved prostaglandins to preservative-free tafluprost in patients with glaucoma on tear film thickness
Kromus M
European Journal of Ophthalmology 2018; 28: 385-392 (IGR: 19-3)

76239 Eyelid Changes Related to Meibomian Gland Dysfunction in Early Middle-Aged Patients Using Topical Glaucoma Medications
Seong M
Cornea 2018; 37: 421-425 (IGR: 19-3)

77020 Co-delivery of timolol and hyaluronic acid from semi-circular ring-implanted contact lenses for the treatment of glaucoma: in vitro and in vivo evaluation
Pandya MM
Biomaterials science 2018; 6: 1580-1591 (IGR: 19-3)

77208 Evaluating Eye Drop Instillation Technique and Its Determinants in Glaucoma Patients
Huang W
Journal of Ophthalmology 2018; 2018: 1376020 (IGR: 19-3)

76957 Delivery of therapeutics for deep-seated ocular conditions - status quo
Ngo T
Journal of Pharmacy and Pharmacology 2018; 70: 994-1001 (IGR: 19-3)

77182 Ocular surface status in glaucoma and ocular hypertension patients with existing corneal disorders switched from latanoprost 0.005% to tafluprost 0.0015%: comparison of two prostaglandin analogues with different concentrations of benzalkonium chloride
Ho CL
Clinical and Experimental Ophthalmology 2018; 0: (IGR: 19-3)

76857 Sustained Dorzolamide Release Prevents Axonal and Retinal Ganglion Cell Loss in a Rat Model of IOP-Glaucoma
Oglesby EN
Translational vision science & technology 2018; 7: 13 (IGR: 19-3)

76887 Intraocular light scatter in patients on topical intraocular pressure-lowering medication
Arriola-Villalobos P
European Journal of Ophthalmology 2018; 0: 1120672117753667 (IGR: 19-3)

77022 Exploring gelatin nanoparticles as novel nanocarriers for Timolol Maleate: Augmented in-vivo efficacy and safe histological profile
Mansour S
International Journal of Pharmaceutics 2018; 545: 229-239 (IGR: 19-3)

76957 Delivery of therapeutics for deep-seated ocular conditions - status quo
Dass CR
Journal of Pharmacy and Pharmacology 2018; 70: 994-1001 (IGR: 19-3)

76812 Effect of changing from preserved prostaglandins to preservative-free tafluprost in patients with glaucoma on tear film thickness
Bata AM
European Journal of Ophthalmology 2018; 28: 385-392 (IGR: 19-3)

77020 Co-delivery of timolol and hyaluronic acid from semi-circular ring-implanted contact lenses for the treatment of glaucoma: in vitro and in vivo evaluation
Ranch KM
Biomaterials science 2018; 6: 1580-1591 (IGR: 19-3)

76638 Exploring topical anti-glaucoma medication effects on the ocular surface in the context of the current understanding of dry eye
Prime ZJ
Ocular Surface 2018; 16: 289-293 (IGR: 19-3)

76990 Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical Hypotensiv
Riva I
Advances in Therapy 2018; 35: 686-696 (IGR: 19-3)

76819 High Prevalence of Ocular Surface Disease Among Glaucoma Patients in Thailand
Tantimala R
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 387-394 (IGR: 19-3)

76887 Intraocular light scatter in patients on topical intraocular pressure-lowering medication
Fernández-Pérez C
European Journal of Ophthalmology 2018; 0: 1120672117753667 (IGR: 19-3)

76188 Drop instillation and glaucoma
Blalock SJ
Current Opinions in Ophthalmology 2018; 29: 171-177 (IGR: 19-3)

77208 Evaluating Eye Drop Instillation Technique and Its Determinants in Glaucoma Patients
Chen T
Journal of Ophthalmology 2018; 2018: 1376020 (IGR: 19-3)

76857 Sustained Dorzolamide Release Prevents Axonal and Retinal Ganglion Cell Loss in a Rat Model of IOP-Glaucoma
Pease ME
Translational vision science & technology 2018; 7: 13 (IGR: 19-3)

76552 Modulation of Schlemm's canal endothelial cell stiffness via latrunculin loaded block copolymer micelles
Scott E
Journal of Biomedical Materials Research - Part A 2018; 106: 1771-1779 (IGR: 19-3)

76239 Eyelid Changes Related to Meibomian Gland Dysfunction in Early Middle-Aged Patients Using Topical Glaucoma Medications
Cho HY
Cornea 2018; 37: 421-425 (IGR: 19-3)

76857 Sustained Dorzolamide Release Prevents Axonal and Retinal Ganglion Cell Loss in a Rat Model of IOP-Glaucoma
Fu J
Translational vision science & technology 2018; 7: 13 (IGR: 19-3)

76239 Eyelid Changes Related to Meibomian Gland Dysfunction in Early Middle-Aged Patients Using Topical Glaucoma Medications
Kang MH
Cornea 2018; 37: 421-425 (IGR: 19-3)

77208 Evaluating Eye Drop Instillation Technique and Its Determinants in Glaucoma Patients
Zuo C
Journal of Ophthalmology 2018; 2018: 1376020 (IGR: 19-3)

76887 Intraocular light scatter in patients on topical intraocular pressure-lowering medication
García-Feijoó J
European Journal of Ophthalmology 2018; 0: 1120672117753667 (IGR: 19-3)

77020 Co-delivery of timolol and hyaluronic acid from semi-circular ring-implanted contact lenses for the treatment of glaucoma: in vitro and in vivo evaluation
Vyas BA
Biomaterials science 2018; 6: 1580-1591 (IGR: 19-3)

76188 Drop instillation and glaucoma
Muir KW
Current Opinions in Ophthalmology 2018; 29: 171-177 (IGR: 19-3)

76990 Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical Hypotensiv
Figus M
Advances in Therapy 2018; 35: 686-696 (IGR: 19-3)

76812 Effect of changing from preserved prostaglandins to preservative-free tafluprost in patients with glaucoma on tear film thickness
Fondi K
European Journal of Ophthalmology 2018; 28: 385-392 (IGR: 19-3)

77020 Co-delivery of timolol and hyaluronic acid from semi-circular ring-implanted contact lenses for the treatment of glaucoma: in vitro and in vivo evaluation
Shah SA
Biomaterials science 2018; 6: 1580-1591 (IGR: 19-3)

76857 Sustained Dorzolamide Release Prevents Axonal and Retinal Ganglion Cell Loss in a Rat Model of IOP-Glaucoma
Schaub J; Schaub J
Translational vision science & technology 2018; 7: 13 (IGR: 19-3)

76188 Drop instillation and glaucoma
Budenz DL
Current Opinions in Ophthalmology 2018; 29: 171-177 (IGR: 19-3)

76638 Exploring topical anti-glaucoma medication effects on the ocular surface in the context of the current understanding of dry eye
Craig JP
Ocular Surface 2018; 16: 289-293 (IGR: 19-3)

76812 Effect of changing from preserved prostaglandins to preservative-free tafluprost in patients with glaucoma on tear film thickness
Werkmeister RM
European Journal of Ophthalmology 2018; 28: 385-392 (IGR: 19-3)

76990 Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical Hypotensiv
Manni G
Advances in Therapy 2018; 35: 686-696 (IGR: 19-3)

77208 Evaluating Eye Drop Instillation Technique and Its Determinants in Glaucoma Patients
Li X
Journal of Ophthalmology 2018; 2018: 1376020 (IGR: 19-3)

77020 Co-delivery of timolol and hyaluronic acid from semi-circular ring-implanted contact lenses for the treatment of glaucoma: in vitro and in vivo evaluation
Shah DO
Biomaterials science 2018; 6: 1580-1591 (IGR: 19-3)

76990 Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical Hypotensiv
Quaranta L
Advances in Therapy 2018; 35: 686-696 (IGR: 19-3)

76857 Sustained Dorzolamide Release Prevents Axonal and Retinal Ganglion Cell Loss in a Rat Model of IOP-Glaucoma
Kim YC
Translational vision science & technology 2018; 7: 13 (IGR: 19-3)

76812 Effect of changing from preserved prostaglandins to preservative-free tafluprost in patients with glaucoma on tear film thickness
Baar C
European Journal of Ophthalmology 2018; 28: 385-392 (IGR: 19-3)

77208 Evaluating Eye Drop Instillation Technique and Its Determinants in Glaucoma Patients
Gao W
Journal of Ophthalmology 2018; 2018: 1376020 (IGR: 19-3)

76990 Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical Hypotensiv
Oddone F
Advances in Therapy 2018; 35: 686-696 (IGR: 19-3)

77208 Evaluating Eye Drop Instillation Technique and Its Determinants in Glaucoma Patients
Xiao H
Journal of Ophthalmology 2018; 2018: 1376020 (IGR: 19-3)

76857 Sustained Dorzolamide Release Prevents Axonal and Retinal Ganglion Cell Loss in a Rat Model of IOP-Glaucoma
Hu Q
Translational vision science & technology 2018; 7: 13 (IGR: 19-3)

76812 Effect of changing from preserved prostaglandins to preservative-free tafluprost in patients with glaucoma on tear film thickness
Schmetterer L; Garhöfer G
European Journal of Ophthalmology 2018; 28: 385-392 (IGR: 19-3)

76857 Sustained Dorzolamide Release Prevents Axonal and Retinal Ganglion Cell Loss in a Rat Model of IOP-Glaucoma
Hanes J; Quigley HA
Translational vision science & technology 2018; 7: 13 (IGR: 19-3)

75497 Formulation and ex vivo-in vivo evaluation of pH-triggered brimonidine tartrate in situ gel for the glaucoma treatment using application of 3 factorial design
Barse RK
Drug Development and Industrial Pharmacy 2018; 44: 800-807 (IGR: 19-2)

75519 Meibomian Gland Performance in Glaucomatous Patients With Long-term Instillation of IOP-lowering Medications
Cho WH
Journal of Glaucoma 2018; 27: 176-183 (IGR: 19-2)

75597 Switch from BAK-preserved to preservative-free latanoprost decreases anterior chamber flare in POAG patients
Kestelyn PA
International Ophthalmology 2017; 0: (IGR: 19-2)

75322 Ultrahigh field MR imaging of a subconjunctival anti-glaucoma drug delivery system in a rabbit model
Kopp F
Scientific reports 2017; 7: 15780 (IGR: 19-2)

75279 Self-Assembling Elastin-Like Hydrogels for Timolol Delivery: Development of an Ophthalmic Formulation Against Glaucoma
Fernández-Colino A
Molecular pharmaceutics 2017; 14: 4498-4508 (IGR: 19-2)

75327 Nanogel-based natural polymers as smart carriers for the controlled delivery of Timolol Maleate through the cornea for glaucoma
Ilka R
International Journal of Biological Macromolecules 2018; 109: 955-962 (IGR: 19-2)

75280 Long-term intraocular pressure reduction with intracameral polycaprolactone glaucoma devices that deliver a novel anti-glaucoma agent
Kim J
Journal of Controlled Release 2018; 269: 45-51 (IGR: 19-2)

75226 Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress
Giannaccini M
Cellular and Molecular Life Sciences 2018; 75: 1255-1267 (IGR: 19-2)

75326 Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
Sánchez-López E
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: (IGR: 19-2)

75392 Fabrication And Characterization Of Timolol Maleate And Brinzolamide Loaded Nanostructured Lipid Carrier System For Ocular Drug Delivery
Shrivastava N
Current Drug Delivery 2017; 0: (IGR: 19-2)

75357 New pharmacotherapy for the treatment of glaucoma
Schehlein EM
Expert Opinion in Pharmacotherapy 2017; 18: 1939-1946 (IGR: 19-2)

75279 Self-Assembling Elastin-Like Hydrogels for Timolol Delivery: Development of an Ophthalmic Formulation Against Glaucoma
Quinteros DA
Molecular pharmaceutics 2017; 14: 4498-4508 (IGR: 19-2)

75327 Nanogel-based natural polymers as smart carriers for the controlled delivery of Timolol Maleate through the cornea for glaucoma
Mohseni M
International Journal of Biological Macromolecules 2018; 109: 955-962 (IGR: 19-2)

75392 Fabrication And Characterization Of Timolol Maleate And Brinzolamide Loaded Nanostructured Lipid Carrier System For Ocular Drug Delivery
Khan S
Current Drug Delivery 2017; 0: (IGR: 19-2)

75226 Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress
Usai A
Cellular and Molecular Life Sciences 2018; 75: 1255-1267 (IGR: 19-2)

75326 Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
Egea MA
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: (IGR: 19-2)

75322 Ultrahigh field MR imaging of a subconjunctival anti-glaucoma drug delivery system in a rabbit model
Eickner T
Scientific reports 2017; 7: 15780 (IGR: 19-2)

75357 New pharmacotherapy for the treatment of glaucoma
Novack G
Expert Opinion in Pharmacotherapy 2017; 18: 1939-1946 (IGR: 19-2)

75519 Meibomian Gland Performance in Glaucomatous Patients With Long-term Instillation of IOP-lowering Medications
Lai IC
Journal of Glaucoma 2018; 27: 176-183 (IGR: 19-2)

75280 Long-term intraocular pressure reduction with intracameral polycaprolactone glaucoma devices that deliver a novel anti-glaucoma agent
Kudisch M
Journal of Controlled Release 2018; 269: 45-51 (IGR: 19-2)

75497 Formulation and ex vivo-in vivo evaluation of pH-triggered brimonidine tartrate in situ gel for the glaucoma treatment using application of 3 factorial design
Tagalpallewar AA
Drug Development and Industrial Pharmacy 2018; 44: 800-807 (IGR: 19-2)

75597 Switch from BAK-preserved to preservative-free latanoprost decreases anterior chamber flare in POAG patients
Kestelyn PG
International Ophthalmology 2017; 0: (IGR: 19-2)

75226 Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress
Chiellini F
Cellular and Molecular Life Sciences 2018; 75: 1255-1267 (IGR: 19-2)

75357 New pharmacotherapy for the treatment of glaucoma
Robin AL
Expert Opinion in Pharmacotherapy 2017; 18: 1939-1946 (IGR: 19-2)

75279 Self-Assembling Elastin-Like Hydrogels for Timolol Delivery: Development of an Ophthalmic Formulation Against Glaucoma
Allemandi DA
Molecular pharmaceutics 2017; 14: 4498-4508 (IGR: 19-2)

75280 Long-term intraocular pressure reduction with intracameral polycaprolactone glaucoma devices that deliver a novel anti-glaucoma agent
da Silva NRK
Journal of Controlled Release 2018; 269: 45-51 (IGR: 19-2)

75392 Fabrication And Characterization Of Timolol Maleate And Brinzolamide Loaded Nanostructured Lipid Carrier System For Ocular Drug Delivery
Baboota S
Current Drug Delivery 2017; 0: (IGR: 19-2)

75497 Formulation and ex vivo-in vivo evaluation of pH-triggered brimonidine tartrate in situ gel for the glaucoma treatment using application of 3 factorial design
Kokare CR
Drug Development and Industrial Pharmacy 2018; 44: 800-807 (IGR: 19-2)

75597 Switch from BAK-preserved to preservative-free latanoprost decreases anterior chamber flare in POAG patients
De Bacquer D
International Ophthalmology 2017; 0: (IGR: 19-2)

75326 Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
Davis BM
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: (IGR: 19-2)

75327 Nanogel-based natural polymers as smart carriers for the controlled delivery of Timolol Maleate through the cornea for glaucoma
Kianirad M
International Journal of Biological Macromolecules 2018; 109: 955-962 (IGR: 19-2)

75519 Meibomian Gland Performance in Glaucomatous Patients With Long-term Instillation of IOP-lowering Medications
Fang PC
Journal of Glaucoma 2018; 27: 176-183 (IGR: 19-2)

75322 Ultrahigh field MR imaging of a subconjunctival anti-glaucoma drug delivery system in a rabbit model
Polei S
Scientific reports 2017; 7: 15780 (IGR: 19-2)

75392 Fabrication And Characterization Of Timolol Maleate And Brinzolamide Loaded Nanostructured Lipid Carrier System For Ocular Drug Delivery
Ali J
Current Drug Delivery 2017; 0: (IGR: 19-2)

75497 Formulation and ex vivo-in vivo evaluation of pH-triggered brimonidine tartrate in situ gel for the glaucoma treatment using application of 3 factorial design
Sharma JP
Drug Development and Industrial Pharmacy 2018; 44: 800-807 (IGR: 19-2)

75326 Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
Guo L
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: (IGR: 19-2)

75597 Switch from BAK-preserved to preservative-free latanoprost decreases anterior chamber flare in POAG patients
Stevens AM
International Ophthalmology 2017; 0: (IGR: 19-2)

75519 Meibomian Gland Performance in Glaucomatous Patients With Long-term Instillation of IOP-lowering Medications
Chien CC
Journal of Glaucoma 2018; 27: 176-183 (IGR: 19-2)

75327 Nanogel-based natural polymers as smart carriers for the controlled delivery of Timolol Maleate through the cornea for glaucoma
Naseripour M
International Journal of Biological Macromolecules 2018; 109: 955-962 (IGR: 19-2)

75226 Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress
Guadagni V
Cellular and Molecular Life Sciences 2018; 75: 1255-1267 (IGR: 19-2)

75279 Self-Assembling Elastin-Like Hydrogels for Timolol Delivery: Development of an Ophthalmic Formulation Against Glaucoma
Girotti A
Molecular pharmaceutics 2017; 14: 4498-4508 (IGR: 19-2)

75322 Ultrahigh field MR imaging of a subconjunctival anti-glaucoma drug delivery system in a rabbit model
Falke K
Scientific reports 2017; 7: 15780 (IGR: 19-2)

75280 Long-term intraocular pressure reduction with intracameral polycaprolactone glaucoma devices that deliver a novel anti-glaucoma agent
Asada H
Journal of Controlled Release 2018; 269: 45-51 (IGR: 19-2)

75497 Formulation and ex vivo-in vivo evaluation of pH-triggered brimonidine tartrate in situ gel for the glaucoma treatment using application of 3 factorial design
Sharma PK
Drug Development and Industrial Pharmacy 2018; 44: 800-807 (IGR: 19-2)

75322 Ultrahigh field MR imaging of a subconjunctival anti-glaucoma drug delivery system in a rabbit model
Witt M
Scientific reports 2017; 7: 15780 (IGR: 19-2)

75519 Meibomian Gland Performance in Glaucomatous Patients With Long-term Instillation of IOP-lowering Medications
Tseng SL
Journal of Glaucoma 2018; 27: 176-183 (IGR: 19-2)

75226 Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress
Andreazzoli M
Cellular and Molecular Life Sciences 2018; 75: 1255-1267 (IGR: 19-2)

75326 Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
Espina M
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: (IGR: 19-2)

75327 Nanogel-based natural polymers as smart carriers for the controlled delivery of Timolol Maleate through the cornea for glaucoma
Ashtari K
International Journal of Biological Macromolecules 2018; 109: 955-962 (IGR: 19-2)

75280 Long-term intraocular pressure reduction with intracameral polycaprolactone glaucoma devices that deliver a novel anti-glaucoma agent
Aya-Shibuya E
Journal of Controlled Release 2018; 269: 45-51 (IGR: 19-2)

75279 Self-Assembling Elastin-Like Hydrogels for Timolol Delivery: Development of an Ophthalmic Formulation Against Glaucoma
Palma SD
Molecular pharmaceutics 2017; 14: 4498-4508 (IGR: 19-2)

75326 Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
Silva AM
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: (IGR: 19-2)

75226 Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress
Ori M
Cellular and Molecular Life Sciences 2018; 75: 1255-1267 (IGR: 19-2)

75280 Long-term intraocular pressure reduction with intracameral polycaprolactone glaucoma devices that deliver a novel anti-glaucoma agent
Bloomer MM
Journal of Controlled Release 2018; 269: 45-51 (IGR: 19-2)

75327 Nanogel-based natural polymers as smart carriers for the controlled delivery of Timolol Maleate through the cornea for glaucoma
Mehravi B
International Journal of Biological Macromolecules 2018; 109: 955-962 (IGR: 19-2)

75322 Ultrahigh field MR imaging of a subconjunctival anti-glaucoma drug delivery system in a rabbit model
Grabow N
Scientific reports 2017; 7: 15780 (IGR: 19-2)

75519 Meibomian Gland Performance in Glaucomatous Patients With Long-term Instillation of IOP-lowering Medications
Lai YH
Journal of Glaucoma 2018; 27: 176-183 (IGR: 19-2)

75279 Self-Assembling Elastin-Like Hydrogels for Timolol Delivery: Development of an Ophthalmic Formulation Against Glaucoma
Arias FJ
Molecular pharmaceutics 2017; 14: 4498-4508 (IGR: 19-2)

75519 Meibomian Gland Performance in Glaucomatous Patients With Long-term Instillation of IOP-lowering Medications
Huang YT
Journal of Glaucoma 2018; 27: 176-183 (IGR: 19-2)

75280 Long-term intraocular pressure reduction with intracameral polycaprolactone glaucoma devices that deliver a novel anti-glaucoma agent
Mudumba S
Journal of Controlled Release 2018; 269: 45-51 (IGR: 19-2)

75326 Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
Calpena AC
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: (IGR: 19-2)

75226 Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress
Pasqualetti M
Cellular and Molecular Life Sciences 2018; 75: 1255-1267 (IGR: 19-2)

75322 Ultrahigh field MR imaging of a subconjunctival anti-glaucoma drug delivery system in a rabbit model
Stachs O
Scientific reports 2017; 7: 15780 (IGR: 19-2)

75280 Long-term intraocular pressure reduction with intracameral polycaprolactone glaucoma devices that deliver a novel anti-glaucoma agent
Bhisitkul RB
Journal of Controlled Release 2018; 269: 45-51 (IGR: 19-2)

75326 Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
Souto EMB
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: (IGR: 19-2)

75226 Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress
Dente L
Cellular and Molecular Life Sciences 2018; 75: 1255-1267 (IGR: 19-2)

75322 Ultrahigh field MR imaging of a subconjunctival anti-glaucoma drug delivery system in a rabbit model
Guthoff RF
Scientific reports 2017; 7: 15780 (IGR: 19-2)

75519 Meibomian Gland Performance in Glaucomatous Patients With Long-term Instillation of IOP-lowering Medications
Kuo MT
Journal of Glaucoma 2018; 27: 176-183 (IGR: 19-2)

75326 Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
Ravindran N
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: (IGR: 19-2)

75280 Long-term intraocular pressure reduction with intracameral polycaprolactone glaucoma devices that deliver a novel anti-glaucoma agent
Desai TA
Journal of Controlled Release 2018; 269: 45-51 (IGR: 19-2)

75226 Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress
Raffa V
Cellular and Molecular Life Sciences 2018; 75: 1255-1267 (IGR: 19-2)

75322 Ultrahigh field MR imaging of a subconjunctival anti-glaucoma drug delivery system in a rabbit model
Lindner T
Scientific reports 2017; 7: 15780 (IGR: 19-2)

75326 Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma
Ettcheto M; Camins A; García ML; Cordeiro MF
Small (Weinheim an der Bergstrasse, Germany) 2018; 14: (IGR: 19-2)

74426 Glaucoma: Biological Trabecular and Neuroretinal Pathology with Perspectives of Therapy Innovation and Preventive Diagnosis
Nuzzi R
Frontiers in neuroscience 2017; 11: 494 (IGR: 19-1)

74105 Poly(ε-caprolactone) nanocapsule carriers with sustained drug release: single dose for long-term glaucoma treatment
Lee CH
Nanoscale 2017; 9: 11754-11764 (IGR: 19-1)

74115 Application of Imaging Mass Spectrometry to Assess Ocular Drug Transit
Grove KJ
SLAS discovery : advancing life sciences R & D 2017; 22: 1239-1245 (IGR: 19-1)

74692 High-precision piezo-ejection ocular microdosing: Phase II study on local and systemic effects of topical phenylephrine
Ianchulev T
Therapeutic delivery 2018; 9: 17-27 (IGR: 19-1)

74176 Long Term Glaucoma Drug Delivery Using a Topically Retained Gel/Microsphere Eye Drop
Fedorchak MV
Scientific reports 2017; 7: 8639 (IGR: 19-1)

74394 Development and characterisation of electrospun timolol maleate-loaded polymeric contact lens coatings containing various permeation enhancers
Mehta P
International Journal of Pharmaceutics 2017; 532: 408-420 (IGR: 19-1)

74544 Co-instillation of nano-solid magnesium hydroxide enhances corneal permeability of dissolved timolol
Nagai N
Experimental Eye Research 2017; 165: 118-124 (IGR: 19-1)

74193 Pure Glaucoma Drugs Are Toxic to Immortalized Human Corneal Epithelial Cells, but They Do Not Destabilize Lipid Membranes
Robciuc A
Cornea 2017; 36: 1249-1255 (IGR: 19-1)

74581 Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications
Shen J
Clinical Ophthalmology 2017; 11: 1761-1767 (IGR: 19-1)

74625 Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits
Kawaguchi I
PLoS ONE 2017; 12: e0186714 (IGR: 19-1)

74675 Multidose Preservative Free Eyedrops by Selective Removal of Benzalkonium Chloride from Ocular Formulations
Hsu KH
Pharmaceutical Research 2017; 34: 2862-2872 (IGR: 19-1)

74789 Fast Dissolving Dendrimer Nanofiber Mats as Alternative to Eye Drops for More Efficient Antiglaucoma Drug Delivery
Lancina MG
ACS biomaterials science & engineering 2017; 3: 1861-1868 (IGR: 19-1)

74481 Dorzolamide nanoliposome as a long action ophthalmic delivery system in open angle glaucoma and ocular hypertension patients
Kouchak M
Drug Development and Industrial Pharmacy 2017; 0: 1-16 (IGR: 19-1)

74206 Evaluation of a photocrosslinkable hydroxyethyl chitosan hydrogel as a potential drug release system for glaucoma surgery
Qiao X
Journal of Materials Science: Materials in Medicine 2017; 28: 149 (IGR: 19-1)

74176 Long Term Glaucoma Drug Delivery Using a Topically Retained Gel/Microsphere Eye Drop
Conner IP
Scientific reports 2017; 7: 8639 (IGR: 19-1)

74203 Changes in Ocular Surface Characteristics after Switching from Benzalkonium Chloride-Preserved Latanoprost to Preservative-Free Tafluprost or Benzalkonium Chloride-Preserved Tafluprost
Kitaoka Y
Journal of Ophthalmology 2017; 2017: 3540749 (IGR: 19-1)

74789 Fast Dissolving Dendrimer Nanofiber Mats as Alternative to Eye Drops for More Efficient Antiglaucoma Drug Delivery
Singh S
ACS biomaterials science & engineering 2017; 3: 1861-1868 (IGR: 19-1)

74675 Multidose Preservative Free Eyedrops by Selective Removal of Benzalkonium Chloride from Ocular Formulations
Gupta K
Pharmaceutical Research 2017; 34: 2862-2872 (IGR: 19-1)

74692 High-precision piezo-ejection ocular microdosing: Phase II study on local and systemic effects of topical phenylephrine
Weinreb R
Therapeutic delivery 2018; 9: 17-27 (IGR: 19-1)

74544 Co-instillation of nano-solid magnesium hydroxide enhances corneal permeability of dissolved timolol
Ogata F
Experimental Eye Research 2017; 165: 118-124 (IGR: 19-1)

74625 Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits
Kobayashi A
PLoS ONE 2017; 12: e0186714 (IGR: 19-1)

74581 Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications
Goodkin ML
Clinical Ophthalmology 2017; 11: 1761-1767 (IGR: 19-1)

74481 Dorzolamide nanoliposome as a long action ophthalmic delivery system in open angle glaucoma and ocular hypertension patients
Malekahmadi M
Drug Development and Industrial Pharmacy 2017; 0: 1-16 (IGR: 19-1)

74426 Glaucoma: Biological Trabecular and Neuroretinal Pathology with Perspectives of Therapy Innovation and Preventive Diagnosis
Tridico F
Frontiers in neuroscience 2017; 11: 494 (IGR: 19-1)

74105 Poly(ε-caprolactone) nanocapsule carriers with sustained drug release: single dose for long-term glaucoma treatment
Li YJ
Nanoscale 2017; 9: 11754-11764 (IGR: 19-1)

74115 Application of Imaging Mass Spectrometry to Assess Ocular Drug Transit
Kansara V
SLAS discovery : advancing life sciences R & D 2017; 22: 1239-1245 (IGR: 19-1)

74206 Evaluation of a photocrosslinkable hydroxyethyl chitosan hydrogel as a potential drug release system for glaucoma surgery
Peng X
Journal of Materials Science: Materials in Medicine 2017; 28: 149 (IGR: 19-1)

74394 Development and characterisation of electrospun timolol maleate-loaded polymeric contact lens coatings containing various permeation enhancers
Al-Kinani AA
International Journal of Pharmaceutics 2017; 532: 408-420 (IGR: 19-1)

74193 Pure Glaucoma Drugs Are Toxic to Immortalized Human Corneal Epithelial Cells, but They Do Not Destabilize Lipid Membranes
Witos J
Cornea 2017; 36: 1249-1255 (IGR: 19-1)

74581 Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications
Tong W
Clinical Ophthalmology 2017; 11: 1761-1767 (IGR: 19-1)

74544 Co-instillation of nano-solid magnesium hydroxide enhances corneal permeability of dissolved timolol
Otake H
Experimental Eye Research 2017; 165: 118-124 (IGR: 19-1)

74625 Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits
Higashide T
PLoS ONE 2017; 12: e0186714 (IGR: 19-1)

74692 High-precision piezo-ejection ocular microdosing: Phase II study on local and systemic effects of topical phenylephrine
Tsai JC
Therapeutic delivery 2018; 9: 17-27 (IGR: 19-1)

74481 Dorzolamide nanoliposome as a long action ophthalmic delivery system in open angle glaucoma and ocular hypertension patients
Bavarsad N
Drug Development and Industrial Pharmacy 2017; 0: 1-16 (IGR: 19-1)

74105 Poly(ε-caprolactone) nanocapsule carriers with sustained drug release: single dose for long-term glaucoma treatment
Huang CC
Nanoscale 2017; 9: 11754-11764 (IGR: 19-1)

74206 Evaluation of a photocrosslinkable hydroxyethyl chitosan hydrogel as a potential drug release system for glaucoma surgery
Qiao J
Journal of Materials Science: Materials in Medicine 2017; 28: 149 (IGR: 19-1)

74789 Fast Dissolving Dendrimer Nanofiber Mats as Alternative to Eye Drops for More Efficient Antiglaucoma Drug Delivery
Kompella UB
ACS biomaterials science & engineering 2017; 3: 1861-1868 (IGR: 19-1)

74115 Application of Imaging Mass Spectrometry to Assess Ocular Drug Transit
Prentiss M
SLAS discovery : advancing life sciences R & D 2017; 22: 1239-1245 (IGR: 19-1)

74193 Pure Glaucoma Drugs Are Toxic to Immortalized Human Corneal Epithelial Cells, but They Do Not Destabilize Lipid Membranes
Ruokonen SK
Cornea 2017; 36: 1249-1255 (IGR: 19-1)

74394 Development and characterisation of electrospun timolol maleate-loaded polymeric contact lens coatings containing various permeation enhancers
Arshad MS
International Journal of Pharmaceutics 2017; 532: 408-420 (IGR: 19-1)

74203 Changes in Ocular Surface Characteristics after Switching from Benzalkonium Chloride-Preserved Latanoprost to Preservative-Free Tafluprost or Benzalkonium Chloride-Preserved Tafluprost
Matsuzawa A
Journal of Ophthalmology 2017; 2017: 3540749 (IGR: 19-1)

74675 Multidose Preservative Free Eyedrops by Selective Removal of Benzalkonium Chloride from Ocular Formulations
Nayaka H
Pharmaceutical Research 2017; 34: 2862-2872 (IGR: 19-1)

74176 Long Term Glaucoma Drug Delivery Using a Topically Retained Gel/Microsphere Eye Drop
Schuman JS
Scientific reports 2017; 7: 8639 (IGR: 19-1)

74789 Fast Dissolving Dendrimer Nanofiber Mats as Alternative to Eye Drops for More Efficient Antiglaucoma Drug Delivery
Husain S
ACS biomaterials science & engineering 2017; 3: 1861-1868 (IGR: 19-1)

74193 Pure Glaucoma Drugs Are Toxic to Immortalized Human Corneal Epithelial Cells, but They Do Not Destabilize Lipid Membranes
Rantamäki AH
Cornea 2017; 36: 1249-1255 (IGR: 19-1)

74394 Development and characterisation of electrospun timolol maleate-loaded polymeric contact lens coatings containing various permeation enhancers
Chang MW
International Journal of Pharmaceutics 2017; 532: 408-420 (IGR: 19-1)

74581 Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications
Attar M
Clinical Ophthalmology 2017; 11: 1761-1767 (IGR: 19-1)

74481 Dorzolamide nanoliposome as a long action ophthalmic delivery system in open angle glaucoma and ocular hypertension patients
Saki Malehi A
Drug Development and Industrial Pharmacy 2017; 0: 1-16 (IGR: 19-1)

74625 Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits
Takeji Y
PLoS ONE 2017; 12: e0186714 (IGR: 19-1)

74105 Poly(ε-caprolactone) nanocapsule carriers with sustained drug release: single dose for long-term glaucoma treatment
Lai JY
Nanoscale 2017; 9: 11754-11764 (IGR: 19-1)

74675 Multidose Preservative Free Eyedrops by Selective Removal of Benzalkonium Chloride from Ocular Formulations
Donthi A
Pharmaceutical Research 2017; 34: 2862-2872 (IGR: 19-1)

74692 High-precision piezo-ejection ocular microdosing: Phase II study on local and systemic effects of topical phenylephrine
Lin S
Therapeutic delivery 2018; 9: 17-27 (IGR: 19-1)

74115 Application of Imaging Mass Spectrometry to Assess Ocular Drug Transit
Long D
SLAS discovery : advancing life sciences R & D 2017; 22: 1239-1245 (IGR: 19-1)

74206 Evaluation of a photocrosslinkable hydroxyethyl chitosan hydrogel as a potential drug release system for glaucoma surgery
Jiang Z
Journal of Materials Science: Materials in Medicine 2017; 28: 149 (IGR: 19-1)

74176 Long Term Glaucoma Drug Delivery Using a Topically Retained Gel/Microsphere Eye Drop
Cugini A
Scientific reports 2017; 7: 8639 (IGR: 19-1)

74544 Co-instillation of nano-solid magnesium hydroxide enhances corneal permeability of dissolved timolol
Kawasaki N
Experimental Eye Research 2017; 165: 118-124 (IGR: 19-1)

74203 Changes in Ocular Surface Characteristics after Switching from Benzalkonium Chloride-Preserved Latanoprost to Preservative-Free Tafluprost or Benzalkonium Chloride-Preserved Tafluprost
Tsukamoto A
Journal of Ophthalmology 2017; 2017: 3540749 (IGR: 19-1)

74394 Development and characterisation of electrospun timolol maleate-loaded polymeric contact lens coatings containing various permeation enhancers
Alany RG
International Journal of Pharmaceutics 2017; 532: 408-420 (IGR: 19-1)

74203 Changes in Ocular Surface Characteristics after Switching from Benzalkonium Chloride-Preserved Latanoprost to Preservative-Free Tafluprost or Benzalkonium Chloride-Preserved Tafluprost
Sase K
Journal of Ophthalmology 2017; 2017: 3540749 (IGR: 19-1)

74115 Application of Imaging Mass Spectrometry to Assess Ocular Drug Transit
Mogi M
SLAS discovery : advancing life sciences R & D 2017; 22: 1239-1245 (IGR: 19-1)

74176 Long Term Glaucoma Drug Delivery Using a Topically Retained Gel/Microsphere Eye Drop
Little SR
Scientific reports 2017; 7: 8639 (IGR: 19-1)

74481 Dorzolamide nanoliposome as a long action ophthalmic delivery system in open angle glaucoma and ocular hypertension patients
Andishmand L
Drug Development and Industrial Pharmacy 2017; 0: 1-16 (IGR: 19-1)

74206 Evaluation of a photocrosslinkable hydroxyethyl chitosan hydrogel as a potential drug release system for glaucoma surgery
Han B
Journal of Materials Science: Materials in Medicine 2017; 28: 149 (IGR: 19-1)

74193 Pure Glaucoma Drugs Are Toxic to Immortalized Human Corneal Epithelial Cells, but They Do Not Destabilize Lipid Membranes
Pisella PJ
Cornea 2017; 36: 1249-1255 (IGR: 19-1)

74544 Co-instillation of nano-solid magnesium hydroxide enhances corneal permeability of dissolved timolol
Nakazawa Y
Experimental Eye Research 2017; 165: 118-124 (IGR: 19-1)

74625 Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits
Sakurai K
PLoS ONE 2017; 12: e0186714 (IGR: 19-1)

74789 Fast Dissolving Dendrimer Nanofiber Mats as Alternative to Eye Drops for More Efficient Antiglaucoma Drug Delivery
Yang H
ACS biomaterials science & engineering 2017; 3: 1861-1868 (IGR: 19-1)

74692 High-precision piezo-ejection ocular microdosing: Phase II study on local and systemic effects of topical phenylephrine
Pasquale LR
Therapeutic delivery 2018; 9: 17-27 (IGR: 19-1)

74675 Multidose Preservative Free Eyedrops by Selective Removal of Benzalkonium Chloride from Ocular Formulations
Kaul S; Chauhan A
Pharmaceutical Research 2017; 34: 2862-2872 (IGR: 19-1)

74544 Co-instillation of nano-solid magnesium hydroxide enhances corneal permeability of dissolved timolol
Kanai K
Experimental Eye Research 2017; 165: 118-124 (IGR: 19-1)

74193 Pure Glaucoma Drugs Are Toxic to Immortalized Human Corneal Epithelial Cells, but They Do Not Destabilize Lipid Membranes
Wiedmer SK
Cornea 2017; 36: 1249-1255 (IGR: 19-1)

74206 Evaluation of a photocrosslinkable hydroxyethyl chitosan hydrogel as a potential drug release system for glaucoma surgery
Yang C
Journal of Materials Science: Materials in Medicine 2017; 28: 149 (IGR: 19-1)

74394 Development and characterisation of electrospun timolol maleate-loaded polymeric contact lens coatings containing various permeation enhancers
Ahmad Z
International Journal of Pharmaceutics 2017; 532: 408-420 (IGR: 19-1)

74203 Changes in Ocular Surface Characteristics after Switching from Benzalkonium Chloride-Preserved Latanoprost to Preservative-Free Tafluprost or Benzalkonium Chloride-Preserved Tafluprost
Sakae S
Journal of Ophthalmology 2017; 2017: 3540749 (IGR: 19-1)

74115 Application of Imaging Mass Spectrometry to Assess Ocular Drug Transit
Kim S
SLAS discovery : advancing life sciences R & D 2017; 22: 1239-1245 (IGR: 19-1)

74625 Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits
Kawaguchi C
PLoS ONE 2017; 12: e0186714 (IGR: 19-1)

74206 Evaluation of a photocrosslinkable hydroxyethyl chitosan hydrogel as a potential drug release system for glaucoma surgery
Liu W
Journal of Materials Science: Materials in Medicine 2017; 28: 149 (IGR: 19-1)

74115 Application of Imaging Mass Spectrometry to Assess Ocular Drug Transit
Rudewicz PJ
SLAS discovery : advancing life sciences R & D 2017; 22: 1239-1245 (IGR: 19-1)

74625 Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits
Sugiyama K
PLoS ONE 2017; 12: e0186714 (IGR: 19-1)

74193 Pure Glaucoma Drugs Are Toxic to Immortalized Human Corneal Epithelial Cells, but They Do Not Destabilize Lipid Membranes
Holopainen JM
Cornea 2017; 36: 1249-1255 (IGR: 19-1)

74544 Co-instillation of nano-solid magnesium hydroxide enhances corneal permeability of dissolved timolol
Okamoto N
Experimental Eye Research 2017; 165: 118-124 (IGR: 19-1)

74203 Changes in Ocular Surface Characteristics after Switching from Benzalkonium Chloride-Preserved Latanoprost to Preservative-Free Tafluprost or Benzalkonium Chloride-Preserved Tafluprost
Takagi H
Journal of Ophthalmology 2017; 2017: 3540749 (IGR: 19-1)

74544 Co-instillation of nano-solid magnesium hydroxide enhances corneal permeability of dissolved timolol
Shimomura Y
Experimental Eye Research 2017; 165: 118-124 (IGR: 19-1)

72930 Ocular Surface and External Filtration Surgery: Mutual Relationships
Baudouin C
Developments in Ophthalmology 2017; 59: 67-79 (IGR: 18-4)

72896 Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation
Huang J
AAPS PharmSciTech 2017; 18: 2919-2926 (IGR: 18-4)

72720 Tear cytokine profile of glaucoma patients treated with preservative-free or preserved latanoprost
Martinez-de-la-Casa JM
Ocular Surface 2017; 15: 723-729 (IGR: 18-4)

72916 Pharmacokinetics and Safety of Travoprost 0.004% Ophthalmic Solution Preserved with Polyquad in Pediatric Patients with Glaucoma
Stahl E
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 361-365 (IGR: 18-4)

71955 Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part II - Ocular drug-loaded lipid nanoparticles
Sánchez-López E
European Journal of Pharmaceutics and Biopharmaceutics 2017; 110: 58-69 (IGR: 18-4)

72747 Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction
Muñoz Negrete FJ
Clinical Ophthalmology 2017; 11: 557-566 (IGR: 18-4)

73001 Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles: For efficient intra ocular pressure reduction
Natesan S
International Journal of Biological Macromolecules 2017; 104: 1837-1845 (IGR: 18-4)

72837 Evaluation of Ocular Surface Disease in Asian Patients with Primary Angle Closure
Ling TE
Open Ophthalmology Journal 2017; 11: 31-39 (IGR: 18-4)

72910 Nanoemulsion-based electrolyte triggered in situ gel for ocular delivery of acetazolamide
Morsi N
European Journal of Pharmaceutical Sciences 2017; 104: 302-314 (IGR: 18-4)

72967 Efficacy and tolerability of preservative-free 0.0015% tafluprost in glaucoma patients: a prospective crossover study
Lee W
BMC Ophthalmology 2017; 17: 61 (IGR: 18-4)

72828 Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability
Adelli GR
Investigative Ophthalmology and Visual Science 2017; 58: 2167-2179 (IGR: 18-4)

72633 Creation of nano eye-drops and effective drug delivery to the interior of the eye
Ikuta Y
Scientific reports 2017; 7: 44229 (IGR: 18-4)

73010 RES-loaded pegylated CS NPs: for efficient ocular delivery
Pandian S
IET nanobiotechnology 2017; 11: 32-39 (IGR: 18-4)

73056 Ocular surface disease in patients under topical treatment for glaucoma
Pérez-Bartolomé F
European Journal of Ophthalmology 2017; 0: 0 (IGR: 18-4)

72840 Predicted patient demand for a new delivery system for glaucoma medicine
Ozdemir S
Medicine 2017; 96: e6626 (IGR: 18-4)

73072 The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case
Battistini FD
European Journal of Pharmaceutical Sciences 2017; 105: 188-194 (IGR: 18-4)

72747 Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction
Lemij HG
Clinical Ophthalmology 2017; 11: 557-566 (IGR: 18-4)

72967 Efficacy and tolerability of preservative-free 0.0015% tafluprost in glaucoma patients: a prospective crossover study
Lee S
BMC Ophthalmology 2017; 17: 61 (IGR: 18-4)

72828 Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability
Bhagav P
Investigative Ophthalmology and Visual Science 2017; 58: 2167-2179 (IGR: 18-4)

72837 Evaluation of Ocular Surface Disease in Asian Patients with Primary Angle Closure
Othman K
Open Ophthalmology Journal 2017; 11: 31-39 (IGR: 18-4)

73072 The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case
Tártara LI
European Journal of Pharmaceutical Sciences 2017; 105: 188-194 (IGR: 18-4)

73010 RES-loaded pegylated CS NPs: for efficient ocular delivery
Jeevanesan V
IET nanobiotechnology 2017; 11: 32-39 (IGR: 18-4)

72633 Creation of nano eye-drops and effective drug delivery to the interior of the eye
Aoyagi S
Scientific reports 2017; 7: 44229 (IGR: 18-4)

73056 Ocular surface disease in patients under topical treatment for glaucoma
Martínez-de-la-Casa JM
European Journal of Ophthalmology 2017; 0: 0 (IGR: 18-4)

72916 Pharmacokinetics and Safety of Travoprost 0.004% Ophthalmic Solution Preserved with Polyquad in Pediatric Patients with Glaucoma
Bremond-Gignac D
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 361-365 (IGR: 18-4)

72840 Predicted patient demand for a new delivery system for glaucoma medicine
Wong TT
Medicine 2017; 96: e6626 (IGR: 18-4)

72910 Nanoemulsion-based electrolyte triggered in situ gel for ocular delivery of acetazolamide
Ibrahim M
European Journal of Pharmaceutical Sciences 2017; 104: 302-314 (IGR: 18-4)

72720 Tear cytokine profile of glaucoma patients treated with preservative-free or preserved latanoprost
Perez-Bartolome F
Ocular Surface 2017; 15: 723-729 (IGR: 18-4)

73001 Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles: For efficient intra ocular pressure reduction
Pandian S
International Journal of Biological Macromolecules 2017; 104: 1837-1845 (IGR: 18-4)

71955 Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part II - Ocular drug-loaded lipid nanoparticles
Espina M
European Journal of Pharmaceutics and Biopharmaceutics 2017; 110: 58-69 (IGR: 18-4)

72896 Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation
Peng T
AAPS PharmSciTech 2017; 18: 2919-2926 (IGR: 18-4)

72828 Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability
Taskar P
Investigative Ophthalmology and Visual Science 2017; 58: 2167-2179 (IGR: 18-4)

72837 Evaluation of Ocular Surface Disease in Asian Patients with Primary Angle Closure
Yan OP
Open Ophthalmology Journal 2017; 11: 31-39 (IGR: 18-4)

71955 Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part II - Ocular drug-loaded lipid nanoparticles
Doktorovova S
European Journal of Pharmaceutics and Biopharmaceutics 2017; 110: 58-69 (IGR: 18-4)

72910 Nanoemulsion-based electrolyte triggered in situ gel for ocular delivery of acetazolamide
Refai H
European Journal of Pharmaceutical Sciences 2017; 104: 302-314 (IGR: 18-4)

72720 Tear cytokine profile of glaucoma patients treated with preservative-free or preserved latanoprost
Urcelay E
Ocular Surface 2017; 15: 723-729 (IGR: 18-4)

72967 Efficacy and tolerability of preservative-free 0.0015% tafluprost in glaucoma patients: a prospective crossover study
Bae H
BMC Ophthalmology 2017; 17: 61 (IGR: 18-4)

72916 Pharmacokinetics and Safety of Travoprost 0.004% Ophthalmic Solution Preserved with Polyquad in Pediatric Patients with Glaucoma
Landry T
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 361-365 (IGR: 18-4)

73010 RES-loaded pegylated CS NPs: for efficient ocular delivery
Ponnusamy C
IET nanobiotechnology 2017; 11: 32-39 (IGR: 18-4)

72840 Predicted patient demand for a new delivery system for glaucoma medicine
Allingham RR
Medicine 2017; 96: e6626 (IGR: 18-4)

73001 Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles: For efficient intra ocular pressure reduction
Ponnusamy C
International Journal of Biological Macromolecules 2017; 104: 1837-1845 (IGR: 18-4)

72896 Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation
Li Y
AAPS PharmSciTech 2017; 18: 2919-2926 (IGR: 18-4)

73072 The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case
Boiero C
European Journal of Pharmaceutical Sciences 2017; 105: 188-194 (IGR: 18-4)

72747 Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction
Erb C
Clinical Ophthalmology 2017; 11: 557-566 (IGR: 18-4)

72633 Creation of nano eye-drops and effective drug delivery to the interior of the eye
Tanaka Y
Scientific reports 2017; 7: 44229 (IGR: 18-4)

73056 Ocular surface disease in patients under topical treatment for glaucoma
Arriola-Villalobos P
European Journal of Ophthalmology 2017; 0: 0 (IGR: 18-4)

73010 RES-loaded pegylated CS NPs: for efficient ocular delivery
Natesan S
IET nanobiotechnology 2017; 11: 32-39 (IGR: 18-4)

71955 Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part II - Ocular drug-loaded lipid nanoparticles
Souto EB
European Journal of Pharmaceutics and Biopharmaceutics 2017; 110: 58-69 (IGR: 18-4)

72910 Nanoemulsion-based electrolyte triggered in situ gel for ocular delivery of acetazolamide
El Sorogy H
European Journal of Pharmaceutical Sciences 2017; 104: 302-314 (IGR: 18-4)

72916 Pharmacokinetics and Safety of Travoprost 0.004% Ophthalmic Solution Preserved with Polyquad in Pediatric Patients with Glaucoma
Curtis M
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 361-365 (IGR: 18-4)

73001 Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles: For efficient intra ocular pressure reduction
Palanichamy R
International Journal of Biological Macromolecules 2017; 104: 1837-1845 (IGR: 18-4)

72840 Predicted patient demand for a new delivery system for glaucoma medicine
Finkelstein EA
Medicine 2017; 96: e6626 (IGR: 18-4)

73056 Ocular surface disease in patients under topical treatment for glaucoma
Fernández-Pérez C
European Journal of Ophthalmology 2017; 0: 0 (IGR: 18-4)

73072 The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case
Guzmán ML
European Journal of Pharmaceutical Sciences 2017; 105: 188-194 (IGR: 18-4)

72896 Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation
Zhan Z
AAPS PharmSciTech 2017; 18: 2919-2926 (IGR: 18-4)

72720 Tear cytokine profile of glaucoma patients treated with preservative-free or preserved latanoprost
Santiago JL
Ocular Surface 2017; 15: 723-729 (IGR: 18-4)

72967 Efficacy and tolerability of preservative-free 0.0015% tafluprost in glaucoma patients: a prospective crossover study
Kim CY
BMC Ophthalmology 2017; 17: 61 (IGR: 18-4)

72828 Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability
Hingorani T
Investigative Ophthalmology and Visual Science 2017; 58: 2167-2179 (IGR: 18-4)

72837 Evaluation of Ocular Surface Disease in Asian Patients with Primary Angle Closure
Rashid RA
Open Ophthalmology Journal 2017; 11: 31-39 (IGR: 18-4)

72633 Creation of nano eye-drops and effective drug delivery to the interior of the eye
Sato K
Scientific reports 2017; 7: 44229 (IGR: 18-4)

73072 The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case
Luciani-Giaccobbe LC
European Journal of Pharmaceutical Sciences 2017; 105: 188-194 (IGR: 18-4)

72633 Creation of nano eye-drops and effective drug delivery to the interior of the eye
Inada S
Scientific reports 2017; 7: 44229 (IGR: 18-4)

72720 Tear cytokine profile of glaucoma patients treated with preservative-free or preserved latanoprost
Moreno-Montañes J
Ocular Surface 2017; 15: 723-729 (IGR: 18-4)

73056 Ocular surface disease in patients under topical treatment for glaucoma
Polo V
European Journal of Ophthalmology 2017; 0: 0 (IGR: 18-4)

72828 Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability
Pettaway S
Investigative Ophthalmology and Visual Science 2017; 58: 2167-2179 (IGR: 18-4)

72967 Efficacy and tolerability of preservative-free 0.0015% tafluprost in glaucoma patients: a prospective crossover study
Seong GJ
BMC Ophthalmology 2017; 17: 61 (IGR: 18-4)

72916 Pharmacokinetics and Safety of Travoprost 0.004% Ophthalmic Solution Preserved with Polyquad in Pediatric Patients with Glaucoma
Gedif K
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 361-365 (IGR: 18-4)

71955 Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part II - Ocular drug-loaded lipid nanoparticles
García ML
European Journal of Pharmaceutics and Biopharmaceutics 2017; 110: 58-69 (IGR: 18-4)

73001 Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles: For efficient intra ocular pressure reduction
Muthusamy S
International Journal of Biological Macromolecules 2017; 104: 1837-1845 (IGR: 18-4)

72837 Evaluation of Ocular Surface Disease in Asian Patients with Primary Angle Closure
Tet CM
Open Ophthalmology Journal 2017; 11: 31-39 (IGR: 18-4)

72896 Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation
Zeng Y
AAPS PharmSciTech 2017; 18: 2919-2926 (IGR: 18-4)

72916 Pharmacokinetics and Safety of Travoprost 0.004% Ophthalmic Solution Preserved with Polyquad in Pediatric Patients with Glaucoma
Al Shahwan S
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 361-365 (IGR: 18-4)

73001 Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles: For efficient intra ocular pressure reduction
Kandasamy R
International Journal of Biological Macromolecules 2017; 104: 1837-1845 (IGR: 18-4)

73056 Ocular surface disease in patients under topical treatment for glaucoma
García-Feijoó J
European Journal of Ophthalmology 2017; 0: 0 (IGR: 18-4)

73072 The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case
Palma SD
European Journal of Pharmaceutical Sciences 2017; 105: 188-194 (IGR: 18-4)

72837 Evaluation of Ocular Surface Disease in Asian Patients with Primary Angle Closure
Yaakob A
Open Ophthalmology Journal 2017; 11: 31-39 (IGR: 18-4)

72896 Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation
Huang Y
AAPS PharmSciTech 2017; 18: 2919-2926 (IGR: 18-4)

72720 Tear cytokine profile of glaucoma patients treated with preservative-free or preserved latanoprost
Arriola-Villalobos P
Ocular Surface 2017; 15: 723-729 (IGR: 18-4)

72633 Creation of nano eye-drops and effective drug delivery to the interior of the eye
Koseki Y
Scientific reports 2017; 7: 44229 (IGR: 18-4)

72828 Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability
Gul W; Elsohly MA
Investigative Ophthalmology and Visual Science 2017; 58: 2167-2179 (IGR: 18-4)

73072 The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case
Allemandi DA
European Journal of Pharmaceutical Sciences 2017; 105: 188-194 (IGR: 18-4)

72896 Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation
Pan X
AAPS PharmSciTech 2017; 18: 2919-2926 (IGR: 18-4)

72633 Creation of nano eye-drops and effective drug delivery to the interior of the eye
Onodera T
Scientific reports 2017; 7: 44229 (IGR: 18-4)

72837 Evaluation of Ocular Surface Disease in Asian Patients with Primary Angle Closure
Tajudin LA
Open Ophthalmology Journal 2017; 11: 31-39 (IGR: 18-4)

72720 Tear cytokine profile of glaucoma patients treated with preservative-free or preserved latanoprost
Benitez-del-Castillo JM
Ocular Surface 2017; 15: 723-729 (IGR: 18-4)

72916 Pharmacokinetics and Safety of Travoprost 0.004% Ophthalmic Solution Preserved with Polyquad in Pediatric Patients with Glaucoma
Dixon ER
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 361-365 (IGR: 18-4)

72720 Tear cytokine profile of glaucoma patients treated with preservative-free or preserved latanoprost
Garcia-Feijoo J
Ocular Surface 2017; 15: 723-729 (IGR: 18-4)

72828 Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability
Repka MA
Investigative Ophthalmology and Visual Science 2017; 58: 2167-2179 (IGR: 18-4)

72896 Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation
Wu CY
AAPS PharmSciTech 2017; 18: 2919-2926 (IGR: 18-4)

73072 The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case
Manzo RH
European Journal of Pharmaceutical Sciences 2017; 105: 188-194 (IGR: 18-4)

72633 Creation of nano eye-drops and effective drug delivery to the interior of the eye
Oikawa H
Scientific reports 2017; 7: 44229 (IGR: 18-4)

72896 Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation
Wu C
AAPS PharmSciTech 2017; 18: 2919-2926 (IGR: 18-4)

72633 Creation of nano eye-drops and effective drug delivery to the interior of the eye
Kasai H
Scientific reports 2017; 7: 44229 (IGR: 18-4)

73072 The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case
Olivera ME
European Journal of Pharmaceutical Sciences 2017; 105: 188-194 (IGR: 18-4)

72828 Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability
Majumdar S
Investigative Ophthalmology and Visual Science 2017; 58: 2167-2179 (IGR: 18-4)

71551 The physical properties of generic latanoprost ophthalmic solutions are not identical
Kolko M
Acta Ophthalmologica 2017; 95: 370-373 (IGR: 18-3)

71521 Effect of benzalkonium chloride on trabecular meshwork cells in a new in vitro 3D trabecular meshwork model for glaucoma
Bouchemi M
Toxicology in Vitro 2017; 41: 21-29 (IGR: 18-3)

71240 An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degeneration
Zhao L
Journal of Controlled Release 2017; 247: 153-166 (IGR: 18-3)

71529 Topical medication instillation techniques for glaucoma
Xu L
Cochrane Database of Systematic Reviews 2017; 2: CD010520 (IGR: 18-3)

71542 Localized and Controlled Delivery of Nitric Oxide to the Conventional Outflow Pathway via Enzyme Biocatalysis: Toward Therapy for Glaucoma
Chandrawati R
Advanced materials (Deerfield Beach, Fla.) 2017; 29: (IGR: 18-3)

71478 In vivo Pharmacological Evaluations of Pilocarpine-Loaded Antioxidant-Functionalized Biodegradable Thermogels in Glaucomatous Rabbits
Chou SF
Scientific reports 2017; 7: 42344 (IGR: 18-3)

71287 Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies
Mandal A
Journal of Controlled Release 2017; 248: 96-116 (IGR: 18-3)

71417 Optimizing novel penetration enhancing hybridized vesicles for augmenting the in-vivo effect of an anti-glaucoma drug
Naguib SS
Drug Delivery 2017; 24: 99-108 (IGR: 18-3)

71499 Efficacy and safety of preoperative IOP reduction using a preservative-free fixed combination of dorzolamide/timolol eye drops versus oral acetazolamide and dexamethasone eye drops and assessment of the clinical outcome of trabeculectomy in glaucoma
Lorenz K
PLoS ONE 2017; 12: e0171636 (IGR: 18-3)

71292 Chitosan-g-poly(N-isopropylacrylamide) copolymers as delivery carriers for intracameral pilocarpine administration
Lai JY
European Journal of Pharmaceutics and Biopharmaceutics 2017; 113: 140-148 (IGR: 18-3)

71633 Six month delivery of gdnf from plga/vitamin e biodegradable microspheres after intravitreal injection in rabbits
García-Caballero C
European Journal of Pharmaceutical Sciences 2017; 103: 19-26 (IGR: 18-3)

71548 PLGA Nanoparticles as Subconjunctival Injection for Management of Glaucoma
Salama HA
AAPS PharmSciTech 2017; 18: 2517-2528 (IGR: 18-3)

71498 Sustained Release of Brimonidine from a New Composite Drug Delivery System for Treatment of Glaucoma
Sun J
ACS applied materials & interfaces 2017; 9: 7990-7999 (IGR: 18-3)

71526 Enhanced Ocular Efficacy of Topically-delivered Dorzolamide with Nanostructured Mucoadhesive Microparticles
Park CG
International Journal of Pharmaceutics 2017; 522: 66-73 (IGR: 18-3)

71312 Sustained-Release Delivery System of a Slow Hydrogen Sulfide Donor, GYY 4137, for Potential Application in Glaucoma
Patil A
AAPS PharmSciTech 2017; 18: 2291-2302 (IGR: 18-3)

71416 Nimodipine Ophthalmic Formulations for Management of Glaucoma
Maria DN
Pharmaceutical Research 2017; 34: 809-824 (IGR: 18-3)

71240 An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degeneration
Chen G
Journal of Controlled Release 2017; 247: 153-166 (IGR: 18-3)

71312 Sustained-Release Delivery System of a Slow Hydrogen Sulfide Donor, GYY 4137, for Potential Application in Glaucoma
Singh S
AAPS PharmSciTech 2017; 18: 2291-2302 (IGR: 18-3)

71416 Nimodipine Ophthalmic Formulations for Management of Glaucoma
Abd-Elgawad AH
Pharmaceutical Research 2017; 34: 809-824 (IGR: 18-3)

71478 In vivo Pharmacological Evaluations of Pilocarpine-Loaded Antioxidant-Functionalized Biodegradable Thermogels in Glaucomatous Rabbits
Luo LJ
Scientific reports 2017; 7: 42344 (IGR: 18-3)

71542 Localized and Controlled Delivery of Nitric Oxide to the Conventional Outflow Pathway via Enzyme Biocatalysis: Toward Therapy for Glaucoma
Chang JY
Advanced materials (Deerfield Beach, Fla.) 2017; 29: (IGR: 18-3)

71417 Optimizing novel penetration enhancing hybridized vesicles for augmenting the in-vivo effect of an anti-glaucoma drug
Hathout RM
Drug Delivery 2017; 24: 99-108 (IGR: 18-3)

71551 The physical properties of generic latanoprost ophthalmic solutions are not identical
Koch Jensen P
Acta Ophthalmologica 2017; 95: 370-373 (IGR: 18-3)

71548 PLGA Nanoparticles as Subconjunctival Injection for Management of Glaucoma
Ghorab M
AAPS PharmSciTech 2017; 18: 2517-2528 (IGR: 18-3)

71526 Enhanced Ocular Efficacy of Topically-delivered Dorzolamide with Nanostructured Mucoadhesive Microparticles
Kim YK
International Journal of Pharmaceutics 2017; 522: 66-73 (IGR: 18-3)

71292 Chitosan-g-poly(N-isopropylacrylamide) copolymers as delivery carriers for intracameral pilocarpine administration
Luo LJ
European Journal of Pharmaceutics and Biopharmaceutics 2017; 113: 140-148 (IGR: 18-3)

71633 Six month delivery of gdnf from plga/vitamin e biodegradable microspheres after intravitreal injection in rabbits
Prieto-Calvo E
European Journal of Pharmaceutical Sciences 2017; 103: 19-26 (IGR: 18-3)

71498 Sustained Release of Brimonidine from a New Composite Drug Delivery System for Treatment of Glaucoma
Lei Y
ACS applied materials & interfaces 2017; 9: 7990-7999 (IGR: 18-3)

71521 Effect of benzalkonium chloride on trabecular meshwork cells in a new in vitro 3D trabecular meshwork model for glaucoma
Roubeix C
Toxicology in Vitro 2017; 41: 21-29 (IGR: 18-3)

71529 Topical medication instillation techniques for glaucoma
Wang X
Cochrane Database of Systematic Reviews 2017; 2: CD010520 (IGR: 18-3)

71499 Efficacy and safety of preoperative IOP reduction using a preservative-free fixed combination of dorzolamide/timolol eye drops versus oral acetazolamide and dexamethasone eye drops and assessment of the clinical outcome of trabeculectomy in glaucoma
Wasielica-Poslednik J
PLoS ONE 2017; 12: e0171636 (IGR: 18-3)

71287 Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies
Bisht R
Journal of Controlled Release 2017; 248: 96-116 (IGR: 18-3)

71417 Optimizing novel penetration enhancing hybridized vesicles for augmenting the in-vivo effect of an anti-glaucoma drug
Mansour S
Drug Delivery 2017; 24: 99-108 (IGR: 18-3)

71548 PLGA Nanoparticles as Subconjunctival Injection for Management of Glaucoma
Mahmoud AA
AAPS PharmSciTech 2017; 18: 2517-2528 (IGR: 18-3)

71529 Topical medication instillation techniques for glaucoma
Wu M
Cochrane Database of Systematic Reviews 2017; 2: CD010520 (IGR: 18-3)

71287 Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies
Rupenthal ID
Journal of Controlled Release 2017; 248: 96-116 (IGR: 18-3)

71498 Sustained Release of Brimonidine from a New Composite Drug Delivery System for Treatment of Glaucoma
Dai Z
ACS applied materials & interfaces 2017; 9: 7990-7999 (IGR: 18-3)

71240 An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degeneration
Li J
Journal of Controlled Release 2017; 247: 153-166 (IGR: 18-3)

71526 Enhanced Ocular Efficacy of Topically-delivered Dorzolamide with Nanostructured Mucoadhesive Microparticles
Kim SN
International Journal of Pharmaceutics 2017; 522: 66-73 (IGR: 18-3)

71312 Sustained-Release Delivery System of a Slow Hydrogen Sulfide Donor, GYY 4137, for Potential Application in Glaucoma
Opere C
AAPS PharmSciTech 2017; 18: 2291-2302 (IGR: 18-3)

71416 Nimodipine Ophthalmic Formulations for Management of Glaucoma
Soliman OA
Pharmaceutical Research 2017; 34: 809-824 (IGR: 18-3)

71542 Localized and Controlled Delivery of Nitric Oxide to the Conventional Outflow Pathway via Enzyme Biocatalysis: Toward Therapy for Glaucoma
Reina-Torres E
Advanced materials (Deerfield Beach, Fla.) 2017; 29: (IGR: 18-3)

71478 In vivo Pharmacological Evaluations of Pilocarpine-Loaded Antioxidant-Functionalized Biodegradable Thermogels in Glaucomatous Rabbits
Lai JY
Scientific reports 2017; 7: 42344 (IGR: 18-3)

71521 Effect of benzalkonium chloride on trabecular meshwork cells in a new in vitro 3D trabecular meshwork model for glaucoma
Kessal K
Toxicology in Vitro 2017; 41: 21-29 (IGR: 18-3)

71633 Six month delivery of gdnf from plga/vitamin e biodegradable microspheres after intravitreal injection in rabbits
Checa-Casalengua P
European Journal of Pharmaceutical Sciences 2017; 103: 19-26 (IGR: 18-3)

71542 Localized and Controlled Delivery of Nitric Oxide to the Conventional Outflow Pathway via Enzyme Biocatalysis: Toward Therapy for Glaucoma
Jumeaux C
Advanced materials (Deerfield Beach, Fla.) 2017; 29: (IGR: 18-3)

71499 Efficacy and safety of preoperative IOP reduction using a preservative-free fixed combination of dorzolamide/timolol eye drops versus oral acetazolamide and dexamethasone eye drops and assessment of the clinical outcome of trabeculectomy in glaucoma
Renieri G
PLoS ONE 2017; 12: e0171636 (IGR: 18-3)

71312 Sustained-Release Delivery System of a Slow Hydrogen Sulfide Donor, GYY 4137, for Potential Application in Glaucoma
Dash A
AAPS PharmSciTech 2017; 18: 2291-2302 (IGR: 18-3)

71633 Six month delivery of gdnf from plga/vitamin e biodegradable microspheres after intravitreal injection in rabbits
García-Martín E
European Journal of Pharmaceutical Sciences 2017; 103: 19-26 (IGR: 18-3)

71416 Nimodipine Ophthalmic Formulations for Management of Glaucoma
El-Dahan MS
Pharmaceutical Research 2017; 34: 809-824 (IGR: 18-3)

71548 PLGA Nanoparticles as Subconjunctival Injection for Management of Glaucoma
Abdel Hady M
AAPS PharmSciTech 2017; 18: 2517-2528 (IGR: 18-3)

71287 Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies
Mitra AK
Journal of Controlled Release 2017; 248: 96-116 (IGR: 18-3)

71498 Sustained Release of Brimonidine from a New Composite Drug Delivery System for Treatment of Glaucoma
Liu X
ACS applied materials & interfaces 2017; 9: 7990-7999 (IGR: 18-3)

71521 Effect of benzalkonium chloride on trabecular meshwork cells in a new in vitro 3D trabecular meshwork model for glaucoma
Riancho L
Toxicology in Vitro 2017; 41: 21-29 (IGR: 18-3)

71240 An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degeneration
Fu Y
Journal of Controlled Release 2017; 247: 153-166 (IGR: 18-3)

71526 Enhanced Ocular Efficacy of Topically-delivered Dorzolamide with Nanostructured Mucoadhesive Microparticles
Lee SH
International Journal of Pharmaceutics 2017; 522: 66-73 (IGR: 18-3)

71416 Nimodipine Ophthalmic Formulations for Management of Glaucoma
Jablonski MM
Pharmaceutical Research 2017; 34: 809-824 (IGR: 18-3)

71542 Localized and Controlled Delivery of Nitric Oxide to the Conventional Outflow Pathway via Enzyme Biocatalysis: Toward Therapy for Glaucoma
Sherwood JM
Advanced materials (Deerfield Beach, Fla.) 2017; 29: (IGR: 18-3)

71499 Efficacy and safety of preoperative IOP reduction using a preservative-free fixed combination of dorzolamide/timolol eye drops versus oral acetazolamide and dexamethasone eye drops and assessment of the clinical outcome of trabeculectomy in glaucoma
Keicher A
PLoS ONE 2017; 12: e0171636 (IGR: 18-3)

71498 Sustained Release of Brimonidine from a New Composite Drug Delivery System for Treatment of Glaucoma
Huang T
ACS applied materials & interfaces 2017; 9: 7990-7999 (IGR: 18-3)

71526 Enhanced Ocular Efficacy of Topically-delivered Dorzolamide with Nanostructured Mucoadhesive Microparticles
Huh BK
International Journal of Pharmaceutics 2017; 522: 66-73 (IGR: 18-3)

71521 Effect of benzalkonium chloride on trabecular meshwork cells in a new in vitro 3D trabecular meshwork model for glaucoma
Raveu AL
Toxicology in Vitro 2017; 41: 21-29 (IGR: 18-3)

71240 An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degeneration
Mavlyutov TA
Journal of Controlled Release 2017; 247: 153-166 (IGR: 18-3)

71633 Six month delivery of gdnf from plga/vitamin e biodegradable microspheres after intravitreal injection in rabbits
Polo-Llorens V
European Journal of Pharmaceutical Sciences 2017; 103: 19-26 (IGR: 18-3)

71526 Enhanced Ocular Efficacy of Topically-delivered Dorzolamide with Nanostructured Mucoadhesive Microparticles
Park MA
International Journal of Pharmaceutics 2017; 522: 66-73 (IGR: 18-3)

71240 An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degeneration
Yao A
Journal of Controlled Release 2017; 247: 153-166 (IGR: 18-3)

71521 Effect of benzalkonium chloride on trabecular meshwork cells in a new in vitro 3D trabecular meshwork model for glaucoma
Soualmia H
Toxicology in Vitro 2017; 41: 21-29 (IGR: 18-3)

71498 Sustained Release of Brimonidine from a New Composite Drug Delivery System for Treatment of Glaucoma
Wu J
ACS applied materials & interfaces 2017; 9: 7990-7999 (IGR: 18-3)

71633 Six month delivery of gdnf from plga/vitamin e biodegradable microspheres after intravitreal injection in rabbits
García-Feijoo J
European Journal of Pharmaceutical Sciences 2017; 103: 19-26 (IGR: 18-3)

71499 Efficacy and safety of preoperative IOP reduction using a preservative-free fixed combination of dorzolamide/timolol eye drops versus oral acetazolamide and dexamethasone eye drops and assessment of the clinical outcome of trabeculectomy in glaucoma
Ruckes C
PLoS ONE 2017; 12: e0171636 (IGR: 18-3)

71542 Localized and Controlled Delivery of Nitric Oxide to the Conventional Outflow Pathway via Enzyme Biocatalysis: Toward Therapy for Glaucoma
Stamer WD
Advanced materials (Deerfield Beach, Fla.) 2017; 29: (IGR: 18-3)

71526 Enhanced Ocular Efficacy of Topically-delivered Dorzolamide with Nanostructured Mucoadhesive Microparticles
Won H
International Journal of Pharmaceutics 2017; 522: 66-73 (IGR: 18-3)

71498 Sustained Release of Brimonidine from a New Composite Drug Delivery System for Treatment of Glaucoma
Xu ZP
ACS applied materials & interfaces 2017; 9: 7990-7999 (IGR: 18-3)

71633 Six month delivery of gdnf from plga/vitamin e biodegradable microspheres after intravitreal injection in rabbits
Molina-Martínez IT
European Journal of Pharmaceutical Sciences 2017; 103: 19-26 (IGR: 18-3)

71499 Efficacy and safety of preoperative IOP reduction using a preservative-free fixed combination of dorzolamide/timolol eye drops versus oral acetazolamide and dexamethasone eye drops and assessment of the clinical outcome of trabeculectomy in glaucoma
Pfeiffer N
PLoS ONE 2017; 12: e0171636 (IGR: 18-3)

71521 Effect of benzalkonium chloride on trabecular meshwork cells in a new in vitro 3D trabecular meshwork model for glaucoma
Baudouin C
Toxicology in Vitro 2017; 41: 21-29 (IGR: 18-3)

71240 An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degeneration
Nickells RW
Journal of Controlled Release 2017; 247: 153-166 (IGR: 18-3)

71542 Localized and Controlled Delivery of Nitric Oxide to the Conventional Outflow Pathway via Enzyme Biocatalysis: Toward Therapy for Glaucoma
Zelikin AN
Advanced materials (Deerfield Beach, Fla.) 2017; 29: (IGR: 18-3)

71633 Six month delivery of gdnf from plga/vitamin e biodegradable microspheres after intravitreal injection in rabbits
Bravo-Osuna I
European Journal of Pharmaceutical Sciences 2017; 103: 19-26 (IGR: 18-3)

71521 Effect of benzalkonium chloride on trabecular meshwork cells in a new in vitro 3D trabecular meshwork model for glaucoma
Brignole-Baudouin F
Toxicology in Vitro 2017; 41: 21-29 (IGR: 18-3)

71526 Enhanced Ocular Efficacy of Topically-delivered Dorzolamide with Nanostructured Mucoadhesive Microparticles
Park KH
International Journal of Pharmaceutics 2017; 522: 66-73 (IGR: 18-3)

71498 Sustained Release of Brimonidine from a New Composite Drug Delivery System for Treatment of Glaucoma
Sun X
ACS applied materials & interfaces 2017; 9: 7990-7999 (IGR: 18-3)

71240 An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degeneration
Gong S
Journal of Controlled Release 2017; 247: 153-166 (IGR: 18-3)

71542 Localized and Controlled Delivery of Nitric Oxide to the Conventional Outflow Pathway via Enzyme Biocatalysis: Toward Therapy for Glaucoma
Overby DR
Advanced materials (Deerfield Beach, Fla.) 2017; 29: (IGR: 18-3)

71499 Efficacy and safety of preoperative IOP reduction using a preservative-free fixed combination of dorzolamide/timolol eye drops versus oral acetazolamide and dexamethasone eye drops and assessment of the clinical outcome of trabeculectomy in glaucoma
Thieme H
PLoS ONE 2017; 12: e0171636 (IGR: 18-3)

71240 An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degeneration
Guo LW
Journal of Controlled Release 2017; 247: 153-166 (IGR: 18-3)

71633 Six month delivery of gdnf from plga/vitamin e biodegradable microspheres after intravitreal injection in rabbits
Herrero-Vanrell R
European Journal of Pharmaceutical Sciences 2017; 103: 19-26 (IGR: 18-3)

71542 Localized and Controlled Delivery of Nitric Oxide to the Conventional Outflow Pathway via Enzyme Biocatalysis: Toward Therapy for Glaucoma
Stevens MM
Advanced materials (Deerfield Beach, Fla.) 2017; 29: (IGR: 18-3)

71526 Enhanced Ocular Efficacy of Topically-delivered Dorzolamide with Nanostructured Mucoadhesive Microparticles
Choy YB
International Journal of Pharmaceutics 2017; 522: 66-73 (IGR: 18-3)

70581 Ocular Surface Evaluation in Patients Treated with Prostaglandin Analogues Considering Preservative Agent
Mlčáková E
?eska a Slovenska Oftalmologie 2016; 72: 120-127 (IGR: 18-2)

70243 Drug-Loaded Nanoparticles Embedded in a Biomembrane Provide a Dual-Release Mechanism for Drug Delivery to the Eye
Sharma M
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 565-573 (IGR: 18-2)

70135 Latanoprost-Eluting Contact Lenses in Glaucomatous Monkeys
Ciolino JB
Ophthalmology 2016; 123: 2085-2092 (IGR: 18-2)

70011 Evaluation of Physical Properties of Generic and Branded Travoprost Formulations
Wadhwani M
Journal of Current Glaucoma Practice 2016; 10: 49-55 (IGR: 18-2)

70827 Aids for Eye Drop Administration
Davies I
Survey of Ophthalmology 2016; 0: (IGR: 18-2)

70467 Efficacy and tolerability of benzalkonium chloride-free travoprost in glaucoma patients switched from benzalkonium chloride-preserved latanoprost or bimatoprost
García-Feijoo J
Clinical Ophthalmology 2016; 10: 2085-2091 (IGR: 18-2)

70194 Long-Term Subconjunctival Delivery of Brimonidine Tartrate for Glaucoma Treatment Using a Microspheres/Carrier System
Pek YS
Advanced healthcare materials 2016; 5: 2823-2831 (IGR: 18-2)

69937 Association Between Corneal Endothelial Cell Density and Topical Glaucoma Medication Use in an Eye Bank Donor Population
Kwon JW
Cornea 2016; 0: (IGR: 18-2)

70097 Natural Compounds and Neuroprotection: Mechanisms of Action and Novel Delivery Systems
Bagli E
In vivo (Athens, Greece) 2016; 30: 535-547 (IGR: 18-2)

70273 Tear Lipid Layer Thickness Change and Topical Anti-Glaucoma Medication Use
Lee SY
Optometry and Vision Science 2016; 93: 1210-1217 (IGR: 18-2)

69991 Novel Polymeric Nanoparticles Intended for Ophthalmic Administration of Acetazolamide
Quinteros DA
Journal of Pharmaceutical Sciences 2016; 105: 3183-3190 (IGR: 18-2)

70780 A novel nanoparticles impregnated ocular insert for enhanced bioavailability to posterior segment of eye: In vitro, in vivo and stability studies
Rathod LV
Materials science & engineering. C, Materials for biological applications 2017; 71: 529-540 (IGR: 18-2)

70355 Pharmacodynamic profile of mydriatic agents delivered by ocular piezo-ejection microdosing compared with conventional eyedropper
Ianchulev T
Therapeutic delivery 2016; 7: 751-760 (IGR: 18-2)

70100 Unpreserved latanoprost in the treatment of open-angle glaucoma and ocular hypertension. A multicenter, randomized, controlled study
Denis P
Journal Fran�ais d'Ophtalmologie 2016; 39: 622-630 (IGR: 18-2)

70665 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monothe
Konstas AG
Advances in Therapy 2017; 34: 221-235 (IGR: 18-2)

70278 Preservative-free bimatoprost 0.03% in patients with primary open-angle glaucoma or ocular hypertension in clinical practice
Pillunat LE
Clinical Ophthalmology 2016; 10: 1759-1765 (IGR: 18-2)

70283 Ocular Drug Delivery through pHEMA-Hydrogel Contact Lenses Co-Loaded with Lipophilic Vitamins
Lee D
Scientific reports 2016; 6: 34194 (IGR: 18-2)

70071 Squeeze Me if You Can: Variability in Force Requirements to Extract a Drop From Common Glaucoma Bottles
Moore DB
Journal of Glaucoma 2016; 25: 780-784 (IGR: 18-2)

70528 Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection
Lavik E
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 642-649 (IGR: 18-2)

70392 Sustained drug delivery for glaucoma: current data and future trends
Aref AA
Current Opinions in Ophthalmology 2017; 28: 169-174 (IGR: 18-2)

70532 Nanoparticle Modified Drug Loaded Biodegradable Polymeric Contact Lenses For Sustainable Ocular Drug Delivery
Dhesingh RS
Current Drug Delivery 2016; 0: (IGR: 18-2)

70269 Extended wear therapeutic contact lens fabricated from timolol imprinted carboxymethyl chitosan-g-hydroxy ethyl methacrylate-g-poly acrylamide as a onetime medication for glaucoma
Anirudhan TS
European Journal of Pharmaceutics and Biopharmaceutics 2016; 109: 61-71 (IGR: 18-2)

70828 Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results from a Phase I/II Clinical Trial
Lewis RA
American Journal of Ophthalmology 2017; 175: 137-147 (IGR: 18-2)

70794 Bottle Characteristics of Topical International Glaucoma Medications versus Local Brands in Saudi Arabia
Al-Jumaian N
Middle East African Journal of Ophthalmology 2016; 23: 296-301 (IGR: 18-2)

70665 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monothe
Boboridis KG
Advances in Therapy 2017; 34: 221-235 (IGR: 18-2)

70100 Unpreserved latanoprost in the treatment of open-angle glaucoma and ocular hypertension. A multicenter, randomized, controlled study

Journal Fran�ais d'Ophtalmologie 2016; 39: 622-630 (IGR: 18-2)

70794 Bottle Characteristics of Topical International Glaucoma Medications versus Local Brands in Saudi Arabia
Malik R
Middle East African Journal of Ophthalmology 2016; 23: 296-301 (IGR: 18-2)

70283 Ocular Drug Delivery through pHEMA-Hydrogel Contact Lenses Co-Loaded with Lipophilic Vitamins
Cho S
Scientific reports 2016; 6: 34194 (IGR: 18-2)

70528 Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection
Kuehn MH
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 642-649 (IGR: 18-2)

70532 Nanoparticle Modified Drug Loaded Biodegradable Polymeric Contact Lenses For Sustainable Ocular Drug Delivery
Prakash M
Current Drug Delivery 2016; 0: (IGR: 18-2)

70269 Extended wear therapeutic contact lens fabricated from timolol imprinted carboxymethyl chitosan-g-hydroxy ethyl methacrylate-g-poly acrylamide as a onetime medication for glaucoma
Nair AS
European Journal of Pharmaceutics and Biopharmaceutics 2016; 109: 61-71 (IGR: 18-2)

70355 Pharmacodynamic profile of mydriatic agents delivered by ocular piezo-ejection microdosing compared with conventional eyedropper
Chayet A
Therapeutic delivery 2016; 7: 751-760 (IGR: 18-2)

70135 Latanoprost-Eluting Contact Lenses in Glaucomatous Monkeys
Ross AE
Ophthalmology 2016; 123: 2085-2092 (IGR: 18-2)

70243 Drug-Loaded Nanoparticles Embedded in a Biomembrane Provide a Dual-Release Mechanism for Drug Delivery to the Eye
Bhowmick R
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 565-573 (IGR: 18-2)

70828 Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results from a Phase I/II Clinical Trial
Christie WC
American Journal of Ophthalmology 2017; 175: 137-147 (IGR: 18-2)

70581 Ocular Surface Evaluation in Patients Treated with Prostaglandin Analogues Considering Preservative Agent
Mlčák P
?eska a Slovenska Oftalmologie 2016; 72: 120-127 (IGR: 18-2)

70273 Tear Lipid Layer Thickness Change and Topical Anti-Glaucoma Medication Use
Lee H
Optometry and Vision Science 2016; 93: 1210-1217 (IGR: 18-2)

69991 Novel Polymeric Nanoparticles Intended for Ophthalmic Administration of Acetazolamide
Ferreira LM
Journal of Pharmaceutical Sciences 2016; 105: 3183-3190 (IGR: 18-2)

70780 A novel nanoparticles impregnated ocular insert for enhanced bioavailability to posterior segment of eye: In vitro, in vivo and stability studies
Kapadia R
Materials science & engineering. C, Materials for biological applications 2017; 71: 529-540 (IGR: 18-2)

70011 Evaluation of Physical Properties of Generic and Branded Travoprost Formulations
Mishra SK
Journal of Current Glaucoma Practice 2016; 10: 49-55 (IGR: 18-2)

70071 Squeeze Me if You Can: Variability in Force Requirements to Extract a Drop From Common Glaucoma Bottles
Hammer JD
Journal of Glaucoma 2016; 25: 780-784 (IGR: 18-2)

70097 Natural Compounds and Neuroprotection: Mechanisms of Action and Novel Delivery Systems
Goussia A
In vivo (Athens, Greece) 2016; 30: 535-547 (IGR: 18-2)

70194 Long-Term Subconjunctival Delivery of Brimonidine Tartrate for Glaucoma Treatment Using a Microspheres/Carrier System
Wu H
Advanced healthcare materials 2016; 5: 2823-2831 (IGR: 18-2)

69937 Association Between Corneal Endothelial Cell Density and Topical Glaucoma Medication Use in an Eye Bank Donor Population
Rand GM
Cornea 2016; 0: (IGR: 18-2)

70827 Aids for Eye Drop Administration
Williams AM
Survey of Ophthalmology 2016; 0: (IGR: 18-2)

70467 Efficacy and tolerability of benzalkonium chloride-free travoprost in glaucoma patients switched from benzalkonium chloride-preserved latanoprost or bimatoprost
Muñoz-Negrete FJ
Clinical Ophthalmology 2016; 10: 2085-2091 (IGR: 18-2)

70278 Preservative-free bimatoprost 0.03% in patients with primary open-angle glaucoma or ocular hypertension in clinical practice
Eschstruth P
Clinical Ophthalmology 2016; 10: 1759-1765 (IGR: 18-2)

70283 Ocular Drug Delivery through pHEMA-Hydrogel Contact Lenses Co-Loaded with Lipophilic Vitamins
Park HS
Scientific reports 2016; 6: 34194 (IGR: 18-2)

70071 Squeeze Me if You Can: Variability in Force Requirements to Extract a Drop From Common Glaucoma Bottles
Akhtari R
Journal of Glaucoma 2016; 25: 780-784 (IGR: 18-2)

70355 Pharmacodynamic profile of mydriatic agents delivered by ocular piezo-ejection microdosing compared with conventional eyedropper
Kahook M
Therapeutic delivery 2016; 7: 751-760 (IGR: 18-2)

70528 Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection
Shoffstall AJ
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 642-649 (IGR: 18-2)

69991 Novel Polymeric Nanoparticles Intended for Ophthalmic Administration of Acetazolamide
Schaffazick SR
Journal of Pharmaceutical Sciences 2016; 105: 3183-3190 (IGR: 18-2)

70780 A novel nanoparticles impregnated ocular insert for enhanced bioavailability to posterior segment of eye: In vitro, in vivo and stability studies
Sawant KK
Materials science & engineering. C, Materials for biological applications 2017; 71: 529-540 (IGR: 18-2)

70278 Preservative-free bimatoprost 0.03% in patients with primary open-angle glaucoma or ocular hypertension in clinical practice
Häsemeyer S
Clinical Ophthalmology 2016; 10: 1759-1765 (IGR: 18-2)

70581 Ocular Surface Evaluation in Patients Treated with Prostaglandin Analogues Considering Preservative Agent
Karhanová M
?eska a Slovenska Oftalmologie 2016; 72: 120-127 (IGR: 18-2)

70269 Extended wear therapeutic contact lens fabricated from timolol imprinted carboxymethyl chitosan-g-hydroxy ethyl methacrylate-g-poly acrylamide as a onetime medication for glaucoma
Parvathy J
European Journal of Pharmaceutics and Biopharmaceutics 2016; 109: 61-71 (IGR: 18-2)

70135 Latanoprost-Eluting Contact Lenses in Glaucomatous Monkeys
Tulsan R
Ophthalmology 2016; 123: 2085-2092 (IGR: 18-2)

70243 Drug-Loaded Nanoparticles Embedded in a Biomembrane Provide a Dual-Release Mechanism for Drug Delivery to the Eye
Gappa-Fahlenkamp H
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 565-573 (IGR: 18-2)

70011 Evaluation of Physical Properties of Generic and Branded Travoprost Formulations
Angmo D
Journal of Current Glaucoma Practice 2016; 10: 49-55 (IGR: 18-2)

70827 Aids for Eye Drop Administration
Muir KW
Survey of Ophthalmology 2016; 0: (IGR: 18-2)

70194 Long-Term Subconjunctival Delivery of Brimonidine Tartrate for Glaucoma Treatment Using a Microspheres/Carrier System
Mohamed ST
Advanced healthcare materials 2016; 5: 2823-2831 (IGR: 18-2)

70097 Natural Compounds and Neuroprotection: Mechanisms of Action and Novel Delivery Systems
Moschos MM
In vivo (Athens, Greece) 2016; 30: 535-547 (IGR: 18-2)

69937 Association Between Corneal Endothelial Cell Density and Topical Glaucoma Medication Use in an Eye Bank Donor Population
Cho KJ
Cornea 2016; 0: (IGR: 18-2)

70828 Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results from a Phase I/II Clinical Trial
Day DG
American Journal of Ophthalmology 2017; 175: 137-147 (IGR: 18-2)

70467 Efficacy and tolerability of benzalkonium chloride-free travoprost in glaucoma patients switched from benzalkonium chloride-preserved latanoprost or bimatoprost
Hubatsch DA
Clinical Ophthalmology 2016; 10: 2085-2091 (IGR: 18-2)

70665 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monothe
Kapis P
Advances in Therapy 2017; 34: 221-235 (IGR: 18-2)

70273 Tear Lipid Layer Thickness Change and Topical Anti-Glaucoma Medication Use
Bae HW
Optometry and Vision Science 2016; 93: 1210-1217 (IGR: 18-2)

70794 Bottle Characteristics of Topical International Glaucoma Medications versus Local Brands in Saudi Arabia
Khandekar R
Middle East African Journal of Ophthalmology 2016; 23: 296-301 (IGR: 18-2)

70097 Natural Compounds and Neuroprotection: Mechanisms of Action and Novel Delivery Systems
Agnantis N
In vivo (Athens, Greece) 2016; 30: 535-547 (IGR: 18-2)

70135 Latanoprost-Eluting Contact Lenses in Glaucomatous Monkeys
Watts AC
Ophthalmology 2016; 123: 2085-2092 (IGR: 18-2)

69937 Association Between Corneal Endothelial Cell Density and Topical Glaucoma Medication Use in an Eye Bank Donor Population
Gore PK
Cornea 2016; 0: (IGR: 18-2)

70273 Tear Lipid Layer Thickness Change and Topical Anti-Glaucoma Medication Use
Kim TI
Optometry and Vision Science 2016; 93: 1210-1217 (IGR: 18-2)

70794 Bottle Characteristics of Topical International Glaucoma Medications versus Local Brands in Saudi Arabia
Al-Humaidan A
Middle East African Journal of Ophthalmology 2016; 23: 296-301 (IGR: 18-2)

69991 Novel Polymeric Nanoparticles Intended for Ophthalmic Administration of Acetazolamide
Palma SD
Journal of Pharmaceutical Sciences 2016; 105: 3183-3190 (IGR: 18-2)

70278 Preservative-free bimatoprost 0.03% in patients with primary open-angle glaucoma or ocular hypertension in clinical practice
Thelen U
Clinical Ophthalmology 2016; 10: 1759-1765 (IGR: 18-2)

70071 Squeeze Me if You Can: Variability in Force Requirements to Extract a Drop From Common Glaucoma Bottles
Beck J
Journal of Glaucoma 2016; 25: 780-784 (IGR: 18-2)

70528 Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection
Atkins K
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 642-649 (IGR: 18-2)

70581 Ocular Surface Evaluation in Patients Treated with Prostaglandin Analogues Considering Preservative Agent
Langová K
?eska a Slovenska Oftalmologie 2016; 72: 120-127 (IGR: 18-2)

70828 Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results from a Phase I/II Clinical Trial
Craven ER
American Journal of Ophthalmology 2017; 175: 137-147 (IGR: 18-2)

70467 Efficacy and tolerability of benzalkonium chloride-free travoprost in glaucoma patients switched from benzalkonium chloride-preserved latanoprost or bimatoprost
Rossi GC
Clinical Ophthalmology 2016; 10: 2085-2091 (IGR: 18-2)

70665 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monothe
Marinopoulos K
Advances in Therapy 2017; 34: 221-235 (IGR: 18-2)

70283 Ocular Drug Delivery through pHEMA-Hydrogel Contact Lenses Co-Loaded with Lipophilic Vitamins
Kwon I
Scientific reports 2016; 6: 34194 (IGR: 18-2)

70011 Evaluation of Physical Properties of Generic and Branded Travoprost Formulations
Velpandian T
Journal of Current Glaucoma Practice 2016; 10: 49-55 (IGR: 18-2)

70355 Pharmacodynamic profile of mydriatic agents delivered by ocular piezo-ejection microdosing compared with conventional eyedropper
Packer M
Therapeutic delivery 2016; 7: 751-760 (IGR: 18-2)

70194 Long-Term Subconjunctival Delivery of Brimonidine Tartrate for Glaucoma Treatment Using a Microspheres/Carrier System
Ying JY
Advanced healthcare materials 2016; 5: 2823-2831 (IGR: 18-2)

70828 Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results from a Phase I/II Clinical Trial
Walters T
American Journal of Ophthalmology 2017; 175: 137-147 (IGR: 18-2)

70071 Squeeze Me if You Can: Variability in Force Requirements to Extract a Drop From Common Glaucoma Bottles
Sanders S
Journal of Glaucoma 2016; 25: 780-784 (IGR: 18-2)

70355 Pharmacodynamic profile of mydriatic agents delivered by ocular piezo-ejection microdosing compared with conventional eyedropper
Pasquale L
Therapeutic delivery 2016; 7: 751-760 (IGR: 18-2)

70665 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monothe
Voudouragkaki IC
Advances in Therapy 2017; 34: 221-235 (IGR: 18-2)

70278 Preservative-free bimatoprost 0.03% in patients with primary open-angle glaucoma or ocular hypertension in clinical practice
Foja C
Clinical Ophthalmology 2016; 10: 1759-1765 (IGR: 18-2)

69991 Novel Polymeric Nanoparticles Intended for Ophthalmic Administration of Acetazolamide
Allemandi DA
Journal of Pharmaceutical Sciences 2016; 105: 3183-3190 (IGR: 18-2)

70011 Evaluation of Physical Properties of Generic and Branded Travoprost Formulations
Sihota R
Journal of Current Glaucoma Practice 2016; 10: 49-55 (IGR: 18-2)

70794 Bottle Characteristics of Topical International Glaucoma Medications versus Local Brands in Saudi Arabia
Al-Madany R
Middle East African Journal of Ophthalmology 2016; 23: 296-301 (IGR: 18-2)

70528 Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection
Dumitrescu AV
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 642-649 (IGR: 18-2)

70097 Natural Compounds and Neuroprotection: Mechanisms of Action and Novel Delivery Systems
Kitsos G
In vivo (Athens, Greece) 2016; 30: 535-547 (IGR: 18-2)

70135 Latanoprost-Eluting Contact Lenses in Glaucomatous Monkeys
Wang RF
Ophthalmology 2016; 123: 2085-2092 (IGR: 18-2)

70581 Ocular Surface Evaluation in Patients Treated with Prostaglandin Analogues Considering Preservative Agent
Marešová K
?eska a Slovenska Oftalmologie 2016; 72: 120-127 (IGR: 18-2)

69937 Association Between Corneal Endothelial Cell Density and Topical Glaucoma Medication Use in an Eye Bank Donor Population
McCartney MD
Cornea 2016; 0: (IGR: 18-2)

70273 Tear Lipid Layer Thickness Change and Topical Anti-Glaucoma Medication Use
Kim CY
Optometry and Vision Science 2016; 93: 1210-1217 (IGR: 18-2)

70528 Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection
Kwon YH
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 642-649 (IGR: 18-2)

70355 Pharmacodynamic profile of mydriatic agents delivered by ocular piezo-ejection microdosing compared with conventional eyedropper
Weinreb RN
Therapeutic delivery 2016; 7: 751-760 (IGR: 18-2)

70794 Bottle Characteristics of Topical International Glaucoma Medications versus Local Brands in Saudi Arabia
Al-Qahtani R
Middle East African Journal of Ophthalmology 2016; 23: 296-301 (IGR: 18-2)

69937 Association Between Corneal Endothelial Cell Density and Topical Glaucoma Medication Use in an Eye Bank Donor Population
Chuck RS
Cornea 2016; 0: (IGR: 18-2)

70071 Squeeze Me if You Can: Variability in Force Requirements to Extract a Drop From Common Glaucoma Bottles
Kryscio RJ
Journal of Glaucoma 2016; 25: 780-784 (IGR: 18-2)

70135 Latanoprost-Eluting Contact Lenses in Glaucomatous Monkeys
Zurakowski D
Ophthalmology 2016; 123: 2085-2092 (IGR: 18-2)

70278 Preservative-free bimatoprost 0.03% in patients with primary open-angle glaucoma or ocular hypertension in clinical practice
Leaback R
Clinical Ophthalmology 2016; 10: 1759-1765 (IGR: 18-2)

70011 Evaluation of Physical Properties of Generic and Branded Travoprost Formulations
Kotnala A
Journal of Current Glaucoma Practice 2016; 10: 49-55 (IGR: 18-2)

70828 Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results from a Phase I/II Clinical Trial
Bejanian M
American Journal of Ophthalmology 2017; 175: 137-147 (IGR: 18-2)

69991 Novel Polymeric Nanoparticles Intended for Ophthalmic Administration of Acetazolamide
Cruz L
Journal of Pharmaceutical Sciences 2016; 105: 3183-3190 (IGR: 18-2)

70665 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monothe
Panayiotou D
Advances in Therapy 2017; 34: 221-235 (IGR: 18-2)

70135 Latanoprost-Eluting Contact Lenses in Glaucomatous Monkeys
Serle JB
Ophthalmology 2016; 123: 2085-2092 (IGR: 18-2)

70828 Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results from a Phase I/II Clinical Trial
Lee SS
American Journal of Ophthalmology 2017; 175: 137-147 (IGR: 18-2)

70665 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monothe
Mikropoulos DG
Advances in Therapy 2017; 34: 221-235 (IGR: 18-2)

70278 Preservative-free bimatoprost 0.03% in patients with primary open-angle glaucoma or ocular hypertension in clinical practice
Pfennigsdorf S
Clinical Ophthalmology 2016; 10: 1759-1765 (IGR: 18-2)

70794 Bottle Characteristics of Topical International Glaucoma Medications versus Local Brands in Saudi Arabia
Altowairqi A
Middle East African Journal of Ophthalmology 2016; 23: 296-301 (IGR: 18-2)

70011 Evaluation of Physical Properties of Generic and Branded Travoprost Formulations
Bhartiya S
Journal of Current Glaucoma Practice 2016; 10: 49-55 (IGR: 18-2)

70794 Bottle Characteristics of Topical International Glaucoma Medications versus Local Brands in Saudi Arabia
Al-Theeb A
Middle East African Journal of Ophthalmology 2016; 23: 296-301 (IGR: 18-2)

70665 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monothe
Pagkalidou E
Advances in Therapy 2017; 34: 221-235 (IGR: 18-2)

70011 Evaluation of Physical Properties of Generic and Branded Travoprost Formulations
Dada T
Journal of Current Glaucoma Practice 2016; 10: 49-55 (IGR: 18-2)

70828 Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results from a Phase I/II Clinical Trial
Goodkin ML
American Journal of Ophthalmology 2017; 175: 137-147 (IGR: 18-2)

70135 Latanoprost-Eluting Contact Lenses in Glaucomatous Monkeys
Kohane DS
Ophthalmology 2016; 123: 2085-2092 (IGR: 18-2)

70828 Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results from a Phase I/II Clinical Trial
Zhang J
American Journal of Ophthalmology 2017; 175: 137-147 (IGR: 18-2)

70794 Bottle Characteristics of Topical International Glaucoma Medications versus Local Brands in Saudi Arabia
Zaman B
Middle East African Journal of Ophthalmology 2016; 23: 296-301 (IGR: 18-2)

70665 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monothe
Haidich AB
Advances in Therapy 2017; 34: 221-235 (IGR: 18-2)

70794 Bottle Characteristics of Topical International Glaucoma Medications versus Local Brands in Saudi Arabia
Al-Djasim L
Middle East African Journal of Ophthalmology 2016; 23: 296-301 (IGR: 18-2)

70828 Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results from a Phase I/II Clinical Trial
Whitcup SM
American Journal of Ophthalmology 2017; 175: 137-147 (IGR: 18-2)

70665 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monothe
Katsanos A; Quaranta L
Advances in Therapy 2017; 34: 221-235 (IGR: 18-2)

70828 Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results from a Phase I/II Clinical Trial
Robinson MR
American Journal of Ophthalmology 2017; 175: 137-147 (IGR: 18-2)

70794 Bottle Characteristics of Topical International Glaucoma Medications versus Local Brands in Saudi Arabia
Craven ER; Edward DP
Middle East African Journal of Ophthalmology 2016; 23: 296-301 (IGR: 18-2)

70828 Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results from a Phase I/II Clinical Trial

American Journal of Ophthalmology 2017; 175: 137-147 (IGR: 18-2)

69485 Biocompatibility and Pharmacokinetic Analysis of an Intracameral Polycaprolactone Drug Delivery Implant for Glaucoma
Kim J
Investigative Ophthalmology and Visual Science 2016; 57: 4341-4346 (IGR: 18-1)

69273 Acute cytotoxic effects of marketed ophthalmic formulations on human corneal epithelial cells
Hakkarainen JJ
International Journal of Pharmaceutics 2016; 511: 73-78 (IGR: 18-1)

69141 Long-term topical application of preservative-free prostaglandin analogues evokes macrophage infiltration in the ocular adnexa
Trzeciecka A
European Journal of Pharmacology 2016; 788: 12-20 (IGR: 18-1)

69483 An upright eyedrop bottle: accuracy, usage of excess drops, and contamination compared to a conventional bottle
Davies IJ
Clinical Ophthalmology 2016; 10: 1411-1417 (IGR: 18-1)

68922 Six-Month Intraocular Pressure Reduction with a Topical Bimatoprost Ocular Insert: Results of a Phase II Randomized Controlled Study
Brandt JD
Ophthalmology 2016; 123: 1685-1694 (IGR: 18-1)

69173 Ultrasound-mediated ocular delivery of therapeutic agents: a review
Lafond M
Expert Opinion on Drug Delivery 2016; 0: 1-12 (IGR: 18-1)

68870 Delivery of steroids into the eye for the treatment of macular edema
Hadayer A
Expert Opinion on Drug Delivery 2016; 13: 1083-1091 (IGR: 18-1)

69203 Evaluation of physical properties and dose equivalency of generic versus branded latanoprost formulations
Angmo D
International Ophthalmology 2017; 37: 423-428 (IGR: 18-1)

69172 Preservative-free versus preserved latanoprost eye drops in patients with open-angle glaucoma or ocular hypertension
Aptel F
Current Medical Research and Opinion 2016; 32: 1457-1463 (IGR: 18-1)

68930 Thermosensitive hexanoyl glycol chitosan-based ocular delivery system for glaucoma therapy
Cho IS
Acta biomaterialia 2016; 39: 124-132 (IGR: 18-1)

69143 Preservative-free tafluprost in the treatment of open-angle glaucoma or ocular hypertension in India: a phase III clinical trial
Chabi A
International Journal of Clinical Pract 2016; 70: 577-586 (IGR: 18-1)

69207 Subconjunctival Delivery of Dorzolamide-Loaded Poly(ether-anhydride) Microparticles Produces Sustained Lowering of Intraocular Pressure in Rabbits
Fu J
Molecular pharmaceutics 2016; 13: 2987-2995 (IGR: 18-1)

69107 Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma
Walimbe T
Clinical Ophthalmology 2016; 10: 821-827 (IGR: 18-1)

68883 Preservative-free tafluprost/timolol fixed combination: a new opportunity in the treatment of glaucoma
Konstas AG
Expert Opinion in Pharmacotherapy 2016; 17: 1271-1283 (IGR: 18-1)

69193 Assessment of alkoxylphenacyl-based polycarbonates as a potential platform for controlled delivery of a model anti-glaucoma drug
Manickavasagam D
European Journal of Pharmaceutics and Biopharmaceutics 2016; 107: 56-66 (IGR: 18-1)

69181 Investigation of Diffusion Characteristics through Microfluidic Channels for Passive Drug Delivery Applications
Goudie MJ
Journal of Drug Delivery 2016; 2016: 7913616 (IGR: 18-1)

68870 Delivery of steroids into the eye for the treatment of macular edema
Schaal S
Expert Opinion on Drug Delivery 2016; 13: 1083-1091 (IGR: 18-1)

69203 Evaluation of physical properties and dose equivalency of generic versus branded latanoprost formulations
Wadhwani M
International Ophthalmology 2017; 37: 423-428 (IGR: 18-1)

68930 Thermosensitive hexanoyl glycol chitosan-based ocular delivery system for glaucoma therapy
Park CG
Acta biomaterialia 2016; 39: 124-132 (IGR: 18-1)

69193 Assessment of alkoxylphenacyl-based polycarbonates as a potential platform for controlled delivery of a model anti-glaucoma drug
Wehrung D
European Journal of Pharmaceutics and Biopharmaceutics 2016; 107: 56-66 (IGR: 18-1)

69172 Preservative-free versus preserved latanoprost eye drops in patients with open-angle glaucoma or ocular hypertension
Choudhry R
Current Medical Research and Opinion 2016; 32: 1457-1463 (IGR: 18-1)

69181 Investigation of Diffusion Characteristics through Microfluidic Channels for Passive Drug Delivery Applications
Ghuman AP
Journal of Drug Delivery 2016; 2016: 7913616 (IGR: 18-1)

69207 Subconjunctival Delivery of Dorzolamide-Loaded Poly(ether-anhydride) Microparticles Produces Sustained Lowering of Intraocular Pressure in Rabbits
Sun F
Molecular pharmaceutics 2016; 13: 2987-2995 (IGR: 18-1)

68883 Preservative-free tafluprost/timolol fixed combination: a new opportunity in the treatment of glaucoma
HollÃ³ G
Expert Opinion in Pharmacotherapy 2016; 17: 1271-1283 (IGR: 18-1)

69273 Acute cytotoxic effects of marketed ophthalmic formulations on human corneal epithelial cells
Reinisalo M
International Journal of Pharmaceutics 2016; 511: 73-78 (IGR: 18-1)

68922 Six-Month Intraocular Pressure Reduction with a Topical Bimatoprost Ocular Insert: Results of a Phase II Randomized Controlled Study
Sall K
Ophthalmology 2016; 123: 1685-1694 (IGR: 18-1)

69483 An upright eyedrop bottle: accuracy, usage of excess drops, and contamination compared to a conventional bottle
Brown NH
Clinical Ophthalmology 2016; 10: 1411-1417 (IGR: 18-1)

69485 Biocompatibility and Pharmacokinetic Analysis of an Intracameral Polycaprolactone Drug Delivery Implant for Glaucoma
Kudisch M
Investigative Ophthalmology and Visual Science 2016; 57: 4341-4346 (IGR: 18-1)

69107 Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma
Chelerkar V
Clinical Ophthalmology 2016; 10: 821-827 (IGR: 18-1)

69141 Long-term topical application of preservative-free prostaglandin analogues evokes macrophage infiltration in the ocular adnexa
Paterno JJ
European Journal of Pharmacology 2016; 788: 12-20 (IGR: 18-1)

69143 Preservative-free tafluprost in the treatment of open-angle glaucoma or ocular hypertension in India: a phase III clinical trial
Baranak C
International Journal of Clinical Pract 2016; 70: 577-586 (IGR: 18-1)

69173 Ultrasound-mediated ocular delivery of therapeutic agents: a review
Aptel F
Expert Opinion on Drug Delivery 2016; 0: 1-12 (IGR: 18-1)

69173 Ultrasound-mediated ocular delivery of therapeutic agents: a review
Mestas JL
Expert Opinion on Drug Delivery 2016; 0: 1-12 (IGR: 18-1)

69193 Assessment of alkoxylphenacyl-based polycarbonates as a potential platform for controlled delivery of a model anti-glaucoma drug
Chamsaz EA
European Journal of Pharmaceutics and Biopharmaceutics 2016; 107: 56-66 (IGR: 18-1)

69203 Evaluation of physical properties and dose equivalency of generic versus branded latanoprost formulations
Velpandian T
International Ophthalmology 2017; 37: 423-428 (IGR: 18-1)

69107 Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma
Bhagat P
Clinical Ophthalmology 2016; 10: 821-827 (IGR: 18-1)

69143 Preservative-free tafluprost in the treatment of open-angle glaucoma or ocular hypertension in India: a phase III clinical trial
Lupinacci R
International Journal of Clinical Pract 2016; 70: 577-586 (IGR: 18-1)

69483 An upright eyedrop bottle: accuracy, usage of excess drops, and contamination compared to a conventional bottle
Wen JC
Clinical Ophthalmology 2016; 10: 1411-1417 (IGR: 18-1)

69181 Investigation of Diffusion Characteristics through Microfluidic Channels for Passive Drug Delivery Applications
Collins SB
Journal of Drug Delivery 2016; 2016: 7913616 (IGR: 18-1)

69485 Biocompatibility and Pharmacokinetic Analysis of an Intracameral Polycaprolactone Drug Delivery Implant for Glaucoma
Mudumba S
Investigative Ophthalmology and Visual Science 2016; 57: 4341-4346 (IGR: 18-1)

69141 Long-term topical application of preservative-free prostaglandin analogues evokes macrophage infiltration in the ocular adnexa
Toropainen E
European Journal of Pharmacology 2016; 788: 12-20 (IGR: 18-1)

69172 Preservative-free versus preserved latanoprost eye drops in patients with open-angle glaucoma or ocular hypertension
Stalmans I
Current Medical Research and Opinion 2016; 32: 1457-1463 (IGR: 18-1)

69273 Acute cytotoxic effects of marketed ophthalmic formulations on human corneal epithelial cells
Ragauskas S
International Journal of Pharmaceutics 2016; 511: 73-78 (IGR: 18-1)

68930 Thermosensitive hexanoyl glycol chitosan-based ocular delivery system for glaucoma therapy
Huh BK
Acta biomaterialia 2016; 39: 124-132 (IGR: 18-1)

68922 Six-Month Intraocular Pressure Reduction with a Topical Bimatoprost Ocular Insert: Results of a Phase II Randomized Controlled Study
DuBiner H
Ophthalmology 2016; 123: 1685-1694 (IGR: 18-1)

69207 Subconjunctival Delivery of Dorzolamide-Loaded Poly(ether-anhydride) Microparticles Produces Sustained Lowering of Intraocular Pressure in Rabbits
Liu W
Molecular pharmaceutics 2016; 13: 2987-2995 (IGR: 18-1)

69143 Preservative-free tafluprost in the treatment of open-angle glaucoma or ocular hypertension in India: a phase III clinical trial
Herring WJ
International Journal of Clinical Pract 2016; 70: 577-586 (IGR: 18-1)

68922 Six-Month Intraocular Pressure Reduction with a Topical Bimatoprost Ocular Insert: Results of a Phase II Randomized Controlled Study
Benza R
Ophthalmology 2016; 123: 1685-1694 (IGR: 18-1)

68930 Thermosensitive hexanoyl glycol chitosan-based ocular delivery system for glaucoma therapy
Cho MO
Acta biomaterialia 2016; 39: 124-132 (IGR: 18-1)

69207 Subconjunctival Delivery of Dorzolamide-Loaded Poly(ether-anhydride) Microparticles Produces Sustained Lowering of Intraocular Pressure in Rabbits
Liu Y
Molecular pharmaceutics 2016; 13: 2987-2995 (IGR: 18-1)

69273 Acute cytotoxic effects of marketed ophthalmic formulations on human corneal epithelial cells
SeppÃ¤nen A
International Journal of Pharmaceutics 2016; 511: 73-78 (IGR: 18-1)

69193 Assessment of alkoxylphenacyl-based polycarbonates as a potential platform for controlled delivery of a model anti-glaucoma drug
Sanders M
European Journal of Pharmaceutics and Biopharmaceutics 2016; 107: 56-66 (IGR: 18-1)

69107 Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma
Joshi A
Clinical Ophthalmology 2016; 10: 821-827 (IGR: 18-1)

69483 An upright eyedrop bottle: accuracy, usage of excess drops, and contamination compared to a conventional bottle
Stinnett SS
Clinical Ophthalmology 2016; 10: 1411-1417 (IGR: 18-1)

69173 Ultrasound-mediated ocular delivery of therapeutic agents: a review
Lafon C
Expert Opinion on Drug Delivery 2016; 0: 1-12 (IGR: 18-1)

69141 Long-term topical application of preservative-free prostaglandin analogues evokes macrophage infiltration in the ocular adnexa
Koskela A
European Journal of Pharmacology 2016; 788: 12-20 (IGR: 18-1)

69181 Investigation of Diffusion Characteristics through Microfluidic Channels for Passive Drug Delivery Applications
Pidaparti RM
Journal of Drug Delivery 2016; 2016: 7913616 (IGR: 18-1)

69203 Evaluation of physical properties and dose equivalency of generic versus branded latanoprost formulations
Kotnal A
International Ophthalmology 2017; 37: 423-428 (IGR: 18-1)

69485 Biocompatibility and Pharmacokinetic Analysis of an Intracameral Polycaprolactone Drug Delivery Implant for Glaucoma
Asada H
Investigative Ophthalmology and Visual Science 2016; 57: 4341-4346 (IGR: 18-1)

69207 Subconjunctival Delivery of Dorzolamide-Loaded Poly(ether-anhydride) Microparticles Produces Sustained Lowering of Intraocular Pressure in Rabbits
Gedam M
Molecular pharmaceutics 2016; 13: 2987-2995 (IGR: 18-1)

69193 Assessment of alkoxylphenacyl-based polycarbonates as a potential platform for controlled delivery of a model anti-glaucoma drug
Bouhenni R
European Journal of Pharmaceutics and Biopharmaceutics 2016; 107: 56-66 (IGR: 18-1)

68930 Thermosensitive hexanoyl glycol chitosan-based ocular delivery system for glaucoma therapy
Khatun Z
Acta biomaterialia 2016; 39: 124-132 (IGR: 18-1)

68922 Six-Month Intraocular Pressure Reduction with a Topical Bimatoprost Ocular Insert: Results of a Phase II Randomized Controlled Study
Alster Y
Ophthalmology 2016; 123: 1685-1694 (IGR: 18-1)

69273 Acute cytotoxic effects of marketed ophthalmic formulations on human corneal epithelial cells
Kaja S
International Journal of Pharmaceutics 2016; 511: 73-78 (IGR: 18-1)

69141 Long-term topical application of preservative-free prostaglandin analogues evokes macrophage infiltration in the ocular adnexa
Podracka L
European Journal of Pharmacology 2016; 788: 12-20 (IGR: 18-1)

69485 Biocompatibility and Pharmacokinetic Analysis of an Intracameral Polycaprolactone Drug Delivery Implant for Glaucoma
Aya-Shibuya E
Investigative Ophthalmology and Visual Science 2016; 57: 4341-4346 (IGR: 18-1)

69483 An upright eyedrop bottle: accuracy, usage of excess drops, and contamination compared to a conventional bottle
Kubelick K
Clinical Ophthalmology 2016; 10: 1411-1417 (IGR: 18-1)

69181 Investigation of Diffusion Characteristics through Microfluidic Channels for Passive Drug Delivery Applications
Handa H
Journal of Drug Delivery 2016; 2016: 7913616 (IGR: 18-1)

69203 Evaluation of physical properties and dose equivalency of generic versus branded latanoprost formulations
Sihota R
International Ophthalmology 2017; 37: 423-428 (IGR: 18-1)

69107 Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma
Raut A
Clinical Ophthalmology 2016; 10: 821-827 (IGR: 18-1)

69485 Biocompatibility and Pharmacokinetic Analysis of an Intracameral Polycaprolactone Drug Delivery Implant for Glaucoma
Bhisitkul RB
Investigative Ophthalmology and Visual Science 2016; 57: 4341-4346 (IGR: 18-1)

68930 Thermosensitive hexanoyl glycol chitosan-based ocular delivery system for glaucoma therapy
Li Z
Acta biomaterialia 2016; 39: 124-132 (IGR: 18-1)

69483 An upright eyedrop bottle: accuracy, usage of excess drops, and contamination compared to a conventional bottle
Patel RP
Clinical Ophthalmology 2016; 10: 1411-1417 (IGR: 18-1)

69193 Assessment of alkoxylphenacyl-based polycarbonates as a potential platform for controlled delivery of a model anti-glaucoma drug
Crish SD
European Journal of Pharmaceutics and Biopharmaceutics 2016; 107: 56-66 (IGR: 18-1)

68922 Six-Month Intraocular Pressure Reduction with a Topical Bimatoprost Ocular Insert: Results of a Phase II Randomized Controlled Study
Walker G
Ophthalmology 2016; 123: 1685-1694 (IGR: 18-1)

69203 Evaluation of physical properties and dose equivalency of generic versus branded latanoprost formulations
Dada T
International Ophthalmology 2017; 37: 423-428 (IGR: 18-1)

69273 Acute cytotoxic effects of marketed ophthalmic formulations on human corneal epithelial cells
Kalesnykas G
International Journal of Pharmaceutics 2016; 511: 73-78 (IGR: 18-1)

69207 Subconjunctival Delivery of Dorzolamide-Loaded Poly(ether-anhydride) Microparticles Produces Sustained Lowering of Intraocular Pressure in Rabbits
Hu Q
Molecular pharmaceutics 2016; 13: 2987-2995 (IGR: 18-1)

69141 Long-term topical application of preservative-free prostaglandin analogues evokes macrophage infiltration in the ocular adnexa
Korhonen E
European Journal of Pharmacology 2016; 788: 12-20 (IGR: 18-1)

69483 An upright eyedrop bottle: accuracy, usage of excess drops, and contamination compared to a conventional bottle
Benokraitis KL
Clinical Ophthalmology 2016; 10: 1411-1417 (IGR: 18-1)

69485 Biocompatibility and Pharmacokinetic Analysis of an Intracameral Polycaprolactone Drug Delivery Implant for Glaucoma
Desai TA
Investigative Ophthalmology and Visual Science 2016; 57: 4341-4346 (IGR: 18-1)

69141 Long-term topical application of preservative-free prostaglandin analogues evokes macrophage infiltration in the ocular adnexa
Kauppinen A
European Journal of Pharmacology 2016; 788: 12-20 (IGR: 18-1)

69207 Subconjunctival Delivery of Dorzolamide-Loaded Poly(ether-anhydride) Microparticles Produces Sustained Lowering of Intraocular Pressure in Rabbits
Fridley C
Molecular pharmaceutics 2016; 13: 2987-2995 (IGR: 18-1)

69193 Assessment of alkoxylphenacyl-based polycarbonates as a potential platform for controlled delivery of a model anti-glaucoma drug
Joy A
European Journal of Pharmaceutics and Biopharmaceutics 2016; 107: 56-66 (IGR: 18-1)

68930 Thermosensitive hexanoyl glycol chitosan-based ocular delivery system for glaucoma therapy
Kang SW
Acta biomaterialia 2016; 39: 124-132 (IGR: 18-1)

68922 Six-Month Intraocular Pressure Reduction with a Topical Bimatoprost Ocular Insert: Results of a Phase II Randomized Controlled Study
Semba CP
Ophthalmology 2016; 123: 1685-1694 (IGR: 18-1)

68930 Thermosensitive hexanoyl glycol chitosan-based ocular delivery system for glaucoma therapy
Choy YB
Acta biomaterialia 2016; 39: 124-132 (IGR: 18-1)

69141 Long-term topical application of preservative-free prostaglandin analogues evokes macrophage infiltration in the ocular adnexa
Kaarniranta K
European Journal of Pharmacology 2016; 788: 12-20 (IGR: 18-1)

69207 Subconjunctival Delivery of Dorzolamide-Loaded Poly(ether-anhydride) Microparticles Produces Sustained Lowering of Intraocular Pressure in Rabbits
Quigley HA
Molecular pharmaceutics 2016; 13: 2987-2995 (IGR: 18-1)

69193 Assessment of alkoxylphenacyl-based polycarbonates as a potential platform for controlled delivery of a model anti-glaucoma drug
Oyewumi MO
European Journal of Pharmaceutics and Biopharmaceutics 2016; 107: 56-66 (IGR: 18-1)

69483 An upright eyedrop bottle: accuracy, usage of excess drops, and contamination compared to a conventional bottle
Greene L
Clinical Ophthalmology 2016; 10: 1411-1417 (IGR: 18-1)

69207 Subconjunctival Delivery of Dorzolamide-Loaded Poly(ether-anhydride) Microparticles Produces Sustained Lowering of Intraocular Pressure in Rabbits
Hanes J
Molecular pharmaceutics 2016; 13: 2987-2995 (IGR: 18-1)

69141 Long-term topical application of preservative-free prostaglandin analogues evokes macrophage infiltration in the ocular adnexa
Smedowski A
European Journal of Pharmacology 2016; 788: 12-20 (IGR: 18-1)

69483 An upright eyedrop bottle: accuracy, usage of excess drops, and contamination compared to a conventional bottle
Cheek C
Clinical Ophthalmology 2016; 10: 1411-1417 (IGR: 18-1)

68930 Thermosensitive hexanoyl glycol chitosan-based ocular delivery system for glaucoma therapy
Huh KM
Acta biomaterialia 2016; 39: 124-132 (IGR: 18-1)

69483 An upright eyedrop bottle: accuracy, usage of excess drops, and contamination compared to a conventional bottle
Muir KW
Clinical Ophthalmology 2016; 10: 1411-1417 (IGR: 18-1)

69207 Subconjunctival Delivery of Dorzolamide-Loaded Poly(ether-anhydride) Microparticles Produces Sustained Lowering of Intraocular Pressure in Rabbits
Pitha I
Molecular pharmaceutics 2016; 13: 2987-2995 (IGR: 18-1)

67607 Deformability properties of timolol-loaded transfersomes based on the extrusion mechanism. Statistical optimization of the process
González-Rodríguez ML
Drug Development and Industrial Pharmacy 2016; 0: 1-12 (IGR: 17-4)

67226 Medical management of glaucoma: focus on ophthalmologic drug delivery systems of timolol maleate
Sah AK
Artificial cells, nanomedicine, and biotechnology 2016; 0: 1-12 (IGR: 17-4)

66820 In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery
Maulvi FA
Journal of Controlled Release 2016; 226: 47-56 (IGR: 17-4)

67477 Gallic acid grafting effect on delivery performance and antiglaucoma efficacy of antioxidant-functionalized intracameral pilocarpine carriers
Chou SF
Acta biomaterialia 2016; 38: 116-128 (IGR: 17-4)

66718 Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma
Chiang B
Journal of Controlled Release 2016; 228: 48-57 (IGR: 17-4)

67559 Ocular Erythropoietin Penetration after Subconjunctival Administration in Glaucomatous Rats
Resende AP
Ophthalmic Research 2016; 56: 104-110 (IGR: 17-4)

67185 Effect of preservative removal from fixed-combination bimatoprost/timolol on intraocular pressure lowering: a potential timolol dose-response phenomenon
Shen J
Clinical Ophthalmology 2016; 10: 373-383 (IGR: 17-4)

66745 Comparison of preservative-free latanoprost and preservative-free bimatoprost in a multicenter, randomized, investigator-masked cross-over clinical trial, the SPORT trial
Stalmans I
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 1151-1158 (IGR: 17-4)

67134 Review on the Eyedrop Self-Instillation Techniques and Factors Affecting These Techniques in Glaucoma Patients
Kayikcioglu O
Scientifica 2016; 2016: 9183272 (IGR: 17-4)

67443 Feasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an Asian population
Perera SA
Clinical Ophthalmology 2016; 10: 757-764 (IGR: 17-4)

67588 Meibomian Gland Dysfunction in Patients Receiving Long-Term Glaucoma Medications
Uzunosmanoglu E
Cornea 2016; 35: 1112-1116 (IGR: 17-4)

67209 Determination of phosphate concentration in glaucoma eye drops commercially available in Spain
Martínez-Soroa I
Archivos de la Sociedad Espa�ola de Oftalmologia 2016; 91: 363-371 (IGR: 17-4)

66627 Effect of preserved and preservative-free timolol eye drops on tear film stability in healthy Africans
Ilechie A
Nigerian medical journal : journal of the Nigeria Medical Association 2016; 57: 104-109 (IGR: 17-4)

67336 Development of a mechanism and an accurate and simple mathematical model for the description of drug release: Application to a relevant example of acetazolamide-controlled release from a bio-inspired elastin-based hydrogel
Fernández-Colino A
Materials science & engineering. C, Materials for biological applications 2016; 61: 286-292 (IGR: 17-4)

67429 Development of a novel CsA-PLGA drug delivery system based on a glaucoma drainage device for the prevention of postoperative fibrosis
Dai Z
Materials science & engineering. C, Materials for biological applications 2016; 66: 206-214 (IGR: 17-4)

67463 In vitro mitomycin C absorption and delivery with different sponge materials used in filtering surgery
Urbaneja D
Clinical Ophthalmology 2016; 10: 665-669 (IGR: 17-4)

67153 Thermosensitive chitosan-based hydrogel as a topical ocular drug delivery system of latanoprost for glaucoma treatment
Cheng YH
Carbohydrate polymers 2016; 144: 390-399 (IGR: 17-4)

67226 Medical management of glaucoma: focus on ophthalmologic drug delivery systems of timolol maleate
Suresh PK
Artificial cells, nanomedicine, and biotechnology 2016; 0: 1-12 (IGR: 17-4)

66745 Comparison of preservative-free latanoprost and preservative-free bimatoprost in a multicenter, randomized, investigator-masked cross-over clinical trial, the SPORT trial
Oddone F
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 1151-1158 (IGR: 17-4)

67134 Review on the Eyedrop Self-Instillation Techniques and Factors Affecting These Techniques in Glaucoma Patients
Bilgin S
Scientifica 2016; 2016: 9183272 (IGR: 17-4)

67477 Gallic acid grafting effect on delivery performance and antiglaucoma efficacy of antioxidant-functionalized intracameral pilocarpine carriers
Luo LJ
Acta biomaterialia 2016; 38: 116-128 (IGR: 17-4)

67336 Development of a mechanism and an accurate and simple mathematical model for the description of drug release: Application to a relevant example of acetazolamide-controlled release from a bio-inspired elastin-based hydrogel
Bermudez JM
Materials science & engineering. C, Materials for biological applications 2016; 61: 286-292 (IGR: 17-4)

67463 In vitro mitomycin C absorption and delivery with different sponge materials used in filtering surgery
Morilla-Grasa A
Clinical Ophthalmology 2016; 10: 665-669 (IGR: 17-4)

67559 Ocular Erythropoietin Penetration after Subconjunctival Administration in Glaucomatous Rats
São Braz B
Ophthalmic Research 2016; 56: 104-110 (IGR: 17-4)

67185 Effect of preservative removal from fixed-combination bimatoprost/timolol on intraocular pressure lowering: a potential timolol dose-response phenomenon
Bejanian M
Clinical Ophthalmology 2016; 10: 373-383 (IGR: 17-4)

67429 Development of a novel CsA-PLGA drug delivery system based on a glaucoma drainage device for the prevention of postoperative fibrosis
Yu X
Materials science & engineering. C, Materials for biological applications 2016; 66: 206-214 (IGR: 17-4)

66627 Effect of preserved and preservative-free timolol eye drops on tear film stability in healthy Africans
Abokyi S
Nigerian medical journal : journal of the Nigeria Medical Association 2016; 57: 104-109 (IGR: 17-4)

67607 Deformability properties of timolol-loaded transfersomes based on the extrusion mechanism. Statistical optimization of the process
Arroyo CM
Drug Development and Industrial Pharmacy 2016; 0: 1-12 (IGR: 17-4)

66820 In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery
Lakdawala DH
Journal of Controlled Release 2016; 226: 47-56 (IGR: 17-4)

67153 Thermosensitive chitosan-based hydrogel as a topical ocular drug delivery system of latanoprost for glaucoma treatment
Tsai TH
Carbohydrate polymers 2016; 144: 390-399 (IGR: 17-4)

67588 Meibomian Gland Dysfunction in Patients Receiving Long-Term Glaucoma Medications
Mocan MC
Cornea 2016; 35: 1112-1116 (IGR: 17-4)

67209 Determination of phosphate concentration in glaucoma eye drops commercially available in Spain
de Frutos-Lezaun M
Archivos de la Sociedad Espa�ola de Oftalmologia 2016; 91: 363-371 (IGR: 17-4)

66718 Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma
Kim YC
Journal of Controlled Release 2016; 228: 48-57 (IGR: 17-4)

67443 Feasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an Asian population
Ting DS
Clinical Ophthalmology 2016; 10: 757-764 (IGR: 17-4)

67463 In vitro mitomycin C absorption and delivery with different sponge materials used in filtering surgery
Jimenez E
Clinical Ophthalmology 2016; 10: 665-669 (IGR: 17-4)

67153 Thermosensitive chitosan-based hydrogel as a topical ocular drug delivery system of latanoprost for glaucoma treatment
Jhan YY
Carbohydrate polymers 2016; 144: 390-399 (IGR: 17-4)

67588 Meibomian Gland Dysfunction in Patients Receiving Long-Term Glaucoma Medications
Kocabeyoglu S
Cornea 2016; 35: 1112-1116 (IGR: 17-4)

66627 Effect of preserved and preservative-free timolol eye drops on tear film stability in healthy Africans
Boateng G
Nigerian medical journal : journal of the Nigeria Medical Association 2016; 57: 104-109 (IGR: 17-4)

66718 Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma
Doty AC
Journal of Controlled Release 2016; 228: 48-57 (IGR: 17-4)

67429 Development of a novel CsA-PLGA drug delivery system based on a glaucoma drainage device for the prevention of postoperative fibrosis
Hong J
Materials science & engineering. C, Materials for biological applications 2016; 66: 206-214 (IGR: 17-4)

67607 Deformability properties of timolol-loaded transfersomes based on the extrusion mechanism. Statistical optimization of the process
Cózar-Bernal MJ
Drug Development and Industrial Pharmacy 2016; 0: 1-12 (IGR: 17-4)

67134 Review on the Eyedrop Self-Instillation Techniques and Factors Affecting These Techniques in Glaucoma Patients
Uyar M
Scientifica 2016; 2016: 9183272 (IGR: 17-4)

67336 Development of a mechanism and an accurate and simple mathematical model for the description of drug release: Application to a relevant example of acetazolamide-controlled release from a bio-inspired elastin-based hydrogel
Arias FJ
Materials science & engineering. C, Materials for biological applications 2016; 61: 286-292 (IGR: 17-4)

66820 In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery
Shaikh AA
Journal of Controlled Release 2016; 226: 47-56 (IGR: 17-4)

67209 Determination of phosphate concentration in glaucoma eye drops commercially available in Spain
Ostra Beldarrain M
Archivos de la Sociedad Espa�ola de Oftalmologia 2016; 91: 363-371 (IGR: 17-4)

67443 Feasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an Asian population
Nongpiur ME
Clinical Ophthalmology 2016; 10: 757-764 (IGR: 17-4)

67477 Gallic acid grafting effect on delivery performance and antiglaucoma efficacy of antioxidant-functionalized intracameral pilocarpine carriers
Lai JY
Acta biomaterialia 2016; 38: 116-128 (IGR: 17-4)

66745 Comparison of preservative-free latanoprost and preservative-free bimatoprost in a multicenter, randomized, investigator-masked cross-over clinical trial, the SPORT trial
Cordeiro MF
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 1151-1158 (IGR: 17-4)

67559 Ocular Erythropoietin Penetration after Subconjunctival Administration in Glaucomatous Rats
Delgado E
Ophthalmic Research 2016; 56: 104-110 (IGR: 17-4)

67429 Development of a novel CsA-PLGA drug delivery system based on a glaucoma drainage device for the prevention of postoperative fibrosis
Liu X
Materials science & engineering. C, Materials for biological applications 2016; 66: 206-214 (IGR: 17-4)

66820 In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery
Desai AR
Journal of Controlled Release 2016; 226: 47-56 (IGR: 17-4)

66718 Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma
Grossniklaus HE
Journal of Controlled Release 2016; 228: 48-57 (IGR: 17-4)

67443 Feasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an Asian population
Chew PT
Clinical Ophthalmology 2016; 10: 757-764 (IGR: 17-4)

67588 Meibomian Gland Dysfunction in Patients Receiving Long-Term Glaucoma Medications
Karakaya J
Cornea 2016; 35: 1112-1116 (IGR: 17-4)

67209 Determination of phosphate concentration in glaucoma eye drops commercially available in Spain
Egía Zurutuza A
Archivos de la Sociedad Espa�ola de Oftalmologia 2016; 91: 363-371 (IGR: 17-4)

67607 Deformability properties of timolol-loaded transfersomes based on the extrusion mechanism. Statistical optimization of the process
González-R PL
Drug Development and Industrial Pharmacy 2016; 0: 1-12 (IGR: 17-4)

66745 Comparison of preservative-free latanoprost and preservative-free bimatoprost in a multicenter, randomized, investigator-masked cross-over clinical trial, the SPORT trial
Hommer A
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 1151-1158 (IGR: 17-4)

67463 In vitro mitomycin C absorption and delivery with different sponge materials used in filtering surgery
Montemayor J
Clinical Ophthalmology 2016; 10: 665-669 (IGR: 17-4)

67153 Thermosensitive chitosan-based hydrogel as a topical ocular drug delivery system of latanoprost for glaucoma treatment
Chiu AW
Carbohydrate polymers 2016; 144: 390-399 (IGR: 17-4)

66627 Effect of preserved and preservative-free timolol eye drops on tear film stability in healthy Africans
Koffuor GA
Nigerian medical journal : journal of the Nigeria Medical Association 2016; 57: 104-109 (IGR: 17-4)

67336 Development of a mechanism and an accurate and simple mathematical model for the description of drug release: Application to a relevant example of acetazolamide-controlled release from a bio-inspired elastin-based hydrogel
Quinteros D
Materials science & engineering. C, Materials for biological applications 2016; 61: 286-292 (IGR: 17-4)

67443 Feasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an Asian population
Aquino MC
Clinical Ophthalmology 2016; 10: 757-764 (IGR: 17-4)

67209 Determination of phosphate concentration in glaucoma eye drops commercially available in Spain
Irastorza Larburu MB
Archivos de la Sociedad Espa�ola de Oftalmologia 2016; 91: 363-371 (IGR: 17-4)

66820 In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery
Choksi HH
Journal of Controlled Release 2016; 226: 47-56 (IGR: 17-4)

67429 Development of a novel CsA-PLGA drug delivery system based on a glaucoma drainage device for the prevention of postoperative fibrosis
Sun J
Materials science & engineering. C, Materials for biological applications 2016; 66: 206-214 (IGR: 17-4)

67336 Development of a mechanism and an accurate and simple mathematical model for the description of drug release: Application to a relevant example of acetazolamide-controlled release from a bio-inspired elastin-based hydrogel
Gonzo E
Materials science & engineering. C, Materials for biological applications 2016; 61: 286-292 (IGR: 17-4)

67463 In vitro mitomycin C absorption and delivery with different sponge materials used in filtering surgery
Marcobal N
Clinical Ophthalmology 2016; 10: 665-669 (IGR: 17-4)

67153 Thermosensitive chitosan-based hydrogel as a topical ocular drug delivery system of latanoprost for glaucoma treatment
Tsai KL
Carbohydrate polymers 2016; 144: 390-399 (IGR: 17-4)

67607 Deformability properties of timolol-loaded transfersomes based on the extrusion mechanism. Statistical optimization of the process
León JM
Drug Development and Industrial Pharmacy 2016; 0: 1-12 (IGR: 17-4)

66718 Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma
Schwendeman SP
Journal of Controlled Release 2016; 228: 48-57 (IGR: 17-4)

66745 Comparison of preservative-free latanoprost and preservative-free bimatoprost in a multicenter, randomized, investigator-masked cross-over clinical trial, the SPORT trial
Montesano G
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 1151-1158 (IGR: 17-4)

67588 Meibomian Gland Dysfunction in Patients Receiving Long-Term Glaucoma Medications
Irkec M
Cornea 2016; 35: 1112-1116 (IGR: 17-4)

67607 Deformability properties of timolol-loaded transfersomes based on the extrusion mechanism. Statistical optimization of the process
Calle M
Drug Development and Industrial Pharmacy 2016; 0: 1-12 (IGR: 17-4)

66718 Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma
Prausnitz MR
Journal of Controlled Release 2016; 228: 48-57 (IGR: 17-4)

67443 Feasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an Asian population
Sng CC
Clinical Ophthalmology 2016; 10: 757-764 (IGR: 17-4)

66820 In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery
Vaidya RJ
Journal of Controlled Release 2016; 226: 47-56 (IGR: 17-4)

67153 Thermosensitive chitosan-based hydrogel as a topical ocular drug delivery system of latanoprost for glaucoma treatment
Chien CS
Carbohydrate polymers 2016; 144: 390-399 (IGR: 17-4)

66745 Comparison of preservative-free latanoprost and preservative-free bimatoprost in a multicenter, randomized, investigator-masked cross-over clinical trial, the SPORT trial
Ribeiro L
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 1151-1158 (IGR: 17-4)

67429 Development of a novel CsA-PLGA drug delivery system based on a glaucoma drainage device for the prevention of postoperative fibrosis
Sun X
Materials science & engineering. C, Materials for biological applications 2016; 66: 206-214 (IGR: 17-4)

67463 In vitro mitomycin C absorption and delivery with different sponge materials used in filtering surgery
Aragay C
Clinical Ophthalmology 2016; 10: 665-669 (IGR: 17-4)

67209 Determination of phosphate concentration in glaucoma eye drops commercially available in Spain
Bachiller Cacho MP
Archivos de la Sociedad Espa�ola de Oftalmologia 2016; 91: 363-371 (IGR: 17-4)

66820 In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery
Ranch KM
Journal of Controlled Release 2016; 226: 47-56 (IGR: 17-4)

66745 Comparison of preservative-free latanoprost and preservative-free bimatoprost in a multicenter, randomized, investigator-masked cross-over clinical trial, the SPORT trial
Sunaric-Mégevand G
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 1151-1158 (IGR: 17-4)

67153 Thermosensitive chitosan-based hydrogel as a topical ocular drug delivery system of latanoprost for glaucoma treatment
Chiou SH
Carbohydrate polymers 2016; 144: 390-399 (IGR: 17-4)

67443 Feasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an Asian population
Ho SW
Clinical Ophthalmology 2016; 10: 757-764 (IGR: 17-4)

67463 In vitro mitomycin C absorption and delivery with different sponge materials used in filtering surgery
Gurdiel C
Clinical Ophthalmology 2016; 10: 665-669 (IGR: 17-4)

67607 Deformability properties of timolol-loaded transfersomes based on the extrusion mechanism. Statistical optimization of the process
Canca D
Drug Development and Industrial Pharmacy 2016; 0: 1-12 (IGR: 17-4)

66745 Comparison of preservative-free latanoprost and preservative-free bimatoprost in a multicenter, randomized, investigator-masked cross-over clinical trial, the SPORT trial
Rossetti L
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 1151-1158 (IGR: 17-4)

67607 Deformability properties of timolol-loaded transfersomes based on the extrusion mechanism. Statistical optimization of the process
Rabasco AM
Drug Development and Industrial Pharmacy 2016; 0: 1-12 (IGR: 17-4)

67463 In vitro mitomycin C absorption and delivery with different sponge materials used in filtering surgery
Armillas M
Clinical Ophthalmology 2016; 10: 665-669 (IGR: 17-4)

67443 Feasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an Asian population
Aung T
Clinical Ophthalmology 2016; 10: 757-764 (IGR: 17-4)

67153 Thermosensitive chitosan-based hydrogel as a topical ocular drug delivery system of latanoprost for glaucoma treatment
Liu CJ
Carbohydrate polymers 2016; 144: 390-399 (IGR: 17-4)

66820 In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery
Koli AR
Journal of Controlled Release 2016; 226: 47-56 (IGR: 17-4)

67463 In vitro mitomycin C absorption and delivery with different sponge materials used in filtering surgery
Ortiz P
Clinical Ophthalmology 2016; 10: 665-669 (IGR: 17-4)

66820 In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery
Vyas BA
Journal of Controlled Release 2016; 226: 47-56 (IGR: 17-4)

67463 In vitro mitomycin C absorption and delivery with different sponge materials used in filtering surgery
Antón A
Clinical Ophthalmology 2016; 10: 665-669 (IGR: 17-4)

66820 In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery
Shah DO
Journal of Controlled Release 2016; 226: 47-56 (IGR: 17-4)

66345 Conjunctival fibrosis following filtering glaucoma surgery
Schlunck G
Experimental Eye Research 2016; 142: 76-82 (IGR: 17-3)

66507 Nanoparticle cross-linked collagen shields for sustained delivery of pilocarpine hydrochloride
Agban Y
International Journal of Pharmaceutics 2016; 501: 96-101 (IGR: 17-3)

65831 New drugs and preparations for open-angle glaucoma in adults

Drug and therapeutics bulletin 2015; 53: 141-144 (IGR: 17-3)

65971 Comparison of Eye Drop Instillation Before and After Use of Drop Application Strips in Glaucoma Patients on Chronic Topical Therapy
Sharma R
Journal of Glaucoma 2016; 25: e438-e440 (IGR: 17-3)

65933 Preservative-free glaucoma treatment : Selection of the correct treatment in 1 min
Pfennigsdorf S; Eschstruth P
Ophthalmologe 2016; 113: 409-415 (IGR: 17-3)

65932 Effect of benzalkonium chloride-free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study
Hubatsch DA
BMC Ophthalmology 2015; 15: 166 (IGR: 17-3)

65971 Comparison of Eye Drop Instillation Before and After Use of Drop Application Strips in Glaucoma Patients on Chronic Topical Therapy
Singhal D
Journal of Glaucoma 2016; 25: e438-e440 (IGR: 17-3)

66507 Nanoparticle cross-linked collagen shields for sustained delivery of pilocarpine hydrochloride
Lian J
International Journal of Pharmaceutics 2016; 501: 96-101 (IGR: 17-3)

66345 Conjunctival fibrosis following filtering glaucoma surgery
Meyer-Ter-Vehn T
Experimental Eye Research 2016; 142: 76-82 (IGR: 17-3)

65932 Effect of benzalkonium chloride-free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study
Amaris P
BMC Ophthalmology 2015; 15: 166 (IGR: 17-3)

65971 Comparison of Eye Drop Instillation Before and After Use of Drop Application Strips in Glaucoma Patients on Chronic Topical Therapy
Shashni A
Journal of Glaucoma 2016; 25: e438-e440 (IGR: 17-3)

66345 Conjunctival fibrosis following filtering glaucoma surgery
Klink T
Experimental Eye Research 2016; 142: 76-82 (IGR: 17-3)

66507 Nanoparticle cross-linked collagen shields for sustained delivery of pilocarpine hydrochloride
Prabakar S
International Journal of Pharmaceutics 2016; 501: 96-101 (IGR: 17-3)

65971 Comparison of Eye Drop Instillation Before and After Use of Drop Application Strips in Glaucoma Patients on Chronic Topical Therapy
Agarwal E
Journal of Glaucoma 2016; 25: e438-e440 (IGR: 17-3)

66345 Conjunctival fibrosis following filtering glaucoma surgery
Grehn F
Experimental Eye Research 2016; 142: 76-82 (IGR: 17-3)

66507 Nanoparticle cross-linked collagen shields for sustained delivery of pilocarpine hydrochloride
Seyfoddin A
International Journal of Pharmaceutics 2016; 501: 96-101 (IGR: 17-3)

65971 Comparison of Eye Drop Instillation Before and After Use of Drop Application Strips in Glaucoma Patients on Chronic Topical Therapy
Wadhwani M
Journal of Glaucoma 2016; 25: e438-e440 (IGR: 17-3)

66507 Nanoparticle cross-linked collagen shields for sustained delivery of pilocarpine hydrochloride
Rupenthal ID
International Journal of Pharmaceutics 2016; 501: 96-101 (IGR: 17-3)

65971 Comparison of Eye Drop Instillation Before and After Use of Drop Application Strips in Glaucoma Patients on Chronic Topical Therapy
Dada T
Journal of Glaucoma 2016; 25: e438-e440 (IGR: 17-3)

61143 New prostaglandin analog formulation for glaucoma treatment containing cyclodextrins for improved stability, solubility and ocular tolerance
Rodriguez-Aller M
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 203-214 (IGR: 17-1)

61596 Development of a novel injectable drug delivery system for subconjunctival glaucoma treatment
Voss K
Journal of Controlled Release 2015; 214: 1-11 (IGR: 17-1)

61728 Polyquaternium-1-Preserved Travoprost 0.003% or Benzalkonium Chloride-Preserved Travoprost 0.004% for Glaucoma and Ocular Hypertension
Peace JH
American Journal of Ophthalmology 2015; 160: 266-274.e1 (IGR: 17-1)

60979 Development of an Experimental Drug Eluting Suprachoroidal Microstent as Glaucoma Drainage Device
Hovakimyan M
Translational vision science & technology 2015; 4: 14 (IGR: 17-1)

61672 Volumetric and cost evaluation study of glaucoma medical therapy
Banga HK
International journal of applied & basic medical research 2015; 5: 96-99 (IGR: 17-1)

61681 Effect of Two Novel Sustained-Release Drug Delivery Systems on Bleb Fibrosis: An In Vivo Glaucoma Drainage Device Study in a Rabbit Model
Schoenberg ED
Translational vision science & technology 2015; 4: 4 (IGR: 17-1)

61068 The Degradation of Mitomycin C Under Various Storage Methods
Kinast RM
Journal of Glaucoma 2016; 25: 477-481 (IGR: 17-1)

61348 A biodegradable ocular implant for long-term suppression of intraocular pressure
Ng XW
Drug delivery and translational research 2015; 5: 469-479 (IGR: 17-1)

61561 Association between Glaucoma Medication Usage and Dry Eye in Taiwan
Chen HY
Optometry and Vision Science 2015; 92: e227-e232 (IGR: 17-1)

60980 Natural Bioadhesive Biodegradable Nanoparticle-Based Topical Ophthalmic Formulations for Management of Glaucoma
Ibrahim MM
Translational vision science & technology 2015; 4: 12 (IGR: 17-1)

61394 Effects of Four Formulations of Prostaglandin Analogs on Eye Surface Cells. A Comparative Study
Pérez-Roca F
PLoS ONE 2015; 10: e0129419 (IGR: 17-1)

61590 The Impact of Glaucoma Medications on Corneal Wound Healing
Pinheiro R
Journal of Glaucoma 2016; 25: 122-127 (IGR: 17-1)

61753 Symptoms and signs of ocular surface disease related to topical medication in patients with glaucoma
Cvenkel B
Clinical Ophthalmology 2015; 9: 625-631 (IGR: 17-1)

61491 In Vivo Effects of Preservative-free and Preserved Prostaglandin Analogs: Mouse Ocular Surface Study
Kim JH
Korean Journal of Ophthalmology 2015; 29: 270-279 (IGR: 17-1)

61137 Effect of Switching to Travoprost Preserved With SofZia in Glaucoma Patients With Chronic Superficial Punctate Keratitis While Receiving BAK-preserved Latanoprost
Aihara M
Journal of Glaucoma 2016; 25: e610-e614 (IGR: 17-1)

61285 Effects of Long-Term Antiglaucoma Eye Drops on Conjunctival Structures: An In Vivo Confocal Microscopy Study
Zhu W
Journal of Ophthalmology 2015; 2015: 165475 (IGR: 17-1)

61390 Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy
Hsu KH
European Journal of Pharmaceutics and Biopharmaceutics 2015; 94: 312-321 (IGR: 17-1)

61068 The Degradation of Mitomycin C Under Various Storage Methods
Akula KK
Journal of Glaucoma 2016; 25: 477-481 (IGR: 17-1)

61728 Polyquaternium-1-Preserved Travoprost 0.003% or Benzalkonium Chloride-Preserved Travoprost 0.004% for Glaucoma and Ocular Hypertension
Ahlberg P
American Journal of Ophthalmology 2015; 160: 266-274.e1 (IGR: 17-1)

61590 The Impact of Glaucoma Medications on Corneal Wound Healing
Panfil C
Journal of Glaucoma 2016; 25: 122-127 (IGR: 17-1)

61348 A biodegradable ocular implant for long-term suppression of intraocular pressure
Liu KL
Drug delivery and translational research 2015; 5: 469-479 (IGR: 17-1)

61143 New prostaglandin analog formulation for glaucoma treatment containing cyclodextrins for improved stability, solubility and ocular tolerance
Guinchard S
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 203-214 (IGR: 17-1)

61285 Effects of Long-Term Antiglaucoma Eye Drops on Conjunctival Structures: An In Vivo Confocal Microscopy Study
Kong X
Journal of Ophthalmology 2015; 2015: 165475 (IGR: 17-1)

61491 In Vivo Effects of Preservative-free and Preserved Prostaglandin Analogs: Mouse Ocular Surface Study
Kim EJ
Korean Journal of Ophthalmology 2015; 29: 270-279 (IGR: 17-1)

61596 Development of a novel injectable drug delivery system for subconjunctival glaucoma treatment
Falke K
Journal of Controlled Release 2015; 214: 1-11 (IGR: 17-1)

61390 Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy
Carbia BE
European Journal of Pharmaceutics and Biopharmaceutics 2015; 94: 312-321 (IGR: 17-1)

61137 Effect of Switching to Travoprost Preserved With SofZia in Glaucoma Patients With Chronic Superficial Punctate Keratitis While Receiving BAK-preserved Latanoprost
Ikeda Y
Journal of Glaucoma 2016; 25: e610-e614 (IGR: 17-1)

61394 Effects of Four Formulations of Prostaglandin Analogs on Eye Surface Cells. A Comparative Study
Rodrigo-Morales E
PLoS ONE 2015; 10: e0129419 (IGR: 17-1)

61753 Symptoms and signs of ocular surface disease related to topical medication in patients with glaucoma
Štunf Š
Clinical Ophthalmology 2015; 9: 625-631 (IGR: 17-1)

60979 Development of an Experimental Drug Eluting Suprachoroidal Microstent as Glaucoma Drainage Device
Siewert S
Translational vision science & technology 2015; 4: 14 (IGR: 17-1)

61561 Association between Glaucoma Medication Usage and Dry Eye in Taiwan
Lin CL
Optometry and Vision Science 2015; 92: e227-e232 (IGR: 17-1)

61672 Volumetric and cost evaluation study of glaucoma medical therapy
Gupta AK
International journal of applied & basic medical research 2015; 5: 96-99 (IGR: 17-1)

60980 Natural Bioadhesive Biodegradable Nanoparticle-Based Topical Ophthalmic Formulations for Management of Glaucoma
Abd-Elgawad AH
Translational vision science & technology 2015; 4: 12 (IGR: 17-1)

61366 Effect of 0.3% Hydroxypropyl Methylcellulose/Dextran Versus 0.18% Sodium Hyaluronate in the Treatment of Ocular Surface Disease in Glaucoma Patients: A Randomized, Double-Blind, and Controlled Study
Ruangvaravate N
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 323-329 (IGR: 17-1)

61681 Effect of Two Novel Sustained-Release Drug Delivery Systems on Bleb Fibrosis: An In Vivo Glaucoma Drainage Device Study in a Rabbit Model
Blake DA
Translational vision science & technology 2015; 4: 4 (IGR: 17-1)

61681 Effect of Two Novel Sustained-Release Drug Delivery Systems on Bleb Fibrosis: An In Vivo Glaucoma Drainage Device Study in a Rabbit Model
Swann FB
Translational vision science & technology 2015; 4: 4 (IGR: 17-1)

61491 In Vivo Effects of Preservative-free and Preserved Prostaglandin Analogs: Mouse Ocular Surface Study
Kim YH
Korean Journal of Ophthalmology 2015; 29: 270-279 (IGR: 17-1)

60980 Natural Bioadhesive Biodegradable Nanoparticle-Based Topical Ophthalmic Formulations for Management of Glaucoma
Soliman OA
Translational vision science & technology 2015; 4: 12 (IGR: 17-1)

61753 Symptoms and signs of ocular surface disease related to topical medication in patients with glaucoma
Srebotnik Kirbiš I
Clinical Ophthalmology 2015; 9: 625-631 (IGR: 17-1)

61348 A biodegradable ocular implant for long-term suppression of intraocular pressure
Veluchamy AB
Drug delivery and translational research 2015; 5: 469-479 (IGR: 17-1)

61728 Polyquaternium-1-Preserved Travoprost 0.003% or Benzalkonium Chloride-Preserved Travoprost 0.004% for Glaucoma and Ocular Hypertension
Wagner M
American Journal of Ophthalmology 2015; 160: 266-274.e1 (IGR: 17-1)

61561 Association between Glaucoma Medication Usage and Dry Eye in Taiwan
Tsai YY
Optometry and Vision Science 2015; 92: e227-e232 (IGR: 17-1)

61143 New prostaglandin analog formulation for glaucoma treatment containing cyclodextrins for improved stability, solubility and ocular tolerance
Guillarme D
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 203-214 (IGR: 17-1)

61366 Effect of 0.3% Hydroxypropyl Methylcellulose/Dextran Versus 0.18% Sodium Hyaluronate in the Treatment of Ocular Surface Disease in Glaucoma Patients: A Randomized, Double-Blind, and Controlled Study
Tesavibul N
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 323-329 (IGR: 17-1)

61672 Volumetric and cost evaluation study of glaucoma medical therapy
Singh G
International journal of applied & basic medical research 2015; 5: 96-99 (IGR: 17-1)

61394 Effects of Four Formulations of Prostaglandin Analogs on Eye Surface Cells. A Comparative Study
Garzón I
PLoS ONE 2015; 10: e0129419 (IGR: 17-1)

61137 Effect of Switching to Travoprost Preserved With SofZia in Glaucoma Patients With Chronic Superficial Punctate Keratitis While Receiving BAK-preserved Latanoprost
Mizoue S
Journal of Glaucoma 2016; 25: e610-e614 (IGR: 17-1)

61590 The Impact of Glaucoma Medications on Corneal Wound Healing
Schrage N
Journal of Glaucoma 2016; 25: 122-127 (IGR: 17-1)

61068 The Degradation of Mitomycin C Under Various Storage Methods
DeBarber AE
Journal of Glaucoma 2016; 25: 477-481 (IGR: 17-1)

61285 Effects of Long-Term Antiglaucoma Eye Drops on Conjunctival Structures: An In Vivo Confocal Microscopy Study
Xu J
Journal of Ophthalmology 2015; 2015: 165475 (IGR: 17-1)

61390 Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy
Plummer C
European Journal of Pharmaceutics and Biopharmaceutics 2015; 94: 312-321 (IGR: 17-1)

60979 Development of an Experimental Drug Eluting Suprachoroidal Microstent as Glaucoma Drainage Device
Schmidt W
Translational vision science & technology 2015; 4: 14 (IGR: 17-1)

61596 Development of a novel injectable drug delivery system for subconjunctival glaucoma treatment
Bernsdorf A
Journal of Controlled Release 2015; 214: 1-11 (IGR: 17-1)

61561 Association between Glaucoma Medication Usage and Dry Eye in Taiwan
Kao CH
Optometry and Vision Science 2015; 92: e227-e232 (IGR: 17-1)

61366 Effect of 0.3% Hydroxypropyl Methylcellulose/Dextran Versus 0.18% Sodium Hyaluronate in the Treatment of Ocular Surface Disease in Glaucoma Patients: A Randomized, Double-Blind, and Controlled Study
Thewthong M
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 323-329 (IGR: 17-1)

61068 The Degradation of Mitomycin C Under Various Storage Methods
Barker GT
Journal of Glaucoma 2016; 25: 477-481 (IGR: 17-1)

61590 The Impact of Glaucoma Medications on Corneal Wound Healing
Dutescu RM
Journal of Glaucoma 2016; 25: 122-127 (IGR: 17-1)

60980 Natural Bioadhesive Biodegradable Nanoparticle-Based Topical Ophthalmic Formulations for Management of Glaucoma
Jablonski MM
Translational vision science & technology 2015; 4: 12 (IGR: 17-1)

61728 Polyquaternium-1-Preserved Travoprost 0.003% or Benzalkonium Chloride-Preserved Travoprost 0.004% for Glaucoma and Ocular Hypertension
Lim JM
American Journal of Ophthalmology 2015; 160: 266-274.e1 (IGR: 17-1)

61285 Effects of Long-Term Antiglaucoma Eye Drops on Conjunctival Structures: An In Vivo Confocal Microscopy Study
Sun X
Journal of Ophthalmology 2015; 2015: 165475 (IGR: 17-1)

61137 Effect of Switching to Travoprost Preserved With SofZia in Glaucoma Patients With Chronic Superficial Punctate Keratitis While Receiving BAK-preserved Latanoprost
Arakaki Y
Journal of Glaucoma 2016; 25: e610-e614 (IGR: 17-1)

61390 Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy
Chauhan A
European Journal of Pharmaceutics and Biopharmaceutics 2015; 94: 312-321 (IGR: 17-1)

61491 In Vivo Effects of Preservative-free and Preserved Prostaglandin Analogs: Mouse Ocular Surface Study
Kim YI
Korean Journal of Ophthalmology 2015; 29: 270-279 (IGR: 17-1)

61143 New prostaglandin analog formulation for glaucoma treatment containing cyclodextrins for improved stability, solubility and ocular tolerance
Pupier M
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 203-214 (IGR: 17-1)

60979 Development of an Experimental Drug Eluting Suprachoroidal Microstent as Glaucoma Drainage Device
Sternberg K
Translational vision science & technology 2015; 4: 14 (IGR: 17-1)

61394 Effects of Four Formulations of Prostaglandin Analogs on Eye Surface Cells. A Comparative Study
Oliveira AC
PLoS ONE 2015; 10: e0129419 (IGR: 17-1)

61681 Effect of Two Novel Sustained-Release Drug Delivery Systems on Bleb Fibrosis: An In Vivo Glaucoma Drainage Device Study in a Rabbit Model
Parlin AW
Translational vision science & technology 2015; 4: 4 (IGR: 17-1)

61348 A biodegradable ocular implant for long-term suppression of intraocular pressure
Lwin NC
Drug delivery and translational research 2015; 5: 469-479 (IGR: 17-1)

61596 Development of a novel injectable drug delivery system for subconjunctival glaucoma treatment
Grabow N
Journal of Controlled Release 2015; 214: 1-11 (IGR: 17-1)

61753 Symptoms and signs of ocular surface disease related to topical medication in patients with glaucoma
Strojan Fležar M
Clinical Ophthalmology 2015; 9: 625-631 (IGR: 17-1)

61681 Effect of Two Novel Sustained-Release Drug Delivery Systems on Bleb Fibrosis: An In Vivo Glaucoma Drainage Device Study in a Rabbit Model
Zurakowski D
Translational vision science & technology 2015; 4: 4 (IGR: 17-1)

61137 Effect of Switching to Travoprost Preserved With SofZia in Glaucoma Patients With Chronic Superficial Punctate Keratitis While Receiving BAK-preserved Latanoprost
Kita N
Journal of Glaucoma 2016; 25: e610-e614 (IGR: 17-1)

61394 Effects of Four Formulations of Prostaglandin Analogs on Eye Surface Cells. A Comparative Study
Martín-Piedra MÁ
PLoS ONE 2015; 10: e0129419 (IGR: 17-1)

61491 In Vivo Effects of Preservative-free and Preserved Prostaglandin Analogs: Mouse Ocular Surface Study
Lee SH
Korean Journal of Ophthalmology 2015; 29: 270-279 (IGR: 17-1)

61596 Development of a novel injectable drug delivery system for subconjunctival glaucoma treatment
Kastner C
Journal of Controlled Release 2015; 214: 1-11 (IGR: 17-1)

61068 The Degradation of Mitomycin C Under Various Storage Methods
Gardiner SK
Journal of Glaucoma 2016; 25: 477-481 (IGR: 17-1)

61348 A biodegradable ocular implant for long-term suppression of intraocular pressure
Wong TT
Drug delivery and translational research 2015; 5: 469-479 (IGR: 17-1)

61143 New prostaglandin analog formulation for glaucoma treatment containing cyclodextrins for improved stability, solubility and ocular tolerance
Jeannerat D
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 203-214 (IGR: 17-1)

61728 Polyquaternium-1-Preserved Travoprost 0.003% or Benzalkonium Chloride-Preserved Travoprost 0.004% for Glaucoma and Ocular Hypertension
Wirta D
American Journal of Ophthalmology 2015; 160: 266-274.e1 (IGR: 17-1)

60979 Development of an Experimental Drug Eluting Suprachoroidal Microstent as Glaucoma Drainage Device
Reske T
Translational vision science & technology 2015; 4: 14 (IGR: 17-1)

61137 Effect of Switching to Travoprost Preserved With SofZia in Glaucoma Patients With Chronic Superficial Punctate Keratitis While Receiving BAK-preserved Latanoprost
Kobayashi S
Journal of Glaucoma 2016; 25: e610-e614 (IGR: 17-1)

61068 The Degradation of Mitomycin C Under Various Storage Methods
Whitson E
Journal of Glaucoma 2016; 25: 477-481 (IGR: 17-1)

61596 Development of a novel injectable drug delivery system for subconjunctival glaucoma treatment
Sternberg K
Journal of Controlled Release 2015; 214: 1-11 (IGR: 17-1)

61143 New prostaglandin analog formulation for glaucoma treatment containing cyclodextrins for improved stability, solubility and ocular tolerance
Rivara-Minten E
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 203-214 (IGR: 17-1)

61348 A biodegradable ocular implant for long-term suppression of intraocular pressure
Venkatraman SS
Drug delivery and translational research 2015; 5: 469-479 (IGR: 17-1)

61728 Polyquaternium-1-Preserved Travoprost 0.003% or Benzalkonium Chloride-Preserved Travoprost 0.004% for Glaucoma and Ocular Hypertension
Branch JD
American Journal of Ophthalmology 2015; 160: 266-274.e1 (IGR: 17-1)

60979 Development of an Experimental Drug Eluting Suprachoroidal Microstent as Glaucoma Drainage Device
Stachs O
Translational vision science & technology 2015; 4: 14 (IGR: 17-1)

61681 Effect of Two Novel Sustained-Release Drug Delivery Systems on Bleb Fibrosis: An In Vivo Glaucoma Drainage Device Study in a Rabbit Model
Margo CE
Translational vision science & technology 2015; 4: 4 (IGR: 17-1)

61394 Effects of Four Formulations of Prostaglandin Analogs on Eye Surface Cells. A Comparative Study
Carriel V
PLoS ONE 2015; 10: e0129419 (IGR: 17-1)

61491 In Vivo Effects of Preservative-free and Preserved Prostaglandin Analogs: Mouse Ocular Surface Study
Jung JC
Korean Journal of Ophthalmology 2015; 29: 270-279 (IGR: 17-1)

61394 Effects of Four Formulations of Prostaglandin Analogs on Eye Surface Cells. A Comparative Study
Ortiz-Pérez AI
PLoS ONE 2015; 10: e0129419 (IGR: 17-1)

61596 Development of a novel injectable drug delivery system for subconjunctival glaucoma treatment
Minrath I
Journal of Controlled Release 2015; 214: 1-11 (IGR: 17-1)

60979 Development of an Experimental Drug Eluting Suprachoroidal Microstent as Glaucoma Drainage Device
Guthoff R
Translational vision science & technology 2015; 4: 14 (IGR: 17-1)

61681 Effect of Two Novel Sustained-Release Drug Delivery Systems on Bleb Fibrosis: An In Vivo Glaucoma Drainage Device Study in a Rabbit Model
Ponnusamy T
Translational vision science & technology 2015; 4: 4 (IGR: 17-1)

61491 In Vivo Effects of Preservative-free and Preserved Prostaglandin Analogs: Mouse Ocular Surface Study
Lee KW
Korean Journal of Ophthalmology 2015; 29: 270-279 (IGR: 17-1)

61137 Effect of Switching to Travoprost Preserved With SofZia in Glaucoma Patients With Chronic Superficial Punctate Keratitis While Receiving BAK-preserved Latanoprost

Journal of Glaucoma 2016; 25: e610-e614 (IGR: 17-1)

61068 The Degradation of Mitomycin C Under Various Storage Methods
Mansberger SL
Journal of Glaucoma 2016; 25: 477-481 (IGR: 17-1)

61143 New prostaglandin analog formulation for glaucoma treatment containing cyclodextrins for improved stability, solubility and ocular tolerance
Veuthey JL
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 203-214 (IGR: 17-1)

61394 Effects of Four Formulations of Prostaglandin Analogs on Eye Surface Cells. A Comparative Study
Sánchez-Montesinos I
PLoS ONE 2015; 10: e0129419 (IGR: 17-1)

61681 Effect of Two Novel Sustained-Release Drug Delivery Systems on Bleb Fibrosis: An In Vivo Glaucoma Drainage Device Study in a Rabbit Model
John VT
Translational vision science & technology 2015; 4: 4 (IGR: 17-1)

61491 In Vivo Effects of Preservative-free and Preserved Prostaglandin Analogs: Mouse Ocular Surface Study
Park YJ
Korean Journal of Ophthalmology 2015; 29: 270-279 (IGR: 17-1)

60979 Development of an Experimental Drug Eluting Suprachoroidal Microstent as Glaucoma Drainage Device
Wree A
Translational vision science & technology 2015; 4: 14 (IGR: 17-1)

61143 New prostaglandin analog formulation for glaucoma treatment containing cyclodextrins for improved stability, solubility and ocular tolerance
Gurny R
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 203-214 (IGR: 17-1)

61596 Development of a novel injectable drug delivery system for subconjunctival glaucoma treatment
Eickner T
Journal of Controlled Release 2015; 214: 1-11 (IGR: 17-1)

61394 Effects of Four Formulations of Prostaglandin Analogs on Eye Surface Cells. A Comparative Study
Campos A
PLoS ONE 2015; 10: e0129419 (IGR: 17-1)

60979 Development of an Experimental Drug Eluting Suprachoroidal Microstent as Glaucoma Drainage Device
Witt M
Translational vision science & technology 2015; 4: 14 (IGR: 17-1)

61681 Effect of Two Novel Sustained-Release Drug Delivery Systems on Bleb Fibrosis: An In Vivo Glaucoma Drainage Device Study in a Rabbit Model
Ayyala RS
Translational vision science & technology 2015; 4: 4 (IGR: 17-1)

61596 Development of a novel injectable drug delivery system for subconjunctival glaucoma treatment
Wree A; Schmitz KP
Journal of Controlled Release 2015; 214: 1-11 (IGR: 17-1)

60979 Development of an Experimental Drug Eluting Suprachoroidal Microstent as Glaucoma Drainage Device
Schmitz KP
Translational vision science & technology 2015; 4: 14 (IGR: 17-1)

61394 Effects of Four Formulations of Prostaglandin Analogs on Eye Surface Cells. A Comparative Study
Alaminos M
PLoS ONE 2015; 10: e0129419 (IGR: 17-1)

60979 Development of an Experimental Drug Eluting Suprachoroidal Microstent as Glaucoma Drainage Device
Allemann R
Translational vision science & technology 2015; 4: 14 (IGR: 17-1)

61596 Development of a novel injectable drug delivery system for subconjunctival glaucoma treatment
Guthoff R; Witt M; Hovakimyan M
Journal of Controlled Release 2015; 214: 1-11 (IGR: 17-1)

60781 Topical glaucoma therapy and ocular surface disease: a prospective, controlled cohort study
Saade CE
Canadian Journal of Ophthalmology 2015; 50: 132-136 (IGR: 16-4)

60578 Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives
Ramli N
Optometry and Vision Science 2015; 92: e222-e226 (IGR: 16-4)

60168 Original preparations versus generics--latanoprost: how similar is different?
Leitritz MA
Ophthalmologe 2015; 112: 127-139 (IGR: 16-4)

60294 Nanosponge-Mediated Drug Delivery Lowers Intraocular Pressure
Lambert WS
Translational vision science & technology 2015; 4: 1 (IGR: 16-4)

60589 Dry eye specific quality of life in veterans using glaucoma drops
Camp A
Contact Lens and Anterior Eye 2015; 38: 220-225 (IGR: 16-4)

60097 Stability of Latanoprost in Generic Formulations Using Controlled Degradation and Patient Usage Simulation Studies
Velpandian T
Current Eye Research 2015; 40: 561-571 (IGR: 16-4)

60624 From benzalkonium chloride-preserved Latanoprost to Polyquad-preserved Travoprost: a 6-month study on ocular surface safety and tolerability
Rossi GC
Expert Opinion on Drug Safety 2015; 14: 619-623 (IGR: 16-4)

60259 A Survey on the Preference of Sustained Glaucoma Drug Delivery Systems by Singaporean Chinese Patients: A Comparison Between Subconjunctival, Intracameral, and Punctal Plug Routes
Chan HH
Journal of Glaucoma 2015; 24: 485-492 (IGR: 16-4)

60017 A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components
Pfeiffer N
Advances in Therapy 2014; 31: 1228-1246 (IGR: 16-4)

60640 Genomic and post-genomic effects of anti-glaucoma drugs preservatives in trabecular meshwork
Izzotti A
Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis 2015; 772: 1-9 (IGR: 16-4)

60323 Sustained drug release by contact lenses for glaucoma treatment-a review
Carvalho IM
Journal of Controlled Release 2015; 202: 76-82 (IGR: 16-4)

60084 A National Survey of Glaucoma Specialists on the Preoperative (Trabeculectomy) Management of the Ocular Surface
Tailor R
Seminars in Ophthalmology 2014; 0: 1-7 (IGR: 16-4)

60628 Impact of supply problems of preservative-free glaucoma medications on patients and hospital staff
Shah S
Ophthalmic and Physiological Optics 2015; 35: 236-241 (IGR: 16-4)

60359 A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure
Nagai N
Experimental Eye Research 2015; 132: 115-123 (IGR: 16-4)

60477 Decreased keratocyte density and central corneal thickness in primary open-angle glaucoma patients undergoing treatment with topical prostaglandin analogues
Kocabeyoglu S
Indian Journal of Ophthalmology 2015; 63: 15-19 (IGR: 16-4)

60630 Usability of prostaglandin monotherapy eye droppers
Drew T
British Journal of Ophthalmology 2015; 99: 1251-1254 (IGR: 16-4)

60542 Microbial contamination of glaucoma eyedrops used by patients compared with ocular medications used in the hospital
Teuchner B
Medicine 2015; 94: e583 (IGR: 16-4)

60330 Progression of drug delivery system for glaucoma
Xu Y
Chinese Journal of Ophthalmology 2014; 50: 946-951 (IGR: 16-4)

60612 Evaluation of the efficacy and safety of a new device for eye drops instillation in patients with glaucoma
Junqueira DM
Clinical Ophthalmology 2015; 9: 367-371 (IGR: 16-4)

60505 Diadenosine tetraphosphate improves adrenergic anti-glaucomatous drug delivery and efficiency
Loma P
Experimental Eye Research 2015; 134: 141-147 (IGR: 16-4)

60575 Nanotherapies for the treatment of ocular diseases
Reimondez-Troitiño S
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 279-293 (IGR: 16-4)

60477 Decreased keratocyte density and central corneal thickness in primary open-angle glaucoma patients undergoing treatment with topical prostaglandin analogues
Mocan MC
Indian Journal of Ophthalmology 2015; 63: 15-19 (IGR: 16-4)

60630 Usability of prostaglandin monotherapy eye droppers
Wolffsohn JS
British Journal of Ophthalmology 2015; 99: 1251-1254 (IGR: 16-4)

60589 Dry eye specific quality of life in veterans using glaucoma drops
Wellik SR
Contact Lens and Anterior Eye 2015; 38: 220-225 (IGR: 16-4)

60505 Diadenosine tetraphosphate improves adrenergic anti-glaucomatous drug delivery and efficiency
Guzman-Aranguez A
Experimental Eye Research 2015; 134: 141-147 (IGR: 16-4)

60640 Genomic and post-genomic effects of anti-glaucoma drugs preservatives in trabecular meshwork
La Maestra S
Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis 2015; 772: 1-9 (IGR: 16-4)

60578 Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives
Supramaniam G
Optometry and Vision Science 2015; 92: e222-e226 (IGR: 16-4)

60781 Topical glaucoma therapy and ocular surface disease: a prospective, controlled cohort study
Lari HB
Canadian Journal of Ophthalmology 2015; 50: 132-136 (IGR: 16-4)

60323 Sustained drug release by contact lenses for glaucoma treatment-a review
Marques CS
Journal of Controlled Release 2015; 202: 76-82 (IGR: 16-4)

60612 Evaluation of the efficacy and safety of a new device for eye drops instillation in patients with glaucoma
Lopes FS
Clinical Ophthalmology 2015; 9: 367-371 (IGR: 16-4)

60624 From benzalkonium chloride-preserved Latanoprost to Polyquad-preserved Travoprost: a 6-month study on ocular surface safety and tolerability
Scudeller L
Expert Opinion on Drug Safety 2015; 14: 619-623 (IGR: 16-4)

60575 Nanotherapies for the treatment of ocular diseases
Csaba N
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 279-293 (IGR: 16-4)

60330 Progression of drug delivery system for glaucoma
Lyu L
Chinese Journal of Ophthalmology 2014; 50: 946-951 (IGR: 16-4)

60259 A Survey on the Preference of Sustained Glaucoma Drug Delivery Systems by Singaporean Chinese Patients: A Comparison Between Subconjunctival, Intracameral, and Punctal Plug Routes
Wong TT
Journal of Glaucoma 2015; 24: 485-492 (IGR: 16-4)

60542 Microbial contamination of glaucoma eyedrops used by patients compared with ocular medications used in the hospital
Wagner J
Medicine 2015; 94: e583 (IGR: 16-4)

60168 Original preparations versus generics--latanoprost: how similar is different?
Lipp HP
Ophthalmologe 2015; 112: 127-139 (IGR: 16-4)

60084 A National Survey of Glaucoma Specialists on the Preoperative (Trabeculectomy) Management of the Ocular Surface
Batra R
Seminars in Ophthalmology 2014; 0: 1-7 (IGR: 16-4)

60359 A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure
Yoshioka C
Experimental Eye Research 2015; 132: 115-123 (IGR: 16-4)

60097 Stability of Latanoprost in Generic Formulations Using Controlled Degradation and Patient Usage Simulation Studies
Kotnala A
Current Eye Research 2015; 40: 561-571 (IGR: 16-4)

60628 Impact of supply problems of preservative-free glaucoma medications on patients and hospital staff
Theodossiades J
Ophthalmic and Physiological Optics 2015; 35: 236-241 (IGR: 16-4)

60294 Nanosponge-Mediated Drug Delivery Lowers Intraocular Pressure
Carlson BJ
Translational vision science & technology 2015; 4: 1 (IGR: 16-4)

60017 A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components
Traverso CE
Advances in Therapy 2014; 31: 1228-1246 (IGR: 16-4)

60259 A Survey on the Preference of Sustained Glaucoma Drug Delivery Systems by Singaporean Chinese Patients: A Comparison Between Subconjunctival, Intracameral, and Punctal Plug Routes
Lamoureux E
Journal of Glaucoma 2015; 24: 485-492 (IGR: 16-4)

60542 Microbial contamination of glaucoma eyedrops used by patients compared with ocular medications used in the hospital
Bechrakis NE
Medicine 2015; 94: e583 (IGR: 16-4)

60323 Sustained drug release by contact lenses for glaucoma treatment-a review
Oliveira RS
Journal of Controlled Release 2015; 202: 76-82 (IGR: 16-4)

60084 A National Survey of Glaucoma Specialists on the Preoperative (Trabeculectomy) Management of the Ocular Surface
Mohamed S
Seminars in Ophthalmology 2014; 0: 1-7 (IGR: 16-4)

60612 Evaluation of the efficacy and safety of a new device for eye drops instillation in patients with glaucoma
de Souza FC
Clinical Ophthalmology 2015; 9: 367-371 (IGR: 16-4)

60359 A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure
Mano Y
Experimental Eye Research 2015; 132: 115-123 (IGR: 16-4)

60097 Stability of Latanoprost in Generic Formulations Using Controlled Degradation and Patient Usage Simulation Studies
Halder N
Current Eye Research 2015; 40: 561-571 (IGR: 16-4)

60477 Decreased keratocyte density and central corneal thickness in primary open-angle glaucoma patients undergoing treatment with topical prostaglandin analogues
Irkec M
Indian Journal of Ophthalmology 2015; 63: 15-19 (IGR: 16-4)

60628 Impact of supply problems of preservative-free glaucoma medications on patients and hospital staff
Chapman K
Ophthalmic and Physiological Optics 2015; 35: 236-241 (IGR: 16-4)

60578 Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives
Samsudin A
Optometry and Vision Science 2015; 92: e222-e226 (IGR: 16-4)

60168 Original preparations versus generics--latanoprost: how similar is different?
Voykov B
Ophthalmologe 2015; 112: 127-139 (IGR: 16-4)

60017 A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components
Lorenz K
Advances in Therapy 2014; 31: 1228-1246 (IGR: 16-4)

60624 From benzalkonium chloride-preserved Latanoprost to Polyquad-preserved Travoprost: a 6-month study on ocular surface safety and tolerability
Rolle T
Expert Opinion on Drug Safety 2015; 14: 619-623 (IGR: 16-4)

60505 Diadenosine tetraphosphate improves adrenergic anti-glaucomatous drug delivery and efficiency
Perez De Lara MJ
Experimental Eye Research 2015; 134: 141-147 (IGR: 16-4)

60781 Topical glaucoma therapy and ocular surface disease: a prospective, controlled cohort study
Berezina TL
Canadian Journal of Ophthalmology 2015; 50: 132-136 (IGR: 16-4)

60575 Nanotherapies for the treatment of ocular diseases
Alonso MJ
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 279-293 (IGR: 16-4)

60294 Nanosponge-Mediated Drug Delivery Lowers Intraocular Pressure
van der Ende AE
Translational vision science & technology 2015; 4: 1 (IGR: 16-4)

60589 Dry eye specific quality of life in veterans using glaucoma drops
Tzu JH
Contact Lens and Anterior Eye 2015; 38: 220-225 (IGR: 16-4)

60640 Genomic and post-genomic effects of anti-glaucoma drugs preservatives in trabecular meshwork
Micale RT
Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis 2015; 772: 1-9 (IGR: 16-4)

60542 Microbial contamination of glaucoma eyedrops used by patients compared with ocular medications used in the hospital
Orth-Höller D
Medicine 2015; 94: e583 (IGR: 16-4)

60294 Nanosponge-Mediated Drug Delivery Lowers Intraocular Pressure
Shih G
Translational vision science & technology 2015; 4: 1 (IGR: 16-4)

60781 Topical glaucoma therapy and ocular surface disease: a prospective, controlled cohort study
Fechtner RD
Canadian Journal of Ophthalmology 2015; 50: 132-136 (IGR: 16-4)

60628 Impact of supply problems of preservative-free glaucoma medications on patients and hospital staff
Murdoch I
Ophthalmic and Physiological Optics 2015; 35: 236-241 (IGR: 16-4)

60575 Nanotherapies for the treatment of ocular diseases
de la Fuente M
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 279-293 (IGR: 16-4)

60323 Sustained drug release by contact lenses for glaucoma treatment-a review
Coelho PB
Journal of Controlled Release 2015; 202: 76-82 (IGR: 16-4)

60640 Genomic and post-genomic effects of anti-glaucoma drugs preservatives in trabecular meshwork
Longobardi MG
Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis 2015; 772: 1-9 (IGR: 16-4)

60505 Diadenosine tetraphosphate improves adrenergic anti-glaucomatous drug delivery and efficiency
Pintor J
Experimental Eye Research 2015; 134: 141-147 (IGR: 16-4)

60578 Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives
Juana A
Optometry and Vision Science 2015; 92: e222-e226 (IGR: 16-4)

60359 A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure
Tnabe W
Experimental Eye Research 2015; 132: 115-123 (IGR: 16-4)

60168 Original preparations versus generics--latanoprost: how similar is different?
Ziemssen F
Ophthalmologe 2015; 112: 127-139 (IGR: 16-4)

60097 Stability of Latanoprost in Generic Formulations Using Controlled Degradation and Patient Usage Simulation Studies
Ravi AK
Current Eye Research 2015; 40: 561-571 (IGR: 16-4)

60624 From benzalkonium chloride-preserved Latanoprost to Polyquad-preserved Travoprost: a 6-month study on ocular surface safety and tolerability
Pasinetti GM
Expert Opinion on Drug Safety 2015; 14: 619-623 (IGR: 16-4)

60259 A Survey on the Preference of Sustained Glaucoma Drug Delivery Systems by Singaporean Chinese Patients: A Comparison Between Subconjunctival, Intracameral, and Punctal Plug Routes
Perera S
Journal of Glaucoma 2015; 24: 485-492 (IGR: 16-4)

60017 A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components
Saarela V
Advances in Therapy 2014; 31: 1228-1246 (IGR: 16-4)

60589 Dry eye specific quality of life in veterans using glaucoma drops
Feuer W
Contact Lens and Anterior Eye 2015; 38: 220-225 (IGR: 16-4)

60612 Evaluation of the efficacy and safety of a new device for eye drops instillation in patients with glaucoma
Dorairaj S
Clinical Ophthalmology 2015; 9: 367-371 (IGR: 16-4)

60624 From benzalkonium chloride-preserved Latanoprost to Polyquad-preserved Travoprost: a 6-month study on ocular surface safety and tolerability
Bianchi PE
Expert Opinion on Drug Safety 2015; 14: 619-623 (IGR: 16-4)

60359 A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure
Ito Y
Experimental Eye Research 2015; 132: 115-123 (IGR: 16-4)

60542 Microbial contamination of glaucoma eyedrops used by patients compared with ocular medications used in the hospital
Nagl M
Medicine 2015; 94: e583 (IGR: 16-4)

60589 Dry eye specific quality of life in veterans using glaucoma drops
Arheart KL
Contact Lens and Anterior Eye 2015; 38: 220-225 (IGR: 16-4)

60017 A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components
Liinamaa J
Advances in Therapy 2014; 31: 1228-1246 (IGR: 16-4)

60097 Stability of Latanoprost in Generic Formulations Using Controlled Degradation and Patient Usage Simulation Studies
Archunan V
Current Eye Research 2015; 40: 561-571 (IGR: 16-4)

60578 Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives
Zahari M
Optometry and Vision Science 2015; 92: e222-e226 (IGR: 16-4)

60294 Nanosponge-Mediated Drug Delivery Lowers Intraocular Pressure
Dobish JN
Translational vision science & technology 2015; 4: 1 (IGR: 16-4)

60640 Genomic and post-genomic effects of anti-glaucoma drugs preservatives in trabecular meshwork
Saccà SC
Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis 2015; 772: 1-9 (IGR: 16-4)

60612 Evaluation of the efficacy and safety of a new device for eye drops instillation in patients with glaucoma
Prata TS
Clinical Ophthalmology 2015; 9: 367-371 (IGR: 16-4)

60781 Topical glaucoma therapy and ocular surface disease: a prospective, controlled cohort study
Khouri AS
Canadian Journal of Ophthalmology 2015; 50: 132-136 (IGR: 16-4)

60323 Sustained drug release by contact lenses for glaucoma treatment-a review
Costa PC
Journal of Controlled Release 2015; 202: 76-82 (IGR: 16-4)

60359 A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure
Okamoto N
Experimental Eye Research 2015; 132: 115-123 (IGR: 16-4)

60294 Nanosponge-Mediated Drug Delivery Lowers Intraocular Pressure
Calkins DJ
Translational vision science & technology 2015; 4: 1 (IGR: 16-4)

60589 Dry eye specific quality of life in veterans using glaucoma drops
Sastry A
Contact Lens and Anterior Eye 2015; 38: 220-225 (IGR: 16-4)

60017 A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components
Uusitalo H
Advances in Therapy 2014; 31: 1228-1246 (IGR: 16-4)

60323 Sustained drug release by contact lenses for glaucoma treatment-a review
Ferreira DC
Journal of Controlled Release 2015; 202: 76-82 (IGR: 16-4)

60578 Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives
Choo MM
Optometry and Vision Science 2015; 92: e222-e226 (IGR: 16-4)

60097 Stability of Latanoprost in Generic Formulations Using Controlled Degradation and Patient Usage Simulation Studies
Sihota R
Current Eye Research 2015; 40: 561-571 (IGR: 16-4)

60294 Nanosponge-Mediated Drug Delivery Lowers Intraocular Pressure
Harth E
Translational vision science & technology 2015; 4: 1 (IGR: 16-4)

60589 Dry eye specific quality of life in veterans using glaucoma drops
Galor A
Contact Lens and Anterior Eye 2015; 38: 220-225 (IGR: 16-4)

60017 A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components
Astakhov Y
Advances in Therapy 2014; 31: 1228-1246 (IGR: 16-4)

60359 A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure
Shimomura Y
Experimental Eye Research 2015; 132: 115-123 (IGR: 16-4)

60017 A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components
Boiko E; Ropo A;
Advances in Therapy 2014; 31: 1228-1246 (IGR: 16-4)

59349 Ocular surface alterations and topical antiglaucomatous therapy: a review
Actis AG; Rolle T
Open Ophthalmology Journal 2014; 8: 67-72 (IGR: 16-3)

59119 The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients
Tsumura T; Yoshikawa K; Kimura T; Suzumura H; Kawashima M; Nanno M; Ishijima K; Takeda R
Clinical Ophthalmology 2014; 8: 1681-1687 (IGR: 16-3)

59238 Intraocular pressure decrease with preservative-free fixed and unfixed combination of tafluprost and timolol in pseudoexfoliative glaucoma
Holló G; Ropo A
Current Medical Research and Opinion 2014; 0: 1-4 (IGR: 16-3)

59260 Potential drug delivery approaches for XFS-associated and XFS-associated glaucoma
Kulkarni SS; Kompella UB
Journal of Glaucoma 2014; 23: S77-9 (IGR: 16-3)

59577 Late-day intraocular pressure-lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a randomized trial
Dubiner HB; Hubatsch DA
BMC Ophthalmology 2014; 14: 151 (IGR: 16-3)

59389 Effect of Eye Drops Containing Disulfiram and Low-Substituted Methylcellulose in Reducing Intraocular Pressure in Rabbit Models
Nagai N; Yoshioka C; Mano Y; Ito Y; Okamoto N; Shimomura Y
Current Eye Research 2014; 0: 1-11 (IGR: 16-3)

59385 Hybrid formulations of liposomes and bioadhesive polymers improve the hypotensive effect of the melatonin analogue 5-MCA-NAT in rabbit eyes
Quinteros D; Vicario-de-la-Torre M; Andrés-Guerrero V; Palma S; Allemandi D; Herrero-Vanrell R; Molina-Martínez IT
PLoS ONE 2014; 9: e110344 (IGR: 16-3)

59261 Noninvasive ocular drug delivery: potential transcorneal and other alternative delivery routes for therapeutic molecules in glaucoma
Foldvari M
Journal of Glaucoma 2014; 23: S80-2 (IGR: 16-3)

58908 Mirror-hat device as a drop delivery aid: a pilot study
Strungaru MH; Peck J; Compeau EC; Trope GE; Buys YM
Canadian Journal of Ophthalmology 2014; 49: 333-338 (IGR: 16-3)

59114 Targeted delivery of antiglaucoma drugs to the supraciliary space using microneedles
Kim YC; Edelhauser HF; Prausnitz MR
Investigative Ophthalmology and Visual Science 2014; 55: 7387-7397 (IGR: 16-3)

58788 Mechanisms of benzalkonium chloride toxicity in a human trabecular meshwork cell line and the protective role of preservative-free tafluprost
Chang C; Zhang AQ; Kagan DB; Liu H; Hutnik CM
Clinical and Experimental Ophthalmology 2015; 43: 164-172 (IGR: 16-3)

59094 Extended latanoprost release from commercial contact lenses: in vitro studies using corneal models
Mohammadi S; Jones L; Gorbet M
PLoS ONE 2014; 9: e106653 (IGR: 16-3)

59269 Balancing antimicrobial efficacy and toxicity of currently available topical ophthalmic preservatives
Tu EY
Saudi Journal of Ophthalmology 2014; 28: 182-187 (IGR: 16-3)

59551 Clinicians' perspectives on the use of drug-eluting contact lenses for the treatment of glaucoma
Taniguchi EV; Kalout P; Pasquale LR; Kohane DS; Ciolino JB
Therapeutic delivery 2014; 5: 1077-1083 (IGR: 16-3)

59000 Dorzolamide-loaded PLGA/vitamin E TPGS nanoparticles for glaucoma therapy: Pharmacoscintigraphy study and evaluation of extended ocular hypotensive effect in rabbits
Warsi MH; Anwar M; Garg V; Jain GK; Talegaonkar S; Ahmad FJ; Khar RK
Colloids and surfaces. B, Biointerfaces 2014; 122: 423-431 (IGR: 16-3)

59612 Cationic solid lipid nanoparticles enhance ocular hypotensive effect of melatonin in rabbit
Leonardi A; Bucolo C; Drago F; Salomone S; Pignatello R
International Journal of Pharmaceutics 2014; 478: 180-186 (IGR: 16-3)

58798 Methazolamide-loaded solid lipid nanoparticles modified with low-molecular weight chitosan for the treatment of glaucoma: vitro and vivo study
Wang F; Chen L; Zhang D; Jiang S; Shi K; Huang Y; Li R; Xu Q
Journal of drug targeting 2014; 22: 849-858 (IGR: 16-3)

56875 Scleral permeability varies by mouse strain and is decreased by chronic experimental glaucoma
Pease ME; Oglesby EN; Cone-Kimball E; Jefferys JL; Steinhart MR; Kim AJ; Hanes J; Quigley HA
Investigative Ophthalmology and Visual Science 2014; 55: 2564-2573 (IGR: 16-2)

57343 Preservative-free latanoprost eye drops in patients with primary open-angle glaucoma/ocular hypertension
Sanford M
Clinical Drug Investigation 2014; 34: 521-528 (IGR: 16-2)

57537 Formulation and evaluation of stimuli-sensitive hydrogels of timolol maleate and brimonidine tartrate for the treatment of glaucoma
Dubey A; Prabhu P
International journal of pharmaceutical investigation 2014; 4: 112-118 (IGR: 16-2)

57250 Ocular cytochrome P450s and transporters: roles in disease and endobiotic and xenobiotic disposition
Nakano M; Lockhart CM; Kelly EJ; Rettie AE
Drug Metabolism Reviews 2014; 46: 247-260 (IGR: 16-2)

57354 Preclinical development and ocular biodistribution of gemini-DNA nanoparticles after intravitreal and topical administration: Towards non-invasive glaucoma gene therapy
Alqawlaq S; Sivak JM; Huzil JT; Ivanova MV; Flanagan JG; Beazely MA; Foldvari M
Nanomedicine: Nanotechnology, Biology, and Medicine 2014; 10: 1637-1647 (IGR: 16-2)

57517 Efficacy and safety of benzalkonium chloride-free fixed-dose combination of latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension
Bhagat P; Sodimalla K; Paul C; Pandav SS; Raman GV; Ramakrishnan R; Joshi A; Raut A
Clinical Ophthalmology 2014; 8: 1241-1252 (IGR: 16-2)

57382 24-hour efficacy of travoprost/timolol BAK-free versus latanoprost/timolol fixed combinations in patients insufficiently controlled with latanoprost
Konstas AG; Voudouragkaki IC; Boboridis KG; Haidich AB; Paschalinou E; Giannopoulos T; Dragoumis ND; Makridis AK; Kahook MY
Advances in Therapy 2014; 31: 592-603 (IGR: 16-2)

57331 Controlled ocular drug delivery with nanomicelles
Vaishya RD; Khurana V; Patel S; Mitra AK
Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology 2014; 6: 422-437 (IGR: 16-2)

57479 28-day intraocular pressure reduction with a single dose of brimonidine tartrate-loaded microspheres
Fedorchak MV; Conner IP; Medina CA; Wingard JB; Schuman JS; Little SR
Experimental Eye Research 2014; 125: 210-216 (IGR: 16-2)

57435 Evaluation of an injectable thermosensitive hydrogel as drug delivery implant for ocular glaucoma surgery
Xi L; Wang T; Zhao F; Zheng Q; Li X; Luo J; Liu J; Quan D; Ge J
PLoS ONE 2014; 9: e100632 (IGR: 16-2)

57475 Advances in ocular drug delivery: emphasis on the posterior segment
Kang-Mieler JJ; Osswald CR; Mieler WF
Expert Opinion on Drug Delivery 2014; 0: 1-14 (IGR: 16-2)

57064 Objective evaluation of applying eye drops by elderly patients
Colomé-Campos J; Martínez-Salcedo I; Martorell-Hallado MC; Romero-Aroca P
Archivos de la Sociedad Espa�ola de Oftalmologia 2014; 89: 177-181 (IGR: 16-2)

56656 Managing adverse effects of glaucoma medications
Inoue K
Clinical Ophthalmology 2014; 8: 903-913 (IGR: 16-1)

56427 Confocal microscopy of epithelial and langerhans cells of the cornea in patients using travoprost drops containing two different preservatives
Marsovszky L; Resch MD; Visontai Z; Németh J
Pathology oncology research : POR 2014; 20: 741-746 (IGR: 16-1)

56088 Sustained drug release in nanomedicine: a long-acting nanocarrier-based formulation for glaucoma
Natarajan JV; Darwitan A; Barathi VA; Ang M; Htoon HM; Boey F; Tam KC; Wong TT; Venkatraman SS
ACS nano 2014; 8: 419-429 (IGR: 16-1)

56517 A temperature-induced and shear-reversible assembly of latanoprost-loaded amphiphilic chitosan colloids: Characterization and in vivo glaucoma treatment
Hsiao MH; Chiou SH; Larsson M; Hung KH; Wang YL; Liu CJ; Liu DM
Acta biomaterialia 2014; 10: 3188-3196 (IGR: 16-1)

56644 Drug-induced corneal damage

Prescrire International 2014; 23: 97-100 (IGR: 16-1)

56188 Sustained drug delivery in glaucoma
Knight OJ; Lawrence SD
Current Opinions in Ophthalmology 2014; 25: 112-117 (IGR: 16-1)

56537 An update on intravitreal implants in use for eye disorders
Lambiase A; Abdolrahimzadeh S; Recupero SM
Drugs of Today 2014; 50: 239-249 (IGR: 16-1)

56493 Bimatoprost 0.03%/timolol 0.5% preservative-free ophthalmic solution versus bimatoprost 0.03%/timolol 0.5% ophthalmic solution (Ganfort) for glaucoma or ocular hypertension: a 12-week randomised controlled trial
Goldberg I; Gil Pina R; Lanzagorta-Aresti A; Schiffman RM; Liu C; Bejanian M
British Journal of Ophthalmology 2014; 98: 926-931 (IGR: 16-1)

56243 Diamond nanogel-embedded contact lenses mediate lysozyme-dependent therapeutic release
Kim HJ; Zhang K; Moore L; Ho D
ACS nano 2014; 8: 2998-3005 (IGR: 16-1)

56313 Mechanism - Based Translational Pharmacokinetic - Pharmacodynamic Model to Predict Intraocular Pressure Lowering Effect of Drugs in Patients with Glaucoma or Ocular Hypertension
Durairaj C; Shen J; Cherukury M
Pharmaceutical Research 2014; 31: 2095-2106 (IGR: 16-1)

56289 Chitosan nanoparticles amplify the ocular hypotensive effect of cateolol in rabbits
Ameeduzzafar ; Ali J; Bhatnagar A; Kumar N; Ali A
International Journal of Biological Macromolecules 2014; 65: 479-491 (IGR: 16-1)

56514 Brinzolamide nanocrystal formulations for ophthalmic delivery: reduction of elevated intraocular pressure in vivo
Tuomela A; Liu P; Puranen J; Rönkkö S; Laaksonen T; Kalesnykas G; Oksala O; Ilkka J; Laru J; Järvinen K; Hirvonen J; Peltonen L
International Journal of Pharmaceutics 2014; 467: 34-41 (IGR: 16-1)

56624 The PEG-PCL-PEG Hydrogel as an Implanted Ophthalmic Delivery System after Glaucoma Filtration Surgery; a Pilot Study
Peng R; Qin G; Li X; Lv H; Qian Z; Yu L
Medical hypothesis, discovery and innovation in ophthalmology 2014; 3: 3-8 (IGR: 16-1)

56641 Comparison of diagnostic tests in distinct well-defined conditions related to dry eye disease
Alves M; Reinach PS; Paula JS; Vellasco E Cruz AA; Bachette L; Faustino J; Aranha FP; Vigorito A; de Souza CA; Rocha EM
PLoS ONE 2014; 9: e97921 (IGR: 16-1)

55601 Improvement in glaucoma patient quality of life by therapy switch to preservative-free timolol/dorzolamide fixed combination
Abegão Pinto L; Vandewalle E; Gerlier L; Stalmans I;
Ophthalmologica 2014; 231: 166-171 (IGR: 15-4)

55673 Ocular Surface Cytotoxicity and Safety Evaluation of Tafluprost, a Recently Developed Anti-Glaucoma Prostaglandin Analog
Niwano Y; Iwasawa A; Ayaki M
Ophthalmology and eye diseases 2014; 6: 5-12 (IGR: 15-4)

55709 The effectiveness of endonasal electrophoresis of neuroprotective agents used in the rehabilitative treatment of the patients presenting with primary open angle glaucoma
Nazarova GA; Konchugova TV; Iurova OV; Sichinava NV; Turova EA; Rassulova MA; Morozova NE
Voprosy kurortologii, fizioterapii, i lechebno? fizichesko? kultury 2013; 0: 27-30 (IGR: 15-4)

55376 Safety and Efficacy of Benzalkonium Chloride-optimized Tafluprost in Japanese Glaucoma Patients With Existing Superficial Punctate Keratitis
Suzuki K; Teranishi S; Sagara T; Yoshino H; Nakayama M; Enoki M; Nuno Y; Hirano S; Wakuta M; Takahashi N; Tokuhisa K; Kondo Y; Shiraishi R; Ishida Y; Sonoda KH;
Journal of Glaucoma 2015; 24: e145-e150 (IGR: 15-4)

55170 In vivo performance of a drug-eluting contact lens to treat glaucoma for a month
Ciolino JB; Stefanescu CF; Ross AE; Salvador-Culla B; Cortez P; Ford EM; Wymbs KA; Sprague SL; Mascoop DR; Rudina SS; Trauger SA; Cade F; Kohane DS
Biomaterials 2014; 35: 432-439 (IGR: 15-4)

55090 Development of inclusion complex of brinzolamide with hydroxypropyl-β-cyclodextrin
Zhang Y; Ren K; He Z; Li H; Chen T; Lei Y; Xia S; He G; Xie Y; Zheng Y; Song X
Carbohydrate polymers 2013; 98: 638-643 (IGR: 15-4)

55298 Biodegradable in situ gelling delivery systems containing pilocarpine as new antiglaucoma formulations: effect of a mercaptoacetic acid/N-isopropylacrylamide molar ratio
Lai JY
Drug design, development and therapy 2013; 7: 1273-1285 (IGR: 15-4)

55757 Bimatoprost-loaded ocular inserts as sustained release drug delivery systems for glaucoma treatment: in vitro and in vivo evaluation
Franca JR; Foureaux G; Fuscaldi LL; Ribeiro TG; Rodrigues LB; Bravo R; Castilho RO; Yoshida MI; Cardoso VN; Fernandes SO; Cronemberger S; Ferreira AJ; Faraco AA
PLoS ONE 2014; 9: e95461 (IGR: 15-4)

55148 Molecular dynamic simulations of ocular tablet dissolution
Ru Q; Fadda HM; Li C; Paul D; Khaw PT; Brocchini S; Zloh M
Journal of Chemical Information and Modeling 2013; 53: 3000-3008 (IGR: 15-4)

55748 Formulation and In-vitro Characterization of Sustained Release Matrix Type Ocular Timolol Maleate Mini-Tablet
Mortazavi SA; Jafariazar Z; Ghadjahani Y; Mahmoodi H; Mehtarpour F
Iranian journal of pharmaceutical research : IJPR 2014; 13: 19-27 (IGR: 15-4)

55443 Acetazolamide encapsulated dendritic nano-architectures for effective glaucoma management in rabbits
Mishra V; Jain NK
International Journal of Pharmaceutics 2014; 461: 380-390 (IGR: 15-4)

55203 Glaucoma and dry eye. Current concepts and future perspectives
Steven P; Cursiefen C
Ophthalmologe 2013; 110: 1155-1159 (IGR: 15-4)

55440 Probing influence of methodological variation on active loading of acetazolamide into nanoliposomes: biophysical, in vitro, ex vivo, in vivo and rheological investigation
Pisal PB; Joshi MA; Padamwar MN; Patil SS; Pokharkar VB
International Journal of Pharmaceutics 2014; 461: 82-88 (IGR: 15-4)

55211 Chick chorioallantoic membrane model for in ovo evaluation of timolol maleate-brimonidine tartrate ocular inserts
Ravindran VK; Repala S; Subadhra S; Appapurapu AK
Drug Delivery 2014; 21: 307-314 (IGR: 15-4)

55672 Changes in the morphological and functional patterns of the ocular surface in patients treated with prostaglandin analogues after the use of TSP 0.5%® preservative-free eyedrops: a prospective, multicenter study
Iester M; Oddone F; Fogagnolo P; Frezzotti P; Figus M;
Ophthalmic Research 2014; 51: 146-152 (IGR: 15-4)

55342 How ocular surface disease impacts the glaucoma treatment outcome
Kaštelan S; Tomić M; Metež Soldo K; Salopek-Rabatić J
BioMed research international 2013; 2013: 696328 (IGR: 15-4)

55232 Meta analysis about the efficacy and safety of anti-ocular hypertension eye drops without benzalkonium chloride
Wang YQ; Wang X; Liu P
Asian Pacific journal of tropical medicine 2013; 6: 1004-1008 (IGR: 15-4)

55321 Benzalkonium chloride and glaucoma
Rasmussen CA; Kaufman PL; Kiland JA
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 163-169 (IGR: 15-4)

55729 Potential use of niosomal hydrogel as an ocular delivery system for atenolol
Abu Hashim II; El-Dahan MS; Yusif RM; Abd-Elgawad AE; Arima H
Biological & Pharmaceutical Bulletin 2014; 37: 541-551 (IGR: 15-4)

55642 In situ gelling dorzolamide loaded chitosan nanoparticles for the treatment of glaucoma
Katiyar S; Pandit J; Mondal RS; Mishra AK; Chuttani K; Aqil M; Ali A; Sultana Y
Carbohydrate polymers 2014; 102: 117-124 (IGR: 15-4)

55339 Development of dorzolamide loaded 6-o-carboxymethyl chitosan nanoparticles for open angle glaucoma
Shinde U; Ahmed MH; Singh K
Journal of Drug Delivery 2013; 2013: 562727 (IGR: 15-4)

55495 Development and characterization of nano-fiber patch for the treatment of glaucoma
Gagandeep ; Garg T; Malik B; Rath G; Goyal AK
European Journal of Pharmaceutical Sciences 2014; 53: 10-16 (IGR: 15-4)

55384 Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine
Kim NJ; Harris A; Gerber A; Tobe LA; Amireskandari A; Huck A; Siesky B
British Journal of Ophthalmology 2014; 98: 427-431 (IGR: 15-4)

54431 Effect of chronic anti-glaucoma medications and trabeculectomy on tear osmolarity
Lee SY; Wong TT; Chua J; Boo C; Soh YF; Tong L
Eye 2013; 27: 1142-1150 (IGR: 15-3)

54564 Ocular pharmacokinetics of bimatoprost formulated in DuraSite compared to bimatoprost 0.03% ophthalmic solution in pigmented rabbit eyes
Shafiee A; Bowman LM; Hou E; Hosseini K
Clinical Ophthalmology 2013; 7: 1549-1556 (IGR: 15-3)

54488 Relative Efficacy and Safety of Preservative-free Latanoprost (T2345) for the Treatment of Open-Angle Glaucoma and Ocular Hypertension: An Adjusted Indirect Comparison Meta-Analysis of Randomized Clinical Trials
Cucherat M; Stalmans I; Rouland JF
Journal of Glaucoma 2014; 23: e69-e75 (IGR: 15-3)

54664 Investigation on novel chitosan nanoparticle-aptamer complexes targeting TGF-β receptor II
Chen X; Zhu X; Li L; Xian G; Wang W; Ma D; Xie L
International Journal of Pharmaceutics 2013; 456: 499-507 (IGR: 15-3)

54844 The effects of ocular hypotensive drugs on the cornea: an in vivo analysis with confocal microscopy
Ferná,ndez Jimé,nez-Ortiz H; Toledano Ferná,ndez N; Ferná,ndez Escamez CS; Perucho Martinez S; Crespo Carballé,s MJ
Archivos de la Sociedad Espa�ola de Oftalmologia 2013; 88: 423-432 (IGR: 15-3)

54769 Critical Assessment of Implantable Drug Delivery Devices in Glaucoma Management
Manickavasagam D; Oyewumi MO
Journal of Drug Delivery 2013; 2013: 895013 (IGR: 15-3)

54528 Novel bioadhesive hyaluronan-itaconic acid crosslinked films for ocular therapy
Calles JA; Tá,rtara LI; Lopez-Garcí,a A; Diebold Y; Palma SD; Vallé,s EM
International Journal of Pharmaceutics 2013; 455: 48-56 (IGR: 15-3)

54735 Development, in vitro and in vivo characterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide
Verma P; Gupta RN; Jha AK; Pandey R
Drug Delivery 2013; 20: 269-276 (IGR: 15-3)

54573 Effect of preservative-free tafluprost on keratocytes, sub-Basal nerves, and endothelium: a single-blind one-year confocal study on naïve or treated glaucoma and hypertensive patients versus a control group
Rossi GC; Blini M; Scudeller L; Ricciardelli G; Depolo L; Amisano A; Bossolesi L; Pasinetti GM; Bianchi PE
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 821-825 (IGR: 15-3)

54746 Poly-(cyclo)dextrins as ethoxzolamide carriers in ophthalmic solutions and in contact lenses
Garcí,a-Ferná,ndez MJ; Tabary N; Martel B; Cazaux F; Oliva A; Taboada P; Concheiro A; Alvarez-Lorenzo C
Carbohydrate polymers 2013; 98: 1343-1352 (IGR: 15-3)

54415 Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study
Singh J; Chhabra G; Pathak K
Drug Development and Industrial Pharmacy 2014; 40: 1223-1232 (IGR: 15-3)

54533 A potential carrier based on liquid crystal nanoparticles for ophthalmic delivery of pilocarpine nitrate
Li J; Wu L; Wu W; Wang B; Wang Z; Xin H; Xu Q
International Journal of Pharmaceutics 2013; 455: 75-84 (IGR: 15-3)

54466 Development of latanoprost-loaded biodegradable nanosheet as a new drug delivery system for glaucoma
Kashiwagi K; Ito K; Haniuda H; Ohtsubo S; Takeoka S
Investigative Ophthalmology and Visual Science 2013; 54: 5629-5637 (IGR: 15-3)

54793 In vitro characterization of a controlled-release ocular insert for delivery of brimonidine tartrate
Mealy JE; Fedorchak MV; Little SR
Acta biomaterialia 2014; 10: 87-93 (IGR: 15-3)

54348 Sustained release of matrix metalloproteinase-3 to trabecular meshwork cells using biodegradable PLGA microparticles
Turturro S; Sunoqrot S; Ying H; Hong S; Yue BY
Molecular pharmaceutics 2013; 10: 3023-3032 (IGR: 15-3)

54785 Physicochemical and Pharmacological Investigation of Topical Ocular w/o Microemulsion of Timolol Maleate for Treatment of Glaucoma
Hegde RR; Bhattacharya SS; Verma A; Ghosh A
Current Eye Research 2014; 39: 155-163 (IGR: 15-3)

54526 Long acting betaxolol ocular inserts based on polymer composite
Gevariya HB; Patel JK
Current Drug Delivery 2013; 10: 384-393 (IGR: 15-3)

54040 Tear film status in glaucoma patients
Jandroković S; Suić SP; Kordić R; Kuzman T; Petricek I
Collegium Antropologicum 2013; 37: 137-140 (IGR: 15-2)

53795 Evaluation of Ocular Surface Disease in Patients with Glaucoma
Mathews PM; Ramulu PY; Friedman DS; Utine CA; Akpek EK
Ophthalmology 2013; 120: 2241-2248 (IGR: 15-2)

53856 An Effective Prodrug Strategy to Selectively Enhance Ocular Exposure of a Cannabinoid Receptor (CB1/2) Agonist
Mainolfi N; Powers J; Amin J; Long D; Lee W; McLaughlin ME; Jaffee B; Brain CT; Elliott J; Sivak JM
Journal of Medicinal Chemistry 2013; 0: (IGR: 15-2)

53739 Twenty-four hour efficacy with preservative free tafluprost compared with latanoprost in patients with primary open angle glaucoma or ocular hypertension
Konstas AG; Quaranta L; Katsanos A; Riva I; Tsai JC; Giannopoulos T; Voudouragkaki IC; Paschalinou E; Floriani I; Haidich AB
British Journal of Ophthalmology 2013; 97: 1510-1515 (IGR: 15-2)

53875 Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trial
Day DG; Walters TR; Schwartz GF; Mundorf TK; Liu C; Schiffman RM; Bejanian M
British Journal of Ophthalmology 2013; 97: 989-993 (IGR: 15-2)

53925 Novel Topical Ophthalmic Formulations for Management of Glaucoma
Ibrahim MM; Abd-Elgawad AE; Soliman OA; Jablonski MM
Pharmaceutical Research 2013; 30: 2818-2831 (IGR: 15-2)

54013 Ophthalmic Delivery of Brinzolamide by Liquid Crystalline Nanoparticles: In Vitro and In Vivo Evaluation
Wu W; Li J; Wu L; Wang B; Wang Z; Xu Q; Xin H
AAPS PharmSciTech 2013; 14: 1063-1071 (IGR: 15-2)

54050 Influence on ocular surface and intraocular pressure of switching from preservative-containing to preservative-free carteolol hydrochloride ophthalmic solution
Chikama T; Araie M; Nishida T
Nippon Ganka Gakkai Zasshi 2013; 117: 419-426 (IGR: 15-2)

53532 Liposomal diltiazem HCl as ocular drug delivery system for glaucoma
Mokhtar Ibrahim M; Tawfique SA; Mahdy MM
Drug Development and Industrial Pharmacy 2014; 40: 765-773 (IGR: 15-2)

53606 Ex vivo characterization of particle transport in mucus secretions coating freshly excised mucosal tissues
Ensign LM; Henning A; Schneider CS; Maisel K; Wang YY; Porosoff MD; Cone R; Hanes J
Molecular pharmaceutics 2013; 10: 2176-2182 (IGR: 15-2)

52537 The effect of Rho-associated kinase inhibition on the ocular penetration of timolol maleate
Arnold JJ; Hansen MS; Gorman GS; Inoue T; Rao V; Spellen S; Hunsinger RN; Chapleau CA; Pozzo-Miller L; Stamer WD; Challa P
Investigative Ophthalmology and Visual Science 2013; 54: 1118-1126 (IGR: 15-1)

52957 Localisation and quantification of benzalkonium chloride in eye tissue by TOF-SIMS imaging and liquid chromatography mass spectrometry
Desbenoit N; Schmitz-Afonso I; Baudouin C; Laprévote O; Touboul D; Brignole-Baudouin F; Brunelle A
Analytical and bioanalytical chemistry 2013; 405: 4039-4049 (IGR: 15-1)

52600 Nanotechnology and glaucoma: little particles for a big disease
Pita-Thomas DW; Goldberg JL
Current Opinions in Ophthalmology 2013; 24: 130-135 (IGR: 15-1)

52947 Preformulation study of methazolamide for topical ophthalmic delivery: physicochemical properties and degradation kinetics in aqueous solutions
Jiang S; Wang F; Zhu S; Zhang X; Guo Z; Li R; Xu Q
International Journal of Pharmaceutics 2013; 448: 390-393 (IGR: 15-1)

52814 Nanotechnology approaches for ocular drug delivery
Xu Q; Kambhampati SP; Kannan RM
Middle East African Journal of Ophthalmology 2013; 20: 26-37 (IGR: 15-1)

52417 Safety Assessment of Subconjunctivally Implanted Devices Containing Latanoprost in Dutch-Belted Rabbits
Jessen BA; Shiue MH; Kaur H; Miller P; Leedle R; Guo H; Evans M
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 574-585 (IGR: 15-1)

52437 Preservative Exposure and Surgical Outcomes in Glaucoma Patients: The PESO Study
Boimer C; Birt CM
Journal of Glaucoma 2013; 22: 730-735 (IGR: 15-1)

52612 Glaucoma therapy and ocular surface disease: current literature and recommendations
Anwar Z; Wellik SR; Galor A
Current Opinions in Ophthalmology 2013; 24: 136-143 (IGR: 15-1)

52452 Betaxolol hydrochloride loaded chitosan nanoparticles for ocular delivery and their anti-glaucoma efficacy
Jain K; Kumar RS; Sood S; Dhyanandhan G
Current Drug Delivery 2013; 10: 493-499 (IGR: 15-1)

53193 Preservative-free tafluprost in the treatment of naive patients with glaucoma and ocular hypertension
Lanzl I; Hamacher T; Rosbach K; Ramez MO; Rothe R; Růžičková E; Karhanová M; Kimmich F
Clinical Ophthalmology 2013; 7: 901-910 (IGR: 15-1)

53079 A comparative study of the safety and efficacy effect of 5-fluorouracil or mitomycin C mounted biological delivery membranes in a rabbit model of glaucoma filtration surgery
Wu Z; Li S; Wang N; Liu W
Clinical Ophthalmology 2013; 7: 655-662 (IGR: 15-1)

51847 Homemade lyophilized cross linking amniotic sustained-release drug membrane with anti-scarring role after filtering surgery in rabbit eyes
Li W; Chen WJ; Liu W; Liang L; Zhang MC
International Journal of Ophthalmology 2012; 5: 555-561 (IGR: 14-4)

51870 Acceptance, attitudes, and beliefs of Singaporean Chinese toward an ocular implant for glaucoma drug delivery
Foo RC; Lamoureux EL; Wong RC; Ho SW; Chiang PP; Rees G; Aung T; Wong TT
Investigative Ophthalmology and Visual Science 2012; 53: 8240-8245 (IGR: 14-4)

52049 Risk factors to develop ocular surface disease in treated glaucoma or ocular hypertension patients
Rossi GC; Pasinetti GM; Scudeller L; Raimondi M; Lanteri S; Bianchi PE
European Journal of Ophthalmology 2012; 0: 0 (IGR: 14-4)

51718 Acute effects of glaucoma medications and benzalkonium chloride on pre-adipocyte proliferation and adipocyte cytotoxicity in vitro
Seibold LK; Ammar DA; Kahook MY
Current Eye Research 2013; 38: 70-74 (IGR: 14-4)

51781 Glaucoma therapy by extended release of timolol from nanoparticle loaded silicone-hydrogel contact lenses
Jung HJ; Abou-Jaoude M; Carbia BE; Plummer C; Chauhan A
Journal of Controlled Release 2013; 165: 82-89 (IGR: 14-4)

51859 Preservative-containing eye drops and adherence in ophthalmological practice
Lanzl I; Kaercher T
Ophthalmologe 2012; 109: 1087-1092 (IGR: 14-4)

51973 Hybrid Dendrimer Hydrogel/Poly(Lactic-Co-Glycolic Acid) Nanoparticle Platform: An Advanced Vehicle for Topical Delivery of Antiglaucoma Drugs and a Likely Solution to Improving Compliance and Adherence in Glaucoma Management
Yang H; Leffler CT
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 166-172 (IGR: 14-4)

52099 Decrease in Corneal Damage due to Benzalkonium Chloride by the Addition of Sericin into Timolol Maleate Eye Drops
Nagai N; Ito Y; Okamoto N; Shimomura Y
Journal of oleo science 2013; 62: 159-166 (IGR: 14-4)

51808 Nanomedicine for the treatment of retinal and optic nerve diseases
Zarbin MA; Montemagno C; Leary JF; Ritch R
Current opinion in pharmacology 2013; 13: 134-148 (IGR: 14-4)

51857 Preservatives from the perspective of glaucoma surgery
Thieme H; van der Velden KK
Ophthalmologe 2012; 109: 1073-1076 (IGR: 14-4)

51858 Influence of dry eye syndrome on glaucoma diagnostic procedures
Rüfer F; Erb C
Ophthalmologe 2012; 109: 1082-1086 (IGR: 14-4)

51746 The triblock copolymers hydrogel through intracameral injection may be a new potential ophthalmic drug delivery with antiscaring drugs after glaucoma filtration surgery
Qiao Y; Qin G; Yu L
Medical Hypotheses 2013; 80: 23-25 (IGR: 14-4)

51897 A new safety concern for glaucoma treatment demonstrated by mass spectrometry imaging of benzalkonium chloride distribution in the eye, an experimental study in rabbits
Brignole-Baudouin F; Desbenoit N; Hamm G; Liang H; Both JP; Brunelle A; Fournier I; Guerineau V; Legouffe R; Stauber J; Touboul D; Wisztorski M; Salzet M; Laprevote O; Baudouin C
PLoS ONE 2012; 7: e50180 (IGR: 14-4)

51890 Extended Release of Timolol from Nanoparticle-Loaded Fornix Insert for Glaucoma Therapy
Jung HJ; Chauhan A
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 229-235 (IGR: 14-4)

51734 New concepts for glaucoma implants - controlled aqueous humor drainage, encapsulation prevention and local drug delivery
Schmidt W; Kastner C; Sternberg K; Allemann R; Lobler M; Guthoff R; Schmitz KP
Current Pharmaceutical Biotechnology 2013; 14: 98-111 (IGR: 14-4)

50883 The relationship between subbasal nerve morphology and corneal sensation in ocular surface disease
Labbé A; Alalwani H; Van Went C; Brasnu E; Georgescu D; Baudouin C
Investigative Ophthalmology and Visual Science 2012; 53: 4926-4931 (IGR: 14-3)

51253 Effects of BAK-free travoprost treatment for 3 years in patients with normal tension glaucoma
Inoue K; Iwasa M; Wakakura M; Tomita G
Clinical Ophthalmology 2012; 6: 1315-1319 (IGR: 14-3)

51391 Efficacy and Tolerability of Preservative-free Tafluprost 0.0015 % in the Treatment of Glaucoma and Ocular Hypertension
Karhanová M; Mlčák P; Fryšák Z; Marešová K
?eska a Slovenska Oftalmologie 2012; 68: 150-155 (IGR: 14-3)

50884 Toxicity evaluation of antiglaucoma drugs using stratified human cultivated corneal epithelial sheets
Nakagawa S; Usui T; Yokoo S; Omichi S; Kimakura M; Mori Y; Miyata K; Aihara M; Amano S; Araie M
Investigative Ophthalmology and Visual Science 2012; 53: 5154-5160 (IGR: 14-3)

51162 Design of an implantable device for ocular drug delivery
Lee JH; Pidaparti RM; Atkinson GM; Moorthy RS
Journal of Drug Delivery 2012; 2012: 527516 (IGR: 14-3)

51044 Investigation of surfactants suitable for stabilizing of latanoprost
Ochiai A; Ohkuma M; Danjo K
International Journal of Pharmaceutics 2012; 436: 732-737 (IGR: 14-3)

50989 Preparation and characterization of polymeric and lipid nanoparticles of pilocarpine HCl for ocular application
Lütfi G; Müzeyyen D
Pharmaceutical Development and Technology 2013; 18: 701-709 (IGR: 14-3)

51140 Characterisation of ilomastat for prolonged ocular drug release
Parkinson G; Gaisford S; Ru Q; Lockwood A; Khalili A; Sheridan R; Khaw PT; Brocchini S; Fadda HM
AAPS PharmSciTech 2012; 13: 1063-1072 (IGR: 14-3)

50556 Tear Film Osmolarity in Patients Treated for Glaucoma or Ocular Hypertension
Labbé A; Terry O; Brasnu E; Van Went C; Baudouin C
Cornea 2012; 31: 994-999 (IGR: 14-2)

50614 Stem cell-based delivery of brain-derived neurotrophic factor gene in the rat retina
Park HY; Kim JH; Sun Kim H; Park CK
Brain Research 2012; 1469: 10-23 (IGR: 14-2)

50462 Differential pharmacology and clinical utility of preservative-free tafluprost in the treatment of ocular hypertension and glaucoma
Ermiş SS
Clinical Ophthalmology 2012; 6: 673-678 (IGR: 14-2)

50570 Extended drug delivery by contact lenses for glaucoma therapy
Peng CC; Burke MT; Carbia BE; Plummer C; Chauhan A
Journal of Controlled Release 2012; 162: 152-158 (IGR: 14-2)

50468 Determination of permeability coefficients of ophthalmic drugs through different layers of porcine, rabbit and bovine eyes
Loch C; Zakelj S; Kristl A; Nagel S; Guthoff R; Weitschies W; Seidlitz A
European Journal of Pharmaceutical Sciences 2012; 47: 131-138 (IGR: 14-2)

50376 Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: Development, characterization and in vitro evaluation of their antitumoral efficacy
Herná,n Pé,rez de la Ossa D; Ligresti A; Gil-Alegre ME; Aberturas MR; Molpeceres J; Di Marzo V; Torres Suá,rez AI
Journal of Controlled Release 2012; 161: 927-932 (IGR: 14-2)

50490 A Comparative Study of a Preservative-Free Latanoprost Cationic Emulsion (Catioprost(®)) and a BAK-Preserved Latanoprost Solution in Animal Models
Daull P; Buggage R; Lambert G; Faure MO; Serle J; Wang RF; Garrigue JS
Journal of Ocular Pharmacology and Therapeutics 2012; 28: 515-523 (IGR: 14-2)

50536 A comparison of 0.1% timolol eye gel and 0.5% timolol eye drop in patients with chronic angle-closure glaucoma
Metheetrairut A; Leumsamran P; Rojananin S; Kitnarong N
Journal of the Medical Association of Thailand 2012; 95: S116-122 (IGR: 14-2)

50214 Single and mixed poloxamine micelles as nanocarriers for solubilization and sustained release of ethoxzolamide for topical glaucoma therapy
Ribeiro A; Sosnik A; Chiappetta DA; Veiga F; Concheiro A; Alvarez-Lorenzo C
Journal of the Royal Society, Interface / the Royal Society 2012; 9: 2059-2069 (IGR: 14-2)

50525 Efficacy and ocular surface tolerability of preservative-free tafluprost 0.0015%: a 6-month, single-blind, observational study on naïve ocular hypertension or glaucoma patients
Rossi GC; Pasinetti GM; Raimondi M; Ricciardelli G; Scudeller L; Blini M; Amisano A; Bianchi PE
Expert Opinion on Drug Safety 2012; 11: 519-525 (IGR: 14-2)

49353 A multicenter evaluation of ocular surface disease prevalence in patients with glaucoma
Garcia-Feijoo J; Sampaolesi JR
Clinical Ophthalmology 2012; 6: 441-446 (IGR: 14-1)

49003 Randomized Clinical Trial of the Efficacy and Safety of Preservative-free Tafluprost and Timolol in Patients With Open-Angle Glaucoma or Ocular Hypertension
Chabi A; Varma R; Tsai JC; Lupinacci R; Pigeon J; Baranak C; Noble L; Lines C; Ho TW
American Journal of Ophthalmology 2012; 153: 1187-1196 (IGR: 14-1)

48735 Comparison of human ocular distribution of bimatoprost and latanoprost
Ichhpujani P; Katz LJ; Hollo G; Shields CL; Shields JA; Marr B; Eagle R; Alvim H; Wizov SS; Acheampong A; Chen J; Wheeler LA
Journal of Ocular Pharmacology and Therapeutics 2012; 28: 134-145 (IGR: 14-1)

48966 Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye
Natarajan JV; Ang M; Darwitan A; Chattopadhyay S; Wong TT; Venkatraman SS
International Journal of Nanomedicine 2012; 7: 123-131 (IGR: 14-1)

49097 Overview of the BAK-free travoprost /timolol BAK-free fixed combination
Konstas AG; Quaranta L; Realini T
Expert Opinion in Pharmacotherapy 2012; 13: 757-766 (IGR: 14-1)

48854 Thermoreversible gel for delivery of activin receptor-like kinase 5 inhibitor SB-505124 for glaucoma filtration surgery
Sutariya V; Miladore N; Geldenhuys W; Bhatia D; Wehrung D; Nakamura H
Pharmaceutical Development and Technology 2013; 18: 957-962 (IGR: 14-1)

48602 Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro/in vivo evaluation
Aburahma MH; Mahmoud AA
AAPS PharmSciTech 2011; 12: 1335-1347 (IGR: 14-1)

49051 Drug delivery by contact lens in spontaneously glaucomatous dogs
Peng CC; Ben-Shlomo A; MacKay EO; Plummer CE; Chauhan A
Current Eye Research 2012; 37: 204-211 (IGR: 14-1)

48818 A gelatin-g-poly(N-isopropylacrylamide) biodegradable in situ gelling delivery system for the intracameral administration of pilocarpine
Lai JY; Hsieh AC
Biomaterials 2012; 33: 2372-2387 (IGR: 14-1)

48791 Timogel® vs timolol 0.5% ophthalmic solution: efficacy, safety, and acceptance
Rolle T; Curto D; Alovisi C; Franzone M; Brogliatti B; Grignolo FM
European Journal of Ophthalmology 0; 22: 28-33 (IGR: 14-1)

48823 Biodegradable Microfabricated Plug-Filters for Glaucoma Drainage Devices
Maleki T; Chitnis G; Park J; Cantor LB; Ziaie B
IEEE Transactions on Bio-Medical Engineering 2012; 59: 1507-1513 (IGR: 14-1)

48653 A comparison of active ingredients and preservatives between brand name and generic topical glaucoma medications using liquid chromatography-tandem mass spectrometry
Kahook MY; Fechtner RD; Katz LJ; Noecker RJ; Ammar DA
Current Eye Research 2012; 37: 101-108 (IGR: 14-1)

49318 Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb
Lallemand F; Daull P; Benita S; Buggage R; Garrigue JS
Journal of Drug Delivery 2012; 2012: 604204 (IGR: 14-1)

49016 New Mucoadhesive Chitosan Film for Ophthalmic Drug Delivery of Timolol Maleate: In Vivo Evaluation
Fulgê,ncio GD; Viana FA; Ribeiro RR; Yoshida MI; Faraco AG; Cunha-Jú,nior AD
Journal of Ocular Pharmacology and Therapeutics 2012; 28: 350-358 (IGR: 14-1)

49041 Generic versus brand-name North American topical glaucoma drops
Mammo ZN; Flanagan JG; James DF; Trope GE
Canadian Journal of Ophthalmology 2012; 47: 55-61 (IGR: 14-1)

48948 Topical drug delivery to the eye: dorzolamide
Loftsson T; Jansook P; Stefá,nsson E
Acta Ophthalmologica 2012; 90: 603-608 (IGR: 14-1)

48921 First experience with BAK-free travoprost 0.004% in topical glaucoma medication
Gado AS; MacKy TA
Clinical Ophthalmology 2012; 6: 1-4 (IGR: 14-1)

49331 Ocular surface and external filtration surgery: mutual relationships
Baudouin C
Developments in Ophthalmology 2012; 50: 64-78 (IGR: 14-1)

47862 Challenges in the clinical measurement of ocular surface disease in glaucoma patients
Pflugfelder SC; Baudouin C
Clinical Ophthalmology 2011; 5: 1575-1583 (IGR: 13-4)

48266 Corneal sensitivity in patients treated medically for glaucoma or ocular hypertension
Van Went C; Alalwani H; Brasnu E; Pham J; Hamard P; Baudouin C; Labb� A
Journal Fran�ais d'Ophtalmologie 2011; 34: 684-690 (IGR: 13-4)

47931 Incidence of new coding for dry eye and ocular infection in open-angle glaucoma and ocular hypertension patients treated with prostaglandin analogs: retrospective analysis of three medical/pharmacy claims databases
Schwartz GF; Kotak S; Mardekian J; Fain JM
BMC Ophthalmology 2011; 11: 14 (IGR: 13-4)

47832 Economic outcomes of glaucoma treatment with prostaglandin eye drops preserved with polyquad(registered trademark) instead of benzalkonium chloride in Germany
Gerlier L; Lamotte M; Lorenz K; Berdeaux G; Verboven Y; Pfeiffer N
Value in Health 2011; 14: A503 (IGR: 13-4)

48030 In vivo and ocular safety study of dorsolamide HCL ocular insert
Ghelani TK; Seth AK; Saini V; Kumar S; Yadav YC; Singhal S
Pharmacologyonline 2011; 2: 1179-1187 (IGR: 13-4)

48398 Periocular injection of in situ hydrogels containing Leu-Ile, an inducer for neurotrophic factors, promotes retinal ganglion cell survival after optic nerve injury
Nakatani M; Shinohara Y; Takii M; Mori H; Asai N; Nishimura S; Furukawa-Hibi Y; Miyamoto Y; Nitta A
Experimental Eye Research 2011; 93: 873-879 (IGR: 13-4)

47824 Pharmacokinetics of pirfenidone after topical administration in rabbit eye
Sun G; Lin X; Zhong H; Yang Y; Qiu X; Ye C; Wu K; Yu M
Molecular Vision 2011; 17: 2191-2196 (IGR: 13-4)

47608 The extended ocular hypotensive effect of positive liposomal cholesterol bound timolol maleate in glaucomatous rabbits
Shafaa MW; Sabra NM; Fouad RA
Biopharmaceutics and Drug Disposition 2011; 32: 507-517 (IGR: 13-4)

48037 Sustained release of an Anti-Glaucoma drug: Demonstration of efficacy of a liposomal formulation in the rabbit eye
Natarajan JV; Chattopadhyay S; Ang M; Darwitan A; Foo S; Zhen M; Koo M; Wong TT; Venkatraman SS
PLoS ONE 2011; 6:9 Article Number: e24513 (IGR: 13-4)

47881 Advances in preservative-free glaucoma drops
Stefan C; Pop A; Cojocaru I
Oftalmologia 2011; 55: 3-6 (IGR: 13-4)

47683 Challenge and treatment strategy for ocular surface damage in patients with long term use of antiglaucoma drugs
He XG
Chinese Journal of Ophthalmology 2011; 47: 101-104 (IGR: 13-4)

47580 Effect of ion pairing on in vitro transcorneal permeability of a (Delta)(9)-tetrahydrocannabinol prodrug: Potential in glaucoma therapy
Hingorani T; Gul W; Elsohly M; Repka MA; Majumdar S
Journal of Pharmaceutical Sciences 2011; (IGR: 13-4)

48004 Ophthalmic preservatives: Focus on polyquaternium-1
Rolando M; Crider JY; Kahook MY
Expert Opinion on Drug Delivery 2011; 8: 1425-1438 (IGR: 13-4)

47599 Chitosan nanoparticles for controlled delivery of brimonidine tartrate to the ocular membrane
Singh KH; Shinde UA
Pharmazie 2011; 66: 594-599 (IGR: 13-4)

47779 Patient acceptance and attitude toward an alternative method of subconjunctival injection for the medical treatment of glaucoma
Chong RS; Su D; Tsai A; Jiang Y; Htoon HM; Lamoureux EL; Aung T; Wong TT
Journal of Glaucoma 2011; (IGR: 13-4)

47753 Pharmacokinetics of antiglaucoma medications
Sachdev M; Yadava U; Bamrolia N
Journal of Current Glaucoma Practice 2011; 5: 21-26 (IGR: 13-4)

48002 Nanotechnology in ocular delivery: Current and future directions
Sultana Y; Maurya DP; Iqbal Z; Aqil M
Drugs of Today 2011; 47: 441-455 (IGR: 13-4)

47887 Antiglaucoma drugs: The role of preservative-free formulations
Bagnis A; Papadia M; Scotto R; Traverso CE
Saudi Journal of Ophthalmology 2011; 25: 389-394 (IGR: 13-4)

47852 Comparison of a travoprost BAK-free formulation preserved with polyquaternium-1 with BAK-preserved travoprost in ocular hypertension or open-angle glaucoma
Gandolfi S; Paredes T; Goldberg I; Coote M; Wells A; Volksone L; Pillai MR; Stalmans I; Denis P
European Journal of Ophthalmology 2011; 22: 34-44 (IGR: 13-4)

47835 A systematic review of observational studies of patients with ocular hypertension or glaucoma receiving long term topical eye therapies
Christova L; Cottrell S; Mudge M; Tilden D; Harvey C
Value in Health 2011; 14: A510 (IGR: 13-4)

47833 Longer term patient benefits of polyquad(registered trademark) preservative instead of benzalkonium chloride in prostaglandin eye drops: A microsimulation model in ocular hypertension and open-angle glaucoma
Gerlier L; Lamotte M; Berdeaux G; Verboven Y; Pfeiffer N
Value in Health 2011; 14: A502 (IGR: 13-4)

47812 Detection of raman spectra in ocular drugs for potential in vivo application of raman spectroscopy
Elshout M; Erckens RJ; Webers CA; Beckers HJ; Berendschot TT; de Brabander J; Hendrikse F; Schouten JS
Journal of Ocular Pharmacology and Therapeutics 2011; 27: 445-451 (IGR: 13-4)

47996 Prodrugs - An efficient way to breach delivery and targeting barriers
Huttunen KM; Rautio J
Current Topics in Medicinal Chemistry 2011; 11: 2265-2287 (IGR: 13-4)

47809 Novel ophthalmic timolol meleate liposomal-hydrogel and its improved local glaucomatous therapeutic effect in vivo
Hui-Hui Z; Qiu-Hua L; Zhi-Jun Y; Wei-San P; Shu-Fang N
Drug Delivery 2011; 18: 502-510 (IGR: 13-4)

47947 Polyamidoamine dendrimer hydrogel for enhanced delivery of antiglaucoma drugs
Holden CA; Tyagi P; Thakur A; Kadam R; Jadhav G; Kompella UB; Yang H
Nanomedicine: Nanotechnology, Biology, and Medicine 2011; (IGR: 13-4)

47853 Timogel((registered trademark)) vs timolol 0.5% ophthalmic solution: Efficacy, safety, and acceptance
Rolle T; Curto D; Alovisi C; Franzone M; Brogliatti B; Grignolo FM
European Journal of Ophthalmology 2011; 22: 28-33 (IGR: 13-4)

48334 Evaluation of Sustained Release of PLC-Loaded Prednisolone Acetate Microfilm on Postoperative Inflammation in an Experimental Model of Glaucoma Filtration Surgery
Ang M; Yan P; Zhen M; Foo S; Venkatraman SS; Wong TT
Current Eye Research 2011; 36: 1123-1128 (IGR: 13-4)

46458 Ocular Surface Disease and Quality of Life in Patients With Glaucoma
Skalicky SE; Goldberg I; McCluskey P
American Journal of Ophthalmology 2011; (IGR: 13-3)

46941 About ocular surface damage
Stefan C; Pop A; Cojocaru I
Oftalmologia 2011; 55: 38-40 (IGR: 13-3)

46956 Preparation of ophthalmic formulations containing cilostazol as an anti-glaucoma agent and improvement in its permeability through the rabbit cornea
Okamoto N; Ito Y; Nagai N; Murao T; Takiguchi Y; Kurimoto T; Mimura O
Journal of oleo science 2010; 59: 423-430 (IGR: 13-3)

46746 Preservative-free tafluprost 0.0015% in the treatment of patients with glaucoma and ocular hypertension
Erb C; Lanzl I; Seidova S-F; Kimmich F
Advances in Therapy 2011; 1-11 (IGR: 13-3)

46375 Travoprost 0.004%/timolol 0.5%-fixed combination with and without benzalkonium chloride: a prospective, randomized, doubled-masked comparison of safety and efficacy
Kitazawa Y; Smith P; Sasaki N; Kotake S; Bae K; Iwamoto Y
Eye 2011; 25: 1161-1169 (IGR: 13-3)

47012 Benzalkonium chloride in glaucoma medications
Noecker R; Miller KV
Ocular Surface 2011; 9: 159-162 (IGR: 13-3)

46668 Retinal ganglion cells survival in a glaucoma model by GDNF/Vit E PLGA microspheres prepared according to a novel microencapsulation procedure
Checa-Casalengua P; Jiang C; Bravo-Osuna I; Tucker BA; Molina-Martinez IT; Young MJ; Herrero-Vanrell R
Journal of Controlled Release 2011; (IGR: 13-3)

47008 Nanovesicular Formulation of Brimonidine Tartrate for the Management of Glaucoma: In Vitro and In Vivo Evaluation
Maiti S; Paul S; Mondol R; Ray S; Sa B
AAPS PharmSciTech 2011; (IGR: 13-3)

46997 Evaluation of the ocular penetration of topical alpha-luminol (Galavit((registered trademark))/GVT((registered trademark)))
da Silva EG; Gionfriddo JR; Hudachek SF; Gustafson DL; Olea-Popelka FJ; Scofield VL; Powell CC; Hill AE
Veterinary Ophthalmology 2011; 14: 180-185 (IGR: 13-3)

46781 Thermosensitive in situ gel of Timolol Maleate for the treatment of open angle glaucoma
Yeole PG; Iyer D
Research Journal of Pharmaceutical, Biological and Chemical Sciences 2011; 2: 1048-1064 (IGR: 13-3)

46778 Formulation and evaluation of dorzolamide hydrochloride polymeric film
Tandale YN; Wagh VD
International Journal of PharmTech Research 2011; 3: 1817-1824 (IGR: 13-3)

47009 Brimonidine Tartrate-Eudragit Long-Acting Nanoparticles: Formulation, Optimization, In Vitro and In Vivo Evaluation
Bhagav P; Upadhyay H; Chandran S
AAPS PharmSciTech 2011; (IGR: 13-3)

46330 Managing treatment side effects: the respective roles of the active ingredient and the preservative
Aptel F; Denis P; Baudouin C
Journal Fran�ais d'Ophtalmologie 2011; 34: 409-412 (IGR: 13-3)

47011 Preservative use in topical glaucoma medications
Tressler CS; Beatty R; Lemp MA
Ocular Surface 2011; 9: 140-158 (IGR: 13-3)

46555 Prescribing for older adults
Boparai MK; Korc-Grodzicki B
Mount Sinai Journal of Medicine 2011; 78: 613-626 (IGR: 13-3)

46441 Sclera-choroid-RPE transport of eight ?-blockers in human, bovine, porcine, rabbit, and rat models
Kadam RS; Cheruvu NP; Edelhauser HF; Kompella UB
Investigative Ophthalmology and Visual Science 2011; 52: 5387-5399 (IGR: 13-3)

46863 Effects of benzalkonium chloride- or polyquad-preserved fixed combination glaucoma medications on human trabecular meshwork cells
Ammar DA; Kahook MY
Molecular Vision 2011; 17: 1806-1813 (IGR: 13-3)

46889 Drug delivery to the posterior segment of the eye
Fischer N; Narayanan R; Loewenstein A; Kuppermann BD
European Journal of Ophthalmology 2011; 21: 20-26 (IGR: 13-3)

46720 In vitro and in vivo evaluation of an intraocular implant for glaucoma treatment
Natu MV; Gaspar MN; Fontes Ribeiro CA; Cabrita AM; De Sousa HC; Gil MH
International Journal of Pharmaceutics 2011; 415: 73-82 (IGR: 13-3)

46926 Benzalkonium chloride daily dose - An important criterion in glaucoma treatment
Vyborny P; Sicakova S
?eska a Slovenska Oftalmologie 2011; 67: 63-66 (IGR: 13-3)

46570 An in vitro evaluation for corneal damages by anti-glaucoma combination eye drops using human corneal epithelial cell (HCE-T)
Nagai N; Murao T; Oe K; Ito Y; Okamoto N; Shimomura Y
Yakugaku Zasshi 2011; 131: 985-991 (IGR: 13-3)

46451 A Video Study of Drop Instillation in Both Glaucoma and Retina Patients with Visual Impairment
Hennessy AL; Katz J; Covert D; Kelly CA; Suan EP; Speicher MA; Sund NJ; Robin AL
American Journal of Ophthalmology 2011; (IGR: 13-3)

45804 Ocular surface disease in patients with ocular hypertension and glaucoma
Stewart WC; Stewart JA; Nelson LA
Current Eye Research 2011; 36: 391-398 (IGR: 13-2)

45610 Effects of glaucoma medications and preservatives on cultured human trabecular meshwork and non-pigmented ciliary epithelial cell lines
Ammar DA; Kahook MK
British Journal of Ophthalmology 2011; (IGR: 13-2)

45734 The use of mucoadhesive polymers to enhance the hypotensive effect of a melatonin analogue, 5-MCA-NAT, in rabbit eyes
Andres-Guerrero V; Molina-Martinez IT; Pera A; de las Heras B; Pintor J; Herrero-Vanrell R
Investigative Ophthalmology and Visual Science 2011; 52: 1507-1515 (IGR: 13-2)

45454 Comparison of the In Vitro Tolerance and In Vivo Efficacy of Traditional Timolol Maleate Eye Drops versus New Formulations with Bioadhesive Polymers
Andr�s-Guerrero V; Vicario-de-la-Torre M; Molina-Mart�nez IT; Ben�tez-Del-Castillo JM; Garc�a-Feijoo J; Herrero-Vanrell R
Investigative Ophthalmology and Visual Science 2011; 52: 3548-3556 (IGR: 13-2)

46315 Bioactivation antioxidant and transglycating properties of N-acetylcarnosine autoinduction prodrug of a dipeptide L-carnosine in mucoadhesive drug delivery eye-drop formulation: Powerful eye health application technique and therapeutic platform
Babizhayev MA
Drug Testing and Analysis 2011; (IGR: 13-2)

45545 Mucoadhesive microparticles in a rapidly dissolving tablet for sustained drug delivery to the eye
Choy YB; Patel SR; Park JH; McCarey BE; Edelhauser HF; Prausnitz MR
Investigative Ophthalmology and Visual Science 2011; 52: 2627-2633 (IGR: 13-2)

45911 Force requirements in topical medicine usethe squeezability factor
Connor AJ; Severn PS
Eye 2011; 25: 466-469 (IGR: 13-2)

46259 Corneal cell culture models: A tool to study corneal drug absorption
Dey S
Expert Opinion on Drug Metabolism and Toxicology 2011; 7: 529-532 (IGR: 13-2)

45937 Enhancement of anti-glaucoma potential by novel ocular drug delivery system
Gupta S; Gilhotra RM
International Journal of Pharmacy and Pharmaceutical Sciences 2011; 3: 55-58 (IGR: 13-2)

46186 Enhanced Solubility, Stability, and Transcorneal Permeability of Delta-8-Tetrahydrocannabinol in the Presence of Cyclodextrins
Hippalgaonkar K; Gul W; Elsohly MA; Repka MA; Majumdar S
AAPS PharmSciTech 2011; (IGR: 13-2)

45645 Efficacy and safety of topical travoprost with sofzia(registered trademark) preservative for Japanese glaucoma patients
Kanamoto T; Kiuchi Y; Suehiro T; Nakano T; Nakano Y; Hirota A; Miyata A
Hiroshima Journal of Medical Sciences 2010; 59: 71-75 (IGR: 13-2)

45938 Effect of a single drop of Latanoprost ophthalmic gel on intra ocular pressure in the treatment of glaucoma
Kulkarni SV; Sandeep HN; Shankar MS; Ranjit Kumar P; Someshwara Rao B; Ramesh B; Ashok Kumar PA
International Journal of Pharmaceutical Sciences 2010; 2: 429-435 (IGR: 13-2)

45917 Novel drug delivery systems for glaucoma
Lavik E; Kuehn MH; Kwon YH
Eye 2011; 25: 578-586 (IGR: 13-2)

45504 Toxicological evaluation of preservative-containing and preservative-free topical prostaglandin analogues on a three-dimensional-reconstituted corneal epithelium system
Liang H; Pauly A; Riancho L; Baudouin C; Brignole-Baudouin F
British Journal of Ophthalmology 2011; 95: 869-875 (IGR: 13-2)

46266 A poly((epsilon)-caprolactone) device for sustained release of an anti-glaucoma drug
Natu MV; Gaspar MN; Ribeiro CAF; Correia IJ; Silva D; De Sousa HC; Gil MH
Biomedical Materials 2011; 6: 025003 (IGR: 13-2)

45940 Formulation and evaluation of Latanoprost ophthalmic gels
Sandeep HN; Kulkarni SV; Vinod R; Shankar MS; Someshwara Rao B; Ashok Kumar P
Journal of Global Pharma Technology 2010; 2: 35-39 (IGR: 13-2)

46101 Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue
Servat JJ; Bernardino CR
Drugs and Aging 2011; 28: 267-282 (IGR: 13-2)

46292 A timely review of state-of-the-art chronopharmaceuticals synchronized with biological rhythms
Sewlall S; Pillay V; Danckwerts MP; Choonara YE; Ndesendo VM; Du Toit LC
Current Drug Delivery 2010; 7: 370-388 (IGR: 13-2)

46288 An updated patent review on ocular drug delivery systems with potential for commercial viability
Srivastava R; Pathak K
Recent Patents on Drug Delivery and Formulation 2011; 5: 146-162 (IGR: 13-2)

46211 Polymers and drugs suitable for the development of a drug delivery drainage system in glaucoma surgery
Lobler M; Sternberg K; Stachs O; Allemann R; Grabow N; Roock A; Kreiner CF; Streufert D; Neffe AT; Hanh BD
Journal of Biomedical Materials Research - Part B Applied Biomaterials 2011; 97: 388-395 (IGR: 13-2)

28155 Efficacy, safety, and tolerability of travoprost 0.004% BAK-free versus prior treatment with latanoprost 0.005% in Japanese patients
Miyashiro MJ; Lo SC; Stewart JA; Stewart WC
Clinical Ophthalmology 2010; 4: 1355-1359 (IGR: 13-1)

27915 Rare case of allergic blepharoconjuctivitis due to dorsolamide eyedrops
Urbancek S; Hazuchova H
Contact Dermatitis 2010; 63 SUPPL. 1 (65-66 (IGR: 13-1)

28110 Efficacy and tolerability of preservative-free eye drops containing a fixed combination of dorzolamide and timolol in glaucoma patients
Renieri G; Fuhrer K; Scheithe K; Lorenz K; Pfeiffer N; Thieme H
Journal of Ocular Pharmacology and Therapeutics 2010; 26: 597-603 (IGR: 13-1)

28045 Timolol maleate a gold standard drug in glaucoma used as ocular films and inserts: An overview
Rathore KS; Nema RK; Sisodia SS
International Journal of Pharmaceutical Sciences Review and Research 2010; 3: 23-29 (IGR: 13-1)

28043 Preparation and evaluation of niosomes of brimonidine tartrate as ocular drug delivery system
Prabhu P; Koland M; Vijaynarayan K; Harish NM; Ganesh D; Charyulu RN; Satynarayana D
Journal of Pharmaceutical Research and Health Care 2010; 2: 293-301 (IGR: 13-1)

28042 Preparation and evaluation of nano-vesicles of brimonidine tartrate as an ocular drug delivery system
Prabhu P; Kumar NR; Koland M; Harish NM; Vijayanarayan K; Dhondge G; Charyulu RN
Journal of Young Pharmacists 2010; 2: 356-361 (IGR: 13-1)

28105 The role of benzalkonium chloride in the occurrence of punctate keratitis: A meta-analysis of randomized, controlled clinical trials
Trocme S; Hwang L-J; Bean GW; Sultan MB
Annals of Pharmacotherapy 2010; 44: 1914-1921 (IGR: 13-1)

27813 Handiness and acceptability of the new Abak((registered trademark)) bottle in chronically treated patients. A cross-sectional, retrospective and multicentre study
Gabisson P; Briat B; Le Foll J; Conan S; Bale-Le Bescond F; Talmud M; Chibret H
Annales Pharmaceutiques Francaises 2011; 69: 22-29 (IGR: 13-1)

27812 Ocular toxicity of benzalkonium
Chibret H
Annales Pharmaceutiques Francaises 2011; 69:108-115 (IGR: 13-1)

27900 Carbopol/chitosan based pH triggered in situ gelling system for ocular delivery of timolol maleate
Gupta S; Vyas SP
Scientia Pharmaceutica 2010; 78: 959-976 (IGR: 13-1)

28206 Newer approaches for optimal bioavailability of ocularly delivered drugs: Review
Kesavan K; Balasubramaniam J; Kant S; Singh PN; Pandit JK
Current Drug Delivery 2011; 8: 172-193 (IGR: 13-1)

27912 Ocular intolerance to antiglaucoma medications is underestimated
Bresson-Dumont H
Bulletin de la Soci�t� Belge d'Ophtalmologie 2010; 315: 47-53 (IGR: 13-1)

28090 Evaluating eye drop instillation technique in glaucoma patients
Gupta R; Patil B; Shah BM; Bali SJ; Mishra SK; Dada T
Journal of Glaucoma 2011; Epub ahead of print (IGR: 13-1)

28211 Ocular drug delivery - A look towards nanobioadhesives
Du Toit LC; Pillay V; Choonara YE; Govender T; Carmichael T
Expert Opinion on Drug Delivery 2011; 8: 71-94 (IGR: 13-1)

27954 Drug delivery to the posterior segment of the eye
Kuppermann BD; Loewenstein A
Developments in Ophthalmology 2010; 47: 59-72 (IGR: 13-1)

27957 A potential new therapeutic system for glaucoma: Solid lipid nanoparticles containing methazolamide
Li R; Jiang S; Liu D; Bi X; Wang F; Zhang Q; Xu Q
Journal of Microencapsulation 2011; 28: 134-141 (IGR: 13-1)

27494 Efficacy and patient tolerability of travoprost bak-free solution in patients with open-angle glaucoma and ocular hypertension
Mirza SK; Johnson SM
Clinical Ophthalmology 2010; 4: 877-888 (IGR: 12-4)

27488 Tolerability and effectiveness of preservativefree dorzolamide-timolol (preservative-free COSOPT((registered trademark))) in patients with open-angle glaucoma or ocular hypertension
Hutnik C; Neima D; Ibrahim F; Scott R; Vaillancourt J; Haine D; Sampalis JS; Bastien N; Foucart S
Clinical Ophthalmology 2010; 4: 581-590 (IGR: 12-4)

27287 Comparison of the efficacy and tolerability of preservative-free and preservative-containing formulations of the dorzolamide/timolol fixed combination (COSOPT(trademark)) in patients with elevated intraocular pressure in a randomized clinical trial
Shedden A; Adamsons IA; Getson AJ; Laurence JK; Lines CR; Hewitt DJ; Ho TW
Graefe's Archive for Clinical and Experimental Ophthalmology 2010; 248: 1757-1764 (IGR: 12-4)

27319 Reduction in intraocular pressure by the instillation of eye drops containing disulfiram included with 2-hydroxypropyl-(beta)-cyclodextrin in rabbit
Ito Y; Nagai N; Shimomura Y
Biological & Pharmaceutical Bulletin 2010; 33: 1574-1578 (IGR: 12-4)

27543 Changing the composition of buffered eye-drops prevents undesired side effects
Schrage NF; Frentz M; Reim M
The British journal of ophthalmology 2010; 94: 1519-1522 (IGR: 12-4)

27647 Ocular drug delivery from molecularly-imprinted contact lenses
Alvarez-Lorenzo C; Yanez F; Concheiro A
Journal of Drug Delivery Science and Technology 2010; 20: 237-248 (IGR: 12-4)

27123 Nanotechnology in ophthalmology
Zarbin MA; Montemagno C; Leary JF; Ritch R
Canadian Journal of Ophthalmology 2010; 45: 457-476 (IGR: 12-4)

27136 Optical fiber-coupled ocular spectrometer for measurement of drug concentration in the anterior eye-applications in pharmaceuticals research
Miller J; Wilson WS; Blue R; Wilson CG; Uttamchandani D
IEEE Transactions on Bio-Medical Engineering 2010; 57: 2903-2909 (IGR: 12-4)

27138 In vitro and in vivo evaluation of stimuli sensitive hydrogel for ophthalmic drug delivery
Singh V; Busheetti SS; Raju SA; Ahmad R; Singh M
Indian Journal of Pharmaceutical Education and Research 2010; 44: 380-385 (IGR: 12-4)

27355 Ocular pharmacokinetics of methazolamide ophthalmic suspension in rabbit aqueous humor
Liu W; Gan Y; Gan L; Ping Q-N; Cao F; Xiao Y-Y
Journal of China Pharmaceutical University 2010; 41: 337-341 (IGR: 12-4)

27323 Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: Formulation of dorzolamide eye drop microparticle suspension
Jansook P; Stefansson E; Thorsteinsdottir M; Sigurdsson BB; Kristjansdottir SS; Bas JF; Sigurdsson HH; Loftsson T
European Journal of Pharmaceutics and Biopharmaceutics 2010; 76: 208-214 (IGR: 12-4)

27523 Applications of nanoparticles in ophthalmology
Diebold Y; Calonge M
Progress in Retinal and Eye Research 2010; 29: 596-609 (IGR: 12-4)

27005 Preservatives in eye drops: toward awareness of their toxicity.
Vaede D; Baudouin C; Warnet JM; Brignole-Baudouin F
Journal Fran�ais d'Ophtalmologie 2010; 33: 505-524 (IGR: 12-4)

27209 Medical devices for the treatment of eye diseases
Yasukawa T; Ogura Y
Handb Exp Pharmacol 2010; 197: 469-489 (IGR: 12-4)

27556 Trends in ophthalmic preservatives: A review
Barot M; Gokulgandhi MR; Parikh JR
Drug Delivery Technology 2010; 10: 46-49 (IGR: 12-4)

27555 New devices for dispensing ophthalmic treatments may be the key to managing the life cycles of established products
Birkhoff M; Marx D
Drug Delivery Technology 2010; 10: 16-21 (IGR: 12-4)

27354 Preparation and characterization of timolol maleate ocular films
Rathore KS; Nema RK; Sisodia SS
International Journal of PharmTech Research 2010; 2: 1995-2000 (IGR: 12-4)

27305 Biodegradable implants for sustained drug release in the eye
Lee SS; Hughes P; Ross AD; Robinson MR
Pharmaceutical Research 2010; 27: 2043-2053 (IGR: 12-4)

27264 Preparation and evaluation of in situ gelling ophthalmic drug delivery system for methazolamide
Qian Y; Wang F; Li R; Zhang Q; Xu Q
Drug Development and Industrial Pharmacy 2010; 36: 1340-1347 (IGR: 12-4)

27118 Changing the composition of buffered eye-drops prevents undesired side effects
Schrage NF; Frentz M; Reim M
British Journal of Ophthalmology 2010; 94: 1519-1522 (IGR: 12-4)

27296 Improved ocular absorption kinetics of timolol maleate loaded into a bioadhesive niosomal delivery system
Kaur IP; Aggarwal D; Singh H; Kakkar S
Graefe's Archive for Clinical and Experimental Ophthalmology 2010; 248: 1467-1472 (IGR: 12-4)

26671 Brimonidine hypersensitivity when switching between 0.2% and 0.15% formulations
Sullivan-Mee M; Pensyl D; Alldredge B; Halverson K; Gerhardt G; Qualls C
Journal of Ocular Pharmacology and Therapeutics 2010; 26: 355-360 (IGR: 12-3)

26875 A review of preserved and preservative-free prostaglandin analogues for the treatment of open-angle glaucoma and ocular hypertension
Hommer A
Drugs of Today 2010; 46: 409-416 (IGR: 12-3)

26547 IOP-lowering efficacy and tolerability of preservative-free tafluprost 0.0015% among patients with ocular hypertension or glaucoma
Hommer A; Mohammed Ramez O; Burchert M; Kimmich F
Current Medical Research and Opinion 2010; 26: 1905-1913 (IGR: 12-3)

26669 Ion-and pH-activated novel in-situ gel system for sustained ocular drug delivery
Gupta H; Velpandian T; Jain S
Journal of Drug Targeting 2010; 18: 499-505 (IGR: 12-3)

26775 Numerical simulations of ethacrynic acid transport from precorneal region to trabecular meshwork
Lin CW; Yuan F
Annals of Biomedical Engineering 2010; 38: 935-944 (IGR: 12-3)

26743 Enhancement of miotic potential of pilocarpine by tamarind gum based in-situ gelling ocular dosage form
Mehra GR; Manish M; Rashi S; Neeraj G; Mishra DN
Acta Pharmaceutica Sciencia 2010; 52: 145-154 (IGR: 12-3)

26885 Impact of glaucoma medication on ocular tissue
Valente C; Iester M
Expert Review of Ophthalmology 2010; 5: 405-412 (IGR: 12-3)

26675 Design and evaluation of thermoreversible in situ gelling system of forskolin for the treatment of glaucoma
Gupta S; Samanta MK
Pharmaceutical Development and Technology 2010; 15: 386-393 (IGR: 12-3)

26695 A case study: Safety evaluation of ophthalmic drug-device combination products
Brown AP
International Journal of Toxicology 2010; 29: 118 (IGR: 12-3)

26629 Anti-glaucomatic niosomal system: Recent trend in ocular drug delivery research
Paul S; Mondol R; Ranjit S; Maiti S
International Journal of Pharmacy and Pharmaceutical Sciences 2010; 2: 15-18 (IGR: 12-3)

26747 Preservatives in eyedrops: The good, the bad and the ugly
Baudouin C; Labbe A; Liang H; Pauly A; Brignole-Baudouin F
Progress in Retinal and Eye Research 2010; 29: 312-334 (IGR: 12-3)

26344 Study of alpha-lipoic acid penetration in the human aqueous after topical administration
Cagini C; Leontiadis A; Ricci MA; Bartolini A; Dragoni A; Pellegrino RM
Clinical and Experimental Ophthalmology 2010; 38: 572-576 (IGR: 12-3)

26904 Microchips and controlled-release drug reservoirs
Staples M
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 2010; 2: 400-417 (IGR: 12-3)

26481 Optimization of benzalkonium chloride concentration in 0.0015% tafluprost ophthalmic solution from the points of ocular surface safety and preservative efficacy
Asada H; Takaoka-Shichijo Y; Nakamura M; Kimura A
Yakugaku Zasshi 2010; 130: 867-871 (IGR: 12-3)

26473 Microbial contamination of nipradiol with and without benzalkonium chloride
Inoue K; Wakakura M; Miyanaga Y; Tomita G
Nippon Ganka Gakkai Zasshi 2010; 114: 604-611 (IGR: 12-3)

26876 Promising complexes of acetazolamide for topical ocular administration
Granero GE; Longhi MR
Expert Opinion on Drug Delivery 2010; 7: 943-953 (IGR: 12-3)

26123 Treatment of glaucoma in patients with dry eye syndrome
Labb� A; Baudouin C
Journal Fran�ais d'Ophtalmologie 2010; 33: 285-290 (IGR: 12-2)

25896 Incidence, severity and factors related to drug-induced keratoepitheliopathy with glaucoma medications
Fukuchi T; Wakai K; Suda K; Nakatsue T; Sawada H; Hara H; Ueda J; Tanaka T; Yamada A; Abe H
Clinical Ophthalmology 2010; 4: 203-209 (IGR: 12-2)

25992 Cytometric assessment of cytostatic and cytotoxic effects of topical glaucoma medications on human epithelial corneal line cells
Pozarowska D; Pozarowski P; Darzynkiewicz Z
Cytometry Part B - Clinical Cytometry 2010; 78: 130-137 (IGR: 12-2)

25888 Considerations in glaucoma therapy: Fixed combinations versus their component medications
Higginbotham EJ
Clinical Ophthalmology 2010; 4: 1-9 (IGR: 12-2)

25717 The ocular surface in glaucoma
Baudouin C
Cornea 2009; 28: S14-S19 (IGR: 12-2)

25674 Methazolamide calcium phosphate nanoparticles in an ocular delivery system
Chen R; Qian Y; Li R; Zhang Q; Liu D; Wang M; Xu Q
Yakugaku Zasshi 2010; 130: 419-424 (IGR: 12-2)

26218 Time course of changes in ocular wavefront aberration after instillation of 0.5% timolol gel-forming solution
Hiraoka T; Daito M; Okamoto F; Kiuchi T; Hirohara Y; Mihashi T; Oshika T
British Journal of Ophthalmology 2010; 94: 433-439 (IGR: 12-2)

25993 Evaluation of the biocompatibility of novel peptide hydrogel in rabbit eye
Liang L; Xu X-D; Chen C-S; Fang J-H; Jiang F-G; Zhang X-Z; Zhuo R-X
Journal of Biomedical Materials Research - Part B Applied Biomaterials 2010; 93: 324-332 (IGR: 12-2)

26276 Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication
Uusitalo H; Chen E; Pfeiffer N; Brignole-Baudouin F; Kaarniranta K; Leino K; Puska P; Palmgren E; Hamacher T; Hofmann G
Acta Ophthalmologica 2010; 88: 329-336 (IGR: 12-2)

25825 Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: Development, characterization, and evaluation
Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
Journal of Drug Targeting 2010; 18: 292-302 (IGR: 12-2)

26051 Molecularly imprinted therapeutic contact lenses
White CJ; Byrne ME
Expert Opinion on Drug Delivery 2010; 7: 765-780 (IGR: 12-2)

25761 Preparation and evaluation of a contact lens vehicle for puerarin delivery
Xu J; Li X; Sun F
Journal of Biomaterials Science, Polymer Edition 2010; 21: 271-288 (IGR: 12-2)

26064 Chitosan and its derivatives as intraocular penetration enhancers
Zambito Y; Di Colo G
Journal of Drug Delivery Science and Technology 2010; 20: 45-52 (IGR: 12-2)

25393 The effect of forskolin ophthalmic inserts on intraocular pressure in rabbit eyes
Wagh V D; Wagh K V; Inamdar B; Samanta M K
International Journal of Pharmacy and Pharmaceutical Sciences 2009; 146-155 (IGR: 12-1)

25305 Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: A prospective, randomized, double-masked, active-controlled, thr
Sonty S; Mundorf T K; Stewart J A; Stewart W C
Clinical Therapeutics 2009; 31: 2063-2071 (IGR: 12-1)

25328 Designing dendrimers for ocular drug delivery
Spataro G; Malecaze F; Turrin C -O; Soler V; Duhayon C; Elena P -P; Majoral J -P; Caminade A -M
European Journal of Medicinal Chemistry 2010; 45: 326-334 (IGR: 12-1)

25239 The effect of lubricating eye drop containing hydroxypropyl guar on perimetry results of patients with glaucoma and trachomatous dry eye
Guzey M; Satici A; Karaman SK; Sezer S; Bozkurt O
Ophthalmologica 2010; 24: 109-115 (IGR: 12-1)

25276 Influence of various concentrations of terpene-4-ol enhancer and carbopol-934 mucoadhesive upon the in vitro ocular transport and the in vivo intraocular pressure lowering effects of dorzolamide ophthalmic formulations using albino rabbits
Afouna M I; Khedr A; Abdel-Naim A B; Al-Marzoqi A
Journal of Pharmaceutical Sciences 2010; 99: 119-127 (IGR: 12-1)

25511 Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride
Ammar H O; Salama H A; Ghorab M; Mahmoud A A
AAPS PharmSciTech 2009; 10: 808-819 (IGR: 12-1)

25512 Dual-Drug Delivery System Based on In Situ Gel-Forming Nanosuspension of Forskolin to Enhance Antiglaucoma Efficacy
Gupta S; Samanta M K; Raichur A M
AAPS PharmSciTech 2010; 1-14 (IGR: 12-1)

25498 Monitoring adherence rates in glaucoma patients using the Travatan Dosing Aid. A 6-month study comparing patients on travoprost 0.004% and patients on travoprost 0.004%/timolol 0.5% fixed combination
Rossi G C M; Pasinetti G M; Scudeller L; Tinelli C; Milano G; Bianchi P E
Expert Opinion in Pharmacotherapy 2010; 11: 499-504 (IGR: 12-1)

25014 The precautionary principle: what is the risk of reusing disposable drops in routine ophthalmology consultations and what are the costs of reducing this risk to zero?
Somner JE; Cavanagh DJ; Wong KK; Whitelaw M; Thomson T; Mansfield D
Eye 2010; 24: 361-363 (IGR: 12-1)

24763 Brimonidine purite solution for open-angle glaucoma or ocular hypertension
Batiste CG; Myers J; Katz LJ
Expert Review of Ophthalmology 2008; 3: 513-515 (IGR: 11-4)

24645 Betaxolol hydrochloride ophthalmic suspension 0.25% and timolol gel-forming solution 0.25% and 0.5% in pediatric glaucoma: A randomized clinical trial
Plager DA; Whitson JT; Netland PA; Vijaya L; Sathyan P; Sood D; Krishnadas SR; Robin AL; Gross RD; Scheib SA
Journal of AAPOS 2009; 13: 384-390 (IGR: 11-4)

24670 Different concepts of drug delivery in disease entities
Serafin A; Stanczak A
Mini Reviews in Medicinal Chemistry 2009; 9: 481-497 (IGR: 11-4)

24757 Drug delivery systems for the eye
Kearns VR; Williams RL
Expert Review of Medical Devices 2009; 6: 277-290 (IGR: 11-4)

24663 Antiglaucoma drops--with or without preservatives
Zemba M
Oftalmologia 2009; 1990 (IGR: 11-4)

24861 Xal-Ease(R): impact of an ocular hypotensive delivery device on ease of eyedrop administration, patient compliance, and satisfaction
Nordmann JP; Baudouin C; Bron A; Denis P; Rouland JF; Sellem E; Renard JP
European Journal of Ophthalmology 2009; 19: 949-956 (IGR: 11-4)

24597 A medical device/drug delivery system for treatment of glaucoma
Schultz CL; Poling TR; Mint JO
Clinical and Experimental Optometry 2009; 92: 343-348 (IGR: 11-4)

24764 Preservatives in topical ophthalmic medications: Historical and clinical perspectives
Freeman PD; Kahook MY
Expert Review of Ophthalmology 2009; 4: 59-64 (IGR: 11-4)

24664 Effects of preservatives in anti-glaucoma agents on the ocular surface
Potop V
Oftalmologia 2009; 1990 (IGR: 11-4)

24372 Toxic effects of antiglaucoma drugs on superficial tissues of the eye
Pozarowska D
International Review of Allergology and Clinical Immunology 2008; 14: 112-114 (IGR: 11-3)

24244 Effects of (-)-carveol and HPMC on the in vitro ocular transport and the in vivo intraocular pressure lowering effects of dorzolamide formulations in normotensive New Zealand rabbits
Afouna MI; Khedr A; Al-Marzoqi A
Drug Development Research 2009; 70: 191-198 (IGR: 11-3)

24514 Sustained Release and Permeation of Timolol from Surface-Modified Solid Lipid Nanoparticles through Bioengineered Human Cornea
Attama AA; Reichl S; Mller-Goymann CC
Current Eye Research 2009; 34: 698-705 (IGR: 11-3)

24212 Cytotoxicity of antiglaucoma ophthalmic solutions for human corneal endothelial cells
Ayaki M; Noda Y; Yaguchi S; Koide R; Iwasawa A; Inoue T; Inoue Y
Nippon Ganka Gakkai Zasshi 2009; 113: 576-582 (IGR: 11-3)

24069 A drug-eluting contact lens
Ciolino JB; Hoare TR; Iwata NG; Behlau I; Dohlman CH; Langer R; Kohane DS
Investigative Ophthalmology and Visual Science 2009; 50: 3346-3352 (IGR: 11-3)

23547 Ocular surface disfunction in glaucoma
Stefan C; Dumitrica DM
Oftalmologia 2008; 52: 114-119 (IGR: 11-2)

23462 Polymeric nanoparticulate system: A potential approach for ocular drug delivery
Nagarwal RC; Kant S; Singh PN; Maiti P; Pandit JK
Journal of Controlled Release 2009; 136: 2-13 (IGR: 11-2)

23594 The importance of eyelid closure and nasolacrimal occlusion following the ocular instillation of topical glaucoma medications, and the need for the universal inclusion of one of these techniques in all patient treatments and clinical studies
Flach AJ
Transactions of the American Ophthalmological Society 2008; 106:- 138-145; discussion 145-148 (IGR: 11-2)

23953 Multiple endpoint analysis of the 3D-reconstituted corneal epithelium after treatment with benzalkonium chloride: early detection of toxic damage
Pauly A; Meloni M; Brignole-Baudouin F; Warnet JM; Baudouin C
Investigative Ophthalmology and Visual Science 2009; 50: 1644-1652 (IGR: 11-2)

23933 The effects of 5-fluorouracil on ocular tissues in vitro and in vivo after controlled release from a multifunctional implant
Huhtala A; R�nkk� S; Ter�svirta M; Puustj�rvi T; Sihvola R; Vehanen K; Laukkanen A; Anttila J; Urtti A; Pohjonen T
Investigative Ophthalmology and Visual Science 2009; 50: 2216-2223 (IGR: 11-2)

23840 Route of penetration of topically instilled nipradilol into the ipsilateral posterior retina
Mizuno K; Koide T; Shimada S; Mori J; Sawanobori K; Araie M
Investigative Ophthalmology and Visual Science 2009; 50: 2839-2847 (IGR: 11-2)

23773 An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology
Martone G; Frezzotti P; Tosi GM; Traversi C; Mittica V; Malandrini A; Pichierri P; Balestrazzi A; Motolese PA; Motolese I
American Journal of Ophthalmology 2009; 147: 725-735 (IGR: 11-2)

22873 Quantitative analysis of conjunctival goblet cells after chronic application of topical drops
Kahook MY; Noecker R
Advances in Therapy 2008; 25: 743-751 (IGR: 11-1)

22842 Poly (ε-caprolactone) microparticles containing Levobunolol HCl prepared by a multiple emulsion (W/O/W) solvent evaporation technique: Effects of some formulation parameters on microparticle characteristics
Karatas A; Sonakin OOzlem; KiliCarslan M; Baykara T
Journal of Microencapsulation 2009; 26: 63-74 (IGR: 11-1)

22885 Ophthalmic timolol in a hydrogel vehicle leads to minor inter-individual variation in timolol concentration in aqueous humor
Volotinen M; Maenpaa J; Kautiainen H; Tolonen A; Uusitalo J; Ropo A; Vapaatalo H; Aine E
European Journal of Pharmaceutical Sciences 2009; 36:-3 292-296 (IGR: 11-1)

22827 Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery
Jiao J
Advanced Drug Delivery Reviews 2008; 60: 1663-1673 (IGR: 11-1)

22642 Dosage variability of topical ocular hypotensive products: a densitometric assessment
Gaynes BI; Singa RM; Cao Y
Journal of Glaucoma 2009; 18: 149-152 (IGR: 11-1)

22965 Poly (epsilon-caprolactone) microparticles containing Levobunolol HCl prepared by a multiple emulsion (W/O/W) solvent evaporation technique: effects of some formulation parameters on microparticle characteristics
Karatas A; Sonakin O; KiliCarslan M; Baykara T
Journal of Microencapsulation 2009; 26: 63-74 (IGR: 11-1)

22755 Development of ocular drug delivery systems
Saska Z; Hajdu M; Laki M; Klebovich I; Antal I
Acta Pharmaceutica Hungarica 2008; 78: 156-164 (IGR: 11-1)

23365 Ophthalmic formulations of the intraocular hypotensive melatonin agent 5-MCA-NAT
Andr�s-Guerrero V; Alarma-Estrany P; Molina-Mart�nez IT; Peral A; Herrero-Vanrell R; Pintor J
Experimental Eye Research 2009; 88: 504-511 (IGR: 11-1)

22843 Sustained delivery of timolol maleate from poly(lactic-co-glycolic acid)/ poly(lactic acid) microspheres for over 3 months
Bertram JP; Saluja SS; McKain J; Lavik EB
Journal of Microencapsulation 2009; 26: 18-26 (IGR: 11-1)

22676 Corneal penetration into rabbit aqueous humor is comparable between preserved and preservative-free tafluprost
Pellinen P; Lokkila J
Ophthalmic Research 2009; 1: 118-122 (IGR: 11-1)

21504 Tafluprost, a new potent prostanoid receptor agonist: A dose-response study on pharmacodynamics and tolerability in healthy volunteers
Sutton A; Gouws P; Ropo A
International Journal of Clinical Pharmacology and Therapeutics 2008; 46: 400-406 (IGR: 10-3)

21655 Ocular novel drug delivery: Impacts of membranes and barriers
Barar J; Javadzadeh AR; Omidi Y
Expert Opinion on Drug Delivery 2008; 5: 567-581 (IGR: 10-3)

21571 Scope and limitations of the co-drug approach to topical drug delivery
Lau WM; White AW; Gallagher SJ; Donaldson M; McNaughton G; Heard CM
Current Pharmaceutical Design 2008; 14: 794-802 (IGR: 10-3)

21883 Prevalence of ocular surface disease in glaucoma patients
Leung EW; Medeiros FA; Weinreb RN
Journal of Glaucoma 2008; 17: 350-355 (IGR: 10-3)

21596 A refillable microfabricated drug delivery device for treatment of ocular diseases
Lo R; Li P-Y; Saati S; Agrawal R; Humayun MS; Meng E
Lab on a Chip - Miniaturisation for Chemistry and Biology 2008; 8: 1027-1030 (IGR: 10-3)

21498 Ocular pharmacokinetic/pharmacodynamic modeling for multiple anti-glaucoma drugs
Sakanaka K; Kawazu K; Tomonari M; Kitahara T; Nakashima M; Nishida K; Nakamura J; Sasaki H; Higuchi S
Biological & Pharmaceutical Bulletin 2008; 31: 1590-1595 (IGR: 10-3)

20974 Duration of IOP reduction with travoprost BAK-free solution
Gross RL; Peace JH; Smith SE; Walters TR; Dubiner HB; Weiss MJ; Ochsner KI
Journal of Glaucoma 2008; 17: 217-222 (IGR: 10-2)

20944 Intravitreal properties of porous silicon photonic crystals: a potential self-reporting intraocular drug-delivery vehicle
Cheng L; Anglin E; Cunin F; Kim D; Sailor MJ; Falkenstein I; Tammewar A; Freeman WR
British Journal of Ophthalmology 2008; 92: 705-711 (IGR: 10-2)

21304 Recent patents on ocular drug delivery systems
Conway BR
Recent Patents on Drug Delivery and Formulation 2008; 2: 1-8 (IGR: 10-2)

21361 Penetration of topically applied levofloxacin into eyes with thin-wall filtering bleb after trabeculectomy
Qiao LY; Wang NL; Liang YB; Zhu SQ; Wan XH; Lee PY
Eye 2008; 22: 666-670 (IGR: 10-2)

21383 Orbital drainage of different sizes of colloids in rabbits: A dynamic scintigraphic study
Beden U; Yapici O; Sullu Y; Sonmez B; Erkan D
Investigative Ophthalmology and Visual Science 2008; 49: 2563-2567 (IGR: 10-2)

21394 Very-high-frequency ultrasound corneal imaging as a new tool for early diagnosis of ocular surface toxicity in rabbits treated with a preserved glaucoma drug
Denoyer A; Ossant F; Arbeille B; Fetissof F; Patat F; Pourcelot L; Pisella PJ
Ophthalmic Research 2008; 40: 298-308 (IGR: 10-2)

20503 Drug-induced ocular disorders
Li J; Tripathi RC; Tripathi BJ
Drug Safety 2008; 31: 127-141 (IGR: 10-1)

20374 Modeling of corneal and retinal pharmacokinetics after periocular drug administration
Amrite AC; Edelhauser HF; Kompella UB
Investigative Ophthalmology and Visual Science 2008; 49: 320-332 (IGR: 10-1)

20610 Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system
Gupta H; Jain S; Mathur R; Mishra P; Mishra AK; Velpandian T
Drug Delivery 2007; 14: 507-515 (IGR: 10-1)

20731 Challenges and solutions in topical ocular drug-delivery systems
Ali M; Byrne ME
Expert Review of Clinical Pharmacology 2008; 1: 145-161 (IGR: 10-1)

20845 Barriers to Glaucoma Drug Delivery
Ghate D; Edelhauser HF
Journal of Glaucoma 2008; 17: 147-156 (IGR: 10-1)

20409 Effect of eye pigmentation on transscleral drug delivery
Cheruvu NP; Amrite AC; Kompella UB
Investigative Ophthalmology and Visual Science 2008; 49: 333-341 (IGR: 10-1)

20730 Controlled release gelatin hydrogels and lyophilisates with potential application as ocular inserts
Natu MV; Sardinha JP; Correia IJ; Gil MH
Biomedical Materials 2007; 2: 241-249 (IGR: 10-1)

20529 A history of the development of eye drops used to treat glaucoma
Komatsu Y
Yakushigaku Zasshi 2007; 42: 7-16 (IGR: 10-1)

20490 Clinical significance of topical instillation technique in Japanese glaucoma patients
Ikeda H; Tsukamoto H; Sugimoto A; Sawa A; Crabtree BL; Byrd HJ; Murakami T; Mishima HK; Kihira K
Pharmazie 2008; 63: 81-85 (IGR: 10-1)

20536 On the correct use of eye drops
Steiner M
Australian Prescriber 2008; 31: 16-17 (IGR: 10-1)

19834 Effect of anti-glaucoma topical medications on expression of TGF-β and MMP of human Tenons fibroblast
Zhang J-Y; Leng F; Peng S-M
International Journal of Ophthalmology 2007; 7: 1294-1297 (IGR: 9-4)

19691 Ocular side effects of glaucoma treatment agents
Ehongo A; Bremer F
Bulletin de la Soci�t� Belge d'Ophtalmologie 2007; 304: 103-110 (IGR: 9-4)

19775 Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma
Jiang C; Moore MJ; Zhang X; Klassen H; Langer R; Young M
Molecular Vision 2007; 13: 1783-1792 (IGR: 9-4)

19757 Immobilization of drugs for glaucoma treatment
Almeida JF; Fonseca A; Baptista CMSG; Leite E; Gil MH
Journal of Materials Science: Materials in Medicine 2007; 18: 2309-2317 (IGR: 9-4)

19677 Timolol transport from microemulsions trapped in HEMA gels
Li C-C; Abrahamson M; Kapoor Y; Chauhan A
Journal of Colloid and Interface Science 2007; 315: 297-306 (IGR: 9-4)

19710 Effects of topical antiglaucoma medications on corneal epithelium as evaluated by gene expression patterns
Okada Y
Cornea 2007; 26: S46-S54 (IGR: 9-4)

19693 Medical applications of poly(styrene-block-isobutylene-block-styrene) ('SIBS')
Pinchuk L; Wilson GJ; Barry JJ; Schoephoerster RT; Parel J-M; Kennedy JP
Biomaterials 2008; 29: 448-460 (IGR: 9-4)

19816 Development of the conceptual framework for the Eye-Drop Satisfaction Questionnaire (EDSQ) in glaucoma using a qualitative study
Nordmann JP; Denis P; Vigneux M; Trudeau E; Guillemin I; Berdeaux G
BMC Health Services Research 2007; 7: Article Number: 124 (IGR: 9-4)

19258 Ocular hypotensive effect of 1% carteolol long-acting eye drops - a double-masked, randomized phase III study in ocular hypertension or primary open-angle glaucoma patients comparing long-acting carteolol eye drops vs. current product
Yamamoto T
Nippon Ganka Gakkai Zasshi 2007; 111: 463-472 (IGR: 9-3)

19308 Study of the extent of ocular absorption of acetazolamide from a developed niosomal formulation, by microdialysis sampling of aqueous humor
Aggarwal D; Pal D; Mitra AK; Kaur IP
International Journal of Pharmaceutics 2007; 338: 21-26 (IGR: 9-3)

19601 In Vitro Studies of Antiglaucomatous Prostaglandin Analogues: Travoprost with and without Benzalkonium Chloride and Preserved Latanoprost
Baudouin C; Riancho L; Warnet JM; Brignole F
Investigative Ophthalmology and Visual Science 2007; 48: 4123-4128 (IGR: 9-3)

19275 Poly(N-isopropylacrylamide)-chitosan as thermosensitive in situ gel-forming system for ocular drug delivery
Cao Y; Zhang C; Shen W; Cheng Z; Yu LL; Ping Q
Journal of Controlled Release 2007; 120: 186-194 (IGR: 9-3)

19607 Coated microneedles for drug delivery to the eye
Jiang J; Gill HS; Ghate D; McCarey BE; Patel SR; Edelhauser HF; Prausnitz MR
Investigative Ophthalmology and Visual Science 2007; 48: 4038-4043 (IGR: 9-3)

19534 A model for quantifying difficulty in squeezing eyedrops from their containers
Nesher R; Ezra-Nimni O; Shumla E; Gur J; Hamisha S; Nesher G
Archives of Ophthalmology 2007; 125: 1114-1117 (IGR: 9-3)

19513 Topical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eye
Sigurdsson HH; Konr��sd�ttir F; Loftsson T; Stef�nsson E
Acta Ophthalmologica Scandinavica 2007; 85: 598-602 (IGR: 9-3)

17562 Neuroprotection of retinal ganglion cells in DBA/2J mice with GDNF-loaded biodegradable microspheres
Ward MS; Khoobehi A; Lavik EB; Langer R; Young MJ
Journal of Pharmaceutical Sciences 2007; 96: 558-568 (IGR: 9-2)

18103 Phosphate concentrations in antiglaucoma medication
Bernauer W; Thiel MA; Rentsch KM
Klinische Monatsbl�tter f�r Augenheilkunde 2007; 224: 249-251 (IGR: 9-2)

17609 Ocular disposition, pharmacokinetics, efficacy and safety of nanoparticle-formulated ophthalmic drugs
Bu H-Z; Gukasyan HJ; Goulet L; Lou X-J; Xiang C; Koudriakova T
Current drug metabolism 2007; 8: 91-107 (IGR: 9-2)

18087 Levels of bimatoprost acid in the aqueous humour after bimatoprost treatment of patients with cataract
Cantor LB; Hoop J; WuDunn D; Yung CW; Catoira Y; Valluri S; Cortes A; Acheampong A; Woodward DF; Wheeler LA
British Journal of Ophthalmology 2007; 91: 629-632 (IGR: 9-2)

17606 Liposome-encapsulated mitomycin C for the reduction of corneal healing rate and ocular toxicity
Chetoni P; Burgalassi S; Monti D; Najarro M; Boldrini E
Journal of Drug Delivery Science and Technology 2007; 17: 43-48 (IGR: 9-2)

17518 Accuracy and performance of a commercially available dosing aid
Cronin TH; Kahook MY; Lathrop KL; Noecker RJ
British Journal of Ophthalmology 2007; 91: 497-499 (IGR: 9-2)

18037 The TRAVATAN Dosing Aid accurately records when drops are taken
Friedman DS; Jampel HD; Congdon NG; Miller R; Quigley HA
American Journal of Ophthalmology 2007; 143: 699-701 (IGR: 9-2)

18019 Ocular symptoms and signs with preserved and preservative-free glaucoma medications
Jaenen N; Baudouin C; Pouliquen P; Manni G; Figueiredo A; Zeyen T
European Journal of Ophthalmology 2007; 17: 341-349 (IGR: 9-2)

17534 Developments in dosing aids and adherence devices for glaucoma therapy: Current and future perspectives
Kahook MY
Expert Review of Medical Devices 2007; 4: 261-266 (IGR: 9-2)

17607 Development of a vesicular system for effective ocular delivery of acetazolamide A comprehensive approach and successful venture
Kaur IP; Mitra AK; Aggarwal D
Journal of Drug Delivery Science and Technology 2007; 17: 33-41 (IGR: 9-2)

17605 Ocular transport model for ophthalmic delivery of timolol through p-HEMA contact lenses
Li CC; Chauhan A
Journal of Drug Delivery Science and Technology 2007; 17: 69-79 (IGR: 9-2)

17610 Transscleral diffusion of ethacrynic acid and sodium fluorescein
Lin C-W; Wang Y; Challa P; Epstein DL; Yuan F
Molecular Vision 2007; 13: 243-251 (IGR: 9-2)

18073 Ocular drug delivery: molecules, cells, and genes
Liu X; Brandt CR; Rasmussen CA; Kaufman PL
Canadian Journal of Ophthalmology 2007; 42: 447-454 (IGR: 9-2)

18015 Penetration of betaxolol HCL ionic suspension 0.25% and betaxolol HCL solution 0.50% into the aqueous humor
Sagdic Yalvac I; Basci NE; Dulger B; Duman S
European Journal of Ophthalmology 2007; 17: 368-371 (IGR: 9-2)

17155 Brimonidine in the treatment of glaucoma and ocular hypertension
Cantor LB
Therapeutics and Clinical Risk Management 2006; 2: 337-346 (IGR: 9-1)

17051 Comparison of the stability, efficacy, and adverse effect profile of the innovator 0.005% latanoprost ophthalmic solution and a novel cyclodextrin-containing formulation
Gonzalez JR; Baiza-Duran L; Quintana-Hau J; Tornero-Montano R; Castaneda-Hernandez G; Ortiz M; Alarcon-Oceguera F; Beltran-Loustaunau M; Cortez-Gastelum M; Garciduenas-Mejia J
Journal of Clinical Pharmacology 2007; 47: 121-126 (IGR: 9-1)

17092 Preparation and testing of buffered eye drops containing pilocarpine chloride with timolol maleate
Rakic D; Antunovic M
Vojnosanitetski pregled. Military-medical and pharmaceutical review 2006; 63: 873-877 (IGR: 9-1)

17081 Efficiency of instillation methods for prostaglandin medications
Fiscella R; Wilensky JT; Chiang TH; Walt JG
Journal of Ocular Pharmacology and Therapeutics 2006; 22: 477-482 (IGR: 9-1)

17176 Effect of switching from aqueous timolol to gel-forming timolol ophthalmic solution
Inoue K; Sogabe M; Wakakura M; Inouye J; Tomita G
Japanese Journal of Clinical Ophthalmology 2006; 60: 1971-1976 (IGR: 9-1)

16897 Travoprost 0.004% with and without benzalkonium chloride: a comparison of safety and efficacy
Lewis RA; Katz GJ; Weiss MJ; Landry TA; Dickerson JE; James JE; Hua SY; Sullivan EK; Montgomery DB; Wells DT
Journal of Glaucoma 2007; 16: 98-103 (IGR: 9-1)

17037 Second Ophthalmic Drug Development and Delivery Summit San Diego, CA, USA, 19-20 September 2006
Marra M; Gukasyan HJ; Raghava S; Kompella UB
Expert Opinion on Drug Delivery 2007; 4: 77-85 (IGR: 9-1)

17154 Assessment of corneal epithelial integrity after acute exposure to ocular hypotensive agents preserved with and without benzalkonium chloride
Whitson JT; Cavanagh HD; Lakshman N; Petroll WM
Advances in Therapy 2006; 23: 663-671 (IGR: 9-1)

16763 The effect of drop vehicle on the efficacy and side effects of topical glaucoma therapy: a review
Yee RW
Current Opinions in Ophthalmology 2007; 18: 134-139 (IGR: 9-1)

17134 Patients' and physicians' perceptions of the travoprost dosing aid: An open-label, multicenter study of adherence with prostaglandin analogue therapy for open-angle glaucoma or ocular hypertension
Flowers B; Wand M; Piltz-Seymour J; Berke SJ; Day D; Teague J; Smoot TM; Landry TA; Bergamini MVW; Mallick S
Clinical Therapeutics 2006; 28: 1803-1811 (IGR: 9-1)

15144 Human scleral hydraulic conductivity: age-related changes, topographical variation, and potential scleral outflow facility
Jackson TL; Hussain A; Hodgetts A; Morley AM; Hillenkamp J; Sullivan PM; Marshall J
Investigative Ophthalmology and Visual Science 2006; 47: 4942-4946 (IGR: 8-4)

15122 Improved systemic safety and risk-benefit ratio of topical 0.1% timolol hydrogel compared with 0.5% timolol aqueous solution in the treatment of glaucoma
Uusitalo H; Kahonen M; Ropo A; Maenpaa J; Bjarnhall G; Hedenstrom H; Turjanmaa V
Graefe's Archive for Clinical and Experimental Ophthalmology 2006; 244: 1491-1496 (IGR: 8-4)

14556 Hypersensitivity reactions to ophthalmic products
Ventura MT; Viola M; Gaeta F; Di Leo E; Buquicchio R; Romano A
Current Pharmaceutical Design 2006; 12: 3401-3410 (IGR: 8-4)

14936 Antiglaucoma drugs - content of preservatives and the patient's compliance
Vyborny P; Sejckova L
?eska a Slovenska Oftalmologie 2006; 62: 270-272, 274 (IGR: 8-4)

13902 Comparison of a non-preserved 0.1% T-Gel eye gel (single dose unit) with a preserved 0.1% T-Gel eye gel (multidose) in ocular hypertension and glaucomatous patients
Easty DL; Nemeth-Wasmer G; Vounatsos JP; Girard B; Besnainou N; Pouliquen P; Delval L; Rouland JF
British Journal of Ophthalmology 2006; 90: 574-578 (IGR: 8-2)

13583 Ocular drug delivery
Ghate D; Edelhauser HF
Expert Opinion on Drug Delivery 2006; 3: 275-287 (IGR: 8-2)

13943 Emphasizing the research for ocular drug delivery system
Chen ZJ
Chinese Journal of Ophthalmology 2006; 42: 292-295 (IGR: 8-2)

13945 The pharmacokinetics of FK506 and its nanoparticles in aqueous humor of rabbits
Fei WL; Chen JQ; Zhong SL; Liu YM; Pang ZQ; Wang Z; Yuan J; Ye CT
Chinese Journal of Ophthalmology 2006; 42: 305-308 (IGR: 8-2)

13273 Physicochemical properties and in vivo assessment of timolol-loaded poly(D,L-lactide-co-glycolide) films for long-term intraocular pressure lowering effects
Huang SF; Chen JL; Yeh MK; Chiang CH
Journal of Ocular Pharmacology and Therapeutics 2005; 21: 445-453 (IGR: 8-1)

13446 Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost in patients with primary open angle glaucoma or ocular hypertension
Chiba T; Kashiwagi K; Chiba N; Tsukahara S
British Journal of Ophthalmology 2006; 90: 314-317 (IGR: 8-1)

13554 Accuracy of an electronic monitoring and reminder device for use with travoprost eye drops
Boden C; Sit A; Weinreb RN
Journal of Glaucoma 2006; 15: 30-34 (IGR: 8-1)

13293 Ocular delivery using poly(ortho esters)
Heller J
Advanced Drug Delivery Reviews 2005; 57: 2053-2062 (IGR: 8-1)

13434 Microbial contamination of preservative free eye drops in multiple application containers
Rahman MQ; Tejwani D; Wilson JA; Butcher I; Ramaesh K
British Journal of Ophthalmology 2006; 90: 139-141 (IGR: 8-1)

13182 Efficacy and systemic side-effects of topical 0.5% timolol aqueous solution and 0.1% timolol hydrogel
Uusitalo H; Nino J; Tahvanainen K; Turjanmaa V; Ropo A; Tuominen J; Kahonen M
Acta Ophthalmologica Scandinavica 2005; 83: 723-728 (IGR: 7-3)

13174 The influence of intraocular pressure on the transscleral diffusion of high-molecular-weight compounds
Cruysberg LP; Nuijts RM; Geroski DH; Gilbert JA; Hendrikse F; Edelhauser HF
Investigative Ophthalmology and Visual Science 2005; 46: 3790-3794 (IGR: 7-3)

12187 Ocular parameters related to drug delivery in the canine and equine eye: aqueous and vitreous humor volume and scleral surface area and thickness
Gilger BC; Reeves KA; Salmon JH
Veterinary Ophthalmology 2005; 8: 265-269 (IGR: 7-2)

11852 Experimental study of an automated system for the delivery of eyedrops using a microinfusion pump
Kwon JW; Kim JS; Choi SB; Lee JH; Wee WR
American Journal of Ophthalmology 2005; 139: 547-549 (IGR: 7-1)

11911 Effect of preservatives in chronic ocular therapy
Noecker RJ; Herrygers LA
Clinical and Surgical Ophthalmology 2003; 21: 88-94 (IGR: 7-1)

12145 Evaluation of an eye drop guide to aid self-administration by patients experienced with topical use of glaucoma medication
Salyani A; Birt C
Canadian Journal of Ophthalmology 2005; 40: 170-174 (IGR: 7-1)

10704 Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging
Kim H; Robinson MR; Lizak MJ; Tansey G; Lutz RJ; Yuan P; Wang NS; Csaky KG
Investigative Ophthalmology and Visual Science 2004; 45: 2722-31 (IGR: 6-2)

10900 Determination of three formulations of pilocarpine in rabbit ocular aqueous by RP-HPLC
Wang XJ; Chen B; Yao TW; Zhang HC; Zeng S
Zhejiang Da Xue Xue Bao Yi Xue Ban 2004; 33: 33-6 (IGR: 6-2)

10322 Influence of molecular weight on intracameral dextran movement to the posterior segment of the mouse eye
Bernd AS; Aihara M; Lindsey JD; Weinreb RN
Investigative Ophthalmology and Visual Science 2004; 45: 480-484 (IGR: 6-1)

10511 Controlled release of ethacrynic acid from poly(lactide-co-glycolide) films for glaucoma treatment
Wang Y; Challa P; Epstein DL; Yuan F
Biomaterials 2004; 25: 4279-4285 (IGR: 6-1)

10113 Feasibility of drug delivery to the posterior pole of the rabbit eye with an episcleral implant
Kato A; Kimura H; Okabe K; Okabe J; Kunou N; Ogura Y
Investigative Ophthalmology and Visual Science 2004; 45: 238-244 (IGR: 6-1)

10058 Determinants of eye drop size
Van Santvliet L; Ludwig A
Survey of Ophthalmology 2004; 49: 197-213 (IGR: 6-1)

10114 Application of polylactides in ophthalmology
Tu Y
Chinese Ophthalmic Research 2003; 21: 661-663 (IGR: 6-1)

10525 Ocular pharmacokinetics of 0.5% pilocarpine with sodium hyaluronate in rabbits
Xu Y; Song JZ; Pang GR; Chen ZJ; Zhang JJ; Lu XF
Zhonghua Yi Xue Za Zhi 2004; 40:87-9 (IGR: 6-1)

9952 Effect of preservatives on the conjunctiva: a comparative study of beta-blocker eye drops with and without preservatives in glaucoma patients
Pisella PJ; Lala E; Parier V; Brignole F; Baudouin C
Journal Fran�ais d'Ophtalmologie 2003; 26: 675-679 (IGR: 5-3)

8940 Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles
Bourges JL; Gautier SE; Delie F; Bejjani RA; Jeanny JC; Gurny R; BenEzra D; Behar-Cohen FF
Investigative Ophthalmology and Visual Science 2003; 44: 3562-3569 (IGR: 5-2)

8673 Development of in situ thermosensitive drug vehicles for glaucoma therapy
Hsiue GH; Chang RW; Wang CH; Lee SH
Biomaterials 2003; 24: 2423-2430 (IGR: 5-1)

8684 Patient preferences for eye drop characteristics: a willingness-to-pay analysis
Jampel HD; Schwartz GF; Robin AL; Abrams DA; Johnson E; Miller RB
Archives of Ophthalmology 2003; 121: 540-546 (IGR: 5-1)

8792 An improved technique of eye drop self-administration for patients with limited vision
Ritch R; Jamal KN; G�rses-?zden R; Liebmann JM
American Journal of Ophthalmology 2003; 135: 530-533 (IGR: 5-1)

8810 Comparison of efficacy and tolerability between two gel-forming timolol maleate ophthalmic solutions in patients with glaucoma or ocular hypertension
Shibuya T; Kashiwagi K; Tsukahara S
Ophthalmologica 2003; 217: 31-38 (IGR: 5-1)

8616 Biodegradable calcium phosphate nanoparticles as a new vehicle for delivery of a potential ocular hypotensive agent
Chu TC; He Q; Potter DE
Journal of Ocular Pharmacology and Therapeutics 2002; 18: 507-514 (IGR: 5-1)

8533 Drop volume, rigidity and required squeezing force of glaucoma ophthalmic solution containers
Yoshikawa K; Yamada H
Japanese Journal of Clinical Ophthalmology 2002; 56: 1587-1593 (IGR: 5-1)

3394 Ocular surface changes induced by topical antiglaucoma monotherapy
Cvenkel B; Ihan A
Ophthalmologica 2002; 216: 175-179 (IGR: 4-2)

3446 Intraocular distribution of 70-kDa dextran after subconjunctival injection in mice
Kim TW; Lindsey JD; Aihara M; Anthony TL; Weinreb RN
Investigative Ophthalmology and Visual Science 2002; 43: 1809-1816 (IGR: 4-2)

3597 Drug delivery systems to target the anterior segment of the eye: fundamental bases and clinical applications
Behar-Cohen F
Journal Fran�ais d'Ophtalmologie 2002; 25: 537-544 (IGR: 4-2)

3598 Iris pigment epithelial cells transplanted into the vitreous accumulate at the optic nerve head
Jordan JF; Semkova I; Kociok N; Welsandt GR; Krieglstein GK; Schraermeyer U
Graefe's Archive for Clinical and Experimental Ophthalmology 2002; 240: 403-407 (IGR: 4-2)

3599 Drug delivery to the posterior segment of the eye: some insights on the penetration pathways after subconjunctival injection
Lee TW; Robinson JR
Journal of Ocular Pharmacology and Therapeutics 2001; 17: 565-572 (IGR: 4-2)

3600 Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication
Pisella PJ; Pouliquen P; Baudouin C
British Journal of Ophthalmology 2002; 86: 418-423 (IGR: 4-2)

3601 Ocular drug delivery using 20-kHz ultrasound
Zderic V; Vaezy S; Martin RW; Clark JI
Ultrasound in Medicine and Biology 2002; 28: 823-829 (IGR: 4-2)

6869 Accumulation of topically applied porcine insulin in the retina and optic nerve in normal and diabetic rats
Koevary SB; Nussey J; Lake S
Investigative Ophthalmology and Visual Science 2002; 43: 797-804 (IGR: 4-1)

18326 Preparation of controlled release ophthalmic drops, for glaucoma therapy using thermosensitive poly-N-isopropylacrylamide
Hsiue GH; Hsu SH; Yang CC; Lee SH; Yang IK
Biomaterials 2002; 23: 457-462 (IGR: 3-3)

18325 Commercially available ocular hypotensive products: preservative concentration, stability, storage, and in-life utilization
Novack GD; Evans R
Journal of Glaucoma 2001; 10: 483-486 (IGR: 3-3)

18324 Drop volume of glaucoma medications
Vaidergorn PG; Susanna R Jr; Borges A; Povoa C; Giampani J
Revista Brasileira de Oftalmologia 2001; 60: 547-553 (IGR: 3-3)

18323 Novel ophthalmic therapeutic modalities based on noninvasive light-targeted drug delivery to the posterior pole of the eye
Zeimer R; Goldberg MF
Advanced Drug Delivery Reviews 2001; 52: 49-61 (IGR: 3-3)

6520 Biodegradable polymers for ocular drug delivery
Kimura H; Ogura Y
Ophthalmologica 2001; 215: 143-155 (IGR: 3-2)

19156 A new poly(ortho ester)-based drug delivery system as an adjunct treatment in filtering surgery
Einmahl S; Behar-Cohen F; D'Hermies F; Rudaz S; Tabatabay C; Renard G; Gurny R
Investigative Ophthalmology and Visual Science 2001; 42: 695-700 (IGR: 3-1)

19157 Insoluble ionic complexes of polyacrylic acid with a cationic drug for use as a mucoadhesive, opthalmic drug delivery system
Lele BS; Hoffman AS
Journal of Biomaterials Science, Polymer Edition 2000; 11: 1319-1331 (IGR: 3-1)

15659 Pharmacokinetic prediction of the ocular absorption of an instilled drug with ophthalmic viscous vehicle
Sasaki H; Yamamura K; Mukai T; Nishida K; Nakamura J; Nakashima M; Ichikawa M
Biological & Pharmaceutical Bulletin 2000; 23: 1352-1356 (IGR: 2-3)

15771 Xyloglucan as a novel vehicle for timolol: pharmacokinetics and pressure lowering activity in rabbits
Burgalassi S; Chetoni P; Panichi L; Boldrini E; Saettone MF
Journal of Ocular Pharmacology and Therapeutics 2000; 16: 497-509 (IGR: 2-3)

5781 Prolonged effect of liposomes encapsulating pilocarpine HCl in normal and glaucomatous rabbits
Monem AS; Ali FM; Ismail MW
International Journal of Pharmaceutics 2000; 198: 29-38 (IGR: 2-1)

1.1 Epidemiology (1860 abstracts found)

94252 Prevalence and risk factors to develop ocular hypertension and glaucoma after penetrating keratoplasty
González-Pérez LM
Archivos de la Sociedad Espanola de Oftalmologia 2021; 96: 415-421 (IGR: 22-2)

94340 Prevalence and 11-year incidence of common eye diseases and their relation to health-related quality of life, mental health, and visual impairment
Purola PKM
Quality of Life Research 2021; 30: 2311-2327 (IGR: 22-2)

94515 Health insurance enrollment and vision health in rural China: an epidemiological survey
Yan X
BMC Health Services Research 2021; 21: 761 (IGR: 22-2)

94466 Visual impairment and the prevalence of ocular pathology in homeless children and adults globally: a systematic review
Sayal AP
Canadian Journal of Ophthalmology 2021; 56: 158-165 (IGR: 22-2)

94884 Suggestive evidence of genetic association of -572G > C polymorphism with primary open angle glaucoma in a North Indian Punjabi population
Thakur N
Human immunology 2021; 82: 791-797 (IGR: 22-2)

94873 The Prevalence of Glaucoma and Its Related Factors in Rural Residents: A Cross-Sectional Study in Jiangxi, China
Zhou X
Journal of Ophthalmology 2021; 2021: 5551837 (IGR: 22-2)

94466 Visual impairment and the prevalence of ocular pathology in homeless children and adults globally: a systematic review
Slomovic J
Canadian Journal of Ophthalmology 2021; 56: 158-165 (IGR: 22-2)

94884 Suggestive evidence of genetic association of -572G > C polymorphism with primary open angle glaucoma in a North Indian Punjabi population
Kumar Pandey R
Human immunology 2021; 82: 791-797 (IGR: 22-2)

94340 Prevalence and 11-year incidence of common eye diseases and their relation to health-related quality of life, mental health, and visual impairment
Nättinen JE
Quality of Life Research 2021; 30: 2311-2327 (IGR: 22-2)

94252 Prevalence and risk factors to develop ocular hypertension and glaucoma after penetrating keratoplasty
Ortiz-Arismendi GE
Archivos de la Sociedad Espanola de Oftalmologia 2021; 96: 415-421 (IGR: 22-2)

94873 The Prevalence of Glaucoma and Its Related Factors in Rural Residents: A Cross-Sectional Study in Jiangxi, China
Zhu Q
Journal of Ophthalmology 2021; 2021: 5551837 (IGR: 22-2)

94515 Health insurance enrollment and vision health in rural China: an epidemiological survey
Yao B
BMC Health Services Research 2021; 21: 761 (IGR: 22-2)

94466 Visual impairment and the prevalence of ocular pathology in homeless children and adults globally: a systematic review
Bhambra NS
Canadian Journal of Ophthalmology 2021; 56: 158-165 (IGR: 22-2)

94340 Prevalence and 11-year incidence of common eye diseases and their relation to health-related quality of life, mental health, and visual impairment
Ojamo MUI
Quality of Life Research 2021; 30: 2311-2327 (IGR: 22-2)

94884 Suggestive evidence of genetic association of -572G > C polymorphism with primary open angle glaucoma in a North Indian Punjabi population
Kumar V
Human immunology 2021; 82: 791-797 (IGR: 22-2)

94252 Prevalence and risk factors to develop ocular hypertension and glaucoma after penetrating keratoplasty
Moreno CJ
Archivos de la Sociedad Espanola de Oftalmologia 2021; 96: 415-421 (IGR: 22-2)

94515 Health insurance enrollment and vision health in rural China: an epidemiological survey
Chen X
BMC Health Services Research 2021; 21: 761 (IGR: 22-2)

94873 The Prevalence of Glaucoma and Its Related Factors in Rural Residents: A Cross-Sectional Study in Jiangxi, China
Yi J
Journal of Ophthalmology 2021; 2021: 5551837 (IGR: 22-2)

94340 Prevalence and 11-year incidence of common eye diseases and their relation to health-related quality of life, mental health, and visual impairment
Koskinen SVP; Koskinen SVP
Quality of Life Research 2021; 30: 2311-2327 (IGR: 22-2)

94466 Visual impairment and the prevalence of ocular pathology in homeless children and adults globally: a systematic review
Popovic MM
Canadian Journal of Ophthalmology 2021; 56: 158-165 (IGR: 22-2)

94515 Health insurance enrollment and vision health in rural China: an epidemiological survey
Bo S
BMC Health Services Research 2021; 21: 761 (IGR: 22-2)

94884 Suggestive evidence of genetic association of -572G > C polymorphism with primary open angle glaucoma in a North Indian Punjabi population
Mannan R
Human immunology 2021; 82: 791-797 (IGR: 22-2)

94873 The Prevalence of Glaucoma and Its Related Factors in Rural Residents: A Cross-Sectional Study in Jiangxi, China
Li J
Journal of Ophthalmology 2021; 2021: 5551837 (IGR: 22-2)

94340 Prevalence and 11-year incidence of common eye diseases and their relation to health-related quality of life, mental health, and visual impairment
Rissanen HA
Quality of Life Research 2021; 30: 2311-2327 (IGR: 22-2)

94515 Health insurance enrollment and vision health in rural China: an epidemiological survey
Qin X
BMC Health Services Research 2021; 21: 761 (IGR: 22-2)

94873 The Prevalence of Glaucoma and Its Related Factors in Rural Residents: A Cross-Sectional Study in Jiangxi, China
Li Q
Journal of Ophthalmology 2021; 2021: 5551837 (IGR: 22-2)

94884 Suggestive evidence of genetic association of -572G > C polymorphism with primary open angle glaucoma in a North Indian Punjabi population
Pruthi A
Human immunology 2021; 82: 791-797 (IGR: 22-2)

94466 Visual impairment and the prevalence of ocular pathology in homeless children and adults globally: a systematic review
Lichter M
Canadian Journal of Ophthalmology 2021; 56: 158-165 (IGR: 22-2)

94873 The Prevalence of Glaucoma and Its Related Factors in Rural Residents: A Cross-Sectional Study in Jiangxi, China
Kuang J
Journal of Ophthalmology 2021; 2021: 5551837 (IGR: 22-2)

94340 Prevalence and 11-year incidence of common eye diseases and their relation to health-related quality of life, mental health, and visual impairment
Sainio PRJ; Sainio PRJ
Quality of Life Research 2021; 30: 2311-2327 (IGR: 22-2)

94515 Health insurance enrollment and vision health in rural China: an epidemiological survey
Yan H
BMC Health Services Research 2021; 21: 761 (IGR: 22-2)

94884 Suggestive evidence of genetic association of -572G > C polymorphism with primary open angle glaucoma in a North Indian Punjabi population
Mehrotra S
Human immunology 2021; 82: 791-797 (IGR: 22-2)

94873 The Prevalence of Glaucoma and Its Related Factors in Rural Residents: A Cross-Sectional Study in Jiangxi, China
Lu Y
Journal of Ophthalmology 2021; 2021: 5551837 (IGR: 22-2)

94340 Prevalence and 11-year incidence of common eye diseases and their relation to health-related quality of life, mental health, and visual impairment
Uusitalo HMT; Uusitalo HMT
Quality of Life Research 2021; 30: 2311-2327 (IGR: 22-2)

94873 The Prevalence of Glaucoma and Its Related Factors in Rural Residents: A Cross-Sectional Study in Jiangxi, China
Zhou R; Chen J
Journal of Ophthalmology 2021; 2021: 5551837 (IGR: 22-2)

92425 Genetic Epidemiology of Primary Congenital Glaucoma in the 22 Arab Countries: A Systematic Review
Jemmeih S
Ophthalmic Epidemiology 2021; 0: 1-12 (IGR: 22-1)

92626 Nationwide Glaucoma incidence in end stage renal disease patients and kidney transplant recipients
Moon JJ
Scientific reports 2021; 11: 7418 (IGR: 22-1)

92095 Study of the Prevalence of Glaucoma in Kazakhstan
Tashtitova L
Klinische Monatsbl�tter f�r Augenheilkunde 2022; 239: 202-207 (IGR: 22-1)

92750 Differences in clinical presentation of primary open-angle glaucoma between African and European populations
Bonnemaijer PWM
Acta Ophthalmologica 2021; 99: e1118-e1126 (IGR: 22-1)

92371 Carbohydrate intake and risk of glaucoma in the sun cohort
Moreno-Montañés J
European Journal of Ophthalmology 2021; 0: 11206721211012862 (IGR: 22-1)

91972 Childhood and Early Onset Glaucoma Classification and Genetic Profile in a Large Australasian Disease Registry
Knight LSW
Ophthalmology 2021; 0: (IGR: 22-1)

92751 The performance of iPad-based noise-field perimeter versus Humphrey Field Analyser in detecting glaucomatous visual field loss
Ding J
Eye 2022; 36: 800-811 (IGR: 22-1)

92098 The GGLEAM Study: Understanding Glaucoma in the Ohio Amish
Waksmunski AR
International journal of environmental research and public health 2021; 18: (IGR: 22-1)

92167 Profile of Glaucoma in the Eastern Region of Saudi Arabia: A Retrospective Study
Helayel HB
Saudi journal of medicine & medical sciences 2021; 9: 167-174 (IGR: 22-1)

92010 The Global Extent of Undetected Glaucoma in Adults: A Systematic Review and Meta-analysis
Da Soh Z
Ophthalmology 2021; 0: (IGR: 22-1)

92373 Investigating the Relationship between Glaucoma Prevalence and Trabecular Meshwork Length
Choi W
Journal of clinical medicine 2021; 10: (IGR: 22-1)

92015 Determinants of lamina cribrosa depth in healthy Asian eyes: the Singapore Epidemiology Eye Study
Tun TA
British Journal of Ophthalmology 2021; 105: 367-373 (IGR: 22-1)

92196 Prevalence of glaucoma in the Lao People's Democratic Republic: the Vientiane Eye Study
Guo B
British Journal of Ophthalmology 2022; 106: 1121-1125 (IGR: 22-1)

92371 Carbohydrate intake and risk of glaucoma in the sun cohort
Gutierrez-Ruiz I
European Journal of Ophthalmology 2021; 0: 11206721211012862 (IGR: 22-1)

92373 Investigating the Relationship between Glaucoma Prevalence and Trabecular Meshwork Length
Cho H
Journal of clinical medicine 2021; 10: (IGR: 22-1)

92626 Nationwide Glaucoma incidence in end stage renal disease patients and kidney transplant recipients
Kim YW
Scientific reports 2021; 11: 7418 (IGR: 22-1)

92098 The GGLEAM Study: Understanding Glaucoma in the Ohio Amish
Song YE
International journal of environmental research and public health 2021; 18: (IGR: 22-1)

91972 Childhood and Early Onset Glaucoma Classification and Genetic Profile in a Large Australasian Disease Registry
Ruddle JB
Ophthalmology 2021; 0: (IGR: 22-1)

92167 Profile of Glaucoma in the Eastern Region of Saudi Arabia: A Retrospective Study
AlOqab A
Saudi journal of medicine & medical sciences 2021; 9: 167-174 (IGR: 22-1)

92015 Determinants of lamina cribrosa depth in healthy Asian eyes: the Singapore Epidemiology Eye Study
Wang X
British Journal of Ophthalmology 2021; 105: 367-373 (IGR: 22-1)

92751 The performance of iPad-based noise-field perimeter versus Humphrey Field Analyser in detecting glaucomatous visual field loss
Tecson IC
Eye 2022; 36: 800-811 (IGR: 22-1)

92095 Study of the Prevalence of Glaucoma in Kazakhstan
Aldasheva N
Klinische Monatsbl�tter f�r Augenheilkunde 2022; 239: 202-207 (IGR: 22-1)

92010 The Global Extent of Undetected Glaucoma in Adults: A Systematic Review and Meta-analysis
Yu M
Ophthalmology 2021; 0: (IGR: 22-1)

92750 Differences in clinical presentation of primary open-angle glaucoma between African and European populations
Lo Faro V
Acta Ophthalmologica 2021; 99: e1118-e1126 (IGR: 22-1)

92196 Prevalence of glaucoma in the Lao People's Democratic Republic: the Vientiane Eye Study
Tan Y
British Journal of Ophthalmology 2022; 106: 1121-1125 (IGR: 22-1)

92425 Genetic Epidemiology of Primary Congenital Glaucoma in the 22 Arab Countries: A Systematic Review
Malik S
Ophthalmic Epidemiology 2021; 0: 1-12 (IGR: 22-1)

92010 The Global Extent of Undetected Glaucoma in Adults: A Systematic Review and Meta-analysis
Betzler BK
Ophthalmology 2021; 0: (IGR: 22-1)

92373 Investigating the Relationship between Glaucoma Prevalence and Trabecular Meshwork Length
Kim EW
Journal of clinical medicine 2021; 10: (IGR: 22-1)

92098 The GGLEAM Study: Understanding Glaucoma in the Ohio Amish
Kinzy TG
International journal of environmental research and public health 2021; 18: (IGR: 22-1)

92750 Differences in clinical presentation of primary open-angle glaucoma between African and European populations
Sanyiwa AJ
Acta Ophthalmologica 2021; 99: e1118-e1126 (IGR: 22-1)

92425 Genetic Epidemiology of Primary Congenital Glaucoma in the 22 Arab Countries: A Systematic Review
Okashah S
Ophthalmic Epidemiology 2021; 0: 1-12 (IGR: 22-1)

92167 Profile of Glaucoma in the Eastern Region of Saudi Arabia: A Retrospective Study
Subaie MA
Saudi journal of medicine & medical sciences 2021; 9: 167-174 (IGR: 22-1)

92626 Nationwide Glaucoma incidence in end stage renal disease patients and kidney transplant recipients
Oh BL
Scientific reports 2021; 11: 7418 (IGR: 22-1)

92371 Carbohydrate intake and risk of glaucoma in the sun cohort
Gándara E
European Journal of Ophthalmology 2021; 0: 11206721211012862 (IGR: 22-1)

92015 Determinants of lamina cribrosa depth in healthy Asian eyes: the Singapore Epidemiology Eye Study
Baskaran M
British Journal of Ophthalmology 2021; 105: 367-373 (IGR: 22-1)

92196 Prevalence of glaucoma in the Lao People's Democratic Republic: the Vientiane Eye Study
Nygaard S
British Journal of Ophthalmology 2022; 106: 1121-1125 (IGR: 22-1)

91972 Childhood and Early Onset Glaucoma Classification and Genetic Profile in a Large Australasian Disease Registry
Taranath DA
Ophthalmology 2021; 0: (IGR: 22-1)

92751 The performance of iPad-based noise-field perimeter versus Humphrey Field Analyser in detecting glaucomatous visual field loss
Ang BCH
Eye 2022; 36: 800-811 (IGR: 22-1)

91972 Childhood and Early Onset Glaucoma Classification and Genetic Profile in a Large Australasian Disease Registry
Goldberg I
Ophthalmology 2021; 0: (IGR: 22-1)

92098 The GGLEAM Study: Understanding Glaucoma in the Ohio Amish
Laux RA
International journal of environmental research and public health 2021; 18: (IGR: 22-1)

92015 Determinants of lamina cribrosa depth in healthy Asian eyes: the Singapore Epidemiology Eye Study
Nongpiur ME
British Journal of Ophthalmology 2021; 105: 367-373 (IGR: 22-1)

92425 Genetic Epidemiology of Primary Congenital Glaucoma in the 22 Arab Countries: A Systematic Review
Zayed H
Ophthalmic Epidemiology 2021; 0: 1-12 (IGR: 22-1)

92196 Prevalence of glaucoma in the Lao People's Democratic Republic: the Vientiane Eye Study
Carrillo C
British Journal of Ophthalmology 2022; 106: 1121-1125 (IGR: 22-1)

92010 The Global Extent of Undetected Glaucoma in Adults: A Systematic Review and Meta-analysis
Majithia S
Ophthalmology 2021; 0: (IGR: 22-1)

92371 Carbohydrate intake and risk of glaucoma in the sun cohort
Moreno-Galarraga L
European Journal of Ophthalmology 2021; 0: 11206721211012862 (IGR: 22-1)

92373 Investigating the Relationship between Glaucoma Prevalence and Trabecular Meshwork Length
Bae HW
Journal of clinical medicine 2021; 10: (IGR: 22-1)

92751 The performance of iPad-based noise-field perimeter versus Humphrey Field Analyser in detecting glaucomatous visual field loss
Chiew W
Eye 2022; 36: 800-811 (IGR: 22-1)

92626 Nationwide Glaucoma incidence in end stage renal disease patients and kidney transplant recipients
Han K
Scientific reports 2021; 11: 7418 (IGR: 22-1)

92750 Differences in clinical presentation of primary open-angle glaucoma between African and European populations
Hassan HG
Acta Ophthalmologica 2021; 99: e1118-e1126 (IGR: 22-1)

92167 Profile of Glaucoma in the Eastern Region of Saudi Arabia: A Retrospective Study
Habash AA
Saudi journal of medicine & medical sciences 2021; 9: 167-174 (IGR: 22-1)

92371 Carbohydrate intake and risk of glaucoma in the sun cohort
Santiago S
European Journal of Ophthalmology 2021; 0: 11206721211012862 (IGR: 22-1)

92015 Determinants of lamina cribrosa depth in healthy Asian eyes: the Singapore Epidemiology Eye Study
Tham YC
British Journal of Ophthalmology 2021; 105: 367-373 (IGR: 22-1)

92196 Prevalence of glaucoma in the Lao People's Democratic Republic: the Vientiane Eye Study
Nouansavanh KO
British Journal of Ophthalmology 2022; 106: 1121-1125 (IGR: 22-1)

92750 Differences in clinical presentation of primary open-angle glaucoma between African and European populations
Cook C
Acta Ophthalmologica 2021; 99: e1118-e1126 (IGR: 22-1)

92373 Investigating the Relationship between Glaucoma Prevalence and Trabecular Meshwork Length
Kim CY
Journal of clinical medicine 2021; 10: (IGR: 22-1)

92010 The Global Extent of Undetected Glaucoma in Adults: A Systematic Review and Meta-analysis
Thakur S
Ophthalmology 2021; 0: (IGR: 22-1)

92626 Nationwide Glaucoma incidence in end stage renal disease patients and kidney transplant recipients
Kim DK
Scientific reports 2021; 11: 7418 (IGR: 22-1)

92098 The GGLEAM Study: Understanding Glaucoma in the Ohio Amish
Sewell J
International journal of environmental research and public health 2021; 18: (IGR: 22-1)

92751 The performance of iPad-based noise-field perimeter versus Humphrey Field Analyser in detecting glaucomatous visual field loss
Chua C
Eye 2022; 36: 800-811 (IGR: 22-1)

91972 Childhood and Early Onset Glaucoma Classification and Genetic Profile in a Large Australasian Disease Registry
Smith JEH
Ophthalmology 2021; 0: (IGR: 22-1)

92751 The performance of iPad-based noise-field perimeter versus Humphrey Field Analyser in detecting glaucomatous visual field loss
Yip LWL
Eye 2022; 36: 800-811 (IGR: 22-1)

92371 Carbohydrate intake and risk of glaucoma in the sun cohort
Ruiz-Canela M
European Journal of Ophthalmology 2021; 0: 11206721211012862 (IGR: 22-1)

92626 Nationwide Glaucoma incidence in end stage renal disease patients and kidney transplant recipients
Joo KW
Scientific reports 2021; 11: 7418 (IGR: 22-1)

92750 Differences in clinical presentation of primary open-angle glaucoma between African and European populations

Acta Ophthalmologica 2021; 99: e1118-e1126 (IGR: 22-1)

92196 Prevalence of glaucoma in the Lao People's Democratic Republic: the Vientiane Eye Study
Souksamone K
British Journal of Ophthalmology 2022; 106: 1121-1125 (IGR: 22-1)

91972 Childhood and Early Onset Glaucoma Classification and Genetic Profile in a Large Australasian Disease Registry
Gole G
Ophthalmology 2021; 0: (IGR: 22-1)

92015 Determinants of lamina cribrosa depth in healthy Asian eyes: the Singapore Epidemiology Eye Study
Nguyen DQ
British Journal of Ophthalmology 2021; 105: 367-373 (IGR: 22-1)

92373 Investigating the Relationship between Glaucoma Prevalence and Trabecular Meshwork Length
Seong GJ
Journal of clinical medicine 2021; 10: (IGR: 22-1)

92098 The GGLEAM Study: Understanding Glaucoma in the Ohio Amish
Fuzzell D
International journal of environmental research and public health 2021; 18: (IGR: 22-1)

92010 The Global Extent of Undetected Glaucoma in Adults: A Systematic Review and Meta-analysis
Tham YC
Ophthalmology 2021; 0: (IGR: 22-1)

92015 Determinants of lamina cribrosa depth in healthy Asian eyes: the Singapore Epidemiology Eye Study
Strouthidis NG
British Journal of Ophthalmology 2021; 105: 367-373 (IGR: 22-1)

92750 Differences in clinical presentation of primary open-angle glaucoma between African and European populations
Van de Laar S
Acta Ophthalmologica 2021; 99: e1118-e1126 (IGR: 22-1)

92010 The Global Extent of Undetected Glaucoma in Adults: A Systematic Review and Meta-analysis
Wong TY
Ophthalmology 2021; 0: (IGR: 22-1)

92196 Prevalence of glaucoma in the Lao People's Democratic Republic: the Vientiane Eye Study
Casson RJ
British Journal of Ophthalmology 2022; 106: 1121-1125 (IGR: 22-1)

92626 Nationwide Glaucoma incidence in end stage renal disease patients and kidney transplant recipients
Kim YS
Scientific reports 2021; 11: 7418 (IGR: 22-1)

92098 The GGLEAM Study: Understanding Glaucoma in the Ohio Amish
Fuzzell S
International journal of environmental research and public health 2021; 18: (IGR: 22-1)

92371 Carbohydrate intake and risk of glaucoma in the sun cohort
Martínez-González J
European Journal of Ophthalmology 2021; 0: 11206721211012862 (IGR: 22-1)

91972 Childhood and Early Onset Glaucoma Classification and Genetic Profile in a Large Australasian Disease Registry
Chiang MY
Ophthalmology 2021; 0: (IGR: 22-1)

92098 The GGLEAM Study: Understanding Glaucoma in the Ohio Amish
Miller S
International journal of environmental research and public health 2021; 18: (IGR: 22-1)

92010 The Global Extent of Undetected Glaucoma in Adults: A Systematic Review and Meta-analysis
Aung T
Ophthalmology 2021; 0: (IGR: 22-1)

92750 Differences in clinical presentation of primary open-angle glaucoma between African and European populations
Lemij HG
Acta Ophthalmologica 2021; 99: e1118-e1126 (IGR: 22-1)

92015 Determinants of lamina cribrosa depth in healthy Asian eyes: the Singapore Epidemiology Eye Study
Aung T
British Journal of Ophthalmology 2021; 105: 367-373 (IGR: 22-1)

92626 Nationwide Glaucoma incidence in end stage renal disease patients and kidney transplant recipients
Park KH
Scientific reports 2021; 11: 7418 (IGR: 22-1)

91972 Childhood and Early Onset Glaucoma Classification and Genetic Profile in a Large Australasian Disease Registry
Willett F
Ophthalmology 2021; 0: (IGR: 22-1)

92371 Carbohydrate intake and risk of glaucoma in the sun cohort
Martínez-González MÁ
European Journal of Ophthalmology 2021; 0: 11206721211012862 (IGR: 22-1)

92626 Nationwide Glaucoma incidence in end stage renal disease patients and kidney transplant recipients
Lee H
Scientific reports 2021; 11: 7418 (IGR: 22-1)

91972 Childhood and Early Onset Glaucoma Classification and Genetic Profile in a Large Australasian Disease Registry
d'Mellow G
Ophthalmology 2021; 0: (IGR: 22-1)

92371 Carbohydrate intake and risk of glaucoma in the sun cohort
Fernandez-Montero A
European Journal of Ophthalmology 2021; 0: 11206721211012862 (IGR: 22-1)

92015 Determinants of lamina cribrosa depth in healthy Asian eyes: the Singapore Epidemiology Eye Study
Cheng CY
British Journal of Ophthalmology 2021; 105: 367-373 (IGR: 22-1)

92750 Differences in clinical presentation of primary open-angle glaucoma between African and European populations
Klaver CCW
Acta Ophthalmologica 2021; 99: e1118-e1126 (IGR: 22-1)

92010 The Global Extent of Undetected Glaucoma in Adults: A Systematic Review and Meta-analysis
Friedman DS
Ophthalmology 2021; 0: (IGR: 22-1)

92098 The GGLEAM Study: Understanding Glaucoma in the Ohio Amish
Wiggs JL
International journal of environmental research and public health 2021; 18: (IGR: 22-1)

91972 Childhood and Early Onset Glaucoma Classification and Genetic Profile in a Large Australasian Disease Registry
Breen J
Ophthalmology 2021; 0: (IGR: 22-1)

92010 The Global Extent of Undetected Glaucoma in Adults: A Systematic Review and Meta-analysis
Cheng CY
Ophthalmology 2021; 0: (IGR: 22-1)

92015 Determinants of lamina cribrosa depth in healthy Asian eyes: the Singapore Epidemiology Eye Study
Boote C
British Journal of Ophthalmology 2021; 105: 367-373 (IGR: 22-1)

92626 Nationwide Glaucoma incidence in end stage renal disease patients and kidney transplant recipients
Kim YC
Scientific reports 2021; 11: 7418 (IGR: 22-1)

92098 The GGLEAM Study: Understanding Glaucoma in the Ohio Amish
Pasquale LR
International journal of environmental research and public health 2021; 18: (IGR: 22-1)

92750 Differences in clinical presentation of primary open-angle glaucoma between African and European populations
Jansonius NM
Acta Ophthalmologica 2021; 99: e1118-e1126 (IGR: 22-1)

91972 Childhood and Early Onset Glaucoma Classification and Genetic Profile in a Large Australasian Disease Registry
Qassim A
Ophthalmology 2021; 0: (IGR: 22-1)

92015 Determinants of lamina cribrosa depth in healthy Asian eyes: the Singapore Epidemiology Eye Study
Girard MJA
British Journal of Ophthalmology 2021; 105: 367-373 (IGR: 22-1)

92098 The GGLEAM Study: Understanding Glaucoma in the Ohio Amish
Skarie JM
International journal of environmental research and public health 2021; 18: (IGR: 22-1)

92626 Nationwide Glaucoma incidence in end stage renal disease patients and kidney transplant recipients
Jeoung JW
Scientific reports 2021; 11: 7418 (IGR: 22-1)

92750 Differences in clinical presentation of primary open-angle glaucoma between African and European populations
Thiadens AAHJ
Acta Ophthalmologica 2021; 99: e1118-e1126 (IGR: 22-1)

92098 The GGLEAM Study: Understanding Glaucoma in the Ohio Amish
Haines JL
International journal of environmental research and public health 2021; 18: (IGR: 22-1)

91972 Childhood and Early Onset Glaucoma Classification and Genetic Profile in a Large Australasian Disease Registry
Mullany S
Ophthalmology 2021; 0: (IGR: 22-1)

92098 The GGLEAM Study: Understanding Glaucoma in the Ohio Amish
Cooke Bailey JN
International journal of environmental research and public health 2021; 18: (IGR: 22-1)

91972 Childhood and Early Onset Glaucoma Classification and Genetic Profile in a Large Australasian Disease Registry
Elder JE; Vincent AL; Staffieri SE; Kearns LS; Mackey DA; Luu S; Siggs OM; Souzeau E; Craig JE
Ophthalmology 2021; 0: (IGR: 22-1)

91373 Epidemiology and clinical presentation of glaucoma in a referral facility in Ghana: Any lessons for public health intervention?
Kyei S
PLoS ONE 2021; 16: e0245486 (IGR: 21-4)

90881 Epidemiology of Glaucoma: The Past, Present, and Predictions for the Future
Allison K
Cureus 2020; 12: e11686 (IGR: 21-4)

91737 Prevalence of Primary Angle Closure Glaucoma in the Last 20 Years: A Meta-Analysis and Systematic Review
Zhang N
Frontiers in medicine 2020; 7: 624179 (IGR: 21-4)

91830 Population-Based Projection of Vision-Related Disability in Australia 2020 - 2060: Prevalence, Causes, Associated Factors and Demand for Orientation and Mobility Services
Chang KJ
Ophthalmic Epidemiology 2021; 0: 1-10 (IGR: 21-4)

90889 Prevalence and associated factors of glaucoma in the Russian Ural Eye and Medical Study
Bikbov MM
Scientific reports 2020; 10: 20307 (IGR: 21-4)

91565 Prevalence of primary open-angle glaucoma in a Somalia population
Kalayci M
International Ophthalmology 2021; 41: 581-586 (IGR: 21-4)

91001 Association between corneal refractive surgery and the prevalence of glaucoma: Korea National Health and Nutrition Examination Survey 2010-2012
Song JS
British Journal of Ophthalmology 2022; 106: 172-176 (IGR: 21-4)

90947 The prevalence and incidence of glaucoma in Norway 2004-2018: A nationwide population-based study
Slettedal JK
PLoS ONE 2020; 15: e0242786 (IGR: 21-4)

91830 Population-Based Projection of Vision-Related Disability in Australia 2020 - 2060: Prevalence, Causes, Associated Factors and Demand for Orientation and Mobility Services
Rogers K
Ophthalmic Epidemiology 2021; 0: 1-10 (IGR: 21-4)

91001 Association between corneal refractive surgery and the prevalence of glaucoma: Korea National Health and Nutrition Examination Survey 2010-2012
Lee YB
British Journal of Ophthalmology 2022; 106: 172-176 (IGR: 21-4)

91565 Prevalence of primary open-angle glaucoma in a Somalia population
Cetinkaya E
International Ophthalmology 2021; 41: 581-586 (IGR: 21-4)

90889 Prevalence and associated factors of glaucoma in the Russian Ural Eye and Medical Study
Gilmanshin TR
Scientific reports 2020; 10: 20307 (IGR: 21-4)

91737 Prevalence of Primary Angle Closure Glaucoma in the Last 20 Years: A Meta-Analysis and Systematic Review
Wang J
Frontiers in medicine 2020; 7: 624179 (IGR: 21-4)

91373 Epidemiology and clinical presentation of glaucoma in a referral facility in Ghana: Any lessons for public health intervention?
Obeng PA
PLoS ONE 2021; 16: e0245486 (IGR: 21-4)

90881 Epidemiology of Glaucoma: The Past, Present, and Predictions for the Future
Patel D
Cureus 2020; 12: e11686 (IGR: 21-4)

90947 The prevalence and incidence of glaucoma in Norway 2004-2018: A nationwide population-based study
Traustadóttir VD
PLoS ONE 2020; 15: e0242786 (IGR: 21-4)

91565 Prevalence of primary open-angle glaucoma in a Somalia population
Erol MK
International Ophthalmology 2021; 41: 581-586 (IGR: 21-4)

91373 Epidemiology and clinical presentation of glaucoma in a referral facility in Ghana: Any lessons for public health intervention?
Kwarteng MA
PLoS ONE 2021; 16: e0245486 (IGR: 21-4)

90947 The prevalence and incidence of glaucoma in Norway 2004-2018: A nationwide population-based study
Sandvik L
PLoS ONE 2020; 15: e0242786 (IGR: 21-4)

90881 Epidemiology of Glaucoma: The Past, Present, and Predictions for the Future
Alabi O
Cureus 2020; 12: e11686 (IGR: 21-4)

90889 Prevalence and associated factors of glaucoma in the Russian Ural Eye and Medical Study
Zainullin RM
Scientific reports 2020; 10: 20307 (IGR: 21-4)

91001 Association between corneal refractive surgery and the prevalence of glaucoma: Korea National Health and Nutrition Examination Survey 2010-2012
Kim JA
British Journal of Ophthalmology 2022; 106: 172-176 (IGR: 21-4)

91737 Prevalence of Primary Angle Closure Glaucoma in the Last 20 Years: A Meta-Analysis and Systematic Review
Chen B
Frontiers in medicine 2020; 7: 624179 (IGR: 21-4)

91830 Population-Based Projection of Vision-Related Disability in Australia 2020 - 2060: Prevalence, Causes, Associated Factors and Demand for Orientation and Mobility Services
Lung T
Ophthalmic Epidemiology 2021; 0: 1-10 (IGR: 21-4)

91373 Epidemiology and clinical presentation of glaucoma in a referral facility in Ghana: Any lessons for public health intervention?
Kwarteng MA
PLoS ONE 2021; 16: e0245486 (IGR: 21-4)

91737 Prevalence of Primary Angle Closure Glaucoma in the Last 20 Years: A Meta-Analysis and Systematic Review
Li Y
Frontiers in medicine 2020; 7: 624179 (IGR: 21-4)

90889 Prevalence and associated factors of glaucoma in the Russian Ural Eye and Medical Study
Kazakbaeva GM
Scientific reports 2020; 10: 20307 (IGR: 21-4)

91001 Association between corneal refractive surgery and the prevalence of glaucoma: Korea National Health and Nutrition Examination Survey 2010-2012
Lee EJ
British Journal of Ophthalmology 2022; 106: 172-176 (IGR: 21-4)

91830 Population-Based Projection of Vision-Related Disability in Australia 2020 - 2060: Prevalence, Causes, Associated Factors and Demand for Orientation and Mobility Services
Shih S
Ophthalmic Epidemiology 2021; 0: 1-10 (IGR: 21-4)

91373 Epidemiology and clinical presentation of glaucoma in a referral facility in Ghana: Any lessons for public health intervention?
Assiamah F
PLoS ONE 2021; 16: e0245486 (IGR: 21-4)

90947 The prevalence and incidence of glaucoma in Norway 2004-2018: A nationwide population-based study
Ringvold A
PLoS ONE 2020; 15: e0242786 (IGR: 21-4)

91373 Epidemiology and clinical presentation of glaucoma in a referral facility in Ghana: Any lessons for public health intervention?
Assiamah F
PLoS ONE 2021; 16: e0245486 (IGR: 21-4)

91830 Population-Based Projection of Vision-Related Disability in Australia 2020 - 2060: Prevalence, Causes, Associated Factors and Demand for Orientation and Mobility Services
Huang-Lung J
Ophthalmic Epidemiology 2021; 0: 1-10 (IGR: 21-4)

91737 Prevalence of Primary Angle Closure Glaucoma in the Last 20 Years: A Meta-Analysis and Systematic Review
Jiang B
Frontiers in medicine 2020; 7: 624179 (IGR: 21-4)

91001 Association between corneal refractive surgery and the prevalence of glaucoma: Korea National Health and Nutrition Examination Survey 2010-2012
Kim H
British Journal of Ophthalmology 2022; 106: 172-176 (IGR: 21-4)

90889 Prevalence and associated factors of glaucoma in the Russian Ural Eye and Medical Study
Arslangareeva II
Scientific reports 2020; 10: 20307 (IGR: 21-4)

91830 Population-Based Projection of Vision-Related Disability in Australia 2020 - 2060: Prevalence, Causes, Associated Factors and Demand for Orientation and Mobility Services
Keay L
Ophthalmic Epidemiology 2021; 0: 1-10 (IGR: 21-4)

90889 Prevalence and associated factors of glaucoma in the Russian Ural Eye and Medical Study
Panda-Jonas S
Scientific reports 2020; 10: 20307 (IGR: 21-4)

91830 Population-Based Projection of Vision-Related Disability in Australia 2020 - 2060: Prevalence, Causes, Associated Factors and Demand for Orientation and Mobility Services
Keay L
Ophthalmic Epidemiology 2021; 0: 1-10 (IGR: 21-4)

90889 Prevalence and associated factors of glaucoma in the Russian Ural Eye and Medical Study
Khikmatullin RI; Aminev SK; Nuriev IF; Zaynetdinov AF; Uzianbaeva YV; Nikitin NA; Mukhamadieva SR; Yakupova DF; Rakhimova EM; Rusakova IA; Bolshakova NI; Safiullina KR; Jonas JB
Scientific reports 2020; 10: 20307 (IGR: 21-4)

89981 Prevalence of glaucoma in the elderly population in Taiwan: The Shihpai Eye Study
Kuo CY
Journal of the Chinese Medical Association 2020; 83: 880-884 (IGR: 21-3)

90040 Profiles and Clinical Characteristics of Newly Diagnosed Glaucoma in Urban Korea: A Multicenter Study
Hong C
Korean Journal of Ophthalmology 2020; 34: 353-360 (IGR: 21-3)

90028 Six-Year Incidence and Risk Factors of Primary Glaucoma in the Singapore Indian Eye Study
Koh V
Ophthalmology. Glaucoma 2021; 4: 201-208 (IGR: 21-3)

90320 Significant intraocular pressure associated with open-angle glaucoma: Korea National Health and Nutrition Examination Survey 2010-2011
Kim KE
PLoS ONE 2020; 15: e0235701 (IGR: 21-3)

90710 Epidemiological factors associated with health knowledge of three common eye diseases: A community-based pilot survey in Hong Kong
Wong PW
SAGE open medicine 2020; 8: 2050312120943044 (IGR: 21-3)

89936 Glaucoma among the Malaysian Community
Al-Naggar RA
TheScientificWorldJournal 2020; 2020: 4859496 (IGR: 21-3)

90414 Glaucoma in large-scale population-based epidemiology: a questionnaire-based proxy
Neustaeter A
Eye 2021; 35: 508-516 (IGR: 21-3)

90858 Association between esodeviation and primary open-angle glaucoma: the 2010-2011 Korea National Health and Nutrition Examination Survey
Kim JS
British Journal of Ophthalmology 2021; 105: 1672-1677 (IGR: 21-3)

90028 Six-Year Incidence and Risk Factors of Primary Glaucoma in the Singapore Indian Eye Study
Tham YC
Ophthalmology. Glaucoma 2021; 4: 201-208 (IGR: 21-3)

90414 Glaucoma in large-scale population-based epidemiology: a questionnaire-based proxy
Vehof J
Eye 2021; 35: 508-516 (IGR: 21-3)

90858 Association between esodeviation and primary open-angle glaucoma: the 2010-2011 Korea National Health and Nutrition Examination Survey
Kim YK
British Journal of Ophthalmology 2021; 105: 1672-1677 (IGR: 21-3)

90320 Significant intraocular pressure associated with open-angle glaucoma: Korea National Health and Nutrition Examination Survey 2010-2011
Kim JM
PLoS ONE 2020; 15: e0235701 (IGR: 21-3)

89981 Prevalence of glaucoma in the elderly population in Taiwan: The Shihpai Eye Study
Ko YC
Journal of the Chinese Medical Association 2020; 83: 880-884 (IGR: 21-3)

90710 Epidemiological factors associated with health knowledge of three common eye diseases: A community-based pilot survey in Hong Kong
Lau JK
SAGE open medicine 2020; 8: 2050312120943044 (IGR: 21-3)

90040 Profiles and Clinical Characteristics of Newly Diagnosed Glaucoma in Urban Korea: A Multicenter Study
Hong SW
Korean Journal of Ophthalmology 2020; 34: 353-360 (IGR: 21-3)

89936 Glaucoma among the Malaysian Community
Alshaikhli H
TheScientificWorldJournal 2020; 2020: 4859496 (IGR: 21-3)

90858 Association between esodeviation and primary open-angle glaucoma: the 2010-2011 Korea National Health and Nutrition Examination Survey
Kim YW
British Journal of Ophthalmology 2021; 105: 1672-1677 (IGR: 21-3)

89936 Glaucoma among the Malaysian Community
Al-Rashidi RR
TheScientificWorldJournal 2020; 2020: 4859496 (IGR: 21-3)

90028 Six-Year Incidence and Risk Factors of Primary Glaucoma in the Singapore Indian Eye Study
Tan NYQ
Ophthalmology. Glaucoma 2021; 4: 201-208 (IGR: 21-3)

90710 Epidemiological factors associated with health knowledge of three common eye diseases: A community-based pilot survey in Hong Kong
Choy BN
SAGE open medicine 2020; 8: 2050312120943044 (IGR: 21-3)

90040 Profiles and Clinical Characteristics of Newly Diagnosed Glaucoma in Urban Korea: A Multicenter Study
Park CK
Korean Journal of Ophthalmology 2020; 34: 353-360 (IGR: 21-3)

90320 Significant intraocular pressure associated with open-angle glaucoma: Korea National Health and Nutrition Examination Survey 2010-2011
Lee J
PLoS ONE 2020; 15: e0235701 (IGR: 21-3)

90414 Glaucoma in large-scale population-based epidemiology: a questionnaire-based proxy
Snieder H
Eye 2021; 35: 508-516 (IGR: 21-3)

89981 Prevalence of glaucoma in the elderly population in Taiwan: The Shihpai Eye Study
Kuang TM
Journal of the Chinese Medical Association 2020; 83: 880-884 (IGR: 21-3)

90858 Association between esodeviation and primary open-angle glaucoma: the 2010-2011 Korea National Health and Nutrition Examination Survey
Baek SU
British Journal of Ophthalmology 2021; 105: 1672-1677 (IGR: 21-3)

90414 Glaucoma in large-scale population-based epidemiology: a questionnaire-based proxy
Jansonius NM
Eye 2021; 35: 508-516 (IGR: 21-3)

89981 Prevalence of glaucoma in the elderly population in Taiwan: The Shihpai Eye Study
Chou P
Journal of the Chinese Medical Association 2020; 83: 880-884 (IGR: 21-3)

90028 Six-Year Incidence and Risk Factors of Primary Glaucoma in the Singapore Indian Eye Study
Yu M
Ophthalmology. Glaucoma 2021; 4: 201-208 (IGR: 21-3)

90040 Profiles and Clinical Characteristics of Newly Diagnosed Glaucoma in Urban Korea: A Multicenter Study
Sung KR
Korean Journal of Ophthalmology 2020; 34: 353-360 (IGR: 21-3)

89936 Glaucoma among the Malaysian Community
Saleh B
TheScientificWorldJournal 2020; 2020: 4859496 (IGR: 21-3)

90320 Significant intraocular pressure associated with open-angle glaucoma: Korea National Health and Nutrition Examination Survey 2010-2011
Lee MY
PLoS ONE 2020; 15: e0235701 (IGR: 21-3)

90710 Epidemiological factors associated with health knowledge of three common eye diseases: A community-based pilot survey in Hong Kong
Shih KC
SAGE open medicine 2020; 8: 2050312120943044 (IGR: 21-3)

90320 Significant intraocular pressure associated with open-angle glaucoma: Korea National Health and Nutrition Examination Survey 2010-2011
Park KH
PLoS ONE 2020; 15: e0235701 (IGR: 21-3)

90710 Epidemiological factors associated with health knowledge of three common eye diseases: A community-based pilot survey in Hong Kong
Ng AL
SAGE open medicine 2020; 8: 2050312120943044 (IGR: 21-3)

89981 Prevalence of glaucoma in the elderly population in Taiwan: The Shihpai Eye Study
Chiou SH
Journal of the Chinese Medical Association 2020; 83: 880-884 (IGR: 21-3)

90858 Association between esodeviation and primary open-angle glaucoma: the 2010-2011 Korea National Health and Nutrition Examination Survey
Ha A
British Journal of Ophthalmology 2021; 105: 1672-1677 (IGR: 21-3)

90028 Six-Year Incidence and Risk Factors of Primary Glaucoma in the Singapore Indian Eye Study
Thakur S
Ophthalmology. Glaucoma 2021; 4: 201-208 (IGR: 21-3)

90040 Profiles and Clinical Characteristics of Newly Diagnosed Glaucoma in Urban Korea: A Multicenter Study
Kim CS
Korean Journal of Ophthalmology 2020; 34: 353-360 (IGR: 21-3)

90028 Six-Year Incidence and Risk Factors of Primary Glaucoma in the Singapore Indian Eye Study
Teo ZL
Ophthalmology. Glaucoma 2021; 4: 201-208 (IGR: 21-3)

90858 Association between esodeviation and primary open-angle glaucoma: the 2010-2011 Korea National Health and Nutrition Examination Survey
Lee J
British Journal of Ophthalmology 2021; 105: 1672-1677 (IGR: 21-3)

89981 Prevalence of glaucoma in the elderly population in Taiwan: The Shihpai Eye Study
Liu CJ
Journal of the Chinese Medical Association 2020; 83: 880-884 (IGR: 21-3)

90710 Epidemiological factors associated with health knowledge of three common eye diseases: A community-based pilot survey in Hong Kong
Chan JC
SAGE open medicine 2020; 8: 2050312120943044 (IGR: 21-3)

90028 Six-Year Incidence and Risk Factors of Primary Glaucoma in the Singapore Indian Eye Study
Mani B
Ophthalmology. Glaucoma 2021; 4: 201-208 (IGR: 21-3)

90858 Association between esodeviation and primary open-angle glaucoma: the 2010-2011 Korea National Health and Nutrition Examination Survey
Lee HJ
British Journal of Ophthalmology 2021; 105: 1672-1677 (IGR: 21-3)

90710 Epidemiological factors associated with health knowledge of three common eye diseases: A community-based pilot survey in Hong Kong
Wong IY
SAGE open medicine 2020; 8: 2050312120943044 (IGR: 21-3)

90028 Six-Year Incidence and Risk Factors of Primary Glaucoma in the Singapore Indian Eye Study
Wong TY
Ophthalmology. Glaucoma 2021; 4: 201-208 (IGR: 21-3)

90858 Association between esodeviation and primary open-angle glaucoma: the 2010-2011 Korea National Health and Nutrition Examination Survey
Kim DW; Jeoung JW
British Journal of Ophthalmology 2021; 105: 1672-1677 (IGR: 21-3)

90028 Six-Year Incidence and Risk Factors of Primary Glaucoma in the Singapore Indian Eye Study
Aung T; Cheng CY
Ophthalmology. Glaucoma 2021; 4: 201-208 (IGR: 21-3)

90858 Association between esodeviation and primary open-angle glaucoma: the 2010-2011 Korea National Health and Nutrition Examination Survey
Kim SJ; Park KH
British Journal of Ophthalmology 2021; 105: 1672-1677 (IGR: 21-3)

86503 Profiles of Ganglion Cell-Inner Plexiform Layer Thickness in a Multi-Ethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Tham YC
Ophthalmology 2020; 127: 1064-1076 (IGR: 21-2)

86121 Glaucoma in the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA): cohort profile, prevalence, awareness and associations
McCann P
British Journal of Ophthalmology 2020; 104: 1492-1499 (IGR: 21-2)

86282 Prevalence of Unknown Ocular Hypertension, Glaucoma Suspects, and Glaucoma in Patients Seen in an Ophthalmology Center in France
Chamard C
Ophthalmic Research 2020; 63: 295-301 (IGR: 21-2)

86297 Paediatric glaucoma in Scotland
Beck D
BMC Ophthalmology 2020; 20: 76 (IGR: 21-2)

86589 Prevalence and causes of vision loss in sub-Saharan Africa in 2015: magnitude, temporal trends and projections
Naidoo K
British Journal of Ophthalmology 2020; 104: 1658-1668 (IGR: 21-2)

86623 Interactions between ocular and systemic disease using national register-based data in the Danish Excellence Centre in Ophthalmic Epidemiology (DECODE-EYE): study perspective
Grauslund J
Acta Ophthalmologica 2020; 98: 573-578 (IGR: 21-2)

86121 Glaucoma in the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA): cohort profile, prevalence, awareness and associations
Hogg R
British Journal of Ophthalmology 2020; 104: 1492-1499 (IGR: 21-2)

86503 Profiles of Ganglion Cell-Inner Plexiform Layer Thickness in a Multi-Ethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Chee ML
Ophthalmology 2020; 127: 1064-1076 (IGR: 21-2)

86282 Prevalence of Unknown Ocular Hypertension, Glaucoma Suspects, and Glaucoma in Patients Seen in an Ophthalmology Center in France
Villain M
Ophthalmic Research 2020; 63: 295-301 (IGR: 21-2)

86589 Prevalence and causes of vision loss in sub-Saharan Africa in 2015: magnitude, temporal trends and projections
Kempen JH
British Journal of Ophthalmology 2020; 104: 1658-1668 (IGR: 21-2)

86623 Interactions between ocular and systemic disease using national register-based data in the Danish Excellence Centre in Ophthalmic Epidemiology (DECODE-EYE): study perspective
Stokholm L
Acta Ophthalmologica 2020; 98: 573-578 (IGR: 21-2)

86297 Paediatric glaucoma in Scotland
Galea M
BMC Ophthalmology 2020; 20: 76 (IGR: 21-2)

86623 Interactions between ocular and systemic disease using national register-based data in the Danish Excellence Centre in Ophthalmic Epidemiology (DECODE-EYE): study perspective
Ohm Kyvik K
Acta Ophthalmologica 2020; 98: 573-578 (IGR: 21-2)

86589 Prevalence and causes of vision loss in sub-Saharan Africa in 2015: magnitude, temporal trends and projections
Gichuhi S
British Journal of Ophthalmology 2020; 104: 1658-1668 (IGR: 21-2)

86121 Glaucoma in the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA): cohort profile, prevalence, awareness and associations
Wright DM
British Journal of Ophthalmology 2020; 104: 1492-1499 (IGR: 21-2)

86297 Paediatric glaucoma in Scotland
Loo CY
BMC Ophthalmology 2020; 20: 76 (IGR: 21-2)

86282 Prevalence of Unknown Ocular Hypertension, Glaucoma Suspects, and Glaucoma in Patients Seen in an Ophthalmology Center in France
Bron A
Ophthalmic Research 2020; 63: 295-301 (IGR: 21-2)

86503 Profiles of Ganglion Cell-Inner Plexiform Layer Thickness in a Multi-Ethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Dai W
Ophthalmology 2020; 127: 1064-1076 (IGR: 21-2)

86121 Glaucoma in the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA): cohort profile, prevalence, awareness and associations
Pose-Bazarra S
British Journal of Ophthalmology 2020; 104: 1492-1499 (IGR: 21-2)

86589 Prevalence and causes of vision loss in sub-Saharan Africa in 2015: magnitude, temporal trends and projections
Braithwaite T
British Journal of Ophthalmology 2020; 104: 1658-1668 (IGR: 21-2)

86503 Profiles of Ganglion Cell-Inner Plexiform Layer Thickness in a Multi-Ethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Lim ZW
Ophthalmology 2020; 127: 1064-1076 (IGR: 21-2)

86297 Paediatric glaucoma in Scotland
Schmoll C
BMC Ophthalmology 2020; 20: 76 (IGR: 21-2)

86623 Interactions between ocular and systemic disease using national register-based data in the Danish Excellence Centre in Ophthalmic Epidemiology (DECODE-EYE): study perspective
Dornonville de la Cour M
Acta Ophthalmologica 2020; 98: 573-578 (IGR: 21-2)

86282 Prevalence of Unknown Ocular Hypertension, Glaucoma Suspects, and Glaucoma in Patients Seen in an Ophthalmology Center in France
Causse A
Ophthalmic Research 2020; 63: 295-301 (IGR: 21-2)

86623 Interactions between ocular and systemic disease using national register-based data in the Danish Excellence Centre in Ophthalmic Epidemiology (DECODE-EYE): study perspective
Kessel L
Acta Ophthalmologica 2020; 98: 573-578 (IGR: 21-2)

86282 Prevalence of Unknown Ocular Hypertension, Glaucoma Suspects, and Glaucoma in Patients Seen in an Ophthalmology Center in France
Bentaleb Y
Ophthalmic Research 2020; 63: 295-301 (IGR: 21-2)

86297 Paediatric glaucoma in Scotland
Burgess FR
BMC Ophthalmology 2020; 20: 76 (IGR: 21-2)

86503 Profiles of Ganglion Cell-Inner Plexiform Layer Thickness in a Multi-Ethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Majithia S
Ophthalmology 2020; 127: 1064-1076 (IGR: 21-2)

86121 Glaucoma in the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA): cohort profile, prevalence, awareness and associations
Chakravarthy U
British Journal of Ophthalmology 2020; 104: 1492-1499 (IGR: 21-2)

86589 Prevalence and causes of vision loss in sub-Saharan Africa in 2015: magnitude, temporal trends and projections
Casson RJ
British Journal of Ophthalmology 2020; 104: 1658-1668 (IGR: 21-2)

86121 Glaucoma in the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA): cohort profile, prevalence, awareness and associations
Peto T
British Journal of Ophthalmology 2020; 104: 1492-1499 (IGR: 21-2)

86623 Interactions between ocular and systemic disease using national register-based data in the Danish Excellence Centre in Ophthalmic Epidemiology (DECODE-EYE): study perspective
Hass Rubin K
Acta Ophthalmologica 2020; 98: 573-578 (IGR: 21-2)

86297 Paediatric glaucoma in Scotland
Montgomery D
BMC Ophthalmology 2020; 20: 76 (IGR: 21-2)

86503 Profiles of Ganglion Cell-Inner Plexiform Layer Thickness in a Multi-Ethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Siantar R
Ophthalmology 2020; 127: 1064-1076 (IGR: 21-2)

86589 Prevalence and causes of vision loss in sub-Saharan Africa in 2015: magnitude, temporal trends and projections
Cicinelli MV
British Journal of Ophthalmology 2020; 104: 1658-1668 (IGR: 21-2)

86282 Prevalence of Unknown Ocular Hypertension, Glaucoma Suspects, and Glaucoma in Patients Seen in an Ophthalmology Center in France
Pelen F
Ophthalmic Research 2020; 63: 295-301 (IGR: 21-2)

86297 Paediatric glaucoma in Scotland
Tatham AJ
BMC Ophthalmology 2020; 20: 76 (IGR: 21-2)

86589 Prevalence and causes of vision loss in sub-Saharan Africa in 2015: magnitude, temporal trends and projections
Das A
British Journal of Ophthalmology 2020; 104: 1658-1668 (IGR: 21-2)

86121 Glaucoma in the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA): cohort profile, prevalence, awareness and associations
Cruise S
British Journal of Ophthalmology 2020; 104: 1492-1499 (IGR: 21-2)

86503 Profiles of Ganglion Cell-Inner Plexiform Layer Thickness in a Multi-Ethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Thakur S
Ophthalmology 2020; 127: 1064-1076 (IGR: 21-2)

86282 Prevalence of Unknown Ocular Hypertension, Glaucoma Suspects, and Glaucoma in Patients Seen in an Ophthalmology Center in France
Baudouin C
Ophthalmic Research 2020; 63: 295-301 (IGR: 21-2)

86503 Profiles of Ganglion Cell-Inner Plexiform Layer Thickness in a Multi-Ethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Rim T
Ophthalmology 2020; 127: 1064-1076 (IGR: 21-2)

86589 Prevalence and causes of vision loss in sub-Saharan Africa in 2015: magnitude, temporal trends and projections
Flaxman SR
British Journal of Ophthalmology 2020; 104: 1658-1668 (IGR: 21-2)

86282 Prevalence of Unknown Ocular Hypertension, Glaucoma Suspects, and Glaucoma in Patients Seen in an Ophthalmology Center in France
Daien V
Ophthalmic Research 2020; 63: 295-301 (IGR: 21-2)

86121 Glaucoma in the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA): cohort profile, prevalence, awareness and associations
McGuinness B; Young IS
British Journal of Ophthalmology 2020; 104: 1492-1499 (IGR: 21-2)

86503 Profiles of Ganglion Cell-Inner Plexiform Layer Thickness in a Multi-Ethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Cheung CY
Ophthalmology 2020; 127: 1064-1076 (IGR: 21-2)

86589 Prevalence and causes of vision loss in sub-Saharan Africa in 2015: magnitude, temporal trends and projections
Jonas JB; Keeffe JE
British Journal of Ophthalmology 2020; 104: 1658-1668 (IGR: 21-2)

86503 Profiles of Ganglion Cell-Inner Plexiform Layer Thickness in a Multi-Ethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Sabanayagam C
Ophthalmology 2020; 127: 1064-1076 (IGR: 21-2)

86121 Glaucoma in the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA): cohort profile, prevalence, awareness and associations
Kee F
British Journal of Ophthalmology 2020; 104: 1492-1499 (IGR: 21-2)

86503 Profiles of Ganglion Cell-Inner Plexiform Layer Thickness in a Multi-Ethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Aung T
Ophthalmology 2020; 127: 1064-1076 (IGR: 21-2)

86589 Prevalence and causes of vision loss in sub-Saharan Africa in 2015: magnitude, temporal trends and projections
Leasher J
British Journal of Ophthalmology 2020; 104: 1658-1668 (IGR: 21-2)

86121 Glaucoma in the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA): cohort profile, prevalence, awareness and associations
Azuara-Blanco A
British Journal of Ophthalmology 2020; 104: 1492-1499 (IGR: 21-2)

86503 Profiles of Ganglion Cell-Inner Plexiform Layer Thickness in a Multi-Ethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Wong TY
Ophthalmology 2020; 127: 1064-1076 (IGR: 21-2)

86589 Prevalence and causes of vision loss in sub-Saharan Africa in 2015: magnitude, temporal trends and projections
Limburg H
British Journal of Ophthalmology 2020; 104: 1658-1668 (IGR: 21-2)

86503 Profiles of Ganglion Cell-Inner Plexiform Layer Thickness in a Multi-Ethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Cheng CY
Ophthalmology 2020; 127: 1064-1076 (IGR: 21-2)

86589 Prevalence and causes of vision loss in sub-Saharan Africa in 2015: magnitude, temporal trends and projections
Pesudovs K; Resnikoff S; Silvester AJ; Tahhan N; Taylor HR; Wong TY; Bourne RRA;
British Journal of Ophthalmology 2020; 104: 1658-1668 (IGR: 21-2)

84654 Epidemiology of Childhood Blindness and Low Vision in Kinshasa-democratic Republic of the Congo
Kilangalanga NJ
Ophthalmic Epidemiology 2020; 27: 45-51 (IGR: 21-1)

84767 Prevalence and risk factors of glaucoma in an adult population from Shahroud, Iran
Hashemi H
Journal of current ophthalmology 2019; 31: 366-372 (IGR: 21-1)

84490 Association of single-nucleotide polymorphisms in TLR4 gene and gene-environment interaction with primary open angle glaucoma in a Chinese northern population
Liu H
Journal of Gene Medicine 2020; 22: e3139 (IGR: 21-1)

85160 Proportion of Glaucoma among Voluntary People Coming for Glaucoma Screening Program at Jimma University Department of Ophthalmology, Jimma, Ethiopia
Daba KT
Ethiopian journal of health sciences 2020; 30: 13-22 (IGR: 21-1)

84488 LVPEI Glaucoma Epidemiology and Molecular Genetic Study: teleophthalmology screening for angle-closure disease in an underserved region
Choudhari NS
Eye 2020; 34: 1399-1405 (IGR: 21-1)

85097 Prevalence of and factors related with abnormal fundoscopic findings among the elderly population in a rural community in South Korea
Choi HR
Seminars in Ophthalmology 2020; 35: 41-49 (IGR: 21-1)

84558 Association of Ambient Particulate Matter Exposure with the Incidence of Glaucoma in Childhood
Min KB
American Journal of Ophthalmology 2020; 211: 176-182 (IGR: 21-1)

84703 Findings from a Rapid Assessment of Avoidable Blindness (RAAB) in the Southwest Region of Kyrgyzstan
Mueller B
Ophthalmic Epidemiology 2020; 27: 141-147 (IGR: 21-1)

84985 Open-angle glaucoma in a rural and urban population in Eastern India-the Hooghly river glaucoma study
Paul C
Indian Journal of Ophthalmology 2020; 68: 371-374 (IGR: 21-1)

84536 Retinal nerve fibre layer thickness in a normal black South African population
Ismail S
Eye 2019; 0: (IGR: 21-1)

84678 Visual impairment among adults in Saudi Arabia
Zeried FM
Clinical and Experimental Optometry 2020; 103: 858-864 (IGR: 21-1)

84746 Nationwide Incidence of Acute Angle Closure Glaucoma in Korea from 2011 to 2015
Park SJ
J Korean Med Sci 2019; 34: e306 (IGR: 21-1)

85055 Utilization of Outpatient Eye Care Services in Taiwan: A Nationwide Population Study
Hsu CA
Journal of Ophthalmology 2020; 2020: 2641683 (IGR: 21-1)

84518 Effects of an Aging Population and Racial Demographics on Eye Disease Prevalence: Projections for Georgia Through 2050
Kelly E
American Journal of Ophthalmology 2020; 210: 35-40 (IGR: 21-1)

85055 Utilization of Outpatient Eye Care Services in Taiwan: A Nationwide Population Study
Hsiao SH
Journal of Ophthalmology 2020; 2020: 2641683 (IGR: 21-1)

84536 Retinal nerve fibre layer thickness in a normal black South African population
Ally N
Eye 2019; 0: (IGR: 21-1)

84746 Nationwide Incidence of Acute Angle Closure Glaucoma in Korea from 2011 to 2015
Park KH
J Korean Med Sci 2019; 34: e306 (IGR: 21-1)

84654 Epidemiology of Childhood Blindness and Low Vision in Kinshasa-democratic Republic of the Congo
Nsiangani LN
Ophthalmic Epidemiology 2020; 27: 45-51 (IGR: 21-1)

84678 Visual impairment among adults in Saudi Arabia
Alshalan FA
Clinical and Experimental Optometry 2020; 103: 858-864 (IGR: 21-1)

84518 Effects of an Aging Population and Racial Demographics on Eye Disease Prevalence: Projections for Georgia Through 2050
Wen Q
American Journal of Ophthalmology 2020; 210: 35-40 (IGR: 21-1)

84767 Prevalence and risk factors of glaucoma in an adult population from Shahroud, Iran
Mohammadi M
Journal of current ophthalmology 2019; 31: 366-372 (IGR: 21-1)

85160 Proportion of Glaucoma among Voluntary People Coming for Glaucoma Screening Program at Jimma University Department of Ophthalmology, Jimma, Ethiopia
Gessesse GW
Ethiopian journal of health sciences 2020; 30: 13-22 (IGR: 21-1)

84488 LVPEI Glaucoma Epidemiology and Molecular Genetic Study: teleophthalmology screening for angle-closure disease in an underserved region
Chandran P
Eye 2020; 34: 1399-1405 (IGR: 21-1)

84703 Findings from a Rapid Assessment of Avoidable Blindness (RAAB) in the Southwest Region of Kyrgyzstan
Ibraimova S
Ophthalmic Epidemiology 2020; 27: 141-147 (IGR: 21-1)

85097 Prevalence of and factors related with abnormal fundoscopic findings among the elderly population in a rural community in South Korea
Rim TH
Seminars in Ophthalmology 2020; 35: 41-49 (IGR: 21-1)

84558 Association of Ambient Particulate Matter Exposure with the Incidence of Glaucoma in Childhood
Min JY
American Journal of Ophthalmology 2020; 211: 176-182 (IGR: 21-1)

84985 Open-angle glaucoma in a rural and urban population in Eastern India-the Hooghly river glaucoma study
Sengupta S
Indian Journal of Ophthalmology 2020; 68: 371-374 (IGR: 21-1)

84490 Association of single-nucleotide polymorphisms in TLR4 gene and gene-environment interaction with primary open angle glaucoma in a Chinese northern population
Qi S
Journal of Gene Medicine 2020; 22: e3139 (IGR: 21-1)

85097 Prevalence of and factors related with abnormal fundoscopic findings among the elderly population in a rural community in South Korea
Lee JH
Seminars in Ophthalmology 2020; 35: 41-49 (IGR: 21-1)

84490 Association of single-nucleotide polymorphisms in TLR4 gene and gene-environment interaction with primary open angle glaucoma in a Chinese northern population
He W
Journal of Gene Medicine 2020; 22: e3139 (IGR: 21-1)

85160 Proportion of Glaucoma among Voluntary People Coming for Glaucoma Screening Program at Jimma University Department of Ophthalmology, Jimma, Ethiopia
Sori SB
Ethiopian journal of health sciences 2020; 30: 13-22 (IGR: 21-1)

84678 Visual impairment among adults in Saudi Arabia
Simmons D
Clinical and Experimental Optometry 2020; 103: 858-864 (IGR: 21-1)

84518 Effects of an Aging Population and Racial Demographics on Eye Disease Prevalence: Projections for Georgia Through 2050
Haddad D
American Journal of Ophthalmology 2020; 210: 35-40 (IGR: 21-1)

84767 Prevalence and risk factors of glaucoma in an adult population from Shahroud, Iran
Zandvakil N
Journal of current ophthalmology 2019; 31: 366-372 (IGR: 21-1)

84985 Open-angle glaucoma in a rural and urban population in Eastern India-the Hooghly river glaucoma study
Banerjee S
Indian Journal of Ophthalmology 2020; 68: 371-374 (IGR: 21-1)

84536 Retinal nerve fibre layer thickness in a normal black South African population
Alli HD
Eye 2019; 0: (IGR: 21-1)

84703 Findings from a Rapid Assessment of Avoidable Blindness (RAAB) in the Southwest Region of Kyrgyzstan
Mamutalieva E
Ophthalmic Epidemiology 2020; 27: 141-147 (IGR: 21-1)

85055 Utilization of Outpatient Eye Care Services in Taiwan: A Nationwide Population Study
Hsu MH
Journal of Ophthalmology 2020; 2020: 2641683 (IGR: 21-1)

84654 Epidemiology of Childhood Blindness and Low Vision in Kinshasa-democratic Republic of the Congo
Dilu AA
Ophthalmic Epidemiology 2020; 27: 45-51 (IGR: 21-1)

84488 LVPEI Glaucoma Epidemiology and Molecular Genetic Study: teleophthalmology screening for angle-closure disease in an underserved region
Rao HL
Eye 2020; 34: 1399-1405 (IGR: 21-1)

84746 Nationwide Incidence of Acute Angle Closure Glaucoma in Korea from 2011 to 2015
Kim TW
J Korean Med Sci 2019; 34: e306 (IGR: 21-1)

84518 Effects of an Aging Population and Racial Demographics on Eye Disease Prevalence: Projections for Georgia Through 2050
O'Banion J
American Journal of Ophthalmology 2020; 210: 35-40 (IGR: 21-1)

84678 Visual impairment among adults in Saudi Arabia
Osuagwu UL
Clinical and Experimental Optometry 2020; 103: 858-864 (IGR: 21-1)

84985 Open-angle glaucoma in a rural and urban population in Eastern India-the Hooghly river glaucoma study
Choudhury S
Indian Journal of Ophthalmology 2020; 68: 371-374 (IGR: 21-1)

85055 Utilization of Outpatient Eye Care Services in Taiwan: A Nationwide Population Study
Yen JC
Journal of Ophthalmology 2020; 2020: 2641683 (IGR: 21-1)

85097 Prevalence of and factors related with abnormal fundoscopic findings among the elderly population in a rural community in South Korea
Lee SW
Seminars in Ophthalmology 2020; 35: 41-49 (IGR: 21-1)

84488 LVPEI Glaucoma Epidemiology and Molecular Genetic Study: teleophthalmology screening for angle-closure disease in an underserved region
Jonnadula GB
Eye 2020; 34: 1399-1405 (IGR: 21-1)

84490 Association of single-nucleotide polymorphisms in TLR4 gene and gene-environment interaction with primary open angle glaucoma in a Chinese northern population
Chang C
Journal of Gene Medicine 2020; 22: e3139 (IGR: 21-1)

84746 Nationwide Incidence of Acute Angle Closure Glaucoma in Korea from 2011 to 2015
Park BJ
J Korean Med Sci 2019; 34: e306 (IGR: 21-1)

84654 Epidemiology of Childhood Blindness and Low Vision in Kinshasa-democratic Republic of the Congo
Moanda KA
Ophthalmic Epidemiology 2020; 27: 45-51 (IGR: 21-1)

84767 Prevalence and risk factors of glaucoma in an adult population from Shahroud, Iran
Khabazkhoob M
Journal of current ophthalmology 2019; 31: 366-372 (IGR: 21-1)

84703 Findings from a Rapid Assessment of Avoidable Blindness (RAAB) in the Southwest Region of Kyrgyzstan
Limburg H
Ophthalmic Epidemiology 2020; 27: 141-147 (IGR: 21-1)

84767 Prevalence and risk factors of glaucoma in an adult population from Shahroud, Iran
Emamian MH
Journal of current ophthalmology 2019; 31: 366-372 (IGR: 21-1)

84488 LVPEI Glaucoma Epidemiology and Molecular Genetic Study: teleophthalmology screening for angle-closure disease in an underserved region
Addepalli UK
Eye 2020; 34: 1399-1405 (IGR: 21-1)

84703 Findings from a Rapid Assessment of Avoidable Blindness (RAAB) in the Southwest Region of Kyrgyzstan
Ibraimova A
Ophthalmic Epidemiology 2020; 27: 141-147 (IGR: 21-1)

85097 Prevalence of and factors related with abnormal fundoscopic findings among the elderly population in a rural community in South Korea
Baek J
Seminars in Ophthalmology 2020; 35: 41-49 (IGR: 21-1)

84654 Epidemiology of Childhood Blindness and Low Vision in Kinshasa-democratic Republic of the Congo
Ilunga MJ
Ophthalmic Epidemiology 2020; 27: 45-51 (IGR: 21-1)

84490 Association of single-nucleotide polymorphisms in TLR4 gene and gene-environment interaction with primary open angle glaucoma in a Chinese northern population
Chen Y
Journal of Gene Medicine 2020; 22: e3139 (IGR: 21-1)

84488 LVPEI Glaucoma Epidemiology and Molecular Genetic Study: teleophthalmology screening for angle-closure disease in an underserved region
Senthil S
Eye 2020; 34: 1399-1405 (IGR: 21-1)

84703 Findings from a Rapid Assessment of Avoidable Blindness (RAAB) in the Southwest Region of Kyrgyzstan
Paduca A
Ophthalmic Epidemiology 2020; 27: 141-147 (IGR: 21-1)

84767 Prevalence and risk factors of glaucoma in an adult population from Shahroud, Iran
Shariati M
Journal of current ophthalmology 2019; 31: 366-372 (IGR: 21-1)

84490 Association of single-nucleotide polymorphisms in TLR4 gene and gene-environment interaction with primary open angle glaucoma in a Chinese northern population
Yu J
Journal of Gene Medicine 2020; 22: e3139 (IGR: 21-1)

85097 Prevalence of and factors related with abnormal fundoscopic findings among the elderly population in a rural community in South Korea
Kim K
Seminars in Ophthalmology 2020; 35: 41-49 (IGR: 21-1)

84654 Epidemiology of Childhood Blindness and Low Vision in Kinshasa-democratic Republic of the Congo
Makwanga ME
Ophthalmic Epidemiology 2020; 27: 45-51 (IGR: 21-1)

85097 Prevalence of and factors related with abnormal fundoscopic findings among the elderly population in a rural community in South Korea
Youm Y
Seminars in Ophthalmology 2020; 35: 41-49 (IGR: 21-1)

84654 Epidemiology of Childhood Blindness and Low Vision in Kinshasa-democratic Republic of the Congo
Stahnke T
Ophthalmic Epidemiology 2020; 27: 45-51 (IGR: 21-1)

84488 LVPEI Glaucoma Epidemiology and Molecular Genetic Study: teleophthalmology screening for angle-closure disease in an underserved region
Garudadri CS
Eye 2020; 34: 1399-1405 (IGR: 21-1)

84767 Prevalence and risk factors of glaucoma in an adult population from Shahroud, Iran
Fotouhi A
Journal of current ophthalmology 2019; 31: 366-372 (IGR: 21-1)

84654 Epidemiology of Childhood Blindness and Low Vision in Kinshasa-democratic Republic of the Congo
Guthoff R
Ophthalmic Epidemiology 2020; 27: 45-51 (IGR: 21-1)

85097 Prevalence of and factors related with abnormal fundoscopic findings among the elderly population in a rural community in South Korea
Kim HC
Seminars in Ophthalmology 2020; 35: 41-49 (IGR: 21-1)

82854 The prevalence and determinants of glaucoma among 40 years and older Saudi residents in the Riyadh Governorate (except the Capital) - A community based survey
Khandekar R
Saudi Journal of Ophthalmology 2019; 33: 332-337 (IGR: 20-4)

82356 Prevalence and causes of blindness and visual impairment; and cataract surgical services in Katsina state of Nigeria
Taryam MO
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82771 The Frequency and Causes of Blindness in a Rural Region of Central Anatolia of Turkey
Mirza E
The Eurasian journal of medicine 2019; 51: 242-246 (IGR: 20-4)

82360 OCT and IOP findings in a healthy worker cohort: results from a teleophthalmic study in occupational medicine
Grau E
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 2571-2578 (IGR: 20-4)

82600 Prevalence and Associated Factors of Pseudoexfoliation in a Russian Population: The Ural Eye and Medical Study
Bikbov MM
American Journal of Ophthalmology 2020; 210: 158-166 (IGR: 20-4)

82536 Incidence and baseline risk factors for pseudoexfoliation in Sweden: a long-term follow-up study
Ekström C
Acta Ophthalmologica 2019; 0: (IGR: 20-4)

82316 Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections
Cheng CY
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82194 Using registry data to characterize the incidence and causes of blindness in Oregon
Brinks MV
PLoS ONE 2019; 14: e0220983 (IGR: 20-4)

82522 The Chinese Glaucoma Study Consortium for Patients With Glaucoma: Design, Rationale and Baseline Patient Characteristics
Zhang H
Journal of Glaucoma 2019; 28: 974-978 (IGR: 20-4)

82205 Singapore Chinese Eye Study: key findings from baseline examination and the rationale, methodology of the 6-year follow-up series
Majithia S
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82234 Increased Incidence of Glaucoma in Sensorineural Hearing Loss: A Population-Based Cohort Study
Chien HW
International journal of environmental research and public health 2019; 16: (IGR: 20-4)

82727 Primary congenital glaucoma in Denmark, 1977-2016
Pedersen KB
Acta Ophthalmologica 2020; 98: 182-189 (IGR: 20-4)

82311 Evaluating correlation between the ocular biometry and genetic variants of and with primary angle-closure glaucoma in a cohort from northern China
Wang SL
International Journal of Ophthalmology 2019; 12: 1317-1322 (IGR: 20-4)

82407 Severity of Visual Field Loss at First Presentation to Glaucoma Clinics in England and Tanzania
Jones PR
Ophthalmic Epidemiology 2020; 27: 10-18 (IGR: 20-4)

82356 Prevalence and causes of blindness and visual impairment; and cataract surgical services in Katsina state of Nigeria
Rabiu MM
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82727 Primary congenital glaucoma in Denmark, 1977-2016
Kappelgaard P
Acta Ophthalmologica 2020; 98: 182-189 (IGR: 20-4)

82311 Evaluating correlation between the ocular biometry and genetic variants of and with primary angle-closure glaucoma in a cohort from northern China
Piao SY
International Journal of Ophthalmology 2019; 12: 1317-1322 (IGR: 20-4)

82600 Prevalence and Associated Factors of Pseudoexfoliation in a Russian Population: The Ural Eye and Medical Study
Zainullin RM
American Journal of Ophthalmology 2020; 210: 158-166 (IGR: 20-4)

82536 Incidence and baseline risk factors for pseudoexfoliation in Sweden: a long-term follow-up study
Winblad von Walter L
Acta Ophthalmologica 2019; 0: (IGR: 20-4)

82234 Increased Incidence of Glaucoma in Sensorineural Hearing Loss: A Population-Based Cohort Study
Wu PH
International journal of environmental research and public health 2019; 16: (IGR: 20-4)

82407 Severity of Visual Field Loss at First Presentation to Glaucoma Clinics in England and Tanzania
Philippin H
Ophthalmic Epidemiology 2020; 27: 10-18 (IGR: 20-4)

82854 The prevalence and determinants of glaucoma among 40 years and older Saudi residents in the Riyadh Governorate (except the Capital) - A community based survey
Chauhan D
Saudi Journal of Ophthalmology 2019; 33: 332-337 (IGR: 20-4)

82360 OCT and IOP findings in a healthy worker cohort: results from a teleophthalmic study in occupational medicine
Horn F
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 2571-2578 (IGR: 20-4)

82771 The Frequency and Causes of Blindness in a Rural Region of Central Anatolia of Turkey
Mirza GD
The Eurasian journal of medicine 2019; 51: 242-246 (IGR: 20-4)

82194 Using registry data to characterize the incidence and causes of blindness in Oregon
Redd T
PLoS ONE 2019; 14: e0220983 (IGR: 20-4)

82205 Singapore Chinese Eye Study: key findings from baseline examination and the rationale, methodology of the 6-year follow-up series
Tham YC
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82316 Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections
Wang N
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82522 The Chinese Glaucoma Study Consortium for Patients With Glaucoma: Design, Rationale and Baseline Patient Characteristics
Jia H
Journal of Glaucoma 2019; 28: 974-978 (IGR: 20-4)

82360 OCT and IOP findings in a healthy worker cohort: results from a teleophthalmic study in occupational medicine
Nixdorff U
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 2571-2578 (IGR: 20-4)

82205 Singapore Chinese Eye Study: key findings from baseline examination and the rationale, methodology of the 6-year follow-up series
Chee ML
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82727 Primary congenital glaucoma in Denmark, 1977-2016
Kessel L
Acta Ophthalmologica 2020; 98: 182-189 (IGR: 20-4)

82522 The Chinese Glaucoma Study Consortium for Patients With Glaucoma: Design, Rationale and Baseline Patient Characteristics
Duan X
Journal of Glaucoma 2019; 28: 974-978 (IGR: 20-4)

82356 Prevalence and causes of blindness and visual impairment; and cataract surgical services in Katsina state of Nigeria
Muhammad N
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82234 Increased Incidence of Glaucoma in Sensorineural Hearing Loss: A Population-Based Cohort Study
Wang K
International journal of environmental research and public health 2019; 16: (IGR: 20-4)

82316 Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections
Wong TY
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82311 Evaluating correlation between the ocular biometry and genetic variants of and with primary angle-closure glaucoma in a cohort from northern China
Xu MY
International Journal of Ophthalmology 2019; 12: 1317-1322 (IGR: 20-4)

82407 Severity of Visual Field Loss at First Presentation to Glaucoma Clinics in England and Tanzania
Makupa WU
Ophthalmic Epidemiology 2020; 27: 10-18 (IGR: 20-4)

82854 The prevalence and determinants of glaucoma among 40 years and older Saudi residents in the Riyadh Governorate (except the Capital) - A community based survey
Yasir ZH
Saudi Journal of Ophthalmology 2019; 33: 332-337 (IGR: 20-4)

82194 Using registry data to characterize the incidence and causes of blindness in Oregon
Lambert WE
PLoS ONE 2019; 14: e0220983 (IGR: 20-4)

82600 Prevalence and Associated Factors of Pseudoexfoliation in a Russian Population: The Ural Eye and Medical Study
Gilmanshin TR
American Journal of Ophthalmology 2020; 210: 158-166 (IGR: 20-4)

82771 The Frequency and Causes of Blindness in a Rural Region of Central Anatolia of Turkey
Oltulu R
The Eurasian journal of medicine 2019; 51: 242-246 (IGR: 20-4)

82522 The Chinese Glaucoma Study Consortium for Patients With Glaucoma: Design, Rationale and Baseline Patient Characteristics
Li L
Journal of Glaucoma 2019; 28: 974-978 (IGR: 20-4)

82407 Severity of Visual Field Loss at First Presentation to Glaucoma Clinics in England and Tanzania
Burton MJ
Ophthalmic Epidemiology 2020; 27: 10-18 (IGR: 20-4)

82316 Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections
Congdon N
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82854 The prevalence and determinants of glaucoma among 40 years and older Saudi residents in the Riyadh Governorate (except the Capital) - A community based survey
Al-Zobidi M
Saudi Journal of Ophthalmology 2019; 33: 332-337 (IGR: 20-4)

82205 Singapore Chinese Eye Study: key findings from baseline examination and the rationale, methodology of the 6-year follow-up series
Teo CL
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82194 Using registry data to characterize the incidence and causes of blindness in Oregon
Zaback T
PLoS ONE 2019; 14: e0220983 (IGR: 20-4)

82356 Prevalence and causes of blindness and visual impairment; and cataract surgical services in Katsina state of Nigeria
Oladigbolu K
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82771 The Frequency and Causes of Blindness in a Rural Region of Central Anatolia of Turkey
Okka M
The Eurasian journal of medicine 2019; 51: 242-246 (IGR: 20-4)

82600 Prevalence and Associated Factors of Pseudoexfoliation in a Russian Population: The Ural Eye and Medical Study
Kazakbaeva GM
American Journal of Ophthalmology 2020; 210: 158-166 (IGR: 20-4)

82727 Primary congenital glaucoma in Denmark, 1977-2016
Sandfeld L
Acta Ophthalmologica 2020; 98: 182-189 (IGR: 20-4)

82311 Evaluating correlation between the ocular biometry and genetic variants of and with primary angle-closure glaucoma in a cohort from northern China
Zhang W
International Journal of Ophthalmology 2019; 12: 1317-1322 (IGR: 20-4)

82360 OCT and IOP findings in a healthy worker cohort: results from a teleophthalmic study in occupational medicine
Michelson G
Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257: 2571-2578 (IGR: 20-4)

82234 Increased Incidence of Glaucoma in Sensorineural Hearing Loss: A Population-Based Cohort Study
Sun CC; Huang JY
International journal of environmental research and public health 2019; 16: (IGR: 20-4)

82727 Primary congenital glaucoma in Denmark, 1977-2016
Zibrandtsen N
Acta Ophthalmologica 2020; 98: 182-189 (IGR: 20-4)

82771 The Frequency and Causes of Blindness in a Rural Region of Central Anatolia of Turkey
Ozkagnici A
The Eurasian journal of medicine 2019; 51: 242-246 (IGR: 20-4)

82311 Evaluating correlation between the ocular biometry and genetic variants of and with primary angle-closure glaucoma in a cohort from northern China
Ma JQ
International Journal of Ophthalmology 2019; 12: 1317-1322 (IGR: 20-4)

82600 Prevalence and Associated Factors of Pseudoexfoliation in a Russian Population: The Ural Eye and Medical Study
Yakupova DF
American Journal of Ophthalmology 2020; 210: 158-166 (IGR: 20-4)

82356 Prevalence and causes of blindness and visual impairment; and cataract surgical services in Katsina state of Nigeria
Abdurrahman H
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82407 Severity of Visual Field Loss at First Presentation to Glaucoma Clinics in England and Tanzania
Crabb DP
Ophthalmic Epidemiology 2020; 27: 10-18 (IGR: 20-4)

82522 The Chinese Glaucoma Study Consortium for Patients With Glaucoma: Design, Rationale and Baseline Patient Characteristics
Wang H
Journal of Glaucoma 2019; 28: 974-978 (IGR: 20-4)

82316 Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections
He M
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82194 Using registry data to characterize the incidence and causes of blindness in Oregon
Randall J
PLoS ONE 2019; 14: e0220983 (IGR: 20-4)

82854 The prevalence and determinants of glaucoma among 40 years and older Saudi residents in the Riyadh Governorate (except the Capital) - A community based survey
Judaibi R
Saudi Journal of Ophthalmology 2019; 33: 332-337 (IGR: 20-4)

82234 Increased Incidence of Glaucoma in Sensorineural Hearing Loss: A Population-Based Cohort Study
Yang SF
International journal of environmental research and public health 2019; 16: (IGR: 20-4)

82316 Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections
Wang YX
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82194 Using registry data to characterize the incidence and causes of blindness in Oregon
Field T
PLoS ONE 2019; 14: e0220983 (IGR: 20-4)

82600 Prevalence and Associated Factors of Pseudoexfoliation in a Russian Population: The Ural Eye and Medical Study
Nuriev IF
American Journal of Ophthalmology 2020; 210: 158-166 (IGR: 20-4)

82205 Singapore Chinese Eye Study: key findings from baseline examination and the rationale, methodology of the 6-year follow-up series
Dai W
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82311 Evaluating correlation between the ocular biometry and genetic variants of and with primary angle-closure glaucoma in a cohort from northern China
Hao J
International Journal of Ophthalmology 2019; 12: 1317-1322 (IGR: 20-4)

82854 The prevalence and determinants of glaucoma among 40 years and older Saudi residents in the Riyadh Governorate (except the Capital) - A community based survey
Edward DP
Saudi Journal of Ophthalmology 2019; 33: 332-337 (IGR: 20-4)

82522 The Chinese Glaucoma Study Consortium for Patients With Glaucoma: Design, Rationale and Baseline Patient Characteristics
Wu J
Journal of Glaucoma 2019; 28: 974-978 (IGR: 20-4)

82727 Primary congenital glaucoma in Denmark, 1977-2016
Bach-Holm D
Acta Ophthalmologica 2020; 98: 182-189 (IGR: 20-4)

82194 Using registry data to characterize the incidence and causes of blindness in Oregon
Wilson D
PLoS ONE 2019; 14: e0220983 (IGR: 20-4)

82522 The Chinese Glaucoma Study Consortium for Patients With Glaucoma: Design, Rationale and Baseline Patient Characteristics
Hu J
Journal of Glaucoma 2019; 28: 974-978 (IGR: 20-4)

82316 Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections
Braithwaite T
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82205 Singapore Chinese Eye Study: key findings from baseline examination and the rationale, methodology of the 6-year follow-up series
Kumari N
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82234 Increased Incidence of Glaucoma in Sensorineural Hearing Loss: A Population-Based Cohort Study
Chen HC
International journal of environmental research and public health 2019; 16: (IGR: 20-4)

82600 Prevalence and Associated Factors of Pseudoexfoliation in a Russian Population: The Ural Eye and Medical Study
Zaynetdinov AF
American Journal of Ophthalmology 2020; 210: 158-166 (IGR: 20-4)

82311 Evaluating correlation between the ocular biometry and genetic variants of and with primary angle-closure glaucoma in a cohort from northern China
Chi H
International Journal of Ophthalmology 2019; 12: 1317-1322 (IGR: 20-4)

82522 The Chinese Glaucoma Study Consortium for Patients With Glaucoma: Design, Rationale and Baseline Patient Characteristics
Cao K
Journal of Glaucoma 2019; 28: 974-978 (IGR: 20-4)

82234 Increased Incidence of Glaucoma in Sensorineural Hearing Loss: A Population-Based Cohort Study
Lee CY
International journal of environmental research and public health 2019; 16: (IGR: 20-4)

82316 Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections
Casson RJ
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82311 Evaluating correlation between the ocular biometry and genetic variants of and with primary angle-closure glaucoma in a cohort from northern China
Xue ZQ
International Journal of Ophthalmology 2019; 12: 1317-1322 (IGR: 20-4)

82600 Prevalence and Associated Factors of Pseudoexfoliation in a Russian Population: The Ural Eye and Medical Study
Khalimov TA
American Journal of Ophthalmology 2020; 210: 158-166 (IGR: 20-4)

82205 Singapore Chinese Eye Study: key findings from baseline examination and the rationale, methodology of the 6-year follow-up series
Lamoureux EL; Sabanayagam C
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82316 Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections
Cicinelli MV
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82311 Evaluating correlation between the ocular biometry and genetic variants of and with primary angle-closure glaucoma in a cohort from northern China
Ha SP
International Journal of Ophthalmology 2019; 12: 1317-1322 (IGR: 20-4)

82600 Prevalence and Associated Factors of Pseudoexfoliation in a Russian Population: The Ural Eye and Medical Study
Panda-Jonas S
American Journal of Ophthalmology 2020; 210: 158-166 (IGR: 20-4)

82522 The Chinese Glaucoma Study Consortium for Patients With Glaucoma: Design, Rationale and Baseline Patient Characteristics
Zhao A
Journal of Glaucoma 2019; 28: 974-978 (IGR: 20-4)

82205 Singapore Chinese Eye Study: key findings from baseline examination and the rationale, methodology of the 6-year follow-up series
Wong TY
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82311 Evaluating correlation between the ocular biometry and genetic variants of and with primary angle-closure glaucoma in a cohort from northern China
Zhuang WJ
International Journal of Ophthalmology 2019; 12: 1317-1322 (IGR: 20-4)

82316 Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections
Das A
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82522 The Chinese Glaucoma Study Consortium for Patients With Glaucoma: Design, Rationale and Baseline Patient Characteristics
Liang J
Journal of Glaucoma 2019; 28: 974-978 (IGR: 20-4)

82600 Prevalence and Associated Factors of Pseudoexfoliation in a Russian Population: The Ural Eye and Medical Study
Uzianbaeva YV
American Journal of Ophthalmology 2020; 210: 158-166 (IGR: 20-4)

82316 Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections
Flaxman SR
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82522 The Chinese Glaucoma Study Consortium for Patients With Glaucoma: Design, Rationale and Baseline Patient Characteristics
Song J
Journal of Glaucoma 2019; 28: 974-978 (IGR: 20-4)

82600 Prevalence and Associated Factors of Pseudoexfoliation in a Russian Population: The Ural Eye and Medical Study
Rakhimova EM
American Journal of Ophthalmology 2020; 210: 158-166 (IGR: 20-4)

82205 Singapore Chinese Eye Study: key findings from baseline examination and the rationale, methodology of the 6-year follow-up series
Cheng CY
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82600 Prevalence and Associated Factors of Pseudoexfoliation in a Russian Population: The Ural Eye and Medical Study
Rusakova IA
American Journal of Ophthalmology 2020; 210: 158-166 (IGR: 20-4)

82522 The Chinese Glaucoma Study Consortium for Patients With Glaucoma: Design, Rationale and Baseline Patient Characteristics
Qiao C
Journal of Glaucoma 2019; 28: 974-978 (IGR: 20-4)

82316 Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections
Jonas JB
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82600 Prevalence and Associated Factors of Pseudoexfoliation in a Russian Population: The Ural Eye and Medical Study
Salavatova VF
American Journal of Ophthalmology 2020; 210: 158-166 (IGR: 20-4)

82316 Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections
Keeffe JE
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82522 The Chinese Glaucoma Study Consortium for Patients With Glaucoma: Design, Rationale and Baseline Patient Characteristics
Wang N
Journal of Glaucoma 2019; 28: 974-978 (IGR: 20-4)

82600 Prevalence and Associated Factors of Pseudoexfoliation in a Russian Population: The Ural Eye and Medical Study
Arslangareeva II
American Journal of Ophthalmology 2020; 210: 158-166 (IGR: 20-4)

82522 The Chinese Glaucoma Study Consortium for Patients With Glaucoma: Design, Rationale and Baseline Patient Characteristics

Journal of Glaucoma 2019; 28: 974-978 (IGR: 20-4)

82316 Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections
Kempen JH; Leasher J
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82600 Prevalence and Associated Factors of Pseudoexfoliation in a Russian Population: The Ural Eye and Medical Study
Bikbova GM; Nikitin NA
American Journal of Ophthalmology 2020; 210: 158-166 (IGR: 20-4)

82316 Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections
Limburg H; Naidoo K
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

82600 Prevalence and Associated Factors of Pseudoexfoliation in a Russian Population: The Ural Eye and Medical Study
Jonas JB
American Journal of Ophthalmology 2020; 210: 158-166 (IGR: 20-4)

82316 Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections
Pesudovs K; Resnikoff S; Silvester AJ; Tahhan N; Taylor HR; Bourne RRA;
British Journal of Ophthalmology 2019; 0: (IGR: 20-4)

80588 Intraocular Pressure and Its Associations in a Russian Population: The Ural Eye and Medical Study
Bikbov MM
American Journal of Ophthalmology 2019; 204: 130-139 (IGR: 20-3)

80840 Anterior Segment Parameters of Filipino-Americans Compared to Chinese-Americans and Caucasian Americans Using Anterior Segment Optical Coherence Tomography
Siguan-Bell CS
Translational vision science & technology 2019; 8: 11 (IGR: 20-3)

80447 Current profile of secondary glaucoma in a Northern India tertiary eye care hospital
Dubey S
Ophthalmic Epidemiology 2019; 26: 200-207 (IGR: 20-3)

81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Furtado JM
Ophthalmic Epidemiology 2019; 26: 345-354 (IGR: 20-3)

81388 Prevalence, incidence, and risk factors of primary open-angle glaucoma - a cohort study based on longitudinal data from a German public health insurance
Kreft D
BMC Public Health 2019; 19: 851 (IGR: 20-3)

80731 National Eye Survey of Trinidad and Tobago (NESTT): prevalence, causes and risk factors for presenting vision impairment in adults over 40 years
Braithwaite T
British Journal of Ophthalmology 2020; 104: 74-80 (IGR: 20-3)

81085 Prevalence of suspected glaucoma in Haiti: a pilot study
Cadet N
Canadian Journal of Ophthalmology 2019; 54: 342-346 (IGR: 20-3)

81057 Prevalence of treatment with glaucoma medication in Scotland, 2010-2017
Rotchford AP
British Journal of Ophthalmology 2019; 0: (IGR: 20-3)

80510 Epidemiological variations and trends in health burden of glaucoma worldwide
Wang W
Acta Ophthalmologica 2019; 97: e349-e355 (IGR: 20-3)

80840 Anterior Segment Parameters of Filipino-Americans Compared to Chinese-Americans and Caucasian Americans Using Anterior Segment Optical Coherence Tomography
Chansangpetch S
Translational vision science & technology 2019; 8: 11 (IGR: 20-3)

81057 Prevalence of treatment with glaucoma medication in Scotland, 2010-2017
Hughes J
British Journal of Ophthalmology 2019; 0: (IGR: 20-3)

81085 Prevalence of suspected glaucoma in Haiti: a pilot study
Nayman T
Canadian Journal of Ophthalmology 2019; 54: 342-346 (IGR: 20-3)

80510 Epidemiological variations and trends in health burden of glaucoma worldwide
He M
Acta Ophthalmologica 2019; 97: e349-e355 (IGR: 20-3)

80731 National Eye Survey of Trinidad and Tobago (NESTT): prevalence, causes and risk factors for presenting vision impairment in adults over 40 years
Verlander NQ
British Journal of Ophthalmology 2020; 104: 74-80 (IGR: 20-3)

80447 Current profile of secondary glaucoma in a Northern India tertiary eye care hospital
Jain K
Ophthalmic Epidemiology 2019; 26: 200-207 (IGR: 20-3)

81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Berezovsky A
Ophthalmic Epidemiology 2019; 26: 345-354 (IGR: 20-3)

81388 Prevalence, incidence, and risk factors of primary open-angle glaucoma - a cohort study based on longitudinal data from a German public health insurance
Doblhammer G
BMC Public Health 2019; 19: 851 (IGR: 20-3)

80588 Intraocular Pressure and Its Associations in a Russian Population: The Ural Eye and Medical Study
Kazakbaeva GM
American Journal of Ophthalmology 2019; 204: 130-139 (IGR: 20-3)

81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Ferraz NN
Ophthalmic Epidemiology 2019; 26: 345-354 (IGR: 20-3)

80510 Epidemiological variations and trends in health burden of glaucoma worldwide
Li Z
Acta Ophthalmologica 2019; 97: e349-e355 (IGR: 20-3)

81388 Prevalence, incidence, and risk factors of primary open-angle glaucoma - a cohort study based on longitudinal data from a German public health insurance
Guthoff RF
BMC Public Health 2019; 19: 851 (IGR: 20-3)

80840 Anterior Segment Parameters of Filipino-Americans Compared to Chinese-Americans and Caucasian Americans Using Anterior Segment Optical Coherence Tomography
Perez CI
Translational vision science & technology 2019; 8: 11 (IGR: 20-3)

81057 Prevalence of treatment with glaucoma medication in Scotland, 2010-2017
Agarwal PK
British Journal of Ophthalmology 2019; 0: (IGR: 20-3)

80731 National Eye Survey of Trinidad and Tobago (NESTT): prevalence, causes and risk factors for presenting vision impairment in adults over 40 years
Peto T
British Journal of Ophthalmology 2020; 104: 74-80 (IGR: 20-3)

80447 Current profile of secondary glaucoma in a Northern India tertiary eye care hospital
Mukherjee S
Ophthalmic Epidemiology 2019; 26: 200-207 (IGR: 20-3)

81085 Prevalence of suspected glaucoma in Haiti: a pilot study
Harasymowycz P
Canadian Journal of Ophthalmology 2019; 54: 342-346 (IGR: 20-3)

80588 Intraocular Pressure and Its Associations in a Russian Population: The Ural Eye and Medical Study
Zainullin RM
American Journal of Ophthalmology 2019; 204: 130-139 (IGR: 20-3)

80731 National Eye Survey of Trinidad and Tobago (NESTT): prevalence, causes and risk factors for presenting vision impairment in adults over 40 years
Bartholomew D
British Journal of Ophthalmology 2020; 104: 74-80 (IGR: 20-3)

81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Muñoz S
Ophthalmic Epidemiology 2019; 26: 345-354 (IGR: 20-3)

81057 Prevalence of treatment with glaucoma medication in Scotland, 2010-2017
Tatham AJ
British Journal of Ophthalmology 2019; 0: (IGR: 20-3)

80840 Anterior Segment Parameters of Filipino-Americans Compared to Chinese-Americans and Caucasian Americans Using Anterior Segment Optical Coherence Tomography
Kutzscher A
Translational vision science & technology 2019; 8: 11 (IGR: 20-3)

80447 Current profile of secondary glaucoma in a Northern India tertiary eye care hospital
Sharma N
Ophthalmic Epidemiology 2019; 26: 200-207 (IGR: 20-3)

81388 Prevalence, incidence, and risk factors of primary open-angle glaucoma - a cohort study based on longitudinal data from a German public health insurance
Frech S
BMC Public Health 2019; 19: 851 (IGR: 20-3)

80510 Epidemiological variations and trends in health burden of glaucoma worldwide
Huang W
Acta Ophthalmologica 2019; 97: e349-e355 (IGR: 20-3)

80588 Intraocular Pressure and Its Associations in a Russian Population: The Ural Eye and Medical Study
Salavatova VF; Gilmanshin TR
American Journal of Ophthalmology 2019; 204: 130-139 (IGR: 20-3)

81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Fernandes AG
Ophthalmic Epidemiology 2019; 26: 345-354 (IGR: 20-3)

80731 National Eye Survey of Trinidad and Tobago (NESTT): prevalence, causes and risk factors for presenting vision impairment in adults over 40 years
Deomansingh F
British Journal of Ophthalmology 2020; 104: 74-80 (IGR: 20-3)

80447 Current profile of secondary glaucoma in a Northern India tertiary eye care hospital
Pegu J
Ophthalmic Epidemiology 2019; 26: 200-207 (IGR: 20-3)

80840 Anterior Segment Parameters of Filipino-Americans Compared to Chinese-Americans and Caucasian Americans Using Anterior Segment Optical Coherence Tomography
Wang D
Translational vision science & technology 2019; 8: 11 (IGR: 20-3)

80447 Current profile of secondary glaucoma in a Northern India tertiary eye care hospital
Gandhi M
Ophthalmic Epidemiology 2019; 26: 200-207 (IGR: 20-3)

80588 Intraocular Pressure and Its Associations in a Russian Population: The Ural Eye and Medical Study
Yakupova DF
American Journal of Ophthalmology 2019; 204: 130-139 (IGR: 20-3)

80840 Anterior Segment Parameters of Filipino-Americans Compared to Chinese-Americans and Caucasian Americans Using Anterior Segment Optical Coherence Tomography
He M
Translational vision science & technology 2019; 8: 11 (IGR: 20-3)

81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Watanabe SS
Ophthalmic Epidemiology 2019; 26: 345-354 (IGR: 20-3)

80731 National Eye Survey of Trinidad and Tobago (NESTT): prevalence, causes and risk factors for presenting vision impairment in adults over 40 years
Bridgemohan P
British Journal of Ophthalmology 2020; 104: 74-80 (IGR: 20-3)

80447 Current profile of secondary glaucoma in a Northern India tertiary eye care hospital
Bhoot M
Ophthalmic Epidemiology 2019; 26: 200-207 (IGR: 20-3)

80588 Intraocular Pressure and Its Associations in a Russian Population: The Ural Eye and Medical Study
Uzianbaeva YV
American Journal of Ophthalmology 2019; 204: 130-139 (IGR: 20-3)

80840 Anterior Segment Parameters of Filipino-Americans Compared to Chinese-Americans and Caucasian Americans Using Anterior Segment Optical Coherence Tomography
Oldenburg C
Translational vision science & technology 2019; 8: 11 (IGR: 20-3)

81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Cunha CC
Ophthalmic Epidemiology 2019; 26: 345-354 (IGR: 20-3)

80731 National Eye Survey of Trinidad and Tobago (NESTT): prevalence, causes and risk factors for presenting vision impairment in adults over 40 years
Saei A; Sharma S
British Journal of Ophthalmology 2020; 104: 74-80 (IGR: 20-3)

80588 Intraocular Pressure and Its Associations in a Russian Population: The Ural Eye and Medical Study
Arslangareeva II
American Journal of Ophthalmology 2019; 204: 130-139 (IGR: 20-3)

80840 Anterior Segment Parameters of Filipino-Americans Compared to Chinese-Americans and Caucasian Americans Using Anterior Segment Optical Coherence Tomography
Hee MR
Translational vision science & technology 2019; 8: 11 (IGR: 20-3)

81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Vasconcelos GC
Ophthalmic Epidemiology 2019; 26: 345-354 (IGR: 20-3)

80840 Anterior Segment Parameters of Filipino-Americans Compared to Chinese-Americans and Caucasian Americans Using Anterior Segment Optical Coherence Tomography
Lin SC
Translational vision science & technology 2019; 8: 11 (IGR: 20-3)

80731 National Eye Survey of Trinidad and Tobago (NESTT): prevalence, causes and risk factors for presenting vision impairment in adults over 40 years
Singh D
British Journal of Ophthalmology 2020; 104: 74-80 (IGR: 20-3)

80588 Intraocular Pressure and Its Associations in a Russian Population: The Ural Eye and Medical Study
Panda-Jonas S
American Journal of Ophthalmology 2019; 204: 130-139 (IGR: 20-3)

81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Sacai PY
Ophthalmic Epidemiology 2019; 26: 345-354 (IGR: 20-3)

80731 National Eye Survey of Trinidad and Tobago (NESTT): prevalence, causes and risk factors for presenting vision impairment in adults over 40 years
Ramsewak SS
British Journal of Ophthalmology 2020; 104: 74-80 (IGR: 20-3)

80588 Intraocular Pressure and Its Associations in a Russian Population: The Ural Eye and Medical Study
Mukhamadieva SR
American Journal of Ophthalmology 2019; 204: 130-139 (IGR: 20-3)

81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Cypel M
Ophthalmic Epidemiology 2019; 26: 345-354 (IGR: 20-3)

80588 Intraocular Pressure and Its Associations in a Russian Population: The Ural Eye and Medical Study
Khikmatullin RI
American Journal of Ophthalmology 2019; 204: 130-139 (IGR: 20-3)

81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Mitsuhiro MH
Ophthalmic Epidemiology 2019; 26: 345-354 (IGR: 20-3)

80731 National Eye Survey of Trinidad and Tobago (NESTT): prevalence, causes and risk factors for presenting vision impairment in adults over 40 years
Bourne RRA
British Journal of Ophthalmology 2020; 104: 74-80 (IGR: 20-3)

81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Morales PH
Ophthalmic Epidemiology 2019; 26: 345-354 (IGR: 20-3)

80588 Intraocular Pressure and Its Associations in a Russian Population: The Ural Eye and Medical Study
Aminev SK; Nuriev IF
American Journal of Ophthalmology 2019; 204: 130-139 (IGR: 20-3)

81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Cohen MJ; Campos M
Ophthalmic Epidemiology 2019; 26: 345-354 (IGR: 20-3)

80588 Intraocular Pressure and Its Associations in a Russian Population: The Ural Eye and Medical Study
Zaynetdinov AF
American Journal of Ophthalmology 2019; 204: 130-139 (IGR: 20-3)

81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Cohen JM
Ophthalmic Epidemiology 2019; 26: 345-354 (IGR: 20-3)

80588 Intraocular Pressure and Its Associations in a Russian Population: The Ural Eye and Medical Study
Jonas JB
American Journal of Ophthalmology 2019; 204: 130-139 (IGR: 20-3)

81201 Prevalence and Causes of Visual Impairment and Blindness in Adults Aged 45 Years and Older from Parintins: The Brazilian Amazon Region Eye Survey
Belfort R; Salomão SR
Ophthalmic Epidemiology 2019; 26: 345-354 (IGR: 20-3)

80033 Central Corneal Thickness Variances Among Different Asian Ethnicities in Glaucoma and Nonglaucoma Patients
Badr M
Journal of Glaucoma 2019; 28: 223-230 (IGR: 20-2)

79564 Prevalence of visual impairment and related factors in Nangarhar Province of Afghanistan: a cross sectional study
Abdianwall MH
International Journal of Ophthalmology 2018; 11: 1968-1977 (IGR: 20-2)

79789 Retinal Nerve Fiber Layer Thickness in a Multiethnic Normal Asian Population: The Singapore Epidemiology of Eye Diseases Study
Ho H
Ophthalmology 2019; 126: 702-711 (IGR: 20-2)

79443 The heritability of phenotypes related to primary angle closure glaucoma
Yang XH
Chinese Journal of Ophthalmology 2018; 54: 864-867 (IGR: 20-2)

79452 Socioeconomic Status and Glaucoma: Associations in High Levels of Income and Education
Oh SA
Current Eye Research 2019; 44: 436-441 (IGR: 20-2)

79470 Association of Long-term Ambient Black Carbon Exposure and Oxidative Stress Allelic Variants With Intraocular Pressure in Older Men
Nwanaji-Enwerem JC
JAMA ophthalmology 2018; 0: (IGR: 20-2)

79481 Prevalence and causes of blindness and vision impairment: magnitude, temporal trends and projections in South and Central Asia
Nangia V
British Journal of Ophthalmology 2019; 103: 871-877 (IGR: 20-2)

79331 Prevalence of Primary Glaucoma as Diagnosed by Study Optometrists of L. V. Prasad eye Institute - Glaucoma Epidemiology and Molecular Genetics Study
Addepalli UK
Ophthalmic Epidemiology 2019; 26: 150-154 (IGR: 20-2)

79789 Retinal Nerve Fiber Layer Thickness in a Multiethnic Normal Asian Population: The Singapore Epidemiology of Eye Diseases Study
Tham YC
Ophthalmology 2019; 126: 702-711 (IGR: 20-2)

79443 The heritability of phenotypes related to primary angle closure glaucoma
Qiao CY
Chinese Journal of Ophthalmology 2018; 54: 864-867 (IGR: 20-2)

79481 Prevalence and causes of blindness and vision impairment: magnitude, temporal trends and projections in South and Central Asia
Jonas JB
British Journal of Ophthalmology 2019; 103: 871-877 (IGR: 20-2)

79331 Prevalence of Primary Glaucoma as Diagnosed by Study Optometrists of L. V. Prasad eye Institute - Glaucoma Epidemiology and Molecular Genetics Study
Jonnadula GB
Ophthalmic Epidemiology 2019; 26: 150-154 (IGR: 20-2)

79452 Socioeconomic Status and Glaucoma: Associations in High Levels of Income and Education
Ra H
Current Eye Research 2019; 44: 436-441 (IGR: 20-2)

80033 Central Corneal Thickness Variances Among Different Asian Ethnicities in Glaucoma and Nonglaucoma Patients
Masis Solano M
Journal of Glaucoma 2019; 28: 223-230 (IGR: 20-2)

79470 Association of Long-term Ambient Black Carbon Exposure and Oxidative Stress Allelic Variants With Intraocular Pressure in Older Men
Wang W
JAMA ophthalmology 2018; 0: (IGR: 20-2)

79564 Prevalence of visual impairment and related factors in Nangarhar Province of Afghanistan: a cross sectional study
Güçiz Doğan B
International Journal of Ophthalmology 2018; 11: 1968-1977 (IGR: 20-2)

79789 Retinal Nerve Fiber Layer Thickness in a Multiethnic Normal Asian Population: The Singapore Epidemiology of Eye Diseases Study
Chee ML
Ophthalmology 2019; 126: 702-711 (IGR: 20-2)

79470 Association of Long-term Ambient Black Carbon Exposure and Oxidative Stress Allelic Variants With Intraocular Pressure in Older Men
Nwanaji-Enwerem O
JAMA ophthalmology 2018; 0: (IGR: 20-2)

79789 Retinal Nerve Fiber Layer Thickness in a Multiethnic Normal Asian Population: The Singapore Epidemiology of Eye Diseases Study
Chee ML
Ophthalmology 2019; 126: 702-711 (IGR: 20-2)

80033 Central Corneal Thickness Variances Among Different Asian Ethnicities in Glaucoma and Nonglaucoma Patients
Amoozgar B
Journal of Glaucoma 2019; 28: 223-230 (IGR: 20-2)

79481 Prevalence and causes of blindness and vision impairment: magnitude, temporal trends and projections in South and Central Asia
George R
British Journal of Ophthalmology 2019; 103: 871-877 (IGR: 20-2)

79331 Prevalence of Primary Glaucoma as Diagnosed by Study Optometrists of L. V. Prasad eye Institute - Glaucoma Epidemiology and Molecular Genetics Study
Garudadri CS
Ophthalmic Epidemiology 2019; 26: 150-154 (IGR: 20-2)

79452 Socioeconomic Status and Glaucoma: Associations in High Levels of Income and Education
Jee D
Current Eye Research 2019; 44: 436-441 (IGR: 20-2)

80033 Central Corneal Thickness Variances Among Different Asian Ethnicities in Glaucoma and Nonglaucoma Patients
Nguyen A
Journal of Glaucoma 2019; 28: 223-230 (IGR: 20-2)

79481 Prevalence and causes of blindness and vision impairment: magnitude, temporal trends and projections in South and Central Asia
Lingam V
British Journal of Ophthalmology 2019; 103: 871-877 (IGR: 20-2)

79331 Prevalence of Primary Glaucoma as Diagnosed by Study Optometrists of L. V. Prasad eye Institute - Glaucoma Epidemiology and Molecular Genetics Study
Khanna RC
Ophthalmic Epidemiology 2019; 26: 150-154 (IGR: 20-2)

79470 Association of Long-term Ambient Black Carbon Exposure and Oxidative Stress Allelic Variants With Intraocular Pressure in Older Men
Vokonas P
JAMA ophthalmology 2018; 0: (IGR: 20-2)

79789 Retinal Nerve Fiber Layer Thickness in a Multiethnic Normal Asian Population: The Singapore Epidemiology of Eye Diseases Study
Shi Y
Ophthalmology 2019; 126: 702-711 (IGR: 20-2)

79481 Prevalence and causes of blindness and vision impairment: magnitude, temporal trends and projections in South and Central Asia
Ellwein L
British Journal of Ophthalmology 2019; 103: 871-877 (IGR: 20-2)

79331 Prevalence of Primary Glaucoma as Diagnosed by Study Optometrists of L. V. Prasad eye Institute - Glaucoma Epidemiology and Molecular Genetics Study
Papas EB
Ophthalmic Epidemiology 2019; 26: 150-154 (IGR: 20-2)

79789 Retinal Nerve Fiber Layer Thickness in a Multiethnic Normal Asian Population: The Singapore Epidemiology of Eye Diseases Study
Tan NYQ
Ophthalmology 2019; 126: 702-711 (IGR: 20-2)

80033 Central Corneal Thickness Variances Among Different Asian Ethnicities in Glaucoma and Nonglaucoma Patients
Porco T
Journal of Glaucoma 2019; 28: 223-230 (IGR: 20-2)

79470 Association of Long-term Ambient Black Carbon Exposure and Oxidative Stress Allelic Variants With Intraocular Pressure in Older Men
Baccarelli A
JAMA ophthalmology 2018; 0: (IGR: 20-2)

79481 Prevalence and causes of blindness and vision impairment: magnitude, temporal trends and projections in South and Central Asia
Cicinelli MV
British Journal of Ophthalmology 2019; 103: 871-877 (IGR: 20-2)

80033 Central Corneal Thickness Variances Among Different Asian Ethnicities in Glaucoma and Nonglaucoma Patients
Lin S
Journal of Glaucoma 2019; 28: 223-230 (IGR: 20-2)

79470 Association of Long-term Ambient Black Carbon Exposure and Oxidative Stress Allelic Variants With Intraocular Pressure in Older Men
Weisskopf M
JAMA ophthalmology 2018; 0: (IGR: 20-2)

79789 Retinal Nerve Fiber Layer Thickness in a Multiethnic Normal Asian Population: The Singapore Epidemiology of Eye Diseases Study
Wong KH
Ophthalmology 2019; 126: 702-711 (IGR: 20-2)

79481 Prevalence and causes of blindness and vision impairment: magnitude, temporal trends and projections in South and Central Asia
Das A
British Journal of Ophthalmology 2019; 103: 871-877 (IGR: 20-2)

79470 Association of Long-term Ambient Black Carbon Exposure and Oxidative Stress Allelic Variants With Intraocular Pressure in Older Men
Herndon LW
JAMA ophthalmology 2018; 0: (IGR: 20-2)

79789 Retinal Nerve Fiber Layer Thickness in a Multiethnic Normal Asian Population: The Singapore Epidemiology of Eye Diseases Study
Majithia S
Ophthalmology 2019; 126: 702-711 (IGR: 20-2)

79481 Prevalence and causes of blindness and vision impairment: magnitude, temporal trends and projections in South and Central Asia
Flaxman SR
British Journal of Ophthalmology 2019; 103: 871-877 (IGR: 20-2)

79789 Retinal Nerve Fiber Layer Thickness in a Multiethnic Normal Asian Population: The Singapore Epidemiology of Eye Diseases Study
Cheung CY
Ophthalmology 2019; 126: 702-711 (IGR: 20-2)

79470 Association of Long-term Ambient Black Carbon Exposure and Oxidative Stress Allelic Variants With Intraocular Pressure in Older Men
Wiggs JL; Park SK
JAMA ophthalmology 2018; 0: (IGR: 20-2)

79481 Prevalence and causes of blindness and vision impairment: magnitude, temporal trends and projections in South and Central Asia
Keeffe JE
British Journal of Ophthalmology 2019; 103: 871-877 (IGR: 20-2)

79789 Retinal Nerve Fiber Layer Thickness in a Multiethnic Normal Asian Population: The Singapore Epidemiology of Eye Diseases Study
Aung T
Ophthalmology 2019; 126: 702-711 (IGR: 20-2)

79470 Association of Long-term Ambient Black Carbon Exposure and Oxidative Stress Allelic Variants With Intraocular Pressure in Older Men
Schwartz J
JAMA ophthalmology 2018; 0: (IGR: 20-2)

79789 Retinal Nerve Fiber Layer Thickness in a Multiethnic Normal Asian Population: The Singapore Epidemiology of Eye Diseases Study
Wong TY
Ophthalmology 2019; 126: 702-711 (IGR: 20-2)

79481 Prevalence and causes of blindness and vision impairment: magnitude, temporal trends and projections in South and Central Asia
Kempen JH
British Journal of Ophthalmology 2019; 103: 871-877 (IGR: 20-2)

79789 Retinal Nerve Fiber Layer Thickness in a Multiethnic Normal Asian Population: The Singapore Epidemiology of Eye Diseases Study
Cheng CY
Ophthalmology 2019; 126: 702-711 (IGR: 20-2)

79481 Prevalence and causes of blindness and vision impairment: magnitude, temporal trends and projections in South and Central Asia
Leasher J; Limburg H; Naidoo K; Pesudovs K; Resnikoff S; Silvester AJ; Tahhan N; Taylor HR; Wong TY; Bourne RRA;
British Journal of Ophthalmology 2019; 103: 871-877 (IGR: 20-2)

78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Keeffe JE
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)

78494 Glaucoma-associated long-term mortality in a rural cohort from India: the Andhra Pradesh Eye Disease Study
Khanna RC
British Journal of Ophthalmology 2018; 102: 1477-1482 (IGR: 20-1)

78966 Prevalence and associated factors of low vision and blindness among patients attending St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia
Cherinet FM
BMC Ophthalmology 2018; 18: 232 (IGR: 20-1)

79231 Comorbidities and Prescribed Medications in Patients With or Without Dry Eye Disease: A Population-Based Study
Dana R
American Journal of Ophthalmology 2019; 198: 181-192 (IGR: 20-1)

78564 A Common Glaucoma-risk Variant of SIX6 Alters Retinal Nerve Fiber Layer and Optic Disc Measures in a European Population: The EPIC-Norfolk Eye Study
Khawaja AP
Journal of Glaucoma 2018; 27: 743-749 (IGR: 20-1)

79212 Leveraging Electronic Health Records to Identify and Characterize Patients with Low Vision
Swenor BK
Ophthalmic Epidemiology 2019; 26: 132-139 (IGR: 20-1)

79222 Eight-Year Incidence of Open-Angle Glaucoma in the Tema Eye Survey
Mwanza JC
Ophthalmology 2019; 126: 372-380 (IGR: 20-1)

79027 Association of Retinal Neurodegeneration on Optical Coherence Tomography With Dementia: A Population-Based Study
Mutlu U
JAMA neurology 2018; 75: 1256-1263 (IGR: 20-1)

78457 Angle closure glaucoma in rural and urban populations in eastern India-The Hooghly River Glaucoma Study
Paul C
Indian Journal of Ophthalmology 2018; 66: 1285-1290 (IGR: 20-1)

79174 Prevalence of Normal-Tension Glaucoma in the Chinese Population: A Systematic Review and Meta-Analysis
Zhao J
American Journal of Ophthalmology 2019; 199: 101-110 (IGR: 20-1)

78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Kahloun R
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)

78581 Familial Risks of Glaucoma in the Population of Sweden
Li X
Journal of Glaucoma 2018; 27: 802-806 (IGR: 20-1)

78933 Prevalence of glaucoma in the Northern Finland Birth Cohort Eye Study
Karvonen E
Acta Ophthalmologica 2019; 97: 200-207 (IGR: 20-1)

78853 Incidence and causes of visual impairment in Japan: the first nation-wide complete enumeration survey of newly certified visually impaired individuals
Morizane Y
Japanese Journal of Ophthalmology 2019; 63: 26-33 (IGR: 20-1)

78963 Overdiagnosis of open-angle glaucoma in the general population: the Thessaloniki Eye Study
Founti P
Acta Ophthalmologica 2018; 96: e859-e864 (IGR: 20-1)

79212 Leveraging Electronic Health Records to Identify and Characterize Patients with Low Vision
Guo X
Ophthalmic Epidemiology 2019; 26: 132-139 (IGR: 20-1)

78933 Prevalence of glaucoma in the Northern Finland Birth Cohort Eye Study
Stoor K
Acta Ophthalmologica 2019; 97: 200-207 (IGR: 20-1)

78853 Incidence and causes of visual impairment in Japan: the first nation-wide complete enumeration survey of newly certified visually impaired individuals
Morimoto N
Japanese Journal of Ophthalmology 2019; 63: 26-33 (IGR: 20-1)

78966 Prevalence and associated factors of low vision and blindness among patients attending St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia
Tekalign SY
BMC Ophthalmology 2018; 18: 232 (IGR: 20-1)

78457 Angle closure glaucoma in rural and urban populations in eastern India-The Hooghly River Glaucoma Study
Sengupta S
Indian Journal of Ophthalmology 2018; 66: 1285-1290 (IGR: 20-1)

78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Khairallah M
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)

78564 A Common Glaucoma-risk Variant of SIX6 Alters Retinal Nerve Fiber Layer and Optic Disc Measures in a European Population: The EPIC-Norfolk Eye Study
Chan MPY
Journal of Glaucoma 2018; 27: 743-749 (IGR: 20-1)

78963 Overdiagnosis of open-angle glaucoma in the general population: the Thessaloniki Eye Study
Coleman AL
Acta Ophthalmologica 2018; 96: e859-e864 (IGR: 20-1)

79174 Prevalence of Normal-Tension Glaucoma in the Chinese Population: A Systematic Review and Meta-Analysis
Solano MM
American Journal of Ophthalmology 2019; 199: 101-110 (IGR: 20-1)

79027 Association of Retinal Neurodegeneration on Optical Coherence Tomography With Dementia: A Population-Based Study
Colijn JM
JAMA neurology 2018; 75: 1256-1263 (IGR: 20-1)

78581 Familial Risks of Glaucoma in the Population of Sweden
Sundquist J
Journal of Glaucoma 2018; 27: 802-806 (IGR: 20-1)

78494 Glaucoma-associated long-term mortality in a rural cohort from India: the Andhra Pradesh Eye Disease Study
Murthy GVS
British Journal of Ophthalmology 2018; 102: 1477-1482 (IGR: 20-1)

79222 Eight-Year Incidence of Open-Angle Glaucoma in the Tema Eye Survey
Tulenko SE
Ophthalmology 2019; 126: 372-380 (IGR: 20-1)

78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Casson RJ
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)

78581 Familial Risks of Glaucoma in the Population of Sweden
Zöller B
Journal of Glaucoma 2018; 27: 802-806 (IGR: 20-1)

78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Pesudovs K
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)

79027 Association of Retinal Neurodegeneration on Optical Coherence Tomography With Dementia: A Population-Based Study
Ikram MA
JAMA neurology 2018; 75: 1256-1263 (IGR: 20-1)

79222 Eight-Year Incidence of Open-Angle Glaucoma in the Tema Eye Survey
Barton K
Ophthalmology 2019; 126: 372-380 (IGR: 20-1)

78933 Prevalence of glaucoma in the Northern Finland Birth Cohort Eye Study
Luodonpää M
Acta Ophthalmologica 2019; 97: 200-207 (IGR: 20-1)

78853 Incidence and causes of visual impairment in Japan: the first nation-wide complete enumeration survey of newly certified visually impaired individuals
Fujiwara A
Japanese Journal of Ophthalmology 2019; 63: 26-33 (IGR: 20-1)

78494 Glaucoma-associated long-term mortality in a rural cohort from India: the Andhra Pradesh Eye Disease Study
Giridhar P
British Journal of Ophthalmology 2018; 102: 1477-1482 (IGR: 20-1)

78457 Angle closure glaucoma in rural and urban populations in eastern India-The Hooghly River Glaucoma Study
Banerjee S
Indian Journal of Ophthalmology 2018; 66: 1285-1290 (IGR: 20-1)

78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Resnikoff S
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)

79231 Comorbidities and Prescribed Medications in Patients With or Without Dry Eye Disease: A Population-Based Study
Guerin A
American Journal of Ophthalmology 2019; 198: 181-192 (IGR: 20-1)

78963 Overdiagnosis of open-angle glaucoma in the general population: the Thessaloniki Eye Study
Wilson MR
Acta Ophthalmologica 2018; 96: e859-e864 (IGR: 20-1)

79174 Prevalence of Normal-Tension Glaucoma in the Chinese Population: A Systematic Review and Meta-Analysis
Oldenburg CE
American Journal of Ophthalmology 2019; 199: 101-110 (IGR: 20-1)

78564 A Common Glaucoma-risk Variant of SIX6 Alters Retinal Nerve Fiber Layer and Optic Disc Measures in a European Population: The EPIC-Norfolk Eye Study
Yip JLY
Journal of Glaucoma 2018; 27: 743-749 (IGR: 20-1)

79212 Leveraging Electronic Health Records to Identify and Characterize Patients with Low Vision
Boland MV
Ophthalmic Epidemiology 2019; 26: 132-139 (IGR: 20-1)

78966 Prevalence and associated factors of low vision and blindness among patients attending St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia
Anbesse DH
BMC Ophthalmology 2018; 18: 232 (IGR: 20-1)

78564 A Common Glaucoma-risk Variant of SIX6 Alters Retinal Nerve Fiber Layer and Optic Disc Measures in a European Population: The EPIC-Norfolk Eye Study
Broadway DC
Journal of Glaucoma 2018; 27: 743-749 (IGR: 20-1)

79212 Leveraging Electronic Health Records to Identify and Characterize Patients with Low Vision
Goldstein JE
Ophthalmic Epidemiology 2019; 26: 132-139 (IGR: 20-1)

78933 Prevalence of glaucoma in the Northern Finland Birth Cohort Eye Study
Hägg P
Acta Ophthalmologica 2019; 97: 200-207 (IGR: 20-1)

79231 Comorbidities and Prescribed Medications in Patients With or Without Dry Eye Disease: A Population-Based Study
Pivneva I
American Journal of Ophthalmology 2019; 198: 181-192 (IGR: 20-1)

78581 Familial Risks of Glaucoma in the Population of Sweden
Sundquist K
Journal of Glaucoma 2018; 27: 802-806 (IGR: 20-1)

78963 Overdiagnosis of open-angle glaucoma in the general population: the Thessaloniki Eye Study
Yu F
Acta Ophthalmologica 2018; 96: e859-e864 (IGR: 20-1)

78457 Angle closure glaucoma in rural and urban populations in eastern India-The Hooghly River Glaucoma Study
Choudhury S
Indian Journal of Ophthalmology 2018; 66: 1285-1290 (IGR: 20-1)

79174 Prevalence of Normal-Tension Glaucoma in the Chinese Population: A Systematic Review and Meta-Analysis
Liu T
American Journal of Ophthalmology 2019; 199: 101-110 (IGR: 20-1)

78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Cicinelli MV
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)

79222 Eight-Year Incidence of Open-Angle Glaucoma in the Tema Eye Survey
Herndon LW
Ophthalmology 2019; 126: 372-380 (IGR: 20-1)

78853 Incidence and causes of visual impairment in Japan: the first nation-wide complete enumeration survey of newly certified visually impaired individuals
Kawasaki R
Japanese Journal of Ophthalmology 2019; 63: 26-33 (IGR: 20-1)

78966 Prevalence and associated factors of low vision and blindness among patients attending St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia
Bizuneh ZY
BMC Ophthalmology 2018; 18: 232 (IGR: 20-1)

78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Taylor HR
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)

79027 Association of Retinal Neurodegeneration on Optical Coherence Tomography With Dementia: A Population-Based Study
Bonnemaijer PWM
JAMA neurology 2018; 75: 1256-1263 (IGR: 20-1)

78494 Glaucoma-associated long-term mortality in a rural cohort from India: the Andhra Pradesh Eye Disease Study
Marmamula S
British Journal of Ophthalmology 2018; 102: 1477-1482 (IGR: 20-1)

79174 Prevalence of Normal-Tension Glaucoma in the Chinese Population: A Systematic Review and Meta-Analysis
Wang Y
American Journal of Ophthalmology 2019; 199: 101-110 (IGR: 20-1)

78494 Glaucoma-associated long-term mortality in a rural cohort from India: the Andhra Pradesh Eye Disease Study
Pant HB
British Journal of Ophthalmology 2018; 102: 1477-1482 (IGR: 20-1)

78963 Overdiagnosis of open-angle glaucoma in the general population: the Thessaloniki Eye Study
Anastasopoulos E
Acta Ophthalmologica 2018; 96: e859-e864 (IGR: 20-1)

78853 Incidence and causes of visual impairment in Japan: the first nation-wide complete enumeration survey of newly certified visually impaired individuals
Yamashita H
Japanese Journal of Ophthalmology 2019; 63: 26-33 (IGR: 20-1)

78933 Prevalence of glaucoma in the Northern Finland Birth Cohort Eye Study
Kuoppala J
Acta Ophthalmologica 2019; 97: 200-207 (IGR: 20-1)

79222 Eight-Year Incidence of Open-Angle Glaucoma in the Tema Eye Survey
Mathenge E
Ophthalmology 2019; 126: 372-380 (IGR: 20-1)

78564 A Common Glaucoma-risk Variant of SIX6 Alters Retinal Nerve Fiber Layer and Optic Disc Measures in a European Population: The EPIC-Norfolk Eye Study
Garway-Heath DF
Journal of Glaucoma 2018; 27: 743-749 (IGR: 20-1)

78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Flaxman SR
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)

79231 Comorbidities and Prescribed Medications in Patients With or Without Dry Eye Disease: A Population-Based Study
Evans AM
American Journal of Ophthalmology 2019; 198: 181-192 (IGR: 20-1)

79027 Association of Retinal Neurodegeneration on Optical Coherence Tomography With Dementia: A Population-Based Study
Licher S
JAMA neurology 2018; 75: 1256-1263 (IGR: 20-1)

78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Cicinelli MV
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)

79222 Eight-Year Incidence of Open-Angle Glaucoma in the Tema Eye Survey
Hall A
Ophthalmology 2019; 126: 372-380 (IGR: 20-1)

79174 Prevalence of Normal-Tension Glaucoma in the Chinese Population: A Systematic Review and Meta-Analysis
Wang N
American Journal of Ophthalmology 2019; 199: 101-110 (IGR: 20-1)

78853 Incidence and causes of visual impairment in Japan: the first nation-wide complete enumeration survey of newly certified visually impaired individuals
Ogura Y
Japanese Journal of Ophthalmology 2019; 63: 26-33 (IGR: 20-1)

79027 Association of Retinal Neurodegeneration on Optical Coherence Tomography With Dementia: A Population-Based Study
Wolters FJ
JAMA neurology 2018; 75: 1256-1263 (IGR: 20-1)

78494 Glaucoma-associated long-term mortality in a rural cohort from India: the Andhra Pradesh Eye Disease Study
Palamaner Subash Shantha G
British Journal of Ophthalmology 2018; 102: 1477-1482 (IGR: 20-1)

78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Das A
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)

78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Das A
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)

78933 Prevalence of glaucoma in the Northern Finland Birth Cohort Eye Study
Lintonen T
Acta Ophthalmologica 2019; 97: 200-207 (IGR: 20-1)

78963 Overdiagnosis of open-angle glaucoma in the general population: the Thessaloniki Eye Study
Harris A
Acta Ophthalmologica 2018; 96: e859-e864 (IGR: 20-1)

78564 A Common Glaucoma-risk Variant of SIX6 Alters Retinal Nerve Fiber Layer and Optic Disc Measures in a European Population: The EPIC-Norfolk Eye Study
Viswanathan AC
Journal of Glaucoma 2018; 27: 743-749 (IGR: 20-1)

78494 Glaucoma-associated long-term mortality in a rural cohort from India: the Andhra Pradesh Eye Disease Study
Chakrabarti S
British Journal of Ophthalmology 2018; 102: 1477-1482 (IGR: 20-1)

78564 A Common Glaucoma-risk Variant of SIX6 Alters Retinal Nerve Fiber Layer and Optic Disc Measures in a European Population: The EPIC-Norfolk Eye Study
Luben R
Journal of Glaucoma 2018; 27: 743-749 (IGR: 20-1)

78933 Prevalence of glaucoma in the Northern Finland Birth Cohort Eye Study
Ohtonen P
Acta Ophthalmologica 2019; 97: 200-207 (IGR: 20-1)

79027 Association of Retinal Neurodegeneration on Optical Coherence Tomography With Dementia: A Population-Based Study
Tiemeier H
JAMA neurology 2018; 75: 1256-1263 (IGR: 20-1)

79174 Prevalence of Normal-Tension Glaucoma in the Chinese Population: A Systematic Review and Meta-Analysis
Lin SC
American Journal of Ophthalmology 2019; 199: 101-110 (IGR: 20-1)

78853 Incidence and causes of visual impairment in Japan: the first nation-wide complete enumeration survey of newly certified visually impaired individuals
Shiraga F
Japanese Journal of Ophthalmology 2019; 63: 26-33 (IGR: 20-1)

78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Flaxman SR
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)

79222 Eight-Year Incidence of Open-Angle Glaucoma in the Tema Eye Survey
Kim HY
Ophthalmology 2019; 126: 372-380 (IGR: 20-1)

78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Jonas JB
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)

78963 Overdiagnosis of open-angle glaucoma in the general population: the Thessaloniki Eye Study
Pappas T; Koskosas A
Acta Ophthalmologica 2018; 96: e859-e864 (IGR: 20-1)

79027 Association of Retinal Neurodegeneration on Optical Coherence Tomography With Dementia: A Population-Based Study
Koudstaal PJ
JAMA neurology 2018; 75: 1256-1263 (IGR: 20-1)

79222 Eight-Year Incidence of Open-Angle Glaucoma in the Tema Eye Survey
Hay-Smith G
Ophthalmology 2019; 126: 372-380 (IGR: 20-1)

78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Keeffe JE
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)

78564 A Common Glaucoma-risk Variant of SIX6 Alters Retinal Nerve Fiber Layer and Optic Disc Measures in a European Population: The EPIC-Norfolk Eye Study
Hayat S
Journal of Glaucoma 2018; 27: 743-749 (IGR: 20-1)

78933 Prevalence of glaucoma in the Northern Finland Birth Cohort Eye Study
Tuulonen A
Acta Ophthalmologica 2019; 97: 200-207 (IGR: 20-1)

78494 Glaucoma-associated long-term mortality in a rural cohort from India: the Andhra Pradesh Eye Disease Study
Gilbert CE
British Journal of Ophthalmology 2018; 102: 1477-1482 (IGR: 20-1)

78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Jonas JB
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)

78933 Prevalence of glaucoma in the Northern Finland Birth Cohort Eye Study
Saarela V
Acta Ophthalmologica 2019; 97: 200-207 (IGR: 20-1)

78564 A Common Glaucoma-risk Variant of SIX6 Alters Retinal Nerve Fiber Layer and Optic Disc Measures in a European Population: The EPIC-Norfolk Eye Study
Hauser MA
Journal of Glaucoma 2018; 27: 743-749 (IGR: 20-1)

78963 Overdiagnosis of open-angle glaucoma in the general population: the Thessaloniki Eye Study
Kilintzis V
Acta Ophthalmologica 2018; 96: e859-e864 (IGR: 20-1)

78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Kempen JH
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)

78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Kempen JH
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)

79222 Eight-Year Incidence of Open-Angle Glaucoma in the Tema Eye Survey
Budenz DL
Ophthalmology 2019; 126: 372-380 (IGR: 20-1)

78494 Glaucoma-associated long-term mortality in a rural cohort from India: the Andhra Pradesh Eye Disease Study
Rao GN
British Journal of Ophthalmology 2018; 102: 1477-1482 (IGR: 20-1)

79027 Association of Retinal Neurodegeneration on Optical Coherence Tomography With Dementia: A Population-Based Study
Klaver CCW
JAMA neurology 2018; 75: 1256-1263 (IGR: 20-1)

78564 A Common Glaucoma-risk Variant of SIX6 Alters Retinal Nerve Fiber Layer and Optic Disc Measures in a European Population: The EPIC-Norfolk Eye Study
Wareham NJ
Journal of Glaucoma 2018; 27: 743-749 (IGR: 20-1)

78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Leasher J
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)

78963 Overdiagnosis of open-angle glaucoma in the general population: the Thessaloniki Eye Study
Salonikiou A
Acta Ophthalmologica 2018; 96: e859-e864 (IGR: 20-1)

78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Leasher J
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)

79027 Association of Retinal Neurodegeneration on Optical Coherence Tomography With Dementia: A Population-Based Study
Ikram MK
JAMA neurology 2018; 75: 1256-1263 (IGR: 20-1)

78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Limburg H
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)

78963 Overdiagnosis of open-angle glaucoma in the general population: the Thessaloniki Eye Study
Raptou A
Acta Ophthalmologica 2018; 96: e859-e864 (IGR: 20-1)

78564 A Common Glaucoma-risk Variant of SIX6 Alters Retinal Nerve Fiber Layer and Optic Disc Measures in a European Population: The EPIC-Norfolk Eye Study
Khaw KT
Journal of Glaucoma 2018; 27: 743-749 (IGR: 20-1)

78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Limburg H
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)

78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Naidoo K
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)

78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Naidoo K
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)

78564 A Common Glaucoma-risk Variant of SIX6 Alters Retinal Nerve Fiber Layer and Optic Disc Measures in a European Population: The EPIC-Norfolk Eye Study
Fortune B
Journal of Glaucoma 2018; 27: 743-749 (IGR: 20-1)

78963 Overdiagnosis of open-angle glaucoma in the general population: the Thessaloniki Eye Study
Topouzis F
Acta Ophthalmologica 2018; 96: e859-e864 (IGR: 20-1)

78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Silvester AJ
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)

78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Pesudovs K
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)

78564 A Common Glaucoma-risk Variant of SIX6 Alters Retinal Nerve Fiber Layer and Optic Disc Measures in a European Population: The EPIC-Norfolk Eye Study
Allingham RR
Journal of Glaucoma 2018; 27: 743-749 (IGR: 20-1)

78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Silvester AJ
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)

78564 A Common Glaucoma-risk Variant of SIX6 Alters Retinal Nerve Fiber Layer and Optic Disc Measures in a European Population: The EPIC-Norfolk Eye Study
Foster PJ
Journal of Glaucoma 2018; 27: 743-749 (IGR: 20-1)

78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Stevens GA
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)

78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Tahhan N
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)

78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Tahhan N; Wong TY
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)

78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Taylor HR; Wong TY
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)

78914 Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections
Resnikoff S; Bourne RRA
British Journal of Ophthalmology 2019; 103: 878-884 (IGR: 20-1)

78915 Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections
Bourne RRA
British Journal of Ophthalmology 2019; 103: 863-870 (IGR: 20-1)

78098 Creation of a childhood glaucoma registry database
Lopes NLV
Arquivos Brasileiros de Oftalmologia 2018; 81: 271-275 (IGR: 19-4)

78155 Global prevalence and causes of visual impairment with special reference to the general population of Saudi Arabia
Alswailmi FK
Pakistan journal of medical sciences 2018; 34: 751-756 (IGR: 19-4)

78178 Association between Open-Angle Glaucoma and the Risks of Alzheimer's and Parkinson's Diseases in South Korea: A 10-year Nationwide Cohort Study
Moon JY
Scientific reports 2018; 8: 11161 (IGR: 19-4)

77432 Epidemiology of Exfoliation Syndrome
Konstas AGP
Journal of Glaucoma 2018; 27: S4-S11 (IGR: 19-4)

77976 The association between glaucoma and risk of depression: a nationwide population-based cohort study
Chen YY
BMC Ophthalmology 2018; 18: 146 (IGR: 19-4)

78144 The Association between Female Reproductive Factors and Open-Angle Glaucoma in Korean Women: The Korean National Health and Nutrition Examination Survey V
Shin YU; Hong EH
Journal of Ophthalmology 2018; 2018: 2750786 (IGR: 19-4)

77432 Epidemiology of Exfoliation Syndrome
Ringvold A
Journal of Glaucoma 2018; 27: S4-S11 (IGR: 19-4)

77976 The association between glaucoma and risk of depression: a nationwide population-based cohort study
Lai YJ
BMC Ophthalmology 2018; 18: 146 (IGR: 19-4)

78098 Creation of a childhood glaucoma registry database
Gracitelli CPB
Arquivos Brasileiros de Oftalmologia 2018; 81: 271-275 (IGR: 19-4)

78178 Association between Open-Angle Glaucoma and the Risks of Alzheimer's and Parkinson's Diseases in South Korea: A 10-year Nationwide Cohort Study
Kim HJ
Scientific reports 2018; 8: 11161 (IGR: 19-4)

77976 The association between glaucoma and risk of depression: a nationwide population-based cohort study
Wang JP
BMC Ophthalmology 2018; 18: 146 (IGR: 19-4)

78144 The Association between Female Reproductive Factors and Open-Angle Glaucoma in Korean Women: The Korean National Health and Nutrition Examination Survey V
Kang MH
Journal of Ophthalmology 2018; 2018: 2750786 (IGR: 19-4)

78178 Association between Open-Angle Glaucoma and the Risks of Alzheimer's and Parkinson's Diseases in South Korea: A 10-year Nationwide Cohort Study
Park YH
Scientific reports 2018; 8: 11161 (IGR: 19-4)

78098 Creation of a childhood glaucoma registry database
Moura CR
Arquivos Brasileiros de Oftalmologia 2018; 81: 271-275 (IGR: 19-4)

77976 The association between glaucoma and risk of depression: a nationwide population-based cohort study
Shen YC
BMC Ophthalmology 2018; 18: 146 (IGR: 19-4)

78178 Association between Open-Angle Glaucoma and the Risks of Alzheimer's and Parkinson's Diseases in South Korea: A 10-year Nationwide Cohort Study
Park TK
Scientific reports 2018; 8: 11161 (IGR: 19-4)

78144 The Association between Female Reproductive Factors and Open-Angle Glaucoma in Korean Women: The Korean National Health and Nutrition Examination Survey V
Cho H; Seong M
Journal of Ophthalmology 2018; 2018: 2750786 (IGR: 19-4)

77976 The association between glaucoma and risk of depression: a nationwide population-based cohort study
Wang CY
BMC Ophthalmology 2018; 18: 146 (IGR: 19-4)

78178 Association between Open-Angle Glaucoma and the Risks of Alzheimer's and Parkinson's Diseases in South Korea: A 10-year Nationwide Cohort Study
Park EC; Kim CY
Scientific reports 2018; 8: 11161 (IGR: 19-4)

77976 The association between glaucoma and risk of depression: a nationwide population-based cohort study
Chen HH
BMC Ophthalmology 2018; 18: 146 (IGR: 19-4)

78178 Association between Open-Angle Glaucoma and the Risks of Alzheimer's and Parkinson's Diseases in South Korea: A 10-year Nationwide Cohort Study
Lee SH
Scientific reports 2018; 8: 11161 (IGR: 19-4)

77976 The association between glaucoma and risk of depression: a nationwide population-based cohort study
Hu HY; Chou P
BMC Ophthalmology 2018; 18: 146 (IGR: 19-4)

77006 Prevalence of glaucoma in the Australian National Eye Health Survey
Keel S
British Journal of Ophthalmology 2018; 0: (IGR: 19-3)

76707 Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
Bourne RRA
British Journal of Ophthalmology 2018; 102: 575-585 (IGR: 19-3)

77032 Systemic and Ocular Determinants of Peripapillary Retinal Nerve Fiber Layer Thickness Measurements in the European Eye Epidemiology (E3) Population
Mauschitz MM
Ophthalmology 2018; 0: (IGR: 19-3)

76739 Glaucoma Features in an East African Population: A 6-Year Cohort Study of Older Adults in Nakuru, Kenya
Bastawrous A
Journal of Glaucoma 2018; 27: 455-463 (IGR: 19-3)

77125 Prevalence of glaucoma in Germany: results from the Gutenberg Health Study
Höhn R
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 1695-1702 (IGR: 19-3)

76743 Prevalence of Ocular Hypertension and Glaucoma as Well as Associated Factors in Graves' Orbitopathy
Kim JW
Journal of Glaucoma 2018; 27: 464-469 (IGR: 19-3)

77069 Causes of low vision and blindness in a Turkish adult population: the Izmir eye study
Koç F
Eastern Mediterranean health journal 2018; 24: 161-168 (IGR: 19-3)

76743 Prevalence of Ocular Hypertension and Glaucoma as Well as Associated Factors in Graves' Orbitopathy
Ko J
Journal of Glaucoma 2018; 27: 464-469 (IGR: 19-3)

77125 Prevalence of glaucoma in Germany: results from the Gutenberg Health Study
Nickels S
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 1695-1702 (IGR: 19-3)

76739 Glaucoma Features in an East African Population: A 6-Year Cohort Study of Older Adults in Nakuru, Kenya
Mathenge W
Journal of Glaucoma 2018; 27: 455-463 (IGR: 19-3)

77006 Prevalence of glaucoma in the Australian National Eye Health Survey
Xie J
British Journal of Ophthalmology 2018; 0: (IGR: 19-3)

76707 Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
Jonas JB
British Journal of Ophthalmology 2018; 102: 575-585 (IGR: 19-3)

77032 Systemic and Ocular Determinants of Peripapillary Retinal Nerve Fiber Layer Thickness Measurements in the European Eye Epidemiology (E3) Population
Bonnemaijer PWM
Ophthalmology 2018; 0: (IGR: 19-3)

77069 Causes of low vision and blindness in a Turkish adult population: the Izmir eye study
Erden V
Eastern Mediterranean health journal 2018; 24: 161-168 (IGR: 19-3)

77006 Prevalence of glaucoma in the Australian National Eye Health Survey
Foreman J
British Journal of Ophthalmology 2018; 0: (IGR: 19-3)

77069 Causes of low vision and blindness in a Turkish adult population: the Izmir eye study
Sefi-Yurdakul N
Eastern Mediterranean health journal 2018; 24: 161-168 (IGR: 19-3)

77032 Systemic and Ocular Determinants of Peripapillary Retinal Nerve Fiber Layer Thickness Measurements in the European Eye Epidemiology (E3) Population
Diers K
Ophthalmology 2018; 0: (IGR: 19-3)

76707 Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
Bron AM
British Journal of Ophthalmology 2018; 102: 575-585 (IGR: 19-3)

76739 Glaucoma Features in an East African Population: A 6-Year Cohort Study of Older Adults in Nakuru, Kenya
Buchan J
Journal of Glaucoma 2018; 27: 455-463 (IGR: 19-3)

76743 Prevalence of Ocular Hypertension and Glaucoma as Well as Associated Factors in Graves' Orbitopathy
Woo YJ
Journal of Glaucoma 2018; 27: 464-469 (IGR: 19-3)

77125 Prevalence of glaucoma in Germany: results from the Gutenberg Health Study
Schuster AK; Wild PS
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 1695-1702 (IGR: 19-3)

77032 Systemic and Ocular Determinants of Peripapillary Retinal Nerve Fiber Layer Thickness Measurements in the European Eye Epidemiology (E3) Population
Rauscher FG
Ophthalmology 2018; 0: (IGR: 19-3)

76743 Prevalence of Ocular Hypertension and Glaucoma as Well as Associated Factors in Graves' Orbitopathy
Bae HW
Journal of Glaucoma 2018; 27: 464-469 (IGR: 19-3)

77006 Prevalence of glaucoma in the Australian National Eye Health Survey
Lee PY
British Journal of Ophthalmology 2018; 0: (IGR: 19-3)

76739 Glaucoma Features in an East African Population: A 6-Year Cohort Study of Older Adults in Nakuru, Kenya
Kyari F
Journal of Glaucoma 2018; 27: 455-463 (IGR: 19-3)

76707 Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
Cicinelli MV
British Journal of Ophthalmology 2018; 102: 575-585 (IGR: 19-3)

76739 Glaucoma Features in an East African Population: A 6-Year Cohort Study of Older Adults in Nakuru, Kenya
Peto T
Journal of Glaucoma 2018; 27: 455-463 (IGR: 19-3)

77006 Prevalence of glaucoma in the Australian National Eye Health Survey
Alwan M
British Journal of Ophthalmology 2018; 0: (IGR: 19-3)

77032 Systemic and Ocular Determinants of Peripapillary Retinal Nerve Fiber Layer Thickness Measurements in the European Eye Epidemiology (E3) Population
Elze T
Ophthalmology 2018; 0: (IGR: 19-3)

76707 Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
Das A
British Journal of Ophthalmology 2018; 102: 575-585 (IGR: 19-3)

77125 Prevalence of glaucoma in Germany: results from the Gutenberg Health Study
Münzel T
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 1695-1702 (IGR: 19-3)

76743 Prevalence of Ocular Hypertension and Glaucoma as Well as Associated Factors in Graves' Orbitopathy
Yoon JS
Journal of Glaucoma 2018; 27: 464-469 (IGR: 19-3)

76739 Glaucoma Features in an East African Population: A 6-Year Cohort Study of Older Adults in Nakuru, Kenya
Rono H
Journal of Glaucoma 2018; 27: 455-463 (IGR: 19-3)

77032 Systemic and Ocular Determinants of Peripapillary Retinal Nerve Fiber Layer Thickness Measurements in the European Eye Epidemiology (E3) Population
Engel C
Ophthalmology 2018; 0: (IGR: 19-3)

76707 Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
Flaxman SR
British Journal of Ophthalmology 2018; 102: 575-585 (IGR: 19-3)

77006 Prevalence of glaucoma in the Australian National Eye Health Survey
Fahy ET
British Journal of Ophthalmology 2018; 0: (IGR: 19-3)

77125 Prevalence of glaucoma in Germany: results from the Gutenberg Health Study
Lackner KJ
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 1695-1702 (IGR: 19-3)

76707 Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
Friedman DS
British Journal of Ophthalmology 2018; 102: 575-585 (IGR: 19-3)

77006 Prevalence of glaucoma in the Australian National Eye Health Survey
Van Wijngaarden P
British Journal of Ophthalmology 2018; 0: (IGR: 19-3)

77125 Prevalence of glaucoma in Germany: results from the Gutenberg Health Study
Schmidtmann I
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 1695-1702 (IGR: 19-3)

77032 Systemic and Ocular Determinants of Peripapillary Retinal Nerve Fiber Layer Thickness Measurements in the European Eye Epidemiology (E3) Population
Loeffler M
Ophthalmology 2018; 0: (IGR: 19-3)

76739 Glaucoma Features in an East African Population: A 6-Year Cohort Study of Older Adults in Nakuru, Kenya
Weiss HA
Journal of Glaucoma 2018; 27: 455-463 (IGR: 19-3)

77006 Prevalence of glaucoma in the Australian National Eye Health Survey
Fan Gaskin JC
British Journal of Ophthalmology 2018; 0: (IGR: 19-3)

76739 Glaucoma Features in an East African Population: A 6-Year Cohort Study of Older Adults in Nakuru, Kenya
Macleod D
Journal of Glaucoma 2018; 27: 455-463 (IGR: 19-3)

77032 Systemic and Ocular Determinants of Peripapillary Retinal Nerve Fiber Layer Thickness Measurements in the European Eye Epidemiology (E3) Population
Colijn JM
Ophthalmology 2018; 0: (IGR: 19-3)

77125 Prevalence of glaucoma in Germany: results from the Gutenberg Health Study
Beutel M
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 1695-1702 (IGR: 19-3)

76707 Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
Keeffe JE
British Journal of Ophthalmology 2018; 102: 575-585 (IGR: 19-3)

77125 Prevalence of glaucoma in Germany: results from the Gutenberg Health Study
Pfeiffer N
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 1695-1702 (IGR: 19-3)

76707 Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
Kempen JH
British Journal of Ophthalmology 2018; 102: 575-585 (IGR: 19-3)

76739 Glaucoma Features in an East African Population: A 6-Year Cohort Study of Older Adults in Nakuru, Kenya
Foster A
Journal of Glaucoma 2018; 27: 455-463 (IGR: 19-3)

77006 Prevalence of glaucoma in the Australian National Eye Health Survey
Ang GS
British Journal of Ophthalmology 2018; 0: (IGR: 19-3)

77032 Systemic and Ocular Determinants of Peripapillary Retinal Nerve Fiber Layer Thickness Measurements in the European Eye Epidemiology (E3) Population
Ikram MA; Vingerling JR
Ophthalmology 2018; 0: (IGR: 19-3)

77006 Prevalence of glaucoma in the Australian National Eye Health Survey
Crowston JG
British Journal of Ophthalmology 2018; 0: (IGR: 19-3)

76707 Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
Leasher J
British Journal of Ophthalmology 2018; 102: 575-585 (IGR: 19-3)

76739 Glaucoma Features in an East African Population: A 6-Year Cohort Study of Older Adults in Nakuru, Kenya
Burton MJ
Journal of Glaucoma 2018; 27: 455-463 (IGR: 19-3)

77032 Systemic and Ocular Determinants of Peripapillary Retinal Nerve Fiber Layer Thickness Measurements in the European Eye Epidemiology (E3) Population
Williams KM
Ophthalmology 2018; 0: (IGR: 19-3)

76707 Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
Limburg H
British Journal of Ophthalmology 2018; 102: 575-585 (IGR: 19-3)

76739 Glaucoma Features in an East African Population: A 6-Year Cohort Study of Older Adults in Nakuru, Kenya
Kuper H
Journal of Glaucoma 2018; 27: 455-463 (IGR: 19-3)

77006 Prevalence of glaucoma in the Australian National Eye Health Survey
Taylor HR
British Journal of Ophthalmology 2018; 0: (IGR: 19-3)

76707 Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
Naidoo K
British Journal of Ophthalmology 2018; 102: 575-585 (IGR: 19-3)

77006 Prevalence of glaucoma in the Australian National Eye Health Survey
Dirani M
British Journal of Ophthalmology 2018; 0: (IGR: 19-3)

77032 Systemic and Ocular Determinants of Peripapillary Retinal Nerve Fiber Layer Thickness Measurements in the European Eye Epidemiology (E3) Population
Hammond CJ; Creuzot-Garcher C
Ophthalmology 2018; 0: (IGR: 19-3)

76707 Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
Pesudovs K; Peto T
British Journal of Ophthalmology 2018; 102: 575-585 (IGR: 19-3)

77032 Systemic and Ocular Determinants of Peripapillary Retinal Nerve Fiber Layer Thickness Measurements in the European Eye Epidemiology (E3) Population
Bron AM
Ophthalmology 2018; 0: (IGR: 19-3)

76707 Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
Saadine J
British Journal of Ophthalmology 2018; 102: 575-585 (IGR: 19-3)

77032 Systemic and Ocular Determinants of Peripapillary Retinal Nerve Fiber Layer Thickness Measurements in the European Eye Epidemiology (E3) Population
Silva R; Nunes S
Ophthalmology 2018; 0: (IGR: 19-3)

76707 Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
Silvester AJ
British Journal of Ophthalmology 2018; 102: 575-585 (IGR: 19-3)

77032 Systemic and Ocular Determinants of Peripapillary Retinal Nerve Fiber Layer Thickness Measurements in the European Eye Epidemiology (E3) Population
Delcourt C
Ophthalmology 2018; 0: (IGR: 19-3)

76707 Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
Tahhan N; Taylor HR
British Journal of Ophthalmology 2018; 102: 575-585 (IGR: 19-3)

77032 Systemic and Ocular Determinants of Peripapillary Retinal Nerve Fiber Layer Thickness Measurements in the European Eye Epidemiology (E3) Population
Cougnard-Grégoire A
Ophthalmology 2018; 0: (IGR: 19-3)

76707 Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
Varma R
British Journal of Ophthalmology 2018; 102: 575-585 (IGR: 19-3)

77032 Systemic and Ocular Determinants of Peripapillary Retinal Nerve Fiber Layer Thickness Measurements in the European Eye Epidemiology (E3) Population
Holz FG
Ophthalmology 2018; 0: (IGR: 19-3)

76707 Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
Wong TY
British Journal of Ophthalmology 2018; 102: 575-585 (IGR: 19-3)

77032 Systemic and Ocular Determinants of Peripapillary Retinal Nerve Fiber Layer Thickness Measurements in the European Eye Epidemiology (E3) Population
Klaver CCW; Brete
Ophthalmology 2018; 0: (IGR: 19-3)

76707 Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
Resnikoff S;
British Journal of Ophthalmology 2018; 102: 575-585 (IGR: 19-3)

75704 Inter-relationship between ocular perfusion pressure, blood pressure, intraocular pressure profiles and primary open-angle glaucoma: the Singapore Epidemiology of Eye Diseases study
Tham YC
British Journal of Ophthalmology 2018; 0: (IGR: 19-2)

74928 Posner-Schlossman syndrome in Wenzhou, China: a retrospective review study
Jiang JH
British Journal of Ophthalmology 2017; 101: 1638-1642 (IGR: 19-2)

75347 Retrospective data on causes of childhood vision impairment in Eritrea
Gyawali R
BMC Ophthalmology 2017; 17: 209 (IGR: 19-2)

75364 Increased Incidence of Visual Field Abnormalities as Determined by Frequency Doubling Technology Perimetry in High Computer Users Among Japanese Workers: A Retrospective Cohort Study
Nakano T
Journal of epidemiology / Japan Epidemiological Association 2018; 28: 214-219 (IGR: 19-2)

75653 National and subnational prevalence and burden of glaucoma in China: A systematic analysis
Song P
Journal of global health 2017; 7: 020705 (IGR: 19-2)

75587 Association of Dietary Fatty Acid Intake With Glaucoma in the United States
Wang YE
JAMA ophthalmology 2018; 136: 141-147 (IGR: 19-2)

75377 Causes and Three-year Incidence of Irreversible Visual Impairment in Jing-An District, Shanghai, China from 2010-2015
Xia F
BMC Ophthalmology 2017; 17: 216 (IGR: 19-2)

75433 Relationship Between Open-angle Glaucoma and Stroke: A 2010 to 2012 Korea National Health and Nutrition Examination Survey
Lee WJ
Journal of Glaucoma 2018; 27: 22-27 (IGR: 19-2)

75704 Inter-relationship between ocular perfusion pressure, blood pressure, intraocular pressure profiles and primary open-angle glaucoma: the Singapore Epidemiology of Eye Diseases study
Lim SH
British Journal of Ophthalmology 2018; 0: (IGR: 19-2)

74928 Posner-Schlossman syndrome in Wenzhou, China: a retrospective review study
Zhang SD
British Journal of Ophthalmology 2017; 101: 1638-1642 (IGR: 19-2)

75347 Retrospective data on causes of childhood vision impairment in Eritrea
Bhayal BK
BMC Ophthalmology 2017; 17: 209 (IGR: 19-2)

75653 National and subnational prevalence and burden of glaucoma in China: A systematic analysis
Wang J
Journal of global health 2017; 7: 020705 (IGR: 19-2)

75377 Causes and Three-year Incidence of Irreversible Visual Impairment in Jing-An District, Shanghai, China from 2010-2015
Wu L
BMC Ophthalmology 2017; 17: 216 (IGR: 19-2)

75587 Association of Dietary Fatty Acid Intake With Glaucoma in the United States
Tseng VL
JAMA ophthalmology 2018; 136: 141-147 (IGR: 19-2)

75433 Relationship Between Open-angle Glaucoma and Stroke: A 2010 to 2012 Korea National Health and Nutrition Examination Survey
Jeoung JW
Journal of Glaucoma 2018; 27: 22-27 (IGR: 19-2)

75364 Increased Incidence of Visual Field Abnormalities as Determined by Frequency Doubling Technology Perimetry in High Computer Users Among Japanese Workers: A Retrospective Cohort Study
Hayashi T; Nakagawa T
Journal of epidemiology / Japan Epidemiological Association 2018; 28: 214-219 (IGR: 19-2)

75377 Causes and Three-year Incidence of Irreversible Visual Impairment in Jing-An District, Shanghai, China from 2010-2015
Weng C
BMC Ophthalmology 2017; 17: 216 (IGR: 19-2)

75433 Relationship Between Open-angle Glaucoma and Stroke: A 2010 to 2012 Korea National Health and Nutrition Examination Survey
Na KI
Journal of Glaucoma 2018; 27: 22-27 (IGR: 19-2)

75587 Association of Dietary Fatty Acid Intake With Glaucoma in the United States
Yu F
JAMA ophthalmology 2018; 136: 141-147 (IGR: 19-2)

75704 Inter-relationship between ocular perfusion pressure, blood pressure, intraocular pressure profiles and primary open-angle glaucoma: the Singapore Epidemiology of Eye Diseases study
Gupta P
British Journal of Ophthalmology 2018; 0: (IGR: 19-2)

74928 Posner-Schlossman syndrome in Wenzhou, China: a retrospective review study
Dai ML
British Journal of Ophthalmology 2017; 101: 1638-1642 (IGR: 19-2)

75347 Retrospective data on causes of childhood vision impairment in Eritrea
Adhikary R
BMC Ophthalmology 2017; 17: 209 (IGR: 19-2)

75653 National and subnational prevalence and burden of glaucoma in China: A systematic analysis
Bucan K
Journal of global health 2017; 7: 020705 (IGR: 19-2)

75364 Increased Incidence of Visual Field Abnormalities as Determined by Frequency Doubling Technology Perimetry in High Computer Users Among Japanese Workers: A Retrospective Cohort Study
Honda T
Journal of epidemiology / Japan Epidemiological Association 2018; 28: 214-219 (IGR: 19-2)

75653 National and subnational prevalence and burden of glaucoma in China: A systematic analysis
Theodoratou E
Journal of global health 2017; 7: 020705 (IGR: 19-2)

75704 Inter-relationship between ocular perfusion pressure, blood pressure, intraocular pressure profiles and primary open-angle glaucoma: the Singapore Epidemiology of Eye Diseases study
Aung T
British Journal of Ophthalmology 2018; 0: (IGR: 19-2)

75377 Causes and Three-year Incidence of Irreversible Visual Impairment in Jing-An District, Shanghai, China from 2010-2015
Zhou X
BMC Ophthalmology 2017; 17: 216 (IGR: 19-2)

75433 Relationship Between Open-angle Glaucoma and Stroke: A 2010 to 2012 Korea National Health and Nutrition Examination Survey
Kim YK
Journal of Glaucoma 2018; 27: 22-27 (IGR: 19-2)

74928 Posner-Schlossman syndrome in Wenzhou, China: a retrospective review study
Yang JY
British Journal of Ophthalmology 2017; 101: 1638-1642 (IGR: 19-2)

75347 Retrospective data on causes of childhood vision impairment in Eritrea
Shrestha A
BMC Ophthalmology 2017; 17: 209 (IGR: 19-2)

75587 Association of Dietary Fatty Acid Intake With Glaucoma in the United States
Caprioli J
JAMA ophthalmology 2018; 136: 141-147 (IGR: 19-2)

75347 Retrospective data on causes of childhood vision impairment in Eritrea
Sah RP
BMC Ophthalmology 2017; 17: 209 (IGR: 19-2)

75653 National and subnational prevalence and burden of glaucoma in China: A systematic analysis
Rudan I
Journal of global health 2017; 7: 020705 (IGR: 19-2)

75704 Inter-relationship between ocular perfusion pressure, blood pressure, intraocular pressure profiles and primary open-angle glaucoma: the Singapore Epidemiology of Eye Diseases study
Wong TY
British Journal of Ophthalmology 2018; 0: (IGR: 19-2)

75587 Association of Dietary Fatty Acid Intake With Glaucoma in the United States
Coleman AL
JAMA ophthalmology 2018; 136: 141-147 (IGR: 19-2)

74928 Posner-Schlossman syndrome in Wenzhou, China: a retrospective review study
Xie YQ
British Journal of Ophthalmology 2017; 101: 1638-1642 (IGR: 19-2)

75364 Increased Incidence of Visual Field Abnormalities as Determined by Frequency Doubling Technology Perimetry in High Computer Users Among Japanese Workers: A Retrospective Cohort Study
Owada S
Journal of epidemiology / Japan Epidemiological Association 2018; 28: 214-219 (IGR: 19-2)

75433 Relationship Between Open-angle Glaucoma and Stroke: A 2010 to 2012 Korea National Health and Nutrition Examination Survey
Kim CY; Park KH
Journal of Glaucoma 2018; 27: 22-27 (IGR: 19-2)

75364 Increased Incidence of Visual Field Abnormalities as Determined by Frequency Doubling Technology Perimetry in High Computer Users Among Japanese Workers: A Retrospective Cohort Study
Endo H
Journal of epidemiology / Japan Epidemiological Association 2018; 28: 214-219 (IGR: 19-2)

75653 National and subnational prevalence and burden of glaucoma in China: A systematic analysis
Chan KY
Journal of global health 2017; 7: 020705 (IGR: 19-2)

75704 Inter-relationship between ocular perfusion pressure, blood pressure, intraocular pressure profiles and primary open-angle glaucoma: the Singapore Epidemiology of Eye Diseases study
Cheng CY
British Journal of Ophthalmology 2018; 0: (IGR: 19-2)

74928 Posner-Schlossman syndrome in Wenzhou, China: a retrospective review study
Hu C; Mao GY
British Journal of Ophthalmology 2017; 101: 1638-1642 (IGR: 19-2)

75364 Increased Incidence of Visual Field Abnormalities as Determined by Frequency Doubling Technology Perimetry in High Computer Users Among Japanese Workers: A Retrospective Cohort Study
Tatemichi M
Journal of epidemiology / Japan Epidemiological Association 2018; 28: 214-219 (IGR: 19-2)

75433 Relationship Between Open-angle Glaucoma and Stroke: A 2010 to 2012 Korea National Health and Nutrition Examination Survey

Journal of Glaucoma 2018; 27: 22-27 (IGR: 19-2)

74928 Posner-Schlossman syndrome in Wenzhou, China: a retrospective review study
Lu F; Liang YB
British Journal of Ophthalmology 2017; 101: 1638-1642 (IGR: 19-2)

74552 Ural Eye and Medical Study: description of study design and methodology
Bikbov M
Ophthalmic Epidemiology 2017; 0: 1-12 (IGR: 19-1)

74593 Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis
Flaxman SR
The Lancet. Global health 2017; 5: e1221-e1234 (IGR: 19-1)

74125 The incidence of acute angle closure in Scotland: a prospective surveillance study
Chua PY
British Journal of Ophthalmology 2017; 0: (IGR: 19-1)

74716 Spectrum of Eye Disorders Seen in a Pediatric Eye Clinic South East Nigeria
Achigbu EO
Nigerian journal of surgery : official publication of the Nigerian Surgical Research Society 2017; 23: 125-129 (IGR: 19-1)

74605 Prevalence of eye pathology in a group of diabetic patients at National District Hospital Outpatient Department in Bloemfontein, South Africa
Cairncross JP
African journal of primary health care & family medicine 2017; 9: e1-e7 (IGR: 19-1)

74748 Type 2 diabetes mellitus and risk of open-angle glaucoma development in Koreans: An 11-year nationwide propensity-score-matched study
Jung Y
Diabetes & metabolism 2017; 0: (IGR: 19-1)

74243 The analysis of the change of the constitution of the admitted patients with glaucoma
Liu T
Chinese Journal of Ophthalmology 2017; 53: 610-615 (IGR: 19-1)

74611 Changing epidemiology of neovascular glaucoma from 2002 to 2012 at King Khaled Eye Specialist Hospital, Saudi Arabia
Al-Bahlal A
Indian Journal of Ophthalmology 2017; 65: 969-973 (IGR: 19-1)

74364 Glaucoma and intraocular pressure in EPIC-Norfolk Eye Study: cross sectional study
Chan MPY
BMJ (Clinical research ed.) 2017; 358: j3889 (IGR: 19-1)

74706 Phenotypic Description of the Spanish Multicentre Genetic Glaucoma Group Cohort
Milla E
Journal of Ophthalmology 2017; 2017: 1907454 (IGR: 19-1)

74179 Ocular morbidity patterns among children in schools for the blind in Chennai
Prakash MV
Indian Journal of Ophthalmology 2017; 65: 733-737 (IGR: 19-1)

74497 Pattern of Ocular Morbidity in the Elderly Population of Northern India
Baldev VF
Journal of clinical and diagnostic research : JCDR 2017; 11: NC20-NC23 (IGR: 19-1)

74125 The incidence of acute angle closure in Scotland: a prospective surveillance study
Day AC
British Journal of Ophthalmology 2017; 0: (IGR: 19-1)

74179 Ocular morbidity patterns among children in schools for the blind in Chennai
Sivakumar S
Indian Journal of Ophthalmology 2017; 65: 733-737 (IGR: 19-1)

74605 Prevalence of eye pathology in a group of diabetic patients at National District Hospital Outpatient Department in Bloemfontein, South Africa
Steinberg WJ
African journal of primary health care & family medicine 2017; 9: e1-e7 (IGR: 19-1)

74748 Type 2 diabetes mellitus and risk of open-angle glaucoma development in Koreans: An 11-year nationwide propensity-score-matched study
Han K
Diabetes & metabolism 2017; 0: (IGR: 19-1)

74497 Pattern of Ocular Morbidity in the Elderly Population of Northern India
Chopra R
Journal of clinical and diagnostic research : JCDR 2017; 11: NC20-NC23 (IGR: 19-1)

74593 Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis
Bourne RRA
The Lancet. Global health 2017; 5: e1221-e1234 (IGR: 19-1)

74716 Spectrum of Eye Disorders Seen in a Pediatric Eye Clinic South East Nigeria
Oguego NC
Nigerian journal of surgery : official publication of the Nigerian Surgical Research Society 2017; 23: 125-129 (IGR: 19-1)

74706 Phenotypic Description of the Spanish Multicentre Genetic Glaucoma Group Cohort
Gamundi MJ
Journal of Ophthalmology 2017; 2017: 1907454 (IGR: 19-1)

74611 Changing epidemiology of neovascular glaucoma from 2002 to 2012 at King Khaled Eye Specialist Hospital, Saudi Arabia
Khandekar R
Indian Journal of Ophthalmology 2017; 65: 969-973 (IGR: 19-1)

74243 The analysis of the change of the constitution of the admitted patients with glaucoma
Qiao CY
Chinese Journal of Ophthalmology 2017; 53: 610-615 (IGR: 19-1)

74552 Ural Eye and Medical Study: description of study design and methodology
Fayzrakhmanov RR
Ophthalmic Epidemiology 2017; 0: 1-12 (IGR: 19-1)

74364 Glaucoma and intraocular pressure in EPIC-Norfolk Eye Study: cross sectional study
Broadway DC
BMJ (Clinical research ed.) 2017; 358: j3889 (IGR: 19-1)

74706 Phenotypic Description of the Spanish Multicentre Genetic Glaucoma Group Cohort
Duch S
Journal of Ophthalmology 2017; 2017: 1907454 (IGR: 19-1)

74179 Ocular morbidity patterns among children in schools for the blind in Chennai
Dayal A
Indian Journal of Ophthalmology 2017; 65: 733-737 (IGR: 19-1)

74243 The analysis of the change of the constitution of the admitted patients with glaucoma
Xu XY
Chinese Journal of Ophthalmology 2017; 53: 610-615 (IGR: 19-1)

74552 Ural Eye and Medical Study: description of study design and methodology
Kazakbaeva G
Ophthalmic Epidemiology 2017; 0: 1-12 (IGR: 19-1)

74125 The incidence of acute angle closure in Scotland: a prospective surveillance study
Lai KL
British Journal of Ophthalmology 2017; 0: (IGR: 19-1)

74605 Prevalence of eye pathology in a group of diabetic patients at National District Hospital Outpatient Department in Bloemfontein, South Africa
Labuschagne MJ
African journal of primary health care & family medicine 2017; 9: e1-e7 (IGR: 19-1)

74497 Pattern of Ocular Morbidity in the Elderly Population of Northern India
Batra N
Journal of clinical and diagnostic research : JCDR 2017; 11: NC20-NC23 (IGR: 19-1)

74748 Type 2 diabetes mellitus and risk of open-angle glaucoma development in Koreans: An 11-year nationwide propensity-score-matched study
Park HL
Diabetes & metabolism 2017; 0: (IGR: 19-1)

74716 Spectrum of Eye Disorders Seen in a Pediatric Eye Clinic South East Nigeria
Achigbu K
Nigerian journal of surgery : official publication of the Nigerian Surgical Research Society 2017; 23: 125-129 (IGR: 19-1)

74611 Changing epidemiology of neovascular glaucoma from 2002 to 2012 at King Khaled Eye Specialist Hospital, Saudi Arabia
Al Rubaie K
Indian Journal of Ophthalmology 2017; 65: 969-973 (IGR: 19-1)

74364 Glaucoma and intraocular pressure in EPIC-Norfolk Eye Study: cross sectional study
Khawaja AP
BMJ (Clinical research ed.) 2017; 358: j3889 (IGR: 19-1)

74593 Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis
Resnikoff S
The Lancet. Global health 2017; 5: e1221-e1234 (IGR: 19-1)

74243 The analysis of the change of the constitution of the admitted patients with glaucoma
Li WH
Chinese Journal of Ophthalmology 2017; 53: 610-615 (IGR: 19-1)

74364 Glaucoma and intraocular pressure in EPIC-Norfolk Eye Study: cross sectional study
Yip JLY
BMJ (Clinical research ed.) 2017; 358: j3889 (IGR: 19-1)

74593 Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis
Ackland P
The Lancet. Global health 2017; 5: e1221-e1234 (IGR: 19-1)

74611 Changing epidemiology of neovascular glaucoma from 2002 to 2012 at King Khaled Eye Specialist Hospital, Saudi Arabia
Alzahim T
Indian Journal of Ophthalmology 2017; 65: 969-973 (IGR: 19-1)

74552 Ural Eye and Medical Study: description of study design and methodology
Jonas JB
Ophthalmic Epidemiology 2017; 0: 1-12 (IGR: 19-1)

74179 Ocular morbidity patterns among children in schools for the blind in Chennai
Chitra A
Indian Journal of Ophthalmology 2017; 65: 733-737 (IGR: 19-1)

74497 Pattern of Ocular Morbidity in the Elderly Population of Northern India
Singh S
Journal of clinical and diagnostic research : JCDR 2017; 11: NC20-NC23 (IGR: 19-1)

74748 Type 2 diabetes mellitus and risk of open-angle glaucoma development in Koreans: An 11-year nationwide propensity-score-matched study
Park CK
Diabetes & metabolism 2017; 0: (IGR: 19-1)

74125 The incidence of acute angle closure in Scotland: a prospective surveillance study
Hall N
British Journal of Ophthalmology 2017; 0: (IGR: 19-1)

74706 Phenotypic Description of the Spanish Multicentre Genetic Glaucoma Group Cohort
Rios J
Journal of Ophthalmology 2017; 2017: 1907454 (IGR: 19-1)

74593 Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis
Braithwaite T
The Lancet. Global health 2017; 5: e1221-e1234 (IGR: 19-1)

74706 Phenotypic Description of the Spanish Multicentre Genetic Glaucoma Group Cohort
Carballo M
Journal of Ophthalmology 2017; 2017: 1907454 (IGR: 19-1)

74125 The incidence of acute angle closure in Scotland: a prospective surveillance study
Tan LL
British Journal of Ophthalmology 2017; 0: (IGR: 19-1)

74611 Changing epidemiology of neovascular glaucoma from 2002 to 2012 at King Khaled Eye Specialist Hospital, Saudi Arabia
Edward DP
Indian Journal of Ophthalmology 2017; 65: 969-973 (IGR: 19-1)

74364 Glaucoma and intraocular pressure in EPIC-Norfolk Eye Study: cross sectional study
Garway-Heath DF
BMJ (Clinical research ed.) 2017; 358: j3889 (IGR: 19-1)

74179 Ocular morbidity patterns among children in schools for the blind in Chennai
Subramaniam S
Indian Journal of Ophthalmology 2017; 65: 733-737 (IGR: 19-1)

74611 Changing epidemiology of neovascular glaucoma from 2002 to 2012 at King Khaled Eye Specialist Hospital, Saudi Arabia
Kozak I
Indian Journal of Ophthalmology 2017; 65: 969-973 (IGR: 19-1)

74125 The incidence of acute angle closure in Scotland: a prospective surveillance study
Khan K
British Journal of Ophthalmology 2017; 0: (IGR: 19-1)

74364 Glaucoma and intraocular pressure in EPIC-Norfolk Eye Study: cross sectional study
Burr JM
BMJ (Clinical research ed.) 2017; 358: j3889 (IGR: 19-1)

74593 Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis
Cicinelli MV
The Lancet. Global health 2017; 5: e1221-e1234 (IGR: 19-1)

74706 Phenotypic Description of the Spanish Multicentre Genetic Glaucoma Group Cohort
Study Group E
Journal of Ophthalmology 2017; 2017: 1907454 (IGR: 19-1)

74593 Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis
Das A
The Lancet. Global health 2017; 5: e1221-e1234 (IGR: 19-1)

74364 Glaucoma and intraocular pressure in EPIC-Norfolk Eye Study: cross sectional study
Luben R
BMJ (Clinical research ed.) 2017; 358: j3889 (IGR: 19-1)

74125 The incidence of acute angle closure in Scotland: a prospective surveillance study
Lim LT
British Journal of Ophthalmology 2017; 0: (IGR: 19-1)

74593 Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis
Jonas JB
The Lancet. Global health 2017; 5: e1221-e1234 (IGR: 19-1)

74125 The incidence of acute angle closure in Scotland: a prospective surveillance study
Foot B
British Journal of Ophthalmology 2017; 0: (IGR: 19-1)

74364 Glaucoma and intraocular pressure in EPIC-Norfolk Eye Study: cross sectional study
Hayat S; Dalzell N
BMJ (Clinical research ed.) 2017; 358: j3889 (IGR: 19-1)

74125 The incidence of acute angle closure in Scotland: a prospective surveillance study
Foster PJ
British Journal of Ophthalmology 2017; 0: (IGR: 19-1)

74593 Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis
Keeffe J; Kempen JH
The Lancet. Global health 2017; 5: e1221-e1234 (IGR: 19-1)

74364 Glaucoma and intraocular pressure in EPIC-Norfolk Eye Study: cross sectional study
Khaw KT
BMJ (Clinical research ed.) 2017; 358: j3889 (IGR: 19-1)

74125 The incidence of acute angle closure in Scotland: a prospective surveillance study
Azuara-Blanco A
British Journal of Ophthalmology 2017; 0: (IGR: 19-1)

74364 Glaucoma and intraocular pressure in EPIC-Norfolk Eye Study: cross sectional study
Foster PJ
BMJ (Clinical research ed.) 2017; 358: j3889 (IGR: 19-1)

74593 Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis
Leasher J; Limburg H; Naidoo K; Pesudovs K; Silvester A; Stevens GA; Tahhan N; Wong TY; Taylor HR;
The Lancet. Global health 2017; 5: e1221-e1234 (IGR: 19-1)

72845 The Prevalence of Glaucoma in Young People
Marx-Gross S
Deutsches Ärzteblatt international 2017; 114: 204-210 (IGR: 18-4)

73050 The prevalence of blindness caused by primary angle closure glaucoma in middle-aged Chinese population: a systematic review and meta-analysis
Liu ML
Chinese Journal of Ophthalmology 2017; 53: 373-377 (IGR: 18-4)

72946 Annual incidences of visual impairment during 10-year period in Mie prefecture, Japan
Ikesugi K
Japanese Journal of Ophthalmology 2017; 61: 293-298 (IGR: 18-4)

72915 Glaucoma correlates with increased risk of Parkinson's disease in the elderly: a national-based cohort study in Taiwan
Lai SW; Lin CL
Current Medical Research and Opinion 2017; 33: 1511-1516 (IGR: 18-4)

73050 The prevalence of blindness caused by primary angle closure glaucoma in middle-aged Chinese population: a systematic review and meta-analysis
Wang YX
Chinese Journal of Ophthalmology 2017; 53: 373-377 (IGR: 18-4)

72946 Annual incidences of visual impairment during 10-year period in Mie prefecture, Japan
Ichio T
Japanese Journal of Ophthalmology 2017; 61: 293-298 (IGR: 18-4)

72845 The Prevalence of Glaucoma in Young People
Laubert-Reh D; Schneider A
Deutsches Ärzteblatt international 2017; 114: 204-210 (IGR: 18-4)

72915 Glaucoma correlates with increased risk of Parkinson's disease in the elderly: a national-based cohort study in Taiwan
Liao KF
Current Medical Research and Opinion 2017; 33: 1511-1516 (IGR: 18-4)

72946 Annual incidences of visual impairment during 10-year period in Mie prefecture, Japan
Tsukitome H; Kondo M
Japanese Journal of Ophthalmology 2017; 61: 293-298 (IGR: 18-4)

72845 The Prevalence of Glaucoma in Young People
Höhn R; Mirshahi A; Münzel T; Wild PS; Beutel ME; Blettner M; Pfeiffer N
Deutsches Ärzteblatt international 2017; 114: 204-210 (IGR: 18-4)

71309 Association of Systemic Medication Use With Intraocular Pressure in a Multiethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Ho H
JAMA ophthalmology 2017; 135: 196-202 (IGR: 18-3)

71314 Longitudinal cohort study on the incidence of primary open-angle glaucoma in Bai Chinese
Pan CW
American Journal of Ophthalmology 2017; 176: 127-133 (IGR: 18-3)

71101 Distribution of intraocular pressure, central corneal thickness and vertical cup-to-disc ratio in a healthy Iranian population: the Yazd Eye Study
Pakravan M
Acta Ophthalmologica 2017; 95: e144-e151 (IGR: 18-3)

71309 Association of Systemic Medication Use With Intraocular Pressure in a Multiethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Shi Y
JAMA ophthalmology 2017; 135: 196-202 (IGR: 18-3)

71314 Longitudinal cohort study on the incidence of primary open-angle glaucoma in Bai Chinese
Yang WY
American Journal of Ophthalmology 2017; 176: 127-133 (IGR: 18-3)

71101 Distribution of intraocular pressure, central corneal thickness and vertical cup-to-disc ratio in a healthy Iranian population: the Yazd Eye Study
Javadi MA
Acta Ophthalmologica 2017; 95: e144-e151 (IGR: 18-3)

71314 Longitudinal cohort study on the incidence of primary open-angle glaucoma in Bai Chinese
Hu DN
American Journal of Ophthalmology 2017; 176: 127-133 (IGR: 18-3)

71309 Association of Systemic Medication Use With Intraocular Pressure in a Multiethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Chua J
JAMA ophthalmology 2017; 135: 196-202 (IGR: 18-3)

71101 Distribution of intraocular pressure, central corneal thickness and vertical cup-to-disc ratio in a healthy Iranian population: the Yazd Eye Study
Yazdani S; Ghahari E
Acta Ophthalmologica 2017; 95: e144-e151 (IGR: 18-3)

71309 Association of Systemic Medication Use With Intraocular Pressure in a Multiethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Tham YC
JAMA ophthalmology 2017; 135: 196-202 (IGR: 18-3)

71314 Longitudinal cohort study on the incidence of primary open-angle glaucoma in Bai Chinese
Xu JG
American Journal of Ophthalmology 2017; 176: 127-133 (IGR: 18-3)

71101 Distribution of intraocular pressure, central corneal thickness and vertical cup-to-disc ratio in a healthy Iranian population: the Yazd Eye Study
Behroozi Z
Acta Ophthalmologica 2017; 95: e144-e151 (IGR: 18-3)

71314 Longitudinal cohort study on the incidence of primary open-angle glaucoma in Bai Chinese
Niu ZQ
American Journal of Ophthalmology 2017; 176: 127-133 (IGR: 18-3)

71309 Association of Systemic Medication Use With Intraocular Pressure in a Multiethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Lim SH
JAMA ophthalmology 2017; 135: 196-202 (IGR: 18-3)

71101 Distribution of intraocular pressure, central corneal thickness and vertical cup-to-disc ratio in a healthy Iranian population: the Yazd Eye Study
Soleimanizad R
Acta Ophthalmologica 2017; 95: e144-e151 (IGR: 18-3)

71314 Longitudinal cohort study on the incidence of primary open-angle glaucoma in Bai Chinese
Yuan YS
American Journal of Ophthalmology 2017; 176: 127-133 (IGR: 18-3)

71309 Association of Systemic Medication Use With Intraocular Pressure in a Multiethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Aung T
JAMA ophthalmology 2017; 135: 196-202 (IGR: 18-3)

71101 Distribution of intraocular pressure, central corneal thickness and vertical cup-to-disc ratio in a healthy Iranian population: the Yazd Eye Study
Moghimi S
Acta Ophthalmologica 2017; 95: e144-e151 (IGR: 18-3)

71309 Association of Systemic Medication Use With Intraocular Pressure in a Multiethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Wong TY
JAMA ophthalmology 2017; 135: 196-202 (IGR: 18-3)

71314 Longitudinal cohort study on the incidence of primary open-angle glaucoma in Bai Chinese
Yu MB
American Journal of Ophthalmology 2017; 176: 127-133 (IGR: 18-3)

71309 Association of Systemic Medication Use With Intraocular Pressure in a Multiethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Cheng CY
JAMA ophthalmology 2017; 135: 196-202 (IGR: 18-3)

71101 Distribution of intraocular pressure, central corneal thickness and vertical cup-to-disc ratio in a healthy Iranian population: the Yazd Eye Study
Nilforoushan N
Acta Ophthalmologica 2017; 95: e144-e151 (IGR: 18-3)

71314 Longitudinal cohort study on the incidence of primary open-angle glaucoma in Bai Chinese
Zhong H
American Journal of Ophthalmology 2017; 176: 127-133 (IGR: 18-3)

71101 Distribution of intraocular pressure, central corneal thickness and vertical cup-to-disc ratio in a healthy Iranian population: the Yazd Eye Study
Zarei R; Eslami Y; Ghassami M; Ziaei H; Katibeh M; Tabesh H; Yaseri M
Acta Ophthalmologica 2017; 95: e144-e151 (IGR: 18-3)

70181 Estimated Cerebrospina Fluid Pressure and the 5-Year Incidence of Primary Open-Angle Glaucoma in a Chinese Population
Li L
PLoS ONE 2016; 11: e0162862 (IGR: 18-2)

70394 Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 - 2010: A Meta-Analysis
Bourne RR
PLoS ONE 2016; 11: e0162229 (IGR: 18-2)

70449 Prevalence, types and awareness of glaucoma in a multi-ethnic population in rural China: the Yunnan Minority Eye Study
Pan CW
Ophthalmic and Physiological Optics 2016; 36: 664-670 (IGR: 18-2)

70548 Major review: Exfoliation syndrome; advances in disease genetics, molecular biology, and epidemiology
Aboobakar IF
Experimental Eye Research 2016; 154: 88-103 (IGR: 18-2)

70321 Trends in Prevalence of Diagnosed Ocular Disease and Utilization of Eye Care Services in American Veterans
Saeedi O
American Journal of Ophthalmology 2017; 173: 70-75 (IGR: 18-2)

69881 Glaucoma-a common disease
Oberacher-Velten I
Ophthalmologe 2016; 113: 746-751 (IGR: 18-2)

70185 Associations with intraocular pressure across Europe: The European Eye Epidemiology (E(3)) Consortium
Khawaja AP
European Journal of Epidemiology 2016; 31: 1101-1111 (IGR: 18-2)

70755 Myopia in China: a population-based cross-sectional, histological, and experimental study
Jonas JB
Lancet 2016; 388: S20 (IGR: 18-2)

70367 Incidence and causes of visual impairment in the district of Mahdia, in east Tunisia: Retrospective study of 1487 cases
Ammari W
Journal Fran�ais d'Ophtalmologie 2016; 39: 771-779 (IGR: 18-2)

70919 Prevalence of pseudoexfoliation syndrome and its association with ocular and systemic diseases in Eskisehir, Turkey
Yildirim N
International Journal of Ophthalmology 2017; 10: 128-134 (IGR: 18-2)

70757 Common eye diseases in older adults of southern Germany: results from the KORA-Age study
Reitmeir P
Age and ageing 2016; 0: (IGR: 18-2)

69902 Association of Vision Impairment and Major Eye Diseases With Mobility and Independence in a Chinese Population
Fenwick EK
JAMA ophthalmology 2016; 134: 1087-1093 (IGR: 18-2)

70548 Major review: Exfoliation syndrome; advances in disease genetics, molecular biology, and epidemiology
Johnson WM
Experimental Eye Research 2016; 154: 88-103 (IGR: 18-2)

70919 Prevalence of pseudoexfoliation syndrome and its association with ocular and systemic diseases in Eskisehir, Turkey
Yasar E
International Journal of Ophthalmology 2017; 10: 128-134 (IGR: 18-2)

70394 Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 - 2010: A Meta-Analysis
Taylor HR
PLoS ONE 2016; 11: e0162229 (IGR: 18-2)

70185 Associations with intraocular pressure across Europe: The European Eye Epidemiology (E(3)) Consortium
Springelkamp H
European Journal of Epidemiology 2016; 31: 1101-1111 (IGR: 18-2)

70367 Incidence and causes of visual impairment in the district of Mahdia, in east Tunisia: Retrospective study of 1487 cases
Harrath S
Journal Fran�ais d'Ophtalmologie 2016; 39: 771-779 (IGR: 18-2)

70449 Prevalence, types and awareness of glaucoma in a multi-ethnic population in rural China: the Yunnan Minority Eye Study
Zhao CH
Ophthalmic and Physiological Optics 2016; 36: 664-670 (IGR: 18-2)

70755 Myopia in China: a population-based cross-sectional, histological, and experimental study
Xu L
Lancet 2016; 388: S20 (IGR: 18-2)

70757 Common eye diseases in older adults of southern Germany: results from the KORA-Age study
Linkohr B
Age and ageing 2016; 0: (IGR: 18-2)

70321 Trends in Prevalence of Diagnosed Ocular Disease and Utilization of Eye Care Services in American Veterans
Ashraf H
American Journal of Ophthalmology 2017; 173: 70-75 (IGR: 18-2)

69902 Association of Vision Impairment and Major Eye Diseases With Mobility and Independence in a Chinese Population
Ong PG
JAMA ophthalmology 2016; 134: 1087-1093 (IGR: 18-2)

69881 Glaucoma-a common disease
Hoffmann E
Ophthalmologe 2016; 113: 746-751 (IGR: 18-2)

70181 Estimated Cerebrospina Fluid Pressure and the 5-Year Incidence of Primary Open-Angle Glaucoma in a Chinese Population
Li C
PLoS ONE 2016; 11: e0162862 (IGR: 18-2)

70757 Common eye diseases in older adults of southern Germany: results from the KORA-Age study
Heier M
Age and ageing 2016; 0: (IGR: 18-2)

70394 Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 - 2010: A Meta-Analysis
Flaxman SR
PLoS ONE 2016; 11: e0162229 (IGR: 18-2)

70919 Prevalence of pseudoexfoliation syndrome and its association with ocular and systemic diseases in Eskisehir, Turkey
Gursoy H
International Journal of Ophthalmology 2017; 10: 128-134 (IGR: 18-2)

70181 Estimated Cerebrospina Fluid Pressure and the 5-Year Incidence of Primary Open-Angle Glaucoma in a Chinese Population
Zhong H
PLoS ONE 2016; 11: e0162862 (IGR: 18-2)

70185 Associations with intraocular pressure across Europe: The European Eye Epidemiology (E(3)) Consortium
Creuzot-Garcher C
European Journal of Epidemiology 2016; 31: 1101-1111 (IGR: 18-2)

69902 Association of Vision Impairment and Major Eye Diseases With Mobility and Independence in a Chinese Population
Man RE
JAMA ophthalmology 2016; 134: 1087-1093 (IGR: 18-2)

70321 Trends in Prevalence of Diagnosed Ocular Disease and Utilization of Eye Care Services in American Veterans
Slade EP
American Journal of Ophthalmology 2017; 173: 70-75 (IGR: 18-2)

70548 Major review: Exfoliation syndrome; advances in disease genetics, molecular biology, and epidemiology
Stamer WD
Experimental Eye Research 2016; 154: 88-103 (IGR: 18-2)

70755 Myopia in China: a population-based cross-sectional, histological, and experimental study
Wei WB
Lancet 2016; 388: S20 (IGR: 18-2)

69881 Glaucoma-a common disease
Helbig H
Ophthalmologe 2016; 113: 746-751 (IGR: 18-2)

70367 Incidence and causes of visual impairment in the district of Mahdia, in east Tunisia: Retrospective study of 1487 cases
Mbarek S
Journal Fran�ais d'Ophtalmologie 2016; 39: 771-779 (IGR: 18-2)

70449 Prevalence, types and awareness of glaucoma in a multi-ethnic population in rural China: the Yunnan Minority Eye Study
Yu MB
Ophthalmic and Physiological Optics 2016; 36: 664-670 (IGR: 18-2)

70367 Incidence and causes of visual impairment in the district of Mahdia, in east Tunisia: Retrospective study of 1487 cases
Mahmoud A
Journal Fran�ais d'Ophtalmologie 2016; 39: 771-779 (IGR: 18-2)

70181 Estimated Cerebrospina Fluid Pressure and the 5-Year Incidence of Primary Open-Angle Glaucoma in a Chinese Population
Tao Y
PLoS ONE 2016; 11: e0162862 (IGR: 18-2)

70757 Common eye diseases in older adults of southern Germany: results from the KORA-Age study
Molnos S
Age and ageing 2016; 0: (IGR: 18-2)

70919 Prevalence of pseudoexfoliation syndrome and its association with ocular and systemic diseases in Eskisehir, Turkey
Colak E
International Journal of Ophthalmology 2017; 10: 128-134 (IGR: 18-2)

70449 Prevalence, types and awareness of glaucoma in a multi-ethnic population in rural China: the Yunnan Minority Eye Study
Cun Q
Ophthalmic and Physiological Optics 2016; 36: 664-670 (IGR: 18-2)

70321 Trends in Prevalence of Diagnosed Ocular Disease and Utilization of Eye Care Services in American Veterans
Medoff DR
American Journal of Ophthalmology 2017; 173: 70-75 (IGR: 18-2)

69902 Association of Vision Impairment and Major Eye Diseases With Mobility and Independence in a Chinese Population
Cheng CY
JAMA ophthalmology 2016; 134: 1087-1093 (IGR: 18-2)

70185 Associations with intraocular pressure across Europe: The European Eye Epidemiology (E(3)) Consortium
Delcourt C
European Journal of Epidemiology 2016; 31: 1101-1111 (IGR: 18-2)

70548 Major review: Exfoliation syndrome; advances in disease genetics, molecular biology, and epidemiology
Hauser MA
Experimental Eye Research 2016; 154: 88-103 (IGR: 18-2)

70755 Myopia in China: a population-based cross-sectional, histological, and experimental study
Wang YX
Lancet 2016; 388: S20 (IGR: 18-2)

70394 Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 - 2010: A Meta-Analysis
Keeffe J
PLoS ONE 2016; 11: e0162229 (IGR: 18-2)

70755 Myopia in China: a population-based cross-sectional, histological, and experimental study
Jiang WJ
Lancet 2016; 388: S20 (IGR: 18-2)

70548 Major review: Exfoliation syndrome; advances in disease genetics, molecular biology, and epidemiology
Allingham RR
Experimental Eye Research 2016; 154: 88-103 (IGR: 18-2)

70321 Trends in Prevalence of Diagnosed Ocular Disease and Utilization of Eye Care Services in American Veterans
Li L
American Journal of Ophthalmology 2017; 173: 70-75 (IGR: 18-2)

69902 Association of Vision Impairment and Major Eye Diseases With Mobility and Independence in a Chinese Population
Sabanayagam C
JAMA ophthalmology 2016; 134: 1087-1093 (IGR: 18-2)

70449 Prevalence, types and awareness of glaucoma in a multi-ethnic population in rural China: the Yunnan Minority Eye Study
Chen Q
Ophthalmic and Physiological Optics 2016; 36: 664-670 (IGR: 18-2)

70757 Common eye diseases in older adults of southern Germany: results from the KORA-Age study
Strobl R
Age and ageing 2016; 0: (IGR: 18-2)

70367 Incidence and causes of visual impairment in the district of Mahdia, in east Tunisia: Retrospective study of 1487 cases
Chebbi W
Journal Fran�ais d'Ophtalmologie 2016; 39: 771-779 (IGR: 18-2)

70181 Estimated Cerebrospina Fluid Pressure and the 5-Year Incidence of Primary Open-Angle Glaucoma in a Chinese Population
Yuan Y
PLoS ONE 2016; 11: e0162862 (IGR: 18-2)

70185 Associations with intraocular pressure across Europe: The European Eye Epidemiology (E(3)) Consortium
Hofman A
European Journal of Epidemiology 2016; 31: 1101-1111 (IGR: 18-2)

70394 Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 - 2010: A Meta-Analysis
Leasher J
PLoS ONE 2016; 11: e0162229 (IGR: 18-2)

70185 Associations with intraocular pressure across Europe: The European Eye Epidemiology (E(3)) Consortium
Höhn R
European Journal of Epidemiology 2016; 31: 1101-1111 (IGR: 18-2)

69902 Association of Vision Impairment and Major Eye Diseases With Mobility and Independence in a Chinese Population
Wong TY
JAMA ophthalmology 2016; 134: 1087-1093 (IGR: 18-2)

70755 Myopia in China: a population-based cross-sectional, histological, and experimental study
Bi HS
Lancet 2016; 388: S20 (IGR: 18-2)

70367 Incidence and causes of visual impairment in the district of Mahdia, in east Tunisia: Retrospective study of 1487 cases
Messaoud R
Journal Fran�ais d'Ophtalmologie 2016; 39: 771-779 (IGR: 18-2)

70394 Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 - 2010: A Meta-Analysis
Naidoo K
PLoS ONE 2016; 11: e0162229 (IGR: 18-2)

70449 Prevalence, types and awareness of glaucoma in a multi-ethnic population in rural China: the Yunnan Minority Eye Study
Shen W
Ophthalmic and Physiological Optics 2016; 36: 664-670 (IGR: 18-2)

70757 Common eye diseases in older adults of southern Germany: results from the KORA-Age study
Schulz H
Age and ageing 2016; 0: (IGR: 18-2)

70181 Estimated Cerebrospina Fluid Pressure and the 5-Year Incidence of Primary Open-Angle Glaucoma in a Chinese Population
Pan CW
PLoS ONE 2016; 11: e0162862 (IGR: 18-2)

70321 Trends in Prevalence of Diagnosed Ocular Disease and Utilization of Eye Care Services in American Veterans
Friedman DS; Kreyenbuhl J
American Journal of Ophthalmology 2017; 173: 70-75 (IGR: 18-2)

70185 Associations with intraocular pressure across Europe: The European Eye Epidemiology (E(3)) Consortium
Iglesias AI
European Journal of Epidemiology 2016; 31: 1101-1111 (IGR: 18-2)

70755 Myopia in China: a population-based cross-sectional, histological, and experimental study
Panda-Jonas S
Lancet 2016; 388: S20 (IGR: 18-2)

70367 Incidence and causes of visual impairment in the district of Mahdia, in east Tunisia: Retrospective study of 1487 cases
Khairallah M
Journal Fran�ais d'Ophtalmologie 2016; 39: 771-779 (IGR: 18-2)

70757 Common eye diseases in older adults of southern Germany: results from the KORA-Age study
Breier M
Age and ageing 2016; 0: (IGR: 18-2)

69902 Association of Vision Impairment and Major Eye Diseases With Mobility and Independence in a Chinese Population
Lamoureux EL
JAMA ophthalmology 2016; 134: 1087-1093 (IGR: 18-2)

70394 Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 - 2010: A Meta-Analysis
Pesudovs K
PLoS ONE 2016; 11: e0162229 (IGR: 18-2)

70449 Prevalence, types and awareness of glaucoma in a multi-ethnic population in rural China: the Yunnan Minority Eye Study
Li J; Xu JG
Ophthalmic and Physiological Optics 2016; 36: 664-670 (IGR: 18-2)

70394 Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 - 2010: A Meta-Analysis
White RA
PLoS ONE 2016; 11: e0162229 (IGR: 18-2)

70185 Associations with intraocular pressure across Europe: The European Eye Epidemiology (E(3)) Consortium
Wolfs RC
European Journal of Epidemiology 2016; 31: 1101-1111 (IGR: 18-2)

70757 Common eye diseases in older adults of southern Germany: results from the KORA-Age study
Faus T
Age and ageing 2016; 0: (IGR: 18-2)

70449 Prevalence, types and awareness of glaucoma in a multi-ethnic population in rural China: the Yunnan Minority Eye Study
Yuan Y
Ophthalmic and Physiological Optics 2016; 36: 664-670 (IGR: 18-2)

70394 Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 - 2010: A Meta-Analysis
Wong TY
PLoS ONE 2016; 11: e0162229 (IGR: 18-2)

70185 Associations with intraocular pressure across Europe: The European Eye Epidemiology (E(3)) Consortium
Korobelnik JF
European Journal of Epidemiology 2016; 31: 1101-1111 (IGR: 18-2)

70757 Common eye diseases in older adults of southern Germany: results from the KORA-Age study
Küster DM; Wulff A
Age and ageing 2016; 0: (IGR: 18-2)

70449 Prevalence, types and awareness of glaucoma in a multi-ethnic population in rural China: the Yunnan Minority Eye Study
Zhong H
Ophthalmic and Physiological Optics 2016; 36: 664-670 (IGR: 18-2)

70185 Associations with intraocular pressure across Europe: The European Eye Epidemiology (E(3)) Consortium
Silva R
European Journal of Epidemiology 2016; 31: 1101-1111 (IGR: 18-2)

70394 Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 - 2010: A Meta-Analysis
Resnikoff S
PLoS ONE 2016; 11: e0162229 (IGR: 18-2)

70185 Associations with intraocular pressure across Europe: The European Eye Epidemiology (E(3)) Consortium
Topouzis F
European Journal of Epidemiology 2016; 31: 1101-1111 (IGR: 18-2)

70757 Common eye diseases in older adults of southern Germany: results from the KORA-Age study
Grallert H
Age and ageing 2016; 0: (IGR: 18-2)

70394 Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 - 2010: A Meta-Analysis
Jonas JB
PLoS ONE 2016; 11: e0162229 (IGR: 18-2)

70757 Common eye diseases in older adults of southern Germany: results from the KORA-Age study
Grill E
Age and ageing 2016; 0: (IGR: 18-2)

70394 Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 - 2010: A Meta-Analysis

PLoS ONE 2016; 11: e0162229 (IGR: 18-2)

70185 Associations with intraocular pressure across Europe: The European Eye Epidemiology (E(3)) Consortium
Williams KM
European Journal of Epidemiology 2016; 31: 1101-1111 (IGR: 18-2)

70757 Common eye diseases in older adults of southern Germany: results from the KORA-Age study
Peters A
Age and ageing 2016; 0: (IGR: 18-2)

70185 Associations with intraocular pressure across Europe: The European Eye Epidemiology (E(3)) Consortium
Bron AM
European Journal of Epidemiology 2016; 31: 1101-1111 (IGR: 18-2)

70757 Common eye diseases in older adults of southern Germany: results from the KORA-Age study
Graw J
Age and ageing 2016; 0: (IGR: 18-2)

70185 Associations with intraocular pressure across Europe: The European Eye Epidemiology (E(3)) Consortium
Buitendijk GH; Cachulo MD; Cougnard-Grégoire A; Dartigues JF; Hammond CJ; Pfeiffer N,
European Journal of Epidemiology 2016; 31: 1101-1111 (IGR: 18-2)

69199 The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications
Hemminki K
Scientific reports 2016; 6: 28500 (IGR: 18-1)

69061 Estimated Prevalence of Glaucoma in South Korea Using the National Claims Database
Seo SJ
Journal of Ophthalmology 2016; 2016: 1690256 (IGR: 18-1)

69371 Epidemiologic characteristics of 10 years hospitalized patients with glaucoma at shanghai eye and ear, nose, and throat hospital
Zheng Y
Medicine 2016; 95: e4254 (IGR: 18-1)

69087 Association of three single nucleotide polymorphisms at the SIX1-SIX6 locus with primary open angle glaucoma in the Chinese population
Sang J
Science China Life Sciences 2016; 59: 694-699 (IGR: 18-1)

68900 Changes in Visual Function in the Elderly Population in the United States: 1995-2010
Chen Y
Ophthalmic Epidemiology 2016; 23: 137-144 (IGR: 18-1)

69013 Association of primary open-angle glaucoma with mitochondrial variants and haplogroups common in African Americans
Collins DW
Molecular Vision 2016; 22: 454-471 (IGR: 18-1)

69093 Risk factors for open-angle glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey
Kyari F
BMC Ophthalmology 2016; 16: 78 (IGR: 18-1)

69498 Prevalence of glaucoma in Eastern India: The Hooghly River Glaucoma Study
Paul C
Indian Journal of Ophthalmology 2016; 64: 578-583 (IGR: 18-1)

69092 The association between intraocular pressure and different combination of metabolic syndrome components
Son J
BMC Ophthalmology 2016; 16: 76 (IGR: 18-1)

68899 Prevalence of Pseudoexfoliation Syndrome and Associated Factors in South Koreans: The Korean National Health and Nutrition Examination Survey
Kim S
Ophthalmic Epidemiology 2016; 23: 298-302 (IGR: 18-1)

69211 Undiagnosed Primary Open-Angle Glaucoma in Korea: The Korean National Health and Nutrition Examination Survey 2008-2009
Kim NR
Ophthalmic Epidemiology 2016; 23: 238-247 (IGR: 18-1)

69064 The Prevalence of Open-Angle Glaucoma by Age in Myopia: The Korea National Health and Nutrition Examination Survey
Shim SH
Current Eye Research 2016; 0: 1-7 (IGR: 18-1)

68973 Geographical variation in glaucoma prescribing trends in England 2008-2012: an observational ecological study
Heng JS
BMJ open 2016; 6: e010429 (IGR: 18-1)

69013 Association of primary open-angle glaucoma with mitochondrial variants and haplogroups common in African Americans
Gudiseva HV
Molecular Vision 2016; 22: 454-471 (IGR: 18-1)

69211 Undiagnosed Primary Open-Angle Glaucoma in Korea: The Korean National Health and Nutrition Examination Survey 2008-2009
Chin HS
Ophthalmic Epidemiology 2016; 23: 238-247 (IGR: 18-1)

69064 The Prevalence of Open-Angle Glaucoma by Age in Myopia: The Korea National Health and Nutrition Examination Survey
Sung KR
Current Eye Research 2016; 0: 1-7 (IGR: 18-1)

69092 The association between intraocular pressure and different combination of metabolic syndrome components
Koh H
BMC Ophthalmology 2016; 16: 76 (IGR: 18-1)

68973 Geographical variation in glaucoma prescribing trends in England 2008-2012: an observational ecological study
Wormald R
BMJ open 2016; 6: e010429 (IGR: 18-1)

68899 Prevalence of Pseudoexfoliation Syndrome and Associated Factors in South Koreans: The Korean National Health and Nutrition Examination Survey
Lim SH
Ophthalmic Epidemiology 2016; 23: 298-302 (IGR: 18-1)

69199 The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications
FÃ¶rsti A
Scientific reports 2016; 6: 28500 (IGR: 18-1)

68900 Changes in Visual Function in the Elderly Population in the United States: 1995-2010
Hahn P
Ophthalmic Epidemiology 2016; 23: 137-144 (IGR: 18-1)

69093 Risk factors for open-angle glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey
Abdull MM
BMC Ophthalmology 2016; 16: 78 (IGR: 18-1)

69061 Estimated Prevalence of Glaucoma in South Korea Using the National Claims Database
Lee YH
Journal of Ophthalmology 2016; 2016: 1690256 (IGR: 18-1)

69087 Association of three single nucleotide polymorphisms at the SIX1-SIX6 locus with primary open angle glaucoma in the Chinese population
Jia L
Science China Life Sciences 2016; 59: 694-699 (IGR: 18-1)

69498 Prevalence of glaucoma in Eastern India: The Hooghly River Glaucoma Study
Sengupta S
Indian Journal of Ophthalmology 2016; 64: 578-583 (IGR: 18-1)

69371 Epidemiologic characteristics of 10 years hospitalized patients with glaucoma at shanghai eye and ear, nose, and throat hospital
Zhang Y
Medicine 2016; 95: e4254 (IGR: 18-1)

69013 Association of primary open-angle glaucoma with mitochondrial variants and haplogroups common in African Americans
Trachtman B
Molecular Vision 2016; 22: 454-471 (IGR: 18-1)

68973 Geographical variation in glaucoma prescribing trends in England 2008-2012: an observational ecological study
Khaw PT
BMJ open 2016; 6: e010429 (IGR: 18-1)

69498 Prevalence of glaucoma in Eastern India: The Hooghly River Glaucoma Study
Choudhury S
Indian Journal of Ophthalmology 2016; 64: 578-583 (IGR: 18-1)

68899 Prevalence of Pseudoexfoliation Syndrome and Associated Factors in South Koreans: The Korean National Health and Nutrition Examination Survey
Sung KR
Ophthalmic Epidemiology 2016; 23: 298-302 (IGR: 18-1)

69211 Undiagnosed Primary Open-Angle Glaucoma in Korea: The Korean National Health and Nutrition Examination Survey 2008-2009
Seong GJ
Ophthalmic Epidemiology 2016; 23: 238-247 (IGR: 18-1)

69371 Epidemiologic characteristics of 10 years hospitalized patients with glaucoma at shanghai eye and ear, nose, and throat hospital
Sun X
Medicine 2016; 95: e4254 (IGR: 18-1)

69061 Estimated Prevalence of Glaucoma in South Korea Using the National Claims Database
Lee SY
Journal of Ophthalmology 2016; 2016: 1690256 (IGR: 18-1)

69064 The Prevalence of Open-Angle Glaucoma by Age in Myopia: The Korea National Health and Nutrition Examination Survey
Kim JM
Current Eye Research 2016; 0: 1-7 (IGR: 18-1)

69093 Risk factors for open-angle glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey
Wormald R
BMC Ophthalmology 2016; 16: 78 (IGR: 18-1)

69199 The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications
Tuuminen R
Scientific reports 2016; 6: 28500 (IGR: 18-1)

69087 Association of three single nucleotide polymorphisms at the SIX1-SIX6 locus with primary open angle glaucoma in the Chinese population
Zhao B
Science China Life Sciences 2016; 59: 694-699 (IGR: 18-1)

68900 Changes in Visual Function in the Elderly Population in the United States: 1995-2010
Sloan FA
Ophthalmic Epidemiology 2016; 23: 137-144 (IGR: 18-1)

69013 Association of primary open-angle glaucoma with mitochondrial variants and haplogroups common in African Americans
Bowman AS
Molecular Vision 2016; 22: 454-471 (IGR: 18-1)

69498 Prevalence of glaucoma in Eastern India: The Hooghly River Glaucoma Study
Banerjee S
Indian Journal of Ophthalmology 2016; 64: 578-583 (IGR: 18-1)

69211 Undiagnosed Primary Open-Angle Glaucoma in Korea: The Korean National Health and Nutrition Examination Survey 2008-2009
Kim CY
Ophthalmic Epidemiology 2016; 23: 238-247 (IGR: 18-1)

69061 Estimated Prevalence of Glaucoma in South Korea Using the National Claims Database
Bae HW
Journal of Ophthalmology 2016; 2016: 1690256 (IGR: 18-1)

69087 Association of three single nucleotide polymorphisms at the SIX1-SIX6 locus with primary open angle glaucoma in the Chinese population
Wang H
Science China Life Sciences 2016; 59: 694-699 (IGR: 18-1)

69064 The Prevalence of Open-Angle Glaucoma by Age in Myopia: The Korea National Health and Nutrition Examination Survey
Kim HT
Current Eye Research 2016; 0: 1-7 (IGR: 18-1)

69199 The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications
Hemminki O
Scientific reports 2016; 6: 28500 (IGR: 18-1)

68899 Prevalence of Pseudoexfoliation Syndrome and Associated Factors in South Koreans: The Korean National Health and Nutrition Examination Survey
Yun SC
Ophthalmic Epidemiology 2016; 23: 298-302 (IGR: 18-1)

69093 Risk factors for open-angle glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey
Evans JR
BMC Ophthalmology 2016; 16: 78 (IGR: 18-1)

69498 Prevalence of glaucoma in Eastern India: The Hooghly River Glaucoma Study
Sleath BL
Indian Journal of Ophthalmology 2016; 64: 578-583 (IGR: 18-1)

69064 The Prevalence of Open-Angle Glaucoma by Age in Myopia: The Korea National Health and Nutrition Examination Survey
Jeong J
Current Eye Research 2016; 0: 1-7 (IGR: 18-1)

69087 Association of three single nucleotide polymorphisms at the SIX1-SIX6 locus with primary open angle glaucoma in the Chinese population
Zhang N
Science China Life Sciences 2016; 59: 694-699 (IGR: 18-1)

69093 Risk factors for open-angle glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey
Nolan W
BMC Ophthalmology 2016; 16: 78 (IGR: 18-1)

69199 The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications
Goldschmidt H
Scientific reports 2016; 6: 28500 (IGR: 18-1)

69211 Undiagnosed Primary Open-Angle Glaucoma in Korea: The Korean National Health and Nutrition Examination Survey 2008-2009

Ophthalmic Epidemiology 2016; 23: 238-247 (IGR: 18-1)

69061 Estimated Prevalence of Glaucoma in South Korea Using the National Claims Database
Hong S
Journal of Ophthalmology 2016; 2016: 1690256 (IGR: 18-1)

69013 Association of primary open-angle glaucoma with mitochondrial variants and haplogroups common in African Americans
Sagaser A
Molecular Vision 2016; 22: 454-471 (IGR: 18-1)

68899 Prevalence of Pseudoexfoliation Syndrome and Associated Factors in South Koreans: The Korean National Health and Nutrition Examination Survey
Kim CY
Ophthalmic Epidemiology 2016; 23: 298-302 (IGR: 18-1)

69093 Risk factors for open-angle glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey
Murthy GV
BMC Ophthalmology 2016; 16: 78 (IGR: 18-1)

69199 The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications
Sundquist K
Scientific reports 2016; 6: 28500 (IGR: 18-1)

69061 Estimated Prevalence of Glaucoma in South Korea Using the National Claims Database
Seong GJ
Journal of Ophthalmology 2016; 2016: 1690256 (IGR: 18-1)

68899 Prevalence of Pseudoexfoliation Syndrome and Associated Factors in South Koreans: The Korean National Health and Nutrition Examination Survey
Park KH
Ophthalmic Epidemiology 2016; 23: 298-302 (IGR: 18-1)

69013 Association of primary open-angle glaucoma with mitochondrial variants and haplogroups common in African Americans
Sankar P
Molecular Vision 2016; 22: 454-471 (IGR: 18-1)

69064 The Prevalence of Open-Angle Glaucoma by Age in Myopia: The Korea National Health and Nutrition Examination Survey
Kim CY
Current Eye Research 2016; 0: 1-7 (IGR: 18-1)

69087 Association of three single nucleotide polymorphisms at the SIX1-SIX6 locus with primary open angle glaucoma in the Chinese population
Wang N
Science China Life Sciences 2016; 59: 694-699 (IGR: 18-1)

68899 Prevalence of Pseudoexfoliation Syndrome and Associated Factors in South Koreans: The Korean National Health and Nutrition Examination Survey
Cha SC
Ophthalmic Epidemiology 2016; 23: 298-302 (IGR: 18-1)

69199 The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications
Sundquist J
Scientific reports 2016; 6: 28500 (IGR: 18-1)

69093 Risk factors for open-angle glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey
Gilbert CE
BMC Ophthalmology 2016; 16: 78 (IGR: 18-1)

69013 Association of primary open-angle glaucoma with mitochondrial variants and haplogroups common in African Americans
Miller-Ellis E
Molecular Vision 2016; 22: 454-471 (IGR: 18-1)

69064 The Prevalence of Open-Angle Glaucoma by Age in Myopia: The Korea National Health and Nutrition Examination Survey
Lee MY
Current Eye Research 2016; 0: 1-7 (IGR: 18-1)

69061 Estimated Prevalence of Glaucoma in South Korea Using the National Claims Database
Kim CY
Journal of Ophthalmology 2016; 2016: 1690256 (IGR: 18-1)

69093 Risk factors for open-angle glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey

BMC Ophthalmology 2016; 16: 78 (IGR: 18-1)

69064 The Prevalence of Open-Angle Glaucoma by Age in Myopia: The Korea National Health and Nutrition Examination Survey
Park KH
Current Eye Research 2016; 0: 1-7 (IGR: 18-1)

69199 The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications
Li X
Scientific reports 2016; 6: 28500 (IGR: 18-1)

69013 Association of primary open-angle glaucoma with mitochondrial variants and haplogroups common in African Americans
Lehman A
Molecular Vision 2016; 22: 454-471 (IGR: 18-1)

69064 The Prevalence of Open-Angle Glaucoma by Age in Myopia: The Korea National Health and Nutrition Examination Survey

Current Eye Research 2016; 0: 1-7 (IGR: 18-1)

69013 Association of primary open-angle glaucoma with mitochondrial variants and haplogroups common in African Americans
Addis V; O'Brien JM
Molecular Vision 2016; 22: 454-471 (IGR: 18-1)

67108 Prevalence of glaucoma in patients with vitiligo
Dertlioğlu SB
Cutis 2016; 97: E21-5 (IGR: 17-4)

67610 The Prevalence and the Incidence of Diagnosed Open-Angle Glaucoma and Diagnosed Angle-Closure Glaucoma: Changes From 2001 to 2010
Chiu SL
Journal of Glaucoma 2016; 25: e514-e519 (IGR: 17-4)

67444 Prevalence of Glaucoma in the United States: The 2005-2008 National Health and Nutrition Examination Survey
Gupta P
Investigative Ophthalmology and Visual Science 2016; 57: 2577-2585 (IGR: 17-4)

66646 Epidemiologic Aspects of Medical Retirement from the Republic of Korea Army due to Visual Impairment
Jeong JH
J Korean Med Sci 2016; 31: 623-629 (IGR: 17-4)

66650 A retrospective survey of childhood glaucoma prevalence according to Childhood Glaucoma Research Network classification
Hoguet A
Indian Journal of Ophthalmology 2016; 64: 118-123 (IGR: 17-4)

66646 Epidemiologic Aspects of Medical Retirement from the Republic of Korea Army due to Visual Impairment
Chun YS
J Korean Med Sci 2016; 31: 623-629 (IGR: 17-4)

67444 Prevalence of Glaucoma in the United States: The 2005-2008 National Health and Nutrition Examination Survey
Zhao D
Investigative Ophthalmology and Visual Science 2016; 57: 2577-2585 (IGR: 17-4)

66650 A retrospective survey of childhood glaucoma prevalence according to Childhood Glaucoma Research Network classification
Grajewski A
Indian Journal of Ophthalmology 2016; 64: 118-123 (IGR: 17-4)

67108 Prevalence of glaucoma in patients with vitiligo
Oğuz H
Cutis 2016; 97: E21-5 (IGR: 17-4)

67610 The Prevalence and the Incidence of Diagnosed Open-Angle Glaucoma and Diagnosed Angle-Closure Glaucoma: Changes From 2001 to 2010
Chu CL
Journal of Glaucoma 2016; 25: e514-e519 (IGR: 17-4)

67444 Prevalence of Glaucoma in the United States: The 2005-2008 National Health and Nutrition Examination Survey
Guallar E
Investigative Ophthalmology and Visual Science 2016; 57: 2577-2585 (IGR: 17-4)

66650 A retrospective survey of childhood glaucoma prevalence according to Childhood Glaucoma Research Network classification
Hodapp E
Indian Journal of Ophthalmology 2016; 64: 118-123 (IGR: 17-4)

66646 Epidemiologic Aspects of Medical Retirement from the Republic of Korea Army due to Visual Impairment
Park KH
J Korean Med Sci 2016; 31: 623-629 (IGR: 17-4)

67108 Prevalence of glaucoma in patients with vitiligo
Çiçek D
Cutis 2016; 97: E21-5 (IGR: 17-4)

67610 The Prevalence and the Incidence of Diagnosed Open-Angle Glaucoma and Diagnosed Angle-Closure Glaucoma: Changes From 2001 to 2010
Muo CH
Journal of Glaucoma 2016; 25: e514-e519 (IGR: 17-4)

66650 A retrospective survey of childhood glaucoma prevalence according to Childhood Glaucoma Research Network classification
Chang TC
Indian Journal of Ophthalmology 2016; 64: 118-123 (IGR: 17-4)

67108 Prevalence of glaucoma in patients with vitiligo
Yücel H
Cutis 2016; 97: E21-5 (IGR: 17-4)

67610 The Prevalence and the Incidence of Diagnosed Open-Angle Glaucoma and Diagnosed Angle-Closure Glaucoma: Changes From 2001 to 2010
Chen CL
Journal of Glaucoma 2016; 25: e514-e519 (IGR: 17-4)

67444 Prevalence of Glaucoma in the United States: The 2005-2008 National Health and Nutrition Examination Survey
Ko F
Investigative Ophthalmology and Visual Science 2016; 57: 2577-2585 (IGR: 17-4)

67610 The Prevalence and the Incidence of Diagnosed Open-Angle Glaucoma and Diagnosed Angle-Closure Glaucoma: Changes From 2001 to 2010
Lan SJ
Journal of Glaucoma 2016; 25: e514-e519 (IGR: 17-4)

67444 Prevalence of Glaucoma in the United States: The 2005-2008 National Health and Nutrition Examination Survey
Boland MV; Friedman DS
Investigative Ophthalmology and Visual Science 2016; 57: 2577-2585 (IGR: 17-4)

66366 A Population-based survey of the prevalence and types of glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey
Kyari F
BMC Ophthalmology 2015; 15: 176 (IGR: 17-3)

66545 Prevalence of Pseudoexfoliation Syndrome in Turkish Patients with Senile Cataract
Gunes A
Seminars in Ophthalmology 2016; 0: 1-5 (IGR: 17-3)

65824 Epidemiology and clinical characteristics of patients with glaucoma: An analysis of hospital data between 2003 and 2012
Zhao Y
Indian Journal of Ophthalmology 2015; 63: 825-831 (IGR: 17-3)

66513 Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013
Quartilho A
Eye 2016; 30: 602-607 (IGR: 17-3)

66232 Prevalence and causes of visual impairment in patients seen at Nkhensani Hospital Eye Clinic, South Africa
Maake MM
African journal of primary health care & family medicine 2015; 7: E1-6 (IGR: 17-3)

66215 Update on the Prevalence, Etiology, Diagnosis, and Monitoring of Normal-Tension Glaucoma
Kim KE
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2016; 5: 23-31 (IGR: 17-3)

65856 An Overview of Ophthalmologic Survey Methodology in the 2008-2015 Korean National Health and Nutrition Examination Surveys
Yoon KC
Korean Journal of Ophthalmology 2015; 29: 359-367 (IGR: 17-3)

66269 Prevalence, Awareness, and Risk Factors of Primary Open-Angle Glaucoma: Korea National Health and Nutrition Examination Survey 2008-2011
Kim KE
Ophthalmology 2016; 123: 532-541 (IGR: 17-3)

66495 Sociodemographic status of severely disabled and visually impaired elderly people in Turkey
Kıvanç SA
Arquivos Brasileiros de Oftalmologia 2016; 79: 24-29 (IGR: 17-3)

66513 Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013
Simkiss P
Eye 2016; 30: 602-607 (IGR: 17-3)

66215 Update on the Prevalence, Etiology, Diagnosis, and Monitoring of Normal-Tension Glaucoma
Park KH
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2016; 5: 23-31 (IGR: 17-3)

66232 Prevalence and causes of visual impairment in patients seen at Nkhensani Hospital Eye Clinic, South Africa
Oduntan OA
African journal of primary health care & family medicine 2015; 7: E1-6 (IGR: 17-3)

66495 Sociodemographic status of severely disabled and visually impaired elderly people in Turkey
Akova-Budak B
Arquivos Brasileiros de Oftalmologia 2016; 79: 24-29 (IGR: 17-3)

65856 An Overview of Ophthalmologic Survey Methodology in the 2008-2015 Korean National Health and Nutrition Examination Surveys
Choi W
Korean Journal of Ophthalmology 2015; 29: 359-367 (IGR: 17-3)

66366 A Population-based survey of the prevalence and types of glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey
Entekume G
BMC Ophthalmology 2015; 15: 176 (IGR: 17-3)

65824 Epidemiology and clinical characteristics of patients with glaucoma: An analysis of hospital data between 2003 and 2012
Fu JL
Indian Journal of Ophthalmology 2015; 63: 825-831 (IGR: 17-3)

66269 Prevalence, Awareness, and Risk Factors of Primary Open-Angle Glaucoma: Korea National Health and Nutrition Examination Survey 2008-2011
Kim MJ
Ophthalmology 2016; 123: 532-541 (IGR: 17-3)

66545 Prevalence of Pseudoexfoliation Syndrome in Turkish Patients with Senile Cataract
Yasar C
Seminars in Ophthalmology 2016; 0: 1-5 (IGR: 17-3)

65856 An Overview of Ophthalmologic Survey Methodology in the 2008-2015 Korean National Health and Nutrition Examination Surveys
Lee HS
Korean Journal of Ophthalmology 2015; 29: 359-367 (IGR: 17-3)

66269 Prevalence, Awareness, and Risk Factors of Primary Open-Angle Glaucoma: Korea National Health and Nutrition Examination Survey 2008-2011
Park KH
Ophthalmology 2016; 123: 532-541 (IGR: 17-3)

65824 Epidemiology and clinical characteristics of patients with glaucoma: An analysis of hospital data between 2003 and 2012
Li YL
Indian Journal of Ophthalmology 2015; 63: 825-831 (IGR: 17-3)

66545 Prevalence of Pseudoexfoliation Syndrome in Turkish Patients with Senile Cataract
Tok L
Seminars in Ophthalmology 2016; 0: 1-5 (IGR: 17-3)

66366 A Population-based survey of the prevalence and types of glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey
Rabiu M
BMC Ophthalmology 2015; 15: 176 (IGR: 17-3)

66495 Sociodemographic status of severely disabled and visually impaired elderly people in Turkey
Olcaysü OO
Arquivos Brasileiros de Oftalmologia 2016; 79: 24-29 (IGR: 17-3)

66513 Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013
Zekite A
Eye 2016; 30: 602-607 (IGR: 17-3)

66495 Sociodemographic status of severely disabled and visually impaired elderly people in Turkey
Çevik SG
Arquivos Brasileiros de Oftalmologia 2016; 79: 24-29 (IGR: 17-3)

65856 An Overview of Ophthalmologic Survey Methodology in the 2008-2015 Korean National Health and Nutrition Examination Surveys
Kim SD
Korean Journal of Ophthalmology 2015; 29: 359-367 (IGR: 17-3)

66513 Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013
Xing W
Eye 2016; 30: 602-607 (IGR: 17-3)

66545 Prevalence of Pseudoexfoliation Syndrome in Turkish Patients with Senile Cataract
Tok O
Seminars in Ophthalmology 2016; 0: 1-5 (IGR: 17-3)

66269 Prevalence, Awareness, and Risk Factors of Primary Open-Angle Glaucoma: Korea National Health and Nutrition Examination Survey 2008-2011
Jeoung JW
Ophthalmology 2016; 123: 532-541 (IGR: 17-3)

66366 A Population-based survey of the prevalence and types of glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey
Spry P
BMC Ophthalmology 2015; 15: 176 (IGR: 17-3)

65824 Epidemiology and clinical characteristics of patients with glaucoma: An analysis of hospital data between 2003 and 2012
Li P; Lou FL
Indian Journal of Ophthalmology 2015; 63: 825-831 (IGR: 17-3)

66366 A Population-based survey of the prevalence and types of glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey
Wormald R
BMC Ophthalmology 2015; 15: 176 (IGR: 17-3)

66513 Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013
Wormald R
Eye 2016; 30: 602-607 (IGR: 17-3)

65856 An Overview of Ophthalmologic Survey Methodology in the 2008-2015 Korean National Health and Nutrition Examination Surveys
Kim SH
Korean Journal of Ophthalmology 2015; 29: 359-367 (IGR: 17-3)

66269 Prevalence, Awareness, and Risk Factors of Primary Open-Angle Glaucoma: Korea National Health and Nutrition Examination Survey 2008-2011
Kim SH; Kim CY
Ophthalmology 2016; 123: 532-541 (IGR: 17-3)

66513 Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013
Bunce C
Eye 2016; 30: 602-607 (IGR: 17-3)

66366 A Population-based survey of the prevalence and types of glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey
Nolan W
BMC Ophthalmology 2015; 15: 176 (IGR: 17-3)

65856 An Overview of Ophthalmologic Survey Methodology in the 2008-2015 Korean National Health and Nutrition Examination Surveys
Kim CY
Korean Journal of Ophthalmology 2015; 29: 359-367 (IGR: 17-3)

66269 Prevalence, Awareness, and Risk Factors of Primary Open-Angle Glaucoma: Korea National Health and Nutrition Examination Survey 2008-2011
Kang SW
Ophthalmology 2016; 123: 532-541 (IGR: 17-3)

65856 An Overview of Ophthalmologic Survey Methodology in the 2008-2015 Korean National Health and Nutrition Examination Surveys
Park KH
Korean Journal of Ophthalmology 2015; 29: 359-367 (IGR: 17-3)

66366 A Population-based survey of the prevalence and types of glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey
Murthy GV
BMC Ophthalmology 2015; 15: 176 (IGR: 17-3)

65856 An Overview of Ophthalmologic Survey Methodology in the 2008-2015 Korean National Health and Nutrition Examination Surveys
Park YJ
Korean Journal of Ophthalmology 2015; 29: 359-367 (IGR: 17-3)

66366 A Population-based survey of the prevalence and types of glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey
Gilbert CE
BMC Ophthalmology 2015; 15: 176 (IGR: 17-3)

66269 Prevalence, Awareness, and Risk Factors of Primary Open-Angle Glaucoma: Korea National Health and Nutrition Examination Survey 2008-2011

Ophthalmology 2016; 123: 532-541 (IGR: 17-3)

65856 An Overview of Ophthalmologic Survey Methodology in the 2008-2015 Korean National Health and Nutrition Examination Surveys
Baek SH
Korean Journal of Ophthalmology 2015; 29: 359-367 (IGR: 17-3)

66366 A Population-based survey of the prevalence and types of glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey

BMC Ophthalmology 2015; 15: 176 (IGR: 17-3)

65856 An Overview of Ophthalmologic Survey Methodology in the 2008-2015 Korean National Health and Nutrition Examination Surveys
Song SJ; Shin JP; Yang SW; Yu SY; Lee JS; Lim KH; Oh KW; Kang SW
Korean Journal of Ophthalmology 2015; 29: 359-367 (IGR: 17-3)

61625 The Prevalence and Types of Glaucoma in an Urban Chinese Population: The Singapore Chinese Eye Study
Baskaran M
JAMA ophthalmology 2015; 133: 874-880 (IGR: 17-1)

61333 Glaucoma in Asia: regional prevalence variations and future projections
Chan EW
British Journal of Ophthalmology 2016; 100: 78-85 (IGR: 17-1)

61506 Hypothyroidism and Glaucoma in The United States
Kakigi C
PLoS ONE 2015; 10: e0133688 (IGR: 17-1)

60975 Functional low vision in adults from Latin America: findings from population-based surveys in 15 countries
Limburg H
Revista panamericana de salud pública = Pan American journal of public health 2015; 37: 371-378 (IGR: 17-1)

61622 Prevalence, Risk Factors, and Visual Features of Undiagnosed Glaucoma: The Singapore Epidemiology of Eye Diseases Study
Chua J
JAMA ophthalmology 2015; 133: 938-946 (IGR: 17-1)

60989 Peripapillary Choroidal Thickness in Adult Chinese: The Beijing Eye Study
Jiang R
Investigative Ophthalmology and Visual Science 2015; 56: 4045-4052 (IGR: 17-1)

61570 The Prevalence and Incidence of Glaucoma in Denmark in a Fifteen Year Period: A Nationwide Study
Kolko M
PLoS ONE 2015; 10: e0132048 (IGR: 17-1)

61595 Dementia is associated with open-angle glaucoma: a population-based study
Chung SD
Eye 2015; 29: 1340-1346 (IGR: 17-1)

61333 Glaucoma in Asia: regional prevalence variations and future projections
Li X
British Journal of Ophthalmology 2016; 100: 78-85 (IGR: 17-1)

61622 Prevalence, Risk Factors, and Visual Features of Undiagnosed Glaucoma: The Singapore Epidemiology of Eye Diseases Study
Baskaran M
JAMA ophthalmology 2015; 133: 938-946 (IGR: 17-1)

61570 The Prevalence and Incidence of Glaucoma in Denmark in a Fifteen Year Period: A Nationwide Study
Horwitz A
PLoS ONE 2015; 10: e0132048 (IGR: 17-1)

61625 The Prevalence and Types of Glaucoma in an Urban Chinese Population: The Singapore Chinese Eye Study
Foo RC
JAMA ophthalmology 2015; 133: 874-880 (IGR: 17-1)

61506 Hypothyroidism and Glaucoma in The United States
Kasuga T
PLoS ONE 2015; 10: e0133688 (IGR: 17-1)

61595 Dementia is associated with open-angle glaucoma: a population-based study
Ho JD
Eye 2015; 29: 1340-1346 (IGR: 17-1)

60975 Functional low vision in adults from Latin America: findings from population-based surveys in 15 countries
Espinoza R
Revista panamericana de salud pública = Pan American journal of public health 2015; 37: 371-378 (IGR: 17-1)

60989 Peripapillary Choroidal Thickness in Adult Chinese: The Beijing Eye Study
Wang YX
Investigative Ophthalmology and Visual Science 2015; 56: 4045-4052 (IGR: 17-1)

61570 The Prevalence and Incidence of Glaucoma in Denmark in a Fifteen Year Period: A Nationwide Study
Thygesen J
PLoS ONE 2015; 10: e0132048 (IGR: 17-1)

60989 Peripapillary Choroidal Thickness in Adult Chinese: The Beijing Eye Study
Wei WB
Investigative Ophthalmology and Visual Science 2015; 56: 4045-4052 (IGR: 17-1)

61622 Prevalence, Risk Factors, and Visual Features of Undiagnosed Glaucoma: The Singapore Epidemiology of Eye Diseases Study
Ong PG
JAMA ophthalmology 2015; 133: 938-946 (IGR: 17-1)

61595 Dementia is associated with open-angle glaucoma: a population-based study
Chen CH
Eye 2015; 29: 1340-1346 (IGR: 17-1)

61625 The Prevalence and Types of Glaucoma in an Urban Chinese Population: The Singapore Chinese Eye Study
Cheng CY
JAMA ophthalmology 2015; 133: 874-880 (IGR: 17-1)

61333 Glaucoma in Asia: regional prevalence variations and future projections
Tham YC
British Journal of Ophthalmology 2016; 100: 78-85 (IGR: 17-1)

61506 Hypothyroidism and Glaucoma in The United States
Wang SY
PLoS ONE 2015; 10: e0133688 (IGR: 17-1)

60975 Functional low vision in adults from Latin America: findings from population-based surveys in 15 countries
Lansingh VC
Revista panamericana de salud pública = Pan American journal of public health 2015; 37: 371-378 (IGR: 17-1)

61595 Dementia is associated with open-angle glaucoma: a population-based study
Lin HC
Eye 2015; 29: 1340-1346 (IGR: 17-1)

61622 Prevalence, Risk Factors, and Visual Features of Undiagnosed Glaucoma: The Singapore Epidemiology of Eye Diseases Study
Zheng Y
JAMA ophthalmology 2015; 133: 938-946 (IGR: 17-1)

60989 Peripapillary Choroidal Thickness in Adult Chinese: The Beijing Eye Study
Xu L
Investigative Ophthalmology and Visual Science 2015; 56: 4045-4052 (IGR: 17-1)

61570 The Prevalence and Incidence of Glaucoma in Denmark in a Fifteen Year Period: A Nationwide Study
Jeppesen J
PLoS ONE 2015; 10: e0132048 (IGR: 17-1)

60975 Functional low vision in adults from Latin America: findings from population-based surveys in 15 countries
Silva JC
Revista panamericana de salud pública = Pan American journal of public health 2015; 37: 371-378 (IGR: 17-1)

61506 Hypothyroidism and Glaucoma in The United States
Singh K
PLoS ONE 2015; 10: e0133688 (IGR: 17-1)

61625 The Prevalence and Types of Glaucoma in an Urban Chinese Population: The Singapore Chinese Eye Study
Narayanaswamy AK
JAMA ophthalmology 2015; 133: 874-880 (IGR: 17-1)

61333 Glaucoma in Asia: regional prevalence variations and future projections
Liao J
British Journal of Ophthalmology 2016; 100: 78-85 (IGR: 17-1)

61625 The Prevalence and Types of Glaucoma in an Urban Chinese Population: The Singapore Chinese Eye Study
Zheng YF
JAMA ophthalmology 2015; 133: 874-880 (IGR: 17-1)

61506 Hypothyroidism and Glaucoma in The United States
Hiratsuka Y
PLoS ONE 2015; 10: e0133688 (IGR: 17-1)

60989 Peripapillary Choroidal Thickness in Adult Chinese: The Beijing Eye Study
Jonas JB
Investigative Ophthalmology and Visual Science 2015; 56: 4045-4052 (IGR: 17-1)

61595 Dementia is associated with open-angle glaucoma: a population-based study
Tsai MC
Eye 2015; 29: 1340-1346 (IGR: 17-1)

61622 Prevalence, Risk Factors, and Visual Features of Undiagnosed Glaucoma: The Singapore Epidemiology of Eye Diseases Study
Wong TY
JAMA ophthalmology 2015; 133: 938-946 (IGR: 17-1)

61333 Glaucoma in Asia: regional prevalence variations and future projections
Wong TY
British Journal of Ophthalmology 2016; 100: 78-85 (IGR: 17-1)

61570 The Prevalence and Incidence of Glaucoma in Denmark in a Fifteen Year Period: A Nationwide Study
Torp-Pedersen C
PLoS ONE 2015; 10: e0132048 (IGR: 17-1)

61595 Dementia is associated with open-angle glaucoma: a population-based study
Sheu JJ
Eye 2015; 29: 1340-1346 (IGR: 17-1)

61625 The Prevalence and Types of Glaucoma in an Urban Chinese Population: The Singapore Chinese Eye Study
Wu R
JAMA ophthalmology 2015; 133: 874-880 (IGR: 17-1)

61506 Hypothyroidism and Glaucoma in The United States
Murakami A
PLoS ONE 2015; 10: e0133688 (IGR: 17-1)

61622 Prevalence, Risk Factors, and Visual Features of Undiagnosed Glaucoma: The Singapore Epidemiology of Eye Diseases Study
Aung T
JAMA ophthalmology 2015; 133: 938-946 (IGR: 17-1)

61333 Glaucoma in Asia: regional prevalence variations and future projections
Aung T
British Journal of Ophthalmology 2016; 100: 78-85 (IGR: 17-1)

61506 Hypothyroidism and Glaucoma in The United States
Lin SC
PLoS ONE 2015; 10: e0133688 (IGR: 17-1)

61333 Glaucoma in Asia: regional prevalence variations and future projections
Cheng CY
British Journal of Ophthalmology 2016; 100: 78-85 (IGR: 17-1)

61625 The Prevalence and Types of Glaucoma in an Urban Chinese Population: The Singapore Chinese Eye Study
Saw SM
JAMA ophthalmology 2015; 133: 874-880 (IGR: 17-1)

61622 Prevalence, Risk Factors, and Visual Features of Undiagnosed Glaucoma: The Singapore Epidemiology of Eye Diseases Study
Cheng CY
JAMA ophthalmology 2015; 133: 938-946 (IGR: 17-1)

61625 The Prevalence and Types of Glaucoma in an Urban Chinese Population: The Singapore Chinese Eye Study
Foster PJ; Wong TY; Aung T
JAMA ophthalmology 2015; 133: 874-880 (IGR: 17-1)

60646 Nigeria normative data for defining glaucoma in prevalence surveys
Kyari F
Ophthalmic Epidemiology 2015; 22: 98-108 (IGR: 16-4)

60472 Prevalence of blindness and diabetic retinopathy in northern Jordan
Rabiu MM
European Journal of Ophthalmology 2015; 0: 0 (IGR: 16-4)

60600 Biogeographic Ancestry in the African Descent and Glaucoma Evaluation Study (ADAGES): Association With Corneal and Optic Nerve Structure
Girkin CA
Investigative Ophthalmology and Visual Science 2015; 56: 2043-2049 (IGR: 16-4)

60783 Diabetes and visual impairment in sub-Saharan Africa: evidence from Cameroon
Jingi AM
Journal of diabetes and metabolic disorders 2015; 14: 21 (IGR: 16-4)

60678 Six-Year Incidence and Baseline Risk Factors for Pseudoexfoliation in a South Indian Population: The Chennai Eye Disease Incidence Study
Vijaya L
Ophthalmology 2015; 122: 1158-1164 (IGR: 16-4)

60644 The ophthalmic branch of the gutenberg health study: study design, cohort profile and self-reported diseases
Höhn R
PLoS ONE 2015; 10: e0120476 (IGR: 16-4)

60170 Association of common SIX6 polymorphisms with peripapillary retinal nerve fiber layer thickness: the Singapore Chinese Eye Study
Cheng CY
Investigative Ophthalmology and Visual Science 2015; 56: 478-483 (IGR: 16-4)

60055 The clinical characteristics of patients with glaucoma presenting to Botswana healthcare facilities: an observational study
Jackson DJ
BMJ open 2014; 4: e005965 (IGR: 16-4)

60205 Rapid assessment of avoidable blindness and diabetic retinopathy in Republic of Moldova
Zatic T
British Journal of Ophthalmology 2015; 99: 832-836 (IGR: 16-4)

60111 The first rapid assessment of avoidable blindness (RAAB) in Thailand
Isipradit S
PLoS ONE 2014; 9: e114245 (IGR: 16-4)

60057 Five-year incidence of primary open-angle glaucoma and rate of progression in health center-based Korean population: the Gangnam Eye Study
Kim YK
PLoS ONE 2014; 9: e114058 (IGR: 16-4)

60663 The Prevalence of Age-Related Eye Diseases and Cataract Surgery among Older Adults in the City of Lodz, Poland
Nowak MS
Journal of Ophthalmology 2015; 2015: 605814 (IGR: 16-4)

60247 The primary open-angle african american glaucoma genetics study: baseline demographics
Charlson ES
Ophthalmology 2015; 122: 711-720 (IGR: 16-4)

60767 Epidemiological study of visual functions--refractive errors, macular degeneration and glaucoma in children in the Karst area of Opatija
Nadarević VS
Collegium Antropologicum 2014; 38: 1095-1097 (IGR: 16-4)

60170 Association of common SIX6 polymorphisms with peripapillary retinal nerve fiber layer thickness: the Singapore Chinese Eye Study
Allingham RR
Investigative Ophthalmology and Visual Science 2015; 56: 478-483 (IGR: 16-4)

60205 Rapid assessment of avoidable blindness and diabetic retinopathy in Republic of Moldova
Bendelic E
British Journal of Ophthalmology 2015; 99: 832-836 (IGR: 16-4)

60678 Six-Year Incidence and Baseline Risk Factors for Pseudoexfoliation in a South Indian Population: The Chennai Eye Disease Incidence Study
Asokan R
Ophthalmology 2015; 122: 1158-1164 (IGR: 16-4)

60055 The clinical characteristics of patients with glaucoma presenting to Botswana healthcare facilities: an observational study
Razai MS
BMJ open 2014; 4: e005965 (IGR: 16-4)

60646 Nigeria normative data for defining glaucoma in prevalence surveys
Abdull MM
Ophthalmic Epidemiology 2015; 22: 98-108 (IGR: 16-4)

60111 The first rapid assessment of avoidable blindness (RAAB) in Thailand
Sirimaharaj M
PLoS ONE 2014; 9: e114245 (IGR: 16-4)

60767 Epidemiological study of visual functions--refractive errors, macular degeneration and glaucoma in children in the Karst area of Opatija
Vojniković B
Collegium Antropologicum 2014; 38: 1095-1097 (IGR: 16-4)

60057 Five-year incidence of primary open-angle glaucoma and rate of progression in health center-based Korean population: the Gangnam Eye Study
Choi HJ
PLoS ONE 2014; 9: e114058 (IGR: 16-4)

60472 Prevalence of blindness and diabetic retinopathy in northern Jordan
Al Bdour MD
European Journal of Ophthalmology 2015; 0: 0 (IGR: 16-4)

60600 Biogeographic Ancestry in the African Descent and Glaucoma Evaluation Study (ADAGES): Association With Corneal and Optic Nerve Structure
Nievergelt CM
Investigative Ophthalmology and Visual Science 2015; 56: 2043-2049 (IGR: 16-4)

60663 The Prevalence of Age-Related Eye Diseases and Cataract Surgery among Older Adults in the City of Lodz, Poland
Smigielski J
Journal of Ophthalmology 2015; 2015: 605814 (IGR: 16-4)

60644 The ophthalmic branch of the gutenberg health study: study design, cohort profile and self-reported diseases
Kottler U
PLoS ONE 2015; 10: e0120476 (IGR: 16-4)

60247 The primary open-angle african american glaucoma genetics study: baseline demographics
Sankar PS
Ophthalmology 2015; 122: 711-720 (IGR: 16-4)

60783 Diabetes and visual impairment in sub-Saharan Africa: evidence from Cameroon
Nansseu JR
Journal of diabetes and metabolic disorders 2015; 14: 21 (IGR: 16-4)

60111 The first rapid assessment of avoidable blindness (RAAB) in Thailand
Charukamnoetkanok P
PLoS ONE 2014; 9: e114245 (IGR: 16-4)

60646 Nigeria normative data for defining glaucoma in prevalence surveys
Sallo FB
Ophthalmic Epidemiology 2015; 22: 98-108 (IGR: 16-4)

60247 The primary open-angle african american glaucoma genetics study: baseline demographics
Miller-Ellis E
Ophthalmology 2015; 122: 711-720 (IGR: 16-4)

60767 Epidemiological study of visual functions--refractive errors, macular degeneration and glaucoma in children in the Karst area of Opatija
Mićović V
Collegium Antropologicum 2014; 38: 1095-1097 (IGR: 16-4)

60170 Association of common SIX6 polymorphisms with peripapillary retinal nerve fiber layer thickness: the Singapore Chinese Eye Study
Aung T
Investigative Ophthalmology and Visual Science 2015; 56: 478-483 (IGR: 16-4)

60678 Six-Year Incidence and Baseline Risk Factors for Pseudoexfoliation in a South Indian Population: The Chennai Eye Disease Incidence Study
Panday M
Ophthalmology 2015; 122: 1158-1164 (IGR: 16-4)

60644 The ophthalmic branch of the gutenberg health study: study design, cohort profile and self-reported diseases
Peto T
PLoS ONE 2015; 10: e0120476 (IGR: 16-4)

60472 Prevalence of blindness and diabetic retinopathy in northern Jordan
Abu Ameerh MA
European Journal of Ophthalmology 2015; 0: 0 (IGR: 16-4)

60783 Diabetes and visual impairment in sub-Saharan Africa: evidence from Cameroon
Noubiap JJ
Journal of diabetes and metabolic disorders 2015; 14: 21 (IGR: 16-4)

60055 The clinical characteristics of patients with glaucoma presenting to Botswana healthcare facilities: an observational study
Falama R
BMJ open 2014; 4: e005965 (IGR: 16-4)

60205 Rapid assessment of avoidable blindness and diabetic retinopathy in Republic of Moldova
Paduca A
British Journal of Ophthalmology 2015; 99: 832-836 (IGR: 16-4)

60057 Five-year incidence of primary open-angle glaucoma and rate of progression in health center-based Korean population: the Gangnam Eye Study
Jeoung JW
PLoS ONE 2014; 9: e114058 (IGR: 16-4)

60600 Biogeographic Ancestry in the African Descent and Glaucoma Evaluation Study (ADAGES): Association With Corneal and Optic Nerve Structure
Kuo JZ
Investigative Ophthalmology and Visual Science 2015; 56: 2043-2049 (IGR: 16-4)

60767 Epidemiological study of visual functions--refractive errors, macular degeneration and glaucoma in children in the Karst area of Opatija
Linsak Z
Collegium Antropologicum 2014; 38: 1095-1097 (IGR: 16-4)

60644 The ophthalmic branch of the gutenberg health study: study design, cohort profile and self-reported diseases
Blettner M
PLoS ONE 2015; 10: e0120476 (IGR: 16-4)

60055 The clinical characteristics of patients with glaucoma presenting to Botswana healthcare facilities: an observational study
Mongwa M
BMJ open 2014; 4: e005965 (IGR: 16-4)

60057 Five-year incidence of primary open-angle glaucoma and rate of progression in health center-based Korean population: the Gangnam Eye Study
Park KH
PLoS ONE 2014; 9: e114058 (IGR: 16-4)

60111 The first rapid assessment of avoidable blindness (RAAB) in Thailand
Thonginnetra O
PLoS ONE 2014; 9: e114245 (IGR: 16-4)

60472 Prevalence of blindness and diabetic retinopathy in northern Jordan
Jadoon MZ
European Journal of Ophthalmology 2015; 0: 0 (IGR: 16-4)

60646 Nigeria normative data for defining glaucoma in prevalence surveys
Spry PG
Ophthalmic Epidemiology 2015; 22: 98-108 (IGR: 16-4)

60678 Six-Year Incidence and Baseline Risk Factors for Pseudoexfoliation in a South Indian Population: The Chennai Eye Disease Incidence Study
Choudhari NS
Ophthalmology 2015; 122: 1158-1164 (IGR: 16-4)

60783 Diabetes and visual impairment in sub-Saharan Africa: evidence from Cameroon
Bilong Y
Journal of diabetes and metabolic disorders 2015; 14: 21 (IGR: 16-4)

60170 Association of common SIX6 polymorphisms with peripapillary retinal nerve fiber layer thickness: the Singapore Chinese Eye Study
Tham YC
Investigative Ophthalmology and Visual Science 2015; 56: 478-483 (IGR: 16-4)

60205 Rapid assessment of avoidable blindness and diabetic retinopathy in Republic of Moldova
Rabiu M
British Journal of Ophthalmology 2015; 99: 832-836 (IGR: 16-4)

60600 Biogeographic Ancestry in the African Descent and Glaucoma Evaluation Study (ADAGES): Association With Corneal and Optic Nerve Structure
Maihofer AX
Investigative Ophthalmology and Visual Science 2015; 56: 2043-2049 (IGR: 16-4)

60247 The primary open-angle african american glaucoma genetics study: baseline demographics
Regina M; Fertig R
Ophthalmology 2015; 122: 711-720 (IGR: 16-4)

60783 Diabetes and visual impairment in sub-Saharan Africa: evidence from Cameroon
Ellong A
Journal of diabetes and metabolic disorders 2015; 14: 21 (IGR: 16-4)

60646 Nigeria normative data for defining glaucoma in prevalence surveys
Wormald R
Ophthalmic Epidemiology 2015; 22: 98-108 (IGR: 16-4)

60600 Biogeographic Ancestry in the African Descent and Glaucoma Evaluation Study (ADAGES): Association With Corneal and Optic Nerve Structure
Huisingh C
Investigative Ophthalmology and Visual Science 2015; 56: 2043-2049 (IGR: 16-4)

60205 Rapid assessment of avoidable blindness and diabetic retinopathy in Republic of Moldova
Corduneanu A
British Journal of Ophthalmology 2015; 99: 832-836 (IGR: 16-4)

60767 Epidemiological study of visual functions--refractive errors, macular degeneration and glaucoma in children in the Karst area of Opatija
Lakoseljac D
Collegium Antropologicum 2014; 38: 1095-1097 (IGR: 16-4)

60644 The ophthalmic branch of the gutenberg health study: study design, cohort profile and self-reported diseases
Münzel T
PLoS ONE 2015; 10: e0120476 (IGR: 16-4)

60057 Five-year incidence of primary open-angle glaucoma and rate of progression in health center-based Korean population: the Gangnam Eye Study
Kim DM
PLoS ONE 2014; 9: e114058 (IGR: 16-4)

60678 Six-Year Incidence and Baseline Risk Factors for Pseudoexfoliation in a South Indian Population: The Chennai Eye Disease Incidence Study
Ramesh SV
Ophthalmology 2015; 122: 1158-1164 (IGR: 16-4)

60170 Association of common SIX6 polymorphisms with peripapillary retinal nerve fiber layer thickness: the Singapore Chinese Eye Study
Hauser MA
Investigative Ophthalmology and Visual Science 2015; 56: 478-483 (IGR: 16-4)

60055 The clinical characteristics of patients with glaucoma presenting to Botswana healthcare facilities: an observational study
Mutapanduwa M
BMJ open 2014; 4: e005965 (IGR: 16-4)

60111 The first rapid assessment of avoidable blindness (RAAB) in Thailand
Wongsawad W
PLoS ONE 2014; 9: e114245 (IGR: 16-4)

60600 Biogeographic Ancestry in the African Descent and Glaucoma Evaluation Study (ADAGES): Association With Corneal and Optic Nerve Structure
Liebmann JM
Investigative Ophthalmology and Visual Science 2015; 56: 2043-2049 (IGR: 16-4)

60170 Association of common SIX6 polymorphisms with peripapillary retinal nerve fiber layer thickness: the Singapore Chinese Eye Study
Vithana EN
Investigative Ophthalmology and Visual Science 2015; 56: 478-483 (IGR: 16-4)

60644 The ophthalmic branch of the gutenberg health study: study design, cohort profile and self-reported diseases
Blankenberg S
PLoS ONE 2015; 10: e0120476 (IGR: 16-4)

60055 The clinical characteristics of patients with glaucoma presenting to Botswana healthcare facilities: an observational study
Baemisi C
BMJ open 2014; 4: e005965 (IGR: 16-4)

60646 Nigeria normative data for defining glaucoma in prevalence surveys
Peto T
Ophthalmic Epidemiology 2015; 22: 98-108 (IGR: 16-4)

60111 The first rapid assessment of avoidable blindness (RAAB) in Thailand
Sathornsumetee B
PLoS ONE 2014; 9: e114245 (IGR: 16-4)

60767 Epidemiological study of visual functions--refractive errors, macular degeneration and glaucoma in children in the Karst area of Opatija
Malatestinić D
Collegium Antropologicum 2014; 38: 1095-1097 (IGR: 16-4)

60205 Rapid assessment of avoidable blindness and diabetic retinopathy in Republic of Moldova
Garaba A
British Journal of Ophthalmology 2015; 99: 832-836 (IGR: 16-4)

60783 Diabetes and visual impairment in sub-Saharan Africa: evidence from Cameroon
Mvogo CE
Journal of diabetes and metabolic disorders 2015; 14: 21 (IGR: 16-4)

60678 Six-Year Incidence and Baseline Risk Factors for Pseudoexfoliation in a South Indian Population: The Chennai Eye Disease Incidence Study
Velumuri L
Ophthalmology 2015; 122: 1158-1164 (IGR: 16-4)

60247 The primary open-angle african american glaucoma genetics study: baseline demographics
Salinas J
Ophthalmology 2015; 122: 711-720 (IGR: 16-4)

60678 Six-Year Incidence and Baseline Risk Factors for Pseudoexfoliation in a South Indian Population: The Chennai Eye Disease Incidence Study
George R
Ophthalmology 2015; 122: 1158-1164 (IGR: 16-4)

60111 The first rapid assessment of avoidable blindness (RAAB) in Thailand
Somboonthanakij S
PLoS ONE 2014; 9: e114245 (IGR: 16-4)

60767 Epidemiological study of visual functions--refractive errors, macular degeneration and glaucoma in children in the Karst area of Opatija
Nadarević T
Collegium Antropologicum 2014; 38: 1095-1097 (IGR: 16-4)

60205 Rapid assessment of avoidable blindness and diabetic retinopathy in Republic of Moldova
Novac V
British Journal of Ophthalmology 2015; 99: 832-836 (IGR: 16-4)

60646 Nigeria normative data for defining glaucoma in prevalence surveys
Faal HB
Ophthalmic Epidemiology 2015; 22: 98-108 (IGR: 16-4)

60247 The primary open-angle african american glaucoma genetics study: baseline demographics
Pistilli M
Ophthalmology 2015; 122: 711-720 (IGR: 16-4)

60600 Biogeographic Ancestry in the African Descent and Glaucoma Evaluation Study (ADAGES): Association With Corneal and Optic Nerve Structure
Ayyagari R
Investigative Ophthalmology and Visual Science 2015; 56: 2043-2049 (IGR: 16-4)

60170 Association of common SIX6 polymorphisms with peripapillary retinal nerve fiber layer thickness: the Singapore Chinese Eye Study
Khor CC
Investigative Ophthalmology and Visual Science 2015; 56: 478-483 (IGR: 16-4)

60644 The ophthalmic branch of the gutenberg health study: study design, cohort profile and self-reported diseases
Lackner KJ
PLoS ONE 2015; 10: e0120476 (IGR: 16-4)

60055 The clinical characteristics of patients with glaucoma presenting to Botswana healthcare facilities: an observational study
Josiah E
BMJ open 2014; 4: e005965 (IGR: 16-4)

60170 Association of common SIX6 polymorphisms with peripapillary retinal nerve fiber layer thickness: the Singapore Chinese Eye Study
Wong TY
Investigative Ophthalmology and Visual Science 2015; 56: 478-483 (IGR: 16-4)

60644 The ophthalmic branch of the gutenberg health study: study design, cohort profile and self-reported diseases
Beutel M
PLoS ONE 2015; 10: e0120476 (IGR: 16-4)

60247 The primary open-angle african american glaucoma genetics study: baseline demographics
Salowe RJ
Ophthalmology 2015; 122: 711-720 (IGR: 16-4)

60767 Epidemiological study of visual functions--refractive errors, macular degeneration and glaucoma in children in the Karst area of Opatija
Sesar Z
Collegium Antropologicum 2014; 38: 1095-1097 (IGR: 16-4)

60600 Biogeographic Ancestry in the African Descent and Glaucoma Evaluation Study (ADAGES): Association With Corneal and Optic Nerve Structure
Weinreb RN
Investigative Ophthalmology and Visual Science 2015; 56: 2043-2049 (IGR: 16-4)

60111 The first rapid assessment of avoidable blindness (RAAB) in Thailand
Soomsawasdi P
PLoS ONE 2014; 9: e114245 (IGR: 16-4)

60055 The clinical characteristics of patients with glaucoma presenting to Botswana healthcare facilities: an observational study
Nkomazana O
BMJ open 2014; 4: e005965 (IGR: 16-4)

60646 Nigeria normative data for defining glaucoma in prevalence surveys
Gilbert CE
Ophthalmic Epidemiology 2015; 22: 98-108 (IGR: 16-4)

60205 Rapid assessment of avoidable blindness and diabetic retinopathy in Republic of Moldova
Curca C
British Journal of Ophthalmology 2015; 99: 832-836 (IGR: 16-4)

60600 Biogeographic Ancestry in the African Descent and Glaucoma Evaluation Study (ADAGES): Association With Corneal and Optic Nerve Structure
Ritch R
Investigative Ophthalmology and Visual Science 2015; 56: 2043-2049 (IGR: 16-4)

60205 Rapid assessment of avoidable blindness and diabetic retinopathy in Republic of Moldova
Sorbala I
British Journal of Ophthalmology 2015; 99: 832-836 (IGR: 16-4)

60055 The clinical characteristics of patients with glaucoma presenting to Botswana healthcare facilities: an observational study
Lehasa A
BMJ open 2014; 4: e005965 (IGR: 16-4)

60247 The primary open-angle african american glaucoma genetics study: baseline demographics
Rhodes AL
Ophthalmology 2015; 122: 711-720 (IGR: 16-4)

60111 The first rapid assessment of avoidable blindness (RAAB) in Thailand
Jitawatanarat U
PLoS ONE 2014; 9: e114245 (IGR: 16-4)

60646 Nigeria normative data for defining glaucoma in prevalence surveys

Ophthalmic Epidemiology 2015; 22: 98-108 (IGR: 16-4)

60644 The ophthalmic branch of the gutenberg health study: study design, cohort profile and self-reported diseases
Wild PS; Pfeiffer N
PLoS ONE 2015; 10: e0120476 (IGR: 16-4)

60247 The primary open-angle african american glaucoma genetics study: baseline demographics
Merritt WT
Ophthalmology 2015; 122: 711-720 (IGR: 16-4)

60111 The first rapid assessment of avoidable blindness (RAAB) in Thailand
Taweebanjongsin W
PLoS ONE 2014; 9: e114245 (IGR: 16-4)

60205 Rapid assessment of avoidable blindness and diabetic retinopathy in Republic of Moldova
Chiaburu A
British Journal of Ophthalmology 2015; 99: 832-836 (IGR: 16-4)

60600 Biogeographic Ancestry in the African Descent and Glaucoma Evaluation Study (ADAGES): Association With Corneal and Optic Nerve Structure
Zangwill LM
Investigative Ophthalmology and Visual Science 2015; 56: 2043-2049 (IGR: 16-4)

60055 The clinical characteristics of patients with glaucoma presenting to Botswana healthcare facilities: an observational study
Brealey E
BMJ open 2014; 4: e005965 (IGR: 16-4)

60205 Rapid assessment of avoidable blindness and diabetic retinopathy in Republic of Moldova
Verega F
British Journal of Ophthalmology 2015; 99: 832-836 (IGR: 16-4)

60111 The first rapid assessment of avoidable blindness (RAAB) in Thailand
Arayangkoon E
PLoS ONE 2014; 9: e114245 (IGR: 16-4)

60247 The primary open-angle african american glaucoma genetics study: baseline demographics
Chua M
Ophthalmology 2015; 122: 711-720 (IGR: 16-4)

60600 Biogeographic Ancestry in the African Descent and Glaucoma Evaluation Study (ADAGES): Association With Corneal and Optic Nerve Structure

Investigative Ophthalmology and Visual Science 2015; 56: 2043-2049 (IGR: 16-4)

60055 The clinical characteristics of patients with glaucoma presenting to Botswana healthcare facilities: an observational study
White AJ
BMJ open 2014; 4: e005965 (IGR: 16-4)

60247 The primary open-angle african american glaucoma genetics study: baseline demographics
Trachtman BT
Ophthalmology 2015; 122: 711-720 (IGR: 16-4)

60055 The clinical characteristics of patients with glaucoma presenting to Botswana healthcare facilities: an observational study
Jankowski D
BMJ open 2014; 4: e005965 (IGR: 16-4)

60205 Rapid assessment of avoidable blindness and diabetic retinopathy in Republic of Moldova
Andronic V
British Journal of Ophthalmology 2015; 99: 832-836 (IGR: 16-4)

60111 The first rapid assessment of avoidable blindness (RAAB) in Thailand
Arame P
PLoS ONE 2014; 9: e114245 (IGR: 16-4)

60247 The primary open-angle african american glaucoma genetics study: baseline demographics
Gudiseva HV
Ophthalmology 2015; 122: 711-720 (IGR: 16-4)

60111 The first rapid assessment of avoidable blindness (RAAB) in Thailand
Kobkoonthon C
PLoS ONE 2014; 9: e114245 (IGR: 16-4)

60205 Rapid assessment of avoidable blindness and diabetic retinopathy in Republic of Moldova
Guzun I
British Journal of Ophthalmology 2015; 99: 832-836 (IGR: 16-4)

60055 The clinical characteristics of patients with glaucoma presenting to Botswana healthcare facilities: an observational study
Kerr-Muir MG; Martin KR
BMJ open 2014; 4: e005965 (IGR: 16-4)

60247 The primary open-angle african american glaucoma genetics study: baseline demographics
Collins DW
Ophthalmology 2015; 122: 711-720 (IGR: 16-4)

60205 Rapid assessment of avoidable blindness and diabetic retinopathy in Republic of Moldova
Căpăţină O
British Journal of Ophthalmology 2015; 99: 832-836 (IGR: 16-4)

60111 The first rapid assessment of avoidable blindness (RAAB) in Thailand
Pangputhipong P
PLoS ONE 2014; 9: e114245 (IGR: 16-4)

60055 The clinical characteristics of patients with glaucoma presenting to Botswana healthcare facilities: an observational study
Ngondi JM
BMJ open 2014; 4: e005965 (IGR: 16-4)

60247 The primary open-angle african american glaucoma genetics study: baseline demographics
Chavali VR
Ophthalmology 2015; 122: 711-720 (IGR: 16-4)

60205 Rapid assessment of avoidable blindness and diabetic retinopathy in Republic of Moldova
Zamă-Mardari I
British Journal of Ophthalmology 2015; 99: 832-836 (IGR: 16-4)

60247 The primary open-angle african american glaucoma genetics study: baseline demographics
Nichols C; Henderer J; Ying GS; Varma R; Jorgenson E; O'Brien JM
Ophthalmology 2015; 122: 711-720 (IGR: 16-4)

58904 Baseline risk factors for incidence of blindness in a South Indian population: the chennai eye disease incidence study
Vijaya L; Asokan R; Panday M; Choudhari NS; Ramesh SV; Velumuri L; Boddupalli SD; Sunil GT; George R
Investigative Ophthalmology and Visual Science 2014; 55: 5545-5550 (IGR: 16-3)

59049 Ocular morbidity among refugees in Southwest Ethiopia
Gelaw Y; Abateneh A
Ethiopian journal of health sciences 2014; 24: 227-234 (IGR: 16-3)

59047 A longitudinal study of age-related changes in intraocular pressure: the Kangbuk Samsung Health Study
Zhao D; Kim MH; Pastor-Barriuso R; Chang Y; Ryu S; Zhang Y; Rampal S; Shin H; Kim JM; Friedman DS; Guallar E; Cho J
Investigative Ophthalmology and Visual Science 2014; 55: 6244-6250 (IGR: 16-3)

59439 Comparison of primary open angle glaucoma patients in rural and urban Ghana
Francis AW; Gyasi ME; Adjuik M; Kesse E; Chen Y; Harrison RS; Kodjo RA
African health sciences 2014; 14: 729-735 (IGR: 16-3)

59227 Prevalence of increased intraocular pressure and optic disk cupping: multicenter glaucoma screening in Israel during the 2009 and 2010 World Glaucoma Weeks
Nesher R;
Israeli Medical Association Journal 2014; 16: 483-486 (IGR: 16-3)

59160 Meta-analysis of genome-wide association studies identifies novel loci that influence cupping and the glaucomatous process
Springelkamp H; Höhn R; Mishra A; Hysi PG; Khor CC; Loomis SJ; Bailey JN; Gibson J; Thorleifsson G; Janssen SF; Luo X; Ramdas WD; Vithana E; Nongpiur ME; Montgomery GW; Xu L; Mountain JE; Gharahkhani P; Lu Y; Amin N; Karssen LC; Sim KS; van Leeuwen E
Nature communications 2014; 5: 4883 (IGR: 16-3)

59161 Association of open-angle glaucoma Loci with incident glaucoma in the blue mountains eye study
Burdon KP; Mitchell P; Lee A; Healey PR; White AJ; Rochtchina E; Thomas PB; Wang JJ; Craig JE
American Journal of Ophthalmology 2015; 159: 31-36.e1 (IGR: 16-3)

59505 Six-year incidence of ocular hypertension in a South Indian population: the Chennai eye disease incidence study
Panday M; George R; Asokan R; Ramesh SV; Velumuri L; Choudhari NS; Boddupalli SD; Sunil GT; Vijaya L
British Journal of Ophthalmology 2015; 99: 604-608 (IGR: 16-3)

59072 Allergic rhinitis is associated with open-angle glaucoma: a population-based case-control study
Chung SD; Lin HC; Hung SH
American journal of rhinology & allergy 2014; 28: e148-e151 (IGR: 16-3)

58821 The prevalence of primary angle closure glaucoma in adult Asians: a systematic review and meta-analysis
Cheng JW; Zong Y; Zeng YY; Wei RL
PLoS ONE 2014; 9: e103222 (IGR: 16-3)

57473 Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040: A Systematic Review and Meta-Analysis
Tham YC; Li X; Wong TY; Quigley HA; Aung T; Cheng CY
Ophthalmology 2014; 121: 2081-2090 (IGR: 16-2)

57041 Pattern of childhood ocular morbidity in rural eye hospital, Central Ethiopia
Mehari ZA
BMC Ophthalmology 2014; 14: 50 (IGR: 16-2)

57512 Prevalence of primary glaucoma among adults aged 50 years or above population in Huamu community: a cross-sectional survey in Shanghai, 2011
He J; Zou H; Tong X; Zhang S; Zhao R; Zhang Y; Zhou W; Tang W; Ge L
Chinese Journal of Ophthalmology 2014; 50: 349-354 (IGR: 16-2)

57147 The maccabi glaucoma study: prevalence and incidence of glaucoma in a large israeli health maintenance organization
Levkovitch-Verbin H; Goldshtein I; Chodick G; Zigman N; Shalev V
American Journal of Ophthalmology 2014; 158: 402-408.e1 (IGR: 16-2)

57222 Population-based glaucoma prevalence studies in Asians
Cho HK; Kee C
Survey of Ophthalmology 2014; 59: 434-447 (IGR: 16-2)

57528 Ophthalmic pathology in tubalars of the Altai Republic

Vestnik Oftalmologii 2014; 130: 35-40 (IGR: 16-2)

57495 Causes and prevalence of visual impairment in Japan
Wako R; Yasukawa T; Kato A; Omori T; Ishida S; Ishibashi T; Ogura Y
Nippon Ganka Gakkai Zasshi 2014; 118: 495-501 (IGR: 16-2)

57077 Gene-rich large deletions are overrepresented in POAG patients of Indian and Caucasian origins
Kaurani L; Vishal M; Kumar D; Sharma A; Mehani B; Sharma C; Chakraborty S; Jha P; Ray J; Sen A; Dash D; Ray K; Mukhopadhyay A
Investigative Ophthalmology and Visual Science 2014; 55: 3258-3264 (IGR: 16-2)

56999 Systemic Medication and Intraocular Pressure in a British Population: The EPIC-Norfolk Eye Study
Khawaja AP; Chan MP; Broadway DC; Garway-Heath DF; Luben R; Yip JL; Hayat S; Wareham NJ; Khaw KT; Foster PJ
Ophthalmology 2014; 121: 1501-1507 (IGR: 16-2)

57056 Spectrum of congenital defects of the eye and its adnexia in the pediatric age group; experience at a tertiary facility in Nigeria
Adekoya BJ; Balogun MM; Balogun BG; Ngwu RA
International Ophthalmology 2015; 35: 311-317 (IGR: 16-2)

57306 Demographic features of subjects with congenital glaucoma
Tamçelik N; Atalay E; Bolukbasi S; Çapar O; Ozkok A
Indian Journal of Ophthalmology 2014; 62: 565-569 (IGR: 16-2)

57247 Extended association study of PLEKHA7 and COL11A1 with primary angle closure glaucoma in a Han Chinese population
Chen Y; Chen X; Wang L; Hughes G; Qian S; Sun X
Investigative Ophthalmology and Visual Science 2014; 55: 3797-3802 (IGR: 16-2)

57236 Exfoliation syndrome in sub-Saharan Africa
Olawoye OO; Pasquale LR; Ritch R
International Ophthalmology 2014; 34: 1165-1173 (IGR: 16-2)

57396 Prevalence and causes of visual impairment in diabetic patients in Tunisia, North Africa
Kahloun R; Jelliti B; Zaouali S; Attia S; Ben Yahia S; Resnikoff S; Khairallah M
Eye 2014; 28: 986-991 (IGR: 16-2)

56116 Prevalence and causes of vision loss in Southeast Asia and Oceania: 1990-2010
Keeffe J; Taylor HR; Fotis K; Pesudovs K; Flaxman SR; Jonas JB; Leasher J; Naidoo K; Price H; White RA; Wong TY; Resnikoff S; Bourne RR;
British Journal of Ophthalmology 2014; 98: 586-591 (IGR: 16-1)

56176 Prevalence and causes of vision loss in Central and South Asia: 1990-2010
Jonas JB; George R; Asokan R; Flaxman SR; Keeffe J; Leasher J; Naidoo K; Pesudovs K; Price H; Vijaya L; White RA; Wong TY; Resnikoff S; Taylor HR; Bourne RR;
British Journal of Ophthalmology 2014; 98: 592-598 (IGR: 16-1)

56213 Posterior segment eye disease in sub-Saharan Africa: review of recent population-based studies
Bastawrous A; Burgess PI; Mahdi AM; Kyari F; Burton MJ; Kuper H
Tropical medicine & international health : TM & IH 2014; 19: 600-609 (IGR: 16-1)

56470 Predictors for Incidence of Primary Open-Angle Glaucoma in a South Indian Population: The Chennai Eye Disease Incidence Study
Vijaya L; Rashima A; Panday M; Choudhari NS; Ramesh SV; Lokapavani V; Boddupalli SD; Sunil GT; George R
Ophthalmology 2014; 121: 1370-1376 (IGR: 16-1)

56029 Results of a patient-directed survey on frequency of family history of glaucoma in 2170 patients
Gramer G; Weber BH; Gramer E
Investigative Ophthalmology and Visual Science 2014; 55: 259-264 (IGR: 16-1)

56232 Prevalence of open-angle glaucoma in southwestern China: the Yongchuan Glaucoma study
Li H; Zhang YY; Liu SC; He XG; Li CJ; Li CH; Li G; Xu J; Wu YF; Song SF
Journal of Huazhong University of Science and Technology. Medical sciences 2014; 34: 137-141 (IGR: 16-1)

56155 Glaucoma in southwest Nigeria: clinical presentation, family history and perceptions
Adekoya BJ; Shah SP; Onakoya AO; Ayanniyi AA
International Ophthalmology 2014; 34: 1027-1036 (IGR: 16-1)

56354 Prevalence and causes of vision loss in sub-Saharan Africa: 1990-2010
Naidoo K; Gichuhi S; Basáñez MG; Flaxman SR; Jonas JB; Keeffe J; Leasher JL; Pesudovs K; Price H; Smith JL; Turner HC; White RA; Wong TY; Resnikoff S; Taylor HR; Bourne RR;
British Journal of Ophthalmology 2014; 98: 612-618 (IGR: 16-1)

56380 Prevalence and causes of vision loss in North Africa and the Middle East: 1990-2010
Khairallah M; Kahloun R; Flaxman SR; Jonas JB; Keeffe J; Leasher J; Naidoo K; Pesudovs K; Price H; White RA; Wong TY; Resnikoff S; Taylor HR; Bourne RR;
British Journal of Ophthalmology 2014; 98: 605-611 (IGR: 16-1)

56492 Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990-2010
Bourne RR; Jonas JB; Flaxman SR; Keeffe J; Leasher J; Naidoo K; Parodi MB; Pesudovs K; Price H; White RA; Wong TY; Resnikoff S; Taylor HR;
British Journal of Ophthalmology 2014; 98: 629-638 (IGR: 16-1)

56424 Prevalence, causes of blindness, visual impairment and cataract surgical services in Sindhudurg district on the western coastal strip of India
Patil S; Gogate P; Vora S; Ainapure S; Hingane RN; Kulkarni AN; Shammanna BR
Indian Journal of Ophthalmology 2014; 62: 240-245 (IGR: 16-1)

56098 Health literacy of common ocular diseases in Nepal
Shrestha MK; Guo CW; Maharjan N; Gurung R; Ruit S
BMC Ophthalmology 2014; 14: 2 (IGR: 16-1)

55938 Is being female a risk factor for shallow anterior chamber? The associations between anterior chamber depth and age, sex, and body height
Hsu WC; Shen EP; Hsieh YT
Indian Journal of Ophthalmology 2014; 62: 446-449 (IGR: 16-1)

56146 Heritabilities of intraocular pressure in the population of Korea: the Korean National Health and Nutrition Examination Survey 2008-2009
Kim NR; Park HJ; Suh YJ; Chin HS; Kim CY
JAMA ophthalmology 2014; 132: 278-285 (IGR: 16-1)

56612 Development of a web-based glaucoma registry at King Khaled Eye Specialist Hospital, Saudi Arabia: a cost-effective methodology
Zaman B; Khandekar R; Al Shahwan S; Song J; Al Jadaan I; Al Jiasim L; Owaydha O; Asghar N; Hijazi A; Edward DP
Middle East African Journal of Ophthalmology 2014; 21: 182-185 (IGR: 16-1)

55630 Body height, estimated cerebrospinal fluid pressure and open-angle glaucoma. The Beijing Eye Study 2011
Jonas JB; Wang N; Wang YX; You QS; Xie X; Yang D; Xu L
PLoS ONE 2014; 9: e86678 (IGR: 15-4)

55212 Prevalence and types of glaucoma among an indigenous African population in southwestern Nigeria
Ashaye A; Ashaolu O; Komolafe O; Ajayi BG; Olawoye O; Olusanya B; Adeoti C
Investigative Ophthalmology and Visual Science 2013; 54: 7410-7416 (IGR: 15-4)

55499 The prevalence of age-related eye diseases and visual impairment in aging: current estimates
Klein R; Klein BE
Investigative Ophthalmology and Visual Science 2013; 54: ORSF5-ORSF13 (IGR: 15-4)

55482 Trans-lamina cribrosa pressure difference and open-angle glaucoma. The central India eye and medical study
Jonas JB; Nangia V; Wang N; Bhate K; Nangia P; Yang D; Xie X; Panda-Jonas S
PLoS ONE 2013; 8: e82284 (IGR: 15-4)

55112 Myopia and glaucoma in the South Korean population
Chon B; Qiu M; Lin SC
Investigative Ophthalmology and Visual Science 2013; 54: 6570-6577 (IGR: 15-4)

55318 Pseudoexfoliation: normative data and associations. The central India eye and medical study
Jonas JB; Nangia V; Matin A; Bhojwani K; Sinha A; Khare A; Agarwal S; Bhate K
PLoS ONE 2013; 8: e76770 (IGR: 15-4)

54301 The prevalence and types of glaucoma in an urban Indian population: the Singapore Indian Eye Study
Narayanaswamy A; Baskaran M; Zheng Y; Lavanya R; Wu R; Wong WL; Saw SM; Cheng CY; Wong TY; Aung T
Investigative Ophthalmology and Visual Science 2013; 54: 4621-4627 (IGR: 15-3)

54734 The chinese american eye study: design and methods
Varma R; Hsu C; Wang D; Torres M; Azen SP;
Ophthalmic Epidemiology 2013; 20: 335-347 (IGR: 15-3)

54810 Prevalence and associated factors of glaucoma in rural central India. The Central India Eye and Medical Study
Nangia V; Jonas JB; Matin A; Bhojwani K; Sinha A; Kulkarni M; Gupta R; Khare A; Agarwal S; Bhate K; Nangia P; Panda-Jonas S
PLoS ONE 2013; 8: e76434 (IGR: 15-3)

54790 Six-year incidence of angle-closure disease in a South Indian population: the chennai eye disease incidence study
Vijaya L; Asokan R; Panday M; Choudhari NS; Ramesh SV; Velumuri L; Boddupalli SD; Sunil GT; George R
American Journal of Ophthalmology 2013; 156: 1308-1315 (IGR: 15-3)

54809 Prevalence of optic disc hemorrhages in rural central India. The Central Indian Eye and Medical Study
Jonas JB; Nangia V; Khare A; Kulkarni M; Matin A; Sinha A; Bhojwani K; Nangia P; Panda-Jonas S
PLoS ONE 2013; 8: e76154 (IGR: 15-3)

54723 Epidemiology and characteristics of childhood glaucoma: results from the Dallas Glaucoma Registry
Fung DS; Roensch MA; Kooner KS; Cavanagh HD; Whitson JT
Clinical Ophthalmology 2013; 7: 1739-1746 (IGR: 15-3)

54628 Identification of persons with incident ocular diseases using health care claims databases
Stein JD; Blachley TS; Musch DC
American Journal of Ophthalmology 2013; 156: 1169-1175 (IGR: 15-3)

53953 Glaucoma Prevalence and the Intake of Iron and Calcium in a Population-based Study
Wang SY; Singh K; Lin SC
Current Eye Research 2013; 38: 1049-1056 (IGR: 15-2)

53641 Prevalence and Severity of Undetected Manifest Glaucoma: Results from the Early Manifest Glaucoma Trial Screening
Heijl A; Bengtsson B; Oskarsdottir SE
Ophthalmology 2013; 120: 1541-1545 (IGR: 15-2)

53482 Prevalence of glaucoma in an urban West African population: the Tema Eye Survey
Budenz DL; Barton K; Whiteside-De Vos J; Schiffman J; Bandi J; Nolan W; Herndon L; Kim H; Hay-Smith G; Tielsch JM;
JAMA ophthalmology 2013; 131: 651-658 (IGR: 15-2)

53722 A Population-based Survey of the Prevalence and Types of Glaucoma in Central Iran: The Yazd Eye Study
Pakravan M; Yazdani S; Javadi MA; Amini H; Behroozi Z; Ziaei H; Katibeh M; Solaimanizad R; Ghahari E; Yaseri M
Ophthalmology 2013; 120: 1977-1984 (IGR: 15-2)

53794 LV Prasad Eye Institute Glaucoma Epidemiology and Molecular Genetic Study (LVPEI- GLEAMS). Report 1: study design and research methodology
Addepalli UK; Jonnadula GB; Garudadri CS; Rao HL; Rani PK; Chakrabarti S; Papas EB; Sankaridurg P; Khanna RC
Ophthalmic Epidemiology 2013; 20: 188-195 (IGR: 15-2)

54021 Veteran eye disease after eligibility reform: prevalence and characteristics
Maa AY; Evans C; Delaune W; Lynch MG
Military medicine 2013; 178: 811-815 (IGR: 15-2)

54029 Unrecognized and unregistered blindness in people 70 or older in Jing'an district, Shanghai, China
Wu LC; Sun XH; Zhou XT; Wen CH
International Journal of Ophthalmology 2013; 6: 321-326 (IGR: 15-2)

53955 Age-related eye diseases and visual impairment among u.s. Adults
Chou CF; Frances Cotch M; Vitale S; Zhang X; Klein R; Friedman DS; Klein BE; Saaddine JB
American journal of preventive medicine 2013; 45: 29-35 (IGR: 15-2)

53920 Government-insured routine eye examinations and prevalence of nonrefractive vision problems among elderly
Jin YP; Buys YM; Xiong J; Trope GE
Canadian Journal of Ophthalmology 2013; 48: 167-172 (IGR: 15-2)

53819 Overview of age-related ocular conditions
Akpek EK; Smith RA
American Journal of Managed Care 2013; 19: s67-75 (IGR: 15-2)

53028 The British Asian community eye study: outline of results on the prevalence of eye disease in British Asians with origins from the Indian subcontinent
Rauf A; Malik R; Bunce C; Wormald R
Indian Journal of Ophthalmology 2013; 61: 53-58 (IGR: 15-1)

52530 Glaucoma subtypes in Ethiopian clinic patients
Tenkir A; Solomon B; Deribew A
Journal of Glaucoma 2013; 22: 110-116 (IGR: 15-1)

52954 Epidemiological properties of primary open angle glaucoma in Nigeria
Abdu L
Journal of Ophthalmology 2013; 2013: 402739 (IGR: 15-1)

52790 Prevalence and risk factors for eye diseases, blindness, and low vision in Lhasa, Tibet
Wang GQ; Bai ZX; Shi J; Luo S; Chang HF; Sai XY
International Journal of Ophthalmology 2013; 6: 237-241 (IGR: 15-1)

53152 Results of the bhaktapur glaucoma study, Nepal
Thapa SS; Poudyal I; Khanal S; Rens GV
Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH 2013; 5: 81-93 (IGR: 15-1)

52534 Epidemiology of glaucoma in sub-saharan Africa: prevalence, incidence and risk factors
Kyari F; Abdull MM; Bastawrous A; Gilbert CE; Faal H
Middle East African Journal of Ophthalmology 2013; 20: 111-125 (IGR: 15-1)

52635 Patterns of presentations at a free eye clinic in an urban state hospital
Hassan MB; Olowookere SA; Adeleke NA; Akinleye CA; Adepoju EG
Nigerian journal of clinical practice 2013; 16: 145-148 (IGR: 15-1)

52870 The prevalence of primary glaucoma in mainland China: a systematic review and meta-analysis
Cheng JW; Cheng SW; Ma XY; Cai JP; Li Y; Wei RL
Journal of Glaucoma 2013; 22: 301-306 (IGR: 15-1)

53153 The association between diagnosed glaucoma and cataract and cognitive performance in very old people: cross-sectional findings from the newcastle 85+ study
Jefferis JM; Taylor JP; Collerton J; Jagger C; Kingston A; Davies K; Kirkwood T; Clarke MP
Ophthalmic Epidemiology 2013; 20: 82-88 (IGR: 15-1)

52999 Distribution of glaucoma in the major religious communities of a north Indian town: a hospital survey
Agarwal S; Shamshad MA; Goel D; Ansari M
Journal of clinical and diagnostic research : JCDR 2013; 7: 499-502 (IGR: 15-1)

52634 Causes of moderate to severe visual impairment and blindness in population aged 50 years or more in rural Shandong province
Li Y; Bi HS; Wang LH; Wang T; Yang SY; Liu LP; Zhou CC
Chinese Journal of Ophthalmology 2013; 49: 144-150 (IGR: 15-1)

53170 Association of open-angle glaucoma with perfusion pressure status in the Thessaloniki Eye Study
Topouzis F; Wilson MR; Harris A; Founti P; Yu F; Anastasopoulos E; Pappas T; Koskosas A; Salonikiou A; Coleman AL
American Journal of Ophthalmology 2013; 155: 843-851 (IGR: 15-1)

52426 Incidence and predictors of glaucoma following surgery for congenital cataract in the first year of life in Victoria, Australia
Ruddle JB; Staffieri SE; Crowston JG; Sherwin JC; Mackey DA
Clinical and Experimental Ophthalmology 2013; 41: 653-661 (IGR: 15-1)

53240 Prevalence and outcomes of cataract surgery in adult rural Chinese populations of the Bai nationality in Dali: the Yunnan minority eye study
Shen W; Yang Y; Yu M; Wei T; Li X; Li J; Su X; Zhong H; Yuan Y
PLoS ONE 2013; 8: e60236 (IGR: 15-1)

53227 Frequency and risk factors of non-retinopathy ocular conditions in people with diabetes: the Singapore Malay Eye Study
Chiang PP; Lamoureux EL; Zheng Y; Tay WT; Mitchell P; Wang JJ; Wong TY
Diabetic Medicine 2013; 30: e32-e40 (IGR: 15-1)

52458 Prevalence of diabetes mellitus and hypertension among Indian glaucoma patients and evaluation of systemic therapy
Dave A; Bali SJ; Sharma R; Khurana AK; Gupta R; Dada T
International Ophthalmology 2013; 33: 527-532 (IGR: 15-1)

51923 Open-angle Glaucoma in Filipino and White Americans: A Comparative Study
Sáles CS; Lee RY; Agadzi AK; Hee MR; Singh K; Lin SC
Journal of Glaucoma 2014; 23: 246-253 (IGR: 14-4)

52056 Prevalence and causes of visual impairment and blindness, cataract surgical coverage and outcomes of cataract surgery in Libya
Rabiu MM; Jenf M; Fituri S; Choudhury A; Agbabiaka I; Mousa A
Ophthalmic Epidemiology 2013; 20: 26-32 (IGR: 14-4)

52058 Lack of awareness of common eye conditions in the community
Huang OS; Zheng Y; Tay WT; Chiang PP; Lamoureux EL; Wong TY
Ophthalmic Epidemiology 2013; 20: 52-60 (IGR: 14-4)

52020 Eye disorders in old people
Khalaj M; Barikani A; Ghasemi H
Global journal of health science 2013; 5: 79-86 (IGR: 14-4)

52016 Prevalence of end-of-life visual impairment in patients followed for glaucoma
Ernest PJ; Busch MJ; Webers CA; Beckers HJ; Hendrikse F; Prins MH; Schouten JS
Acta Ophthalmologica 2013; 91: 738-743 (IGR: 14-4)

51742 Five-year incidence of angle closure among glaucoma health examination participants
Kashiwagi K; Chiba T; Mabuchi F; Furuya T; Tsukahara S
Graefe's Archive for Clinical and Experimental Ophthalmology 2013; 251: 1219-1228 (IGR: 14-4)

52057 Prevalence and causes of patient dropout after glaucoma surgery
Gupta V; Chandra A; Yogi R; Sihota R; Singh D
Ophthalmic Epidemiology 2013; 20: 40-44 (IGR: 14-4)

51948 Vision Insurance, Eye Care Visits, and Vision Impairment Among Working-Age Adults in the United States
Li YJ; Xirasagar S; Pumkam C; Krishnaswamy M; Bennett CL
Archives of Ophthalmology 2012; 0: 1-8 (IGR: 14-4)

51833 Vision health disparities in the United States by race/ethnicity, education, and economic status: findings from two nationally representative surveys
Zhang X; Cotch MF; Ryskulova A; Primo SA; Nair P; Chou CF; Geiss LS; Barker LE; Elliott AF; Crews JE; Saaddine JB
American Journal of Ophthalmology 2012; 154: S53-62.e1 (IGR: 14-4)

51239 Prevalence and causes of visual impairment in elderly Amis aborigines in eastern Taiwan (the Amis Eye Study)
Chen N; Huang TL; Tsai RK; Sheu MM
Japanese Journal of Ophthalmology 2012; 56: 624-630 (IGR: 14-3)

51380 Analysis of eye health in the Thai population
Yospaiboon Y; Yospaiboon K; Ratanapakorn T; Sinawat S; Sanguansak T; Bhoomibunchoo C
Journal of the Medical Association of Thailand 2012; 95: S170-6 (IGR: 14-3)

50873 The prevalence and causes of visual impairment in an elderly Chinese Bai ethnic rural population: the Yunnan minority eye study
Zhong H; Cai N; Luo T; Li J; Su X; Li X; Qiu X; Yang Y; Yuan Y; Yu M
Investigative Ophthalmology and Visual Science 2012; 53: 4498-4504 (IGR: 14-3)

51361 Blindness and visual impairment in Remo, Ogun State, Nigeria: A hospital-based study
Otulana TO
The Nigerian postgraduate medical journal 2012; 19: 153-156 (IGR: 14-3)

51185 Low prevalence of myocilin mutations in an African American population with primary open-angle glaucoma
Liu W; Liu Y; Challa P; Herndon LW; Wiggs JL; Girkin CA; Allingham RR; Hauser MA
Molecular Vision 2012; 18: 2241-2246 (IGR: 14-3)

51186 A cross-ethnicity investigation of genes previously implicated in primary angle closure glaucoma
Awadalla MS; Burdon KP; Thapa SS; Hewitt AW; Craig JE
Molecular Vision 2012; 18: 2247-2254 (IGR: 14-3)

51013 The NEIGHBOR Consortium Primary Open-Angle Glaucoma Genome-wide Association Study: Rationale, Study Design, and Clinical Variables
Wiggs JL; Hauser MA; Abdrabou W; Allingham RR; Budenz DL; Delbono E; Friedman DS; Kang JH; Gaasterland D; Gaasterland T; Lee RK; Lichter PR; Loomis S; Liu Y; McCarty C; Medeiros FA; Moroi SE; Olson LM; Realini A; Richards JE; Rozsa FW; Schuman JS; Singh K; Stein JD; Vollrath D; Weinreb RN; Wollstein G; Yaspan BL; Yoneyama S; Zack D; Zhang K; Pericak-Vance M; Pasquale LR; Haines JL
Journal of Glaucoma 2013; 22: 517-525 (IGR: 14-3)

51271 Intraocular pressure and its relationship to ocular and systemic factors in a healthy Chinese rural population: the Handan Eye Study
Zhou Q; Liang YB; Wong TY; Yang XH; Lian L; Zhu D; Sun LP; Wang NL; Friedman DS
Ophthalmic Epidemiology 2012; 19: 278-284 (IGR: 14-3)

50972 Baseline Risk Factors that Predict the Development of Open-Angle Glaucoma in a Population: The Los Angeles Latino Eye Study
Jiang X; Varma R; Wu S; Torres M; Azen SP; Francis BA; Chopra V; Nguyen BB;
Ophthalmology 2012; 119: 2245-2253 (IGR: 14-3)

51346 Pseudoexfoliation Syndrome and the Long-Term Incidence of Cataract and Cataract Surgery: The Blue Mountains Eye Study
Kanthan GL; Mitchell P; Burlutsky G; Rochtchina E; Wang JJ
American Journal of Ophthalmology 2013; 155: 83-88.e1 (IGR: 14-3)

50432 Five year incidence of visual field loss in adult Chinese. The Beijing Eye Study
Wang YX; Xu L; Sun XY; Zou Y; Zhang HT; Jonas JB
PLoS ONE 2012; 7: e37232 (IGR: 14-2)

50236 The prevalence of glaucoma in adult rural Chinese populations of the Bai nationality in Dali: the Yunnan Minority Eye Study
Zhong H; Li J; Li C; Wei T; Cha X; Cai N; Luo T; Yu M; Yuan Y
Investigative Ophthalmology and Visual Science 2012; 53: 3221-3225 (IGR: 14-2)

50423 Visual status and ocular morbidity in older adults living in residential care
Dev MK; Shrestha GS; Paudel N; Joshi ND; Thapa M; Shah DN
Graefe's Archive for Clinical and Experimental Ophthalmology 2012; 250: 1387-1393 (IGR: 14-2)

50193 Regional variations and trends in the prevalence of diagnosed glaucoma in the medicare population
Cassard SD; Quigley HA; Gower EW; Friedman DS; Ramulu PY; Jampel HD
Ophthalmology 2012; 119: 1342-1351 (IGR: 14-2)

50286 Validity of Self-reported Eye Disease and Treatment in a Population-based Study: The Los Angeles Latino Eye Study
Patty L; Wu C; Torres M; Azen S; Varma R;
Ophthalmology 2012; 119: 1725-1730 (IGR: 14-2)

50291 Four-year incidence of open-angle glaucoma and ocular hypertension: the los angeles latino eye study
Varma R; Wang D; Wu C; Francis BA; Nguyen BB; Chopra V; Memarzadeh F; Torres M; Azen SP;
American Journal of Ophthalmology 2012; 154: 315-325 (IGR: 14-2)

50292 The changing face of primary open-angle glaucoma in the United States: demographic and geographic changes from 2011 to 2050
Vajaranant TS; Wu S; Torres M; Varma R
American Journal of Ophthalmology 2012; 154: 303-314 (IGR: 14-2)

50450 High intraocular pressure and open angle glaucoma
Tchabi-Hounnou S; Agbahoungba L; Sounouvou I; Yè,houessi L; Alamou S; Doutetien C; Bassabi SK
Journal Fran�ais d'Ophtalmologie 2012; 35: 523-528 (IGR: 14-2)

50460 The prevalence of primary angle closure glaucoma in European derived populations: a systematic review
Day AC; Baio G; Gazzard G; Bunce C; Azuara-Blanco A; Munoz B; Friedman DS; Foster PJ
British Journal of Ophthalmology 2012; 96: 1162-1167 (IGR: 14-2)

50517 Epidemiology of glaucoma: what's new?
Cook C; Foster P
Canadian Journal of Ophthalmology 2012; 47: 223-226 (IGR: 14-2)

50447 Disparities in Adult Vision Health in the United States
Zambelli-Weiner A; Crews JE; Friedman DS
American Journal of Ophthalmology 2012; 154: S23-30.e1 (IGR: 14-2)

50500 Blindness and Visual Impairment in an Urban West African Population: The Tema Eye Survey
Budenz DL; Bandi JR; Barton K; Nolan W; Herndon L; Whiteside-De Vos J; Hay-Smith G; Kim H; Tielsch J;
Ophthalmology 2012; 119: 1744-1753 (IGR: 14-2)

50560 Evidence for a considerable decrease in total and cause-specific incidences of blindness in Germany
Claessen H; Genz J; Bertram B; Trautner C; Giani G; Zö,llner I; Icks A
European Journal of Epidemiology 2012; 27: 519-524 (IGR: 14-2)

50511 Review of the publications of the Nigeria national blindness survey: methodology, prevalence, causes of blindness and visual impairment and outcome of cataract surgery
Rabiu MM; Kyari F; Ezelum C; Elhassan E; Sanda S; Murthy GV; Sivasubramaniam S; Glibert C; Abdull MM; Abiose A; Bankole O; Entekume G; Faal H; Imam A; Sang LP; Abubakar T
Annals of African medicine 2012; 11: 125-130 (IGR: 14-2)

50509 Visual impairment and blindness in rural central India: the Central India Eye and Medical Study
Nangia V; Jonas JB; Gupta R; Khare A; Sinha A
Acta Ophthalmologica 2013; 91: 483-486 (IGR: 14-2)

50231 The distribution of intraocular pressure in urban and in rural populations: the namil study in South Korea
Suh W; Kee C;
American Journal of Ophthalmology 2012; 154: 99-106 (IGR: 14-2)

49917 Risk factors for incident open-angle glaucoma: a population-based 20-year follow-up study
Ekströ,m C
Acta Ophthalmologica 2012; 90: 316-321 (IGR: 14-2)

49964 Prevalence of pseudoexfoliation syndrome in indigenous Australians within central Australia: The Central Australian Ocular Health Study
Landers J; Henderson T; Craig J
Clinical and Experimental Ophthalmology 2012; 40: 454-457 (IGR: 14-2)

50399 Patient satisfaction with topical ocular hypotensives
Kerr NM; Patel HY; Chew SS; Ali NQ; Eady EK; Danesh-Meyer HV
Clinical and Experimental Ophthalmology 2013; 41: 27-35 (IGR: 14-2)

49323 Causes of Visual Impairment among Patients Referred to a Visual Rehabilitation Clinic in Iran
Ramezani A; Pardis M; Rafati N; Kazemi-Moghaddam M; Katibeh M; Rostami P; Dehghan MH; Javadi MA; Rabbanikhah Z
Korean Journal of Ophthalmology 2012; 26: 80-83 (IGR: 14-1)

48928 Time trends in the incidence and causes of blindness in Israel
Skaat A; Chetrit A; Belkin M; Kinori M; Kalter-Leibovici O
American Journal of Ophthalmology 2012; 153: 214-221.e1 (IGR: 14-1)

48897 Epidemiologic characteristics of intraocular pressure in the Korean and Mongolian populations: the Healthy Twin and the GENDISCAN study
Lee MK; Cho SI; Kim H; Song YM; Lee K; Kim JI; Kim DM; Chung TY; Kim YS; Seo JS; Ham DI; Sung J
Ophthalmology 2012; 119: 450-457 (IGR: 14-1)

48808 The Australian and New Zealand Registry of Advanced Glaucoma: methodology and recruitment
Souzeau E; Goldberg I; Healey PR; Mills RA; Landers J; Graham SL; Grigg JR; Usher B; Straga T; Crawford A; Casson RJ; Morgan WH; Ruddle JB; Coote MA; White A; Stewart J; Hewitt AW; Mackey DA; Burdon KP; Craig JE
Clinical and Experimental Ophthalmology 2012; 40: 569-575 (IGR: 14-1)

48995 A Population-based Survey of the Prevalence and Types of Glaucoma in Nepal: The Bhaktapur Glaucoma Study
Thapa SS; Paudyal I; Khanal S; Twyana SN; Paudyal G; Gurung R; Ruit S; van Rens GH
Ophthalmology 2012; 119: 759-764 (IGR: 14-1)

49057 Review of key findings from the Singapore Malay Eye Study (SiMES-1)
Rosman M; Zheng Y; Lamoureux E; Saw SM; Aung T; Tay WT; Wang JJ; Mitchell P; Tai ES; Wong TY
Singapore Medical Journal 2012; 53: 82-87 (IGR: 14-1)

49070 Ocular morbidity in the rural areas of Allahabad, India
Singh A; Dwivedi S; Dabral SB; Bihari V; Rastogi AK; Kumar D
Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH 2012; 4: 49-53 (IGR: 14-1)

48806 Anterior chamber depth and its associations with ocular and general parameters in adults
Jonas JB; Nangia V; Gupta R; Khare A; Sinha A; Agarwal S; Bhate K
Clinical and Experimental Ophthalmology 2012; 40: 550-556 (IGR: 14-1)

49099 Prevalence of Primary Angle Closure and Primary Angle-Closure Glaucoma in a Southwestern Rural Population of Japan: The Kumejima Study
Sawaguchi S; Sakai H; Iwase A; Yamamoto T; Abe H; Tomita G; Tomidokoro A; Araie M
Ophthalmology 2012; 119: 1134-1142 (IGR: 14-1)

48775 One month outcome of ocular related emergencies in a tertiary hospital in Central Saudi Arabia
Alotaibi AG; Osman EA; Allam KH; Abdel-Rahim AM; Abu-Amero KK
Saudi Medical Journal 2011; 32: 1256-1260 (IGR: 14-1)

48768 Prevalence and risk factors for primary open-angle glaucoma in a rural northeast China population: a population-based survey in Bin County, Harbin
Sun J; Zhou X; Kang Y; Yan L; Sun X; Sui H; Qin D; Yuan H
Eye 2012; 26: 283-291 (IGR: 14-1)

49181 Beijing Eye Public Health Care Project
Xu L; Jonas JB; Cui TT; You QS; Wang YX; Yang H; Li JJ; Wei WB; Liang QF; Wang S; Yang XH; Zhang L
Ophthalmology 2012; 119: 1167-1174 (IGR: 14-1)

48725 Prevalence of eye diseases in South Korea: data from the Korea National Health and Nutrition Examination Survey 2008-2009
Yoon KC; Mun GH; Kim SD; Kim SH; Kim CY; Park KH; Park YJ; Baek SH; Song SJ; Shin JP; Yang SW; Yu SY; Lee JS; Lim KH; Park HJ; Pyo EY; Yang JE; Kim YT; Oh KW; Kang SW
Korean Journal of Ophthalmology 2011; 25: 421-433 (IGR: 14-1)

49199 Visual Impairment, Age-Related Eye Diseases, and Cognitive Function: The Singapore Malay Eye Study
Ong SY; Cheung CY; Li X; Lamoureux EL; Ikram MK; Ding J; Cheng CY; Haaland BA; Saw SM; Venketasubramanian N; Chen CP; Wong TY
Archives of Ophthalmology 2012; 130: 895-900 (IGR: 14-1)

49257 Glaucoma diseases in Rhineland-Palatine 2010. Epidemiology and utilization of healthcare
Wolfram C; Pfeiffer N
Ophthalmologe 2012; 109: 271-276 (IGR: 14-1)

49316 Geriatric vision loss due to cataracts, macular degeneration, and glaucoma
Eichenbaum JW
Mount Sinai Journal of Medicine 2012; 79: 276-294 (IGR: 14-1)

48439 The 12-year incidence of glaucoma and glaucoma-related visual field loss in Italy: the Ponza eye study
Cedrone C; Mancino R; Ricci F; Cerulli A; Culasso F; Nucci C
Journal of Glaucoma 2012; 21: 1-6 (IGR: 14-1)

48737 Causes of blindness and visual impairment in Latin America
Furtado JM; Lansingh VC; Carter MJ; Milanese MF; Peñ,a BN; Ghersi HA; Bote PL; Nano ME; Silva JC
Survey of Ophthalmology 0; 57: 149-177 (IGR: 14-1)

49103 Managing Glaucoma in those with Co-morbidity: Not as Easy as it Seems
Roughead EE; Kalisch LM; Pratt NL; Killer G; Barnard A; Gilbert AL
Ophthalmic Epidemiology 2012; 19: 74-82 (IGR: 14-1)

49171 The ophthalmic anomalies in children with Down syndrome in Split-Dalmatian County
Karlica D; Skelin S; Culic V; Galetović D; Znaor L; Karlica H; Paveli? J
Collegium Antropologicum 2011; 35: 1115-1118 (IGR: 14-1)

47681 The Rotterdam Study: 2012 objectives and design update
Hofman A; Van Duijn CM; Franco OH; Ikram MA; Janssen HLA; Klaver CCW; Kuipers EJ; Nijsten TEC; Stricker BHC; Tiemeier H
European Journal of Epidemiology 2011; 26: 657-686 (IGR: 13-4)

48110 Prevalence of primary open angle glaucoma in a rural adult chinese population: the handan eye study
Liang YB; Friedman DS; Zhou Q; Yang X; Sun LP; Guo LX; Tao QS; Chang DS; Wang NL
Investigative Ophthalmology and Visual Science 2011; 52: 8250-8257 (IGR: 13-4)

47893 The profile of glaucoma in a tertiary ophthalmic university center in riyadh, Saudi Arabia
Al Obeidan SA; Dewedar A; Osman EA; Mousa A
Saudi Journal of Ophthalmology 2011; 25: 373-379 (IGR: 13-4)

47685 New progresses of glaucoma research in China and abroad
Ge J; Huang J-J; Lan W-Z; Sun X-R
Chinese Journal of Ophthalmology 2010; 46: 893-899 (IGR: 13-4)

48310 Prevalence of glaucoma in a rural northern china adult population: a population-based survey in kailu county, inner mongolia
Song W; Shan L; Cheng F; Fan P; Zhang L; Qu W; Zhang Q; Yuan H
Ophthalmology 2011; 118: 1982-1988 (IGR: 13-4)

48126 Distribution and associations of intraocular pressure in indigenous Australians within central Australia: the Central Australian Ocular Health Study
Anders J; Henderson T; Craig J
Clinical and Experimental Ophthalmology 2011; 39: 607-613 (IGR: 13-4)

47734 Defining glaucomatous optic neuropathy from a continuous measure of optic nerve damage the optimal cut-off point for risk-factor analysis in population-based epidemiology
Ramdas WD; Rizopoulos D; Wolfs RCW; Hofman A; de Jong PTVM; Vingerling JR; Jansonius NM
Ophthalmic Epidemiology 2011; 18: 211-216 (IGR: 13-4)

48128 Prevalence and Characteristics of Primary Angle-Closure Diseases in a Rural Adult Chinese Population: The Handan Eye Study
Liang Y; Friedman DS; Zhou Q; Yang XH; Sun LP; Guo L; Chang DS; Lian L; Wang NL
Investigative Ophthalmology and Visual Science 2011; 52: 8672-8679 (IGR: 13-4)

47932 Causes and 3-year-incidence of blindness in Jing-An District, Shanghai, China 2001-2009
Wu L; Sun X; Zhou X; Weng C
BMC Ophthalmology 2011; 11: 10 (IGR: 13-4)

47966 Incidence of blindness and severe visual impairment in Germany: projections for 2030
Finger RP; Fimmers R; Holz FG; Scholl HP
Investigative ophthalmology & visual science 2011; 52: 4381-4389 (IGR: 13-4)

47643 Prevalence and causes of visual impairment among Saudi adults attending primary health care centers in northern Saudi Arabia
Al-Shaaln FF; Bakrman MA; Ibrahim AM; Aljoudi AS
Annals of Saudi Medicine 2011; 31: 473-480 (IGR: 13-4)

47594 Epidemiology of Major Eye Diseases Leading to Blindness in Europe: A Literature Review
Prokofyeva E; Zrenner E
Ophthalmic Research 2011; 47: 171-188 (IGR: 13-4)

47977 Prevalence, causes, and risk factors for functional low vision in Nigeria: results from the national survey of blindness and visual impairment
Entekume G; Patel J; Sivasubramaniam S; Gilbert CE; Ezelum CC; Murthy GV; Rabiu MM; Nigeria National Blindness and Visual Impairment Study Group
Investigative ophthalmology & visual science 2011; 52: 6714-6719 (IGR: 13-4)

47686 Present status and development of prevention of blindness and ophthalmic epidemiologic studies in China
Guan H-J
Chinese Journal of Ophthalmology 2010; 46: 938-943 (IGR: 13-4)

47980 Ocular perfusion pressure and the incidence of glaucoma: real effect or artifact? The Rotterdam Study
Ramdas WD; Wolfs RC; Hofman A; De Jong PT; Vingerling JR; Jansonius NM
Investigative ophthalmology & visual science 2011; 52: 6875-6881 (IGR: 13-4)

47928 Prevalence of pseudoexfoliation syndrome and pseudoexfoliation glaucoma in Upper Egypt
Shazly TA; Farrag AN; Kamel A; Al-Hussaini AK
BMC Ophthalmology 2011; 11: 18 (IGR: 13-4)

47626 Demographic and Geographic Features of Exfoliation Glaucoma in 2 United States-Based Prospective Cohorts
Kang JH; Loomis S; Wiggs JL; Stein JD; Pasquale LR
Ophthalmology 2011; (IGR: 13-4)

47717 Prevalence of cataract surgery and postoperative visual outcome in rural central India: Central India Eye and Medical Study
Nangia V; Jonas JB; Gupta R; Khare A; Sinha A
Journal of Cataract and Refractive Surgery 2011; 37: 1932-1938 (IGR: 13-4)

47614 Open-Angle Glaucoma and the Risk of Erectile Dysfunction. A Population-based Case-control Study
Chung S-D; Hu C-C; Ho J-D; Keller JJ; Wang T-J; Lin H-C
Ophthalmology 2011; (IGR: 13-4)

46686 Glaucoma and clinical characteristics in Vietnamese Americans
Peng P-H; Manivanh R; Nguyen N; Weinreb RN; Lin SC
Current Eye Research 2011; 36: 733-738 (IGR: 13-3)

47086 Prevalence and risk factors for angle-closure disease in a rural Northeast China population: A population-based survey in Bin County, Harbin
Qu W; Li Y; Song W; Zhou X; Kang Y; Yan L; Sui H; Yuan H
Acta Ophthalmologica 2011; 89: e515-e520 (IGR: 13-3)

46569 Frequency of primary open angle glaucoma in Abbasi Shaheed Hospital
Taqi U; Fasih U; Jafri SFA; Sheikh A
Journal of the Pakistan Medical Association 2011; 61: 778-781 (IGR: 13-3)

46782 Prevalence and characteristics of glaucoma among Korean adults
Kim JH; Kang SY; Kim NR; Lee ES; Hong S; Seong GJ; Hong YJ; Kim CY
Korean Journal of Ophthalmology 2011; 25: 110-115 (IGR: 13-3)

46340 Prevalence and causes of visual impairment and blindness in an urban Indian population: the singapore Indian eye study
Zheng Y; Lavanya R; Wu R; Wong WL; Wang JJ; Mitchell P; Cheung N; Cajucom-Uy H; Lamoureux E; Aung T
Ophthalmology 2011; 118: 1798-1804 (IGR: 13-3)

46341 Risk factors for four-year incident visual impairment and blindness: the los angeles latino eye study
Yonekawa Y; Varma R; Choudhury F; Torres M; Azen SP; Los Angeles Latino Eye Study Group
Ophthalmology 2011; 118: 1790-1797 (IGR: 13-3)

47106 Epidemiology of Eye Diseases Among Ethnic Chinese: Data From the Shihpai Eye Study
Hsu W-M
Journal of Experimental and Clinical Medicine 2011; (IGR: 13-3)

46656 Prevalence of Glaucoma in a Rural Northern China Adult Population. A Population-Based Survey in Kailu County, Inner Mongolia
Song W; Shan L; Cheng F; Fan P; Zhang L; Qu W; Zhang Q; Yuan H
Ophthalmology 2011; (IGR: 13-3)

46336 Anthropomorphic measurements and general and ocular parameters in adult Chinese: the Beijing Eye Study
Xu L; Wang YX; Zhang HT; Jonas JB
Acta Ophthalmologica 2011; 89: 442-447 (IGR: 13-3)

46975 Missing X and Y: A review of participant ages in population-based eye studies
Forward H; Hewitt AW; Mackey DA
Clinical and Experimental Ophthalmology 2011; (IGR: 13-3)

46461 Intraocular pressure, central corneal thickness, and glaucoma in Chinese adults: The Liwan eye study
Wang D; Huang W; Li Y; Zheng Y; Foster PJ; Congdon N; He M
American Journal of Ophthalmology 2011; 152: 454-462 (IGR: 13-3)

46361 The Toronto epidemiology glaucoma survey: a pilot study
Anraku A; Jin YP; Butty Z; Jinapriya D; Alasbali T; Mammo Z; Flanagan JG; Trope GE
Canadian Journal of Ophthalmology 2011; 46: 352-357 (IGR: 13-3)

46622 Prevalence of primary open-angle Glaucoma in central South Korea: The Namil study
Kim C-s; Seong GJ; Lee N-h; Song K-c
Ophthalmology 2011; 118: 1024-1030 (IGR: 13-3)

47129 Profile of the glaucomas and intervention in a large eye care centre in south-east Nepal
Sarkar S; Mardin C; Hennig A
Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH 2010; 2: 3-9 (IGR: 13-3)

46920 Epidemiology of ocular emergencies in the Egyptian population: A five-year retrospective study
El-Mekawey HE; Abu El Einen KG; Abdelmaboud M; Khafagy A; Eltahawy EM
Clinical Ophthalmology 2011; 5: 955-960 (IGR: 13-3)

46504 Quality of life and visual function in Nigeria: Findings from the National Survey of Blindness and Visual Impairment
Tran HM; Mahdi AM; Sivasubramaniam S; Gudlavalleti MVS; Gilbert CE; Shah SP; Ezelum CC; Abubakar T; Bankole OO
British Journal of Ophthalmology 2011; (IGR: 13-3)

46338 Visual acuity level, ocular morbidity, and the better seeing eye affect sensitivity and responsiveness of the visual function index
Las Hayas C; Quintana JM; Bilbao A; Garcia S; Lafuente I
Ophthalmology 2011; 118: 1303-1309 (IGR: 13-3)

46659 Five-year incidence of visual impairment and blindness in adult Chinese: The Beijing eye study
You QS; Xu L; Yang H; Wang YX; Jonas JB
Ophthalmology 2011; 118: 1069-1075 (IGR: 13-3)

46793 A population-based study of care-seeking behavior in rural tanzanians with glaucoma blindness
Lewallen S; Hassan HG; Al Attas AH; Courtright P
Journal of Glaucoma 2011; 20: 361-365 (IGR: 13-3)

46677 Predisease: When does it make sense?
Viera AJ
Epidemiologic Reviews 2011; 33: 122-134 (IGR: 13-3)

46334 Intraocular pressure and associated factors: the central India eye and medical study
Jonas JB; Nangia V; Matin A; Sinha A; Kulkarni M; Bhojwani K
Journal of Glaucoma 2011; 20: 405-409 (IGR: 13-3)

46894 High prevalence of pseudoexfoliation syndrome and its complications in Tarragona in northeast Spain
Romero-Aroca P; Masip-Serra R; Martinez-Salcedo I; Salvat-Serra M; Fernandez-Ballart J; Bautista-Perez A
European Journal of Ophthalmology 2011; 21: 580-588 (IGR: 13-3)

46354 Geographic and climatic factors associated with exfoliation syndrome
Stein JD; Pasquale LR; Talwar N; Kim DS; Reed DM; Nan B; Kang JH; Wiggs JL; Richards JE
Archives of Ophthalmology 2011; 129: 1053-1060 (IGR: 13-3)

46780 Prevalence of diabetes mellitus and arterial hypertension in ocular disorders
Venkateswaramurthy N; Abdul Fathah MA; Perumal P
International Journal of Pharmacy and Technology 2011; 3: 2765-2771 (IGR: 13-3)

46790 Glaucoma management in the patient with airways disease: Are we helping or harming?
Gilbert AL; Roughead EE
Pharmacoepidemiology and Drug Safety 2010; 19: S98 (IGR: 13-3)

47069 Socioeconomic status and open-angle glaucoma
Coleman AL; Kodjebacheva G
Expert Review of Ophthalmology 2011; 6: 295-296 (IGR: 13-3)

45934 Prevalence and determinants of glaucoma in citizens of Qatar aged 40 years or older: A community-based survey
Al-Mansouri F; Kanaan A; Gamra H; Khandekar R; Hashim S; Al Qahtani O; Ahmed MF
Middle East African Journal of Ophthalmology 2011; 18: 141-149 (IGR: 13-2)

45478 Prevalence of primary open-angle glaucoma in central South Korea the namil study
Kim CS; Seong GJ; Lee NH; Song KC
Ophthalmology 2011; 118: 1024-1030 (IGR: 13-2)

45597 The prevalence of glaucoma in indigenous Australians within Central Australia: The Central Australian ocular health study
Landers J; Henderson T; Craig J
British Journal of Ophthalmology 2011; (IGR: 13-2)

45848 Importance of population-based studies in clinical practice
Ronnie G; Ve R; Velumuri L; Asokan R; Vijaya L
Indian Journal of Ophthalmology 2011; 59: 11-18 (IGR: 13-2)

45893 Prevalence of chronic ocular diseases in a genetic isolate: The norfolk island eye study (NIES)
Sherwin JC; Kearns LS; Hewitt AW; Ma Y; Kelly J; Griffiths LR; Mackey DA
Ophthalmic Epidemiology 2011; 18: 61-71 (IGR: 13-2)

46181 Glaucoma among patients enrolled in a national vision care plan
Soroka M; Krumholz DM; Wende J
Optometry 2010; 81: 663-670 (IGR: 13-2)

46166 Prevalence of visual impairment, cataract surgery and awareness of cataract and glaucoma in Bhaktapur district of Nepal: the Bhaktapur Glaucoma Study
Thapa SS; Berg RV; Khanal S; Paudyal I; Pandey P; Maharjan N; Twyana SN; Paudyal G; Gurung R; Ruit S
BMC Ophthalmology 2011; 11: 2 (IGR: 13-2)

45993 Central corneal thickness and intraocular pressure in a nepalese population: The bhaktapur glaucoma study
Thapa SS; Paudyal I; Khanal S; Paudel N; Mansberger SL; van Rens G
Journal of Glaucoma 2011; (IGR: 13-2)

45968 A Prospective Study of Diabetes, Lifestyle Factors, and Glaucoma Among African-American Women
Wise LA; Rosenberg L; Radin RG; Mattox C; Yang EB; Palmer JR; Seddon JM
Annals of Epidemiology 2011; 21: 430-439 (IGR: 13-2)

45933 Prevalence and causes of blindness and visual impairment in Sokoto State, Nigeria: Baseline data for Vision 2020: The right to sight eye care programme
Muhammad N; Mansur R; Dantani A; Elhassan E; Isiyaku S
Middle East African Journal of Ophthalmology 2011; 18: 123-128 (IGR: 13-2)

45756 Prevalence and Causes of Visual Impairment and Blindness in an Urban Indian Population. The Singapore Indian Eye Study
Zheng Y; Lavanya R; Wu R; Wong W-L; Wang JJ; Mitchell P; Cheung N; Cajucom-Uy H; Lamoureux E; Aung T
Ophthalmology 2011; (IGR: 13-2)

46205 The 97.5th and 99.5th percentile of vertical cup disc ratio in the United States
Swanson MW
Optometry and Vision Science 2011; 88: 86-92 (IGR: 13-2)

45473 Perimetry, tonometry and epidemiology: the fate of glaucoma management
Heijl A
Acta Ophthalmologica 2011; 89: 309-315 (IGR: 13-2)

46198 Cost-effectiveness of glaucoma interventions in Barbados and Ghana
Wittenborn JS; Rein DB
Optometry and Vision Science 2011; 88: 155-163 (IGR: 13-2)

27793 Rationale, methods and baseline demographics of the Bhaktapur Glaucoma Study
Thapa SS; Rana PP; Twayana SN; Shrestha MK; Paudel I; Paudyal G; Gurung R; Ruit S; Hewitt AW; Craig JE
Clinical and Experimental Ophthalmology 2011; 39: 126�134 (IGR: 13-1)

27923 Differences in Rates of Glaucoma among Asian Americans and Other Racial Groups, and among Various Asian Ethnic Groups
Stein JD; Kim DS; Niziol LM; Talwar N; Nan B; Musch DC; Richards JE
Ophthalmology 2011; 118: 1031-1037 (IGR: 13-1)

27922 Prevalence of Primary Open-Angle Glaucoma in Central South Korea. The Namil Study
Kim C-s; Seong GJ; Lee N-h; Song K-c
Ophthalmology 2011; 118: 1024-1030 (IGR: 13-1)

27987 Correlated or not: Glaucoma prevalence and modern industrialization
Wang L; Zhang X; Cai S; Ma J; Liu X; Wang N
Medical Hypotheses 2011; 76: 220-224 (IGR: 13-1)

27775 Associations between Gender, Ocular Parameters and Diseases: The Beijing Eye Study
Xua L; Youa QS; Wanga YX; Jonasa JB
Ophthalmic Research 2011; 45: 197-203 (IGR: 13-1)

27679 High prevalence of narrow angles among filipino-american patients
Seider MI; S�les CS; Lee RY; Agadzi AK; Porco TC; Weinreb RN; Lin SC
Journal of Glaucoma 2011; 20: 139-142 (IGR: 13-1)

27780 Anophthalmos, Microphthalmos, and Typical Coloboma in the United Kingdom: A Prospective Study of Incidence and Risk
Shah SP; Taylor AE; Sowden JC; Ragge NK; Russell-Eggitt I; Rahi JS; Gilbert CE
Investigative Ophthalmology and Visual Science 2011; 52: 558-564 (IGR: 13-1)

27109 Research into Glaucoma and Ethnicity (ReGAE) 8: Is there a relationship between social deprivation and acute primary angle closure?
Nessim M; Denniston AK; Nolan W; Holder R; Shah P
British Journal of Ophthalmology 2010; 94: 1304-1306 (IGR: 12-4)

27102 Prevalence of visual impairment and eye diseases in Arkansas
Irak-Dersu I; Balamurugan A
The Journal of the Arkansas Medical Society 2010; 107: 62-64 (IGR: 12-4)

27334 A glaucoma equity profile: Correlating disease distribution with service provision and uptake in a population in Northern England, UK
Day F; Buchan JC; Cassells-Brown A; Fear J; Dixon R; Wood F
Eye 2010; 24: 1478-1485 (IGR: 12-4)

27164 Associations between Gender, Ocular Parameters and Diseases: The Beijing Eye Study
Xu L; You QS; Wang YX; Jonas JB
Ophthalmic Research 2010; 45: 197-203 (IGR: 12-4)

27372 Glaucoma medications and mortality: A retrospective cohort study
French DD; Margo CE
Annals of Epidemiology 2010; 20: 917-923 (IGR: 12-4)

27640 Prevalence and causes of visual impairment in a rural North-east China adult population: A population-based survey in Bin County, Harbin
Song W; Sun X; Shao Z; Zhou X; Kang Y; Sui H; Yuan H
Acta Ophthalmologica 2010; 88: 669-674 (IGR: 12-4)

27119 Glaucoma prevalence in indigenous Australians
Chua BE; Xie J; Arnold A-L; Koukouras I; Keeffe JE; Taylor HR
British Journal of Ophthalmology 2010; (IGR: 12-4)

27172 Using the Utah Population Database to assess familial risk of primary open angle glaucoma
Wang X; Harmon J; Zabrieskie N; Chen Y; Grob S; Williams B; Lee C; Kasuga D; Shaw PX; Buehler J
Vision Research 2010; 50: 2391-2395 (IGR: 12-4)

27210 Characteristics of cup/disc ratios in a population of northern Togo aged 20-40 years
Ayena KD; Agbo ADR; Attaya ABM; Djagnikpo AP; Kondi GM; Dzidzinyo KB; Amedome KM; Nononsaa KB; Banla M; Balo KP
Journal Fran�ais d'Ophtalmologie 2010; 33: 408-413 (IGR: 12-4)

27368 Creating synergies for health systems strengthening through partnerships in Pakistan - a case study of the national eye health programme
Khan AA; Khan NU; Bile KM; Awan H
Eastern Mediterranean health journal 2010; 16: S61-68 (IGR: 12-4)

27628 Ophthalmic admissions in a tertiary hospital in Nigeria
Onakpoya OH; Adegbehingbe BO; Adeoye AO; Adewara BA
African health sciences 2010; 10: 54-57 (IGR: 12-4)

27352 Profile of patients of glaucoma in Kashmir valley (A hospital based study)
Rashid W; Rather S; Singh T
JK Science 2010; 12: 137-140 (IGR: 12-4)

27087 Prevalence of glaucoma in North China: The Beijing eye study
Wang YX; Xu L; Yang H; Jonas JB
American Journal of Ophthalmology 2010; 150: 917-924 (IGR: 12-4)

26998 Prevalence and causes of low vision and blindness in a rural southwest island of Japan the kumejima study.
Nakamura Y; Tomidokoro A; Sawaguchi S; Sakai H; Iwase A; Araie M
Ophthalmology 2010; 117: 2315-2321 (IGR: 12-4)

27320 Prevalence and causes of blindness, low vision and status of cataract in 50 years and older citizen of Qatar-A community based survey
Gamra HA; Mansouri FA; Khandekar R; Elshafei M; Qahtani OA; Singh R; Hashim SP; Mujahed A; Makled A; Pai A
Ophthalmic Epidemiology 2010; 17: 292-300 (IGR: 12-4)

27612 Epidemiological survey on blindness and low vision among adults aged 50 years or above in Sanya outskirts
Wen X-F; Fan X-Q
International Journal of Ophthalmology 2010; 10: 1797-1798 (IGR: 12-4)

27215 Causes of blindness and low vision in Bayelsa State, Nigeria: a clinic based study
Richard AI
Nigerian quarterly journal of hospital medicine 2010; 20: 125-128 (IGR: 12-4)

27042 The frequency of pseudoexfoliation syndrome in the middle Black Sea region of Turkey.
Cumurcu T; Kilic R; Yologlu S
European Journal of Ophthalmology 2010; 20: 1007-1011 (IGR: 12-4)

27081 Prevalence of exfoliation syndrome in Estonia.
Kaljurand K; Teesalu P
European Journal of Ophthalmology 2010; 20: 1012-107 (IGR: 12-4)

27191 Comparison of comorbid conditions between open-angle glaucoma patients and a control cohort: A case-control study
Lin H-C; Chien C-W; Hu C-C; Ho J-D
Ophthalmology 2010; 117: 2088-2095 (IGR: 12-4)

26891 Ocular findings among young men: A 12-year prevalence study of military service in Poland
Nowak MS; Jurowski P; Gos R; Smigielski J
Acta Ophthalmologica 2010; 88: 535-540 (IGR: 12-3)

26862 Survey of diagnosis and treatment of glaucoma in the middle-aged and aged population in China
Hao Y-H; Zhao X
International Journal of Ophthalmology 2010; 10: 1095-1099 (IGR: 12-3)

26457 Etiology of ocular diseases in elderly Amis aborigines in Eastern Taiwan (The Amis Eye Study)
Huang T-L; Hsu S-Y; Tsai R-K; Sheu M-M
Japanese Journal of Ophthalmology 2010; 54: 266-271 (IGR: 12-3)

26329 Incidence of Glaucomatous Visual Field Loss: A Ten-Year Follow-up from the Rotterdam Study
Czudowska MA; Ramdas WD; Wolfs RC; Hofman A; De Jong PT; Vingerling JR; Jansonius NM
Ophthalmology 2010; 117: 1705-1712 (IGR: 12-3)

26400 A glaucoma equity profile: correlating disease distribution with service provision and uptake in a population in Northern England, UK
Day F; Buchan JC; Cassells-Brown A; Fear J; Dixon R; Wood F
Eye 2010; 24: 1478-1485 (IGR: 12-3)

26504 Prevalence and risk factors for primary glaucomas in adult urban and rural populations in the Andhra Pradesh eye disease study
Garudadri C; Senthil S; Khanna RC; Sannapaneni K; Rao HBL
Ophthalmology 2010; 117: 1352-1359 (IGR: 12-3)

26594 Prevalence of and risk factors for primary open-angle glaucoma in central Sri Lanka: The Kandy Eye Study
Sia DIT; Edussuriya K; Sennanayake S; Senaratne T; Selva D; Casson RJ
Ophthalmic Epidemiology 2010; 17: 211-216 (IGR: 12-3)

26472 Causes of visual impairment in Mie Prefecture during a 5-year period
Ikesugi K; Tsukitome H; Yagi T; Yamaguchi T; Tamei I; Sasoh M; Uji Y
Nippon Ganka Gakkai Zasshi 2010; 114: 505-511 (IGR: 12-3)

26845 Ophthalmopathy analysis on physical examination of staff of 40 years old and above in the University of Science and Technology Beijing
Wang X-L; Feng H
International Journal of Ophthalmology 2010; 10: 988-989 (IGR: 12-3)

26410 Intraocular pressure and related systemic and ocular biometric factors in a population-based study in Japan: The kumejima study
Tomoyose E; Higa A; Sakai H; Sawaguchi S; Iwase A; Tomidokoro A; Amano S; Araie M
American Journal of Ophthalmology 2010; 150: 279-286 (IGR: 12-3)

26358 Ocular biometry and open-angle glaucoma: the los angeles latino eye study
Kuzin AA; Varma R; Reddy HS; Torres M; Azen SP; Los Angeles Latino Eye Study Group
Ophthalmology 2010; 117: 1713-1719 (IGR: 12-3)

26308 Ultrasound biomicroscopic configurations of the anterior ocular segment in a population-based study the kumejima study
Henzan IM; Tomidokoro A; Uejo C; Sakai H; Sawaguchi S; Iwase A; Araie M
Ophthalmology 2010; 117: 1720-1728 (IGR: 12-3)

26708 Incidence and clinical characteristics of childhood glaucoma from 1965 to 2005
Mohney BG; Aponte EP; Diehl N
Journal of AAPOS 2009; 13: 23 (IGR: 12-3)

26345 Angle closure in the andhra pradesh eye disease study
Senthil S; Garudadri C; Khanna RC; Sannapaneni K
Ophthalmology 2010; 117: 1729-1735 (IGR: 12-3)

26911 The Chennai glaucoma study: prevalence and risk factors for glaucoma in cataract operated eyes in urban Chennai
George R; Arvind H; Baskaran M; Ramesh SV; Raju P; Vijaya L
Indian Journal of Ophthalmology 2010; 58: 243-245 (IGR: 12-3)

26644 Glaucoma in India: Estimated burden of disease
George R; Ve RS; Vijaya L
Journal of Glaucoma 2010; 19: 391-397 (IGR: 12-3)

26060 Prevalence of major eye diseases and causes of visual impairment in the adult Finnish population: A nationwide population-based survey
Laitinen A; Laatikainen L; Harkanen T; Koskinen S; Reunanen A; Aromaa A
Acta Ophthalmologica 2010; 88: 463-471 (IGR: 12-2)

26100 Commingling analyses of central corneal thickness and adjusted intraocular pressure in an older Australian population
Rahman ML; Bunce C; Healey PR; Mitchell P; Sham PC; McGuffin P; Viswanathan AC
Investigative Ophthalmology and Visual Science 2010; 51: 2512-2518 (IGR: 12-2)

26204 Four-year incidence and progression of visual impairment in Latinos: the Los Angeles Latino Eye Study
Varma R; Chung J; Foong AW; Torres M; Choudhury F; Azen SP; Los Angeles Latino Eye Study Group
American Journal of Ophthalmology 2010; 149: 713-727 (IGR: 12-2)

26116 Blood pressure, perfusion pressure, and open-angle glaucoma: the Los Angeles Latino Eye Study
Memarzadeh F; Ying-Lai M; Chung J; Azen SP; Varma R; Los Angeles Latino Eye Study Group
Investigative Ophthalmology and Visual Science 2010; 51: 2872-2877 (IGR: 12-2)

25823 Epidemiology of glaucoma and drug utilization in UK primary care
Maguire A; Thompson M
Pharmacoepidemiology and Drug Safety 2009; 18: S143 (IGR: 12-2)

25822 Quantification of patient population impact of contra-indications: Glaucoma therapy
Maguire A; MacLachlan S
Pharmacoepidemiology and Drug Safety 2009; 18: S100 (IGR: 12-2)

25380 Methodology of the Singapore Indian Chinese Cohort (SICC) eye study: Quantifying ethnic variations in the epidemiology of eye diseases in Asians
Lavanya R; Jeganathan V S E; Zheng Y; Raju P; Cheung N; Tai E S; Wang J J; Lamoureux E; Mitchell P; Young T L
Ophthalmic Epidemiology 2009; 16: 325-336 (IGR: 12-1)

25379 Prevalence of visual impairment in the adult Japanese population by cause and severity and future projections
Yamada M; Hiratsuka Y; Roberts C B; Pezzullo M L; Yates K; Takano S; Miyake K; Taylor H R
Ophthalmic Epidemiology 2010; 17: 50-57 (IGR: 12-1)

25085 Glaucoma in latinos/hispanics
Kim E; Varma R
Current Opinions in Ophthalmology 2010; 21: 100-105 (IGR: 12-1)

25089 Gender and glaucoma: what we know and what we need to know
Vajaranant TS; Nayak S; Wilensky JT; Joslin CE
Current Opinions in Ophthalmology 2010; 21: 91-99 (IGR: 12-1)

25050 Level of education associated with ophthalmic diseases. The Beijing Eye Study
Xu L; Wang YX; Jonas JB
Graefe's Archive for Clinical and Experimental Ophthalmology 2010; 248: 49-57 (IGR: 12-1)

25339 Gender inequality in vision loss and eye diseases: Evidence from the Sultanate of Oman
Khandekar R; Mohammed A J
Indian Journal of Ophthalmology 2009; 57: 443-449 (IGR: 12-1)

25621 Twins Eye Study in Tasmania (TEST): Rationale and methodology to recruit and examine twins
Mackey D A; MacKinnon J R; Brown S A; Kearns L S; Ruddle J B; Sanfilippo P G; Sun C; Hammond C J; Young T L; Martin N G
Twin Research and Human Genetics: the Official Journal of the International Society for Twin Studies 2009; 12: 441-454 (IGR: 12-1)

25309 Presentation of glaucoma in an urban tertiary care hospital in South America: legal blindness and prevalence
Osaki T H; Kasahara N; Paolera M D; Cohen R; Nishiwaki-Dantas M C
International Ophthalmology 2010; 1-6 (IGR: 12-1)

25154 Distribution and determinants of ocular biometric parameters in an Asian population: the Singapore Malay eye study
Lim LS; Saw SM; Jeganathan VS; Tay WT; Aung T; Tong L; Mitchell P; Wong TY
Investigative Ophthalmology and Visual Science 2010; 51: 103-109 (IGR: 12-1)

25013 Mortality in primary open-angle glaucoma: 'two cupped discs and a funeral'
Hewitt AW; Sanfilippo P; Ring MA; Craig JE; Mackey DA
Eye 2010; 24: 59-63 (IGR: 12-1)

24871 Increased likelihood of glaucoma at the same screening intraocular pressure in subjects with pseudoexfoliation: the Thessaloniki Eye Study
Topouzis F; Harris A; Wilson MR; Koskosas A; Founti P; Yu F; Anastasopoulos E; Pappas T; Coleman AL
American Journal of Ophthalmology 2009; 148: 606-613 (IGR: 11-4)

24971 Comparing specific disc findings of a European and a bantu population
Krueger H; Schittkowski MP; Kilangalanga N; Hopkins A; Guthoff R
Klinische Monatsbl�tter f�r Augenheilkunde 2009; 226: 844-848 (IGR: 11-4)

24988 Prevalence of glaucoma types and legal blindness from glaucoma in the western region of Saudi Arabia: a hospital-based study
Eid TM; el-Hawary I; El-Menawy W
International Ophthalmology 2009; 29: 477-483 (IGR: 11-4)

24821 Direct and indirect effects of visual impairment on mortality risk in older persons
Karpa MJ; Mitchell P; Beath K; Rochtchina E; Cumming RG; Wang JJ; Blue Mountains Eye Study
Archives of Ophthalmology 2009; 127: 1347-1353 (IGR: 11-4)

24773 Causes of vision impairment and assessment of need for low vision services for students of blind schools in Nepal
Kansakar I; Thapa HB; Salma KC; Ganguly S; Kandel RP; Rajasekaran S
Kathmandu University Medical Journal 2009; 7: 44-49 (IGR: 11-4)

24896 Incorporating mortality risk into estimates of 5-year glaucoma risk
Griffin BA; Elliott MN; Coleman AL; Cheng EM
American Journal of Ophthalmology 2009; 148: 925-931 (IGR: 11-4)

24983 Body height and ocular diseases. The Beijing Eye Study
Xie XW; Xu L; Wang YX; Jonas JB
Graefe's Archive for Clinical and Experimental Ophthalmology 2009; 247: 1651-1657 (IGR: 11-4)

24161 Causes of blindness and visual impairment in Nigeria: the Nigeria national blindness and visual impairment survey
Abdull MM; Sivasubramaniam S; Murthy GV; Gilbert C; Abubakar T; Ezelum C; Rabiu MM; Nigeria National Blindness and Visual Impairment Study Group
Investigative Ophthalmology and Visual Science 2009; 50: 4114-4120 (IGR: 11-3)

24109 Visual function survey of commercial intercity vehicle drivers in Ilorin, Nigeria
Adekoya BJ; Owoeye JF; Adepoju FG; Ajaiyeoba AI
Canadian Journal of Ophthalmology 2009; 44: 261-264 (IGR: 11-3)

24094 Prevalence and determinants of angle closure in central Sri Lanka: the Kandy Eye Study
Casson RJ; Baker M; Edussuriya K; Senaratne T; Selva D; Sennanayake S
Ophthalmology 2009; 116: 1444-1449 (IGR: 11-3)

24092 Nine-year incidence of visual impairment in the Barbados Eye Studies
Hennis AJ; Wu SY; Nemesure B; Hyman L; Schachat AP; Leske MC; Barbados Eye Studies Group
Ophthalmology 2009; 116: 1461-1468 (IGR: 11-3)

24311 Types and presentation of glaucoma
Iqbal S; Khan Z; Shah SA; Khan MY
Journal of Postgraduate Medical Institute 2008; 22: 324-332 (IGR: 11-3)

24475 Prevalence of open angle glaucoma in accompanying first degree relatives of patients with glaucoma
Vegini F; Figueiroa Filho N; Lenci RF; Neto DG; Susanna Jr R
Clinics 2008; 63: 329-332 (IGR: 11-3)

24026 Population prevalence of tilted and torted optic discs among an adult Chinese population in Singapore: the Tanjong Pagar Study
How AC; Tan GS; Chan YH; Wong TT; Seah SK; Foster PJ; Aung T
Archives of Ophthalmology 2009; 127: 894-899 (IGR: 11-3)

24274 Epidemiology of hospitalized pediatric glaucoma patients in Beijing Tongren Hospital
Qiao C-Y; Wang L-H; Tang X; Wang T; Yang D-Y; Wang N-L
Chinese Medical Journal 2009; 122: 1162-1166 (IGR: 11-3)

24023 Pseudoexfoliation in the reykjavik eye study: five-year incidence and changes in related ophthalmologic variables
Arnarsson A; Damji KF; Sasaki H; Sverrisson T; Jonasson F
American Journal of Ophthalmology 2009; 148: 291-297 (IGR: 11-3)

24128 From epidemiology to lysyl oxidase like one (LOXL1) polymorphisms discovery: phenotyping and genotyping exfoliation syndrome and exfoliation glaucoma in Iceland
Jonasson F
Acta Ophthalmologica 2009; 87: 478-487 (IGR: 11-3)

23477 APOC impact assessment studies: baseline ophthalmological findings in Morogoro, Tanzania
Babalola OE; Maegga B; Katenga S; Ogbuagu FK; Umeh RE; Seketeli E; Braide E
African Journal of Medicine and Medical Science 2008; 37: 327-332 (IGR: 11-2)

23759 The Beijing Eye Study
Jonas JB; Xu L; Wang YX
Acta Ophthalmologica 2009; 87: 247-261 (IGR: 11-2)

23433 Gender differences in adult blindness and low vision, Central Ethiopia
Woldeyes A; Adamu Y
Ethiopian medical journal 2008; 46: 211-218 (IGR: 11-2)

23445 Tajimi Study review
Suzuki Y; Yamamoto T; Araie M; Iwase A; Tomidokoro A; Abe H; Shirato S; Kuwayama Y; Mishima HK; Shimizu H
Nippon Ganka Gakkai Zasshi 2008; 112: 1039-1058 (IGR: 11-2)

23592 Assessment of visual status of the Aeta, a hunter-gatherer population of the Philippines (an AOS thesis)
Allingham RR
Transactions of the American Ophthalmological Society 2008; 106:- 240-251 (IGR: 11-2)

23931 Prevalence of blindness and visual impairment in Nigeria: the National Blindness and Visual Impairment Study
Kyari F; Gudlavalleti MV; Sivsubramaniam S; Gilbert CE; Abdull MM; Entekume G; Foster A; Nigeria National Blindness and Visual Impairment Study Group
Investigative Ophthalmology and Visual Science 2009; 50: 2033-2039 (IGR: 11-2)

23771 Central corneal thickness and its associations with ocular and systemic factors: the Singapore Malay Eye Study
Su DH; Wong TY; Foster PJ; Tay WT; Saw SM; Aung T
American Journal of Ophthalmology 2009; 147: 709-716 (IGR: 11-2)

23898 Population-based prevalence of optic disc haemorrhages in elderly Japanese
Tomidokoro A; Iwase A; Araie M; Yamamoto T; Kitazawa Y
Eye 2009; 23: 1032-1037 (IGR: 11-2)

23419 Pseudoexfoliation syndrome in various ethnic population of Nepal
Shakya S; Dulal S; Maharjan IM
Nepal Medical College journal: NMCJ 2008; 10: 147-150 (IGR: 11-2)

23847 Prevalence of superior segmental optic nerve hypoplasia in Korea
Han SB; Park KH; Kim DM; Kim TW
Japanese Journal of Ophthalmology 2009; 53: 225-228 (IGR: 11-2)

23796 Biobanks and the importance of detailed phenotyping: a case study--the European Glaucoma Society GlaucoGENE project
Founti P; Topouzis F; van Koolwijk L; Traverso CE; Pfeiffer N; Viswanathan AC
British Journal of Ophthalmology 2009; 93: 577-581 (IGR: 11-2)

22639 Glaucoma in Africa: size of the problem and possible solutions
Cook C
Journal of Glaucoma 2009; 18: 124-128 (IGR: 11-1)

22864 Visual acuity and acute angle-closure glaucoma in split-dalmatia county
Kljajic Z; Bojic L
Acta Clinica Croatica 2008; 47: 137-140 (IGR: 11-1)

22915 Oman Eye Study 2005: prevalence and determinants of glaucoma
Khandekar R; Jaffer MA; Al Raisi A; Zutshi R; Mahabaleshwar M; Shah R; Choudhury AH
Eastern Mediterranean health journal 2008; 14: 1349-1359 (IGR: 11-1)

22565 The characteristics of glaucoma in Japanese Americans
Pekmezci M; Vo B; Lim AK; Hirabayashi DR; Tanaka GH; Weinreb RN; Lin SC
Archives of Ophthalmology 2009; 127: 167-171 (IGR: 11-1)

22940 Clinical and epidemiological characteristics of chronic open angle glaucoma at a Yaounde Hospital
Eballe AO; Owono D; Bella AL; Ebana C; Long D; Aboutou R
Sant� 2008; 18: 19-23 (IGR: 11-1)

22759 Population-Based Studies in Ophthalmology
Wong TY; Hyman L
American Journal of Ophthalmology 2008; 146: 656-663 (IGR: 11-1)

23396 Trends in rates of primary angle closure glaucoma and cataract surgery in England from 1968 to 2004
Keenan TD; Salmon JF; Yeates D; Goldacre M
Journal of Glaucoma 2009; 18: 201-205 (IGR: 11-1)

23033 Analysis of the distribution characteristics and related factors of glaucoma in Urumchi
Zhao H; Chen X-Y; Li J; Zhao J-F; Fu J; Yang K-M
International Journal of Ophthalmology 2008; 8: 2079-2081 (IGR: 11-1)

22653 Reducing the visual burden of glaucoma in Asia: what we know and what we need to know
Congdon N
Journal of Glaucoma 2009; 18: 88-92 (IGR: 11-1)

23375 Anterior chamber depth correlated with anthropomorphic measurements: the Beijing Eye Study
Xu L; Li JJ; Xia CR; Wang YX; Jonas JB
Eye 2009; 23: 632-634 (IGR: 11-1)

23380 Ocular perfusion pressure and glaucoma: the Beijing Eye Study
Xu L; Wang YX; Jonas JB
Eye 2009; 23: 734-736 (IGR: 11-1)

23016 Congenital eye and adnexial disorders in tertiary health institutions in Abakaliki, Nigeria
Onyekonwu CG; Onyekonwu CL
International Journal of Ophthalmology 2009; 9: 14-16 (IGR: 11-1)

23356 Primary angle closure glaucoma: a descriptive study in Scottish Caucasians
Ng WS; Ang GS; Azuara-Blanco A
Clinical and Experimental Ophthalmology 2008; 36: 847-51 (IGR: 11-1)

23035 To determine prevalence of pseudo exfoliation at a tertiary eye care centre: A hospital based study
Junejo SA; Jatoi SM; Khan NA; Qureshi MA
Pakistan Journal of Medical Sciences 2008; 24: 821-826 (IGR: 11-1)

22768 Cataract-operated individuals at the Center-Western zone of Sao Paulo state: populational survey
Matai O; Schellini SA; Padovani CR
Arquivos Brasileiros de Oftalmologia 2008; 71: 52-56 (IGR: 11-1)

22633 Ocular hypertension and diabetes mellitus in the Beijing Eye Study
Xu L; Wang YX; Jonas JB; Wang YS; Wang S
Journal of Glaucoma 2009; 18: 21-25 (IGR: 11-1)

21481 Eye disease in Wesley Guild Hospital, Ilesa, Nigeria
Adeoye AO; Omotoye OJ
African Journal of Medicine and Medical Science 2007; 36: 377-380 (IGR: 10-3)

21767 Neural rim characteristics of healthy South Indians: The Chennai Glaucoma Study
Arvind H; George R; Raju P; Ve RS; Mani B; Kannan P; Vijaya L
Investigative Ophthalmology and Visual Science 2008; 49: 3457-3464 (IGR: 10-3)

21743 Corneal thickness and intraocular pressure in a nonglaucomatous Burmese population: The Meiktila Eye Study
Casson RJ; Abraham LM; Newland HS; Muecke J; Sullivan T; Selva D; Aung T
Archives of Ophthalmology 2008; 126: 981-985 (IGR: 10-3)

21499 Childhood blindness in a rural population of southern India: Prevalence and etiology
Dorairaj SK; Bandrakalli P; Shetty C; Vathsala R; Misquith D; Ritch R
Ophthalmic Epidemiology 2008; 15: 176-182 (IGR: 10-3)

21696 Anterior chamber depth in elderly Chinese: The Liwan Eye Study
He M; Huang W; Zheng Y; Alsbirk PH; Foster PJ
Ophthalmology 2008; 115: 1286-1290 (IGR: 10-3)

21507 Spectrum of ocular diseases at a military hospital in Ladakh, North India
Jha KN
Journal of Clinical and Diagnostic Research 2008; 2: 843-846 (IGR: 10-3)

21697 Associations with intraocular pressure in Latinos: The Los Angeles Latino Eye Study
Memarzadeh F; Ying-Lai M; Azen SP; Varma R; Los Angeles Latino Eye Study Group
American Journal of Ophthalmology 2008; 146: 69-76 (IGR: 10-3)

21475 Prevalence and distribution of glaucoma in central India (Glaucoma Survey - 2001)
Palimkar A; Khandekar R; Venkataraman V
Indian Journal of Ophthalmology 2008; 56: 57-62 (IGR: 10-3)

21781 The prevalence and types of glaucoma in malay people: The Singapore Malay Eye Study
Shen SY; Wong TY; Foster PJ; Loo JL; Rosman M; Loon SC; Wong WL; Saw SM; Aung T
Investigative Ophthalmology and Visual Science 2008; 49: 3846-3851 (IGR: 10-3)

21437 Burden and predictors of undetected eye disease in Mexican-Americans: The Los Angeles Latino Eye Study
Varma R; Mohanty SA; Deneen J; Wu J; Azen SP; Paz SH; Abbott L; Cisneros L; Cuestas C; Corona E
Medical care 2008; 46: 497-506 (IGR: 10-3)

21774 Prevalence of crowded optic discs in adult Chinese: The Beijing Eye Study
You QS; Xu L; Jonas JB
Graefe's Archive for Clinical and Experimental Ophthalmology 2008; 246: 1291-1293 (IGR: 10-3)

21620 Sampling survey of prevalence and cause of visual impairment in Shaanxi Province
Chu M-F; Ai H; Peng J; Wang Y; Yang X-G
International Journal of Ophthalmology 2008; 8: 1412-1415 (IGR: 10-3)

21648 Epidemiological survey of blindness in Foping of Shaanxi province
Zhang J
International Journal of Ophthalmology 2008; 8: 1416-1417 (IGR: 10-3)

21870 Central corneal thickness in a Puerto Rican population
Graeber CP; Torres MB; Shields MB
Journal of Glaucoma 2008; 17: 356-360 (IGR: 10-3)

21859 Is there an association between hypothyroidism and open-angle glaucoma in an elderly population? An epidemiologic study
Motsko SP; Jones JK
Ophthalmology 2008; 115: 1581-1584 (IGR: 10-3)

20956 Prevalence of primary angle-closure disease in an urban south Indian population and comparison with a rural population. The Chennai Glaucoma Study
Vijaya L; George R; Arvind H; Baskaran M; Ve Ramesh S; Raju P; Kumaramanickavel G; McCarty C
Ophthalmology 2008; 115: 655-660 (IGR: 10-2)

20957 Prevalence of primary open-angle glaucoma in an urban south Indian population and comparison with a rural population. The Chennai Glaucoma Study
Vijaya L; George R; Baskaran M; Arvind H; Raju P; Ramesh SV; Kumaramanickavel G; McCarty C
Ophthalmology 2008; 115: 648-654 (IGR: 10-2)

21069 The Venezuela eye evaluation study
Mitchell JP; Williams N; Martin R; Keshava P; Bynum MM; Figueroa M; Yancy A; DellaRocca R
Journal of the National Medical Association 2008; 100: 435-438 (IGR: 10-2)

21302 Prevalence of glaucoma in Sunsari district of eastern Nepal
Sah RP; Badhu BP; Pokharel PK; Thakur SKD; Das H; Panda A
Kathmandu University Medical Journal 2007; 5: 343-348 (IGR: 10-2)

20887 Central corneal thickness in adult Chinese. Association with ocular and general parameters. The Beijing Eye Study
Zhang H; Xu L; Chen C; Jonas JB
Graefe's Archive for Clinical and Experimental Ophthalmology 2008; 246: 587-592 (IGR: 10-2)

20913 Anterior chamber depth and chamber angle and their associations with ocular and general parameters: The Beijing Eye Study
Xu L; Cao WF; Wang YX; Chen CX; Jonas JB
American Journal of Ophthalmology 2008; 145: 929-936 (IGR: 10-2)

21167 Myocilin variations and familial glaucoma in Taxiarchis, a small Greek village
Wirtz MK; Konstas AGP; Samples JR; Kaltsos K; Economou A; Dimopoulos A; Georgiadou I; Petersen MB
Molecular Vision 2008; 14: 774-781 (IGR: 10-2)

21421 Intraocular pressure in an ophthalmologically normal Japanese population
Fukuoka S; Aihara M; Iwase A; Araie M
Acta Ophthalmologica 2008; 86: 434-439 (IGR: 10-2)

21004 Retinal vascular caliber, blood pressure, and cardiovascular risk factors in an Asian population: The Singapore Malay Eye Study
Sun C; Liew G; Wang JJ; Mitchell P; Saw SM; Aung T; Tai ES; Wong TY
Investigative Ophthalmology and Visual Science 2008; 49: 1784-1790 (IGR: 10-2)

20998 Caffeine consumption and the risk of primary open-angle glaucoma: A prospective cohort study
Kang JH; Willett WC; Rosner BA; Hankinson SE; Pasquale LR
Investigative Ophthalmology and Visual Science 2008; 49: 1924-1931 (IGR: 10-2)

21422 Reduction in admissions of patients with acute primary angle closure occurring in conjunction with a rise in cataract surgery in Taiwan
Hu C-C; Lin H-C; Chen C-S; Kuo N-W
Acta Ophthalmologica 2008; 86: 440-445 (IGR: 10-2)

21321 Determinants of angle closure in older Singaporeans
Lavanya R; Wong TY; Friedman DS; Aung HT; Alfred T; Gao H; Seah SK; Kashiwagi K; Foster PJ; Aung T
Archives of Ophthalmology 2008; 126: 686-691 (IGR: 10-2)

21363 Tilted optic discs: The Beijing Eye Study
You QS; Xu L; Jonas JB
Eye 2008; 22: 728-729 (IGR: 10-2)

21322 Functional health literacy in patients with glaucoma in urban settings
Juzych MS; Randhawa S; Shukairy A; Kaushal P; Gupta A; Shalauta N
Archives of Ophthalmology 2008; 126: 718-724 (IGR: 10-2)

20567 The epidemiology of age-related eye diseases in Mainland China
Zhou Q; Friedman DS; Lu H; Duan X; Liang Y; Yang X; Wang F; Wang N
Ophthalmic Epidemiology 2007; 14: 399-407 (IGR: 10-1)

20301 How significant is a family history of glaucoma? Experience from the Glaucoma Inheritance Study in Tasmania
Green CM; Kearns LS; Wu J; Barbour JM; Wilkinson RM; Ring MA; Craig JE; Wong TL; Hewitt AW; Mackey DA
Clinical and Experimental Ophthalmology 2007; 35: 793-799 (IGR: 10-1)

20338 Factors associated with undiagnosed open-angle glaucoma: the thessaloniki eye study
Topouzis F; Coleman AL; Harris A; Koskosas A; Founti P; Gong G; Yu F; Anastasopoulos E; Pappas T; Wilson MR
American Journal of Ophthalmology 2008; 145: 327-335 (IGR: 10-1)

20833 Glaucoma and mortality in the Beijing Eye Study
Xu L; Wang YX; Jonas JB
Eye 2008; 22: 434-438 (IGR: 10-1)

20006 Prevalence and causes of visual impairment in rural myanmar the Meiktila Eye Study
Casson RJ; Newland HS; Muecke J; McGovern S; Durkin S; Sullivan T; Oo TZ; Aung TH; Shein WK; Selva D
Ophthalmology 2007; 114: 2302-2308 (IGR: 9-4)

20044 Awareness of incident open-angle glaucoma in a population study: the Barbados Eye Studies
Hennis A; Wu SY; Nemesure B; Honkanen R; Leske MC; Barbados Eye Studies Group
Ophthalmology 2007; 114: 1816-1821 (IGR: 9-4)

19749 Open-angle glaucoma - An epidemiologic overview
Leske MC
Ophthalmic Epidemiology 2007; 14: 166-172 (IGR: 9-4)

19700 Prevalence of refractive error and other eye diseases in schoolchildren in the Greater Accra region of Ghana
Ntim-Amponsah CT; Ofosu-Amaah S
Journal of Pediatric Ophthalmology & Strabismus 2007; 44: 294-297 (IGR: 9-4)

20103 Prevalence of glaucoma in a South Brazilian population: Projeto Glaucoma
Sakata K; Sakata LM; Sakata VM; Santini C; Hopker LM; Bernardes R; Yabumoto C; Moreira AT
Investigative Ophthalmology and Visual Science 2007; 48: 4974-4979 (IGR: 9-4)

19981 Prevalence of open-angle glaucoma in Greece: the Thessaloniki Eye Study
Topouzis F; Wilson MR; Harris A; Anastasopoulos E; Yu F; Mavroudis L; Pappas T; Koskosas A; Coleman AL
American Journal of Ophthalmology 2007; 144: 511-519 (IGR: 9-4)

19958 The prevalence of primary angle-closure glaucoma and its causes in rural area of Shuangyang district in Changchun, Jilin province
Yuan HP; Yu H; Xiao Z; Shao ZB; Zhang XL; Yang BB; Sui H; Zhao YS
Zhonghua Yan Ke Za Zhi 2007; 43: 775-778 (IGR: 9-4)

20073 Progress in prevalence of primary angle-closure glaucoma
Zhong H; Yu M
Eye Science 2007; 23: 186-192 (IGR: 9-4)

19737 Prevalence of blindness and visual impairment in Atakunmosa West Local Government area of southwestern Nigeria
Onakpoya OH; Adeoye AO; Akinsola FB; Adegbehingbe BO
Tanzan Health Res Bull 2007; 9: 126-131 (IGR: 9-4)

20007 Risk factors for primary open-angle glaucoma in a Burmese population: the Meiktila Eye Study
Casson RJ; Gupta A; Newland HS; McGovern S; Muecke J; Selva D; Aung T
Clinical and Experimental Ophthalmology 2007; 35: 739-744 (IGR: 9-4)

19727 The Rotterdam Study: Objectives and design update
Hofman A; Breteler MMB; Van Duijn CM; Krestin GP; Pols HA; Stricker BHCh; Tiemeier H; Uitterlinden AG; Vingerling JR; Witteman JCM
European Journal of Epidemiology 2007; 22: 819-829 (IGR: 9-4)

19350 Ocular health status of rural dwellers in south-western Nigeria
Adegbehingbe BO; Majengbasan TO
Australian Journal of Rural Health 2007; 15: 269-272 (IGR: 9-3)

19427 Epidemiology investigation of eye diseases in people over 50 years old in Guangzhou, China
Liu J-M; Zhang L; Huang Z-N; Shen Y-Y; Fei W-L; Chen J-P; Xiong Z-Q
International Journal of Ophthalmology 2007; 7: 852-853 (IGR: 9-3)

19604 The British Infantile and Childhood Glaucoma (BIG) Eye Study
Papadopoulos M; Cable N; Rahi J; Khaw PT; the BIG Eye Study Investigators
Investigative Ophthalmology and Visual Science 2007; 48: 4100-4106 (IGR: 9-3)

19279 Causes of visual impairment in children: A study of 3,210 cases
Haddad MAO; Sei M; Sampaio MW; Kara-Jose N
Journal of Pediatric Ophthalmology & Strabismus 2007; 44: 232-240 (IGR: 9-3)

18095 Prevalence of glaucoma in rural Myanmar: The Meiktila Eye Study
Casson RJ; Newland HS; Muecke J; McGovern S; Abraham L; Shein WK; Selva D; Aung T
British Journal of Ophthalmology 2007; 91: 710-714 (IGR: 9-2)

18207 Blood groups and open-angle glaucoma in Tunisia
Jeddi Blouza A; Loukil I; Mhenni A; Ben Rayana C; Hmida S
Journal Fran�ais d'Ophtalmologie 2007; 30: 493-496 (IGR: 9-2)

18111 Nine-year incidence of open-angle glaucoma in the Barbados Eye Studies
Leske MC; Wu SY; Honkanen R; Nemesure B; Schachat A; Hyman L; Hennis A; Barbados Eye Studies Group
Ophthalmology 2007; 114: 1058-1064 (IGR: 9-2)

17985 Self-reported glaucoma in Canada: Findings from population-based surveys, 1994-2003
Perruccio AV; Badley EM; Trope GE
Canadian Journal of Ophthalmology 2007; 42: 219-226 (IGR: 9-2)

17472 Prevalence and causes of visual impairment and blindness in Sistan-va-Baluchestan Province, Iran: Zahedan Eye Study
Shahriari H-A; Izadi S; Rouhani M-R; Ghasemzadeh F; Maleki A-R
British Journal of Ophthalmology 2007; 91: 579-584 (IGR: 9-2)

18123 Lifetime visual disability in open-angle glaucoma and ocular hypertension
Forsman E; Kivel� T; Vesti E
Journal of Glaucoma 2007; 16: 313-319 (IGR: 9-2)

17628 The pattern of glaucoma in Menelik II hospital Addis Ababa, Ethiopia
Melka F; Alemu B
Ethiopian medical journal 2006; 44: 159-165 (IGR: 9-2)

17536 Primary-open glaucoma and myopia: A narrative review
Loyo-Berrios NI; Blustein JN
Wisconsin Medical Journal 2007; 106: 85-95 (IGR: 9-2)

17652 Neovascular glaucoma in a Nigerian African population
Ashaye AO; Adeoti CO
East African Medical Journal 2006; 83: 559-564 (IGR: 9-2)

17156 Estimation of prevalence and incidence rates and causes of blindness in Israel, 1998-2003
Avisar R; Friling R; Snir M; Avisar I; Weinberger D
Israeli Medical Association Journal 2006; 8: 880-881 (IGR: 9-1)

16838 Obesity and eye diseases
Cheung N; Wong TY
Survey of Ophthalmology 2007; 52: 180-195 (IGR: 9-1)

17182 Prevalence of glaucomas in a Black Cameroonian population
Ellong A; Mvogo CE; Bella-Hiag AL; Mouney EN; Ngosso A; Litumbe CN
Sant� 2006; 16: 83-88 (IGR: 9-1)

16810 The projected increase in glaucoma due to the aging population in Austria from 2001 to 2031: results based on data of the Salzburg-Moorfields Collaborative Glaucoma Study
Hitzl W; Bunce C; Reitsamer HA; Grabner G; Hornykewycz K
European Journal of Ophthalmology 2007; 17: 45-52 (IGR: 9-1)

16914 On the relationship between age and prevalence and/or incidence of primary open-angle glaucoma in the 'Salzburg-Moorfields Collaborative Glaucoma Study'
Hitzl W; Hornykewycz K; Grabner G; Reitsamer HA
Klinische Monatsbl�tter f�r Augenheilkunde 2007; 224: 115-119 (IGR: 9-1)

16942 The Salzburg-Moorfields Collaborative Glaucoma Study: first results of the prevalence and 5-year incidences in this prospective, population-based longitudinal study
Hitzl W; Stollinger M; Grabner G; Reitsamer HA; Hornykewycz K
Klinische Monatsbl�tter f�r Augenheilkunde 2006; 223: 970-973 (IGR: 9-1)

16896 No increased risk of developing Alzheimer disease in patients with glaucoma
Kessing LV; Lopez AG; Andersen PK; Kessing SV
Journal of Glaucoma 2007; 16: 47-51 (IGR: 9-1)

17124 Leading causes of blindness and visual impairment in the region of Eastern Herzegovina
Ceklic L; Latinovic S; Aleksic P
Medicinski Pregled 2006; 59: 15-18 (IGR: 9-1)

17195 The analysis of visual invalidity causes based on medical-court opinions
Czepita D; Zejmo M
Klinika Oczna 2005; 107: 300-303 (IGR: 9-1)

15294 Canadian Glaucoma Study: 1. Study design, baseline characteristics, and preliminary analyses
Canadian Glaucoma Study Group
Canadian Journal of Ophthalmology 2006; 41: 566-575 (IGR: 8-4)

15209 The prevalence of open-angle glaucoma among blacks and whites 73 years and older: the Salisbury Eye Evaluation Glaucoma Study
Friedman DS; Jampel HD; Munoz B; West SK
Archives of Ophthalmology 2006; 124: 1625-1630 (IGR: 8-4)

15134 Gonioscopy in adult Chinese: the Liwan Eye Study
He M; Foster PJ; Ge J; Huang W; Wang D; Friedman DS; Khaw PT
Investigative Ophthalmology and Visual Science 2006; 47: 4772-4779 (IGR: 8-4)

14997 Race, ethnicity and prevalence of primary open-angle glaucoma
Kosoko Lasaki O; Gong G; Haynatzki G; Wilson MR
Journal of the National Medical Association 2006; 98: 1626-1629 (IGR: 8-4)

15124 Variations in primary open-angle glaucoma prevalence by age, gender, and race: a Bayesian meta-analysis
Rudnicka AR; Mt-Isa S; Owen CG; Cook DG; Ashby D
Investigative Ophthalmology and Visual Science 2006; 47: 4254-4261 (IGR: 8-4)

14794 Causal models in primary open angle glaucoma
Bahrami H
Ophthalmic Epidemiology 2006; 13: 291-298 (IGR: 8-4)

14795 Causal inference in primary open angle glaucoma: Specific discussion on intraocular pressure
Bahrami H
Ophthalmic Epidemiology 2006; 13: 283-289 (IGR: 8-4)

14793 Blindness and low vision in Cape Verde Islands: Results of a national eye survey
Schemann J; Inocencio F; De Lourdes Monteiro M; Andrade J; Auzemery A; Guelfi Y
Ophthalmic Epidemiology 2006; 13: 219-226 (IGR: 8-4)

14944 Cup-to-disc ratios of Aboriginal and non-Aboriginal youths
Gerry P; Johnson K
Clinical and Experimental Optometry 2006; 89: 306-309 (IGR: 8-4)

14470 The prevalence of pseudoexfoliation syndrome in Pakistan. Hospital based study
Rao RQ; Arain TM; Ahad MA
BMC Ophthalmology 2006; 6: 27 (IGR: 8-4)

15044 Is diabetes mellitus a risk factor for open-angle glaucoma? The Rotterdam Study
de Voogd S; Ikram MK; Wolfs RC; Jansonius NM; Witteman JC; Hofman A; De Jong PT
Ophthalmology 2006; 113: 1827-1831 (IGR: 8-4)

15223 Nail-patella syndrome and its association with glaucoma: a review of eight families
Mimiwati Z; Mackey DA; Craig JE; Mackinnon JR; Rait JL; Liebelt JE; Ayala-Lugo R; Vollrath D; Richards JE
British Journal of Ophthalmology 2006; 90: 1505-1509 (IGR: 8-4)

14075 What do we know about intraocular pressure in the Togolese population?
Balo KP; Serouis AG; Djagnikpo PA; Agbo RA; Ayena DK; Agla EK; Banla M
Journal Fran�ais d'Ophtalmologie 2006; 29: 629-634 (IGR: 8-3)

14074 Prevalence of intraocular hypertension and glaucoma in a nonselected French population
Bron A; Baudouin C; Nordmann JP; Rouland JF; Thomas F; Bean K; De Clercq B; Benetos A; Solesse De Gendre A; Lefebvre S
Journal Fran�ais d'Ophtalmologie 2006; 29: 635-641 (IGR: 8-3)

14066 Prevalence and clinical characteristics of glaucoma in adult Chinese: a population-based study in Liwan District, Guangzhou
He M; Foster PJ; Ge J; Huang W; Zheng Y; Friedman DS; Lee PS; Khaw PT
Investigative Ophthalmology and Visual Science 2006; 47: 2782-2788 (IGR: 8-3)

14203 Primary angle closure glaucoma in East Asia: An overview of the Mongolia-based research programme
Nolan WP
Asian Journal of Ophthalmology 2006; 8: 6-12 (IGR: 8-3)

14105 Risk factors for open-angle glaucoma in a Japanese population: the Tajimi Study
Suzuki Y; Iwase A; Araie M; Yamamoto T; Abe H; Shirato S; Kuwayama Y; Mishima HK; Shimizu H; Tomita G
Ophthalmology 2006; 113: 1613-1617 (IGR: 8-3)

13973 Association of blood pressure status with the optic disk structure in non-glaucoma subjects: the Thessaloniki eye study
Topouzis F; Coleman AL; Harris A; Jonescu-Cuypers C; Yu F; Mavroudis L; Anastasopoulos E; Pappas T; Koskosas A; Wilson MR
American Journal of Ophthalmology 2006; 142: 60-67 (IGR: 8-3)

13967 Frequency of optic disk hemorrhages in adult chinese in rural and urban china: the Beijing eye study
Wang Y; Xu L; Hu L; Yang H; Jonas JB
American Journal of Ophthalmology 2006; 142: 241-246 (IGR: 8-3)

13766 Glaucoma in Oman: A review
Khandekarl R; Zutshi R
Journal of Glaucoma 2006; 15: 271-273 (IGR: 8-2)

13765 Prevalence of glaucoma in adults with Down's syndrome
Yokoyama T; Tamura H; Tsukamoto H; Yamane K; Mishima HK
Japanese Journal of Ophthalmology 2006; 50: 274-276 (IGR: 8-2)

13518 Associations between elevated intraocular pressure and glaucoma, use of glaucoma medications, and 5-year incident cataract: the Blue Mountains Eye Study
Chandrasekaran S; Cumming RG; Rochtchina E; Mitchell P
Ophthalmology 2006; 113: 417-424 (IGR: 8-1)

13418 Age-related eye disease, visual impairment, and survival: the Beaver Dam Eye Study
Knudtson MD; Klein BE; Klein R
Archives of Ophthalmology 2006; 124: 243-249 (IGR: 8-1)

13456 The number of people with glaucoma worldwide in 2010 and 2020
Quigley HA; Broman AT
British Journal of Ophthalmology 2006; 90: 262-267 (IGR: 8-1)

13449 Optic disc size in a population based study in northern China: the Beijing Eye Study
Wang Y; Xu L; Zhang L; Yang H; Ma Y; Jonas JB
British Journal of Ophthalmology 2006; 90: 353-356 (IGR: 8-1)

13134 Incidence of open-angle glaucoma in a general elderly population: the Rotterdam Study
de Voogd S; Ikram MK; Wolfs RC; Jansonius NM; Hofman A; De Jong PT
Ophthalmology 2005; 112: 1487-1493 (IGR: 7-3)

13061 Can the prevalence of open-angle glaucoma be estimated from a retrospective clinical material? A study on the west coast of Iceland
Johannesson G; Gudmundsdottir GJ; Linden C
Acta Ophthalmologica Scandinavica 2005; 83: 549-553 (IGR: 7-3)

12573 Prevalence of glaucoma in the Wroclaw population. The Wroclaw epidemiological study
Nizankowska MH; Kaczmarek R
Ophthalmic Epidemiology 2005; 12: 363-371 (IGR: 7-3)

13091 A population based survey of the prevalence and types of glaucoma in rural West Bengal: the West Bengal Glaucoma Study
Raychaudhuri A; Lahiri SK; Bandyopadhyay M; Foster PJ; Reeves BC; Johnson GJ
British Journal of Ophthalmology 2005; 89: 1559-1564 (IGR: 7-3)

13017 Prevalence of open-angle glaucoma in a rural south Indian population
Vijaya L; George R; Paul PG; Baskaran M; Arvind H; Raju P; Ramesh SV; Kumaramanickavel G; McCarty C
Investigative Ophthalmology and Visual Science 2005; 46: 4461-4467 (IGR: 7-3)

13058 Intraocular pressure in northern china in an urban and rural population: the beijing eye study
Xu L; Li J; Zheng Y; Cui T; Zhu J; Ma K; Yang H; Ma B; Jonas JB
American Journal of Ophthalmology 2005; 140: 913-915 (IGR: 7-3)

13137 The Tajimi Study report 2: prevalence of primary angle closure and secondary glaucoma in a Japanese population
Yamamoto T; Iwase A; Araie M; Suzuki Y; Abe H; Shirato S; Kuwayama Y; Mishima HK; Shimizu H; Tomita G
Ophthalmology 2005; 112: 1661-1669 (IGR: 7-3)

12402 Distribution of intraocular pressure in healthy Iranian individuals: the Tehran Eye Study
Hashemi H; Kashi AH; Fotouhi A; Mohammad K
British Journal of Ophthalmology 2005; 89: 652-657 (IGR: 7-2)

12257 A comparison of participants and non-participants in the Chennai Glaucoma Study-rural population
Paul PP; George RJ; Arvind H; Raj M; Augustian; Ramesh SV; Sriram P; Kumaramanickavel G; McCarthy C; Vijaya L
Ophthalmic Epidemiology 2005; 12: 125-135 (IGR: 7-2)

12405 Glaucoma in aphakia and pseudophakia in the Chennai Glaucoma Study
Arvind H; George R; Raju P; Ramesh SV; Baskaran M; Paul PG; McCarty C; Vijaya L
British Journal of Ophthalmology 2005; 89: 699-703 (IGR: 7-2)

11832 De novo age-related retinal disease and intraocular-pressure changes during a 10-year period in a Japanese adult population
Kashiwagi K; Shibuya T; Tsukahara S
Japanese Journal of Ophthalmology 2005; 49: 36-40 (IGR: 7-1)

11849 Epidemiology for ophthalmologists: an introduction to concepts, study designs, and interpreting findings
Kuper H; Gilbert C
British Journal of Ophthalmology 2005; 89: 378-384 (IGR: 7-1)

11863 Intraocular pressure measured with a noncontact tonometer in an elderly Chinese population: the Shihpai Eye Study
Lin HY; Hsu WM; Chou P; Liu CJ; Chou JC; Tsai SY; Cheng CY
Archives of Ophthalmology 2005; 123: 381-386 (IGR: 7-1)

11889 Retinal vessel diameter and open-angle glaucoma: the Blue Mountains Eye Study
Mitchell P; Leung H; Wang JJ; Rochtchina E; Lee AJ; Wong TY; Klein R
Ophthalmology 2005; 112: 245-250 (IGR: 7-1)

11987 Causes of incident visual field loss in a general elderly population: the Rotterdam study
Skenduli-Bala E; de Voogd S; Wolfs RC; van Leeuwen R; Ikram MK; Jonas JB; Bakker D; Hofman A; De Jong PT
Archives of Ophthalmology 2005; 123: 233-238 (IGR: 7-1)

11316 Prevalence of primary open-angle glaucoma in a Spanish population: the Segovia study
Anton A; Andrada MT; Mujica V; Calle MA; Portela J; Mayo A
Journal of Glaucoma 2004; 13: 371-376 (IGR: 6-3)

11339 The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study
Iwase A; Suzuki Y; Araie M; Yamamoto T; Abe H; Shirato S; Kuwayama Y; Mishima HK; Shimizu H; Tomita G
Ophthalmology 2004; 111: 1641-1648 (IGR: 6-3)

11428 Characteristic of intraocular pressure distribution in urban and rural defined-populations
Li J; Xu L; Zhu J; Cui T; Ma K; Sun X; Yang H; Ma Y
Chinese Ophthalmic Research 2004; 22: 540-543 (IGR: 6-3)

11517 Detection level of glaucoma and ocular hypertension in Wroclaw population - Wroclaw Epidemiological Study
Nizankowska MH; Kaczmarek R; Jakubaszko J
Advances in Clinical and Experimental Medicine 2004; 13: 607-613 (IGR: 6-3)

11435 The prevalence of glaucoma in Bangladesh: a population based survey in Dhaka division
Rahman MM; Rahman N; Foster PJ; Haque Z; Zaman AU; Dineen B; Johnson GJ
British Journal of Ophthalmology 2004; 88: 1493-1497 (IGR: 6-3)

11518 The prevalence and its screening methods of primary open angle glaucoma in defined population-based study of rural and urban in Beijing
Xu L; Chen JH; Li JJ; Luo L; Yang H; Zhang RX; Sun XY; Zheng YY; Song WX; Shi YY
Chinese Journal of Ophthalmology 2004; 40: 726-732 (IGR: 6-3)

10791 Prevalence of glaucoma in an African population
Ntim-Amponsah CT; Amoaku WM; Ofosu-Amaah S; Ewusi RK; Idirisuriya-Khair R; Nyatepe-Coo E; Adu-Darko M
Eye 2004; 18: 491-7 (IGR: 6-2)

10889 Prevalence of open-angle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye Study
Varma R; Ying-Lai M; Francis BA; Nguyen BB,; Deneen J; Wilson MR; Azen SP; Los Angeles Latino Eye Study Group
Ophthalmology 2004; 111: 1439-48 (IGR: 6-2)

10066 Prevalence of open-angle glaucoma among adults in the United States
Friedman DS; Wolfs RC; O'Colmain BJ; Klein BE; Taylor HR; West S; Leske MC; Mitchell P; Congdon N; Kempen J
Archives of Ophthalmology 2004; 22: 532-538 (IGR: 6-1)

10068 Glaucoma in Ghana, West Africa: clinical features and the role of mutations in myocilin
Herndon LW; Challa P; Allingham RR
Ophthalmology Clinics of North America 2003; 16: 631-637 (IGR: 6-1)

9646 Methods and design of the Chennai glaucoma study
Arvind H; Paul PG; Raju P; Baskaran M; George R; Balu S; Sripriya S; Ve Ramesh S; Mukesh BN; Vijaya L
Ophthalmic Epidemiology 2003; 10: 337-348 (IGR: 5-3)

9648 Prevalence of glaucoma in Thailand: a population based survey in Rom Klao District, Bangkok
Bourne RR; Sukudom P; Foster PJ; Tantisevi V; Jitapunkul S; Lee PS; Johnson GJ; Rojanapongpun P
British Journal of Ophthalmology 2003; 87: 1069-1074 (IGR: 5-3)

9650 Determinants of intraocular pressure and its association with glaucomatous optic neuropathy in Chinese Singaporeans: the Tanjong Pagar Study
Foster PJ; Machin D; Wong TY; Ng TP; Kirwan JF; Johnson GJ; Khaw PT; Seah SK
Investigative Ophthalmology and Visual Science 2003; 44: 3885-3891 (IGR: 5-3)

9649 Risk factors associated with the incidence of open-angle glaucoma: the visual impairment project
Le A; Mukesh BN; McCarty CA; Taylor HR
Investigative Ophthalmology and Visual Science 2003; 44: 3783-3789 (IGR: 5-3)

9647 Longitudinal prevalence of major eye diseases
Lee PP; Feldman ZW; Ostermann J; Brown DS; Sloan FA
Archives of Ophthalmology 2003; 121: 1303-1310 (IGR: 5-3)

9652 Glaucoma prevalence may not be uniformly high in all 'black' populations
Murdoch IE; Cousens SN; Babalola OE; Yang YF; Abiose A; Jones BR
African Journal of Medicine and Medical Science 2001; 30: 337-339 (IGR: 5-3)

8896 Is there a direct association between age-related eye diseases and mortality? The Rotterdam Study
Borger PH; van Leeuwen R; Hulsman CA; Wolfs RC; Van der Kuip DA; Hofman A; De Jong PT
Ophthalmology 2003; 110: 1292-1296 (IGR: 5-2)

8897 Hypertension, diabetes, and longitudinal changes in intraocular pressure
Hennis A; Wu SY; Nemesure B; Leske MC; Barbados Eye Studies Group
Ophthalmology 2003; 110: 908-914 (IGR: 5-2)

8899 Prevalence of open-angle glaucoma in Iceland: Reykjavik Eye Study
Jonasson F; Damji KF; Arnarsson A; Sverrisson T; Wang L; Sasaki H; Sasaki K
Eye 2003; 17: 747-753 (IGR: 5-2)

8901 Does smoking affect intraocular pressure? Findings from the Blue Mountains Eye Study
Lee AJ; Rochtchina E; Wang JJ; Healey PR; Mitchell P
Journal of Glaucoma 2003; 12: 209-212 (IGR: 5-2)

8895 Relationships between age, blood pressure, and retinal vessel diameters in an older population
Leung H; Wang JJ; Rochtchina E; Tan AG; Wong TY; Klein R; Hubbard LD; Mitchell P
Investigative Ophthalmology and Visual Science 2003; 44: 2900-2904 (IGR: 5-2)

8894 Factors related to the 4-year risk of high intraocular pressure: the Barbados Eye Studies
Nemesure B; Wu SY; Hennis A; Leske MC; Barbados Eye Studies Group
Archives of Ophthalmology 2003; 121: 856-862 (IGR: 5-2)

8898 Primary open-angle glaucoma in blacks: a review
Racette L; Wilson MR; Zangwill LM; Weinreb RN; Sample PA
Survey of Ophthalmology 2003; 48: 295-313 (IGR: 5-2)

8902 Glaucoma in a rural population of southern India: The Aravind comprehensive eye survey
Ramakrishnan R; Nirmalan PK; Krishnadas R; Thulasiraj RD; Tielsch JM; Katz J; Friedman DS; Robin AL
Ophthalmology 2003; 110: 1484-1490 (IGR: 5-2)

8900 Intraocular pressure in a Somali population living in the United States
Read RW; Chen PP; Bhandari A; Mills RP; Cinciripini GS; Taylor CC
Journal of Glaucoma 2003; 12: 365-369 (IGR: 5-2)

8903 The projected increase in glaucoma due to an ageing population
Tuck MW; Crick RP
Ophthalmic and Physiological Optics 2003; 23: 175-179 (IGR: 5-2)

8361 Relationship between intraocular pressure and systemic health parameters in the Korean population
Lee JS; Choi YR; Lee JE; Choi HY; Lee SH; Oum BS
Korean Journal of Ophthalmology 2002; 16: 13-19 (IGR: 5-1)

8360 Bias in self-reported family history and relationship to glaucoma: The Blue Mountains Eye Study
Mitchell P; Rochtchina E; Lee AJ; Wang JJ
Ophthalmic Epidemiology 2002; 9: 333-345 (IGR: 5-1)

8366 Iris color and intraocular pressure: the Blue Mountains Eye Study
Mitchell R; Rochtchina E; Lee AJ; Wang JJ; Mitchell P
American Journal of Ophthalmology 2003; 135: 384-386 (IGR: 5-1)

8363 Corneal thickness and intraocular pressure in the Barbados eye studies
Nemesure B; Wu SY; Hennis A; Leske MC; Barbados Eye Study Group
Archives of Ophthalmology 2003; 121: 240-244 (IGR: 5-1)

8364 Temba glaucoma study: a population-based cross-sectional survey in urban South Africa
Rotchford AP; Kirwan JF; Muller MA; Johnson GJ; Roux P
Ophthalmology 2003; 110: 376-382 (IGR: 5-1)

8365 Refractive errors, intraocular pressure, and glaucoma in a white population
Wong TY; Klein BEK; Klein R; Knudtson MD; Lee KE
Ophthalmology 2003; 110: 211-217 (IGR: 5-1)

8219 The pattern and severity of primary glaucoma in Qatar
Al Mansouri F
Qatar Medical Journal 2002; 11: 31-35 (IGR: 4-3)

8222 Survey of glaucoma in an eye clinic in Ghana, West Africa
Herndon LW; Challa P; Ababio-Danso B; Boateng JO; Broomer B; Ridenhour P; Allingham RR
Journal of Glaucoma 2002; 11: 421-425 (IGR: 4-3)

8218 Risk factors for open angle glaucoma: a study in two rural areas of the Democratic Republic of Congo
Kaimbo wa Kaimbo D; Buntinx F; Missotten L
Archives of Public Health 2002; 60: 101-114 (IGR: 4-3)

8220 Prevalence of primary open angle glaucoma in general ophthalmic practice in the United Kingdom
Kroese M; Burton H; Vardy S; Rimmer T; McCarter D
British Journal of Ophthalmology 2002; 86: 978-980 (IGR: 4-3)

8221 Progression of visual field loss in untreated glaucoma patients and glaucoma suspects in St Lucia, West Indies
Wilson MR; Kosoko O; Cowan Jr CL; Sample PA; Johnson CA; Haynatzki G; Enger C; Crandall D
American Journal of Ophthalmology 2002; 134: 399-405 (IGR: 4-3)

3361 Relationship between age and intraocular pressure: the Blue Mountains eye study
Rochtchina E; Mitchell P; Wang JJ
Clinical and Experimental Ophthalmology 2002; 30: 173-175 (IGR: 4-2)

3696 Prevalence of glaucoma and normal intraocular pressure among adults aged 50 years or above in Shunyi county of Beijing
Zhao J; Sui R; Jia L
Chinese Journal of Ophthalmology 2002; 38: 335-339 (IGR: 4-2)

6590 Glaucoma in Zulus: a population-based cross-sectional survey in a rural district in South Africa
Rotchford AP; Johnson GJ
Archives of Ophthalmology 2002; 120: 471-478 (IGR: 4-1)

6591 Frequency of sustained glaucomatous-type visual field loss and associated optic nerve cupping in Beaver Dam, Wisconsin
Sponsel WE; Shoemaker J; Trigo Y; Mensah J; Rugwani R; Garrett B
Clinical and Experimental Ophthalmology 2001; 29: 352-358 (IGR: 4-1)

18553 Glaucoma in East Greenlandic Inuit: a population survey in Ittoqqortoormiit (Scoresbysund)
Bourne RRA; Sfrensen KE; Klauber A; Foster PJ; Johnson GJ; Alsbirk PH
Acta Ophthalmologica Scandinavica 2001; 79: 462-467 (IGR: 3-3)

18552 The Prevalence of glaucoma in a population-based study of Hispanic subjects
Quigley HA; West SK; Rodriguez J; Munoz B; Klein R; Snyder R
Annals of ophthalmology (Skokie, Ill.) 2001; 119: 1819-1826 (IGR: 3-3)

18551 Prevalence and predictors of open-angle glaucoma: results from the visual impairment project
Weih LM; Nanjan M; McCarty CA; Taylor HR
Ophthalmology 2001; 108: 1966-1972 (IGR: 3-3)

18550 Age-specific prevalence of open-angle glaucoma and its relationship to refraction among more than 60,000 asymptomatic Japanese subjects
Yoshida M; Okada E; Mizuki N; Kokaze A; Sekine Y; Onari K; Uchida Y; Harada N; Takashima Y
Journal of Clinical Epidemiology 2001; 54: 1151-1158 (IGR: 3-3)

6292 Patterns of open-angle glaucoma in the Barbados Family Study
Leske MC; Nemesure B; He Q; Wu SY; Hejtmancik JF; Hennis A
Ophthalmology 2001; 108: 1015-1022 (IGR: 3-2)

6293 Estimated prevalence and incidence of open-angle glaucoma in Japan
Nakamura H; Suzuki Y; Yamada Y; Ohara K
Japanese Journal of Clinical Ophthalmology 2001; 55: 1417-1421 (IGR: 3-2)

6294 Estimated incidence of open-angle glaucoma in Olmsted County, Minnesota
Schoff EO; Hattenhauer MG; Ing HH; Hodge DO; Kennedy RH; Herman DC; Johnson DH
Ophthalmology 2001; 108: 882-886 (IGR: 3-2)

6295 Association of demographic, familial, medical, and ocular factors with intraocular pressure
Weih LM; Mukesh BN; McCarty CA; Taylor HR
Archives of Ophthalmology 2001; 119: 875-880 (IGR: 3-2)

18897 New epidemiologic approach to intraocular pressure in an Antananarivo population
Bernardin P; Rabeantoandro H; Ratsimbazafy J; Rasikindrahona E
Journal Fran�ais d'Ophtalmologie 2001; 24: 21-28 (IGR: 3-1)

18898 The relationship between intraocular pressure and glaucoma in a defined population: data from the Egna-Neumarkt glaucoma study
Bonomi L; Marchini G; Marraffa M; Morbio R
Ophthalmologica 2001; 215: 34-38 (IGR: 3-1)

18899 Incidence of open-angle glaucoma: the Barbados Eye Studies
Leske MC; Connell AMS; Wu S-Y; Nemesure B; Li X; Schachat A; Hennis A
Archives of Ophthalmology 2001; 119: 89-95 (IGR: 3-1)

18900 Insights from incidence: the Barbados eye studies
Musch DC
Archives of Ophthalmology 2001; 119: 117-118 (IGR: 3-1)

18901 Observed versus indirect estimates of incidence of open-angle glaucoma
Wu S-Y; Nemesure B; Leske MC
American Journal of Epidemiology 2001; 153: 184-187 (IGR: 3-1)

15683 Angle-closure glaucoma in an urban population in southern India: the Andhra Pradesh eye disease study
Dandona L; Dandona R; Mandal P; Srinivas M; John RK; McCarty CA; Rao GN
Ophthalmology 2000; 107: 1710-1716 (IGR: 2-3)

15865 Open-angle glaucoma in an urban population in southern India: the Andhra Pradesh eye disease study
Dandona L; Dandona R; Srinivas M; Mandal P; John RK; McCarty CA; Rao GN
Ophthalmology 2000; 107: 1702-1709 (IGR: 2-3)

15846 Utility of predictive equations for estimating the prevalence and incidence of primary open-angle glaucoma in the UK
Minassian DC; Reidy A; Coffey M; Minassian A
British Journal of Ophthalmology 2000; 84: 1159-1161 (IGR: 2-3)

15940 Projected number of Australians with glaucoma in 2000 and 2030
Rochtchina E; Mitchell P
Clinical and Experimental Ophthalmology 2000; 28: 146-148 (IGR: 2-3)

15871 Changing views on open-angle glaucoma: definitions and prevalences: the Rotterdam Study
Wolfs RC; Borger PH; Ramrattan RS; Klaver CC; Hulsman CA; Hofman A; Vingerling JR; Hitchings RA; De Jong PT
Investigative Ophthalmology and Visual Science 2000; 41: 3309-3321 (IGR: 2-3)

5927 Epidemiology of angle-closure glaucoma: prevalence, clinical types, and association with peripheral anterior chamber depth in the Egna-Neumarket glaucoma study
Bonomi L; Marchini G; Marraffa M; Bernardi P; De Franco I; Perfetti S; Varotto A
Ophthalmology 2000; 107L 998-1003 (IGR: 2-2)

5928 The prevalence of glaucoma in Chinese residents of Singapore: a cross-sectional population survey of the Tanjong Pagar district
Foster PJ; Oen FT; Machin D; Ng TP; Devereux JG; Johnson GJ; Khaw PT; Seah SK
Archives of Ophthalmology 2000; 118: 1105-1111 (IGR: 2-2)

5929 Glaucoma patients treated by practicing ophthalmologists in Denmark: estimated number of patients and the extent of visual field defects
Lundberg LU; Thygesen J; Damgaard-Jensen L; Serup L; Kessing SV
Ugeskrift for Laeger 2000; 162: 3028-3033 (IGR: 2-2)

5548 Correlation between neuroretinal rim and optic disc areas in normal melanoderm and glaucoma patients
Balo KP; Mihluedo H; Djagnikpo PA; Akpandja MS; B�chetoille A
Journal Fran�ais d'Ophtalmologie 2000; 23:37-41 (IGR: 2-1)

5549 Prevalence of glaucoma in a rural East African population
Buhrmann RR; Quigley HA; Barron Y; West SK; Oliva MS; Mmbaga BB
Investigative Ophthalmology and Visual Science 2000; 41:40-48 (IGR: 2-1)

5550 Crete, Greece Glaucoma Study
Kozobolis VP; Detorakis ET; Tsilimbaris M; Siganos DS; Vlachonikolis IG; Pallikaris IG
Journal of Glaucoma 2000; 9: 143-149 (IGR: 2-1)

5551 The epidemiology of pediatric glaucoma: the Toronto experience
Taylor RH; Ainsworth JR; Evans AR; Levin AV
Journal of AAPOS 1999; 3:308-315 (IGR: 2-1)

15316 Optic disk size in open-angle glaucoma: the Blue Mountains Eye Study
Healy PR; Mitchell P
American Journal of Ophthalmology 1999; 128: 515-517 (IGR: 1-3)

15317 Age-related changes in intraocular pressure in a large Japanese population: a cross-sectional and longitudinal study
Nomura H; Shimokata H; Ando F; Miyake Y; Kuzuya F
Ophthalmology 1999; 106: 2016-2022 (IGR: 1-3)

15318 Refractive errors in a black adult population: the Barbados Eye Study
Wu SY; Nemesure B; Leske MC
Investigative Ophthalmology and Visual Science 1999; 40: 2179-2184 (IGR: 1-3)

5149 Epidemiology of the pseudo-exfoliation syndrome
Ringvold A
Acta Ophthalmologica Scandinavica 1999; 77: 371-375 (IGR: 1-2)

5150 Glaucoma pattern amongst the elderly Chinese in Singapore.
Sim DH; Goh LG; Ho T
Annals of the Academy of Medicine, Singapore 1998; 27: 819-823 (IGR: 1-2)

Issue 12-1

Table of Contents Editor's Selection

Change Issue